data_1k5w_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1k5w _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 34.8 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.879 0.371 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.92 -162.71 16.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.266 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -144.01 135.41 25.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.77 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.451 HG13 HG23 ' A' ' 312' ' ' VAL . 0.1 OUTLIER -124.46 128.95 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.097 0.475 . . . . 0.0 110.914 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.03 127.15 43.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.717 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.615 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.5 p90 -141.85 150.26 41.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.012 0.434 . . . . 0.0 110.341 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.62 161.67 13.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.018 -178.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.499 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 94.8 mt -133.57 143.9 48.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.15 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.407 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.0 OUTLIER -158.94 106.82 1.84 Allowed 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.972 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.493 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 25.7 t80 -100.68 137.44 39.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.986 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.61 94.76 48.38 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.529 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 8.1 Cg_exo -69.89 -33.9 15.21 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.937 2.425 . . . . 0.0 112.425 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.51 -30.19 4.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.196 0.522 . . . . 0.0 110.042 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.44 -20.29 8.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.967 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.31 48.65 6.7 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.542 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -124.58 129.8 51.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 0.0 111.792 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.418 HD13 ' HE3' ' A' ' 393' ' ' MET . 33.2 tp -95.42 147.6 23.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.805 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 7.4 m -138.48 134.52 34.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.385 0.612 . . . . 0.0 111.936 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 8.7 t -127.24 123.13 61.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.206 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 22.1 t -117.24 114.95 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.912 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.479 HG21 ' HB2' ' A' ' 339' ' ' TYR . 35.9 mm -74.59 136.95 24.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.422 HD22 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.02 -60.9 1.82 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.429 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 0.9 OUTLIER -175.61 157.42 2.05 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.488 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -117.12 151.73 36.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.773 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -148.08 153.54 39.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.612 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 60.98 23.98 14.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.872 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 50.3 mt -58.92 138.79 57.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.07 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.04 146.9 53.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.504 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.418 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 16.0 mttt -85.41 114.39 22.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.581 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.433 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 9.9 mmm -92.93 -18.81 22.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.729 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 46.7 m-20 -96.17 118.35 32.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.844 0.355 . . . . 0.0 110.635 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.15 116.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.426 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 60.05 16.57 41.14 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.334 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.59 -157.08 9.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.8 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 16.5 mt -100.82 -160.38 0.79 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 110.492 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.418 ' OG ' ' HA ' ' A' ' 301' ' ' LYS . 15.2 m -135.07 172.03 13.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.239 0.542 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.419 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 8.9 m-20 -133.69 56.36 19.89 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 309' ' ' ASP . 64.6 Cg_endo -75.39 141.71 25.86 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.044 2.496 . . . . 0.0 114.75 -177.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.539 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 17.1 p90 -139.85 165.31 27.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.424 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.451 HG23 HG13 ' A' ' 276' ' ' ILE . 42.4 t -112.81 149.98 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 360' ' ' THR . 6.6 mttm -132.02 151.92 51.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.197 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.2 mp -125.51 133.96 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.763 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.44 125.69 37.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.815 0.34 . . . . 0.0 111.181 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.4 HD22 ' CG2' ' A' ' 347' ' ' VAL . 27.5 tp -96.01 106.68 18.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.312 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.4 mtm -112.68 145.6 40.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 111.467 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.44 99.73 10.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.066 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 10.9 p30 42.83 37.45 1.08 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.386 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 104.46 28.85 5.59 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.982 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 317' ' ' MET . 0.2 OUTLIER -136.99 109.38 7.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.725 0.298 . . . . 0.0 110.885 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.13 130.84 39.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 7.6 mt -125.0 -51.66 1.67 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.202 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -130.62 153.42 48.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.037 0.446 . . . . 0.0 111.516 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 325' ' ' LYS . 0.0 OUTLIER -136.11 130.5 33.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.431 179.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 44.6 mmtt -135.44 160.38 38.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.96 0.409 . . . . 0.0 111.314 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.68 143.52 26.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.796 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.423 HG21 ' CE1' ' A' ' 343' ' ' PHE . 14.5 p -101.22 176.63 5.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.95 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 10.1 t -56.96 169.88 0.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.504 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.539 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.3 mt -112.39 120.59 62.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.948 0.404 . . . . 0.0 111.465 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.406 ' HG3' ' CG ' ' A' ' 337' ' ' PRO . 3.7 mmpt? -82.74 84.59 7.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.762 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.23 135.45 44.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.082 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.3 83.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.39 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 4.8 t -176.86 174.08 1.82 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.748 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 4.3 mt -145.06 -16.33 0.51 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.322 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.472 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 4.9 m-80 -132.9 55.63 18.19 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.863 0.364 . . . . 0.0 110.213 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 51.4 Cg_endo -88.64 167.64 6.02 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.137 2.558 . . . . 0.0 113.636 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.429 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -110.9 160.02 17.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.3 179.181 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.479 ' HB2' HG21 ' A' ' 293' ' ' ILE . 86.6 m-85 -133.45 -63.63 0.75 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 111.325 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 58.36 37.55 25.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.753 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 292' ' ' VAL . 41.9 mt-10 -91.39 142.99 27.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.808 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.94 120.08 40.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.416 . . . . 0.0 111.566 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' A' ' 328' ' ' THR . 52.2 m-85 -112.58 146.74 38.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.208 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 18.1 p -118.97 142.2 47.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 0.0 111.457 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 40.0 m-85 -129.63 165.83 20.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.517 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -116.57 79.81 1.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.512 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.425 ' O ' ' OH ' ' A' ' 282' ' ' TYR . 24.7 t -110.11 122.74 37.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.438 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 24.4 Cg_exo -62.19 147.92 94.15 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.51 2.14 . . . . 0.0 111.464 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -53.95 -24.02 15.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 111.336 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -91.64 -8.66 46.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.564 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.441 ' CB ' ' HD2' ' A' ' 348' ' ' PRO . 1.1 tt0 -106.52 -25.54 11.8 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.493 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 2.1 tp -48.68 -27.68 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 110.66 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -90.57 -23.08 20.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.107 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -95.58 -4.83 43.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 31.3 m -106.61 167.77 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.881 0.372 . . . . 0.0 111.306 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -144.49 126.49 15.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.039 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.423 HG22 ' CZ3' ' A' ' 390' ' ' TRP . 66.8 t -90.83 115.64 30.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.268 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.416 ' CG1' ' HE3' ' A' ' 375' ' ' LYS . 0.3 OUTLIER -101.29 116.83 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.755 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.618 ' HB ' HG23 ' A' ' 376' ' ' VAL . 48.3 t -97.33 108.06 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.939 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.44 ' HA ' ' HB2' ' A' ' 375' ' ' LYS . 6.5 m -110.68 133.81 53.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.027 0.442 . . . . 0.0 111.801 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 42.9 t -107.57 119.8 57.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.13 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.454 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.5 mp -121.46 148.0 45.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.978 0.418 . . . . 0.0 111.741 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.433 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 4.1 t70 -92.8 131.97 37.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.358 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -87.97 146.95 25.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.66 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.462 -179.507 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.917 0.389 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.17 151.02 44.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.431 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -95.89 109.8 22.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 0.0 111.352 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -73.34 -35.25 45.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.78 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 156.13 179.05 30.88 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.059 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.534 ' CD ' ' HG2' ' A' ' 410' ' ' GLU . 0.0 OUTLIER -160.23 142.32 12.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.363 0.601 . . . . 0.0 112.029 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.621 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -109.22 158.67 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.879 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -141.41 141.96 33.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.059 0.457 . . . . 0.0 111.721 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.791 179.896 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.754 0.311 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.47 -34.62 78.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.569 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -64.18 -35.78 81.89 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.269 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.454 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 18.8 t-160 -67.43 -53.56 28.03 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.163 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.476 ' CZ2' HD11 ' A' ' 352' ' ' ILE . 68.2 t-105 -54.99 -40.62 70.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.017 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -42.13 76.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.989 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -59.86 -34.31 72.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.638 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.499 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 8.4 ttm -60.36 -56.65 18.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.405 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.82 -29.96 67.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.472 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.55 -31.49 70.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.188 0.518 . . . . 0.0 109.942 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.3 m-80 -114.29 70.79 2.09 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.639 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.556 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 43.4 Cg_endo -69.08 35.37 0.19 Allowed 'Trans proline' 0 N--CA 1.474 0.364 0 C-N-CA 123.291 2.661 . . . . 0.0 113.642 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . 0.556 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 19.8 mmt85 -159.95 -44.35 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.955 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.91 142.17 24.68 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.57 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 58.3 Cg_endo -71.18 156.38 59.48 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.661 2.241 . . . . 0.0 112.953 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -127.74 110.26 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.664 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -103.73 144.36 31.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.844 0.354 . . . . 0.0 110.833 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.25 153.21 11.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.29 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -81.95 120.72 25.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.736 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.621 ' HB3' HG11 ' A' ' 376' ' ' VAL . 60.5 m-70 -111.28 118.37 35.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 85.0 m -78.24 116.7 18.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.946 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.453 HD23 HG21 ' A' ' 376' ' ' VAL . 95.9 mt -61.59 127.35 31.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.313 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -113.42 167.17 10.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.54 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.499 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 90.5 t -52.58 117.85 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.534 ' HG2' ' CD ' ' A' ' 375' ' ' LYS . 8.6 mt-10 -50.48 -45.79 56.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.153 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -55.34 -45.96 76.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 0.0 110.947 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.499 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 16.5 mt-10 -66.71 -38.58 87.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.414 HG13 ' HG3' ' A' ' 375' ' ' LYS . 73.4 t -58.39 -48.15 85.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.255 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.537 179.713 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.914 0.388 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 118.2 -166.08 12.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.231 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -142.86 132.53 23.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.776 0.322 . . . . 0.0 110.63 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -120.17 130.75 73.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.163 0.506 . . . . 0.0 111.03 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.84 124.7 42.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.732 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.659 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 19.1 p90 -141.96 148.22 38.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.436 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.0 OUTLIER -101.04 160.9 13.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.175 -178.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.443 HD11 ' CE1' ' A' ' 389' ' ' HIS . 9.2 mt -133.66 150.25 51.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.03 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.433 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 5.2 ttp180 -158.81 112.14 2.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.243 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.487 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 32.7 t80 -106.14 131.66 53.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.766 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.46 98.04 50.94 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.501 ' CG ' ' CB ' ' A' ' 397' ' ' PRO . 6.4 Cg_exo -71.06 -33.26 12.02 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.673 2.249 . . . . 0.0 112.67 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.2 -29.76 6.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.181 0.515 . . . . 0.0 110.058 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.81 -21.67 8.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.957 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.81 48.78 6.41 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.747 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -124.98 130.05 51.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.994 0.426 . . . . 0.0 111.68 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 30.5 tp -93.79 147.89 22.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.092 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 1.9 m -135.16 140.66 45.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.305 0.574 . . . . 0.0 112.022 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 18.2 t -134.01 120.91 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.357 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 32.3 t -116.19 116.3 51.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.012 0.434 . . . . 0.0 112.057 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.516 HG22 ' HB2' ' A' ' 339' ' ' TYR . 40.1 mm -74.96 135.69 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.424 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.7 OUTLIER -113.47 -61.89 1.67 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.411 ' OE1' ' CZ ' ' A' ' 338' ' ' TYR . 11.1 pm0 -174.16 148.16 1.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.512 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -108.38 153.63 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.006 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.84 152.49 33.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.077 0.465 . . . . 0.0 111.488 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 61.02 24.75 14.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.405 HD11 ' CB ' ' A' ' 310' ' ' PRO . 60.3 mt -59.66 139.01 57.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.222 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.68 143.77 53.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.404 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.417 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 15.9 mttp -84.61 115.18 22.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.601 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.491 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.6 mmt -90.74 -20.0 22.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.408 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 41.9 m-20 -99.81 123.79 44.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.876 0.369 . . . . 0.0 110.709 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 48.8 t -60.56 118.83 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.215 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 64.0 13.51 53.04 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.718 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.89 -144.46 6.19 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.694 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 19.9 mt -115.46 -159.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.848 0.356 . . . . 0.0 110.511 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 334' ' ' THR . 5.6 m -138.26 172.01 13.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.314 0.578 . . . . 0.0 110.92 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.96 71.5 77.9 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.405 ' CB ' HD11 ' A' ' 299' ' ' LEU . 95.3 Cg_endo -87.73 143.27 6.07 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.526 2.151 . . . . 0.0 115.351 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 9.8 p90 -139.49 167.65 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.039 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.474 HG23 HG13 ' A' ' 276' ' ' ILE . 42.7 t -118.0 149.56 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.386 0.612 . . . . 0.0 112.504 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -131.09 146.97 52.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.292 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.413 HG21 ' CZ ' ' A' ' 345' ' ' PHE . 4.6 mp -122.6 131.87 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.622 0.248 . . . . 0.0 111.089 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -130.17 134.89 47.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.93 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 26.7 tp -104.14 107.17 17.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.612 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.74 126.67 52.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.45 ' O ' ' HG3' ' A' ' 318' ' ' GLN . 0.4 OUTLIER -95.16 99.8 11.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 60.15 37.92 20.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.727 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.03 22.35 45.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.78 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt -123.85 109.56 13.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.19 130.7 39.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 6.9 mt -126.71 -42.21 1.79 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.234 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -130.6 147.69 52.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.212 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 115.61 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.954 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -124.09 166.51 15.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.48 149.51 30.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.07 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.42 HG22 ' CE1' ' A' ' 343' ' ' PHE . 21.2 p -106.11 174.05 6.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.736 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.76 174.07 0.37 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.43 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.558 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.7 mt -119.87 118.96 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.051 0.453 . . . . 0.0 111.688 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.452 ' HE2' ' CG ' ' A' ' 339' ' ' TYR . 0.0 OUTLIER -82.57 91.19 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.249 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -56.88 137.21 55.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.885 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.85 83.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.592 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 308' ' ' SER . 4.5 t -177.2 174.05 1.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.486 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 4.0 mt -146.17 -16.22 0.45 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.401 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.463 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.9 m-80 -133.97 57.18 22.97 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.486 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 59.2 Cg_endo -90.41 167.74 4.23 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.095 2.53 . . . . 0.0 113.662 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.424 ' CE2' HD23 ' A' ' 294' ' ' LEU . 1.3 t80 -105.26 160.68 14.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.201 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.516 ' HB2' HG22 ' A' ' 293' ' ' ILE . 9.3 m-85 -131.72 -65.38 0.76 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.963 0.411 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 59.11 36.85 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.946 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 293' ' ' ILE . 41.8 mt-10 -93.92 144.79 25.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.78 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 98.5 p -116.56 123.07 46.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 0.0 111.375 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . 0.42 ' CE1' HG22 ' A' ' 328' ' ' THR . 66.0 m-85 -116.35 150.61 37.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.192 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 41.8 p -121.53 143.16 49.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.119 0.485 . . . . 0.0 111.462 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.413 ' CZ ' HG21 ' A' ' 314' ' ' ILE . 48.2 m-85 -129.58 164.95 22.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.572 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.71 80.32 1.36 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.637 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.405 ' O ' ' OH ' ' A' ' 282' ' ' TYR . 71.0 t -113.09 123.77 32.88 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.117 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 351' ' ' GLN . 56.1 Cg_endo -70.69 153.4 64.66 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.491 2.127 . . . . 0.0 111.523 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -51.21 -24.14 4.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.489 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -85.42 -8.6 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.823 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.452 ' HB2' ' HD2' ' A' ' 348' ' ' PRO . 24.5 mt-30 -107.21 -36.79 6.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.653 0.264 . . . . 0.0 111.62 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.487 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 6.1 tp -46.45 -27.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.846 0.355 . . . . 0.0 111.118 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -90.77 -27.79 18.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.678 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.427 ' CG ' ' HA ' ' A' ' 351' ' ' GLN . 14.9 ptmt -109.95 15.67 22.44 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.4 ' C ' ' HG3' ' A' ' 356' ' ' GLN . 31.1 m -116.09 167.91 8.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.766 0.317 . . . . 0.0 110.64 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . 0.4 ' HG3' ' C ' ' A' ' 355' ' ' VAL . 3.0 mt-30 -140.11 138.65 35.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.0 0.429 . . . . 0.0 111.447 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.433 HG21 ' CH2' ' A' ' 390' ' ' TRP . 91.9 t -104.39 106.96 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.903 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -91.01 114.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.98 0.419 . . . . 0.0 112.033 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.613 ' HB ' HG22 ' A' ' 376' ' ' VAL . 43.9 t -98.73 108.08 21.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.637 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.402 ' CG2' ' HB3' ' A' ' 375' ' ' LYS . 3.5 m -109.27 136.11 49.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 0.0 111.995 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 47.2 t -111.1 120.25 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.913 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.438 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.6 mp -122.45 150.22 42.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.032 0.444 . . . . 0.0 111.718 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.491 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.9 t70 -96.4 131.26 43.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.586 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -83.96 146.82 27.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.535 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.323 -179.526 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 CA-C-O 120.945 0.403 . . . . 0.0 110.811 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.78 139.94 30.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -86.91 110.87 20.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.111 0.481 . . . . 0.0 110.899 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 373' ' ' ILE . 33.4 mt -80.34 -34.64 14.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.073 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.22 178.92 39.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.303 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.456 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 17.2 ptmt -162.75 141.27 8.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.179 0.514 . . . . 0.0 111.604 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.24 158.77 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.103 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -141.77 145.2 34.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.801 0.334 . . . . 0.0 111.039 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.44 HG23 ' CE3' ' A' ' 390' ' ' TRP . 20.4 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.166 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.756 0.313 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 48.6 tp -57.56 -36.62 71.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.625 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 5.1 mtp85 -60.6 -46.75 89.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.384 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.475 ' CD2' HG22 ' A' ' 401' ' ' ILE . 18.6 t-160 -61.76 -56.22 21.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.46 ' NE1' ' O ' ' A' ' 352' ' ' ILE . 63.5 t-105 -50.91 -49.64 59.17 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.153 0.501 . . . . 0.0 109.723 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.9 t -65.03 -30.39 71.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.606 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 0.6 OUTLIER -62.36 -42.32 99.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.968 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.439 ' HE1' ' CZ3' ' A' ' 390' ' ' TRP . 22.3 ttp -58.66 -55.58 33.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.68 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.8 mt -59.21 -24.63 63.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.567 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.95 77.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -126.96 74.03 76.48 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.466 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.501 ' CB ' ' CG ' ' A' ' 284' ' ' PRO . 8.4 Cg_exo -72.38 50.4 1.59 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.997 2.465 . . . . 0.0 113.032 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . 0.499 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 4.5 mmm180 -158.37 -45.69 0.06 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.178 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -94.27 158.48 35.79 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.353 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -87.56 138.71 4.63 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.012 2.475 . . . . 0.0 112.815 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.475 HG22 ' CD2' ' A' ' 389' ' ' HIS . 1.1 mm -112.14 120.16 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.587 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -112.07 145.23 40.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.758 0.313 . . . . 0.0 110.938 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -163.04 155.26 18.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 0.0 111.349 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -83.13 116.38 22.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.697 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.763 ' HB3' HG13 ' A' ' 376' ' ' VAL . 29.3 m-70 -103.81 120.75 41.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.78 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 86.9 m -78.18 116.44 18.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.226 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.418 ' CD2' HG23 ' A' ' 376' ' ' VAL . 67.3 mt -61.64 127.44 31.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.218 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -114.16 168.82 9.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.465 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 61.2 t -55.73 119.93 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.456 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 19.4 mt-10 -53.52 -42.34 67.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.756 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.58 -50.06 74.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.332 . . . . 0.0 110.613 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.465 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.1 mt-10 -64.52 -38.27 90.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.423 ' HB ' ' HD3' ' A' ' 375' ' ' LYS . 81.0 t -59.06 -49.96 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.351 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.926 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 68.6 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.983 0.421 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.09 -165.63 13.61 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.036 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -141.94 136.95 30.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.332 . . . . 0.0 110.827 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.47 HG13 HG22 ' A' ' 312' ' ' VAL . 0.1 OUTLIER -124.11 130.22 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.139 0.495 . . . . 0.0 110.919 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 294' ' ' LEU . 0.1 OUTLIER -97.2 126.23 42.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.76 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.622 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.7 p90 -142.08 151.19 42.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.331 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.1 OUTLIER -99.67 162.25 13.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.027 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.49 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 94.4 mt -134.74 144.15 47.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.085 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.423 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 9.7 ttm180 -159.13 106.55 1.79 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.966 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.471 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 28.9 t80 -101.22 137.21 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.845 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 44.9 t -122.31 97.79 44.79 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.489 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.53 -32.62 9.59 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.687 2.258 . . . . 0.0 112.612 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.04 -30.12 5.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.193 0.521 . . . . 0.0 109.919 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.52 -18.95 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.909 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 77.48 48.59 7.95 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.692 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -123.79 130.14 52.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 111.745 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.42 HD12 ' HE2' ' A' ' 393' ' ' MET . 34.8 tp -96.09 147.63 23.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.924 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 4.9 m -136.35 138.42 41.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.356 0.598 . . . . 0.0 112.045 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 17.1 t -131.95 120.97 45.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.312 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.4 ' HB ' ' OG ' ' A' ' 279' ' ' SER . 30.5 t -116.97 115.56 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.08 0.467 . . . . 0.0 111.938 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 341' ' ' GLU . 37.0 mm -74.17 136.98 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 277' ' ' CYS . 0.3 OUTLIER -112.44 -61.48 1.72 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.028 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.421 ' HB3' ' CG ' ' A' ' 338' ' ' TYR . 0.3 OUTLIER -175.71 151.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.24 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -112.48 152.66 28.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.849 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.422 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 7.8 pttt -149.07 152.64 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.478 . . . . 0.0 111.458 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 60.04 27.09 16.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.565 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.419 HD12 ' CG ' ' A' ' 310' ' ' PRO . 87.1 mt -63.97 139.21 58.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.951 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -60.59 149.61 34.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.514 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 8.4 mttp -90.03 119.32 30.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.573 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.482 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.7 mmt -92.26 -17.24 25.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.402 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 54.4 m-20 -99.66 115.77 30.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.849 0.357 . . . . 0.0 110.601 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.58 116.06 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.445 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.09 47.27 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.45 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.6 -156.89 9.35 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.704 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.9 mt -101.43 -161.05 0.83 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.837 0.351 . . . . 0.0 110.789 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.423 ' HB2' HD21 ' A' ' 335' ' ' LEU . 66.6 m -139.51 172.19 13.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.302 0.573 . . . . 0.0 111.11 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.411 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -129.73 57.49 31.02 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.419 ' CG ' HD12 ' A' ' 299' ' ' LEU . 37.5 Cg_endo -68.29 150.82 76.65 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.146 2.564 . . . . 0.0 114.688 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.541 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 53.0 p90 -154.36 156.7 37.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.249 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.47 HG22 HG13 ' A' ' 276' ' ' ILE . 36.6 t -106.73 149.8 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 360' ' ' THR . 12.1 mtmt -130.39 152.81 49.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.253 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.439 HG21 ' CZ ' ' A' ' 345' ' ' PHE . 5.4 mp -126.51 133.35 68.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.521 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 325' ' ' LYS . 13.3 m80 -129.85 127.35 40.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.143 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 22.0 tp -100.04 105.1 16.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.453 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.2 mtm -108.06 138.86 43.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.28 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.56 99.58 10.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.364 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 57.21 37.36 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.82 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 91.18 28.72 14.17 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.804 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.31 109.58 9.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.762 0.315 . . . . 0.0 110.988 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 13.3 mtm-85 -49.77 128.5 18.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.292 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 11.4 mt -123.31 -49.63 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.232 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -130.59 150.93 51.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.345 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . 0.423 ' HA ' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -134.92 132.33 38.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.678 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.443 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 14.5 mmtt -138.25 159.53 41.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.889 0.376 . . . . 0.0 111.133 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -148.15 143.38 27.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.81 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.412 HG22 ' CZ ' ' A' ' 343' ' ' PHE . 5.1 p -99.46 178.89 4.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.331 . . . . 0.0 110.689 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.2 t -59.81 162.61 5.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.264 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -106.27 122.28 59.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.884 0.373 . . . . 0.0 111.273 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -85.4 89.86 7.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.075 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -55.39 136.53 49.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.857 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 43.68 84.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.316 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 4.9 t -177.21 174.01 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.814 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 308' ' ' SER . 4.4 mt -146.42 -16.27 0.44 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.258 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.46 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.0 m-80 -132.24 57.69 31.31 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 120.72 0.295 . . . . 0.0 110.446 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 43.5 Cg_endo -92.4 167.79 2.82 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.26 2.64 . . . . 0.0 113.73 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.421 ' CG ' ' HB3' ' A' ' 295' ' ' GLU . 0.2 OUTLIER -106.99 160.81 15.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.235 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.457 ' C ' ' ND2' ' A' ' 340' ' ' ASN . 47.7 m-85 -134.84 -51.62 0.79 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.689 0.281 . . . . 0.0 111.269 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . 0.457 ' ND2' ' C ' ' A' ' 339' ' ' TYR . 1.8 p30 44.45 36.12 1.56 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.105 0.479 . . . . 0.0 110.975 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 293' ' ' ILE . 28.0 mt-10 -91.02 140.68 29.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 80.6 p -110.85 121.36 45.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.936 0.398 . . . . 0.0 111.667 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . 0.412 ' CZ ' HG22 ' A' ' 328' ' ' THR . 82.9 m-85 -111.31 156.65 21.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.01 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 56.5 m -130.91 138.65 49.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.449 . . . . 0.0 111.698 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.443 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 63.8 m-85 -127.91 165.92 19.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.604 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -115.5 79.12 1.25 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.247 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.411 ' O ' ' OH ' ' A' ' 282' ' ' TYR . 37.3 t -106.44 123.19 39.58 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.268 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 35.5 Cg_exo -60.28 150.89 77.56 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.576 2.184 . . . . 0.0 111.855 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -57.16 -23.83 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -91.53 -8.59 47.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.491 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.412 ' CB ' ' HD2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -105.2 -24.41 12.74 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.471 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 3.2 tp -53.0 -27.61 13.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 0.0 110.759 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -95.01 3.05 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.378 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -122.27 -20.78 6.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.6 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.87 167.9 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 111.483 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -139.92 126.55 20.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.291 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.424 HG21 ' CZ3' ' A' ' 390' ' ' TRP . 52.4 t -95.17 103.68 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.099 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.04 115.55 31.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.903 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.603 ' HB ' HG21 ' A' ' 376' ' ' VAL . 56.7 t -94.92 108.18 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.463 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.47 ' CG2' ' HB3' ' A' ' 375' ' ' LYS . 2.3 m -110.59 134.43 52.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 0.0 112.014 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 48.6 t -109.58 115.12 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.276 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 311' ' ' TYR . 3.9 mp -118.28 148.61 42.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 111.467 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.482 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.1 OUTLIER -98.43 125.02 43.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -72.45 144.56 48.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.875 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.071 -179.954 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.761 0.315 . . . . 0.0 110.842 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.59 149.33 25.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.3 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -98.29 111.49 23.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.409 HG21 HD12 ' A' ' 373' ' ' ILE . 32.8 mt -79.62 -33.99 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.186 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 169.01 179.2 40.92 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.08 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.471 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 15.6 ptmt -164.56 141.34 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.109 0.481 . . . . 0.0 111.794 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.624 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.67 158.81 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.29 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -138.32 140.97 39.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 111.334 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.914 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 . . . . . 0 CA--C 1.52 -0.203 0 CA-C-O 120.823 0.344 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.68 -32.56 71.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.269 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.1 OUTLIER -61.54 -41.9 98.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.203 179.513 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.455 ' CD2' HG23 ' A' ' 401' ' ' ILE . 16.5 t-160 -65.43 -58.0 6.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.619 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.452 ' CZ2' HD11 ' A' ' 352' ' ' ILE . 62.9 t-105 -49.71 -44.68 48.4 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.136 0.493 . . . . 0.0 109.927 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.21 -34.29 77.17 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.553 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.458 ' HB3' HD12 ' A' ' 401' ' ' ILE . 1.8 t0 -65.17 -36.39 84.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.49 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 14.0 ttm -61.36 -57.57 11.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.119 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.2 mt -61.05 -29.25 69.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.439 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.03 73.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.209 0.528 . . . . 0.0 109.843 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -125.46 77.74 68.52 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.374 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.533 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 5.8 Cg_exo -76.98 44.93 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.131 2.554 . . . . 0.0 113.002 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . 0.533 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 9.9 mmm180 -159.94 -46.74 0.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.908 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.414 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.0 OUTLIER -94.26 137.4 22.82 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.961 -179.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.414 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 56.6 Cg_endo -70.41 156.24 62.07 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.553 2.169 . . . . 0.0 112.747 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.458 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.26 117.13 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.971 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -108.82 144.36 36.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.716 0.293 . . . . 0.0 110.731 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -166.49 156.9 12.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.918 0.39 . . . . 0.0 111.376 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . 0.422 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 57.9 m95 -84.38 121.48 27.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.84 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.624 ' HB3' HG11 ' A' ' 376' ' ' VAL . 53.4 m-70 -110.09 122.62 48.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.405 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.6 m -78.29 118.21 20.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.423 ' CD2' HG22 ' A' ' 376' ' ' VAL . 67.3 mt -64.02 128.16 34.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.178 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -116.75 169.97 8.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.73 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.461 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 58.8 t -53.96 119.44 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.471 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 36.8 mt-10 -54.57 -43.67 72.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.993 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -56.33 -47.65 78.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 110.721 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.461 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.6 mt-10 -66.54 -38.07 86.37 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.425 ' HB ' ' HD3' ' A' ' 375' ' ' LYS . 57.4 t -60.15 -50.73 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.335 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.167 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.703 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 373' ' ' ILE . 18.3 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.815 0.341 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 119.41 -169.17 13.62 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.255 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -138.76 134.24 33.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.745 0.307 . . . . 0.0 110.818 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -125.11 130.67 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.2 0.524 . . . . 0.0 111.013 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.11 126.93 44.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.725 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.605 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.4 p90 -142.04 151.83 42.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.324 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.42 161.44 13.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.965 -178.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.486 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 83.9 mt -135.65 141.74 45.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.486 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -158.94 114.7 2.59 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.856 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.462 ' CD1' HD11 ' A' ' 352' ' ' ILE . 25.0 t80 -105.98 138.87 41.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.64 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.35 97.51 45.0 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.496 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.4 -32.0 10.68 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.552 2.168 . . . . 0.0 112.472 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.6 -29.84 7.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.229 0.538 . . . . 0.0 109.941 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.28 -17.5 8.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.052 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.72 48.44 8.83 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.587 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -123.62 130.45 52.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.441 . . . . 0.0 111.834 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 345' ' ' PHE . 28.7 tp -95.76 147.56 23.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.793 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 3.1 m -137.39 134.29 35.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.331 0.586 . . . . 0.0 112.062 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 3.3 t -127.29 123.67 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.146 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 39.7 t -118.17 115.26 47.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.062 0.458 . . . . 0.0 111.848 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.421 HG13 ' CG2' ' A' ' 328' ' ' THR . 34.2 mm -74.55 137.04 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.437 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.5 OUTLIER -113.86 -60.64 1.86 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 2.6 pt-20 -175.63 157.8 2.1 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.296 -0.561 . . . . 0.0 112.448 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -115.98 154.04 30.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.897 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.0 ptmm? -150.93 151.97 32.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.037 0.446 . . . . 0.0 111.614 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 59.58 23.95 12.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.986 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.401 ' CD1' ' CG ' ' A' ' 310' ' ' PRO . 55.2 mt -58.14 138.91 55.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.077 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -62.6 144.44 56.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.472 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.415 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 11.2 mttt -83.46 114.63 21.61 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.449 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.428 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 5.8 mmm -93.79 -17.75 22.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.739 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 45.6 m-20 -96.03 117.89 31.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.4 116.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.643 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.39 16.32 35.02 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.423 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.27 -156.26 9.19 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.938 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 8.3 mt -100.63 -160.43 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 110.305 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 334' ' ' THR . 65.3 m -135.98 171.77 13.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.231 0.539 . . . . 0.0 111.122 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.418 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 5.9 m-20 -134.47 56.5 18.36 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 309' ' ' ASP . 72.4 Cg_endo -77.27 144.72 23.5 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.886 2.39 . . . . 0.0 115.043 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 11.3 p90 -139.07 167.9 21.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.185 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.452 ' CG1' ' CG1' ' A' ' 359' ' ' VAL . 47.4 t -114.08 150.08 16.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.432 0.634 . . . . 0.0 112.663 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 360' ' ' THR . 7.0 mtmm -134.14 156.79 47.68 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.186 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.4 mp -129.96 138.44 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.707 0.289 . . . . 0.0 111.061 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -130.66 121.59 25.83 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.905 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.403 HD22 HG22 ' A' ' 347' ' ' VAL . 36.3 tp -87.96 106.78 18.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.804 0.335 . . . . 0.0 110.117 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 31.7 mtp -109.26 128.59 55.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.299 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.419 ' O ' ' HG3' ' A' ' 318' ' ' GLN . 0.3 OUTLIER -104.93 103.31 12.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.991 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 61.31 37.67 16.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.782 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 83.79 25.04 47.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.565 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -129.3 110.07 11.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 110.847 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -56.68 135.55 55.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 5.7 mt -125.01 -48.13 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.29 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.416 ' HB2' ' HE2' ' A' ' 345' ' ' PHE . 0.4 OUTLIER -130.54 147.22 52.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.961 0.41 . . . . 0.0 111.353 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.39 140.6 52.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.515 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 1.7 mmpt? -139.79 162.61 34.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 0.0 111.153 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.21 149.85 29.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.889 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.423 HG21 ' CE1' ' A' ' 343' ' ' PHE . 15.6 p -110.29 179.47 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.943 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 12.6 t -59.03 167.21 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.518 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.522 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.2 mt -110.74 122.4 65.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.928 0.394 . . . . 0.0 111.338 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -86.95 93.06 9.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.854 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -60.71 136.69 58.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.238 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 43.94 84.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.537 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 308' ' ' SER . 4.7 t -179.38 171.02 1.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.434 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 1.6 mt -140.73 -14.36 0.94 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.495 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.432 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.1 m-80 -133.53 58.52 33.93 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-O 120.692 0.282 . . . . 0.0 110.378 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 52.0 Cg_endo -90.49 167.69 4.16 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.146 2.564 . . . . 0.0 113.686 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.439 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.4 OUTLIER -109.53 160.72 16.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.329 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.427 ' CD2' ' HA ' ' A' ' 295' ' ' GLU . 63.9 m-85 -133.99 -63.43 0.73 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.826 0.346 . . . . 0.0 111.243 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 58.15 37.96 26.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 293' ' ' ILE . 31.2 mt-10 -93.3 145.51 24.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.711 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 78.0 p -116.07 121.5 42.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.927 0.394 . . . . 0.0 111.586 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' A' ' 328' ' ' THR . 70.2 m-85 -113.05 151.33 30.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.349 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 15.1 m -121.88 138.44 54.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.083 0.468 . . . . 0.0 111.546 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.444 ' HB2' ' HB3' ' A' ' 289' ' ' LEU . 34.2 m-85 -124.36 165.93 16.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.547 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.21 73.55 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.403 HG22 HD22 ' A' ' 316' ' ' LEU . 74.1 t -108.01 131.75 21.53 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.159 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.479 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 84.4 Cg_endo -82.24 154.94 16.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.778 2.319 . . . . 0.0 111.715 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -51.26 -22.71 2.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.829 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -86.42 -8.6 57.5 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.479 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -112.71 -29.86 7.28 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.596 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.49 ' O ' ' NE1' ' A' ' 390' ' ' TRP . 3.9 tp -51.14 -33.67 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.665 0.269 . . . . 0.0 111.034 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -88.47 1.48 54.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.699 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -122.73 -20.65 5.85 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 36.0 m -91.65 167.99 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.968 0.413 . . . . 0.0 111.386 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.49 127.83 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.775 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 98.9 t -86.86 104.77 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.439 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.23 109.67 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.618 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.661 ' HB ' HG22 ' A' ' 376' ' ' VAL . 43.9 t -90.53 108.02 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.788 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 375' ' ' LYS . 11.8 m -110.96 129.74 55.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 111.949 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 48.7 t -104.12 131.0 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.114 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.452 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.9 mp -129.93 145.6 51.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.925 0.393 . . . . 0.0 111.481 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.428 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 9.1 t70 -90.08 126.81 35.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -79.42 146.97 32.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.562 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.33 . . . . 0.0 111.745 -179.442 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.837 0.351 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.09 157.25 38.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.914 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -98.68 109.45 22.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.08 0.467 . . . . 0.0 111.216 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 273' ' ' LEU . 2.0 mm -71.4 -35.08 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.941 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 157.47 -174.1 34.93 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.154 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.468 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 18.2 ptmt -162.47 140.7 8.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.394 0.597 . . . . 0.0 112.058 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.661 HG22 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -113.9 158.9 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.174 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -139.54 140.57 37.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.954 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.425 ' CG1' ' CE1' ' A' ' 405' ' ' HIS . 11.5 m . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.474 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.442 0.163 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 26.2 tp -71.32 -35.64 71.3 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.369 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 7.7 ptt180 -62.85 -33.58 75.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.345 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.446 ' CD2' HG23 ' A' ' 401' ' ' ILE . 18.5 t-160 -70.27 -55.44 9.23 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.321 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.49 ' NE1' ' O ' ' A' ' 352' ' ' ILE . 58.4 t-105 -50.12 -45.13 52.68 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.092 0.472 . . . . 0.0 109.907 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.54 -33.21 73.71 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.614 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.453 ' HB3' HD13 ' A' ' 401' ' ' ILE . 0.5 OUTLIER -62.11 -39.38 92.29 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.486 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 20.1 ttm -59.18 -53.03 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.978 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.405 ' O ' ' HG3' ' A' ' 397' ' ' PRO . 2.2 mt -64.26 -30.7 71.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.244 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.68 -31.56 72.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.184 0.516 . . . . 0.0 109.668 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -125.49 77.92 68.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.337 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.549 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 5.9 Cg_exo -76.87 42.88 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.111 2.541 . . . . 0.0 113.061 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . 0.549 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 20.4 mmt180 -158.88 -47.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.093 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.436 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.1 OUTLIER -94.27 140.26 22.74 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.167 -179.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.436 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 57.9 Cg_endo -70.73 156.32 61.05 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.677 2.251 . . . . 0.0 112.885 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -127.76 115.35 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.745 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.56 144.44 33.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.808 0.337 . . . . 0.0 111.039 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.5 153.95 11.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.124 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -81.83 121.75 26.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.906 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.605 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 56.7 m-70 -111.98 117.61 33.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.551 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 89.6 m -78.44 116.46 18.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.459 HD22 HG23 ' A' ' 376' ' ' VAL . 95.0 mt -60.53 127.61 32.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.134 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -115.06 168.8 9.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.605 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.507 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 91.8 t -55.3 120.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.468 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 14.8 mt-10 -52.35 -41.13 62.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.774 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.62 -51.08 71.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.638 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.507 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 19.7 mt-10 -63.76 -38.8 92.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.409 HG23 ' HG2' ' A' ' 375' ' ' LYS . 97.5 t -57.36 -49.15 81.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.147 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.471 179.583 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 55.5 mt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.36 -166.08 15.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.247 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -142.12 130.7 22.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.497 HG13 HG21 ' A' ' 312' ' ' VAL . 0.0 OUTLIER -120.04 131.01 73.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.99 126.02 46.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.898 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.634 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.4 p90 -142.32 152.59 43.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.345 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.49 161.3 13.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.134 -178.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.484 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 95.4 mt -135.08 142.82 46.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.053 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -158.85 110.89 2.19 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.092 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.486 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 22.0 t80 -102.87 139.36 38.55 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.896 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.04 94.18 47.49 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.524 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 8.0 Cg_exo -69.86 -32.72 17.6 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.914 2.41 . . . . 0.0 112.337 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -29.79 8.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.089 0.471 . . . . 0.0 109.96 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.73 -20.22 7.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.073 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.14 48.02 6.7 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.585 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -123.08 129.87 52.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.029 0.443 . . . . 0.0 111.802 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.401 ' CD1' ' HE1' ' A' ' 393' ' ' MET . 36.6 tp -96.88 147.55 23.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.991 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 8.7 m -138.25 137.01 37.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.444 0.64 . . . . 0.0 111.993 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.7 t -129.88 124.06 57.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.238 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 24.5 t -119.69 115.43 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.094 0.473 . . . . 0.0 111.902 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 339' ' ' TYR . 44.2 mm -74.52 137.2 23.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.17 -58.64 2.12 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 16.8 pt-20 -175.74 162.1 2.65 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.537 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -119.06 152.41 36.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.647 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.42 ' HD2' ' CH2' ' A' ' 404' ' ' TRP . 0.4 OUTLIER -150.65 150.19 30.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.124 0.488 . . . . 0.0 111.572 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 61.61 24.02 14.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.996 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.4 ' CD1' ' CG ' ' A' ' 310' ' ' PRO . 53.4 mt -57.7 138.31 55.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 110.796 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.54 129.35 39.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.475 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.441 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 14.9 mttt -63.44 112.11 2.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.279 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.503 ' SD ' ' HB2' ' A' ' 371' ' ' ASP . 0.2 OUTLIER -85.06 -19.85 31.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.8 -179.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 28.7 m-20 -99.34 117.2 33.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.652 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 23.8 t -50.06 116.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.268 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 63.93 14.12 54.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.428 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -129.03 -159.88 10.09 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.677 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.1 mt -98.13 -162.87 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.792 0.33 . . . . 0.0 110.66 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.441 ' OG ' ' HA ' ' A' ' 301' ' ' LYS . 13.0 m -135.69 172.02 13.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.38 0.609 . . . . 0.0 111.205 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.422 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -134.16 56.18 17.96 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.829 178.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 363' ' ' ASP . 66.7 Cg_endo -75.58 142.66 26.43 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.114 2.542 . . . . 0.0 115.034 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.597 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 7.1 p90 -140.57 168.17 20.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.006 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.497 HG21 HG13 ' A' ' 276' ' ' ILE . 41.3 t -117.02 149.83 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.403 ' CE ' HD11 ' A' ' 362' ' ' LEU . 9.2 mttm -130.7 160.19 35.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.316 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.404 HG22 ' CZ ' ' A' ' 345' ' ' PHE . 5.3 mp -128.82 136.42 59.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.526 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 79.1 m80 -130.83 130.84 44.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.884 0.373 . . . . 0.0 110.987 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 324' ' ' LYS . 41.1 tp -108.94 108.12 18.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.376 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' MET . . . . . 0.456 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 3.4 mtm -117.79 134.55 54.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.438 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.4 ' NE2' ' CG ' ' A' ' 351' ' ' GLN . 0.0 OUTLIER -95.4 99.62 11.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.414 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 59.44 37.69 22.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.08 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 92.73 17.15 45.86 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.181 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 317' ' ' MET . 10.6 mmmm -120.33 109.06 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.841 0.32 . . . . 0.0 110.805 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.39 132.02 38.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.615 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 5.0 mt -125.89 -50.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.85 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 12.1 mmtm -130.7 146.04 52.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.959 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . 0.425 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -143.5 116.4 8.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.613 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -118.87 168.58 10.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.966 0.412 . . . . 0.0 111.291 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -148.71 145.27 27.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.836 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 14.4 p -102.15 173.76 6.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.829 0.347 . . . . 0.0 110.924 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 6.3 t -54.68 175.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.675 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.597 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -118.5 124.08 72.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 111.432 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.73 87.08 7.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.981 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -54.93 136.21 47.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.96 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 44.81 84.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.401 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 4.9 t -178.02 173.66 1.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.784 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 3.8 mt -144.94 -15.94 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.373 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.418 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.32 57.61 30.61 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.843 0.354 . . . . 0.0 110.106 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 66.3 Cg_endo -86.27 167.62 9.13 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.133 2.555 . . . . 0.0 113.891 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.512 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 50.7 t80 -112.48 155.48 24.19 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.95 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.451 ' HB2' HG23 ' A' ' 293' ' ' ILE . 76.0 m-85 -133.2 -71.61 0.52 Allowed 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.817 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . 0.512 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 24.2 t-20 66.16 37.54 5.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 293' ' ' ILE . 38.4 mt-10 -91.15 142.27 27.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.52 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 94.5 p -112.63 121.7 45.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.023 0.439 . . . . 0.0 111.757 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -113.85 148.53 36.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.014 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 52.1 p -122.99 140.47 52.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.043 0.449 . . . . 0.0 111.532 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.404 ' CZ ' HG22 ' A' ' 314' ' ' ILE . 72.1 m-85 -129.51 165.85 20.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.493 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -115.78 80.67 1.48 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.416 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.421 ' O ' ' OH ' ' A' ' 282' ' ' TYR . 33.3 t -108.19 122.81 39.43 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.287 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 27.7 Cg_exo -60.84 149.43 88.29 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.578 2.185 . . . . 0.0 111.8 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -55.2 -23.91 24.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.138 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -91.48 -8.7 46.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.522 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.431 ' CB ' ' HD2' ' A' ' 348' ' ' PRO . 0.2 OUTLIER -105.53 -25.93 12.11 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.486 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 3.1 tp -50.15 -25.66 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.727 0.299 . . . . 0.0 110.874 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -93.45 -17.06 23.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.359 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -102.6 -17.28 15.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.635 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 30.9 m -89.47 168.04 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.827 0.346 . . . . 0.0 111.17 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -142.99 126.36 16.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.282 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.432 HG23 ' CH2' ' A' ' 390' ' ' TRP . 74.2 t -92.16 101.37 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.036 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.408 ' CG1' ' HE2' ' A' ' 375' ' ' LYS . 0.7 OUTLIER -89.18 112.04 23.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.863 -178.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.628 ' HB ' HG21 ' A' ' 376' ' ' VAL . 16.2 t -95.57 107.86 20.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 8.7 m -108.31 142.95 37.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 111.697 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 60.3 t -118.5 115.77 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.203 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.465 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.7 mp -119.42 149.91 41.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 111.191 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.467 ' HB3' ' SD ' ' A' ' 302' ' ' MET . 0.1 OUTLIER -97.88 131.64 44.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.699 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -80.98 140.84 34.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.683 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.314 -179.666 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.728 0.299 . . . . 0.0 110.533 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . 0.503 ' HB2' ' SD ' ' A' ' 302' ' ' MET . 0.0 OUTLIER -98.01 142.45 29.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.967 0.413 . . . . 0.0 110.685 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -82.65 122.51 28.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.26 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.44 HD11 HG23 ' A' ' 373' ' ' ILE . 13.0 mt -82.43 -30.08 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.787 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 169.41 -179.3 42.05 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.74 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.482 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 17.7 ptmt -164.61 140.93 6.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 111.934 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.788 HG12 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.37 158.6 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.098 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -143.26 144.37 32.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.849 0.357 . . . . 0.0 111.055 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.214 -179.939 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.822 0.344 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 21.3 tp -62.21 -28.19 69.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.549 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -69.06 -32.44 71.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.382 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.454 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 20.8 t-160 -78.88 -51.27 9.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.687 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.448 ' CZ2' HD11 ' A' ' 352' ' ' ILE . 63.4 t-105 -51.84 -46.9 64.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.042 0.449 . . . . 0.0 110.051 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -33.61 76.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.607 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.458 ' HB3' HD13 ' A' ' 401' ' ' ILE . 0.8 OUTLIER -62.48 -38.33 89.42 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.484 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 11.5 ttm -61.35 -52.61 63.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.067 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.88 -35.88 79.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.407 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.85 -29.64 70.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.205 0.526 . . . . 0.0 109.851 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.425 ' C ' ' H ' ' A' ' 398' ' ' ARG . 11.3 m-80 -114.79 71.91 2.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.537 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.536 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 48.2 Cg_endo -70.42 32.9 0.21 Allowed 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.219 2.613 . . . . 0.0 113.552 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . 0.536 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 3.1 mmm180 -159.08 -46.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.013 0.435 . . . . 0.0 110.981 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.469 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 17.2 ttp180 -94.03 134.92 25.24 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.352 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.469 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 39.5 Cg_endo -66.41 156.35 65.68 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.7 2.266 . . . . 0.0 112.84 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.458 HD13 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -126.14 115.93 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.651 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.63 144.38 32.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.791 0.329 . . . . 0.0 110.853 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -166.6 152.1 8.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.16 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . 0.42 ' CH2' ' HD2' ' A' ' 297' ' ' LYS . 61.2 m95 -80.34 118.1 21.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.885 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.788 ' HB3' HG12 ' A' ' 376' ' ' VAL . 28.9 m-70 -105.01 117.01 32.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.572 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.7 m -78.32 115.42 18.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.781 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.484 HD23 HG22 ' A' ' 376' ' ' VAL . 89.7 mt -60.23 127.12 30.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.359 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -112.94 171.63 7.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.582 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.466 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 59.0 t -55.8 123.36 6.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.991 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.482 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 6.8 mt-10 -55.32 -42.3 73.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.704 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.16 -50.32 73.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.79 0.329 . . . . 0.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.466 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.2 mt-10 -62.89 -39.42 94.42 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.405 HG23 ' HG2' ' A' ' 375' ' ' LYS . 89.4 t -56.08 -48.65 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.372 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.804 0.335 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 121.68 -164.54 14.8 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.185 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -143.3 130.94 21.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.812 0.339 . . . . 0.0 110.844 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -120.34 128.85 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.061 0.458 . . . . 0.0 110.804 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.91 126.53 42.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.948 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.635 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.6 p90 -142.15 150.64 41.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.267 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.3 OUTLIER -99.43 163.21 12.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.281 0.562 . . . . 0.0 112.084 -178.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.5 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 76.6 mt -133.44 144.26 49.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.213 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.421 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 7.8 ttp85 -159.19 106.82 1.79 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.82 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.495 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 27.6 t80 -98.25 139.57 33.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.481 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 287' ' ' GLY . 44.4 t -116.14 92.98 37.46 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.505 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 16.4 Cg_exo -66.03 -31.8 45.49 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.94 2.426 . . . . 0.0 112.501 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -30.96 62.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.921 0.391 . . . . 0.0 110.751 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -121.54 -12.06 8.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.717 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 74.07 45.53 25.63 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.992 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -120.03 130.06 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 111.464 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.419 HD12 ' CH2' ' A' ' 390' ' ' TRP . 33.1 tp -94.3 147.58 23.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.225 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 3.9 m -136.26 137.6 40.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.276 0.56 . . . . 0.0 111.924 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 15.1 t -131.78 121.82 48.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.369 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 20.5 t -116.9 115.14 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.967 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.494 HG23 ' HB2' ' A' ' 339' ' ' TYR . 41.6 mm -74.17 137.09 23.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.38 -58.2 2.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.456 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 0.3 OUTLIER -175.73 164.42 2.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.391 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -123.94 153.35 41.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.798 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.48 150.93 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.693 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 61.24 24.32 14.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.915 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.403 HD12 ' HG3' ' A' ' 310' ' ' PRO . 58.9 mt -58.84 138.38 57.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.079 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -61.01 142.79 56.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.492 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -82.0 118.6 23.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.539 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.49 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.5 mmt -93.75 -18.93 21.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.395 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 44.6 m-20 -99.65 117.04 33.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.911 0.386 . . . . 0.0 110.745 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.01 116.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.438 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 61.33 15.41 45.16 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.354 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.34 -156.46 9.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.8 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.7 mt -100.78 -161.18 0.84 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.847 0.356 . . . . 0.0 110.741 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.422 ' HB2' HD22 ' A' ' 335' ' ' LEU . 58.5 m -138.15 172.13 13.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.313 0.577 . . . . 0.0 111.066 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -131.77 57.73 32.5 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.403 ' HG3' HD12 ' A' ' 299' ' ' LEU . 60.3 Cg_endo -74.33 143.2 31.18 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.987 2.458 . . . . 0.0 114.707 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.52 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 31.6 p90 -143.71 162.16 36.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.363 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.439 HG13 ' CG1' ' A' ' 359' ' ' VAL . 39.7 t -109.37 149.9 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.425 0.631 . . . . 0.0 112.461 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 360' ' ' THR . 10.5 mtmt -132.38 134.81 45.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.388 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 4.7 mp -101.43 145.4 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.802 0.334 . . . . 0.0 110.65 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . 0.45 ' CD2' ' CG ' ' A' ' 325' ' ' LYS . 0.5 OUTLIER -135.43 133.9 39.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.069 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.0 tp -117.95 109.18 16.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.514 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 0.0 OUTLIER -117.31 148.01 42.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.395 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -105.74 99.63 9.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.294 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 59.51 38.15 22.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.082 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.8 10.75 57.45 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.226 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 317' ' ' MET . 4.5 mmtt -117.61 109.33 16.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.878 0.339 . . . . 0.0 110.849 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.66 136.92 54.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.294 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 1.7 mt -128.71 -45.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.117 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 148.8 52.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.287 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . 0.45 ' CG ' ' CD2' ' A' ' 315' ' ' HIS . 0.5 OUTLIER -142.51 125.61 16.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.456 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.03 165.44 17.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.976 0.417 . . . . 0.0 111.248 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -146.16 142.0 28.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.538 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.404 ' CG2' HG13 ' A' ' 293' ' ' ILE . 5.8 p -98.57 -179.63 4.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.868 0.366 . . . . 0.0 111.026 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.4 p -60.02 159.41 9.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.537 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.52 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.2 mt -102.71 122.12 54.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.894 0.378 . . . . 0.0 111.38 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.421 ' HE3' ' CD1' ' A' ' 339' ' ' TYR . 2.3 mmtt -87.4 92.14 8.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.956 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -61.47 136.83 58.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.168 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.76 82.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.464 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.7 t -175.92 174.37 2.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.791 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 308' ' ' SER . 4.5 mt -144.95 -16.86 0.51 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.264 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.415 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.5 m-80 -132.54 58.87 39.4 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 60.3 Cg_endo -88.26 167.6 6.51 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.174 2.582 . . . . 0.0 113.867 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 12.6 t80 -107.39 158.03 17.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.907 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.494 ' HB2' HG23 ' A' ' 293' ' ' ILE . 63.7 m-85 -132.37 -71.73 0.53 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.88 0.372 . . . . 0.0 111.28 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . 0.471 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 9.6 t-20 63.87 34.98 11.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.019 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 293' ' ' ILE . 37.9 mt-10 -91.15 140.39 29.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.718 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.2 m -111.21 121.32 44.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.97 0.414 . . . . 0.0 111.66 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -113.34 148.34 35.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.101 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 23.9 m -127.02 138.21 53.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.028 0.442 . . . . 0.0 111.533 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -127.06 165.82 18.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.596 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -110.44 77.14 1.02 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.719 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.422 ' O ' ' OH ' ' A' ' 282' ' ' TYR . 40.5 t -108.04 114.17 60.09 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.983 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.443 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 32.9 Cg_endo -65.49 157.43 58.26 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.338 2.026 . . . . 0.0 111.395 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -51.42 -25.24 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.482 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -85.23 -11.55 54.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.576 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.443 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.6 OUTLIER -102.08 -36.38 8.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.575 0.226 . . . . 0.0 111.187 -179.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.495 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 4.9 tp -50.81 -28.61 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.32 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -95.0 0.82 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.677 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -125.64 -13.83 6.4 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 26.5 m -94.09 166.84 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 111.271 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -143.2 126.38 16.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.426 HG22 ' CZ3' ' A' ' 390' ' ' TRP . 85.9 t -89.09 115.61 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.205 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 315' ' ' HIS . 0.2 OUTLIER -101.54 109.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.584 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.613 ' HB ' HG21 ' A' ' 376' ' ' VAL . 42.9 t -93.69 107.84 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 313' ' ' LYS . 3.6 m -110.74 134.21 52.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.964 0.412 . . . . 0.0 111.587 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 40.9 t -108.19 117.22 53.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.223 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.442 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.4 mp -120.63 148.16 44.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.013 0.435 . . . . 0.0 111.604 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.49 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -96.01 131.95 41.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.46 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 365' ' ' ASP . 8.5 t80 -87.04 142.63 27.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.736 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . 0.448 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 22.9 m-20 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.639 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.829 0.347 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -98.94 139.82 34.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.013 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -87.15 110.84 20.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.176 0.513 . . . . 0.0 110.852 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 37.3 mt -79.83 -34.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.285 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 168.71 -178.51 42.09 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.746 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.458 ' CG ' ' HG2' ' A' ' 410' ' ' GLU . 11.0 ptmt -164.83 140.74 5.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.336 0.589 . . . . 0.0 112.275 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.703 HG12 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.81 159.15 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.746 178.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -146.44 131.99 18.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 0.0 111.756 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 26.5 m . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.787 179.797 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.693 0.282 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 39.5 tp -72.24 -36.09 68.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 0.0 110.298 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 9.8 ptt180 -62.45 -32.04 72.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.235 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.473 ' CE1' ' HG ' ' A' ' 280' ' ' LEU . 17.7 t-160 -74.26 -52.08 13.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.42 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.451 ' CZ3' ' HE3' ' A' ' 393' ' ' MET . 70.0 t-105 -54.91 -45.28 74.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.53 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -37.86 84.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 13.0 t0 -61.2 -35.64 77.72 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.5 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 10.9 ttm -59.68 -52.82 63.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.174 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.424 HD23 ' CG2' ' A' ' 352' ' ' ILE . 2.3 mt -61.75 -25.83 67.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.964 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -76.72 -44.77 32.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.255 0.55 . . . . 0.0 109.594 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.411 ' HB2' HD12 ' A' ' 401' ' ' ILE . 21.9 m-80 -119.33 64.39 7.6 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.489 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.505 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 5.0 Cg_endo -45.67 -80.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.498 2.799 . . . . 0.0 113.23 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.51 -17.56 2.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.79 116.72 66.83 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.818 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.5 136.83 78.28 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.472 2.115 . . . . 0.0 112.691 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.47 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.2 mm -116.75 107.38 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.327 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.81 143.62 36.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.858 0.361 . . . . 0.0 110.829 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.52 152.33 10.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.321 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -79.13 116.31 19.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.582 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.703 ' HB3' HG12 ' A' ' 376' ' ' VAL . 33.5 m-70 -102.87 119.88 39.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.685 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 74.4 m -78.33 116.01 18.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.4 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.422 HD22 HG22 ' A' ' 376' ' ' VAL . 93.4 mt -62.38 127.78 32.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.252 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -115.88 172.57 7.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.454 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 41.3 t -56.18 121.82 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.002 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.458 ' HG2' ' CG ' ' A' ' 375' ' ' LYS . 12.2 mt-10 -54.23 -43.65 71.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.101 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.5 -50.4 73.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.886 0.374 . . . . 0.0 110.795 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.454 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.4 mt-10 -63.38 -37.8 88.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.42 HG21 ' HG2' ' A' ' 375' ' ' LYS . 99.6 t -57.61 -48.09 83.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.715 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 62.5 mt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.919 0.39 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.63 -163.2 16.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.255 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -143.44 135.87 27.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.71 0.291 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -123.63 129.43 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.057 0.456 . . . . 0.0 110.822 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -97.35 124.96 41.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.017 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.606 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 20.3 p90 -142.26 149.73 39.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.802 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.738 ' OG ' ' HB ' ' A' ' 292' ' ' VAL . 16.1 p -110.83 168.0 9.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.197 0.522 . . . . 0.0 111.892 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.414 HD12 ' CE1' ' A' ' 389' ' ' HIS . 1.2 mt -137.67 160.09 40.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.78 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.51 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.9 OUTLIER -159.14 102.47 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.767 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.472 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 39.7 t80 -100.14 130.82 46.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.944 0.402 . . . . 0.0 111.878 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.48 97.82 51.16 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.508 ' CG ' ' CB ' ' A' ' 397' ' ' PRO . 6.0 Cg_exo -71.13 -29.93 16.88 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.643 2.229 . . . . 0.0 112.299 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -30.56 11.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.187 0.518 . . . . 0.0 109.774 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.76 -20.83 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.822 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.44 47.17 7.01 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.908 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -123.98 129.66 51.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 111.482 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 33.5 tp -96.36 147.63 23.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.26 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 6.0 m -135.28 137.24 42.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.287 0.565 . . . . 0.0 112.003 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.8 t -130.33 123.07 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.412 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.738 ' HB ' ' OG ' ' A' ' 279' ' ' SER . 5.0 t -118.54 116.32 50.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.664 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 341' ' ' GLU . 44.1 mm -75.65 137.15 23.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.16 -57.94 2.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -175.54 162.43 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.422 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -122.33 154.81 37.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.933 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.404 ' HD3' ' CZ3' ' A' ' 404' ' ' TRP . 4.0 ptmt -150.79 150.4 30.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 111.519 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 59.62 25.54 14.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.421 HD12 ' CG ' ' A' ' 310' ' ' PRO . 89.3 mt -61.43 138.95 58.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.813 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -58.25 151.48 19.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.546 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 13.7 mttp -91.46 118.13 30.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.547 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.519 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.6 mmt -91.48 -18.57 23.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.341 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 30.6 m-20 -104.46 98.18 7.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.729 0.3 . . . . 0.0 110.408 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.22 114.73 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 111.44 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.95 -3.52 84.68 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.681 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -129.36 -143.17 5.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.87 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 34.6 mt -113.63 -159.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.909 0.385 . . . . 0.0 110.842 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 334' ' ' THR . 74.2 m -134.74 172.24 13.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.307 0.575 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.405 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -129.13 58.07 34.59 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.421 ' CG ' HD12 ' A' ' 299' ' ' LEU . 47.6 Cg_endo -70.15 150.64 66.13 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.13 2.554 . . . . 0.0 114.974 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.528 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 51.4 p90 -153.51 156.54 38.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.169 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.441 HG12 ' CG1' ' A' ' 359' ' ' VAL . 42.7 t -107.6 149.97 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 360' ' ' THR . 12.8 mtmt -131.09 139.21 49.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.313 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.415 HG22 ' CZ ' ' A' ' 345' ' ' PHE . 5.2 mp -114.77 130.31 69.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.296 . . . . 0.0 110.963 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -126.17 136.76 53.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 0.0 111.042 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 21.8 tp -105.51 105.25 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.594 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 1.4 mtm -107.69 144.18 35.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.38 99.68 9.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.572 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 57.68 35.48 25.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.352 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 100.56 11.77 40.18 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.753 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.439 ' HG3' HD22 ' A' ' 323' ' ' LEU . 0.1 OUTLIER -125.01 110.73 14.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.377 0.589 . . . . 0.0 110.921 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.82 137.85 37.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.688 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.439 HD22 ' HG3' ' A' ' 321' ' ' LYS . 5.8 mt -126.8 -43.16 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.079 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.46 151.57 50.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.34 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.0 133.68 41.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.836 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -136.35 160.25 39.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.032 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -147.8 144.22 28.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.825 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 18.0 p -103.78 174.0 6.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.695 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.2 t -55.02 162.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.682 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.528 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.0 mt -108.8 128.55 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.949 0.404 . . . . 0.0 111.245 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 337' ' ' PRO . 2.1 mmtt -94.99 93.14 7.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.46 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -57.79 137.38 56.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.693 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.79 83.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.401 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 308' ' ' SER . 4.9 t -175.87 173.33 2.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.685 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 308' ' ' SER . 4.1 mt -146.9 -15.97 0.41 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.264 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -131.48 60.26 51.14 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.86 0.362 . . . . 0.0 110.08 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.428 ' HB2' ' HG3' ' A' ' 331' ' ' LYS . 73.5 Cg_endo -86.79 167.59 8.4 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.081 2.521 . . . . 0.0 114.106 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.464 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 74.0 t80 -119.95 149.46 42.08 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.605 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.409 ' HB2' HG22 ' A' ' 293' ' ' ILE . 32.9 m-85 -132.46 -67.73 0.64 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.909 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . 0.464 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 11.6 t-20 67.85 36.53 3.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.688 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 293' ' ' ILE . 46.3 mt-10 -91.04 135.0 34.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.4 m -104.72 121.69 44.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.836 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -109.08 164.72 12.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.891 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 18.3 m -134.7 142.65 46.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.05 0.452 . . . . 0.0 111.73 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.415 ' CZ ' HG22 ' A' ' 314' ' ' ILE . 50.3 m-85 -132.14 162.1 31.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -112.5 77.69 1.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.562 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.444 ' O ' ' OH ' ' A' ' 282' ' ' TYR . 38.3 t -105.26 122.13 43.98 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.323 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 27.1 Cg_exo -60.85 146.66 97.18 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.571 2.181 . . . . 0.0 111.564 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 284' ' ' PRO . 11.3 t80 -54.08 -23.74 14.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 111.243 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 15.1 pm0 -91.5 -8.59 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.372 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.432 ' CB ' ' HD2' ' A' ' 348' ' ' PRO . 0.1 OUTLIER -104.45 -24.58 13.03 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.496 HD11 ' CZ2' ' A' ' 390' ' ' TRP . 1.7 tp -52.4 -32.59 16.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.879 0.371 . . . . 0.0 110.547 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -87.58 3.33 47.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.338 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -124.29 -21.25 5.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.503 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 24.0 m -87.88 166.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.879 0.371 . . . . 0.0 111.285 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -143.47 126.28 16.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.778 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.433 HG21 ' CZ3' ' A' ' 390' ' ' TRP . 64.5 t -88.26 119.55 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.287 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.46 111.65 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.74 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.613 ' HB ' HG23 ' A' ' 376' ' ' VAL . 46.6 t -97.52 107.91 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.674 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 313' ' ' LYS . 3.1 m -110.59 134.41 52.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.011 0.434 . . . . 0.0 111.859 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 55.5 t -108.37 115.02 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.128 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 311' ' ' TYR . 3.8 mp -118.87 150.31 40.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 111.506 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.519 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.4 OUTLIER -97.22 129.94 44.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.638 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -78.99 146.86 33.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.652 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.542 -179.527 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.802 0.334 . . . . 0.0 110.5 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.89 153.64 40.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.522 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -100.86 111.74 24.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.616 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.461 HD11 HG21 ' A' ' 373' ' ' ILE . 25.5 mt -79.66 -33.23 14.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.317 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.13 -178.24 41.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.854 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.459 ' CG ' ' HG2' ' A' ' 410' ' ' GLU . 17.1 ptmt -164.66 140.61 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.292 0.568 . . . . 0.0 111.967 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.638 HG12 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.77 159.07 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.01 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.417 ' CE1' ' OE1' ' A' ' 386' ' ' GLU . 9.4 p90 -143.82 131.98 21.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.417 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.434 ' CG1' ' CE1' ' A' ' 405' ' ' HIS . 30.1 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.793 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.417 ' OE1' ' CE1' ' A' ' 377' ' ' PHE . 13.2 mt-10 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.749 0.309 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.0 tp -56.99 -34.44 68.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.58 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 6.0 mtt180 -61.82 -48.52 80.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.359 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.45 ' CD2' HG22 ' A' ' 401' ' ' ILE . 19.6 t-160 -60.27 -57.53 12.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.496 ' CZ2' HD11 ' A' ' 352' ' ' ILE . 65.2 t-105 -51.41 -44.96 62.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.963 0.411 . . . . 0.0 110.203 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.0 t -68.86 -34.79 76.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.932 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 4.4 t0 -62.04 -31.67 72.1 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.444 ' HA ' HG13 ' A' ' 401' ' ' ILE . 5.7 tpt -66.61 -56.42 10.78 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.74 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.3 mt -58.42 -21.45 50.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.665 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . 0.407 ' C ' ' HD3' ' A' ' 397' ' ' PRO . . . -70.39 -34.08 72.14 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -127.96 70.52 78.03 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.669 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.531 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 11.2 Cg_exo -71.59 51.65 1.52 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.101 2.534 . . . . 0.0 112.954 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . 0.531 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 4.7 mmm180 -158.99 -40.89 0.06 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.351 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.0 160.72 31.73 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.491 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -89.87 123.23 1.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.131 2.554 . . . . 0.0 112.664 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.45 HG22 ' CD2' ' A' ' 389' ' ' HIS . 1.1 mm -98.38 130.44 47.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.717 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -124.57 146.01 49.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.701 0.286 . . . . 0.0 110.809 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.29 155.78 9.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 111.411 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . 0.404 ' CZ3' ' HD3' ' A' ' 297' ' ' LYS . 54.1 m95 -83.63 123.38 29.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.776 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.638 ' HB3' HG12 ' A' ' 376' ' ' VAL . 47.5 m-70 -111.05 119.21 38.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -78.34 116.52 18.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.811 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.472 HD23 HG21 ' A' ' 376' ' ' VAL . 94.9 mt -61.89 127.66 32.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.352 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -114.97 171.59 7.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.561 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.472 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 60.5 t -54.17 120.25 2.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.459 ' HG2' ' CG ' ' A' ' 375' ' ' LYS . 10.6 mt-10 -54.57 -42.37 70.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.879 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -48.87 77.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.36 . . . . 0.0 110.74 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.472 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.5 mt-10 -64.67 -38.84 92.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.349 0.595 . . . . 0.0 109.417 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 95.2 t -58.44 -49.27 82.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.544 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.936 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 48.4 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.791 0.329 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 117.41 -168.47 12.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.225 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.11 132.42 32.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.707 0.289 . . . . 0.0 110.987 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -118.58 129.29 75.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.058 0.456 . . . . 0.0 110.964 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.52 124.87 41.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.828 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.608 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 20.5 p90 -142.3 149.67 39.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.691 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.765 ' OG ' ' HB ' ' A' ' 292' ' ' VAL . 13.2 p -109.78 160.65 16.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.233 0.54 . . . . 0.0 112.214 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.44 HD11 ' CD2' ' A' ' 389' ' ' HIS . 6.8 mt -128.69 153.82 46.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.806 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.438 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 9.8 ttp180 -159.27 107.28 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.86 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.514 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 31.3 t80 -99.04 139.48 34.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.721 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 287' ' ' GLY . 60.1 t -116.54 92.83 38.55 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 17.1 Cg_exo -65.14 -30.88 55.28 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.891 2.394 . . . . 0.0 112.322 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -31.54 63.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.732 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.84 -11.9 8.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.637 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 73.5 45.41 29.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.059 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -120.08 130.06 54.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 111.447 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.406 HD21 ' CG2' ' A' ' 357' ' ' VAL . 25.0 tp -94.34 148.02 22.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.381 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 3.6 m -136.82 134.3 36.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.254 0.55 . . . . 0.0 111.903 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.81 122.65 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.363 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.765 ' HB ' ' OG ' ' A' ' 279' ' ' SER . 4.3 t -117.68 115.48 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.758 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.479 HG22 ' HB2' ' A' ' 339' ' ' TYR . 40.8 mm -74.6 137.14 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.45 -58.3 2.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.49 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 11.4 pt-20 -175.72 163.77 2.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.665 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -125.24 149.01 48.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.677 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.425 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 17.7 pttt -146.17 153.29 40.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.104 0.478 . . . . 0.0 111.549 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 60.1 27.1 16.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.621 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.517 HD11 ' HG3' ' A' ' 310' ' ' PRO . 91.7 mt -63.36 138.55 58.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.599 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.71 136.73 53.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.689 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -69.51 123.54 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.185 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.428 ' SD ' ' HB3' ' A' ' 363' ' ' ASP . 0.1 OUTLIER -100.49 -11.58 20.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.687 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 53.1 m-20 -103.05 121.94 43.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.807 0.337 . . . . 0.0 110.284 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -47.02 115.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 111.664 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 57.37 17.27 24.55 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.405 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.97 -160.43 10.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.956 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 6.3 mt -94.84 -160.86 0.81 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.449 0.3 . . . . 0.0 110.27 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.433 ' HB2' HD21 ' A' ' 335' ' ' LEU . 67.3 m -136.68 171.86 13.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.344 0.592 . . . . 0.0 111.105 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.448 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -132.12 55.12 16.23 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.819 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.517 ' HG3' HD11 ' A' ' 299' ' ' LEU . 35.4 Cg_endo -65.97 149.94 85.85 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.168 2.578 . . . . 0.0 114.551 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.512 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 48.1 p90 -154.18 150.09 27.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.401 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.455 HG13 ' CG1' ' A' ' 359' ' ' VAL . 39.3 t -101.23 148.96 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 360' ' ' THR . 11.7 mtmt -130.33 138.54 50.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.154 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.45 HG21 ' CZ ' ' A' ' 345' ' ' PHE . 5.3 mp -115.66 131.06 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.774 0.321 . . . . 0.0 110.771 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -129.13 133.38 47.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 18.9 tp -106.06 104.97 14.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.638 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 3.5 mtm -106.57 142.79 35.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.21 99.77 9.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.48 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 58.65 38.3 25.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 92.18 22.52 29.65 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.027 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.5 mtpm? -128.86 109.3 11.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.741 0.305 . . . . 0.0 110.805 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.88 131.59 40.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.26 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 4.9 mt -126.01 -42.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.131 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -130.72 151.32 51.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.502 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 132.1 32.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.582 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 53.2 mmtt -139.34 155.27 47.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.236 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -141.31 149.47 41.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.72 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.416 HG23 ' CE1' ' A' ' 343' ' ' PHE . 21.2 p -106.17 175.51 5.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.826 0.346 . . . . 0.0 111.031 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -57.24 148.7 21.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.69 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.512 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -92.12 122.49 43.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.514 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -86.67 85.87 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.016 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.68 139.29 50.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.99 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 42.81 79.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.496 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 5.1 t -173.44 173.48 3.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.165 0.507 . . . . 0.0 110.911 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.433 HD21 ' HB2' ' A' ' 308' ' ' SER . 4.0 mt -146.19 -16.09 0.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.186 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.475 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.57 58.5 36.64 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 110.217 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 84.6 Cg_endo -90.39 167.79 4.24 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.175 2.583 . . . . 0.0 114.076 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.501 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 35.9 t80 -114.1 152.48 31.02 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.067 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.479 ' HB2' HG22 ' A' ' 293' ' ' ILE . 2.2 m-85 -130.03 -70.53 0.63 Allowed 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.921 0.391 . . . . 0.0 111.519 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . 0.501 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 24.3 t-20 66.67 35.14 5.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.714 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 293' ' ' ILE . 52.1 mt-10 -91.11 133.81 35.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.973 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.2 m -104.07 121.25 42.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.695 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . 0.416 ' CE1' HG23 ' A' ' 328' ' ' THR . 69.2 m-85 -110.08 156.5 20.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.022 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 57.9 p -130.65 140.54 50.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.088 0.47 . . . . 0.0 111.588 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.45 ' CZ ' HG21 ' A' ' 314' ' ' ILE . 62.7 m-85 -128.54 165.91 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.58 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -111.6 78.48 1.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.412 ' O ' ' OH ' ' A' ' 282' ' ' TYR . 41.4 t -111.72 117.81 47.96 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.059 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.477 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 48.3 Cg_endo -69.52 157.47 60.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.383 2.055 . . . . 0.0 111.434 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -51.3 -23.02 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -86.7 -10.23 54.19 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.477 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -107.8 -33.16 7.34 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.537 0.208 . . . . 0.0 111.544 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.514 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 5.1 tp -49.26 -27.21 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.638 0.256 . . . . 0.0 111.136 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -95.17 -9.42 33.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.842 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -113.29 -18.62 12.02 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 23.7 m -87.92 167.89 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 111.377 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -143.81 126.34 15.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.824 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.446 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 53.9 t -89.87 104.83 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.69 110.78 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.615 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.616 ' HB ' HG22 ' A' ' 376' ' ' VAL . 44.3 t -93.81 107.85 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 313' ' ' LYS . 5.2 m -111.55 131.77 55.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 0.0 111.968 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 42.5 t -105.03 119.47 54.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.163 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 311' ' ' TYR . 3.5 mp -124.73 147.61 48.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.134 0.492 . . . . 0.0 111.797 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.428 ' HB3' ' SD ' ' A' ' 302' ' ' MET . 3.4 t70 -91.13 129.87 37.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.012 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.424 ' CD2' HD12 ' A' ' 330' ' ' ILE . 21.7 t80 -79.63 141.95 36.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.232 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.496 -179.442 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.91 0.386 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -72.68 145.01 47.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.291 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -101.1 112.44 24.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.135 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 373' ' ' ILE . 12.3 mt -79.98 -33.37 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.336 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 166.35 179.21 39.57 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.945 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.421 ' HB3' ' CG2' ' A' ' 360' ' ' THR . 13.3 ptmt -161.2 140.37 10.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.24 0.543 . . . . 0.0 112.075 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.616 HG22 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -111.84 159.06 12.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.21 179.324 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -142.98 135.17 27.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 0.0 111.546 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.408 ' CG1' ' CE1' ' A' ' 405' ' ' HIS . 18.8 m . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.986 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.527 0.203 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.02 -32.42 69.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.571 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 31.7 mtt180 -63.55 -50.88 67.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.619 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.46 ' CD2' HG22 ' A' ' 401' ' ' ILE . 16.2 t-160 -56.82 -54.14 49.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.448 ' CZ2' HD13 ' A' ' 352' ' ' ILE . 61.1 t-105 -54.06 -50.67 66.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.091 0.472 . . . . 0.0 110.335 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.4 t -63.69 -34.94 78.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.345 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 8.2 t0 -62.74 -36.57 83.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.047 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.434 ' HE3' ' CZ3' ' A' ' 390' ' ' TRP . 31.2 ttp -62.96 -55.32 26.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.724 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.401 HD23 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -57.52 -24.68 57.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.662 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -79.94 -37.75 33.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.299 0.571 . . . . 0.0 109.526 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 399' ' ' ARG . 13.6 m-80 -126.82 60.99 43.61 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.646 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.512 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 3.9 Cg_endo -45.11 -79.32 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.791 2.994 . . . . 0.0 113.266 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -48.51 -21.8 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.126 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.469 ' HB3' ' HB3' ' A' ' 396' ' ' ASN . 1.1 tpt180 -93.73 126.71 48.59 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.826 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.34 131.39 21.72 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.46 2.106 . . . . 0.0 112.547 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.46 HG22 ' CD2' ' A' ' 389' ' ' HIS . 1.1 mm -110.46 112.06 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.093 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -108.95 145.65 35.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.687 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.95 152.7 6.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.927 0.394 . . . . 0.0 111.322 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . 0.425 ' CH2' ' HG3' ' A' ' 295' ' ' GLU . 64.2 m95 -80.89 118.74 22.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.823 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.608 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 46.3 m-70 -107.17 119.77 40.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 86.6 m -78.29 116.26 18.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.091 0.472 . . . . 0.0 110.961 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.488 HD22 HG23 ' A' ' 376' ' ' VAL . 94.9 mt -61.75 127.55 31.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.28 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -114.42 171.9 7.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.491 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.473 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 57.1 t -54.58 115.65 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.408 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 3.6 mp0 -52.05 -41.16 62.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.803 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -57.21 -48.91 77.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 110.622 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.473 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 24.4 mt-10 -65.04 -39.91 94.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 70.5 t -59.5 -49.54 83.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.158 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.741 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 44.6 mt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.896 0.379 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.12 -159.63 16.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.192 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -148.17 131.12 16.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.787 0.327 . . . . 0.0 110.56 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.466 HG13 HG23 ' A' ' 312' ' ' VAL . 0.0 OUTLIER -120.63 130.14 74.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 110.935 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.21 126.22 42.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.736 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.619 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.5 p90 -141.94 149.33 39.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.321 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.75 159.37 15.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.045 -178.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.486 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 85.2 mt -130.49 144.99 51.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.855 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.438 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 7.2 ttm180 -158.86 103.94 1.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.781 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.52 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 27.8 t80 -99.22 138.86 35.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.241 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.8 t -123.55 94.59 46.16 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.394 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.52 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.15 -32.57 16.71 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.927 2.418 . . . . 0.0 112.325 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.53 -29.8 7.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.176 0.512 . . . . 0.0 110.07 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.95 -21.1 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.117 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 81.06 48.03 6.26 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.538 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -123.76 129.32 50.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.058 0.456 . . . . 0.0 111.626 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 345' ' ' PHE . 33.7 tp -96.08 147.74 23.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.9 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 2.6 m -136.05 135.99 39.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.319 0.58 . . . . 0.0 111.998 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.43 118.19 44.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.12 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 23.1 t -113.92 115.74 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.058 0.456 . . . . 0.0 111.961 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 341' ' ' GLU . 34.2 mm -74.75 137.02 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 339' ' ' TYR . 0.4 OUTLIER -113.49 -60.34 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.423 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 4.9 pt-20 -175.73 155.89 1.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.357 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -112.03 153.3 27.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.724 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -150.95 150.71 31.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.148 0.499 . . . . 0.0 111.614 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 61.38 22.74 13.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.005 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 52.0 mt -57.8 138.46 55.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.109 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -64.09 149.88 46.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.502 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.416 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 11.1 mttt -88.32 116.22 26.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.54 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.4 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 9.0 mmm -95.93 -19.98 19.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.486 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 48.6 m-20 -91.91 121.57 33.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.543 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -48.35 115.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.648 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 56.17 18.56 20.81 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.304 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.42 -157.74 9.75 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.005 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.0 mt -98.53 -161.38 0.87 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.781 0.324 . . . . 0.0 110.529 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 301' ' ' LYS . 15.1 m -134.91 171.89 13.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.246 0.546 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.414 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -135.16 56.61 16.91 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 363' ' ' ASP . 73.7 Cg_endo -77.57 143.68 21.78 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.963 2.442 . . . . 0.0 114.805 -177.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.547 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 10.6 p90 -138.8 166.94 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.242 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.466 HG23 HG13 ' A' ' 276' ' ' ILE . 24.4 t -112.73 149.96 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 360' ' ' THR . 7.0 mttm -133.97 144.05 48.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.871 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.4 mp -118.86 124.09 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 111.201 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 70.2 m80 -117.98 130.98 56.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.597 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.458 HD21 ' HG3' ' A' ' 324' ' ' LYS . 22.5 tp -102.82 104.64 14.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 0.0 OUTLIER -127.59 129.09 46.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.408 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 319' ' ' ASN . 0.0 OUTLIER -105.53 103.15 12.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 110.372 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 318' ' ' GLN . 83.2 m-20 71.15 36.43 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.199 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 82.12 21.22 61.3 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.175 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.6 mtpm? -113.34 109.07 18.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.837 0.318 . . . . 0.0 110.628 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -56.92 127.2 30.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.221 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 11.9 mt -122.7 -56.01 1.79 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.914 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.486 ' HB2' ' HE2' ' A' ' 345' ' ' PHE . 11.7 mttp -137.85 153.98 49.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.944 0.402 . . . . 0.0 111.256 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . 0.429 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -142.57 129.42 20.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.435 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -127.37 167.88 15.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 111.269 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.55 144.87 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.421 HG22 ' CE1' ' A' ' 343' ' ' PHE . 17.3 p -104.21 178.35 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 7.2 p -57.52 176.5 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.502 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.4 mt -118.21 118.39 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.97 0.414 . . . . 0.0 111.329 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.407 ' HG3' ' CG ' ' A' ' 337' ' ' PRO . 8.8 mmtt -82.95 84.86 7.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.978 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -55.96 136.86 51.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.015 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.45 82.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.294 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 308' ' ' SER . 4.9 t -176.45 173.86 2.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.725 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 4.3 mt -145.13 -16.31 0.5 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.219 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.469 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.6 m-80 -132.9 56.05 20.3 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 120.796 0.332 . . . . 0.0 110.117 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.469 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 55.8 Cg_endo -88.32 167.67 6.43 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.199 2.599 . . . . 0.0 113.79 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.423 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 1.1 t80 -107.04 160.83 15.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.327 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.435 ' HB2' HG23 ' A' ' 293' ' ' ILE . 70.9 m-85 -134.01 -64.49 0.7 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.865 0.364 . . . . 0.0 111.075 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 56.99 36.95 28.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.976 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 293' ' ' ILE . 47.5 mt-10 -92.97 142.13 27.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.778 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 12.7 m -114.0 120.56 41.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.44 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . 0.421 ' CE1' HG22 ' A' ' 328' ' ' THR . 79.4 m-85 -112.97 153.42 28.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.252 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 9.7 m -123.74 137.73 54.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.152 0.501 . . . . 0.0 111.675 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.486 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 32.2 m-85 -120.88 165.96 14.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.584 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -116.43 72.43 0.82 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.85 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.445 ' CG2' HD22 ' A' ' 316' ' ' LEU . 40.0 t -108.97 117.53 53.53 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.236 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 38.4 Cg_endo -67.61 153.33 76.53 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.113 1.875 . . . . 0.0 111.104 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -48.19 -24.58 1.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.38 -18.02 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.925 0.342 . . . . 0.0 111.925 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.5 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.1 OUTLIER -96.0 -36.56 11.0 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.52 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 4.3 tp -48.36 -27.12 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 111.243 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -89.16 -17.77 28.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.987 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.462 ' HG2' ' HA ' ' A' ' 351' ' ' GLN . 0.0 OUTLIER -119.06 10.52 12.16 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.415 HG12 ' HB3' ' A' ' 351' ' ' GLN . 31.0 m -108.36 167.71 3.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -141.22 126.45 18.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.922 0.392 . . . . 0.0 111.224 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.404 HG21 ' CZ3' ' A' ' 390' ' ' TRP . 85.4 t -97.25 117.66 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.13 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.2 OUTLIER -105.22 116.13 48.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.085 -178.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.616 ' HB ' HG21 ' A' ' 376' ' ' VAL . 47.7 t -94.66 107.77 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 313' ' ' LYS . 5.2 m -109.76 134.74 51.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.062 0.458 . . . . 0.0 111.993 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 47.5 t -110.88 118.88 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.237 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.458 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.7 mp -119.8 143.49 47.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.975 0.417 . . . . 0.0 111.43 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 310' ' ' PRO . 3.4 t70 -90.37 126.44 35.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.716 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.443 ' CD2' ' ND2' ' A' ' 370' ' ' ASN . 22.7 t80 -81.94 141.82 32.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.782 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.983 -179.963 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . 0.443 ' ND2' ' CD2' ' A' ' 364' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.775 0.322 . . . . 0.0 110.907 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.01 157.28 20.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.714 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -100.9 111.29 23.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.076 0.465 . . . . 0.0 111.269 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 1.4 mm -75.61 -35.64 32.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.817 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 157.29 -174.6 34.81 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.44 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.475 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 15.9 ptmt -164.31 141.03 6.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.195 0.521 . . . . 0.0 111.851 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.616 HG21 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -111.93 158.63 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.167 179.31 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.413 ' HB3' HG13 ' A' ' 358' ' ' VAL . 5.4 p90 -142.1 148.25 38.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.006 0.431 . . . . 0.0 111.593 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.421 HG23 ' CE3' ' A' ' 390' ' ' TRP . 19.8 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.857 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.736 0.303 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 32.9 tp -57.12 -36.57 70.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.67 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 2.6 mtt180 -59.11 -44.77 92.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.129 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.445 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 16.6 t-160 -59.95 -57.43 12.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.93 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.451 ' CZ3' ' HE1' ' A' ' 393' ' ' MET . 71.3 t-105 -50.51 -46.43 57.15 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.174 0.512 . . . . 0.0 109.954 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.6 t -67.04 -33.44 75.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.597 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.482 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.8 OUTLIER -64.65 -38.0 89.49 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.565 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.486 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 7.6 ttm -62.21 -53.61 52.73 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.88 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.405 ' CD2' HG12 ' A' ' 352' ' ' ILE . 1.6 mt -61.64 -35.9 79.24 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.338 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.1 -29.55 69.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.865 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.3 m-80 -114.28 71.48 2.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.66 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.525 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 52.6 Cg_endo -70.28 32.88 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.249 2.633 . . . . 0.0 113.594 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . 0.525 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 16.5 mmm180 -159.33 -44.31 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.979 0.419 . . . . 0.0 110.854 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.464 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.0 OUTLIER -93.92 136.95 23.27 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.314 -178.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.464 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 58.9 Cg_endo -71.34 156.46 58.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.52 2.147 . . . . 0.0 112.814 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.482 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.89 116.92 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.61 144.1 35.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.702 0.287 . . . . 0.0 110.822 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.56 153.09 10.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.972 0.415 . . . . 0.0 111.388 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . 0.414 ' CH2' ' HG3' ' A' ' 295' ' ' GLU . 59.0 m95 -82.24 118.71 23.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.619 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 55.9 m-70 -106.74 123.68 48.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.6 m -78.29 118.56 20.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.783 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.413 ' CD2' HG22 ' A' ' 376' ' ' VAL . 58.7 mt -64.5 127.98 33.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.102 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -117.9 170.89 8.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.961 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.469 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 60.8 t -55.64 119.91 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.863 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.475 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 26.9 mt-10 -53.74 -42.54 68.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.969 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -49.36 76.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.759 0.314 . . . . 0.0 110.64 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.469 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 22.2 mt-10 -65.06 -37.96 89.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 63.8 t -59.33 -50.18 80.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.463 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.776 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 18.7 mt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.846 0.355 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 114.31 -166.38 12.15 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.319 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.26 132.48 23.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.722 0.296 . . . . 0.0 110.771 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.518 HG13 HG21 ' A' ' 312' ' ' VAL . 0.0 OUTLIER -121.78 131.51 72.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.074 0.464 . . . . 0.0 111.043 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.84 125.42 44.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.938 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.611 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.7 p90 -142.11 150.47 41.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.439 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -103.75 161.17 14.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.395 0.617 . . . . 0.0 112.356 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.456 ' CD1' ' CE1' ' A' ' 389' ' ' HIS . 10.9 mt -133.39 150.26 51.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.857 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.8 106.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.928 0.395 . . . . 0.0 111.362 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.526 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 27.7 t80 -99.93 138.12 37.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.211 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.29 95.03 46.11 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.431 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.492 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.24 -32.13 17.12 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.853 2.369 . . . . 0.0 112.238 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -30.65 7.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.155 0.502 . . . . 0.0 109.887 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.34 -20.55 8.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.918 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.15 48.24 6.57 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.565 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -123.86 129.97 51.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.842 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 40.6 tp -95.67 147.54 23.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.968 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 5.4 m -137.85 140.16 40.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.551 . . . . 0.0 111.98 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 23.6 t -132.49 125.33 53.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.451 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.68 115.41 47.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.904 0.383 . . . . 0.0 111.997 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.424 HG22 ' HB2' ' A' ' 339' ' ' TYR . 38.7 mm -74.51 136.99 24.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.56 -58.62 2.12 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.426 ' HG3' ' CH2' ' A' ' 404' ' ' TRP . 8.7 pt-20 -175.59 162.01 2.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.139 -0.625 . . . . 0.0 112.335 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -118.43 153.58 33.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.764 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.427 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 11.8 pttt -150.93 148.52 28.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.11 0.481 . . . . 0.0 111.705 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 60.65 23.85 13.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.067 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 52.1 mt -56.88 138.09 54.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.083 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 143.33 51.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.322 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.421 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 35.3 mttt -85.14 108.39 17.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.644 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.498 ' HG2' ' HB3' ' A' ' 363' ' ' ASP . 0.0 OUTLIER -83.02 -20.94 34.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.958 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 56.0 m-20 -96.16 116.25 28.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.838 0.351 . . . . 0.0 110.718 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.3 t -49.95 116.11 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.444 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 63.26 14.28 53.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.419 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.32 -156.75 9.22 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.79 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.7 mt -100.8 -162.26 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 334' ' ' THR . 67.3 m -135.61 172.07 13.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.139 0.495 . . . . 0.0 110.927 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.419 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -133.73 56.02 18.33 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 362' ' ' LEU . 72.8 Cg_endo -77.11 147.08 26.06 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.88 2.387 . . . . 0.0 114.969 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.533 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 11.5 p90 -141.53 167.74 21.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.069 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.518 HG21 HG13 ' A' ' 276' ' ' ILE . 29.4 t -116.89 148.18 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.414 ' HE3' ' CD1' ' A' ' 362' ' ' LEU . 17.3 mttt -129.84 157.13 43.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.968 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.74 128.48 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.647 0.261 . . . . 0.0 110.819 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -126.4 138.46 53.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.887 0.375 . . . . 0.0 111.077 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.447 HD23 ' CG2' ' A' ' 347' ' ' VAL . 29.7 tp -99.36 108.38 20.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -107.45 121.11 43.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.162 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.52 ' O ' ' HG3' ' A' ' 318' ' ' GLN . 0.0 OUTLIER -92.24 100.17 12.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 57.84 38.37 27.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.834 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.01 28.84 24.69 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.668 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.24 109.48 9.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.357 . . . . 0.0 110.918 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -53.31 129.65 32.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.155 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.4 ' CD1' ' CB ' ' A' ' 318' ' ' GLN . 10.5 mt -123.52 -46.06 2.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.063 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -130.56 151.37 51.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.85 132.79 40.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.763 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -136.97 156.52 48.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.881 0.372 . . . . 0.0 111.117 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 0.5 OUTLIER -146.87 143.85 28.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.9 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.409 ' CG2' HG13 ' A' ' 293' ' ' ILE . 13.7 p -101.49 177.46 4.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.757 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 11.1 t -59.49 166.14 2.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.582 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.533 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 5.5 mt -108.15 130.21 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.005 0.431 . . . . 0.0 111.246 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 337' ' ' PRO . 22.3 mmmt -97.67 89.92 4.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.378 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -57.57 137.58 56.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.756 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 44.9 85.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.366 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 308' ' ' SER . 4.5 t -176.72 173.47 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.696 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.414 HD21 ' HB2' ' A' ' 308' ' ' SER . 4.6 mt -147.14 -16.1 0.4 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.407 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.2 m-80 -134.07 58.94 34.68 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.817 0.341 . . . . 0.0 110.158 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.426 ' HB2' ' HG3' ' A' ' 331' ' ' LYS . 80.9 Cg_endo -86.63 167.59 8.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.076 2.517 . . . . 0.0 113.952 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.493 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 68.1 t80 -116.86 152.04 35.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.995 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.424 ' HB2' HG22 ' A' ' 293' ' ' ILE . 92.9 m-85 -133.19 -68.73 0.57 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . 0.493 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 14.5 t-20 66.24 38.29 4.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.812 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 293' ' ' ILE . 52.0 mt-10 -91.02 141.9 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.663 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 85.5 p -110.09 121.92 46.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 111.662 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -111.71 163.1 14.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.032 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 13.2 m -133.8 145.14 49.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.139 0.495 . . . . 0.0 111.643 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 316' ' ' LEU . 35.1 m-85 -131.26 165.79 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.436 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -114.57 79.45 1.27 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.006 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.447 ' CG2' HD23 ' A' ' 316' ' ' LEU . 50.4 t -115.27 123.58 31.43 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.352 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 73.8 Cg_endo -75.2 158.91 41.17 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.529 2.153 . . . . 0.0 111.376 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -51.37 -21.13 2.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -90.66 -8.68 49.35 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.496 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.6 OUTLIER -111.75 -27.23 8.59 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.526 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 5.7 tp -47.47 -28.66 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -95.09 -25.14 16.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -91.45 -4.91 55.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.872 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 31.4 m -108.92 167.84 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 111.388 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -144.73 126.44 15.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.655 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.43 HG22 ' CZ3' ' A' ' 390' ' ' TRP . 58.9 t -87.17 109.41 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.379 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -94.63 111.85 26.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.598 ' HB ' HG21 ' A' ' 376' ' ' VAL . 39.7 t -95.62 107.87 20.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.769 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.421 ' CG2' ' HB3' ' A' ' 375' ' ' LYS . 6.3 m -109.39 139.32 44.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.064 0.459 . . . . 0.0 111.845 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 59.9 t -115.56 120.58 65.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.03 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.446 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.6 mp -120.89 142.92 49.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.363 . . . . 0.0 111.755 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.498 ' HB3' ' HG2' ' A' ' 302' ' ' MET . 2.6 t70 -90.15 124.43 34.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.511 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -76.01 146.77 39.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.786 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 . . . . . 0 CA--C 1.53 0.208 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.505 -179.535 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.844 0.354 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . 0.407 ' HB2' ' HG2' ' A' ' 302' ' ' MET . 2.5 m-20 -71.05 152.05 43.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.893 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -100.88 111.44 23.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.063 0.459 . . . . 0.0 111.003 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 2.3 mm -72.06 -32.22 42.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.072 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 152.1 -178.81 29.12 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.471 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 15.4 ptmt -160.55 140.78 11.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.34 0.591 . . . . 0.0 111.864 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.598 HG21 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -112.52 158.9 12.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.158 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.418 ' N ' ' CD1' ' A' ' 377' ' ' PHE . 2.6 p90 -141.58 145.2 34.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.918 0.39 . . . . 0.0 111.224 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.42 HG21 ' CE3' ' A' ' 390' ' ' TRP . 15.3 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.146 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.644 0.259 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 22.3 tp -64.66 -32.64 74.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.352 . . . . 0.0 110.332 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -65.39 -28.5 69.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.371 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.461 ' CD2' HG21 ' A' ' 401' ' ' ILE . 20.6 t-160 -79.89 -54.05 6.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.815 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.451 ' NE1' ' O ' ' A' ' 352' ' ' ILE . 51.2 t-105 -51.27 -47.22 62.54 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.048 0.451 . . . . 0.0 109.944 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 15.0 t -67.81 -29.28 68.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.722 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.467 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.3 OUTLIER -62.98 -42.9 99.96 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.789 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.448 ' HE1' ' CH2' ' A' ' 390' ' ' TRP . 30.4 ttp -59.61 -52.49 65.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.671 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.4 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.6 mt -56.66 -31.74 64.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.329 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.46 -30.19 69.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 109.722 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.484 ' C ' ' H ' ' A' ' 398' ' ' ARG . 17.1 m-80 -115.26 71.12 2.99 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.614 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.539 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 39.9 Cg_endo -68.07 31.37 0.14 Allowed 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.225 2.616 . . . . 0.0 113.396 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . 0.539 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 2.5 mmt180 -158.2 -42.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.092 0.472 . . . . 0.0 110.34 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.587 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 38.8 ttt85 -93.86 145.73 30.4 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.858 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.587 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 84.4 Cg_endo -81.03 156.24 20.09 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.457 2.105 . . . . 0.0 112.925 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -125.5 116.44 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.778 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -108.33 144.9 35.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.685 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.39 154.88 10.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.916 0.389 . . . . 0.0 111.298 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . 0.427 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 49.8 m95 -81.35 120.79 25.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.611 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 46.1 m-70 -108.54 122.7 47.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.516 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -78.24 117.19 19.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.746 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.426 HD21 HG22 ' A' ' 376' ' ' VAL . 79.9 mt -62.61 127.67 32.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.086 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -116.06 168.94 9.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.828 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.467 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 59.6 t -55.7 119.34 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.798 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.471 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 20.0 mt-10 -52.7 -43.63 65.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.911 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -56.52 -48.8 76.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.34 . . . . 0.0 110.657 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.467 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.0 mt-10 -65.52 -38.51 89.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.43 -49.91 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.229 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.888 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 33.9 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.898 0.38 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.06 -165.67 13.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.215 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -142.33 133.23 25.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -121.87 131.07 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 0.0 111.026 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.38 126.02 43.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.831 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.618 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.7 p90 -141.89 149.94 40.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.202 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.38 159.53 15.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.085 -178.543 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.448 ' HG ' ' CE1' ' A' ' 389' ' ' HIS . 75.4 mt -128.9 148.34 50.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.177 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -158.81 104.58 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 111.597 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.478 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 29.9 t80 -96.65 139.54 32.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.385 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 287' ' ' GLY . 61.1 t -116.12 92.96 37.29 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 17.1 Cg_exo -65.27 -32.49 51.27 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.941 2.427 . . . . 0.0 112.366 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -31.62 62.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.872 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.6 -10.08 9.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.639 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 71.86 45.56 42.3 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.036 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -120.91 130.18 53.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.926 0.393 . . . . 0.0 111.55 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 32.7 tp -93.75 147.58 22.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.135 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.9 m -136.69 136.99 39.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.32 0.581 . . . . 0.0 112.122 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.09 123.8 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.455 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 27.1 t -118.04 115.08 47.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.03 0.443 . . . . 0.0 111.767 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.465 HG23 ' HB2' ' A' ' 339' ' ' TYR . 38.8 mm -74.7 137.04 23.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.427 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.5 OUTLIER -113.74 -59.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -177.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 2.4 pt-20 -175.7 159.48 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.362 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -118.73 154.01 33.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.873 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -150.87 151.89 32.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.968 0.414 . . . . 0.0 111.679 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 60.91 24.76 14.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.796 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.404 HD13 ' HG3' ' A' ' 310' ' ' PRO . 54.8 mt -59.69 139.38 57.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.282 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -62.17 144.49 55.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.483 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -84.19 118.73 24.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.548 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.539 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.7 mmt -93.91 -18.78 21.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.334 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 49.5 m-20 -98.39 116.97 31.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.841 0.353 . . . . 0.0 110.619 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -48.95 116.68 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.443 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.8 16.59 39.29 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.287 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.79 -157.58 9.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.804 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.6 mt -100.33 -161.08 0.84 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.83 0.348 . . . . 0.0 110.702 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.434 ' HB2' HD23 ' A' ' 335' ' ' LEU . 70.9 m -139.39 172.13 13.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.33 0.586 . . . . 0.0 111.077 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.401 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -131.99 57.44 29.93 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.404 ' HG3' HD13 ' A' ' 299' ' ' LEU . 57.7 Cg_endo -72.75 144.65 39.67 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.132 2.555 . . . . 0.0 114.682 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 38.4 p90 -143.61 163.47 33.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.252 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.447 ' CG1' ' CG1' ' A' ' 359' ' ' VAL . 38.0 t -111.6 149.97 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.43 0.633 . . . . 0.0 112.577 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 360' ' ' THR . 11.1 mtmt -131.4 138.49 49.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.378 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.69 132.44 60.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 0.0 110.8 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -127.76 135.32 49.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 0.0 110.975 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.472 HD23 ' HD3' ' A' ' 324' ' ' LYS . 51.5 tp -103.76 110.84 23.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 2.9 mtm -117.0 134.96 54.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.539 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.65 99.49 11.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.29 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 59.52 37.7 22.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.36 7.43 60.63 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.224 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 317' ' ' MET . 5.5 mptt -111.02 109.76 20.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.834 0.317 . . . . 0.0 110.975 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.39 131.59 33.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.377 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.533 ' HB2' ' HD2' ' A' ' 324' ' ' LYS . 5.9 mt -125.35 -47.72 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.261 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.533 ' HD2' ' HB2' ' A' ' 323' ' ' LEU . 0.1 OUTLIER -129.89 160.59 33.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.085 0.469 . . . . 0.0 111.448 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.31 143.74 37.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.881 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 20.9 mmtm -145.78 162.13 38.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.943 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.6 146.75 27.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 14.6 p -106.11 176.73 5.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 13.3 t -58.09 164.61 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.514 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.522 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.4 mt -107.83 123.55 63.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.938 0.399 . . . . 0.0 111.39 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -86.28 87.45 7.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.953 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -55.14 136.42 48.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.987 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 44.22 85.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.33 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 308' ' ' SER . 4.9 t -178.55 174.21 1.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.808 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 308' ' ' SER . 4.4 mt -145.59 -16.71 0.48 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.176 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.462 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.3 m-80 -132.65 56.36 22.17 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.318 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 46.8 Cg_endo -89.54 167.76 5.04 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.165 2.577 . . . . 0.0 113.628 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.434 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -108.97 160.67 15.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.299 179.302 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.465 ' HB2' HG23 ' A' ' 293' ' ' ILE . 81.6 m-85 -133.96 -63.97 0.71 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.755 0.312 . . . . 0.0 111.224 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.5 t30 59.12 38.52 23.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.956 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 293' ' ' ILE . 31.7 mt-10 -93.4 144.69 25.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.679 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 99.3 p -114.67 122.5 46.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 111.718 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -114.87 152.85 31.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.156 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 64.4 p -129.37 138.93 51.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.116 0.484 . . . . 0.0 111.763 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -125.13 166.01 17.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.569 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -111.02 76.84 1.0 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 50.0 t -110.0 122.2 39.62 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.035 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 71.0 Cg_endo -75.28 157.83 41.39 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.418 2.079 . . . . 0.0 111.64 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -51.72 -22.68 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.702 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -87.27 -8.55 56.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.516 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -111.97 -28.4 8.04 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.478 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 4.4 tp -52.2 -29.94 12.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.767 0.318 . . . . 0.0 110.864 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.67 3.31 55.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.411 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -124.1 -21.78 4.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.471 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 32.4 m -88.04 163.28 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.002 0.429 . . . . 0.0 111.485 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -137.88 126.28 23.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.5 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.425 HG21 ' CZ3' ' A' ' 390' ' ' TRP . 88.9 t -88.3 116.2 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 0.0 110.28 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.28 113.8 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.758 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.613 ' HB ' HG22 ' A' ' 376' ' ' VAL . 47.8 t -99.09 107.79 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 313' ' ' LYS . 3.7 m -110.4 135.38 51.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.964 0.411 . . . . 0.0 111.825 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 45.7 t -109.38 118.74 57.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.228 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.436 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.8 mp -121.28 145.76 47.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.502 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.539 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -94.57 125.16 39.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.664 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -75.75 146.91 39.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.899 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.596 -179.576 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.791 0.329 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.92 149.76 30.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.055 0.455 . . . . 0.0 111.57 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -100.95 111.11 23.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.72 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 373' ' ' ILE . 33.3 mt -82.39 -32.73 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.491 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.05 -178.5 41.24 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.034 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.459 ' CG ' ' HG2' ' A' ' 410' ' ' GLU . 17.5 ptmt -164.72 140.98 5.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.221 0.534 . . . . 0.0 112.041 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.613 HG22 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -113.53 159.27 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.048 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -144.85 132.0 20.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.055 0.455 . . . . 0.0 111.79 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.756 179.446 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.897 0.38 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 23.8 tp -56.4 -34.4 66.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.728 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -62.0 -46.84 87.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.523 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.474 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 15.2 t-160 -62.58 -53.84 48.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.148 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.455 ' CZ3' ' HE3' ' A' ' 393' ' ' MET . 68.1 t-105 -54.83 -51.44 65.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.952 0.406 . . . . 0.0 110.461 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.5 t -66.25 -32.61 74.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.144 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.534 ' HB3' HD12 ' A' ' 401' ' ' ILE . 6.4 m-20 -64.87 -31.59 72.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.79 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.499 ' HA ' HG13 ' A' ' 401' ' ' ILE . 25.8 ttp -65.88 -54.27 28.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.91 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.4 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.5 mt -55.76 -22.79 25.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.124 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -80.8 -38.45 28.44 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 399' ' ' ARG . 40.0 m-80 -125.01 60.37 27.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.563 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.511 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 2.4 Cg_endo -44.06 -77.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.759 2.973 . . . . 0.0 113.356 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -51.38 -17.85 0.86 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.406 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.402 ' HB3' ' HB3' ' A' ' 396' ' ' ASN . 0.9 OUTLIER -93.67 133.47 27.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.906 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 74.1 Cg_endo -75.41 115.41 4.22 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.435 2.09 . . . . 0.0 112.548 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.534 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -93.62 108.39 20.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.881 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.57 144.0 32.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.737 0.303 . . . . 0.0 110.623 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.44 154.38 12.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.406 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -82.46 117.12 22.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.618 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 48.9 m-70 -106.68 118.38 36.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.576 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 91.6 m -78.33 116.25 18.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.952 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.475 HD23 HG23 ' A' ' 376' ' ' VAL . 93.5 mt -61.29 127.94 33.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.405 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -116.04 172.25 7.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.497 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.463 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 61.2 t -54.98 121.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.459 ' HG2' ' CG ' ' A' ' 375' ' ' LYS . 23.9 mt-10 -55.16 -42.47 73.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.88 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.16 -49.11 76.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.463 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.7 mt-10 -64.89 -38.17 90.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.371 0.605 . . . . 0.0 109.418 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.412 HG21 ' HG2' ' A' ' 375' ' ' LYS . 94.9 t -57.28 -47.29 84.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.534 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.979 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 41.4 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.943 0.402 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 124.11 -164.35 17.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.162 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.04 132.53 22.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.703 0.287 . . . . 0.0 110.72 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.45 HG13 HG21 ' A' ' 312' ' ' VAL . 0.1 OUTLIER -122.71 122.43 65.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.161 0.505 . . . . 0.0 110.821 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 294' ' ' LEU . 0.1 OUTLIER -92.01 126.17 36.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.786 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.616 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.0 p90 -142.22 148.94 38.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.383 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -101.92 160.61 14.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.064 -178.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.435 ' HG ' ' CE1' ' A' ' 389' ' ' HIS . 73.0 mt -128.81 147.81 50.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.214 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 290' ' ' THR . 1.6 ttm180 -158.92 106.7 1.84 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.579 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.491 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 30.0 t80 -98.25 139.52 33.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.599 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 287' ' ' GLY . 83.1 t -116.37 93.11 38.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.498 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 16.5 Cg_exo -65.65 -30.94 50.58 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.892 2.394 . . . . 0.0 112.211 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -30.67 65.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.699 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -122.4 -5.3 8.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.643 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 66.49 45.98 80.97 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.629 -0.795 . . . . 0.0 112.033 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -121.36 129.32 53.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 111.493 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 34.2 tp -93.05 147.64 22.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.068 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.405 ' CB ' ' O ' ' A' ' 281' ' ' ARG . 1.6 m -136.68 136.7 39.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.347 0.594 . . . . 0.0 112.177 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 15.1 t -128.36 123.53 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.306 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 38.1 t -117.25 116.04 50.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.995 0.426 . . . . 0.0 111.942 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.453 HG13 ' CG2' ' A' ' 328' ' ' THR . 26.6 mm -74.55 137.05 23.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.417 HD22 ' CE2' ' A' ' 338' ' ' TYR . 0.7 OUTLIER -113.46 -57.44 2.28 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 4.9 pt-20 -175.96 158.53 2.05 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.131 -0.628 . . . . 0.0 112.444 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 336' ' ' ASN . . . -117.98 145.56 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.497 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.424 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 10.7 pttt -145.68 151.04 37.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 111.542 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 61.47 23.01 13.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.072 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 58.2 mt -56.79 138.27 53.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.901 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -66.34 150.67 48.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.562 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.43 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 25.1 mttt -86.43 115.59 24.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.614 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.448 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 6.9 mmm -94.12 -18.37 21.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.563 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 55.6 m-20 -94.88 118.56 31.98 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.764 0.316 . . . . 0.0 110.332 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -47.61 115.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.02 0.438 . . . . 0.0 111.598 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.5 16.83 37.98 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.433 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.37 -159.26 10.07 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.961 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 6.6 mt -96.67 -161.55 0.88 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.72 0.295 . . . . 0.0 110.292 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.43 ' OG ' ' HA ' ' A' ' 301' ' ' LYS . 5.5 m -134.97 170.66 15.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.228 0.537 . . . . 0.0 111.166 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.453 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 6.8 m-20 -135.72 55.44 12.53 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.554 ' O ' ' HG2' ' A' ' 331' ' ' LYS . 34.4 Cg_endo -66.88 154.81 73.32 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.233 2.622 . . . . 0.0 114.697 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 48.6 p90 -153.06 149.55 28.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.503 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.45 HG21 HG13 ' A' ' 276' ' ' ILE . 41.0 t -99.98 150.14 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.435 ' HE2' ' CD1' ' A' ' 362' ' ' LEU . 5.6 mtmm -133.08 136.16 45.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.219 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 325' ' ' LYS . 5.1 mp -107.72 137.27 39.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.251 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -131.45 128.45 39.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.388 . . . . 0.0 111.21 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 28.6 tp -104.64 106.64 17.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.464 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.6 mtm -112.87 140.65 47.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.912 0.387 . . . . 0.0 111.243 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.38 99.48 9.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.324 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 55.46 38.14 29.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 93.22 25.8 18.08 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.866 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 317' ' ' MET . 3.8 mptt -130.67 109.26 10.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.888 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.22 130.78 31.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.449 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 8.9 mt -124.34 -53.56 1.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.969 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -130.64 150.2 51.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.06 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 314' ' ' ILE . 0.6 OUTLIER -143.44 120.1 11.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.815 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 7.8 mmtm -118.39 172.75 7.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.995 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.15 138.5 15.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.261 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.453 ' CG2' HG13 ' A' ' 293' ' ' ILE . 25.1 p -92.06 -171.65 2.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.855 0.36 . . . . 0.0 110.47 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.8 t -70.54 171.71 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.064 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.492 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.3 mp -110.3 114.35 46.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.078 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 310' ' ' PRO . 0.0 OUTLIER -75.08 90.78 2.51 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -58.42 135.96 57.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.404 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 41.29 80.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.528 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 331' ' ' LYS . 3.5 t -179.06 173.64 1.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.963 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.49 -11.46 0.53 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.224 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.467 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.3 m-80 -137.84 59.33 19.08 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.733 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.519 ' HG3' ' HG3' ' A' ' 331' ' ' LYS . 54.8 Cg_endo -98.48 167.91 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.532 2.822 . . . . 0.0 113.509 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.422 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.6 OUTLIER -104.12 160.79 14.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.729 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.482 ' HH ' ' HA ' ' A' ' 311' ' ' TYR . 6.7 m-85 -129.73 -75.71 0.55 Allowed 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.981 0.42 . . . . 0.0 111.778 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 69.93 35.4 2.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.491 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 293' ' ' ILE . 29.3 mt-10 -91.12 143.11 27.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.584 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 26.5 p -115.41 121.29 42.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.0 111.765 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . 0.419 ' CE1' HG23 ' A' ' 328' ' ' THR . 71.7 m-85 -110.49 159.98 17.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.977 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 6.2 m -135.72 137.97 42.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.118 0.485 . . . . 0.0 111.828 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.445 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 57.1 m-85 -125.25 166.07 17.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.609 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -112.29 74.49 0.87 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.866 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 47.7 t -108.31 122.75 39.53 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.509 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 74.5 Cg_endo -75.76 158.06 39.36 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.418 2.079 . . . . 0.0 111.547 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -51.71 -22.43 3.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.629 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -87.82 -8.56 55.74 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.509 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.2 OUTLIER -112.59 -28.2 7.92 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.696 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.491 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 4.0 tp -51.44 -34.89 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.79 0.329 . . . . 0.0 110.779 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -89.99 3.07 54.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.374 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -123.06 -15.99 7.14 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.405 HG23 ' CZ2' ' A' ' 390' ' ' TRP . 33.7 m -95.63 165.15 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.858 0.361 . . . . 0.0 111.469 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.85 126.49 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.989 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.437 HG22 ' CZ3' ' A' ' 390' ' ' TRP . 47.7 t -89.11 110.18 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.442 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -95.83 110.01 23.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.503 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.627 ' HB ' HG21 ' A' ' 376' ' ' VAL . 43.1 t -91.9 107.89 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.868 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.456 ' CG2' ' HB3' ' A' ' 375' ' ' LYS . 4.3 m -112.68 126.93 55.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.021 0.439 . . . . 0.0 111.949 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 46.7 t -101.98 118.37 48.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.216 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 311' ' ' TYR . 2.7 mp -119.44 147.33 44.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 0.0 111.529 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 310' ' ' PRO . 5.2 t70 -90.02 130.19 36.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.821 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -81.95 141.45 33.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.584 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.157 -179.72 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.128 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -71.27 152.1 43.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.067 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -100.84 112.62 25.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.392 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 1.3 mm -74.31 -34.28 36.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.751 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 155.98 -178.27 32.61 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.32 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.456 ' HB3' ' CG2' ' A' ' 360' ' ' THR . 11.9 ptmt -161.9 139.64 8.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.351 0.596 . . . . 0.0 112.303 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.684 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.18 158.93 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.077 179.264 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -141.2 135.48 30.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.906 0.384 . . . . 0.0 111.6 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.898 179.54 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 120.658 0.266 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 46.4 tp -65.11 -37.15 86.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.623 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -62.58 -37.59 86.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.207 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.468 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 16.9 t-160 -65.54 -55.48 17.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 110.448 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.455 ' CZ2' HD13 ' A' ' 352' ' ' ILE . 69.1 t-105 -53.83 -50.03 67.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.039 0.447 . . . . 0.0 110.262 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.42 -29.76 69.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.479 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.545 ' HB3' HD11 ' A' ' 401' ' ' ILE . 5.4 m-20 -67.86 -33.02 73.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.491 ' HA ' HG13 ' A' ' 401' ' ' ILE . 27.6 ttp -63.73 -52.61 59.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.695 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.416 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.6 mt -57.02 -22.9 42.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.91 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -81.16 -36.25 30.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.309 0.576 . . . . 0.0 109.483 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.418 ' HB2' HD12 ' A' ' 401' ' ' ILE . 22.7 m-80 -126.11 60.2 34.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.555 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.498 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 3.2 Cg_endo -44.67 -78.69 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.595 2.863 . . . . 0.0 112.91 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -51.24 -18.88 1.03 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.133 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -93.74 132.63 29.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.596 0.236 . . . . 0.0 110.813 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.7 Cg_endo -75.6 124.35 8.18 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.44 2.094 . . . . 0.0 112.712 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.545 HD11 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -102.59 107.63 22.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.761 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.28 144.26 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.858 0.361 . . . . 0.0 110.891 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.1 151.22 10.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.375 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . 0.424 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 36.4 m95 -78.17 115.77 18.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.688 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.684 ' HB3' HG11 ' A' ' 376' ' ' VAL . 51.0 m-70 -104.15 119.96 40.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.389 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 90.6 m -78.2 116.47 18.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.437 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.408 ' CD2' HG22 ' A' ' 376' ' ' VAL . 64.2 mt -61.63 126.9 28.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.038 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -115.72 170.08 8.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.944 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.447 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 55.5 t -54.83 117.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.725 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.4 ' CG ' ' HD2' ' A' ' 375' ' ' LYS . 9.0 mp0 -55.4 -41.22 72.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.642 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -56.83 -48.63 77.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 110.58 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.447 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.0 mt-10 -65.7 -40.07 91.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 97.9 t -58.59 -48.79 84.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.17 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.499 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 47.6 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.914 0.388 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 116.97 -168.1 12.73 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.234 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.18 132.28 26.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 0.0 110.723 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.1 OUTLIER -120.99 129.93 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.171 0.51 . . . . 0.0 110.983 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.404 ' N ' ' CD1' ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.14 125.38 41.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.829 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.618 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 21.2 p90 -142.29 149.88 40.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.321 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.1 OUTLIER -102.54 161.31 13.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.362 0.601 . . . . 0.0 112.268 -178.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 400' ' ' PRO . 27.7 mt -132.2 149.93 52.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.958 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.434 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.3 OUTLIER -158.92 102.8 1.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.443 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.513 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 29.6 t80 -98.57 136.69 38.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 43.0 t -122.8 95.88 45.92 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.518 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.57 -32.2 15.61 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.881 2.387 . . . . 0.0 112.317 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -31.17 6.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.191 0.52 . . . . 0.0 109.957 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.39 -21.15 8.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.813 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 81.16 47.6 6.43 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.778 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -123.65 129.74 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.97 0.414 . . . . 0.0 111.798 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 31.4 tp -95.48 147.67 23.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.994 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 3.4 m -134.73 137.64 43.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 112.0 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.87 120.28 47.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.32 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 21.7 t -116.2 115.45 49.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.039 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.443 HG22 ' HB2' ' A' ' 339' ' ' TYR . 42.1 mm -75.05 137.13 23.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.442 HD21 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.98 -61.97 1.67 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -177.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.427 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 1.5 pt-20 -175.62 151.77 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.329 -0.549 . . . . 0.0 112.329 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -110.33 154.56 23.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.859 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -150.99 152.17 33.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 111.719 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 60.28 24.35 13.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.932 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.411 HD12 ' HG3' ' A' ' 310' ' ' PRO . 48.8 mt -58.96 138.82 57.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.162 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.59 141.62 58.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.31 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -80.73 117.81 21.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.694 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.555 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.1 mmt -90.96 -19.03 23.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.343 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 49.2 m-20 -98.78 114.99 27.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.779 0.323 . . . . 0.0 110.524 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 26.3 t -48.84 116.38 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.45 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 62.11 15.44 50.38 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.369 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.29 -157.25 9.39 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.727 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.3 mt -100.34 -161.24 0.85 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 0.0 110.784 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.44 ' HB2' HD23 ' A' ' 335' ' ' LEU . 66.5 m -139.39 172.01 13.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.309 0.576 . . . . 0.0 111.103 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.409 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 15.3 m-20 -131.24 57.13 29.05 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.825 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.411 ' HG3' HD12 ' A' ' 299' ' ' LEU . 50.2 Cg_endo -70.56 148.56 60.13 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.096 2.531 . . . . 0.0 114.82 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.517 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 33.8 p90 -150.35 161.25 42.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.266 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.447 HG12 ' CG1' ' A' ' 359' ' ' VAL . 38.9 t -110.41 150.0 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -132.41 134.95 45.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.215 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.426 HG21 ' CZ ' ' A' ' 345' ' ' PHE . 5.3 mp -108.79 131.57 59.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.954 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -127.01 142.5 51.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.877 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 28.9 tp -113.31 106.01 14.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.527 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.5 mtm -106.79 131.17 54.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.311 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' A' ' 318' ' ' GLN . 0.4 OUTLIER -99.62 99.54 10.41 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.248 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 59.94 36.92 21.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.731 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 88.3 26.52 27.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.714 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.42 109.4 11.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.785 0.326 . . . . 0.0 110.883 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.79 129.24 25.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.184 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.401 ' CD1' ' CB ' ' A' ' 318' ' ' GLN . 10.0 mt -123.21 -41.38 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.47 147.74 49.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.897 0.38 . . . . 0.0 111.371 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -135.56 117.51 15.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 15.9 mmtp -124.26 160.85 27.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.927 0.394 . . . . 0.0 111.384 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.93 148.27 33.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.716 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 20.5 p -106.37 176.04 5.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.33 158.66 5.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.703 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.517 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.0 mt -102.13 126.08 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.979 0.418 . . . . 0.0 111.383 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.4 ' HG3' ' CG ' ' A' ' 337' ' ' PRO . 3.7 mmpt? -90.64 88.78 7.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.132 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -56.18 136.62 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.877 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 43.9 84.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.285 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 4.8 t -177.61 174.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.947 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 308' ' ' SER . 4.4 mt -145.95 -16.57 0.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.149 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.445 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.4 m-80 -132.29 56.99 26.13 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-O 120.765 0.317 . . . . 0.0 110.348 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 59.1 Cg_endo -88.33 167.69 6.41 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.18 2.587 . . . . 0.0 113.707 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.442 ' CE2' HD21 ' A' ' 294' ' ' LEU . 0.4 OUTLIER -111.31 159.29 18.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.302 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.443 ' HB2' HG22 ' A' ' 293' ' ' ILE . 83.6 m-85 -134.76 -62.25 0.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.792 0.329 . . . . 0.0 111.241 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.3 t30 57.87 37.58 26.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 293' ' ' ILE . 61.9 mt-10 -92.66 141.47 28.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 91.0 p -110.64 120.27 41.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.888 0.375 . . . . 0.0 111.544 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -113.34 147.91 36.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.361 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 83.0 p -123.09 140.5 52.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.972 0.415 . . . . 0.0 111.443 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.426 ' CZ ' HG21 ' A' ' 314' ' ' ILE . 63.1 m-85 -127.24 165.88 18.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.583 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.63 78.1 1.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.817 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.413 HG13 HG22 ' A' ' 355' ' ' VAL . 46.0 t -111.62 120.67 41.93 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.094 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.466 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.7 Cg_endo -72.07 156.97 55.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.468 2.112 . . . . 0.0 111.619 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -51.89 -22.94 4.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.54 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -85.72 -8.55 58.1 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.466 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.9 OUTLIER -109.96 -35.09 6.23 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.521 0.201 . . . . 0.0 111.473 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.513 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 5.9 tp -49.24 -26.72 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.651 0.263 . . . . 0.0 111.478 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -93.27 -7.92 43.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.771 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -116.41 -23.54 8.27 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.413 HG22 HG13 ' A' ' 347' ' ' VAL . 35.0 m -88.69 168.03 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.908 0.385 . . . . 0.0 111.428 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -143.29 133.48 24.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.1 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.1 t -87.0 101.98 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.443 ' CG1' ' HE2' ' A' ' 375' ' ' LYS . 0.8 OUTLIER -86.45 114.18 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.969 -178.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.596 ' HB ' HG23 ' A' ' 376' ' ' VAL . 40.4 t -99.75 107.85 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.92 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 375' ' ' LYS . 7.4 m -110.93 134.73 52.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 111.628 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 45.9 t -109.29 121.37 62.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.4 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.443 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.6 mp -123.07 147.55 46.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.918 0.389 . . . . 0.0 111.353 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.555 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.3 OUTLIER -96.54 125.19 40.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.601 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.407 ' CD2' ' OD1' ' A' ' 370' ' ' ASN . 20.3 t80 -75.8 139.45 41.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.818 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.871 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . 0.407 ' OD1' ' CD2' ' A' ' 364' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.8 0.333 . . . . 0.0 110.701 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.99 150.94 43.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.548 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -97.32 111.63 23.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.608 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.496 HG21 HD12 ' A' ' 373' ' ' ILE . 30.0 mt -80.99 -33.12 12.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.386 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 168.13 -179.22 41.43 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.162 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.503 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 14.8 ptmt -164.67 140.92 5.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.175 0.512 . . . . 0.0 111.791 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.596 HG23 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -114.35 158.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.176 179.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -142.23 132.03 24.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 111.179 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.466 ' CG1' ' CE1' ' A' ' 405' ' ' HIS . 15.8 m . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.962 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.627 0.251 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.36 -33.53 71.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.551 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 1.0 OUTLIER -61.8 -49.83 74.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.54 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.45 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 17.4 t-160 -57.91 -58.39 8.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.967 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.467 ' CZ3' ' HE3' ' A' ' 393' ' ' MET . 64.0 t-105 -50.83 -46.11 59.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.217 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.5 t -67.75 -35.82 79.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.233 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.421 ' HB3' HD12 ' A' ' 401' ' ' ILE . 4.4 t0 -64.08 -34.92 79.13 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.467 ' HE3' ' CZ3' ' A' ' 390' ' ' TRP . 26.6 ttp -64.5 -58.0 7.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.552 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.403 HD22 ' CG2' ' A' ' 352' ' ' ILE . 1.5 mt -55.22 -31.93 61.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.399 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.52 -30.64 69.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.786 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.9 m-80 -114.27 70.66 2.06 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.629 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.543 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 42.8 Cg_endo -68.77 37.67 0.21 Allowed 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.203 2.602 . . . . 0.0 113.479 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . 0.543 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 10.6 mmm180 -160.0 -45.69 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.918 0.39 . . . . 0.0 110.86 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.403 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 5.8 tpt180 -93.87 141.82 24.23 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.198 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.7 Cg_endo -75.37 156.31 41.34 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.585 2.19 . . . . 0.0 112.807 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.45 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.2 mm -126.53 119.32 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -111.86 144.53 41.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.721 0.296 . . . . 0.0 110.693 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.31 155.68 11.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.976 0.417 . . . . 0.0 111.378 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -81.69 119.17 23.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.79 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.618 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 47.1 m-70 -106.81 122.34 46.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.557 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -78.19 117.09 19.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.672 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.481 ' CD2' HG21 ' A' ' 376' ' ' VAL . 55.9 mt -62.44 128.37 35.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.194 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -114.46 171.98 7.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.756 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.409 ' HB ' ' CG ' ' A' ' 412' ' ' GLU . 3.6 t -59.46 122.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.503 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 5.4 mt-10 -51.09 -38.37 51.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.325 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -52.64 63.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.651 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.409 ' CG ' ' HB ' ' A' ' 409' ' ' VAL . 3.0 mm-40 -60.79 -41.13 95.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.455 HG21 ' HG2' ' A' ' 375' ' ' LYS . 61.7 t -56.22 -52.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.251 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.597 179.812 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.408 ' HB3' ' O ' ' A' ' 373' ' ' ILE . 46.7 mt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.788 0.328 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 116.24 -166.82 12.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.946 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -141.08 136.23 31.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.819 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.1 OUTLIER -125.09 125.4 69.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.207 0.527 . . . . 0.0 110.885 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.52 126.72 39.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.741 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.626 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 19.2 p90 -142.37 150.18 40.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.57 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.1 OUTLIER -103.87 160.36 14.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.05 -178.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 400' ' ' PRO . 10.6 mt -133.34 150.51 51.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.866 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.405 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.6 OUTLIER -158.97 105.08 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.552 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.528 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 28.4 t80 -99.14 138.66 35.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.08 95.28 44.17 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.403 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.515 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 6.9 Cg_exo -70.53 -31.06 17.76 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.844 2.362 . . . . 0.0 112.265 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.26 -32.07 15.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.147 0.499 . . . . 0.0 109.844 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.12 -18.71 9.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.816 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 78.77 47.58 7.73 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.617 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.97 129.46 51.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.04 0.447 . . . . 0.0 111.834 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 33.1 tp -96.55 147.56 23.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.932 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 4.3 m -137.63 139.53 40.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.235 0.541 . . . . 0.0 111.995 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.3 t -132.86 123.35 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.529 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.89 116.21 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 341' ' ' GLU . 36.5 mm -74.64 135.95 26.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.79 -64.98 1.22 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 338' ' ' TYR . 0.3 OUTLIER -174.67 148.62 1.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.524 -179.315 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -107.76 154.19 21.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.982 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -150.96 151.86 32.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 111.652 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 62.68 22.81 13.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.843 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 47.8 mt -57.02 138.53 54.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.163 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.35 142.97 58.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.588 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.408 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 14.1 mttt -82.64 113.06 20.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.444 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.415 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 8.2 mmm -91.6 -20.44 21.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.642 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 42.6 m-20 -92.28 118.86 31.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 110.527 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -48.04 115.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.611 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 57.5 17.95 28.16 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.264 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.97 -157.47 9.6 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.001 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.1 mt -99.27 -161.12 0.85 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 0.0 110.54 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.408 ' OG ' ' HA ' ' A' ' 301' ' ' LYS . 14.8 m -135.68 171.8 13.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.178 0.513 . . . . 0.0 111.017 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.414 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 6.5 m-20 -135.69 56.95 16.71 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 363' ' ' ASP . 73.3 Cg_endo -77.91 144.21 21.39 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.902 2.402 . . . . 0.0 114.891 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 10.9 p90 -139.12 167.73 21.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.025 177.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.432 ' CG1' ' CG1' ' A' ' 359' ' ' VAL . 47.6 t -116.85 149.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.325 0.584 . . . . 0.0 112.572 -179.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -132.38 155.78 47.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.434 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.411 HG22 ' CZ ' ' A' ' 345' ' ' PHE . 5.4 mp -124.51 134.19 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.417 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -128.93 127.74 42.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.013 0.435 . . . . 0.0 111.049 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.478 HD22 ' HD3' ' A' ' 324' ' ' LYS . 28.8 tp -99.32 114.27 27.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.288 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.9 mtm -122.05 133.62 54.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 111.441 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.77 99.49 10.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.02 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 59.95 36.68 21.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.38 25.61 32.89 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.853 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -122.06 117.46 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.7 0.286 . . . . 0.0 110.9 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -51.72 128.21 22.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.219 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.406 ' HB3' ' CE ' ' A' ' 324' ' ' LYS . 18.1 mt -125.5 -58.86 1.41 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.251 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.478 ' HD3' HD22 ' A' ' 316' ' ' LEU . 0.1 OUTLIER -129.93 159.94 35.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.179 0.514 . . . . 0.0 111.743 -179.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 325' ' ' LYS . 0.3 OUTLIER -139.7 138.07 35.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.721 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -143.98 158.62 43.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 111.157 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.93 145.3 26.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.948 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.432 HG22 ' CE1' ' A' ' 343' ' ' PHE . 12.9 p -102.0 -178.93 3.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.846 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 10.1 t -60.2 172.05 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.463 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 5.6 mt -113.44 121.54 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 111.454 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.404 ' HG3' ' CG ' ' A' ' 337' ' ' PRO . 7.1 mmpt? -86.43 85.73 7.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.997 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -56.45 136.77 53.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.981 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.19 83.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.255 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 4.8 t -176.99 174.0 1.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.76 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 4.0 mt -145.25 -15.8 0.5 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.378 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.471 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.79 56.09 20.64 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 120.75 0.309 . . . . 0.0 110.516 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 61.3 Cg_endo -89.04 167.69 5.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.15 2.567 . . . . 0.0 113.723 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.426 ' CG ' ' HB3' ' A' ' 295' ' ' GLU . 0.2 OUTLIER -110.03 160.4 16.47 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.456 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.449 ' C ' ' ND2' ' A' ' 340' ' ' ASN . 7.9 m-85 -135.17 -50.3 0.75 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.692 0.282 . . . . 0.0 111.192 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . 0.449 ' ND2' ' C ' ' A' ' 339' ' ' TYR . 1.7 p30 44.41 36.7 1.73 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.029 0.442 . . . . 0.0 110.976 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 293' ' ' ILE . 44.3 mt-10 -90.91 141.25 29.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.816 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 88.0 p -111.24 121.2 44.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.932 0.396 . . . . 0.0 111.558 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . 0.432 ' CE1' HG22 ' A' ' 328' ' ' THR . 67.6 m-85 -111.78 155.21 23.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.058 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 59.6 p -130.91 139.59 50.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.115 0.483 . . . . 0.0 111.692 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.411 ' CZ ' HG22 ' A' ' 314' ' ' ILE . 55.5 m-85 -126.41 165.97 18.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.581 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -113.16 76.94 1.01 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.546 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 49.4 t -109.84 122.21 39.76 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.322 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.493 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 63.2 Cg_endo -73.42 158.97 47.43 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.453 2.102 . . . . 0.0 111.492 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -52.06 -20.67 2.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.857 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -90.45 -8.7 49.83 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.493 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -110.47 -29.73 7.96 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.528 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 6.3 tp -47.09 -28.6 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.829 0.347 . . . . 0.0 111.059 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -95.11 -27.77 15.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.058 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -91.33 -3.94 56.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.875 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 29.9 m -106.96 166.3 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 111.278 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -141.65 126.23 17.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.658 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.453 HG21 ' CH2' ' A' ' 390' ' ' TRP . 64.9 t -90.77 105.01 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.145 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.98 111.34 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.811 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.596 ' HB ' HG21 ' A' ' 376' ' ' VAL . 48.2 t -91.52 108.0 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.421 ' CG2' ' HB3' ' A' ' 375' ' ' LYS . 2.6 m -110.26 131.93 54.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.061 0.457 . . . . 0.0 111.923 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 58.2 t -107.05 119.67 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.926 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.432 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.6 mp -119.94 141.88 49.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.992 0.425 . . . . 0.0 111.722 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 310' ' ' PRO . 6.3 t70 -90.09 125.94 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.585 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -80.06 145.98 32.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.593 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.554 -179.481 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.889 0.376 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.16 149.86 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.915 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -91.0 112.03 23.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.019 0.438 . . . . 0.0 111.119 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.408 ' O ' ' HB3' ' A' ' 273' ' ' LEU . 1.3 mm -73.26 -33.88 42.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.997 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 155.61 -178.37 32.25 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.258 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.421 ' HB3' ' CG2' ' A' ' 360' ' ' THR . 12.2 ptmt -162.16 140.59 9.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.294 0.569 . . . . 0.0 112.017 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.596 HG21 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -112.98 158.79 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.155 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.405 ' CZ ' ' OE1' ' A' ' 386' ' ' GLU . 9.4 p90 -139.53 142.95 37.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.933 0.397 . . . . 0.0 111.121 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.066 179.942 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.405 ' OE1' ' CZ ' ' A' ' 377' ' ' PHE . 14.4 mt-10 . . . . . 0 CA--C 1.522 -0.101 0 CA-C-O 120.808 0.337 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.19 -32.06 71.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.501 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 2.6 ptt180 -64.94 -31.7 73.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.324 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.456 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 17.5 t-160 -77.29 -57.33 3.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.453 ' CH2' HG21 ' A' ' 357' ' ' VAL . 50.4 t-105 -49.47 -44.95 46.21 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.093 0.473 . . . . 0.0 109.901 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.0 t -69.06 -30.67 69.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.739 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.489 ' HB3' HD13 ' A' ' 401' ' ' ILE . 0.3 OUTLIER -63.14 -42.25 99.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.923 179.119 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.441 ' HE1' ' CH2' ' A' ' 390' ' ' TRP . 31.9 ttp -59.96 -54.83 41.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.971 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.4 mt -56.46 -31.57 64.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.417 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.2 -31.61 71.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.529 . . . . 0.0 109.691 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 398' ' ' ARG . 36.0 m-80 -115.17 71.17 2.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.55 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.522 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 39.6 Cg_endo -68.34 35.29 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.249 2.632 . . . . 0.0 113.443 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . 0.522 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 11.3 mmm180 -159.26 -45.23 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.0 0.428 . . . . 0.0 110.578 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.409 ' NH1' ' HB2' ' A' ' 399' ' ' ARG . 0.2 OUTLIER -94.04 140.75 23.01 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.037 -179.19 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 72.3 Cg_endo -75.02 156.3 42.89 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.52 2.147 . . . . 0.0 112.839 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.489 HD13 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -124.99 117.95 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.578 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -110.13 144.57 38.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.677 0.275 . . . . 0.0 110.763 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.77 155.57 10.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.965 0.412 . . . . 0.0 111.246 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -82.23 121.63 26.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.753 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.626 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 54.3 m-70 -109.46 122.68 47.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.593 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 90.4 m -78.28 117.11 19.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.542 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.453 HD21 HG21 ' A' ' 361' ' ' VAL . 61.8 mt -62.16 128.09 34.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.253 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -114.44 173.29 6.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.672 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.404 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 4.6 t -58.54 115.77 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.818 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.421 ' CG ' ' HD2' ' A' ' 375' ' ' LYS . 4.6 mp0 -52.42 -25.52 10.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.42 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.94 -51.18 19.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.481 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.404 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 2.6 mm-40 -64.35 -38.8 92.33 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 59.6 t -56.8 -50.63 74.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.363 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.495 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 72.3 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.918 0.39 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 124.12 -166.07 16.82 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.307 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -140.91 132.55 27.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.75 0.31 . . . . 0.0 110.709 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.494 HG13 HG21 ' A' ' 312' ' ' VAL . 0.0 OUTLIER -123.14 130.17 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.165 0.507 . . . . 0.0 111.013 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.71 126.38 44.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.67 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.611 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.3 p90 -142.2 150.0 40.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.399 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.9 159.65 15.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.21 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 400' ' ' PRO . 31.8 mt -130.7 149.39 52.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.798 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.412 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 16.2 ttp180 -158.95 106.47 1.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.611 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.494 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 27.7 t80 -101.49 137.91 39.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.14 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 44.2 t -123.5 95.81 44.58 Favored Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.522 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.3 Cg_exo -70.54 -34.38 12.06 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.931 2.421 . . . . 0.0 112.733 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.25 -30.71 5.02 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.16 0.505 . . . . 0.0 109.957 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -116.64 -21.72 8.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.844 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.26 48.87 6.17 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.642 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -124.15 129.74 51.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.073 0.463 . . . . 0.0 111.891 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 39.2 tp -95.43 147.63 23.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.867 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 8.3 m -139.33 138.7 36.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 112.06 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.5 124.41 57.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.316 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 25.3 t -117.16 114.67 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.028 0.442 . . . . 0.0 111.852 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.438 HG13 ' CG2' ' A' ' 328' ' ' THR . 26.1 mm -74.68 137.01 23.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.446 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.29 -60.49 1.87 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.421 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 2.4 pt-20 -175.81 159.28 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.243 0.544 . . . . 0.0 112.24 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -123.64 149.5 45.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.853 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -145.55 153.68 41.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.987 0.423 . . . . 0.0 111.375 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 60.54 29.02 18.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.495 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.401 HD12 ' HG3' ' A' ' 310' ' ' PRO . 91.8 mt -66.01 138.79 58.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.951 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -58.41 148.59 27.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.59 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.45 121.9 32.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.465 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.502 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.8 mmt -96.48 -16.67 21.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.316 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 33.1 m-20 -106.97 101.3 10.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.767 0.318 . . . . 0.0 110.504 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.07 116.61 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.54 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.04 87.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.907 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -124.93 -139.47 5.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.85 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 34.1 mt -119.46 -159.21 0.76 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.01 0.433 . . . . 0.0 110.566 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.443 ' HB2' HD21 ' A' ' 335' ' ' LEU . 66.5 m -135.68 172.06 13.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.222 0.534 . . . . 0.0 110.638 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.407 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -131.44 57.57 31.91 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.037 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 309' ' ' ASP . 38.3 Cg_endo -67.66 153.85 74.97 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.136 2.557 . . . . 0.0 114.51 -177.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.516 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 25.1 p90 -156.82 148.3 22.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.355 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.494 HG21 HG13 ' A' ' 276' ' ' ILE . 39.8 t -102.99 143.59 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 327' ' ' LYS . 17.7 mttt -122.08 157.43 31.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.278 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.429 HG21 ' CZ ' ' A' ' 345' ' ' PHE . 5.4 mp -131.51 124.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.651 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -123.5 133.25 54.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 111.157 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 22.5 tp -102.15 105.83 16.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.285 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 0.9 OUTLIER -107.2 143.6 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.245 -179.47 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.58 99.56 9.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.416 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 59.84 37.75 21.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.937 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 90.16 25.56 26.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.902 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 317' ' ' MET . 7.8 mmtm -128.88 109.47 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -52.84 130.81 34.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.227 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 8.3 mt -126.26 -43.21 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.241 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -130.62 158.08 41.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.921 0.391 . . . . 0.0 111.341 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.59 134.21 23.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.837 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -142.3 159.11 42.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.916 0.388 . . . . 0.0 111.247 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 2.9 mttt -142.75 154.65 44.46 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.601 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.438 ' CG2' HG13 ' A' ' 293' ' ' ILE . 13.4 p -111.12 177.22 4.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.847 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.4 142.99 36.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.693 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.516 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.2 mt -90.55 119.17 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.109 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -83.56 89.47 7.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.3 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -57.42 137.4 56.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.799 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 43.91 83.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.365 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 308' ' ' SER . 4.5 t -176.82 174.78 1.73 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.803 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' A' ' 308' ' ' SER . 5.1 mt -146.65 -16.96 0.42 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.223 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.447 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.7 m-80 -132.6 59.26 42.11 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.387 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 44.5 Cg_endo -92.47 167.66 2.79 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.301 2.667 . . . . 0.0 113.756 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.446 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.4 OUTLIER -107.82 160.82 15.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.053 179.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -133.93 -61.62 0.79 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.857 0.361 . . . . 0.0 111.236 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 54.76 36.9 27.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 292' ' ' VAL . 51.6 mt-10 -92.33 142.44 27.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 14.9 m -112.67 117.22 31.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.442 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . 0.404 ' CE1' HG21 ' A' ' 328' ' ' THR . 81.2 m-85 -109.72 156.93 19.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.276 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 17.4 p -129.67 142.67 50.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 111.683 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.429 ' CZ ' HG21 ' A' ' 314' ' ' ILE . 45.0 m-85 -128.59 165.96 19.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.539 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -112.88 78.31 1.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.78 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.425 HG12 HG22 ' A' ' 355' ' ' VAL . 44.0 t -112.95 118.47 44.52 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.49 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 43.2 Cg_endo -68.7 151.87 74.52 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.286 1.991 . . . . 0.0 111.113 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -47.5 -24.39 0.83 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 354' ' ' LYS . 47.3 mt-10 -83.02 -20.7 34.53 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.49 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -93.67 -39.36 10.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.494 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 3.8 tp -45.62 -28.12 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.911 0.386 . . . . 0.0 110.994 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -86.41 -31.11 21.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.806 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 350' ' ' GLU . 3.2 pttm -105.34 11.37 32.87 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.425 HG22 HG12 ' A' ' 347' ' ' VAL . 32.6 m -112.98 163.61 9.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.733 0.302 . . . . 0.0 110.883 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.2 126.51 18.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.222 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.44 HG21 ' CH2' ' A' ' 390' ' ' TRP . 86.5 t -89.56 134.06 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.195 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.52 116.93 53.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.96 0.409 . . . . 0.0 111.692 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.603 ' HB ' HG22 ' A' ' 376' ' ' VAL . 46.0 t -97.67 108.11 21.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.834 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.425 ' CG2' ' HB3' ' A' ' 375' ' ' LYS . 2.2 m -111.65 132.09 54.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.945 0.403 . . . . 0.0 111.978 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.412 HG21 HD22 ' A' ' 407' ' ' LEU . 52.7 t -106.59 113.8 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.906 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.466 ' HB2' ' CE1' ' A' ' 311' ' ' TYR . 3.1 mp -118.6 146.92 44.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.046 0.451 . . . . 0.0 111.69 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.502 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -92.9 134.33 35.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.443 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 365' ' ' ASP . 6.9 t80 -90.29 144.28 25.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.064 0.459 . . . . 0.0 110.911 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . 0.51 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 19.8 m-20 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.018 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.89 0.376 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -106.11 151.56 24.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.68 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -98.35 110.32 22.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.04 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.477 HG22 HD11 ' A' ' 373' ' ' ILE . 36.9 mt -81.26 -34.17 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.196 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 170.63 178.01 41.05 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.098 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.454 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 16.9 ptmt -164.44 140.47 6.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.192 0.52 . . . . 0.0 111.729 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.603 HG22 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -113.24 158.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.116 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -140.68 150.63 43.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 111.345 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.433 HG23 ' CE3' ' A' ' 390' ' ' TRP . 15.4 m . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.997 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.485 0.183 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 31.0 tp -68.94 -32.82 72.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 110.336 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . 0.431 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -66.93 -30.07 70.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.253 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.454 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 20.1 t-160 -77.9 -52.77 8.32 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.646 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.45 ' CZ2' HD11 ' A' ' 352' ' ' ILE . 65.0 t-105 -51.57 -49.02 62.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.074 0.464 . . . . 0.0 109.764 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.2 t -65.69 -29.99 70.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.721 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.466 ' HB3' HD11 ' A' ' 401' ' ' ILE . 0.4 OUTLIER -62.54 -43.76 98.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.753 179.037 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.438 ' HE1' ' CZ3' ' A' ' 390' ' ' TRP . 29.8 ttp -60.39 -52.48 65.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.665 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.7 mt -57.96 -33.37 68.79 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.36 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -67.89 -30.52 69.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.305 0.574 . . . . 0.0 109.692 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.453 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.3 m-80 -114.92 71.41 2.63 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.591 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.546 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 41.4 Cg_endo -68.7 32.95 0.16 Allowed 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.23 2.62 . . . . 0.0 113.534 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . 0.546 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 0.5 OUTLIER -158.77 -44.56 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.933 0.397 . . . . 0.0 110.77 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.439 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.0 OUTLIER -93.84 137.6 23.07 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.154 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.439 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 58.3 Cg_endo -71.43 156.37 58.51 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.571 2.181 . . . . 0.0 112.902 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -126.14 116.11 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.786 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.85 144.71 34.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.312 . . . . 0.0 110.828 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.34 154.25 10.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.37 . . . . 0.0 111.344 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -81.97 120.9 25.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.611 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 55.2 m-70 -109.61 122.36 47.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 85.4 m -78.26 117.27 19.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.674 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.431 ' CD2' HG23 ' A' ' 376' ' ' VAL . 45.2 mt -61.73 127.81 33.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.013 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -115.32 169.58 9.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.888 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.465 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 41.1 t -55.59 121.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.973 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.454 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 6.7 mt-10 -55.17 -40.6 70.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.451 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.75 -51.13 71.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.469 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.465 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.1 mt-10 -63.57 -40.13 96.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.413 ' HB ' ' HD3' ' A' ' 375' ' ' LYS . 98.6 t -56.45 -48.03 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.295 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 24.0 t0 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.745 179.89 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 47.9 mt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.911 0.386 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 127.57 -162.52 21.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.335 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.32 133.37 22.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.691 0.281 . . . . 0.0 110.731 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.551 HG13 HG21 ' A' ' 312' ' ' VAL . 0.1 OUTLIER -123.04 128.98 75.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.302 0.573 . . . . 0.0 111.165 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.26 126.71 41.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.556 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.622 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.2 p90 -142.16 149.51 39.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.474 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -100.94 160.47 14.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.04 -178.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.462 ' CD1' ' CD2' ' A' ' 389' ' ' HIS . 67.0 mt -130.21 147.05 51.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.162 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 290' ' ' THR . 0.7 OUTLIER -158.86 106.48 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 0.0 111.141 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.524 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 38.0 t80 -99.12 139.4 34.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.549 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 287' ' ' GLY . 98.9 t -114.89 93.8 35.54 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.97 0.414 . . . . 0.0 109.956 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 397' ' ' PRO . 16.7 Cg_exo -66.33 -31.38 43.52 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.916 2.411 . . . . 0.0 112.343 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -28.39 67.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.807 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -123.66 -2.92 8.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.677 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 62.97 46.55 93.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.09 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -121.98 128.83 51.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.059 0.457 . . . . 0.0 111.338 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 345' ' ' PHE . 32.8 tp -93.08 147.64 22.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.332 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.402 ' CB ' ' O ' ' A' ' 281' ' ' ARG . 1.8 m -136.0 137.34 41.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.344 0.592 . . . . 0.0 111.857 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.1 t -129.95 122.98 55.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.439 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 24.0 t -116.21 116.12 51.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.979 0.418 . . . . 0.0 111.788 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 339' ' ' TYR . 34.8 mm -76.09 136.89 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.443 HD22 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.21 -59.62 1.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -177.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.457 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 2.2 pt-20 -175.64 156.79 1.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.479 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -117.59 150.63 38.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.766 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.3 pttp -147.73 152.36 37.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 111.507 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 62.92 24.24 14.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.833 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.4 HD12 ' CB ' ' A' ' 310' ' ' PRO . 60.7 mt -59.79 138.68 57.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.997 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -67.01 147.99 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.705 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.427 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 20.0 mttp -81.11 120.9 25.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.581 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.442 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 4.5 mmm -101.13 -15.38 17.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.644 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 52.9 m-20 -98.52 123.05 42.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.839 0.352 . . . . 0.0 110.548 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.0 t -48.07 114.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.627 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 56.77 17.89 22.86 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.274 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.13 -159.72 10.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.06 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 6.6 mt -95.56 -161.67 0.88 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 110.466 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 301' ' ' LYS . 14.4 m -133.99 171.81 13.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.278 0.561 . . . . 0.0 111.181 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.418 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 13.7 m-20 -131.87 56.11 21.99 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 309' ' ' ASP . 58.5 Cg_endo -73.01 146.28 41.29 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.047 2.498 . . . . 0.0 114.842 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.501 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 42.2 p90 -146.2 165.85 27.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.171 -1.377 . . . . 0.0 107.948 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.551 HG21 HG13 ' A' ' 276' ' ' ILE . 48.1 t -115.11 149.95 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.4 ' HG2' ' CB ' ' A' ' 327' ' ' LYS . 13.0 mttt -129.44 164.48 23.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.042 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.433 HG22 ' CE1' ' A' ' 345' ' ' PHE . 4.8 mp -137.86 124.97 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.689 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -119.46 135.56 54.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.89 0.376 . . . . 0.0 111.313 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 345' ' ' PHE . 20.5 tp -103.92 105.55 15.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.457 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.1 mtm -111.04 127.9 55.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.408 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.38 99.6 12.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.283 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 55.16 38.1 29.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.024 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 91.79 27.48 16.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.867 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 317' ' ' MET . 2.3 mptt -130.71 109.39 10.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.732 0.301 . . . . 0.0 110.843 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.35 130.42 27.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.364 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 15.9 mt -124.58 -58.93 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.132 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.66 152.06 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.8 128.86 20.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.709 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -125.71 167.31 15.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.98 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.4 ' CB ' ' HG2' ' A' ' 313' ' ' LYS . 36.6 pttt -147.54 148.66 31.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.142 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.423 ' CG2' HG13 ' A' ' 293' ' ' ILE . 9.7 p -104.7 179.83 4.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.749 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 10.1 t -59.15 172.28 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.501 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.4 mt -116.96 125.1 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.955 0.407 . . . . 0.0 111.377 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.423 ' HG3' ' HB2' ' A' ' 337' ' ' PRO . 0.2 OUTLIER -91.08 91.45 8.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.281 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -58.83 137.09 57.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.833 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 44.54 80.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.413 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 4.7 t -172.98 173.49 3.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.556 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 3.2 mt -146.99 -14.75 0.41 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.391 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.466 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.8 m-80 -135.81 57.63 19.78 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 120.704 0.288 . . . . 0.0 110.506 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.466 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 45.5 Cg_endo -92.79 167.82 2.58 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.155 2.57 . . . . 0.0 113.721 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.443 ' CE2' HD22 ' A' ' 294' ' ' LEU . 0.6 OUTLIER -106.31 160.76 15.12 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.192 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.533 ' HB2' HG23 ' A' ' 293' ' ' ILE . 66.1 m-85 -132.65 -66.83 0.67 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.916 0.388 . . . . 0.0 110.982 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 60.72 37.35 19.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.843 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' A' ' 293' ' ' ILE . 29.9 mt-10 -93.65 143.91 25.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 93.1 p -113.21 121.92 45.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.007 0.432 . . . . 0.0 111.481 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . 0.421 ' CZ ' HG23 ' A' ' 328' ' ' THR . 36.7 m-85 -110.42 164.85 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.321 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 21.6 m -137.49 140.1 40.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.092 0.472 . . . . 0.0 111.679 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.433 ' CE1' HG22 ' A' ' 314' ' ' ILE . 38.3 m-85 -126.88 166.0 18.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.503 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.33 72.99 0.79 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.727 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.419 ' CG2' HD21 ' A' ' 316' ' ' LEU . 46.9 t -108.38 121.08 44.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.135 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.539 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 68.5 Cg_endo -74.4 157.84 44.93 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.358 2.038 . . . . 0.0 111.247 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -50.9 -22.23 2.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -89.15 -8.46 53.65 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.539 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -111.98 -27.19 8.52 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.524 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 4.5 tp -48.37 -26.92 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.741 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -95.09 -26.58 15.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.618 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -92.32 -0.66 57.37 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.883 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 24.8 m -110.24 163.18 7.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.92 0.39 . . . . 0.0 111.317 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -139.24 126.33 21.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.62 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.428 HG22 ' CZ3' ' A' ' 390' ' ' TRP . 98.9 t -90.88 111.81 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.533 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.95 109.39 24.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.399 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.612 ' HB ' HG22 ' A' ' 376' ' ' VAL . 48.8 t -90.48 108.0 19.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.442 ' CG2' ' HB3' ' A' ' 375' ' ' LYS . 1.5 m -108.25 133.43 52.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.02 0.438 . . . . 0.0 111.894 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 51.1 t -108.3 114.8 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.839 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.437 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.5 mp -118.3 150.05 40.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.063 0.458 . . . . 0.0 111.838 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.442 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 1.3 t70 -95.53 132.36 40.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.679 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -83.74 146.2 28.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.538 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 . . . . . 0 CA--C 1.531 0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.7 -179.372 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.523 -0.068 0 CA-C-O 120.94 0.4 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.94 139.38 35.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -87.71 111.57 21.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.882 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.439 HD13 HG21 ' A' ' 373' ' ' ILE . 37.2 mt -79.78 -34.42 15.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.01 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.92 -179.81 40.97 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.961 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.442 ' HB3' ' CG2' ' A' ' 360' ' ' THR . 9.6 ptmt -164.6 140.62 5.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.513 . . . . 0.0 111.81 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.618 HG12 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -109.47 158.89 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.128 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -139.58 151.4 46.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 0.0 111.813 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.414 HG23 ' CE3' ' A' ' 390' ' ' TRP . 17.0 m . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.03 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.729 0.299 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.76 -35.96 79.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.463 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 392' ' ' ASP . 4.0 mtt85 -61.77 -41.37 97.62 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.978 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.471 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 13.9 t-160 -60.99 -55.69 29.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.738 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.449 ' CZ3' ' HE1' ' A' ' 393' ' ' MET . 62.5 t-105 -55.44 -50.99 68.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.462 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -37.26 86.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.312 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.514 ' HB3' HD11 ' A' ' 401' ' ' ILE . 14.8 m-20 -63.07 -32.83 74.29 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.48 ' HA ' HG13 ' A' ' 401' ' ' ILE . 26.0 ttp -63.42 -56.4 16.54 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.426 HD23 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -56.38 -23.26 36.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.715 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -78.99 -33.63 44.87 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.372 0.606 . . . . 0.0 109.374 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.408 ' N ' ' HD3' ' A' ' 397' ' ' PRO . 28.6 m-80 -130.1 59.76 47.45 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.459 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.627 ' HB3' ' HD3' ' A' ' 284' ' ' PRO . 65.5 Cg_exo -46.28 -76.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.921 2.414 . . . . 0.0 112.992 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -49.45 -21.94 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.87 133.49 27.67 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 110.881 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.3 Cg_endo -75.21 133.76 16.66 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.492 2.128 . . . . 0.0 112.614 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' ' 392' ' ' ASP . 1.1 mm -111.68 110.75 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.803 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.18 143.96 34.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.783 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.43 152.39 7.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.874 0.369 . . . . 0.0 111.378 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -80.12 124.09 28.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.686 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.622 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 61.0 m-70 -112.31 123.0 49.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.628 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 91.5 m -78.36 117.08 19.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.653 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.401 ' CD2' HG23 ' A' ' 276' ' ' ILE . 80.9 mt -62.45 127.73 32.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.077 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -115.85 170.26 8.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.791 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.465 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 61.1 t -55.22 117.39 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.812 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -52.01 -43.09 63.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.832 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -58.06 -50.16 74.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.738 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.465 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 23.0 mt-10 -64.04 -38.8 92.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 89.0 t -57.43 -48.32 83.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.286 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 33.1 t0 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.468 179.504 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 55.0 mt . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.922 0.391 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 135.16 -170.16 23.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.19 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -136.74 135.15 37.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.719 0.295 . . . . 0.0 111.01 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -125.37 128.7 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.03 0.443 . . . . 0.0 110.875 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.37 126.6 42.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.826 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.612 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.0 p90 -142.22 152.15 42.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.406 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.49 163.4 12.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.005 -178.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.485 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 96.1 mt -136.81 143.43 43.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.281 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.408 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 7.3 ttm180 -159.13 110.76 2.11 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.884 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.504 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 26.9 t80 -104.42 139.15 39.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.802 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.54 97.22 42.48 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.5 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.84 -33.47 7.9 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.669 2.246 . . . . 0.0 112.632 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -29.36 6.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.165 0.507 . . . . 0.0 109.983 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.29 -18.16 8.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.945 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.79 48.87 8.29 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.548 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -123.69 129.9 51.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.986 0.422 . . . . 0.0 111.621 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.411 ' CD1' ' HE3' ' A' ' 393' ' ' MET . 38.5 tp -97.42 147.49 24.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.977 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 2.8 m -137.61 137.21 38.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.429 0.633 . . . . 0.0 111.965 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.7 t -130.92 123.6 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.162 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 23.9 t -117.9 115.13 47.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.057 0.456 . . . . 0.0 111.794 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 339' ' ' TYR . 40.0 mm -74.83 137.11 23.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.02 -59.4 2.02 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.426 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 4.7 pt-20 -175.75 162.89 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.415 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -122.31 153.06 39.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.897 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -149.61 150.02 31.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.104 0.478 . . . . 0.0 111.534 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 60.38 26.27 15.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.878 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.417 HD12 ' CB ' ' A' ' 310' ' ' PRO . 94.2 mt -62.08 138.75 58.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.832 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.81 150.7 23.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.57 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -91.58 115.84 28.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.423 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.484 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.5 mmt -88.56 -19.26 26.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.541 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 50.1 m-20 -99.26 112.16 24.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.512 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -49.27 116.37 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.476 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 65.69 12.74 57.5 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.536 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.17 -151.01 7.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.75 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 10.6 mt -108.29 -161.51 0.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.697 0.284 . . . . 0.0 110.68 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.425 ' HB2' HD21 ' A' ' 335' ' ' LEU . 49.8 m -137.68 172.04 13.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.369 0.604 . . . . 0.0 111.276 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.407 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 8.7 m-20 -131.38 57.86 34.13 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.735 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.417 ' CB ' HD12 ' A' ' 299' ' ' LEU . 45.0 Cg_endo -69.74 151.92 69.32 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.196 2.597 . . . . 0.0 114.729 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 35.0 p90 -154.35 155.44 35.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.108 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.449 ' CG1' ' CG1' ' A' ' 359' ' ' VAL . 47.1 t -106.38 149.79 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 360' ' ' THR . 9.9 mtmt -131.93 140.99 49.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.307 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.42 HG23 ' CZ ' ' A' ' 345' ' ' PHE . 5.3 mp -115.79 127.74 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.556 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . 0.421 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 57.7 m80 -122.39 133.4 54.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.369 . . . . 0.0 111.378 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.404 HD22 HG21 ' A' ' 347' ' ' VAL . 38.7 tp -106.39 107.53 18.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.095 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.1 mtm -116.12 147.82 40.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.391 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.411 ' NE2' ' CD ' ' A' ' 354' ' ' LYS . 1.4 mt-30 -107.0 99.47 9.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.521 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 56.55 37.83 29.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 96.6 13.82 46.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.166 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 317' ' ' MET . 32.3 mmtt -119.18 109.12 15.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.808 0.304 . . . . 0.0 110.734 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.48 135.37 56.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.4 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.401 ' CD1' ' HG3' ' A' ' 318' ' ' GLN . 3.3 mt -127.08 -49.36 1.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.849 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.487 ' HB2' ' HE2' ' A' ' 345' ' ' PHE . 2.5 mttt -130.53 148.97 52.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.962 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . 0.421 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -144.25 119.54 10.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.753 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -122.96 155.88 35.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -137.58 148.58 45.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.842 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.412 ' CG2' HG13 ' A' ' 293' ' ' ILE . 4.3 p -101.71 -179.0 3.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.844 0.354 . . . . 0.0 110.712 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.0 t -60.45 162.2 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.468 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.483 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.6 mt -105.07 121.92 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.921 0.391 . . . . 0.0 111.219 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.6 94.65 9.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.109 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -60.8 136.8 58.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.928 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 43.83 83.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.51 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.5 t -177.06 174.5 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.879 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 308' ' ' SER . 4.3 mt -145.26 -16.86 0.49 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.294 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -131.42 61.68 60.41 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.862 0.363 . . . . 0.0 110.05 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -88.57 167.63 6.11 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.145 2.564 . . . . 0.0 114.045 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 58.8 t80 -114.09 153.18 29.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.846 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.474 ' HB2' HG21 ' A' ' 293' ' ' ILE . 83.9 m-85 -132.98 -69.83 0.55 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.85 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . 0.481 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 26.2 t-20 64.45 37.21 8.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.505 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 293' ' ' ILE . 31.3 mt-10 -91.42 142.9 27.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.787 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 13.7 m -110.28 122.18 47.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 0.0 111.581 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -113.2 148.36 35.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.091 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 3.0 m -120.8 140.0 52.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.1 0.476 . . . . 0.0 111.554 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.487 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 45.0 m-85 -126.88 165.87 18.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.437 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -116.62 76.1 1.01 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.958 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.461 HG13 HG23 ' A' ' 355' ' ' VAL . 55.7 t -109.16 122.92 38.31 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.209 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.514 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.4 Cg_endo -72.3 156.43 54.93 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.293 1.996 . . . . 0.0 111.3 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -50.68 -21.92 1.82 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.67 -8.5 52.27 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.514 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -107.88 -31.36 8.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.504 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 6.4 tp -46.81 -27.28 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 111.319 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -90.02 -47.54 7.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.627 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.43 ' CG ' ' HA ' ' A' ' 351' ' ' GLN . 5.9 ptpt -80.72 2.18 27.1 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.461 HG23 HG13 ' A' ' 347' ' ' VAL . 33.1 m -107.66 165.38 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.729 0.299 . . . . 0.0 110.872 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.67 126.46 15.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.087 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.426 HG22 ' CH2' ' A' ' 390' ' ' TRP . 61.4 t -88.54 114.14 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.276 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.16 116.29 43.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.756 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.596 ' HB ' HG23 ' A' ' 376' ' ' VAL . 58.3 t -98.46 108.11 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.856 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 313' ' ' LYS . 1.6 m -108.73 132.68 53.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.998 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 54.6 t -105.93 114.96 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.636 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 311' ' ' TYR . 3.3 mp -118.71 147.84 43.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.096 0.474 . . . . 0.0 111.895 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.484 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.8 t70 -93.8 137.36 33.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.744 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -90.09 145.62 24.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.376 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 . . . . . 0 C--N 1.33 -0.268 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.288 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.916 0.388 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.01 148.9 37.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.15 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -95.4 110.89 22.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 373' ' ' ILE . 23.9 mt -79.59 -32.88 14.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.316 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 166.48 -178.87 40.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.746 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.471 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 10.9 ptmt -164.54 141.04 6.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.181 0.515 . . . . 0.0 111.686 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.61 HG13 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.86 158.79 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.226 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.409 ' CZ ' ' OE1' ' A' ' 386' ' ' GLU . 8.3 p90 -141.78 143.03 33.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.374 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.6 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.082 -179.939 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.409 ' OE1' ' CZ ' ' A' ' 377' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.57 0.224 . . . . 0.0 110.984 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.9 tp -67.96 -30.91 70.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.781 0.324 . . . . 0.0 110.43 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 5.1 ptt180 -68.23 -28.21 67.03 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.329 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.444 ' CD2' HG21 ' A' ' 401' ' ' ILE . 18.4 t-160 -81.33 -54.48 5.44 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.456 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.426 ' CH2' HG22 ' A' ' 357' ' ' VAL . 48.2 t-105 -49.96 -43.97 50.44 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.008 0.432 . . . . 0.0 109.863 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 31.3 t -69.72 -34.1 73.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.694 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 0.5 OUTLIER -61.08 -39.57 90.4 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.485 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 19.8 ttm -59.42 -53.79 54.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.115 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.9 mt -63.81 -29.74 70.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.374 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.82 -31.02 71.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.226 0.536 . . . . 0.0 109.694 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -125.3 77.86 67.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.329 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.505 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 6.0 Cg_exo -77.8 42.76 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.145 2.564 . . . . 0.0 113.162 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . 0.505 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 16.2 mmm-85 -158.98 -46.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.069 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.21 142.84 25.45 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.925 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.01 156.27 52.2 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.654 2.236 . . . . 0.0 112.904 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.448 HD13 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.81 114.69 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.749 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.91 144.21 35.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.759 0.314 . . . . 0.0 110.832 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.43 154.68 10.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.959 0.409 . . . . 0.0 111.291 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -81.38 120.35 24.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.959 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.612 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 48.3 m-70 -109.56 117.72 34.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.459 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 89.8 m -78.43 116.22 18.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.792 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.469 HD21 HG21 ' A' ' 376' ' ' VAL . 93.7 mt -61.09 128.12 34.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.347 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -115.47 171.96 7.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.558 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.494 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 44.2 t -54.59 120.72 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.471 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 14.8 mt-10 -54.29 -41.56 69.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.815 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.16 -51.33 70.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 0.0 110.539 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.494 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 24.6 mt-10 -62.49 -39.83 94.73 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 75.6 t -57.64 -50.11 78.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.378 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 58.2 t0 . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.887 179.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 22.0 mt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.827 0.346 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 117.75 -163.98 12.73 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.177 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -143.6 132.18 22.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.731 0.301 . . . . 0.0 110.589 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -121.04 131.57 72.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.184 0.516 . . . . 0.0 111.184 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.407 ' N ' ' CD1' ' A' ' 276' ' ' ILE . 0.1 OUTLIER -99.59 125.08 45.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.709 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.626 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 16.0 p90 -139.91 150.69 44.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.24 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.0 OUTLIER -99.62 158.03 16.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.056 -178.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.492 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 77.3 mt -129.44 144.87 51.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.018 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.437 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 22.7 ttp85 -158.89 109.22 2.02 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.702 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.5 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 26.1 t80 -103.39 137.98 40.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.93 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.0 t -122.29 94.6 47.78 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.523 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.5 Cg_exo -70.04 -32.63 17.06 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.939 2.426 . . . . 0.0 112.44 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.44 -30.03 7.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.184 0.516 . . . . 0.0 110.015 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.53 -21.45 7.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.962 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.92 48.44 6.11 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.549 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -124.04 130.18 52.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.983 0.421 . . . . 0.0 111.803 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 33.2 tp -95.66 147.5 23.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.74 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 7.1 m -138.19 136.58 36.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.31 0.576 . . . . 0.0 112.001 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.36 123.92 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.297 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 34.8 t -118.06 115.44 48.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.976 0.417 . . . . 0.0 112.006 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.439 HG21 ' HB2' ' A' ' 339' ' ' TYR . 31.3 mm -73.85 135.34 27.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.41 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.7 OUTLIER -112.62 -62.76 1.53 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.459 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 1.6 pt-20 -175.55 150.15 1.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.247 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -110.46 157.77 19.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.168 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -150.98 153.41 35.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.014 0.435 . . . . 0.0 111.724 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 59.08 25.2 13.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.93 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 335' ' ' LEU . 49.6 mt -59.04 138.63 57.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.168 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.83 144.78 47.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.406 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 25.5 mttp -85.69 109.64 18.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.406 ' HG2' ' CB ' ' A' ' 363' ' ' ASP . 0.0 OUTLIER -86.13 -21.62 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.872 -179.404 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 50.5 m-20 -95.39 123.56 38.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 20.5 t -54.19 117.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.546 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.11 16.74 34.61 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.407 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.84 -154.92 8.71 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.679 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 15.1 mt -102.26 -161.36 0.84 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.788 0.327 . . . . 0.0 110.43 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 334' ' ' THR . 68.8 m -135.32 172.05 13.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.231 0.539 . . . . 0.0 110.972 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.419 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -133.53 55.86 18.09 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 363' ' ' ASP . 69.5 Cg_endo -76.71 142.58 23.02 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.944 2.429 . . . . 0.0 114.93 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.577 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 14.7 p90 -137.46 167.05 22.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.36 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 276' ' ' ILE . 43.1 t -113.05 150.07 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -133.41 139.91 47.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.189 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.4 mp -114.63 131.01 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.685 0.279 . . . . 0.0 111.03 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -127.37 134.08 49.97 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.863 0.363 . . . . 0.0 111.015 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.429 HD23 ' CG2' ' A' ' 347' ' ' VAL . 22.5 tp -103.99 106.47 16.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.409 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' MET . . . . . 0.423 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.6 mtm -110.7 135.33 51.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.138 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.48 99.46 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.546 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 59.58 35.66 22.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.301 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 98.21 7.99 55.56 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.676 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 317' ' ' MET . 0.0 OUTLIER -115.47 112.74 22.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.387 0.593 . . . . 0.0 110.94 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.25 134.19 33.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.526 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 13.4 mt -125.91 -45.95 1.71 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 9.5 mmtp -130.59 153.63 48.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.364 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 117.31 10.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.903 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 3.4 mmtm -123.63 164.68 18.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.104 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.52 152.68 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.97 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.42 HG22 ' CE1' ' A' ' 343' ' ' PHE . 16.1 p -109.83 -178.89 3.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 11.3 t -63.0 165.85 6.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.577 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.9 mt -108.49 117.29 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 111.509 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.4 ' CD ' ' HB2' ' A' ' 337' ' ' PRO . 8.3 mmpt? -80.07 85.95 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.875 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -55.12 135.84 48.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.021 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.32 83.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.49 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 308' ' ' SER . 4.5 t -175.63 174.39 2.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.681 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.408 ' O ' ' HG ' ' A' ' 299' ' ' LEU . 5.2 mt -145.59 -17.16 0.48 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.185 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.467 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.72 56.53 22.98 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.908 0.385 . . . . 0.0 110.123 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 42.7 Cg_endo -90.1 167.79 4.51 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.203 2.602 . . . . 0.0 113.746 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -109.63 159.6 16.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.167 179.244 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.459 ' CD2' ' HA ' ' A' ' 295' ' ' GLU . 51.1 m-85 -132.48 -62.32 0.83 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.68 37.42 25.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 293' ' ' ILE . 30.1 mt-10 -92.47 144.47 25.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.706 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 51.6 p -115.48 120.76 40.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.393 . . . . 0.0 111.749 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . 0.42 ' CE1' HG22 ' A' ' 328' ' ' THR . 80.8 m-85 -112.38 155.06 24.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.11 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 83.4 p -127.16 139.62 52.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.083 0.468 . . . . 0.0 111.591 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 66.3 m-85 -127.89 165.86 19.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.545 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.56 79.93 1.33 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.998 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.429 ' CG2' HD23 ' A' ' 316' ' ' LEU . 47.9 t -112.16 118.99 45.04 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.991 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.465 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 37.2 Cg_endo -66.52 154.02 75.88 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.321 2.014 . . . . 0.0 111.353 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -51.9 -24.74 6.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.752 0.31 . . . . 0.0 111.444 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.27 -8.57 57.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.54 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.465 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 31.2 mt-30 -105.99 -37.14 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.667 0.27 . . . . 0.0 111.329 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.5 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 4.7 tp -47.13 -25.52 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 111.195 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -88.99 -24.86 22.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.831 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.69 2.14 17.08 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.416 HG22 ' CZ2' ' A' ' 390' ' ' TRP . 33.8 m -96.77 167.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.766 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -141.28 126.33 18.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.928 0.394 . . . . 0.0 111.472 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.405 HG22 ' CZ3' ' A' ' 390' ' ' TRP . 99.6 t -96.93 115.33 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.833 178.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.442 ' CG1' ' HE2' ' A' ' 375' ' ' LYS . 0.4 OUTLIER -101.22 117.17 46.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.605 ' HB ' HG21 ' A' ' 376' ' ' VAL . 45.9 t -98.22 107.85 20.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.435 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 4.7 m -111.28 129.58 55.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.054 0.454 . . . . 0.0 111.9 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 58.5 t -103.81 121.1 54.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.074 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.444 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 2.8 mp -123.18 146.26 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 111.816 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 310' ' ' PRO . 5.0 t70 -90.17 137.62 32.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.642 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -94.14 142.52 27.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.425 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.584 -179.488 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.902 0.382 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.23 147.25 48.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.51 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -91.7 110.22 21.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.094 0.473 . . . . 0.0 111.373 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 2.4 mm -71.95 -35.57 54.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.783 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 157.38 -175.16 34.84 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.117 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.484 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 9.9 ptmt -164.1 140.5 6.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.287 0.565 . . . . 0.0 111.906 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.605 HG21 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -113.71 158.85 13.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.219 179.375 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 377' ' ' PHE . 2.6 p90 -140.45 150.85 44.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.563 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.151 179.837 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 . . . . . 0 CA--C 1.52 -0.197 0 CA-C-O 120.903 0.382 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.45 -30.91 71.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.368 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 4.7 ptt180 -65.52 -28.63 69.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.312 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.47 ' CD2' HG23 ' A' ' 401' ' ' ILE . 19.7 t-160 -81.56 -58.13 3.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.715 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.458 ' CZ2' HD11 ' A' ' 352' ' ' ILE . 73.9 t-105 -49.82 -46.32 50.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.07 0.462 . . . . 0.0 109.979 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 5.4 t -64.49 -32.94 74.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.593 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.486 ' HB3' HD11 ' A' ' 401' ' ' ILE . 0.6 OUTLIER -65.47 -40.46 93.19 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.492 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 7.1 ttm -57.86 -53.06 62.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.378 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.8 mt -61.94 -34.37 75.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.359 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.65 -29.71 69.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.181 0.515 . . . . 0.0 109.943 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.425 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.7 m-80 -114.1 71.04 2.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.754 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.55 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 48.6 Cg_endo -70.07 33.98 0.21 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.167 2.578 . . . . 0.0 113.486 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . 0.55 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 10.2 mmm180 -159.25 -47.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.952 0.406 . . . . 0.0 110.952 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.482 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 36.1 ttt180 -93.94 136.66 23.55 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.385 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.482 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 48.6 Cg_endo -68.48 156.41 65.71 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.601 2.201 . . . . 0.0 112.939 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.37 118.72 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.797 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -105.64 144.58 32.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.839 0.352 . . . . 0.0 110.729 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.07 154.51 15.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.159 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -85.81 119.28 25.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.774 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.626 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 58.4 m-70 -108.56 122.16 46.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.251 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 89.9 m -78.08 117.41 19.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.721 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 67.5 mt -61.66 127.57 32.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.2 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -115.0 169.07 9.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.755 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.453 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 45.0 t -56.76 121.25 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.484 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 5.7 mt-10 -52.2 -44.83 64.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.993 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.06 -49.66 75.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 110.74 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.453 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 29.8 mt-10 -64.59 -38.76 92.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.414 HG23 ' HG2' ' A' ' 375' ' ' LYS . 96.3 t -58.24 -49.49 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.381 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 t70 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.829 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 60.8 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.868 0.366 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.24 -165.73 13.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.233 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.18 133.06 27.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -121.94 129.56 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.088 0.47 . . . . 0.0 110.914 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.86 125.35 41.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.668 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.609 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.6 p90 -142.08 149.29 39.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.406 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.97 161.31 13.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.269 -178.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.438 HD11 ' CE1' ' A' ' 389' ' ' HIS . 11.3 mt -133.27 149.67 51.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.942 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.44 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.1 OUTLIER -158.92 105.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.446 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.515 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 30.7 t80 -98.19 134.87 40.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.832 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.51 97.88 48.56 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.493 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.9 Cg_exo -72.46 -31.49 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.691 2.261 . . . . 0.0 112.377 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.26 -30.26 6.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.294 0.569 . . . . 0.0 109.715 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.16 -17.38 8.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.767 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.11 47.94 10.46 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.689 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -123.31 129.38 51.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.934 0.397 . . . . 0.0 111.853 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 36.5 tp -92.59 147.66 22.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.796 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 2.9 m -137.16 138.54 40.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.323 0.582 . . . . 0.0 112.091 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.1 t -131.42 123.91 53.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.449 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 29.0 t -116.74 115.3 48.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.942 0.401 . . . . 0.0 111.848 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 339' ' ' TYR . 31.6 mm -75.83 133.7 30.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.57 -59.86 1.89 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 7.3 pt-20 -175.72 165.17 3.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.241 0.543 . . . . 0.0 112.081 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -127.84 155.35 44.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.258 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -149.7 150.2 31.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 111.5 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 59.87 26.34 15.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.735 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.449 HD11 ' CG ' ' A' ' 310' ' ' PRO . 87.5 mt -64.83 139.0 58.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.108 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -57.62 145.61 33.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.381 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 127.77 41.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.405 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.479 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 14.7 mmt -97.78 -9.82 25.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.405 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 25.4 m-20 -108.52 119.17 38.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.718 0.294 . . . . 0.0 110.445 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.32 118.77 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.576 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 76.86 2.18 75.83 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.195 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -120.82 -123.26 3.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.932 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 44.0 mt -137.32 -159.28 0.94 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.906 0.384 . . . . 0.0 110.071 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.492 ' HB3' ' HD3' ' A' ' 310' ' ' PRO . 0.2 OUTLIER -140.13 167.98 20.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.933 0.397 . . . . 0.0 110.255 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.08 64.43 52.8 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 308' ' ' SER . 60.7 Cg_endo -74.03 142.68 31.49 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.827 2.351 . . . . 0.0 114.697 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.539 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 43.1 p90 -144.25 158.52 43.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.212 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.447 ' CG1' ' CG1' ' A' ' 359' ' ' VAL . 44.2 t -107.82 149.91 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.409 0.623 . . . . 0.0 112.625 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 360' ' ' THR . 9.7 mtmt -132.85 136.94 46.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.517 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.418 HG22 ' CZ ' ' A' ' 345' ' ' PHE . 5.4 mp -107.97 136.97 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.513 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . 0.431 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 77.9 m80 -130.89 133.6 46.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.379 . . . . 0.0 111.131 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.79 110.23 22.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.376 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.7 mtm -118.99 139.73 51.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.939 0.4 . . . . 0.0 111.378 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.63 99.44 10.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.411 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 53.02 38.1 26.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.4 26.82 12.83 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.87 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.8 mptt -129.23 109.3 11.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.706 0.288 . . . . 0.0 110.779 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.14 130.0 29.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.52 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 11.5 mt -125.86 -55.04 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.973 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -130.62 150.71 51.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.319 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . 0.431 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -144.45 123.41 12.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.422 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 21.6 mmtt -125.19 170.79 10.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.25 147.01 27.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.418 ' CG2' HG13 ' A' ' 293' ' ' ILE . 5.5 p -104.27 -178.71 3.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.758 0.313 . . . . 0.0 110.782 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 13.9 t -60.33 164.02 4.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.432 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.539 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.9 mt -108.11 116.87 52.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.973 0.416 . . . . 0.0 111.379 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.405 ' HG3' ' CG ' ' A' ' 337' ' ' PRO . 0.7 OUTLIER -78.81 85.93 4.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.034 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -53.51 136.45 38.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.167 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 43.6 86.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.277 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 308' ' ' SER . 5.0 t 177.31 173.16 0.5 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.52 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.448 ' CD2' ' HB2' ' A' ' 308' ' ' SER . 2.8 mt -144.28 -15.29 0.58 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.357 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.418 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.0 OUTLIER -132.6 61.14 55.11 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-O 120.857 0.361 . . . . 0.0 110.039 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 52.0 Cg_endo -91.21 167.71 3.55 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.196 2.597 . . . . 0.0 114.028 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.463 ' CD1' ' HB3' ' A' ' 295' ' ' GLU . 20.7 t80 -110.76 154.09 24.41 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.748 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.489 ' HB2' HG22 ' A' ' 293' ' ' ILE . 75.8 m-85 -131.39 -68.93 0.64 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.855 0.36 . . . . 0.0 111.727 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . 0.424 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 0.1 OUTLIER 63.71 36.65 10.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.703 -179.4 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 293' ' ' ILE . 37.4 mt-10 -91.8 144.68 25.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.6 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 51.5 p -114.87 121.81 44.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.934 0.397 . . . . 0.0 111.656 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -113.75 151.84 31.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.163 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 87.9 p -125.97 138.89 53.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.155 0.502 . . . . 0.0 111.789 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.418 ' CZ ' HG22 ' A' ' 314' ' ' ILE . 56.9 m-85 -125.42 166.05 17.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.585 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -113.27 78.21 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.913 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.414 ' O ' ' OH ' ' A' ' 282' ' ' TYR . 48.6 t -110.6 122.12 39.25 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.82 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.4 Cg_endo -72.54 157.55 52.51 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.352 2.035 . . . . 0.0 111.657 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -51.46 -21.89 2.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.841 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.33 -8.54 53.04 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.526 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -109.86 -30.31 7.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.515 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 6.4 tp -47.4 -28.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.811 0.338 . . . . 0.0 111.026 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -95.0 -25.82 16.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.897 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -95.1 0.84 54.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.875 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 17.2 m -113.18 161.11 12.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.833 0.349 . . . . 0.0 111.302 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -137.1 126.34 24.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.713 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.433 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 91.6 t -87.08 107.43 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.402 . . . . 0.0 110.248 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.411 ' CG1' ' HE2' ' A' ' 375' ' ' LYS . 0.7 OUTLIER -93.36 113.68 28.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.592 -179.29 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.602 ' HB ' HG21 ' A' ' 376' ' ' VAL . 41.7 t -96.69 107.74 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.915 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 313' ' ' LYS . 1.7 m -109.01 131.34 55.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.966 0.412 . . . . 0.0 111.774 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 50.5 t -106.16 114.95 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.946 178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 311' ' ' TYR . 3.5 mp -118.3 150.54 39.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.025 0.44 . . . . 0.0 111.885 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.479 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.1 t70 -94.76 131.37 40.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.361 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -85.67 146.91 26.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.759 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.321 -179.553 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.874 0.369 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . 0.427 ' HB2' ' HG3' ' A' ' 302' ' ' MET . 1.8 m-20 -85.8 151.3 23.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.035 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -98.07 111.34 23.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.974 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.419 HG22 HD13 ' A' ' 373' ' ' ILE . 31.3 mt -80.97 -34.08 13.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.086 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.29 -178.96 41.16 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.88 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.471 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 14.7 ptmt -164.59 141.07 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.196 0.522 . . . . 0.0 111.792 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.602 HG21 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -113.78 158.99 13.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.189 179.516 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 377' ' ' PHE . 2.8 p90 -141.04 144.77 35.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 0.0 111.266 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 13.5 m . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.115 -179.964 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.567 0.223 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 20.5 tp -66.13 -31.75 72.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.867 0.365 . . . . 0.0 110.387 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -65.12 -29.69 70.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.456 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.463 ' CD2' HG21 ' A' ' 401' ' ' ILE . 20.3 t-160 -77.99 -53.07 7.84 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.444 ' CZ2' HD13 ' A' ' 352' ' ' ILE . 55.7 t-105 -51.36 -49.23 61.89 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.177 0.513 . . . . 0.0 109.993 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -29.32 69.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.696 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 0.5 OUTLIER -61.98 -42.54 99.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.672 178.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.425 ' HE2' ' CH2' ' A' ' 390' ' ' TRP . 27.9 ttp -59.53 -52.61 64.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.58 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.403 ' O ' ' HG3' ' A' ' 397' ' ' PRO . 2.9 mt -60.87 -30.01 69.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.361 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.98 -33.02 75.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.218 0.532 . . . . 0.0 109.584 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -126.24 77.9 71.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.278 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.544 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 2.7 Cg_exo -75.79 44.37 1.27 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.238 2.625 . . . . 0.0 113.258 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . 0.544 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 0.4 OUTLIER -158.12 -46.52 0.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.231 179.675 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.452 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.3 OUTLIER -94.15 139.43 22.53 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.721 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.452 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 56.7 Cg_endo -70.48 156.16 62.05 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.548 2.165 . . . . 0.0 113.015 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.463 HG21 ' CD2' ' A' ' 389' ' ' HIS . 1.2 mm -127.02 113.73 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.603 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.24 145.01 32.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.731 0.301 . . . . 0.0 110.801 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.95 154.39 11.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.912 0.386 . . . . 0.0 111.195 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -81.6 120.52 25.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.609 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 49.1 m-70 -108.86 121.87 45.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.427 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.0 m -78.3 116.44 18.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.444 HD23 HG22 ' A' ' 376' ' ' VAL . 96.6 mt -62.45 128.1 34.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.004 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -116.9 171.64 7.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.778 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.455 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 43.5 t -56.57 120.81 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.471 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 19.0 mt-10 -53.73 -43.25 68.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.857 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -57.31 -49.52 75.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 0.0 110.602 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.455 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 30.7 mt-10 -64.55 -39.28 93.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 178.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 74.8 t -58.57 -49.93 80.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.258 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 18.3 t0 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.921 179.918 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 42.5 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.83 0.347 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 125.17 -160.63 19.77 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.271 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -147.13 131.93 17.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.733 0.301 . . . . 0.0 110.75 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -119.97 132.2 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.144 0.497 . . . . 0.0 111.174 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.407 ' HB2' ' CE3' ' A' ' 404' ' ' TRP . 0.1 OUTLIER -99.48 126.01 45.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.758 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.617 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.7 p90 -141.94 151.53 42.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.303 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.68 160.75 14.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.987 -178.451 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.487 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 98.2 mt -134.44 144.18 47.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.318 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.409 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 6.4 ttp180 -159.02 111.19 2.18 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.909 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 25.1 t80 -104.45 138.85 40.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.977 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.04 94.29 47.37 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.526 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.5 Cg_exo -70.24 -33.86 14.01 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.916 2.411 . . . . 0.0 112.385 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -30.23 5.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.157 0.503 . . . . 0.0 110.019 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.72 -20.0 8.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.985 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.75 48.16 6.8 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.639 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.57 130.27 52.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.008 0.433 . . . . 0.0 111.703 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.401 ' CD1' ' HE3' ' A' ' 393' ' ' MET . 28.7 tp -97.82 147.53 24.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.868 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 12.2 m -138.82 136.67 35.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.272 0.558 . . . . 0.0 112.002 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 11.9 t -129.15 125.36 62.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.372 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 24.5 t -119.2 115.34 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.965 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.447 HG23 ' HB2' ' A' ' 339' ' ' TYR . 34.3 mm -74.69 137.02 23.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.444 HD21 ' CE2' ' A' ' 338' ' ' TYR . 0.6 OUTLIER -114.22 -62.22 1.63 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 1.9 pt-20 -175.02 150.27 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.568 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -109.5 154.65 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.931 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.92 152.42 33.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.045 0.45 . . . . 0.0 111.552 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 61.29 24.19 14.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.853 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 66.5 mt -59.14 141.23 54.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.109 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -63.69 146.4 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.424 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.41 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 17.8 mttt -84.91 116.99 23.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.522 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' MET . . . . . 0.493 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.5 mmt -93.46 -18.89 21.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.488 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 35.7 m-20 -103.98 102.65 12.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.852 0.358 . . . . 0.0 110.573 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.14 116.46 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.445 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 83.98 -4.34 83.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.811 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.53 -149.1 7.23 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.881 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 60.3 mt -107.49 -159.97 0.71 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.01 0.433 . . . . 0.0 110.79 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 334' ' ' THR . 73.4 m -132.9 172.22 12.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.252 0.549 . . . . 0.0 110.725 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.92 57.58 32.71 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 363' ' ' ASP . 74.2 Cg_endo -76.23 143.42 25.29 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.02 2.48 . . . . 0.0 114.901 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.593 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 8.5 p90 -140.48 168.12 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.124 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.455 HG22 HG13 ' A' ' 276' ' ' ILE . 42.5 t -116.36 149.96 18.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.371 0.605 . . . . 0.0 112.508 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -131.0 152.76 49.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.383 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.18 135.09 64.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.763 0.316 . . . . 0.0 110.579 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 79.9 m80 -130.98 132.54 45.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.35 . . . . 0.0 110.994 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.3 tp -105.79 106.67 17.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.407 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.8 mtm -111.58 126.78 55.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.131 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' A' ' 318' ' ' GLN . 0.4 OUTLIER -95.77 99.56 11.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.477 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 59.91 37.76 21.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.706 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.09 21.43 49.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.675 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -121.65 109.65 15.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.745 0.307 . . . . 0.0 110.806 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 10.8 ptt85 -51.25 128.07 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.351 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.415 ' CD1' ' CB ' ' A' ' 318' ' ' GLN . 9.3 mt -123.6 -49.53 1.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -135.03 147.92 49.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . 0.425 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.4 OUTLIER -144.09 120.56 11.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.584 179.616 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -125.5 166.43 16.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.231 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -142.87 149.92 39.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.793 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.422 ' CG2' HG13 ' A' ' 293' ' ' ILE . 20.7 p -104.75 176.52 5.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.029 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.2 p -59.6 162.43 5.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.577 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.593 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.2 mt -105.84 123.88 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 111.434 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -89.16 88.17 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.049 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -55.1 136.3 48.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.987 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 43.91 87.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.311 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 308' ' ' SER . 3.9 t -179.11 174.55 1.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.518 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 308' ' ' SER . 4.7 mt -145.96 -16.91 0.46 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.203 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' ASN . . . . . 0.453 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.5 m-80 -133.46 57.77 28.85 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.774 0.321 . . . . 0.0 110.283 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 53.3 Cg_endo -90.16 167.76 4.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.204 2.602 . . . . 0.0 113.738 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' TYR . . . . . 0.444 ' CE2' HD21 ' A' ' 294' ' ' LEU . 0.5 OUTLIER -110.15 159.07 17.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.305 179.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' TYR . . . . . 0.447 ' HB2' HG23 ' A' ' 293' ' ' ILE . 6.1 m-85 -134.25 -62.29 0.76 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.31 38.65 23.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.669 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 293' ' ' ILE . 32.1 mt-10 -91.91 143.2 26.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.77 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 4.2 m -114.03 119.51 37.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 111.656 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -111.02 153.77 25.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.248 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 73.5 m -128.38 142.29 51.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.012 0.434 . . . . 0.0 111.408 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -130.85 165.87 22.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -114.02 76.22 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 48.2 t -109.04 125.27 31.93 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.017 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.528 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 73.9 Cg_endo -76.67 155.42 35.35 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.499 2.132 . . . . 0.0 111.678 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -50.95 -23.13 2.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.839 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.23 -8.6 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' GLN . . . . . 0.528 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -112.69 -31.69 6.67 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.696 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.498 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 4.0 tp -47.98 -27.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 111.134 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -92.14 -20.69 20.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.616 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -99.92 -21.32 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.679 0.276 . . . . 0.0 111.638 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.92 167.88 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.919 0.39 . . . . 0.0 111.222 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -148.59 126.95 12.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.028 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.415 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 47.7 t -86.9 114.19 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.637 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.63 109.68 23.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.205 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.59 ' HB ' HG23 ' A' ' 376' ' ' VAL . 26.8 t -93.48 107.76 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.425 ' CG2' ' HB3' ' A' ' 375' ' ' LYS . 11.0 m -109.33 141.08 42.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.91 0.386 . . . . 0.0 111.575 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 41.8 t -115.46 120.2 64.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.072 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.452 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.5 mp -124.62 147.21 48.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.058 0.456 . . . . 0.0 111.679 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.493 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.9 OUTLIER -91.96 134.47 34.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.328 179.552 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 365' ' ' ASP . 7.0 t80 -90.83 141.73 28.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.0 110.831 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . 0.463 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 14.0 m-20 . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.89 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.13 0 CA-C-O 120.85 0.357 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.81 149.39 21.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -98.3 110.99 23.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.12 0.486 . . . . 0.0 110.977 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.475 HG22 HD11 ' A' ' 373' ' ' ILE . 43.6 mt -83.44 -34.54 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.192 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.57 175.02 37.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.037 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.44 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 11.6 ptmt -160.47 140.96 11.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.217 0.532 . . . . 0.0 111.779 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.59 HG23 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -111.61 159.21 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.472 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -143.1 131.98 22.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.985 0.422 . . . . 0.0 111.133 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.435 ' CG1' ' CE1' ' A' ' 405' ' ' HIS . 19.6 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.045 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.667 0.27 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 42.0 tp -59.38 -33.95 71.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 0.0 110.582 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 23.6 mtm180 -61.46 -49.34 77.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.343 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.45 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 14.8 t-160 -60.76 -57.93 10.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.792 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' TRP . . . . . 0.459 ' NE1' ' O ' ' A' ' 352' ' ' ILE . 58.0 t-105 -49.52 -44.29 46.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.05 0.452 . . . . 0.0 110.004 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 4.7 t -68.57 -36.81 79.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.803 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' ASP . . . . . 0.418 ' HB3' HD13 ' A' ' 401' ' ' ILE . 1.9 t0 -63.08 -36.22 82.85 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' MET . . . . . 0.487 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 10.2 ttm -61.84 -55.09 33.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.189 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.1 mt -60.85 -33.26 72.79 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.331 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.37 -29.81 70.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.276 0.56 . . . . 0.0 109.84 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.9 m-80 -114.97 71.68 2.73 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.596 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.528 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 50.4 Cg_endo -70.47 33.88 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.186 2.59 . . . . 0.0 113.616 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . 0.528 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 23.7 mmm-85 -159.51 -44.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.922 0.391 . . . . 0.0 110.972 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.429 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 1.7 tpp180 -93.96 140.48 22.96 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.455 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.429 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 57.0 Cg_endo -70.43 156.47 61.53 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.742 2.295 . . . . 0.0 112.751 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -128.15 113.45 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.818 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.27 144.46 32.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 110.82 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.67 153.71 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.963 0.411 . . . . 0.0 111.235 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . 0.407 ' CE3' ' HB2' ' A' ' 277' ' ' CYS . 55.8 m95 -83.02 120.01 25.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . 0.617 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 45.4 m-70 -108.21 120.82 43.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.576 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 89.2 m -78.36 116.21 18.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.024 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.465 ' CD2' HG21 ' A' ' 376' ' ' VAL . 84.8 mt -62.47 128.2 34.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.288 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -114.82 170.9 7.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.512 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.451 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 47.0 t -52.71 115.77 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.44 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 4.1 mp0 -54.77 -43.07 72.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.79 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -55.35 -47.55 75.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.802 0.334 . . . . 0.0 110.537 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.451 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 35.2 mt-10 -64.24 -48.71 74.74 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.411 HG13 ' HG3' ' A' ' 375' ' ' LYS . 92.0 t -48.86 -45.41 15.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.771 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.8 t70 . . . . . 0 C--N 1.333 -0.147 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.837 179.067 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.82 0.343 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 34.8 mt -108.84 -40.16 5.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.92 -162.71 16.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.266 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -144.01 135.41 25.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.77 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.451 HG13 HG23 ' A' ' 312' ' ' VAL . 0.1 OUTLIER -124.46 128.95 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.097 0.475 . . . . 0.0 110.914 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.03 127.15 43.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.717 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.615 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.5 p90 -141.85 150.26 41.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.012 0.434 . . . . 0.0 110.341 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.62 161.67 13.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.018 -178.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.499 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 94.8 mt -133.57 143.9 48.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.15 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.407 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.0 OUTLIER -158.94 106.82 1.84 Allowed 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.972 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.493 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 25.7 t80 -100.68 137.44 39.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.986 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.61 94.76 48.38 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.529 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 8.1 Cg_exo -69.89 -33.9 15.21 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.937 2.425 . . . . 0.0 112.425 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.51 -30.19 4.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.196 0.522 . . . . 0.0 110.042 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.44 -20.29 8.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.967 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.31 48.65 6.7 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.542 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -124.58 129.8 51.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 0.0 111.792 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.418 HD13 ' HE3' ' A' ' 393' ' ' MET . 33.2 tp -95.42 147.6 23.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.805 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 7.4 m -138.48 134.52 34.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.385 0.612 . . . . 0.0 111.936 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 8.7 t -127.24 123.13 61.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.206 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 22.1 t -117.24 114.95 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.912 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.479 HG21 ' HB2' ' A' ' 339' ' ' TYR . 35.9 mm -74.59 136.95 24.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.422 HD22 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.02 -60.9 1.82 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.429 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 0.9 OUTLIER -175.61 157.42 2.05 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.488 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -117.12 151.73 36.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.773 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -148.08 153.54 39.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.612 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 60.98 23.98 14.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.872 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 50.3 mt -58.92 138.79 57.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.07 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.04 146.9 53.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.504 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.418 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 16.0 mttt -85.41 114.39 22.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.581 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.433 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 9.9 mmm -92.93 -18.81 22.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.729 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 46.7 m-20 -96.17 118.35 32.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.844 0.355 . . . . 0.0 110.635 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.15 116.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.426 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 60.05 16.57 41.14 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.334 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.59 -157.08 9.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.8 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 16.5 mt -100.82 -160.38 0.79 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 110.492 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.418 ' OG ' ' HA ' ' A' ' 301' ' ' LYS . 15.2 m -135.07 172.03 13.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.239 0.542 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.419 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 8.9 m-20 -133.69 56.36 19.89 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 309' ' ' ASP . 64.6 Cg_endo -75.39 141.71 25.86 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.044 2.496 . . . . 0.0 114.75 -177.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.539 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 17.1 p90 -139.85 165.31 27.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.424 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.451 HG23 HG13 ' A' ' 276' ' ' ILE . 42.4 t -112.81 149.98 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 360' ' ' THR . 6.6 mttm -132.02 151.92 51.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.197 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.2 mp -125.51 133.96 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.763 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.44 125.69 37.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.815 0.34 . . . . 0.0 111.181 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.4 HD22 ' CG2' ' A' ' 347' ' ' VAL . 27.5 tp -96.01 106.68 18.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.312 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.4 mtm -112.68 145.6 40.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 111.467 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.44 99.73 10.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.066 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 10.9 p30 42.83 37.45 1.08 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.386 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 104.46 28.85 5.59 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.982 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 317' ' ' MET . 0.2 OUTLIER -136.99 109.38 7.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.725 0.298 . . . . 0.0 110.885 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.13 130.84 39.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 7.6 mt -125.0 -51.66 1.67 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.202 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -130.62 153.42 48.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.037 0.446 . . . . 0.0 111.516 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 325' ' ' LYS . 0.0 OUTLIER -136.11 130.5 33.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.431 179.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 44.6 mmtt -135.44 160.38 38.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.96 0.409 . . . . 0.0 111.314 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.68 143.52 26.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.796 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.423 HG21 ' CE1' ' A' ' 343' ' ' PHE . 14.5 p -101.22 176.63 5.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.95 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 10.1 t -56.96 169.88 0.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.504 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.539 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.3 mt -112.39 120.59 62.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.948 0.404 . . . . 0.0 111.465 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.406 ' HG3' ' CG ' ' A' ' 337' ' ' PRO . 3.7 mmpt? -82.74 84.59 7.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.762 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.23 135.45 44.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.082 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.3 83.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.39 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 4.8 t -176.86 174.08 1.82 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.748 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 4.3 mt -145.06 -16.33 0.51 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.322 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.472 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 4.9 m-80 -132.9 55.63 18.19 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.863 0.364 . . . . 0.0 110.213 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 51.4 Cg_endo -88.64 167.64 6.02 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.137 2.558 . . . . 0.0 113.636 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.429 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -110.9 160.02 17.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.3 179.181 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.479 ' HB2' HG21 ' A' ' 293' ' ' ILE . 86.6 m-85 -133.45 -63.63 0.75 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 111.325 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 58.36 37.55 25.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.753 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 292' ' ' VAL . 41.9 mt-10 -91.39 142.99 27.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.808 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.94 120.08 40.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.416 . . . . 0.0 111.566 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' A' ' 328' ' ' THR . 52.2 m-85 -112.58 146.74 38.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.208 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 18.1 p -118.97 142.2 47.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 0.0 111.457 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 40.0 m-85 -129.63 165.83 20.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.517 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -116.57 79.81 1.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.512 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.425 ' O ' ' OH ' ' A' ' 282' ' ' TYR . 24.7 t -110.11 122.74 37.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.438 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 24.4 Cg_exo -62.19 147.92 94.15 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.51 2.14 . . . . 0.0 111.464 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -53.95 -24.02 15.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 111.336 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -91.64 -8.66 46.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.564 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.441 ' CB ' ' HD2' ' A' ' 348' ' ' PRO . 1.1 tt0 -106.52 -25.54 11.8 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.493 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 2.1 tp -48.68 -27.68 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 110.66 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -90.57 -23.08 20.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.107 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -95.58 -4.83 43.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 31.3 m -106.61 167.77 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.881 0.372 . . . . 0.0 111.306 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -144.49 126.49 15.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.039 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.423 HG22 ' CZ3' ' A' ' 390' ' ' TRP . 66.8 t -90.83 115.64 30.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.268 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.416 ' CG1' ' HE3' ' A' ' 375' ' ' LYS . 0.3 OUTLIER -101.29 116.83 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.755 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.618 ' HB ' HG23 ' A' ' 376' ' ' VAL . 48.3 t -97.33 108.06 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.939 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.44 ' HA ' ' HB2' ' A' ' 375' ' ' LYS . 6.5 m -110.68 133.81 53.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.027 0.442 . . . . 0.0 111.801 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 42.9 t -107.57 119.8 57.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.13 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.454 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.5 mp -121.46 148.0 45.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.978 0.418 . . . . 0.0 111.741 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.433 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 4.1 t70 -92.8 131.97 37.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.358 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.555 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 26.0 t80 -87.97 146.95 25.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.66 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 367' ' ' ILE . 23.2 m-20 -142.73 61.62 1.42 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.462 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.555 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 12.9 tttp 34.78 -89.66 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 365' ' ' ASP . 4.5 mp -84.82 -66.42 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.694 0.283 . . . . 0.0 111.209 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -43.53 163.5 0.04 OUTLIER Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.925 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 31.2 tttp -65.79 159.34 25.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.22 122.15 28.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.17 151.02 44.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.431 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -95.89 109.8 22.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 0.0 111.352 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -73.34 -35.25 45.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.78 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 156.13 179.05 30.88 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.059 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.534 ' CD ' ' HG2' ' A' ' 410' ' ' GLU . 0.0 OUTLIER -160.23 142.32 12.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.363 0.601 . . . . 0.0 112.029 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.621 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -109.22 158.67 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.879 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.403 ' CE1' ' SD ' ' A' ' 416' ' ' MET . 19.7 p90 -141.41 141.96 33.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.059 0.457 . . . . 0.0 111.721 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.29 135.72 57.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.791 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 144.14 -156.15 26.59 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.145 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -46.42 -73.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.48 -23.66 6.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.032 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 12.1 m -65.19 159.81 22.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 110.857 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 39.3 p -158.04 155.08 28.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.002 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 78.6 -128.85 8.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.65 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -67.29 -29.91 69.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 111.264 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -71.94 -49.02 41.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.614 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.47 -34.62 78.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.569 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 385' ' ' ALA . 4.5 ptm180 -64.18 -35.78 81.89 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.269 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.454 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 18.8 t-160 -67.43 -53.56 28.03 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.163 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.476 ' CZ2' HD11 ' A' ' 352' ' ' ILE . 68.2 t-105 -54.99 -40.62 70.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.017 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -42.13 76.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.989 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -59.86 -34.31 72.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.638 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.499 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 8.4 ttm -60.36 -56.65 18.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.405 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.82 -29.96 67.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.472 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.55 -31.49 70.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.188 0.518 . . . . 0.0 109.942 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.3 m-80 -114.29 70.79 2.09 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.639 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.556 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 43.4 Cg_endo -69.08 35.37 0.19 Allowed 'Trans proline' 0 N--CA 1.474 0.364 0 C-N-CA 123.291 2.661 . . . . 0.0 113.642 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . 0.556 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 19.8 mmt85 -159.95 -44.35 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.955 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.91 142.17 24.68 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.57 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 58.3 Cg_endo -71.18 156.38 59.48 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.661 2.241 . . . . 0.0 112.953 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -127.74 110.26 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.664 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -103.73 144.36 31.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.844 0.354 . . . . 0.0 110.833 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.25 153.21 11.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.29 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -81.95 120.72 25.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.736 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.621 ' HB3' HG11 ' A' ' 376' ' ' VAL . 60.5 m-70 -111.28 118.37 35.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 85.0 m -78.24 116.7 18.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.946 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.453 HD23 HG21 ' A' ' 376' ' ' VAL . 95.9 mt -61.59 127.35 31.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.313 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -113.42 167.17 10.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.54 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.499 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 90.5 t -52.58 117.85 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.534 ' HG2' ' CD ' ' A' ' 375' ' ' LYS . 8.6 mt-10 -50.48 -45.79 56.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.153 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -55.34 -45.96 76.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 0.0 110.947 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.499 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 16.5 mt-10 -66.71 -38.58 87.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.414 HG13 ' HG3' ' A' ' 375' ' ' LYS . 73.4 t -58.39 -48.15 85.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.255 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -65.73 -31.78 72.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.537 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.21 80.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.586 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' MET . . . . . 0.403 ' SD ' ' CE1' ' A' ' 377' ' ' PHE . 15.0 mtt -65.33 -50.05 67.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.461 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.2 mt -58.17 -30.68 66.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.941 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.49 118.98 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.04 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.081 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.848 0.356 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 63.8 mt -90.74 -32.79 16.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 118.2 -166.08 12.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.231 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -142.86 132.53 23.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.776 0.322 . . . . 0.0 110.63 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -120.17 130.75 73.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.163 0.506 . . . . 0.0 111.03 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.84 124.7 42.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.732 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.659 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 19.1 p90 -141.96 148.22 38.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.436 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.0 OUTLIER -101.04 160.9 13.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.175 -178.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.443 HD11 ' CE1' ' A' ' 389' ' ' HIS . 9.2 mt -133.66 150.25 51.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.03 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.433 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 5.2 ttp180 -158.81 112.14 2.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.243 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.487 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 32.7 t80 -106.14 131.66 53.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.766 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.46 98.04 50.94 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.501 ' CG ' ' CB ' ' A' ' 397' ' ' PRO . 6.4 Cg_exo -71.06 -33.26 12.02 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.673 2.249 . . . . 0.0 112.67 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.2 -29.76 6.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.181 0.515 . . . . 0.0 110.058 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.81 -21.67 8.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.957 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.81 48.78 6.41 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.747 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -124.98 130.05 51.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.994 0.426 . . . . 0.0 111.68 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 30.5 tp -93.79 147.89 22.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.092 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 1.9 m -135.16 140.66 45.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.305 0.574 . . . . 0.0 112.022 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 18.2 t -134.01 120.91 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.357 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 32.3 t -116.19 116.3 51.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.012 0.434 . . . . 0.0 112.057 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.516 HG22 ' HB2' ' A' ' 339' ' ' TYR . 40.1 mm -74.96 135.69 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.424 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.7 OUTLIER -113.47 -61.89 1.67 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.411 ' OE1' ' CZ ' ' A' ' 338' ' ' TYR . 11.1 pm0 -174.16 148.16 1.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.512 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -108.38 153.63 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.006 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.84 152.49 33.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.077 0.465 . . . . 0.0 111.488 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 61.02 24.75 14.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.405 HD11 ' CB ' ' A' ' 310' ' ' PRO . 60.3 mt -59.66 139.01 57.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.222 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.68 143.77 53.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.404 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.417 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 15.9 mttp -84.61 115.18 22.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.601 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.491 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.6 mmt -90.74 -20.0 22.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.408 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 41.9 m-20 -99.81 123.79 44.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.876 0.369 . . . . 0.0 110.709 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 48.8 t -60.56 118.83 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.215 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 64.0 13.51 53.04 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.718 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.89 -144.46 6.19 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.694 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 19.9 mt -115.46 -159.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.848 0.356 . . . . 0.0 110.511 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 334' ' ' THR . 5.6 m -138.26 172.01 13.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.314 0.578 . . . . 0.0 110.92 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.96 71.5 77.9 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.405 ' CB ' HD11 ' A' ' 299' ' ' LEU . 95.3 Cg_endo -87.73 143.27 6.07 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.526 2.151 . . . . 0.0 115.351 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 9.8 p90 -139.49 167.65 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.039 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.474 HG23 HG13 ' A' ' 276' ' ' ILE . 42.7 t -118.0 149.56 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.386 0.612 . . . . 0.0 112.504 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -131.09 146.97 52.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.292 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.413 HG21 ' CZ ' ' A' ' 345' ' ' PHE . 4.6 mp -122.6 131.87 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.622 0.248 . . . . 0.0 111.089 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -130.17 134.89 47.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.93 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 26.7 tp -104.14 107.17 17.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.612 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.74 126.67 52.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.45 ' O ' ' HG3' ' A' ' 318' ' ' GLN . 0.4 OUTLIER -95.16 99.8 11.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 60.15 37.92 20.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.727 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.03 22.35 45.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.78 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt -123.85 109.56 13.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.19 130.7 39.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 6.9 mt -126.71 -42.21 1.79 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.234 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -130.6 147.69 52.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.212 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 115.61 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.954 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -124.09 166.51 15.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.48 149.51 30.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.07 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.42 HG22 ' CE1' ' A' ' 343' ' ' PHE . 21.2 p -106.11 174.05 6.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.736 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.76 174.07 0.37 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.43 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.558 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.7 mt -119.87 118.96 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.051 0.453 . . . . 0.0 111.688 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.452 ' HE2' ' CG ' ' A' ' 339' ' ' TYR . 0.0 OUTLIER -82.57 91.19 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.249 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -56.88 137.21 55.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.885 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.85 83.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.592 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 308' ' ' SER . 4.5 t -177.2 174.05 1.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.486 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 4.0 mt -146.17 -16.22 0.45 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.401 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.463 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.9 m-80 -133.97 57.18 22.97 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.486 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 59.2 Cg_endo -90.41 167.74 4.23 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.095 2.53 . . . . 0.0 113.662 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.424 ' CE2' HD23 ' A' ' 294' ' ' LEU . 1.3 t80 -105.26 160.68 14.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.201 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.516 ' HB2' HG22 ' A' ' 293' ' ' ILE . 9.3 m-85 -131.72 -65.38 0.76 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.963 0.411 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 59.11 36.85 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.946 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 293' ' ' ILE . 41.8 mt-10 -93.92 144.79 25.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.78 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 98.5 p -116.56 123.07 46.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 0.0 111.375 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . 0.42 ' CE1' HG22 ' A' ' 328' ' ' THR . 66.0 m-85 -116.35 150.61 37.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.192 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 41.8 p -121.53 143.16 49.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.119 0.485 . . . . 0.0 111.462 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.413 ' CZ ' HG21 ' A' ' 314' ' ' ILE . 48.2 m-85 -129.58 164.95 22.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.572 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.71 80.32 1.36 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.637 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.405 ' O ' ' OH ' ' A' ' 282' ' ' TYR . 71.0 t -113.09 123.77 32.88 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.117 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 351' ' ' GLN . 56.1 Cg_endo -70.69 153.4 64.66 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.491 2.127 . . . . 0.0 111.523 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -51.21 -24.14 4.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.489 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -85.42 -8.6 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.823 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.452 ' HB2' ' HD2' ' A' ' 348' ' ' PRO . 24.5 mt-30 -107.21 -36.79 6.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.653 0.264 . . . . 0.0 111.62 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.487 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 6.1 tp -46.45 -27.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.846 0.355 . . . . 0.0 111.118 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . 0.441 ' O ' ' CD1' ' A' ' 380' ' ' TYR . 1.7 mt-30 -90.77 -27.79 18.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.678 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.488 ' HA ' ' CD1' ' A' ' 380' ' ' TYR . 14.9 ptmt -109.95 15.67 22.44 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.4 ' C ' ' HG3' ' A' ' 356' ' ' GLN . 31.1 m -116.09 167.91 8.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.766 0.317 . . . . 0.0 110.64 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . 0.4 ' HG3' ' C ' ' A' ' 355' ' ' VAL . 3.0 mt-30 -140.11 138.65 35.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.0 0.429 . . . . 0.0 111.447 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.433 HG21 ' CH2' ' A' ' 390' ' ' TRP . 91.9 t -104.39 106.96 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.903 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -91.01 114.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.98 0.419 . . . . 0.0 112.033 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.613 ' HB ' HG22 ' A' ' 376' ' ' VAL . 43.9 t -98.73 108.08 21.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.637 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.402 ' CG2' ' HB3' ' A' ' 375' ' ' LYS . 3.5 m -109.27 136.11 49.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 0.0 111.995 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 47.2 t -111.1 120.25 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.913 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.438 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.6 mp -122.45 150.22 42.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.032 0.444 . . . . 0.0 111.718 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.491 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.9 t70 -96.4 131.26 43.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.586 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.551 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 27.3 t80 -83.96 146.82 27.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.535 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 367' ' ' ILE . 35.9 m-20 -140.36 65.55 1.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.323 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.551 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 18.4 mttt 28.12 -84.91 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 365' ' ' ASP . 5.0 mp -86.38 -70.68 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.807 0.337 . . . . 0.0 111.26 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -44.12 164.28 0.04 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.149 -0.548 . . . . 0.0 113.024 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 40.6 tttt -66.01 161.34 21.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.9 134.03 35.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.811 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.78 139.94 30.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -86.91 110.87 20.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.111 0.481 . . . . 0.0 110.899 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 373' ' ' ILE . 33.4 mt -80.34 -34.64 14.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.073 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.22 178.92 39.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.303 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.456 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 17.2 ptmt -162.75 141.27 8.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.179 0.514 . . . . 0.0 111.604 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.24 158.77 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.103 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -141.77 145.2 34.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.801 0.334 . . . . 0.0 111.039 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.44 HG23 ' CE3' ' A' ' 390' ' ' TRP . 20.4 m -141.46 114.21 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.166 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.447 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 167.01 -148.89 13.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.049 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 354' ' ' LYS . 0.0 OUTLIER -50.08 -75.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.76 0.314 . . . . 0.0 111.349 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -69.82 80.72 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.816 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 15.6 m -165.14 163.39 20.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.797 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 43.9 p -158.09 147.87 19.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.735 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 94.02 -157.75 22.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.618 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -45.46 -31.24 1.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -63.88 -55.06 25.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.858 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 48.6 tp -57.56 -36.62 71.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.625 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 5.1 mtp85 -60.6 -46.75 89.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.384 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.475 ' CD2' HG22 ' A' ' 401' ' ' ILE . 18.6 t-160 -61.76 -56.22 21.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.46 ' NE1' ' O ' ' A' ' 352' ' ' ILE . 63.5 t-105 -50.91 -49.64 59.17 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.153 0.501 . . . . 0.0 109.723 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.9 t -65.03 -30.39 71.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.606 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 0.6 OUTLIER -62.36 -42.32 99.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.968 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.439 ' HE1' ' CZ3' ' A' ' 390' ' ' TRP . 22.3 ttp -58.66 -55.58 33.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.68 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.8 mt -59.21 -24.63 63.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.567 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.95 77.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -126.96 74.03 76.48 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.466 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.501 ' CB ' ' CG ' ' A' ' 284' ' ' PRO . 8.4 Cg_exo -72.38 50.4 1.59 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.997 2.465 . . . . 0.0 113.032 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . 0.499 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 4.5 mmm180 -158.37 -45.69 0.06 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.178 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -94.27 158.48 35.79 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.353 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -87.56 138.71 4.63 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.012 2.475 . . . . 0.0 112.815 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.475 HG22 ' CD2' ' A' ' 389' ' ' HIS . 1.1 mm -112.14 120.16 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.587 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -112.07 145.23 40.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.758 0.313 . . . . 0.0 110.938 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -163.04 155.26 18.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 0.0 111.349 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -83.13 116.38 22.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.697 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.763 ' HB3' HG13 ' A' ' 376' ' ' VAL . 29.3 m-70 -103.81 120.75 41.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.78 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 86.9 m -78.18 116.44 18.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.226 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.418 ' CD2' HG23 ' A' ' 376' ' ' VAL . 67.3 mt -61.64 127.44 31.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.218 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -114.16 168.82 9.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.465 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 61.2 t -55.73 119.93 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.456 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 19.4 mt-10 -53.52 -42.34 67.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.756 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.58 -50.06 74.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.332 . . . . 0.0 110.613 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.465 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.1 mt-10 -64.52 -38.27 90.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.423 ' HB ' ' HD3' ' A' ' 375' ' ' LYS . 81.0 t -59.06 -49.96 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.351 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.16 -36.51 80.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.926 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -69.52 -36.07 76.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.067 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 44.6 mtm -70.2 -36.37 74.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 15.2 mt -69.27 -31.16 69.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.973 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -71.52 145.56 49.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 29.0 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.074 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.839 0.352 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 68.6 mt -85.93 -31.89 21.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.09 -165.63 13.61 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.036 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -141.94 136.95 30.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.332 . . . . 0.0 110.827 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.47 HG13 HG22 ' A' ' 312' ' ' VAL . 0.1 OUTLIER -124.11 130.22 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.139 0.495 . . . . 0.0 110.919 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 294' ' ' LEU . 0.1 OUTLIER -97.2 126.23 42.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.76 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.622 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.7 p90 -142.08 151.19 42.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.331 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.1 OUTLIER -99.67 162.25 13.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.027 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.49 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 94.4 mt -134.74 144.15 47.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.085 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.423 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 9.7 ttm180 -159.13 106.55 1.79 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.966 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.471 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 28.9 t80 -101.22 137.21 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.845 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 44.9 t -122.31 97.79 44.79 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.489 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.53 -32.62 9.59 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.687 2.258 . . . . 0.0 112.612 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.04 -30.12 5.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.193 0.521 . . . . 0.0 109.919 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.52 -18.95 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.909 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 77.48 48.59 7.95 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.692 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -123.79 130.14 52.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 111.745 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.42 HD12 ' HE2' ' A' ' 393' ' ' MET . 34.8 tp -96.09 147.63 23.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.924 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 4.9 m -136.35 138.42 41.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.356 0.598 . . . . 0.0 112.045 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 17.1 t -131.95 120.97 45.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.312 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.4 ' HB ' ' OG ' ' A' ' 279' ' ' SER . 30.5 t -116.97 115.56 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.08 0.467 . . . . 0.0 111.938 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 341' ' ' GLU . 37.0 mm -74.17 136.98 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 277' ' ' CYS . 0.3 OUTLIER -112.44 -61.48 1.72 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.028 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.421 ' HB3' ' CG ' ' A' ' 338' ' ' TYR . 0.3 OUTLIER -175.71 151.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.24 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -112.48 152.66 28.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.849 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.422 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 7.8 pttt -149.07 152.64 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.478 . . . . 0.0 111.458 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 60.04 27.09 16.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.565 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.419 HD12 ' CG ' ' A' ' 310' ' ' PRO . 87.1 mt -63.97 139.21 58.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.951 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -60.59 149.61 34.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.514 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 8.4 mttp -90.03 119.32 30.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.573 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.482 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.7 mmt -92.26 -17.24 25.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.402 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 54.4 m-20 -99.66 115.77 30.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.849 0.357 . . . . 0.0 110.601 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.58 116.06 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.445 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.09 47.27 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.45 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.6 -156.89 9.35 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.704 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.9 mt -101.43 -161.05 0.83 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.837 0.351 . . . . 0.0 110.789 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.423 ' HB2' HD21 ' A' ' 335' ' ' LEU . 66.6 m -139.51 172.19 13.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.302 0.573 . . . . 0.0 111.11 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.411 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -129.73 57.49 31.02 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.419 ' CG ' HD12 ' A' ' 299' ' ' LEU . 37.5 Cg_endo -68.29 150.82 76.65 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.146 2.564 . . . . 0.0 114.688 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.541 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 53.0 p90 -154.36 156.7 37.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.249 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.47 HG22 HG13 ' A' ' 276' ' ' ILE . 36.6 t -106.73 149.8 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 360' ' ' THR . 12.1 mtmt -130.39 152.81 49.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.253 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.439 HG21 ' CZ ' ' A' ' 345' ' ' PHE . 5.4 mp -126.51 133.35 68.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.521 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 325' ' ' LYS . 13.3 m80 -129.85 127.35 40.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.143 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 22.0 tp -100.04 105.1 16.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.453 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.2 mtm -108.06 138.86 43.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.28 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.56 99.58 10.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.364 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 57.21 37.36 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.82 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 91.18 28.72 14.17 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.804 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.31 109.58 9.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.762 0.315 . . . . 0.0 110.988 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 13.3 mtm-85 -49.77 128.5 18.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.292 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 11.4 mt -123.31 -49.63 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.232 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -130.59 150.93 51.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.345 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . 0.423 ' HA ' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -134.92 132.33 38.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.678 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.443 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 14.5 mmtt -138.25 159.53 41.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.889 0.376 . . . . 0.0 111.133 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -148.15 143.38 27.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.81 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.412 HG22 ' CZ ' ' A' ' 343' ' ' PHE . 5.1 p -99.46 178.89 4.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.331 . . . . 0.0 110.689 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.2 t -59.81 162.61 5.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.264 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -106.27 122.28 59.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.884 0.373 . . . . 0.0 111.273 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -85.4 89.86 7.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.075 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -55.39 136.53 49.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.857 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 43.68 84.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.316 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 4.9 t -177.21 174.01 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.814 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 308' ' ' SER . 4.4 mt -146.42 -16.27 0.44 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.258 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.46 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.0 m-80 -132.24 57.69 31.31 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 120.72 0.295 . . . . 0.0 110.446 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 43.5 Cg_endo -92.4 167.79 2.82 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.26 2.64 . . . . 0.0 113.73 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.421 ' CG ' ' HB3' ' A' ' 295' ' ' GLU . 0.2 OUTLIER -106.99 160.81 15.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.235 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.457 ' C ' ' ND2' ' A' ' 340' ' ' ASN . 47.7 m-85 -134.84 -51.62 0.79 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.689 0.281 . . . . 0.0 111.269 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . 0.457 ' ND2' ' C ' ' A' ' 339' ' ' TYR . 1.8 p30 44.45 36.12 1.56 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.105 0.479 . . . . 0.0 110.975 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 293' ' ' ILE . 28.0 mt-10 -91.02 140.68 29.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 80.6 p -110.85 121.36 45.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.936 0.398 . . . . 0.0 111.667 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . 0.412 ' CZ ' HG22 ' A' ' 328' ' ' THR . 82.9 m-85 -111.31 156.65 21.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.01 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 56.5 m -130.91 138.65 49.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.449 . . . . 0.0 111.698 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.443 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 63.8 m-85 -127.91 165.92 19.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.604 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -115.5 79.12 1.25 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.247 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.411 ' O ' ' OH ' ' A' ' 282' ' ' TYR . 37.3 t -106.44 123.19 39.58 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.268 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 35.5 Cg_exo -60.28 150.89 77.56 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.576 2.184 . . . . 0.0 111.855 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -57.16 -23.83 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -91.53 -8.59 47.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.491 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.412 ' CB ' ' HD2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -105.2 -24.41 12.74 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.471 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 3.2 tp -53.0 -27.61 13.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 0.0 110.759 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . 0.412 ' O ' ' CD1' ' A' ' 380' ' ' TYR . 14.1 mt-30 -95.01 3.05 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.378 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.455 ' HA ' ' CD1' ' A' ' 380' ' ' TYR . 24.2 mtpp -122.27 -20.78 6.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.6 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.87 167.9 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 111.483 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . 0.411 ' HA ' ' HA3' ' A' ' 379' ' ' GLY . 35.3 mt-30 -139.92 126.55 20.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.424 HG21 ' CZ3' ' A' ' 390' ' ' TRP . 52.4 t -95.17 103.68 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.099 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.04 115.55 31.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.903 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.603 ' HB ' HG21 ' A' ' 376' ' ' VAL . 56.7 t -94.92 108.18 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.463 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.47 ' CG2' ' HB3' ' A' ' 375' ' ' LYS . 2.3 m -110.59 134.43 52.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 0.0 112.014 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 48.6 t -109.58 115.12 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.276 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 311' ' ' TYR . 3.9 mp -118.28 148.61 42.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 111.467 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.482 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.1 OUTLIER -98.43 125.02 43.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.416 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 26.9 t80 -72.45 144.56 48.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 367' ' ' ILE . 19.8 m-20 -132.72 72.4 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.071 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.448 ' O ' ' C ' ' A' ' 367' ' ' ILE . 0.0 OUTLIER 32.96 -88.79 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 366' ' ' LYS . 5.2 mp -22.96 -86.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -161.47 -55.67 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.632 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -65.42 141.71 58.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.928 0.394 . . . . 0.0 110.616 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 0.7 OUTLIER -120.98 148.85 43.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.842 -179.529 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.59 149.33 25.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.3 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -98.29 111.49 23.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.409 HG21 HD12 ' A' ' 373' ' ' ILE . 32.8 mt -79.62 -33.99 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.186 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 169.01 179.2 40.92 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.08 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.471 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 15.6 ptmt -164.56 141.34 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.109 0.481 . . . . 0.0 111.794 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.624 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.67 158.81 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.29 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -138.32 140.97 39.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 111.334 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.85 104.85 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.914 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.506 ' HA2' ' CG ' ' A' ' 390' ' ' TRP . . . 166.56 -146.89 11.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.342 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . 0.455 ' CD1' ' HA ' ' A' ' 354' ' ' LYS . 0.0 OUTLIER -45.49 137.58 4.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.691 0.281 . . . . 0.0 110.43 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 72.84 -153.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.22 165.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.726 0.298 . . . . 0.0 110.601 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 39.9 p -158.28 147.5 19.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.066 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 102.04 -145.43 16.64 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.951 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -57.4 -31.2 65.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.732 0.301 . . . . 0.0 111.648 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -64.91 -59.1 4.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.823 0.344 . . . . 0.0 110.706 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.68 -32.56 71.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.269 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.1 OUTLIER -61.54 -41.9 98.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.203 179.513 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.455 ' CD2' HG23 ' A' ' 401' ' ' ILE . 16.5 t-160 -65.43 -58.0 6.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.619 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.506 ' CG ' ' HA2' ' A' ' 379' ' ' GLY . 62.9 t-105 -49.71 -44.68 48.4 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.136 0.493 . . . . 0.0 109.927 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.21 -34.29 77.17 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.553 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.458 ' HB3' HD12 ' A' ' 401' ' ' ILE . 1.8 t0 -65.17 -36.39 84.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.49 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 14.0 ttm -61.36 -57.57 11.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.119 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.2 mt -61.05 -29.25 69.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.439 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.03 73.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.209 0.528 . . . . 0.0 109.843 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -125.46 77.74 68.52 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.374 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.533 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 5.8 Cg_exo -76.98 44.93 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.131 2.554 . . . . 0.0 113.002 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . 0.533 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 9.9 mmm180 -159.94 -46.74 0.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.908 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.414 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.0 OUTLIER -94.26 137.4 22.82 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.961 -179.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.414 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 56.6 Cg_endo -70.41 156.24 62.07 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.553 2.169 . . . . 0.0 112.747 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.458 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.26 117.13 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.971 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -108.82 144.36 36.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.716 0.293 . . . . 0.0 110.731 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -166.49 156.9 12.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.918 0.39 . . . . 0.0 111.376 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . 0.422 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 57.9 m95 -84.38 121.48 27.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.84 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.624 ' HB3' HG11 ' A' ' 376' ' ' VAL . 53.4 m-70 -110.09 122.62 48.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.405 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.6 m -78.29 118.21 20.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.423 ' CD2' HG22 ' A' ' 376' ' ' VAL . 67.3 mt -64.02 128.16 34.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.178 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -116.75 169.97 8.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.73 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.461 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 58.8 t -53.96 119.44 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.471 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 36.8 mt-10 -54.57 -43.67 72.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.993 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -56.33 -47.65 78.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 110.721 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.461 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.6 mt-10 -66.54 -38.07 86.37 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.425 ' HB ' ' HD3' ' A' ' 375' ' ' LYS . 57.4 t -60.15 -50.73 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.335 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -38.16 89.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.703 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.13 -31.87 72.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.017 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 45.4 mtm -72.16 -30.38 64.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.83 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 4.2 mt -77.49 -34.19 54.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -65.68 143.73 57.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.044 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 1.5 pttt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.823 0.345 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 373' ' ' ILE . 18.3 mt -78.65 -34.89 46.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 119.41 -169.17 13.62 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.255 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -138.76 134.24 33.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.745 0.307 . . . . 0.0 110.818 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -125.11 130.67 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.2 0.524 . . . . 0.0 111.013 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.11 126.93 44.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.725 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.605 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.4 p90 -142.04 151.83 42.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.324 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.42 161.44 13.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.965 -178.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.486 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 83.9 mt -135.65 141.74 45.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.486 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -158.94 114.7 2.59 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.856 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.462 ' CD1' HD11 ' A' ' 352' ' ' ILE . 25.0 t80 -105.98 138.87 41.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.64 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.35 97.51 45.0 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.496 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.4 -32.0 10.68 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.552 2.168 . . . . 0.0 112.472 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.6 -29.84 7.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.229 0.538 . . . . 0.0 109.941 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.28 -17.5 8.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.052 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.72 48.44 8.83 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.587 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -123.62 130.45 52.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.441 . . . . 0.0 111.834 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 345' ' ' PHE . 28.7 tp -95.76 147.56 23.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.793 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 3.1 m -137.39 134.29 35.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.331 0.586 . . . . 0.0 112.062 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 3.3 t -127.29 123.67 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.146 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 39.7 t -118.17 115.26 47.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.062 0.458 . . . . 0.0 111.848 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.421 HG13 ' CG2' ' A' ' 328' ' ' THR . 34.2 mm -74.55 137.04 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.437 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.5 OUTLIER -113.86 -60.64 1.86 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 2.6 pt-20 -175.63 157.8 2.1 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.296 -0.561 . . . . 0.0 112.448 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -115.98 154.04 30.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.897 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.0 ptmm? -150.93 151.97 32.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.037 0.446 . . . . 0.0 111.614 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 59.58 23.95 12.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.986 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.401 ' CD1' ' CG ' ' A' ' 310' ' ' PRO . 55.2 mt -58.14 138.91 55.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.077 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -62.6 144.44 56.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.472 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.415 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 11.2 mttt -83.46 114.63 21.61 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.449 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.428 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 5.8 mmm -93.79 -17.75 22.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.739 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 45.6 m-20 -96.03 117.89 31.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.4 116.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.643 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.39 16.32 35.02 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.423 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.27 -156.26 9.19 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.938 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 8.3 mt -100.63 -160.43 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 110.305 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 334' ' ' THR . 65.3 m -135.98 171.77 13.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.231 0.539 . . . . 0.0 111.122 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.418 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 5.9 m-20 -134.47 56.5 18.36 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 309' ' ' ASP . 72.4 Cg_endo -77.27 144.72 23.5 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.886 2.39 . . . . 0.0 115.043 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 11.3 p90 -139.07 167.9 21.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.185 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.452 ' CG1' ' CG1' ' A' ' 359' ' ' VAL . 47.4 t -114.08 150.08 16.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.432 0.634 . . . . 0.0 112.663 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 360' ' ' THR . 7.0 mtmm -134.14 156.79 47.68 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.186 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.4 mp -129.96 138.44 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.707 0.289 . . . . 0.0 111.061 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -130.66 121.59 25.83 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.905 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.403 HD22 HG22 ' A' ' 347' ' ' VAL . 36.3 tp -87.96 106.78 18.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.804 0.335 . . . . 0.0 110.117 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 31.7 mtp -109.26 128.59 55.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.299 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.419 ' O ' ' HG3' ' A' ' 318' ' ' GLN . 0.3 OUTLIER -104.93 103.31 12.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.991 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 61.31 37.67 16.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.782 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 83.79 25.04 47.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.565 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -129.3 110.07 11.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 110.847 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -56.68 135.55 55.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 5.7 mt -125.01 -48.13 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.29 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.416 ' HB2' ' HE2' ' A' ' 345' ' ' PHE . 0.4 OUTLIER -130.54 147.22 52.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.961 0.41 . . . . 0.0 111.353 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.39 140.6 52.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.515 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 1.7 mmpt? -139.79 162.61 34.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 0.0 111.153 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.21 149.85 29.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.889 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.423 HG21 ' CE1' ' A' ' 343' ' ' PHE . 15.6 p -110.29 179.47 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.943 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 12.6 t -59.03 167.21 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.518 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.522 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.2 mt -110.74 122.4 65.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.928 0.394 . . . . 0.0 111.338 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -86.95 93.06 9.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.854 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -60.71 136.69 58.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.238 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 43.94 84.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.537 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 308' ' ' SER . 4.7 t -179.38 171.02 1.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.434 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 1.6 mt -140.73 -14.36 0.94 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.495 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.432 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.1 m-80 -133.53 58.52 33.93 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-O 120.692 0.282 . . . . 0.0 110.378 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 52.0 Cg_endo -90.49 167.69 4.16 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.146 2.564 . . . . 0.0 113.686 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.439 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.4 OUTLIER -109.53 160.72 16.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.329 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.427 ' CD2' ' HA ' ' A' ' 295' ' ' GLU . 63.9 m-85 -133.99 -63.43 0.73 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.826 0.346 . . . . 0.0 111.243 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 58.15 37.96 26.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 293' ' ' ILE . 31.2 mt-10 -93.3 145.51 24.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.711 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 78.0 p -116.07 121.5 42.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.927 0.394 . . . . 0.0 111.586 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' A' ' 328' ' ' THR . 70.2 m-85 -113.05 151.33 30.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.349 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 15.1 m -121.88 138.44 54.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.083 0.468 . . . . 0.0 111.546 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.444 ' HB2' ' HB3' ' A' ' 289' ' ' LEU . 34.2 m-85 -124.36 165.93 16.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.547 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.21 73.55 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.403 HG22 HD22 ' A' ' 316' ' ' LEU . 74.1 t -108.01 131.75 21.53 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.159 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.479 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 84.4 Cg_endo -82.24 154.94 16.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.778 2.319 . . . . 0.0 111.715 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -51.26 -22.71 2.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.829 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -86.42 -8.6 57.5 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.479 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -112.71 -29.86 7.28 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.596 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.49 ' O ' ' NE1' ' A' ' 390' ' ' TRP . 3.9 tp -51.14 -33.67 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.665 0.269 . . . . 0.0 111.034 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -88.47 1.48 54.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.699 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.447 ' HA ' ' CD1' ' A' ' 380' ' ' TYR . 23.9 mttm -122.73 -20.65 5.85 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 36.0 m -91.65 167.99 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.968 0.413 . . . . 0.0 111.386 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.49 127.83 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.775 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 98.9 t -86.86 104.77 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.439 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.23 109.67 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.618 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.661 ' HB ' HG22 ' A' ' 376' ' ' VAL . 43.9 t -90.53 108.02 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.788 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 375' ' ' LYS . 11.8 m -110.96 129.74 55.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 111.949 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 48.7 t -104.12 131.0 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.114 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.452 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.9 mp -129.93 145.6 51.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.925 0.393 . . . . 0.0 111.481 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.428 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 9.1 t70 -90.08 126.81 35.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.533 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 29.1 t80 -79.42 146.97 32.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.562 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -141.3 64.98 1.4 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.33 . . . . 0.0 111.745 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.533 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 1.7 tptt 31.39 -91.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.404 ' CD1' ' HG2' ' A' ' 366' ' ' LYS . 4.5 mp -84.77 -66.93 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-O 120.748 0.309 . . . . 0.0 111.361 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -45.87 168.25 0.04 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.761 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -65.7 164.29 14.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.728 0.299 . . . . 0.0 110.626 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.47 126.41 35.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.65 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.09 157.25 38.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.914 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -98.68 109.45 22.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.08 0.467 . . . . 0.0 111.216 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 273' ' ' LEU . 2.0 mm -71.4 -35.08 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.941 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 157.47 -174.1 34.93 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.154 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.468 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 18.2 ptmt -162.47 140.7 8.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.394 0.597 . . . . 0.0 112.058 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.661 HG22 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -113.9 158.9 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.174 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.451 ' CE1' ' SD ' ' A' ' 416' ' ' MET . 25.7 p90 -139.54 140.57 37.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.954 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.425 ' CG1' ' CE1' ' A' ' 405' ' ' HIS . 11.5 m -130.19 110.53 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.474 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.553 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 141.2 -150.62 21.97 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.5 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . 0.447 ' CD1' ' HA ' ' A' ' 354' ' ' LYS . 0.2 OUTLIER -44.09 156.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.871 0.367 . . . . 0.0 111.508 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.2 m120 55.13 36.23 26.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.004 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 3.1 m -138.75 161.51 37.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.977 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 52.0 p -157.94 148.03 20.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.911 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 101.16 -124.08 8.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.743 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -83.6 -28.54 28.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 111.495 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -70.91 -45.32 64.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.23 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 26.2 tp -71.32 -35.64 71.3 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.369 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 385' ' ' ALA . 7.7 ptt180 -62.85 -33.58 75.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.345 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.446 ' CD2' HG23 ' A' ' 401' ' ' ILE . 18.5 t-160 -70.27 -55.44 9.23 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.321 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.553 ' CD1' ' HA2' ' A' ' 379' ' ' GLY . 58.4 t-105 -50.12 -45.13 52.68 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.092 0.472 . . . . 0.0 109.907 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.54 -33.21 73.71 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.614 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.453 ' HB3' HD13 ' A' ' 401' ' ' ILE . 0.5 OUTLIER -62.11 -39.38 92.29 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.486 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 20.1 ttm -59.18 -53.03 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.978 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.405 ' O ' ' HG3' ' A' ' 397' ' ' PRO . 2.2 mt -64.26 -30.7 71.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.244 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.68 -31.56 72.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.184 0.516 . . . . 0.0 109.668 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -125.49 77.92 68.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.337 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.549 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 5.9 Cg_exo -76.87 42.88 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.111 2.541 . . . . 0.0 113.061 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . 0.549 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 20.4 mmt180 -158.88 -47.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.093 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.436 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.1 OUTLIER -94.27 140.26 22.74 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.167 -179.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.436 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 57.9 Cg_endo -70.73 156.32 61.05 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.677 2.251 . . . . 0.0 112.885 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -127.76 115.35 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.745 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.56 144.44 33.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.808 0.337 . . . . 0.0 111.039 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.5 153.95 11.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.124 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -81.83 121.75 26.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.906 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.605 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 56.7 m-70 -111.98 117.61 33.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.551 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 89.6 m -78.44 116.46 18.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.459 HD22 HG23 ' A' ' 376' ' ' VAL . 95.0 mt -60.53 127.61 32.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.134 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -115.06 168.8 9.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.605 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.507 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 91.8 t -55.3 120.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.468 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 14.8 mt-10 -52.35 -41.13 62.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.774 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.62 -51.08 71.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.638 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.507 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 19.7 mt-10 -63.76 -38.8 92.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.409 HG23 ' HG2' ' A' ' 375' ' ' LYS . 97.5 t -57.36 -49.15 81.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.147 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.41 -32.57 73.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.471 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.22 90.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.651 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' MET . . . . . 0.451 ' SD ' ' CE1' ' A' ' 377' ' ' PHE . 9.1 mtt -64.87 -50.84 64.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.497 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 10.2 mt -59.87 -28.21 67.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.932 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -71.75 -175.26 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.998 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.102 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.788 0.328 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 55.5 mt -75.63 -31.11 59.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.36 -166.08 15.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.247 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -142.12 130.7 22.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.497 HG13 HG21 ' A' ' 312' ' ' VAL . 0.0 OUTLIER -120.04 131.01 73.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.99 126.02 46.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.898 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.634 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.4 p90 -142.32 152.59 43.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.345 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.49 161.3 13.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.134 -178.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.484 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 95.4 mt -135.08 142.82 46.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.053 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -158.85 110.89 2.19 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.092 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.486 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 22.0 t80 -102.87 139.36 38.55 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.896 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.04 94.18 47.49 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.524 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 8.0 Cg_exo -69.86 -32.72 17.6 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.914 2.41 . . . . 0.0 112.337 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -29.79 8.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.089 0.471 . . . . 0.0 109.96 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.73 -20.22 7.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.073 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.14 48.02 6.7 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.585 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -123.08 129.87 52.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.029 0.443 . . . . 0.0 111.802 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.401 ' CD1' ' HE1' ' A' ' 393' ' ' MET . 36.6 tp -96.88 147.55 23.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.991 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 8.7 m -138.25 137.01 37.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.444 0.64 . . . . 0.0 111.993 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.7 t -129.88 124.06 57.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.238 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 24.5 t -119.69 115.43 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.094 0.473 . . . . 0.0 111.902 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 339' ' ' TYR . 44.2 mm -74.52 137.2 23.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.17 -58.64 2.12 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 16.8 pt-20 -175.74 162.1 2.65 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.537 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -119.06 152.41 36.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.647 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.42 ' HD2' ' CH2' ' A' ' 404' ' ' TRP . 0.4 OUTLIER -150.65 150.19 30.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.124 0.488 . . . . 0.0 111.572 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 61.61 24.02 14.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.996 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.4 ' CD1' ' CG ' ' A' ' 310' ' ' PRO . 53.4 mt -57.7 138.31 55.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 110.796 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.54 129.35 39.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.475 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.441 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 14.9 mttt -63.44 112.11 2.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.279 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.503 ' SD ' ' HB2' ' A' ' 371' ' ' ASP . 0.2 OUTLIER -85.06 -19.85 31.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.8 -179.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 28.7 m-20 -99.34 117.2 33.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.652 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 23.8 t -50.06 116.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.268 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 63.93 14.12 54.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.428 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -129.03 -159.88 10.09 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.677 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.1 mt -98.13 -162.87 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.792 0.33 . . . . 0.0 110.66 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.441 ' OG ' ' HA ' ' A' ' 301' ' ' LYS . 13.0 m -135.69 172.02 13.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.38 0.609 . . . . 0.0 111.205 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.422 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -134.16 56.18 17.96 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.829 178.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 363' ' ' ASP . 66.7 Cg_endo -75.58 142.66 26.43 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.114 2.542 . . . . 0.0 115.034 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.597 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 7.1 p90 -140.57 168.17 20.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.006 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.497 HG21 HG13 ' A' ' 276' ' ' ILE . 41.3 t -117.02 149.83 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.403 ' CE ' HD11 ' A' ' 362' ' ' LEU . 9.2 mttm -130.7 160.19 35.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.316 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.404 HG22 ' CZ ' ' A' ' 345' ' ' PHE . 5.3 mp -128.82 136.42 59.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.526 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 79.1 m80 -130.83 130.84 44.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.884 0.373 . . . . 0.0 110.987 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 324' ' ' LYS . 41.1 tp -108.94 108.12 18.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.376 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' MET . . . . . 0.456 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 3.4 mtm -117.79 134.55 54.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.438 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.4 ' NE2' ' CG ' ' A' ' 351' ' ' GLN . 0.0 OUTLIER -95.4 99.62 11.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.414 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 59.44 37.69 22.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.08 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 92.73 17.15 45.86 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.181 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 317' ' ' MET . 10.6 mmmm -120.33 109.06 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.841 0.32 . . . . 0.0 110.805 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.39 132.02 38.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.615 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 5.0 mt -125.89 -50.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.85 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 12.1 mmtm -130.7 146.04 52.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.959 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . 0.425 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -143.5 116.4 8.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.613 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -118.87 168.58 10.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.966 0.412 . . . . 0.0 111.291 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -148.71 145.27 27.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.836 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 14.4 p -102.15 173.76 6.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.829 0.347 . . . . 0.0 110.924 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 6.3 t -54.68 175.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.675 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.597 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -118.5 124.08 72.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 111.432 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.73 87.08 7.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.981 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -54.93 136.21 47.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.96 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 44.81 84.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.401 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 4.9 t -178.02 173.66 1.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.784 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 3.8 mt -144.94 -15.94 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.373 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.418 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.32 57.61 30.61 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.843 0.354 . . . . 0.0 110.106 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 66.3 Cg_endo -86.27 167.62 9.13 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.133 2.555 . . . . 0.0 113.891 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.512 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 50.7 t80 -112.48 155.48 24.19 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.95 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.451 ' HB2' HG23 ' A' ' 293' ' ' ILE . 76.0 m-85 -133.2 -71.61 0.52 Allowed 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.817 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . 0.512 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 24.2 t-20 66.16 37.54 5.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 293' ' ' ILE . 38.4 mt-10 -91.15 142.27 27.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.52 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 94.5 p -112.63 121.7 45.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.023 0.439 . . . . 0.0 111.757 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -113.85 148.53 36.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.014 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 52.1 p -122.99 140.47 52.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.043 0.449 . . . . 0.0 111.532 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.404 ' CZ ' HG22 ' A' ' 314' ' ' ILE . 72.1 m-85 -129.51 165.85 20.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.493 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -115.78 80.67 1.48 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.416 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.421 ' O ' ' OH ' ' A' ' 282' ' ' TYR . 33.3 t -108.19 122.81 39.43 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.287 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 27.7 Cg_exo -60.84 149.43 88.29 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.578 2.185 . . . . 0.0 111.8 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -55.2 -23.91 24.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.138 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -91.48 -8.7 46.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.522 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.431 ' CB ' ' HD2' ' A' ' 348' ' ' PRO . 0.2 OUTLIER -105.53 -25.93 12.11 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.486 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 3.1 tp -50.15 -25.66 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.727 0.299 . . . . 0.0 110.874 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -93.45 -17.06 23.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.359 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -102.6 -17.28 15.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.635 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 30.9 m -89.47 168.04 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.827 0.346 . . . . 0.0 111.17 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . 0.479 ' HA ' ' HA3' ' A' ' 379' ' ' GLY . 5.1 mt-30 -142.99 126.36 16.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.282 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.432 HG23 ' CH2' ' A' ' 390' ' ' TRP . 74.2 t -92.16 101.37 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.036 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.408 ' CG1' ' HE2' ' A' ' 375' ' ' LYS . 0.7 OUTLIER -89.18 112.04 23.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.863 -178.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.628 ' HB ' HG21 ' A' ' 376' ' ' VAL . 16.2 t -95.57 107.86 20.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 8.7 m -108.31 142.95 37.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 111.697 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 60.3 t -118.5 115.77 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.203 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.465 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.7 mp -119.42 149.91 41.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 111.191 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.467 ' HB3' ' SD ' ' A' ' 302' ' ' MET . 0.1 OUTLIER -97.88 131.64 44.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.699 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.548 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 20.6 t80 -80.98 140.84 34.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.683 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 366' ' ' LYS . 69.9 m-20 -132.45 72.58 1.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.314 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.548 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 9.8 tttp 16.1 -86.79 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 33.0 mm -77.57 -77.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.495 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -46.09 165.26 0.08 OUTLIER Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.991 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -65.85 165.68 12.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.849 0.357 . . . . 0.0 111.04 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 0.1 OUTLIER -87.9 132.57 34.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.533 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . 0.503 ' HB2' ' SD ' ' A' ' 302' ' ' MET . 0.0 OUTLIER -98.01 142.45 29.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.967 0.413 . . . . 0.0 110.685 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -82.65 122.51 28.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.26 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.44 HD11 HG23 ' A' ' 373' ' ' ILE . 13.0 mt -82.43 -30.08 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.787 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 169.41 -179.3 42.05 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.74 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.482 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 17.7 ptmt -164.61 140.93 6.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 111.934 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.788 HG12 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.37 158.6 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.098 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.461 ' CZ ' ' HG2' ' A' ' 416' ' ' MET . 53.0 p90 -143.26 144.37 32.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.849 0.357 . . . . 0.0 111.055 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 25.3 m -144.68 108.09 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.214 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.481 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 152.96 141.56 3.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.248 -0.977 . . . . 0.0 113.377 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . 0.414 ' HB3' ' H ' ' A' ' 381' ' ' ASN . 0.2 OUTLIER 39.68 -85.97 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 379' ' ' GLY . 9.6 m120 -79.79 86.16 5.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.886 0.374 . . . . 0.0 111.02 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 38.3 m -164.54 159.22 19.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.942 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 58.0 p -152.73 147.96 26.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.765 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 90.01 -146.57 18.81 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.451 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -53.98 -30.76 48.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.319 . . . . 0.0 111.492 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.68 -60.07 3.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 21.3 tp -62.21 -28.19 69.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.549 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -69.06 -32.44 71.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.382 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.454 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 20.8 t-160 -78.88 -51.27 9.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.687 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.481 ' CD1' ' HA2' ' A' ' 379' ' ' GLY . 63.4 t-105 -51.84 -46.9 64.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.042 0.449 . . . . 0.0 110.051 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -33.61 76.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.607 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.458 ' HB3' HD13 ' A' ' 401' ' ' ILE . 0.8 OUTLIER -62.48 -38.33 89.42 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.484 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 11.5 ttm -61.35 -52.61 63.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.067 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.88 -35.88 79.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.407 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.85 -29.64 70.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.205 0.526 . . . . 0.0 109.851 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.425 ' C ' ' H ' ' A' ' 398' ' ' ARG . 11.3 m-80 -114.79 71.91 2.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.537 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.536 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 48.2 Cg_endo -70.42 32.9 0.21 Allowed 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.219 2.613 . . . . 0.0 113.552 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . 0.536 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 3.1 mmm180 -159.08 -46.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.013 0.435 . . . . 0.0 110.981 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.469 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 17.2 ttp180 -94.03 134.92 25.24 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.352 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.469 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 39.5 Cg_endo -66.41 156.35 65.68 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.7 2.266 . . . . 0.0 112.84 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.458 HD13 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -126.14 115.93 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.651 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.63 144.38 32.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.791 0.329 . . . . 0.0 110.853 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -166.6 152.1 8.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.16 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . 0.42 ' CH2' ' HD2' ' A' ' 297' ' ' LYS . 61.2 m95 -80.34 118.1 21.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.885 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.788 ' HB3' HG12 ' A' ' 376' ' ' VAL . 28.9 m-70 -105.01 117.01 32.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.572 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.7 m -78.32 115.42 18.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.781 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.484 HD23 HG22 ' A' ' 376' ' ' VAL . 89.7 mt -60.23 127.12 30.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.359 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -112.94 171.63 7.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.582 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.466 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 59.0 t -55.8 123.36 6.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.991 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.482 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 6.8 mt-10 -55.32 -42.3 73.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.704 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.16 -50.32 73.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.79 0.329 . . . . 0.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.466 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.2 mt-10 -62.89 -39.42 94.42 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.405 HG23 ' HG2' ' A' ' 375' ' ' LYS . 89.4 t -56.08 -48.65 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.372 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.84 -33.89 67.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.46 81.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.568 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' MET . . . . . 0.461 ' HG2' ' CZ ' ' A' ' 377' ' ' PHE . 0.0 OUTLIER -55.05 -36.14 65.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.75 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 5.7 mt -82.57 -32.51 28.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.887 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -84.29 122.9 29.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.083 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.126 -179.961 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 11.1 tptt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.817 0.341 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 42.7 mt -89.43 -30.81 18.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.045 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 121.68 -164.54 14.8 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.185 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -143.3 130.94 21.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.812 0.339 . . . . 0.0 110.844 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -120.34 128.85 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.061 0.458 . . . . 0.0 110.804 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.91 126.53 42.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.948 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.635 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.6 p90 -142.15 150.64 41.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.267 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.3 OUTLIER -99.43 163.21 12.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.281 0.562 . . . . 0.0 112.084 -178.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.5 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 76.6 mt -133.44 144.26 49.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.213 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.421 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 7.8 ttp85 -159.19 106.82 1.79 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.82 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.495 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 27.6 t80 -98.25 139.57 33.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.481 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 287' ' ' GLY . 44.4 t -116.14 92.98 37.46 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.505 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 16.4 Cg_exo -66.03 -31.8 45.49 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.94 2.426 . . . . 0.0 112.501 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -30.96 62.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.921 0.391 . . . . 0.0 110.751 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -121.54 -12.06 8.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.717 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 74.07 45.53 25.63 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.992 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -120.03 130.06 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 111.464 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.419 HD12 ' CH2' ' A' ' 390' ' ' TRP . 33.1 tp -94.3 147.58 23.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.225 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 3.9 m -136.26 137.6 40.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.276 0.56 . . . . 0.0 111.924 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 15.1 t -131.78 121.82 48.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.369 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 20.5 t -116.9 115.14 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.967 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.494 HG23 ' HB2' ' A' ' 339' ' ' TYR . 41.6 mm -74.17 137.09 23.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.38 -58.2 2.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.456 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 0.3 OUTLIER -175.73 164.42 2.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.391 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -123.94 153.35 41.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.798 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.48 150.93 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.693 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 61.24 24.32 14.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.915 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.403 HD12 ' HG3' ' A' ' 310' ' ' PRO . 58.9 mt -58.84 138.38 57.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.079 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -61.01 142.79 56.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.492 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -82.0 118.6 23.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.539 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.49 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.5 mmt -93.75 -18.93 21.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.395 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 44.6 m-20 -99.65 117.04 33.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.911 0.386 . . . . 0.0 110.745 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.01 116.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.438 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 61.33 15.41 45.16 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.354 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.34 -156.46 9.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.8 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.7 mt -100.78 -161.18 0.84 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.847 0.356 . . . . 0.0 110.741 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.422 ' HB2' HD22 ' A' ' 335' ' ' LEU . 58.5 m -138.15 172.13 13.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.313 0.577 . . . . 0.0 111.066 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -131.77 57.73 32.5 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.403 ' HG3' HD12 ' A' ' 299' ' ' LEU . 60.3 Cg_endo -74.33 143.2 31.18 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.987 2.458 . . . . 0.0 114.707 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.52 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 31.6 p90 -143.71 162.16 36.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.363 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.439 HG13 ' CG1' ' A' ' 359' ' ' VAL . 39.7 t -109.37 149.9 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.425 0.631 . . . . 0.0 112.461 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 360' ' ' THR . 10.5 mtmt -132.38 134.81 45.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.388 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 4.7 mp -101.43 145.4 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.802 0.334 . . . . 0.0 110.65 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . 0.45 ' CD2' ' CG ' ' A' ' 325' ' ' LYS . 0.5 OUTLIER -135.43 133.9 39.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.069 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.0 tp -117.95 109.18 16.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.514 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 0.0 OUTLIER -117.31 148.01 42.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.395 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -105.74 99.63 9.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.294 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 59.51 38.15 22.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.082 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.8 10.75 57.45 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.226 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 317' ' ' MET . 4.5 mmtt -117.61 109.33 16.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.878 0.339 . . . . 0.0 110.849 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.66 136.92 54.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.294 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 1.7 mt -128.71 -45.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.117 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 148.8 52.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.287 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . 0.45 ' CG ' ' CD2' ' A' ' 315' ' ' HIS . 0.5 OUTLIER -142.51 125.61 16.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.456 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.03 165.44 17.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.976 0.417 . . . . 0.0 111.248 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -146.16 142.0 28.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.538 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.404 ' CG2' HG13 ' A' ' 293' ' ' ILE . 5.8 p -98.57 -179.63 4.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.868 0.366 . . . . 0.0 111.026 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.4 p -60.02 159.41 9.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.537 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.52 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.2 mt -102.71 122.12 54.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.894 0.378 . . . . 0.0 111.38 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.421 ' HE3' ' CD1' ' A' ' 339' ' ' TYR . 2.3 mmtt -87.4 92.14 8.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.956 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -61.47 136.83 58.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.168 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.76 82.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.464 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.7 t -175.92 174.37 2.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.791 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 308' ' ' SER . 4.5 mt -144.95 -16.86 0.51 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.264 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.415 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.5 m-80 -132.54 58.87 39.4 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 60.3 Cg_endo -88.26 167.6 6.51 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.174 2.582 . . . . 0.0 113.867 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 12.6 t80 -107.39 158.03 17.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.907 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.494 ' HB2' HG23 ' A' ' 293' ' ' ILE . 63.7 m-85 -132.37 -71.73 0.53 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.88 0.372 . . . . 0.0 111.28 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . 0.471 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 9.6 t-20 63.87 34.98 11.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.019 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 293' ' ' ILE . 37.9 mt-10 -91.15 140.39 29.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.718 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.2 m -111.21 121.32 44.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.97 0.414 . . . . 0.0 111.66 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -113.34 148.34 35.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.101 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 23.9 m -127.02 138.21 53.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.028 0.442 . . . . 0.0 111.533 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -127.06 165.82 18.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.596 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -110.44 77.14 1.02 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.719 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.422 ' O ' ' OH ' ' A' ' 282' ' ' TYR . 40.5 t -108.04 114.17 60.09 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.983 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.443 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 32.9 Cg_endo -65.49 157.43 58.26 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.338 2.026 . . . . 0.0 111.395 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -51.42 -25.24 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.482 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -85.23 -11.55 54.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.576 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.443 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.6 OUTLIER -102.08 -36.38 8.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.575 0.226 . . . . 0.0 111.187 -179.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.495 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 4.9 tp -50.81 -28.61 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.32 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -95.0 0.82 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.677 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -125.64 -13.83 6.4 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 26.5 m -94.09 166.84 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 111.271 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . 0.402 ' CG ' ' HA3' ' A' ' 379' ' ' GLY . 7.5 mp0 -143.2 126.38 16.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.426 HG22 ' CZ3' ' A' ' 390' ' ' TRP . 85.9 t -89.09 115.61 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.205 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 315' ' ' HIS . 0.2 OUTLIER -101.54 109.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.584 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.613 ' HB ' HG21 ' A' ' 376' ' ' VAL . 42.9 t -93.69 107.84 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 313' ' ' LYS . 3.6 m -110.74 134.21 52.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.964 0.412 . . . . 0.0 111.587 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 40.9 t -108.19 117.22 53.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.223 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.442 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.4 mp -120.63 148.16 44.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.013 0.435 . . . . 0.0 111.604 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.49 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -96.01 131.95 41.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.46 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 365' ' ' ASP . 8.5 t80 -87.04 142.63 27.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.736 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.448 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 22.9 m-20 -126.41 104.54 8.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.639 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.422 ' HD3' HG12 ' A' ' 367' ' ' ILE . 0.0 OUTLIER -29.18 -46.22 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.915 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.422 HG12 ' HD3' ' A' ' 366' ' ' LYS . 39.5 mm -107.15 -69.33 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.745 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -57.41 166.67 5.4 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.482 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.73 165.61 20.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.5 135.5 45.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.776 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -98.94 139.82 34.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.013 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -87.15 110.84 20.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.176 0.513 . . . . 0.0 110.852 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 37.3 mt -79.83 -34.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.285 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 168.71 -178.51 42.09 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.746 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.458 ' CG ' ' HG2' ' A' ' 410' ' ' GLU . 11.0 ptmt -164.83 140.74 5.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.336 0.589 . . . . 0.0 112.275 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.703 HG12 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.81 159.15 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.746 178.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -146.44 131.99 18.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 0.0 111.756 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 26.5 m -127.01 105.6 14.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.787 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.402 ' HA3' ' CG ' ' A' ' 356' ' ' GLN . . . -145.7 -149.42 5.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.775 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.84 -31.11 13.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.805 0.336 . . . . 0.0 110.727 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.6 -27.52 41.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.79 173.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 68.6 p -153.52 148.21 26.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 93.18 -147.09 18.43 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.702 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . 0.489 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -57.44 -29.49 64.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.931 0.396 . . . . 0.0 111.245 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -72.29 -41.24 66.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.903 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 39.5 tp -72.24 -36.09 68.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 0.0 110.298 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 385' ' ' ALA . 9.8 ptt180 -62.45 -32.04 72.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.235 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.473 ' CE1' ' HG ' ' A' ' 280' ' ' LEU . 17.7 t-160 -74.26 -52.08 13.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.42 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.451 ' CZ3' ' HE3' ' A' ' 393' ' ' MET . 70.0 t-105 -54.91 -45.28 74.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.53 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -37.86 84.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 13.0 t0 -61.2 -35.64 77.72 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.5 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 10.9 ttm -59.68 -52.82 63.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.174 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.424 HD23 ' CG2' ' A' ' 352' ' ' ILE . 2.3 mt -61.75 -25.83 67.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.964 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -76.72 -44.77 32.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.255 0.55 . . . . 0.0 109.594 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.411 ' HB2' HD12 ' A' ' 401' ' ' ILE . 21.9 m-80 -119.33 64.39 7.6 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.489 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.505 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 5.0 Cg_endo -45.67 -80.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.498 2.799 . . . . 0.0 113.23 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.51 -17.56 2.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.79 116.72 66.83 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.818 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.5 136.83 78.28 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.472 2.115 . . . . 0.0 112.691 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.47 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.2 mm -116.75 107.38 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.327 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.81 143.62 36.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.858 0.361 . . . . 0.0 110.829 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.52 152.33 10.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.321 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -79.13 116.31 19.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.582 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.703 ' HB3' HG12 ' A' ' 376' ' ' VAL . 33.5 m-70 -102.87 119.88 39.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.685 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 74.4 m -78.33 116.01 18.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.4 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.422 HD22 HG22 ' A' ' 376' ' ' VAL . 93.4 mt -62.38 127.78 32.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.252 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -115.88 172.57 7.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.454 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 41.3 t -56.18 121.82 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.002 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.458 ' HG2' ' CG ' ' A' ' 375' ' ' LYS . 12.2 mt-10 -54.23 -43.65 71.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.101 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.5 -50.4 73.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.886 0.374 . . . . 0.0 110.795 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.454 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.4 mt-10 -63.38 -37.8 88.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.42 HG21 ' HG2' ' A' ' 375' ' ' LYS . 99.6 t -57.61 -48.09 83.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.715 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -31.1 72.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -75.05 -30.95 61.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.075 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 28.7 mtm -72.15 -32.96 67.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.998 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 9.4 mt -78.16 -32.79 50.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -87.88 -177.07 5.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 28.6 t . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.037 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 62.5 mt -75.13 -33.05 61.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.63 -163.2 16.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.255 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -143.44 135.87 27.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.71 0.291 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -123.63 129.43 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.057 0.456 . . . . 0.0 110.822 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -97.35 124.96 41.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.017 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.606 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 20.3 p90 -142.26 149.73 39.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.802 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.738 ' OG ' ' HB ' ' A' ' 292' ' ' VAL . 16.1 p -110.83 168.0 9.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.197 0.522 . . . . 0.0 111.892 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.414 HD12 ' CE1' ' A' ' 389' ' ' HIS . 1.2 mt -137.67 160.09 40.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.78 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.51 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.9 OUTLIER -159.14 102.47 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.767 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.472 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 39.7 t80 -100.14 130.82 46.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.944 0.402 . . . . 0.0 111.878 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.48 97.82 51.16 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.508 ' CG ' ' CB ' ' A' ' 397' ' ' PRO . 6.0 Cg_exo -71.13 -29.93 16.88 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.643 2.229 . . . . 0.0 112.299 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -30.56 11.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.187 0.518 . . . . 0.0 109.774 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.76 -20.83 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.822 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.44 47.17 7.01 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.908 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -123.98 129.66 51.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 111.482 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 33.5 tp -96.36 147.63 23.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.26 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 6.0 m -135.28 137.24 42.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.287 0.565 . . . . 0.0 112.003 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.8 t -130.33 123.07 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.412 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.738 ' HB ' ' OG ' ' A' ' 279' ' ' SER . 5.0 t -118.54 116.32 50.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.664 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 341' ' ' GLU . 44.1 mm -75.65 137.15 23.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.16 -57.94 2.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -175.54 162.43 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.422 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -122.33 154.81 37.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.933 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.404 ' HD3' ' CZ3' ' A' ' 404' ' ' TRP . 4.0 ptmt -150.79 150.4 30.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 111.519 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 59.62 25.54 14.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.421 HD12 ' CG ' ' A' ' 310' ' ' PRO . 89.3 mt -61.43 138.95 58.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.813 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -58.25 151.48 19.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.546 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 13.7 mttp -91.46 118.13 30.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.547 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.519 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.6 mmt -91.48 -18.57 23.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.341 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 30.6 m-20 -104.46 98.18 7.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.729 0.3 . . . . 0.0 110.408 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.22 114.73 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 111.44 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.95 -3.52 84.68 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.681 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -129.36 -143.17 5.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.87 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 34.6 mt -113.63 -159.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.909 0.385 . . . . 0.0 110.842 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 334' ' ' THR . 74.2 m -134.74 172.24 13.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.307 0.575 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.405 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -129.13 58.07 34.59 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.421 ' CG ' HD12 ' A' ' 299' ' ' LEU . 47.6 Cg_endo -70.15 150.64 66.13 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.13 2.554 . . . . 0.0 114.974 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.528 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 51.4 p90 -153.51 156.54 38.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.169 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.441 HG12 ' CG1' ' A' ' 359' ' ' VAL . 42.7 t -107.6 149.97 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 360' ' ' THR . 12.8 mtmt -131.09 139.21 49.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.313 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.415 HG22 ' CZ ' ' A' ' 345' ' ' PHE . 5.2 mp -114.77 130.31 69.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.296 . . . . 0.0 110.963 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -126.17 136.76 53.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 0.0 111.042 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 21.8 tp -105.51 105.25 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.594 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 1.4 mtm -107.69 144.18 35.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.38 99.68 9.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.572 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 57.68 35.48 25.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.352 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 100.56 11.77 40.18 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.753 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.439 ' HG3' HD22 ' A' ' 323' ' ' LEU . 0.1 OUTLIER -125.01 110.73 14.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.377 0.589 . . . . 0.0 110.921 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.82 137.85 37.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.688 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.439 HD22 ' HG3' ' A' ' 321' ' ' LYS . 5.8 mt -126.8 -43.16 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.079 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.46 151.57 50.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.34 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.0 133.68 41.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.836 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -136.35 160.25 39.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.032 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -147.8 144.22 28.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.825 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 18.0 p -103.78 174.0 6.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.695 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.2 t -55.02 162.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.682 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.528 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.0 mt -108.8 128.55 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.949 0.404 . . . . 0.0 111.245 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 337' ' ' PRO . 2.1 mmtt -94.99 93.14 7.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.46 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -57.79 137.38 56.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.693 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.79 83.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.401 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 308' ' ' SER . 4.9 t -175.87 173.33 2.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.685 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 308' ' ' SER . 4.1 mt -146.9 -15.97 0.41 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.264 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -131.48 60.26 51.14 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.86 0.362 . . . . 0.0 110.08 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.428 ' HB2' ' HG3' ' A' ' 331' ' ' LYS . 73.5 Cg_endo -86.79 167.59 8.4 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.081 2.521 . . . . 0.0 114.106 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.464 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 74.0 t80 -119.95 149.46 42.08 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.605 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.409 ' HB2' HG22 ' A' ' 293' ' ' ILE . 32.9 m-85 -132.46 -67.73 0.64 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.909 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . 0.464 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 11.6 t-20 67.85 36.53 3.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.688 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 293' ' ' ILE . 46.3 mt-10 -91.04 135.0 34.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.4 m -104.72 121.69 44.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.836 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -109.08 164.72 12.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.891 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 18.3 m -134.7 142.65 46.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.05 0.452 . . . . 0.0 111.73 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.415 ' CZ ' HG22 ' A' ' 314' ' ' ILE . 50.3 m-85 -132.14 162.1 31.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -112.5 77.69 1.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.562 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.444 ' O ' ' OH ' ' A' ' 282' ' ' TYR . 38.3 t -105.26 122.13 43.98 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.323 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 27.1 Cg_exo -60.85 146.66 97.18 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.571 2.181 . . . . 0.0 111.564 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 284' ' ' PRO . 11.3 t80 -54.08 -23.74 14.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 111.243 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 15.1 pm0 -91.5 -8.59 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.372 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.432 ' CB ' ' HD2' ' A' ' 348' ' ' PRO . 0.1 OUTLIER -104.45 -24.58 13.03 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.496 HD11 ' CZ2' ' A' ' 390' ' ' TRP . 1.7 tp -52.4 -32.59 16.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.879 0.371 . . . . 0.0 110.547 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 380' ' ' TYR . 6.4 mt-30 -87.58 3.33 47.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.338 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -124.29 -21.25 5.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.503 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 24.0 m -87.88 166.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.879 0.371 . . . . 0.0 111.285 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . 0.4 ' CG ' ' HA3' ' A' ' 379' ' ' GLY . 7.2 mp0 -143.47 126.28 16.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.778 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.433 HG21 ' CZ3' ' A' ' 390' ' ' TRP . 64.5 t -88.26 119.55 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.287 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.46 111.65 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.74 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.613 ' HB ' HG23 ' A' ' 376' ' ' VAL . 46.6 t -97.52 107.91 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.674 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 313' ' ' LYS . 3.1 m -110.59 134.41 52.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.011 0.434 . . . . 0.0 111.859 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 55.5 t -108.37 115.02 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.128 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 311' ' ' TYR . 3.8 mp -118.87 150.31 40.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 111.506 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.519 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.4 OUTLIER -97.22 129.94 44.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.638 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.532 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 27.0 t80 -78.99 146.86 33.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.652 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 367' ' ' ILE . 27.5 m-20 -139.2 66.59 1.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.542 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.532 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 0.1 OUTLIER 25.12 -88.26 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.417 ' N ' ' O ' ' A' ' 365' ' ' ASP . 4.4 mp -82.52 -68.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -47.98 167.53 0.13 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.888 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.9 165.45 13.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.333 . . . . 0.0 110.779 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.62 124.97 35.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.5 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.89 153.64 40.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.522 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -100.86 111.74 24.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.616 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.461 HD11 HG21 ' A' ' 373' ' ' ILE . 25.5 mt -79.66 -33.23 14.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.317 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.13 -178.24 41.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.854 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.459 ' CG ' ' HG2' ' A' ' 410' ' ' GLU . 17.1 ptmt -164.66 140.61 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.292 0.568 . . . . 0.0 111.967 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.638 HG12 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.77 159.07 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.01 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.417 ' CE1' ' OE1' ' A' ' 386' ' ' GLU . 9.4 p90 -143.82 131.98 21.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.417 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.434 ' CG1' ' CE1' ' A' ' 405' ' ' HIS . 30.1 m -126.45 109.36 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.793 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 390' ' ' TRP . . . -152.63 -141.08 3.22 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.864 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . 0.418 ' CB ' ' O ' ' A' ' 353' ' ' GLN . 0.1 OUTLIER -105.78 -30.28 9.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.797 0.332 . . . . 0.0 110.898 -179.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -79.0 -28.97 43.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.04 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' SER . . . . . 0.4 ' OG ' ' CD2' ' A' ' 377' ' ' PHE . 1.4 m -58.42 176.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.067 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 75.3 p -153.28 148.33 26.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.728 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 95.9 -156.95 21.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.472 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . 0.426 ' HA ' ' HG3' ' A' ' 388' ' ' ARG . . . -47.39 -31.51 4.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.765 0.317 . . . . 0.0 111.447 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.417 ' OE1' ' CE1' ' A' ' 377' ' ' PHE . 13.2 mt-10 -64.67 -54.77 26.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.0 tp -56.99 -34.44 68.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.58 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.426 ' HG3' ' HA ' ' A' ' 385' ' ' ALA . 6.0 mtt180 -61.82 -48.52 80.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.359 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.45 ' CD2' HG22 ' A' ' 401' ' ' ILE . 19.6 t-160 -60.27 -57.53 12.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.496 ' CZ2' HD11 ' A' ' 352' ' ' ILE . 65.2 t-105 -51.41 -44.96 62.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.963 0.411 . . . . 0.0 110.203 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.0 t -68.86 -34.79 76.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.932 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 4.4 t0 -62.04 -31.67 72.1 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.444 ' HA ' HG13 ' A' ' 401' ' ' ILE . 5.7 tpt -66.61 -56.42 10.78 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.74 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.3 mt -58.42 -21.45 50.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.665 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . 0.407 ' C ' ' HD3' ' A' ' 397' ' ' PRO . . . -70.39 -34.08 72.14 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -127.96 70.52 78.03 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.669 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.531 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 11.2 Cg_exo -71.59 51.65 1.52 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.101 2.534 . . . . 0.0 112.954 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . 0.531 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 4.7 mmm180 -158.99 -40.89 0.06 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.351 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.0 160.72 31.73 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.491 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -89.87 123.23 1.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.131 2.554 . . . . 0.0 112.664 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.45 HG22 ' CD2' ' A' ' 389' ' ' HIS . 1.1 mm -98.38 130.44 47.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.717 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -124.57 146.01 49.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.701 0.286 . . . . 0.0 110.809 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.29 155.78 9.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 111.411 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . 0.404 ' CZ3' ' HD3' ' A' ' 297' ' ' LYS . 54.1 m95 -83.63 123.38 29.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.776 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.638 ' HB3' HG12 ' A' ' 376' ' ' VAL . 47.5 m-70 -111.05 119.21 38.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -78.34 116.52 18.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.811 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.472 HD23 HG21 ' A' ' 376' ' ' VAL . 94.9 mt -61.89 127.66 32.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.352 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -114.97 171.59 7.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.561 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.472 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 60.5 t -54.17 120.25 2.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.459 ' HG2' ' CG ' ' A' ' 375' ' ' LYS . 10.6 mt-10 -54.57 -42.37 70.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.879 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -48.87 77.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.36 . . . . 0.0 110.74 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.472 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.5 mt-10 -64.67 -38.84 92.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.349 0.595 . . . . 0.0 109.417 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 95.2 t -58.44 -49.27 82.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.544 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -33.71 75.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.936 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -71.21 -31.92 68.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 33.9 mtm -73.46 -34.62 65.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 8.1 mt -81.21 -31.24 34.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -84.83 138.82 32.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.098 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.865 0.364 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 48.4 mt -83.76 -31.15 26.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 117.41 -168.47 12.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.225 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.11 132.42 32.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.707 0.289 . . . . 0.0 110.987 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -118.58 129.29 75.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.058 0.456 . . . . 0.0 110.964 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.52 124.87 41.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.828 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.608 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 20.5 p90 -142.3 149.67 39.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.691 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.765 ' OG ' ' HB ' ' A' ' 292' ' ' VAL . 13.2 p -109.78 160.65 16.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.233 0.54 . . . . 0.0 112.214 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.44 HD11 ' CD2' ' A' ' 389' ' ' HIS . 6.8 mt -128.69 153.82 46.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.806 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.438 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 9.8 ttp180 -159.27 107.28 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.86 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.514 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 31.3 t80 -99.04 139.48 34.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.721 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 287' ' ' GLY . 60.1 t -116.54 92.83 38.55 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 17.1 Cg_exo -65.14 -30.88 55.28 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.891 2.394 . . . . 0.0 112.322 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -31.54 63.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.732 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.84 -11.9 8.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.637 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 73.5 45.41 29.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.059 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -120.08 130.06 54.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 111.447 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.406 HD21 ' CG2' ' A' ' 357' ' ' VAL . 25.0 tp -94.34 148.02 22.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.381 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 3.6 m -136.82 134.3 36.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.254 0.55 . . . . 0.0 111.903 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.81 122.65 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.363 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.765 ' HB ' ' OG ' ' A' ' 279' ' ' SER . 4.3 t -117.68 115.48 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.758 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.479 HG22 ' HB2' ' A' ' 339' ' ' TYR . 40.8 mm -74.6 137.14 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.45 -58.3 2.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.49 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 11.4 pt-20 -175.72 163.77 2.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.665 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -125.24 149.01 48.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.677 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.425 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 17.7 pttt -146.17 153.29 40.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.104 0.478 . . . . 0.0 111.549 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 60.1 27.1 16.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.621 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.517 HD11 ' HG3' ' A' ' 310' ' ' PRO . 91.7 mt -63.36 138.55 58.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.599 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.71 136.73 53.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.689 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -69.51 123.54 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.185 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.428 ' SD ' ' HB3' ' A' ' 363' ' ' ASP . 0.1 OUTLIER -100.49 -11.58 20.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.687 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 53.1 m-20 -103.05 121.94 43.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.807 0.337 . . . . 0.0 110.284 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -47.02 115.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 111.664 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 57.37 17.27 24.55 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.405 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.97 -160.43 10.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.956 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 6.3 mt -94.84 -160.86 0.81 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.449 0.3 . . . . 0.0 110.27 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.433 ' HB2' HD21 ' A' ' 335' ' ' LEU . 67.3 m -136.68 171.86 13.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.344 0.592 . . . . 0.0 111.105 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.448 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -132.12 55.12 16.23 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.819 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.517 ' HG3' HD11 ' A' ' 299' ' ' LEU . 35.4 Cg_endo -65.97 149.94 85.85 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.168 2.578 . . . . 0.0 114.551 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.512 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 48.1 p90 -154.18 150.09 27.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.401 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.455 HG13 ' CG1' ' A' ' 359' ' ' VAL . 39.3 t -101.23 148.96 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 360' ' ' THR . 11.7 mtmt -130.33 138.54 50.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.154 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.45 HG21 ' CZ ' ' A' ' 345' ' ' PHE . 5.3 mp -115.66 131.06 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.774 0.321 . . . . 0.0 110.771 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -129.13 133.38 47.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 18.9 tp -106.06 104.97 14.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.638 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 3.5 mtm -106.57 142.79 35.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.21 99.77 9.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.48 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 58.65 38.3 25.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 92.18 22.52 29.65 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.027 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.5 mtpm? -128.86 109.3 11.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.741 0.305 . . . . 0.0 110.805 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.88 131.59 40.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.26 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 4.9 mt -126.01 -42.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.131 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -130.72 151.32 51.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.502 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 132.1 32.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.582 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 53.2 mmtt -139.34 155.27 47.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.236 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -141.31 149.47 41.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.72 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.416 HG23 ' CE1' ' A' ' 343' ' ' PHE . 21.2 p -106.17 175.51 5.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.826 0.346 . . . . 0.0 111.031 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -57.24 148.7 21.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.69 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.512 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -92.12 122.49 43.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.514 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -86.67 85.87 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.016 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.68 139.29 50.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.99 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 42.81 79.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.496 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 5.1 t -173.44 173.48 3.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.165 0.507 . . . . 0.0 110.911 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.433 HD21 ' HB2' ' A' ' 308' ' ' SER . 4.0 mt -146.19 -16.09 0.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.186 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.475 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.57 58.5 36.64 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 110.217 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 84.6 Cg_endo -90.39 167.79 4.24 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.175 2.583 . . . . 0.0 114.076 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.501 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 35.9 t80 -114.1 152.48 31.02 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.067 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.479 ' HB2' HG22 ' A' ' 293' ' ' ILE . 2.2 m-85 -130.03 -70.53 0.63 Allowed 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.921 0.391 . . . . 0.0 111.519 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . 0.501 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 24.3 t-20 66.67 35.14 5.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.714 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 293' ' ' ILE . 52.1 mt-10 -91.11 133.81 35.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.973 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.2 m -104.07 121.25 42.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.695 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . 0.416 ' CE1' HG23 ' A' ' 328' ' ' THR . 69.2 m-85 -110.08 156.5 20.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.022 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 57.9 p -130.65 140.54 50.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.088 0.47 . . . . 0.0 111.588 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.45 ' CZ ' HG21 ' A' ' 314' ' ' ILE . 62.7 m-85 -128.54 165.91 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.58 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -111.6 78.48 1.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.412 ' O ' ' OH ' ' A' ' 282' ' ' TYR . 41.4 t -111.72 117.81 47.96 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.059 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.477 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 48.3 Cg_endo -69.52 157.47 60.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.383 2.055 . . . . 0.0 111.434 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -51.3 -23.02 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -86.7 -10.23 54.19 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.477 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -107.8 -33.16 7.34 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.537 0.208 . . . . 0.0 111.544 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.514 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 5.1 tp -49.26 -27.21 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.638 0.256 . . . . 0.0 111.136 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . 0.423 ' O ' ' CD1' ' A' ' 380' ' ' TYR . 2.6 mm-40 -95.17 -9.42 33.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.842 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -113.29 -18.62 12.02 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 23.7 m -87.92 167.89 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 111.377 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . 0.448 ' HA ' ' HA3' ' A' ' 379' ' ' GLY . 3.4 mt-30 -143.81 126.34 15.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.824 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.446 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 53.9 t -89.87 104.83 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.69 110.78 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.615 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.616 ' HB ' HG22 ' A' ' 376' ' ' VAL . 44.3 t -93.81 107.85 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 313' ' ' LYS . 5.2 m -111.55 131.77 55.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 0.0 111.968 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 42.5 t -105.03 119.47 54.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.163 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 311' ' ' TYR . 3.5 mp -124.73 147.61 48.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.134 0.492 . . . . 0.0 111.797 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.428 ' HB3' ' SD ' ' A' ' 302' ' ' MET . 3.4 t70 -91.13 129.87 37.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.012 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.424 ' CD2' HD12 ' A' ' 330' ' ' ILE . 21.7 t80 -79.63 141.95 36.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.232 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 366' ' ' LYS . 80.0 m-20 -138.62 71.77 1.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.496 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 365' ' ' ASP . 2.5 pttm 24.16 -89.59 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.408 HD11 ' N ' ' A' ' 367' ' ' ILE . 0.0 OUTLIER -99.19 129.44 49.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.092 0.472 . . . . 0.0 111.156 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.02 179.45 21.98 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.62 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 165.12 13.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.721 0.295 . . . . 0.0 110.686 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.93 138.72 37.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.834 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -72.68 145.01 47.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.291 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -101.1 112.44 24.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.135 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 373' ' ' ILE . 12.3 mt -79.98 -33.37 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.336 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 166.35 179.21 39.57 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.945 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.421 ' HB3' ' CG2' ' A' ' 360' ' ' THR . 13.3 ptmt -161.2 140.37 10.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.24 0.543 . . . . 0.0 112.075 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.616 HG22 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -111.84 159.06 12.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.21 179.324 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -142.98 135.17 27.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 0.0 111.546 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.408 ' CG1' ' CE1' ' A' ' 405' ' ' HIS . 18.8 m -130.22 100.2 4.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.986 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.495 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 166.94 -156.62 28.6 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.165 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . 0.423 ' CD1' ' O ' ' A' ' 353' ' ' GLN . 0.0 OUTLIER -51.17 153.04 2.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 111.188 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.16 31.09 20.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 20.2 m -121.34 161.9 21.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.883 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 48.1 p -153.33 147.96 26.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.729 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 94.86 -156.91 22.04 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.522 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -50.44 -31.14 14.28 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -63.94 -51.88 62.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.429 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.02 -32.42 69.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.571 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 31.7 mtt180 -63.55 -50.88 67.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.619 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.46 ' CD2' HG22 ' A' ' 401' ' ' ILE . 16.2 t-160 -56.82 -54.14 49.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.495 ' CD1' ' HA2' ' A' ' 379' ' ' GLY . 61.1 t-105 -54.06 -50.67 66.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.091 0.472 . . . . 0.0 110.335 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.4 t -63.69 -34.94 78.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.345 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 8.2 t0 -62.74 -36.57 83.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.047 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.434 ' HE3' ' CZ3' ' A' ' 390' ' ' TRP . 31.2 ttp -62.96 -55.32 26.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.724 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.401 HD23 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -57.52 -24.68 57.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.662 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -79.94 -37.75 33.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.299 0.571 . . . . 0.0 109.526 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 399' ' ' ARG . 13.6 m-80 -126.82 60.99 43.61 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.646 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.512 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 3.9 Cg_endo -45.11 -79.32 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.791 2.994 . . . . 0.0 113.266 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -48.51 -21.8 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.126 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.469 ' HB3' ' HB3' ' A' ' 396' ' ' ASN . 1.1 tpt180 -93.73 126.71 48.59 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.826 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.34 131.39 21.72 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.46 2.106 . . . . 0.0 112.547 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.46 HG22 ' CD2' ' A' ' 389' ' ' HIS . 1.1 mm -110.46 112.06 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.093 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -108.95 145.65 35.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.687 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.95 152.7 6.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.927 0.394 . . . . 0.0 111.322 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . 0.425 ' CH2' ' HG3' ' A' ' 295' ' ' GLU . 64.2 m95 -80.89 118.74 22.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.823 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.608 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 46.3 m-70 -107.17 119.77 40.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 86.6 m -78.29 116.26 18.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.091 0.472 . . . . 0.0 110.961 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.488 HD22 HG23 ' A' ' 376' ' ' VAL . 94.9 mt -61.75 127.55 31.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.28 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -114.42 171.9 7.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.491 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.473 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 57.1 t -54.58 115.65 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.408 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 3.6 mp0 -52.05 -41.16 62.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.803 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -57.21 -48.91 77.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 110.622 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.473 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 24.4 mt-10 -65.04 -39.91 94.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 70.5 t -59.5 -49.54 83.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.158 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.33 -37.15 84.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.741 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -66.17 -35.26 80.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 63.3 mtm -70.24 -30.36 67.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 8.0 mt -81.27 -34.43 32.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.87 -179.73 5.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.089 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.092 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.779 0.323 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 44.6 mt -77.44 -31.94 54.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.12 -159.63 16.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.192 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -148.17 131.12 16.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.787 0.327 . . . . 0.0 110.56 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.466 HG13 HG23 ' A' ' 312' ' ' VAL . 0.0 OUTLIER -120.63 130.14 74.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 110.935 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.21 126.22 42.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.736 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.619 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.5 p90 -141.94 149.33 39.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.321 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.75 159.37 15.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.045 -178.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.486 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 85.2 mt -130.49 144.99 51.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.855 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.438 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 7.2 ttm180 -158.86 103.94 1.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.781 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.52 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 27.8 t80 -99.22 138.86 35.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.241 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.8 t -123.55 94.59 46.16 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.394 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.52 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.15 -32.57 16.71 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.927 2.418 . . . . 0.0 112.325 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.53 -29.8 7.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.176 0.512 . . . . 0.0 110.07 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.95 -21.1 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.117 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 81.06 48.03 6.26 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.538 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -123.76 129.32 50.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.058 0.456 . . . . 0.0 111.626 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 345' ' ' PHE . 33.7 tp -96.08 147.74 23.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.9 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 2.6 m -136.05 135.99 39.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.319 0.58 . . . . 0.0 111.998 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.43 118.19 44.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.12 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 23.1 t -113.92 115.74 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.058 0.456 . . . . 0.0 111.961 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 341' ' ' GLU . 34.2 mm -74.75 137.02 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 339' ' ' TYR . 0.4 OUTLIER -113.49 -60.34 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.423 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 4.9 pt-20 -175.73 155.89 1.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.357 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -112.03 153.3 27.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.724 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -150.95 150.71 31.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.148 0.499 . . . . 0.0 111.614 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 61.38 22.74 13.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.005 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 52.0 mt -57.8 138.46 55.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.109 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -64.09 149.88 46.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.502 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.416 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 11.1 mttt -88.32 116.22 26.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.54 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.4 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 9.0 mmm -95.93 -19.98 19.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.486 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 48.6 m-20 -91.91 121.57 33.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.543 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -48.35 115.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.648 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 56.17 18.56 20.81 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.304 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.42 -157.74 9.75 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.005 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.0 mt -98.53 -161.38 0.87 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.781 0.324 . . . . 0.0 110.529 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 301' ' ' LYS . 15.1 m -134.91 171.89 13.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.246 0.546 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.414 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -135.16 56.61 16.91 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 363' ' ' ASP . 73.7 Cg_endo -77.57 143.68 21.78 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.963 2.442 . . . . 0.0 114.805 -177.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.547 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 10.6 p90 -138.8 166.94 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.242 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.466 HG23 HG13 ' A' ' 276' ' ' ILE . 24.4 t -112.73 149.96 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 360' ' ' THR . 7.0 mttm -133.97 144.05 48.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.871 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.4 mp -118.86 124.09 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 111.201 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 70.2 m80 -117.98 130.98 56.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.597 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.458 HD21 ' HG3' ' A' ' 324' ' ' LYS . 22.5 tp -102.82 104.64 14.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 0.0 OUTLIER -127.59 129.09 46.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.408 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 319' ' ' ASN . 0.0 OUTLIER -105.53 103.15 12.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 110.372 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 318' ' ' GLN . 83.2 m-20 71.15 36.43 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.199 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 82.12 21.22 61.3 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.175 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.6 mtpm? -113.34 109.07 18.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.837 0.318 . . . . 0.0 110.628 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -56.92 127.2 30.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.221 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 11.9 mt -122.7 -56.01 1.79 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.914 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.486 ' HB2' ' HE2' ' A' ' 345' ' ' PHE . 11.7 mttp -137.85 153.98 49.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.944 0.402 . . . . 0.0 111.256 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . 0.429 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -142.57 129.42 20.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.435 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -127.37 167.88 15.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 111.269 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.55 144.87 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.421 HG22 ' CE1' ' A' ' 343' ' ' PHE . 17.3 p -104.21 178.35 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 7.2 p -57.52 176.5 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.502 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.4 mt -118.21 118.39 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.97 0.414 . . . . 0.0 111.329 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.407 ' HG3' ' CG ' ' A' ' 337' ' ' PRO . 8.8 mmtt -82.95 84.86 7.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.978 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -55.96 136.86 51.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.015 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.45 82.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.294 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 308' ' ' SER . 4.9 t -176.45 173.86 2.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.725 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 4.3 mt -145.13 -16.31 0.5 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.219 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.469 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.6 m-80 -132.9 56.05 20.3 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 120.796 0.332 . . . . 0.0 110.117 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.469 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 55.8 Cg_endo -88.32 167.67 6.43 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.199 2.599 . . . . 0.0 113.79 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.423 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 1.1 t80 -107.04 160.83 15.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.327 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.435 ' HB2' HG23 ' A' ' 293' ' ' ILE . 70.9 m-85 -134.01 -64.49 0.7 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.865 0.364 . . . . 0.0 111.075 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 56.99 36.95 28.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.976 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 293' ' ' ILE . 47.5 mt-10 -92.97 142.13 27.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.778 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 12.7 m -114.0 120.56 41.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.44 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . 0.421 ' CE1' HG22 ' A' ' 328' ' ' THR . 79.4 m-85 -112.97 153.42 28.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.252 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 9.7 m -123.74 137.73 54.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.152 0.501 . . . . 0.0 111.675 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.486 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 32.2 m-85 -120.88 165.96 14.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.584 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -116.43 72.43 0.82 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.85 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.445 ' CG2' HD22 ' A' ' 316' ' ' LEU . 40.0 t -108.97 117.53 53.53 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.236 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 38.4 Cg_endo -67.61 153.33 76.53 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.113 1.875 . . . . 0.0 111.104 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -48.19 -24.58 1.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.38 -18.02 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.925 0.342 . . . . 0.0 111.925 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.5 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.1 OUTLIER -96.0 -36.56 11.0 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.52 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 4.3 tp -48.36 -27.12 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 111.243 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . 0.422 ' O ' ' CD2' ' A' ' 380' ' ' TYR . 5.6 mt-30 -89.16 -17.77 28.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.987 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.462 ' HA ' ' HD2' ' A' ' 380' ' ' TYR . 0.0 OUTLIER -119.06 10.52 12.16 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.415 HG12 ' HB3' ' A' ' 351' ' ' GLN . 31.0 m -108.36 167.71 3.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -141.22 126.45 18.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.922 0.392 . . . . 0.0 111.224 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.404 HG21 ' CZ3' ' A' ' 390' ' ' TRP . 85.4 t -97.25 117.66 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.13 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.2 OUTLIER -105.22 116.13 48.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.085 -178.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.616 ' HB ' HG21 ' A' ' 376' ' ' VAL . 47.7 t -94.66 107.77 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 313' ' ' LYS . 5.2 m -109.76 134.74 51.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.062 0.458 . . . . 0.0 111.993 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 47.5 t -110.88 118.88 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.237 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.458 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.7 mp -119.8 143.49 47.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.975 0.417 . . . . 0.0 111.43 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 310' ' ' PRO . 3.4 t70 -90.37 126.44 35.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.716 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.443 ' CD2' ' ND2' ' A' ' 370' ' ' ASN . 22.7 t80 -81.94 141.82 32.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.782 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 367' ' ' ILE . 28.0 m-20 -132.03 73.78 1.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.983 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.431 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 0.0 OUTLIER 31.24 -84.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 365' ' ' ASP . 5.1 mp -27.57 -83.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -169.56 -52.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.935 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 109.86 2.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.001 0.429 . . . . 0.0 110.928 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . 0.443 ' ND2' ' CD2' ' A' ' 364' ' ' TYR . 0.2 OUTLIER -92.82 145.61 24.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.907 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.01 157.28 20.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.714 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -100.9 111.29 23.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.076 0.465 . . . . 0.0 111.269 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 1.4 mm -75.61 -35.64 32.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.817 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 157.29 -174.6 34.81 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.44 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.475 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 15.9 ptmt -164.31 141.03 6.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.195 0.521 . . . . 0.0 111.851 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.616 HG21 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -111.93 158.63 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.167 179.31 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.421 ' CE1' ' HE3' ' A' ' 416' ' ' MET . 5.4 p90 -142.1 148.25 38.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.006 0.431 . . . . 0.0 111.593 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.421 HG23 ' CE3' ' A' ' 390' ' ' TRP . 19.8 m -140.85 127.76 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.857 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.437 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 159.26 -137.12 4.99 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.263 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . 0.462 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 0.2 OUTLIER -64.71 -77.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -50.74 -25.02 3.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.809 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 23.0 m -53.24 159.74 1.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.916 0.389 . . . . 0.0 110.679 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 58.8 p -155.95 150.05 25.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.716 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 81.65 -154.75 34.66 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.238 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -45.17 -31.97 1.66 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.753 0.311 . . . . 0.0 111.68 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -63.52 -55.34 24.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.767 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 32.9 tp -57.12 -36.57 70.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.67 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 2.6 mtt180 -59.11 -44.77 92.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.129 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.445 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 16.6 t-160 -59.95 -57.43 12.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.93 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.451 ' CZ3' ' HE1' ' A' ' 393' ' ' MET . 71.3 t-105 -50.51 -46.43 57.15 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.174 0.512 . . . . 0.0 109.954 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.6 t -67.04 -33.44 75.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.597 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.482 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.8 OUTLIER -64.65 -38.0 89.49 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.565 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.486 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 7.6 ttm -62.21 -53.61 52.73 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.88 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.405 ' CD2' HG12 ' A' ' 352' ' ' ILE . 1.6 mt -61.64 -35.9 79.24 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.338 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.1 -29.55 69.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.865 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.3 m-80 -114.28 71.48 2.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.66 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.525 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 52.6 Cg_endo -70.28 32.88 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.249 2.633 . . . . 0.0 113.594 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . 0.525 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 16.5 mmm180 -159.33 -44.31 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.979 0.419 . . . . 0.0 110.854 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.464 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.0 OUTLIER -93.92 136.95 23.27 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.314 -178.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.464 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 58.9 Cg_endo -71.34 156.46 58.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.52 2.147 . . . . 0.0 112.814 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.482 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.89 116.92 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.61 144.1 35.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.702 0.287 . . . . 0.0 110.822 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.56 153.09 10.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.972 0.415 . . . . 0.0 111.388 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . 0.414 ' CH2' ' HG3' ' A' ' 295' ' ' GLU . 59.0 m95 -82.24 118.71 23.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.619 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 55.9 m-70 -106.74 123.68 48.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.6 m -78.29 118.56 20.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.783 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.413 ' CD2' HG22 ' A' ' 376' ' ' VAL . 58.7 mt -64.5 127.98 33.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.102 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -117.9 170.89 8.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.961 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.469 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 60.8 t -55.64 119.91 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.863 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.475 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 26.9 mt-10 -53.74 -42.54 68.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.969 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -49.36 76.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.759 0.314 . . . . 0.0 110.64 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.469 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 22.2 mt-10 -65.06 -37.96 89.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 63.8 t -59.33 -50.18 80.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.463 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.36 -40.55 91.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.776 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -66.42 -33.85 76.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.03 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' MET . . . . . 0.421 ' HE3' ' CE1' ' A' ' 377' ' ' PHE . 71.6 mtm -71.81 -28.21 63.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.967 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 5.8 mt -79.19 -33.72 43.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.856 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.9 145.77 40.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.055 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.105 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.807 0.337 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 18.7 mt -88.42 -30.12 19.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 114.31 -166.38 12.15 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.319 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.26 132.48 23.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.722 0.296 . . . . 0.0 110.771 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.518 HG13 HG21 ' A' ' 312' ' ' VAL . 0.0 OUTLIER -121.78 131.51 72.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.074 0.464 . . . . 0.0 111.043 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.84 125.42 44.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.938 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.611 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.7 p90 -142.11 150.47 41.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.439 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -103.75 161.17 14.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.395 0.617 . . . . 0.0 112.356 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.456 ' CD1' ' CE1' ' A' ' 389' ' ' HIS . 10.9 mt -133.39 150.26 51.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.857 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.8 106.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.928 0.395 . . . . 0.0 111.362 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.526 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 27.7 t80 -99.93 138.12 37.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.211 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.29 95.03 46.11 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.431 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.492 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.24 -32.13 17.12 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.853 2.369 . . . . 0.0 112.238 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -30.65 7.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.155 0.502 . . . . 0.0 109.887 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.34 -20.55 8.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.918 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.15 48.24 6.57 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.565 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -123.86 129.97 51.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.842 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 40.6 tp -95.67 147.54 23.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.968 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 5.4 m -137.85 140.16 40.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.551 . . . . 0.0 111.98 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 23.6 t -132.49 125.33 53.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.451 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.68 115.41 47.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.904 0.383 . . . . 0.0 111.997 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.424 HG22 ' HB2' ' A' ' 339' ' ' TYR . 38.7 mm -74.51 136.99 24.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.56 -58.62 2.12 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.426 ' HG3' ' CH2' ' A' ' 404' ' ' TRP . 8.7 pt-20 -175.59 162.01 2.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.139 -0.625 . . . . 0.0 112.335 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -118.43 153.58 33.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.764 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.427 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 11.8 pttt -150.93 148.52 28.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.11 0.481 . . . . 0.0 111.705 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 60.65 23.85 13.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.067 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 52.1 mt -56.88 138.09 54.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.083 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 143.33 51.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.322 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.421 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 35.3 mttt -85.14 108.39 17.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.644 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.498 ' HG2' ' HB3' ' A' ' 363' ' ' ASP . 0.0 OUTLIER -83.02 -20.94 34.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.958 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 56.0 m-20 -96.16 116.25 28.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.838 0.351 . . . . 0.0 110.718 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.3 t -49.95 116.11 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.444 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 63.26 14.28 53.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.419 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.32 -156.75 9.22 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.79 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.7 mt -100.8 -162.26 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 334' ' ' THR . 67.3 m -135.61 172.07 13.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.139 0.495 . . . . 0.0 110.927 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.419 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -133.73 56.02 18.33 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 362' ' ' LEU . 72.8 Cg_endo -77.11 147.08 26.06 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.88 2.387 . . . . 0.0 114.969 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.533 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 11.5 p90 -141.53 167.74 21.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.069 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.518 HG21 HG13 ' A' ' 276' ' ' ILE . 29.4 t -116.89 148.18 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.414 ' HE3' ' CD1' ' A' ' 362' ' ' LEU . 17.3 mttt -129.84 157.13 43.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.968 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.74 128.48 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.647 0.261 . . . . 0.0 110.819 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -126.4 138.46 53.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.887 0.375 . . . . 0.0 111.077 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.447 HD23 ' CG2' ' A' ' 347' ' ' VAL . 29.7 tp -99.36 108.38 20.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -107.45 121.11 43.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.162 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.52 ' O ' ' HG3' ' A' ' 318' ' ' GLN . 0.0 OUTLIER -92.24 100.17 12.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 57.84 38.37 27.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.834 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.01 28.84 24.69 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.668 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.24 109.48 9.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.357 . . . . 0.0 110.918 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -53.31 129.65 32.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.155 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.4 ' CD1' ' CB ' ' A' ' 318' ' ' GLN . 10.5 mt -123.52 -46.06 2.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.063 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -130.56 151.37 51.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.85 132.79 40.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.763 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -136.97 156.52 48.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.881 0.372 . . . . 0.0 111.117 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 0.5 OUTLIER -146.87 143.85 28.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.9 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.409 ' CG2' HG13 ' A' ' 293' ' ' ILE . 13.7 p -101.49 177.46 4.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.757 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 11.1 t -59.49 166.14 2.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.582 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.533 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 5.5 mt -108.15 130.21 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.005 0.431 . . . . 0.0 111.246 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 337' ' ' PRO . 22.3 mmmt -97.67 89.92 4.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.378 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -57.57 137.58 56.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.756 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 44.9 85.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.366 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 308' ' ' SER . 4.5 t -176.72 173.47 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.696 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.414 HD21 ' HB2' ' A' ' 308' ' ' SER . 4.6 mt -147.14 -16.1 0.4 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.407 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.2 m-80 -134.07 58.94 34.68 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.817 0.341 . . . . 0.0 110.158 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.426 ' HB2' ' HG3' ' A' ' 331' ' ' LYS . 80.9 Cg_endo -86.63 167.59 8.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.076 2.517 . . . . 0.0 113.952 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.493 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 68.1 t80 -116.86 152.04 35.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.995 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.424 ' HB2' HG22 ' A' ' 293' ' ' ILE . 92.9 m-85 -133.19 -68.73 0.57 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . 0.493 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 14.5 t-20 66.24 38.29 4.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.812 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 293' ' ' ILE . 52.0 mt-10 -91.02 141.9 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.663 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 85.5 p -110.09 121.92 46.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 111.662 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -111.71 163.1 14.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.032 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 13.2 m -133.8 145.14 49.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.139 0.495 . . . . 0.0 111.643 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 316' ' ' LEU . 35.1 m-85 -131.26 165.79 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.436 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -114.57 79.45 1.27 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.006 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.447 ' CG2' HD23 ' A' ' 316' ' ' LEU . 50.4 t -115.27 123.58 31.43 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.352 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 73.8 Cg_endo -75.2 158.91 41.17 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.529 2.153 . . . . 0.0 111.376 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -51.37 -21.13 2.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -90.66 -8.68 49.35 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.496 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.6 OUTLIER -111.75 -27.23 8.59 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.526 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 5.7 tp -47.47 -28.66 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -95.09 -25.14 16.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -91.45 -4.91 55.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.872 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 31.4 m -108.92 167.84 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 111.388 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -144.73 126.44 15.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.655 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.43 HG22 ' CZ3' ' A' ' 390' ' ' TRP . 58.9 t -87.17 109.41 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.379 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -94.63 111.85 26.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.598 ' HB ' HG21 ' A' ' 376' ' ' VAL . 39.7 t -95.62 107.87 20.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.769 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.421 ' CG2' ' HB3' ' A' ' 375' ' ' LYS . 6.3 m -109.39 139.32 44.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.064 0.459 . . . . 0.0 111.845 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 59.9 t -115.56 120.58 65.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.03 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.446 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.6 mp -120.89 142.92 49.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.363 . . . . 0.0 111.755 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.498 ' HB3' ' HG2' ' A' ' 302' ' ' MET . 2.6 t70 -90.15 124.43 34.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.511 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.471 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 19.8 t80 -76.01 146.77 39.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.786 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -143.5 58.92 1.39 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.505 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.471 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 1.1 tppt? 35.17 -104.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.45 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.22 137.43 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.344 0.593 . . . . 0.0 111.048 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.22 -178.43 30.47 Favored Glycine 0 C--N 1.318 -0.452 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.596 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.9 165.65 12.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 0.0 110.579 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.39 139.95 40.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.665 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . 0.407 ' HB2' ' HG2' ' A' ' 302' ' ' MET . 2.5 m-20 -71.05 152.05 43.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.893 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -100.88 111.44 23.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.063 0.459 . . . . 0.0 111.003 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 2.3 mm -72.06 -32.22 42.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.072 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 152.1 -178.81 29.12 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.471 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 15.4 ptmt -160.55 140.78 11.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.34 0.591 . . . . 0.0 111.864 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.598 HG21 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -112.52 158.9 12.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.158 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.418 ' N ' ' CD1' ' A' ' 377' ' ' PHE . 2.6 p90 -141.58 145.2 34.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.918 0.39 . . . . 0.0 111.224 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.42 HG21 ' CE3' ' A' ' 390' ' ' TRP . 15.3 m -134.79 101.15 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.146 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.461 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 172.25 -159.23 30.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.631 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . 0.433 ' O ' ' HB2' ' A' ' 381' ' ' ASN . 0.1 OUTLIER -47.77 162.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.632 0.253 . . . . 0.0 110.986 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 380' ' ' TYR . 29.4 m-80 70.66 -57.29 0.59 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.48 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.48 165.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.908 0.385 . . . . 0.0 111.464 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 44.4 p -158.09 154.14 27.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.917 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 92.27 -142.83 16.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.573 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -56.96 -33.02 66.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.854 0.359 . . . . 0.0 111.325 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.88 -55.15 21.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.082 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 22.3 tp -64.66 -32.64 74.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.352 . . . . 0.0 110.332 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -65.39 -28.5 69.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.371 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.461 ' CD2' HG21 ' A' ' 401' ' ' ILE . 20.6 t-160 -79.89 -54.05 6.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.815 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.461 ' CD1' ' HA2' ' A' ' 379' ' ' GLY . 51.2 t-105 -51.27 -47.22 62.54 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.048 0.451 . . . . 0.0 109.944 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 15.0 t -67.81 -29.28 68.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.722 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.467 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.3 OUTLIER -62.98 -42.9 99.96 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.789 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.448 ' HE1' ' CH2' ' A' ' 390' ' ' TRP . 30.4 ttp -59.61 -52.49 65.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.671 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.4 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.6 mt -56.66 -31.74 64.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.329 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.46 -30.19 69.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 109.722 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.484 ' C ' ' H ' ' A' ' 398' ' ' ARG . 17.1 m-80 -115.26 71.12 2.99 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.614 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.539 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 39.9 Cg_endo -68.07 31.37 0.14 Allowed 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.225 2.616 . . . . 0.0 113.396 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . 0.539 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 2.5 mmt180 -158.2 -42.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.092 0.472 . . . . 0.0 110.34 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.587 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 38.8 ttt85 -93.86 145.73 30.4 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.858 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.587 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 84.4 Cg_endo -81.03 156.24 20.09 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.457 2.105 . . . . 0.0 112.925 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -125.5 116.44 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.778 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -108.33 144.9 35.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.685 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.39 154.88 10.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.916 0.389 . . . . 0.0 111.298 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . 0.427 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 49.8 m95 -81.35 120.79 25.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.611 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 46.1 m-70 -108.54 122.7 47.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.516 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -78.24 117.19 19.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.746 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.426 HD21 HG22 ' A' ' 376' ' ' VAL . 79.9 mt -62.61 127.67 32.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.086 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -116.06 168.94 9.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.828 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.467 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 59.6 t -55.7 119.34 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.798 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.471 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 20.0 mt-10 -52.7 -43.63 65.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.911 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -56.52 -48.8 76.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.34 . . . . 0.0 110.657 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.467 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.0 mt-10 -65.52 -38.51 89.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.43 -49.91 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.229 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -40.64 90.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.888 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -64.84 -35.86 82.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.108 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 48.9 mtm -72.27 -34.24 68.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 17.4 mt -76.77 -31.24 56.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -71.07 143.06 50.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.173 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.15 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . 0.415 'CA ' ' HB3' ' A' ' 302' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.743 0.306 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 33.9 mt -81.4 -33.92 31.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.06 -165.67 13.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.215 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -142.33 133.23 25.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -121.87 131.07 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 0.0 111.026 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.38 126.02 43.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.831 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.618 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.7 p90 -141.89 149.94 40.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.202 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.38 159.53 15.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.085 -178.543 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.448 ' HG ' ' CE1' ' A' ' 389' ' ' HIS . 75.4 mt -128.9 148.34 50.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.177 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -158.81 104.58 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 111.597 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.478 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 29.9 t80 -96.65 139.54 32.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.385 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 287' ' ' GLY . 61.1 t -116.12 92.96 37.29 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 17.1 Cg_exo -65.27 -32.49 51.27 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.941 2.427 . . . . 0.0 112.366 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -31.62 62.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.872 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.6 -10.08 9.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.639 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 71.86 45.56 42.3 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.036 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -120.91 130.18 53.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.926 0.393 . . . . 0.0 111.55 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 32.7 tp -93.75 147.58 22.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.135 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.9 m -136.69 136.99 39.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.32 0.581 . . . . 0.0 112.122 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.09 123.8 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.455 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 27.1 t -118.04 115.08 47.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.03 0.443 . . . . 0.0 111.767 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.465 HG23 ' HB2' ' A' ' 339' ' ' TYR . 38.8 mm -74.7 137.04 23.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.427 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.5 OUTLIER -113.74 -59.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -177.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 2.4 pt-20 -175.7 159.48 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.362 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -118.73 154.01 33.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.873 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -150.87 151.89 32.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.968 0.414 . . . . 0.0 111.679 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 60.91 24.76 14.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.796 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.404 HD13 ' HG3' ' A' ' 310' ' ' PRO . 54.8 mt -59.69 139.38 57.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.282 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -62.17 144.49 55.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.483 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -84.19 118.73 24.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.548 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.539 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.7 mmt -93.91 -18.78 21.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.334 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 49.5 m-20 -98.39 116.97 31.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.841 0.353 . . . . 0.0 110.619 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -48.95 116.68 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.443 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.8 16.59 39.29 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.287 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.79 -157.58 9.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.804 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.6 mt -100.33 -161.08 0.84 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.83 0.348 . . . . 0.0 110.702 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.434 ' HB2' HD23 ' A' ' 335' ' ' LEU . 70.9 m -139.39 172.13 13.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.33 0.586 . . . . 0.0 111.077 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.401 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -131.99 57.44 29.93 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.404 ' HG3' HD13 ' A' ' 299' ' ' LEU . 57.7 Cg_endo -72.75 144.65 39.67 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.132 2.555 . . . . 0.0 114.682 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 38.4 p90 -143.61 163.47 33.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.252 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.447 ' CG1' ' CG1' ' A' ' 359' ' ' VAL . 38.0 t -111.6 149.97 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.43 0.633 . . . . 0.0 112.577 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 360' ' ' THR . 11.1 mtmt -131.4 138.49 49.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.378 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.69 132.44 60.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 0.0 110.8 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -127.76 135.32 49.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 0.0 110.975 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.472 HD23 ' HD3' ' A' ' 324' ' ' LYS . 51.5 tp -103.76 110.84 23.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 2.9 mtm -117.0 134.96 54.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.539 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.65 99.49 11.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.29 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 59.52 37.7 22.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.36 7.43 60.63 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.224 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 317' ' ' MET . 5.5 mptt -111.02 109.76 20.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.834 0.317 . . . . 0.0 110.975 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.39 131.59 33.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.377 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.533 ' HB2' ' HD2' ' A' ' 324' ' ' LYS . 5.9 mt -125.35 -47.72 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.261 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.533 ' HD2' ' HB2' ' A' ' 323' ' ' LEU . 0.1 OUTLIER -129.89 160.59 33.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.085 0.469 . . . . 0.0 111.448 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.31 143.74 37.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.881 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 20.9 mmtm -145.78 162.13 38.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.943 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.6 146.75 27.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 14.6 p -106.11 176.73 5.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 13.3 t -58.09 164.61 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.514 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.522 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.4 mt -107.83 123.55 63.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.938 0.399 . . . . 0.0 111.39 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -86.28 87.45 7.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.953 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -55.14 136.42 48.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.987 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 44.22 85.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.33 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 308' ' ' SER . 4.9 t -178.55 174.21 1.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.808 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 308' ' ' SER . 4.4 mt -145.59 -16.71 0.48 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.176 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.462 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.3 m-80 -132.65 56.36 22.17 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.318 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 46.8 Cg_endo -89.54 167.76 5.04 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.165 2.577 . . . . 0.0 113.628 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.434 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -108.97 160.67 15.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.299 179.302 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.465 ' HB2' HG23 ' A' ' 293' ' ' ILE . 81.6 m-85 -133.96 -63.97 0.71 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.755 0.312 . . . . 0.0 111.224 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.5 t30 59.12 38.52 23.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.956 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 293' ' ' ILE . 31.7 mt-10 -93.4 144.69 25.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.679 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 99.3 p -114.67 122.5 46.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 111.718 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -114.87 152.85 31.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.156 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 64.4 p -129.37 138.93 51.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.116 0.484 . . . . 0.0 111.763 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -125.13 166.01 17.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.569 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -111.02 76.84 1.0 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 50.0 t -110.0 122.2 39.62 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.035 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 71.0 Cg_endo -75.28 157.83 41.39 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.418 2.079 . . . . 0.0 111.64 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -51.72 -22.68 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.702 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -87.27 -8.55 56.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.516 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -111.97 -28.4 8.04 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.478 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 4.4 tp -52.2 -29.94 12.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.767 0.318 . . . . 0.0 110.864 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . 0.415 ' O ' ' CG ' ' A' ' 380' ' ' TYR . 77.9 mt-30 -93.67 3.31 55.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.411 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -124.1 -21.78 4.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.471 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 32.4 m -88.04 163.28 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.002 0.429 . . . . 0.0 111.485 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -137.88 126.28 23.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.5 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.425 HG21 ' CZ3' ' A' ' 390' ' ' TRP . 88.9 t -88.3 116.2 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 0.0 110.28 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.28 113.8 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.758 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.613 ' HB ' HG22 ' A' ' 376' ' ' VAL . 47.8 t -99.09 107.79 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 313' ' ' LYS . 3.7 m -110.4 135.38 51.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.964 0.411 . . . . 0.0 111.825 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 45.7 t -109.38 118.74 57.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.228 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.436 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.8 mp -121.28 145.76 47.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.502 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.539 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -94.57 125.16 39.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.664 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.46 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 24.6 t80 -75.75 146.91 39.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.899 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -145.54 60.94 1.28 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.596 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.46 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 0.0 OUTLIER 38.33 -106.35 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.154 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.41 ' CD1' ' CG ' ' A' ' 366' ' ' LYS . 0.9 OUTLIER -83.65 137.28 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.364 0.602 . . . . 0.0 110.963 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 101.94 169.07 27.3 Favored Glycine 0 C--N 1.319 -0.394 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.538 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.92 140.76 58.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.802 0.334 . . . . 0.0 110.641 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.83 149.65 43.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.641 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.92 149.76 30.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.055 0.455 . . . . 0.0 111.57 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -100.95 111.11 23.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.72 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 373' ' ' ILE . 33.3 mt -82.39 -32.73 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.491 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.05 -178.5 41.24 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.034 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.459 ' CG ' ' HG2' ' A' ' 410' ' ' GLU . 17.5 ptmt -164.72 140.98 5.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.221 0.534 . . . . 0.0 112.041 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.613 HG22 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -113.53 159.27 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.048 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.423 ' CD2' HD21 ' A' ' 417' ' ' LEU . 22.1 p90 -144.85 132.0 20.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.055 0.455 . . . . 0.0 111.79 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 22.9 m -125.21 108.97 20.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.756 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -148.73 -149.42 4.97 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.646 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . 0.415 ' CG ' ' O ' ' A' ' 353' ' ' GLN . 0.0 OUTLIER -100.42 -26.3 13.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.747 0.308 . . . . 0.0 110.937 -179.67 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -84.07 -28.0 27.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.967 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' SER . . . . . 0.406 ' OG ' ' CD2' ' A' ' 377' ' ' PHE . 3.5 m -54.78 175.66 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.161 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 22.2 p -148.56 148.54 30.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.742 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 92.4 -158.65 24.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.41 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -46.49 -31.32 2.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 111.601 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.03 -54.68 38.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.625 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 23.8 tp -56.4 -34.4 66.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.728 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -62.0 -46.84 87.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.523 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.474 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 15.2 t-160 -62.58 -53.84 48.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.148 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.455 ' CZ3' ' HE3' ' A' ' 393' ' ' MET . 68.1 t-105 -54.83 -51.44 65.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.952 0.406 . . . . 0.0 110.461 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.5 t -66.25 -32.61 74.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.144 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.534 ' HB3' HD12 ' A' ' 401' ' ' ILE . 6.4 m-20 -64.87 -31.59 72.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.79 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.499 ' HA ' HG13 ' A' ' 401' ' ' ILE . 25.8 ttp -65.88 -54.27 28.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.91 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.4 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.5 mt -55.76 -22.79 25.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.124 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -80.8 -38.45 28.44 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 399' ' ' ARG . 40.0 m-80 -125.01 60.37 27.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.563 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.511 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 2.4 Cg_endo -44.06 -77.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.759 2.973 . . . . 0.0 113.356 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -51.38 -17.85 0.86 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.406 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.402 ' HB3' ' HB3' ' A' ' 396' ' ' ASN . 0.9 OUTLIER -93.67 133.47 27.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.906 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 74.1 Cg_endo -75.41 115.41 4.22 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.435 2.09 . . . . 0.0 112.548 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.534 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -93.62 108.39 20.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.881 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.57 144.0 32.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.737 0.303 . . . . 0.0 110.623 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.44 154.38 12.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.406 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -82.46 117.12 22.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.618 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 48.9 m-70 -106.68 118.38 36.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.576 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 91.6 m -78.33 116.25 18.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.952 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.475 HD23 HG23 ' A' ' 376' ' ' VAL . 93.5 mt -61.29 127.94 33.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.405 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -116.04 172.25 7.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.497 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.463 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 61.2 t -54.98 121.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.459 ' HG2' ' CG ' ' A' ' 375' ' ' LYS . 23.9 mt-10 -55.16 -42.47 73.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.88 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.16 -49.11 76.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.463 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.7 mt-10 -64.89 -38.17 90.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.371 0.605 . . . . 0.0 109.418 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.412 HG21 ' HG2' ' A' ' 375' ' ' LYS . 94.9 t -57.28 -47.29 84.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.534 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.16 -30.61 71.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -72.43 -37.92 68.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 36.2 mtm -67.91 -32.3 72.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . 0.423 HD21 ' CD2' ' A' ' 377' ' ' PHE . 11.7 mt -80.13 -33.92 38.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -63.04 146.1 53.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.036 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 25.4 t . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.247 -0.883 . . . . 0.0 111.091 179.95 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 8.3 tptt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.831 0.348 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 41.4 mt -77.64 -36.28 51.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 124.11 -164.35 17.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.162 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.04 132.53 22.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.703 0.287 . . . . 0.0 110.72 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.45 HG13 HG21 ' A' ' 312' ' ' VAL . 0.1 OUTLIER -122.71 122.43 65.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.161 0.505 . . . . 0.0 110.821 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 294' ' ' LEU . 0.1 OUTLIER -92.01 126.17 36.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.786 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.616 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.0 p90 -142.22 148.94 38.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.383 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -101.92 160.61 14.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.064 -178.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.435 ' HG ' ' CE1' ' A' ' 389' ' ' HIS . 73.0 mt -128.81 147.81 50.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.214 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 290' ' ' THR . 1.6 ttm180 -158.92 106.7 1.84 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.579 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.491 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 30.0 t80 -98.25 139.52 33.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.599 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 287' ' ' GLY . 83.1 t -116.37 93.11 38.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.498 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 16.5 Cg_exo -65.65 -30.94 50.58 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.892 2.394 . . . . 0.0 112.211 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -30.67 65.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.699 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -122.4 -5.3 8.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.643 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 66.49 45.98 80.97 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.629 -0.795 . . . . 0.0 112.033 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -121.36 129.32 53.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 111.493 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 34.2 tp -93.05 147.64 22.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.068 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.405 ' CB ' ' O ' ' A' ' 281' ' ' ARG . 1.6 m -136.68 136.7 39.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.347 0.594 . . . . 0.0 112.177 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 15.1 t -128.36 123.53 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.306 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 38.1 t -117.25 116.04 50.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.995 0.426 . . . . 0.0 111.942 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.453 HG13 ' CG2' ' A' ' 328' ' ' THR . 26.6 mm -74.55 137.05 23.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.417 HD22 ' CE2' ' A' ' 338' ' ' TYR . 0.7 OUTLIER -113.46 -57.44 2.28 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 4.9 pt-20 -175.96 158.53 2.05 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.131 -0.628 . . . . 0.0 112.444 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 336' ' ' ASN . . . -117.98 145.56 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.497 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.424 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 10.7 pttt -145.68 151.04 37.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 111.542 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 61.47 23.01 13.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.072 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 58.2 mt -56.79 138.27 53.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.901 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -66.34 150.67 48.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.562 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.43 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 25.1 mttt -86.43 115.59 24.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.614 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.448 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 6.9 mmm -94.12 -18.37 21.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.563 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 55.6 m-20 -94.88 118.56 31.98 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.764 0.316 . . . . 0.0 110.332 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -47.61 115.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.02 0.438 . . . . 0.0 111.598 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.5 16.83 37.98 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.433 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.37 -159.26 10.07 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.961 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 6.6 mt -96.67 -161.55 0.88 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.72 0.295 . . . . 0.0 110.292 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.43 ' OG ' ' HA ' ' A' ' 301' ' ' LYS . 5.5 m -134.97 170.66 15.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.228 0.537 . . . . 0.0 111.166 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.453 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 6.8 m-20 -135.72 55.44 12.53 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.554 ' O ' ' HG2' ' A' ' 331' ' ' LYS . 34.4 Cg_endo -66.88 154.81 73.32 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.233 2.622 . . . . 0.0 114.697 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 48.6 p90 -153.06 149.55 28.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.503 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.45 HG21 HG13 ' A' ' 276' ' ' ILE . 41.0 t -99.98 150.14 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.435 ' HE2' ' CD1' ' A' ' 362' ' ' LEU . 5.6 mtmm -133.08 136.16 45.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.219 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 325' ' ' LYS . 5.1 mp -107.72 137.27 39.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.251 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -131.45 128.45 39.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.388 . . . . 0.0 111.21 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 28.6 tp -104.64 106.64 17.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.464 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.6 mtm -112.87 140.65 47.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.912 0.387 . . . . 0.0 111.243 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.38 99.48 9.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.324 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 55.46 38.14 29.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 93.22 25.8 18.08 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.866 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 317' ' ' MET . 3.8 mptt -130.67 109.26 10.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.888 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.22 130.78 31.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.449 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 8.9 mt -124.34 -53.56 1.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.969 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -130.64 150.2 51.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.06 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 314' ' ' ILE . 0.6 OUTLIER -143.44 120.1 11.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.815 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 7.8 mmtm -118.39 172.75 7.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.995 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.15 138.5 15.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.261 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.453 ' CG2' HG13 ' A' ' 293' ' ' ILE . 25.1 p -92.06 -171.65 2.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.855 0.36 . . . . 0.0 110.47 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.8 t -70.54 171.71 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.064 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.492 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.3 mp -110.3 114.35 46.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.078 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 310' ' ' PRO . 0.0 OUTLIER -75.08 90.78 2.51 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -58.42 135.96 57.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.404 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 41.29 80.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.528 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 331' ' ' LYS . 3.5 t -179.06 173.64 1.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.963 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.49 -11.46 0.53 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.224 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.467 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.3 m-80 -137.84 59.33 19.08 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.733 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.519 ' HG3' ' HG3' ' A' ' 331' ' ' LYS . 54.8 Cg_endo -98.48 167.91 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.532 2.822 . . . . 0.0 113.509 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.422 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.6 OUTLIER -104.12 160.79 14.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.729 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.482 ' HH ' ' HA ' ' A' ' 311' ' ' TYR . 6.7 m-85 -129.73 -75.71 0.55 Allowed 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.981 0.42 . . . . 0.0 111.778 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 69.93 35.4 2.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.491 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 293' ' ' ILE . 29.3 mt-10 -91.12 143.11 27.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.584 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 26.5 p -115.41 121.29 42.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.0 111.765 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . 0.419 ' CE1' HG23 ' A' ' 328' ' ' THR . 71.7 m-85 -110.49 159.98 17.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.977 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 6.2 m -135.72 137.97 42.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.118 0.485 . . . . 0.0 111.828 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.445 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 57.1 m-85 -125.25 166.07 17.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.609 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -112.29 74.49 0.87 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.866 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 47.7 t -108.31 122.75 39.53 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.509 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 74.5 Cg_endo -75.76 158.06 39.36 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.418 2.079 . . . . 0.0 111.547 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -51.71 -22.43 3.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.629 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -87.82 -8.56 55.74 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.509 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.2 OUTLIER -112.59 -28.2 7.92 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.696 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.491 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 4.0 tp -51.44 -34.89 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.79 0.329 . . . . 0.0 110.779 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -89.99 3.07 54.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.374 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -123.06 -15.99 7.14 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.405 HG23 ' CZ2' ' A' ' 390' ' ' TRP . 33.7 m -95.63 165.15 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.858 0.361 . . . . 0.0 111.469 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.85 126.49 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.989 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.437 HG22 ' CZ3' ' A' ' 390' ' ' TRP . 47.7 t -89.11 110.18 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.442 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -95.83 110.01 23.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.503 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.627 ' HB ' HG21 ' A' ' 376' ' ' VAL . 43.1 t -91.9 107.89 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.868 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.456 ' CG2' ' HB3' ' A' ' 375' ' ' LYS . 4.3 m -112.68 126.93 55.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.021 0.439 . . . . 0.0 111.949 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 46.7 t -101.98 118.37 48.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.216 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 311' ' ' TYR . 2.7 mp -119.44 147.33 44.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 0.0 111.529 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 310' ' ' PRO . 5.2 t70 -90.02 130.19 36.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.821 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.45 ' CE1' ' N ' ' A' ' 366' ' ' LYS . 8.9 t80 -81.95 141.45 33.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.584 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -143.01 78.83 1.62 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.157 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.45 ' N ' ' CE1' ' A' ' 364' ' ' TYR . 6.3 tptm 50.33 -89.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.575 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.514 ' O ' ' C ' ' A' ' 368' ' ' GLY . 40.0 mm -134.89 -69.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.412 0.149 . . . . 0.0 111.008 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 367' ' ' ILE . . . -7.4 -102.95 0.0 OUTLIER Glycine 0 C--N 1.336 0.556 0 O-C-N 123.68 0.612 . . . . 0.0 114.19 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.74 154.24 47.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.939 0.399 . . . . 0.0 111.216 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.61 119.94 40.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.13 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -71.27 152.1 43.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.067 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -100.84 112.62 25.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.392 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 1.3 mm -74.31 -34.28 36.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.751 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 155.98 -178.27 32.61 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.32 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.456 ' HB3' ' CG2' ' A' ' 360' ' ' THR . 11.9 ptmt -161.9 139.64 8.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.351 0.596 . . . . 0.0 112.303 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.684 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.18 158.93 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.077 179.264 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.41 ' CE1' ' SD ' ' A' ' 416' ' ' MET . 25.5 p90 -141.2 135.48 30.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.906 0.384 . . . . 0.0 111.6 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 15.5 m -125.75 105.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.898 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.47 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 160.0 -159.84 31.06 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.569 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -49.71 164.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 110.861 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 59.0 24.6 12.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.007 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 4.7 m -127.12 161.21 29.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.705 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 46.4 p -157.96 148.24 20.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 101.45 -123.88 8.05 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.693 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . 0.484 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -83.07 -29.2 28.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.946 0.403 . . . . 0.0 111.354 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -69.42 -50.45 45.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.786 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 46.4 tp -65.11 -37.15 86.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.623 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 385' ' ' ALA . 5.8 ptt180 -62.58 -37.59 86.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.207 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.468 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 16.9 t-160 -65.54 -55.48 17.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 110.448 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.47 ' CD1' ' HA2' ' A' ' 379' ' ' GLY . 69.1 t-105 -53.83 -50.03 67.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.039 0.447 . . . . 0.0 110.262 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.42 -29.76 69.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.479 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.545 ' HB3' HD11 ' A' ' 401' ' ' ILE . 5.4 m-20 -67.86 -33.02 73.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.491 ' HA ' HG13 ' A' ' 401' ' ' ILE . 27.6 ttp -63.73 -52.61 59.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.695 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.416 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.6 mt -57.02 -22.9 42.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.91 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -81.16 -36.25 30.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.309 0.576 . . . . 0.0 109.483 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.418 ' HB2' HD12 ' A' ' 401' ' ' ILE . 22.7 m-80 -126.11 60.2 34.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.555 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.498 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 3.2 Cg_endo -44.67 -78.69 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.595 2.863 . . . . 0.0 112.91 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -51.24 -18.88 1.03 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.133 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -93.74 132.63 29.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.596 0.236 . . . . 0.0 110.813 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.7 Cg_endo -75.6 124.35 8.18 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.44 2.094 . . . . 0.0 112.712 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.545 HD11 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -102.59 107.63 22.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.761 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.28 144.26 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.858 0.361 . . . . 0.0 110.891 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.1 151.22 10.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.375 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . 0.424 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 36.4 m95 -78.17 115.77 18.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.688 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.684 ' HB3' HG11 ' A' ' 376' ' ' VAL . 51.0 m-70 -104.15 119.96 40.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.389 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 90.6 m -78.2 116.47 18.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.437 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.408 ' CD2' HG22 ' A' ' 376' ' ' VAL . 64.2 mt -61.63 126.9 28.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.038 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -115.72 170.08 8.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.944 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.447 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 55.5 t -54.83 117.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.725 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.4 ' CG ' ' HD2' ' A' ' 375' ' ' LYS . 9.0 mp0 -55.4 -41.22 72.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.642 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -56.83 -48.63 77.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 110.58 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.447 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.0 mt-10 -65.7 -40.07 91.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 97.9 t -58.59 -48.79 84.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.17 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.05 -35.9 80.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.499 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.32 87.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.617 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' MET . . . . . 0.41 ' SD ' ' CE1' ' A' ' 377' ' ' PHE . 30.3 mtt -61.44 -37.35 83.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.476 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 5.7 mt -79.24 -31.69 43.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.833 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -59.83 138.86 57.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 26.7 t . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.055 -179.984 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 47.6 mt -88.21 -29.68 20.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.841 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 116.97 -168.1 12.73 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.234 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.18 132.28 26.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 0.0 110.723 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.1 OUTLIER -120.99 129.93 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.171 0.51 . . . . 0.0 110.983 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.404 ' N ' ' CD1' ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.14 125.38 41.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.829 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.618 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 21.2 p90 -142.29 149.88 40.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.321 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.1 OUTLIER -102.54 161.31 13.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.362 0.601 . . . . 0.0 112.268 -178.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 400' ' ' PRO . 27.7 mt -132.2 149.93 52.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.958 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.434 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.3 OUTLIER -158.92 102.8 1.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.443 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.513 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 29.6 t80 -98.57 136.69 38.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 43.0 t -122.8 95.88 45.92 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.518 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.57 -32.2 15.61 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.881 2.387 . . . . 0.0 112.317 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -31.17 6.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.191 0.52 . . . . 0.0 109.957 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.39 -21.15 8.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.813 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 81.16 47.6 6.43 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.778 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -123.65 129.74 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.97 0.414 . . . . 0.0 111.798 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 31.4 tp -95.48 147.67 23.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.994 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 3.4 m -134.73 137.64 43.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 112.0 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.87 120.28 47.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.32 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 21.7 t -116.2 115.45 49.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.039 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.443 HG22 ' HB2' ' A' ' 339' ' ' TYR . 42.1 mm -75.05 137.13 23.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.442 HD21 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.98 -61.97 1.67 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -177.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.427 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 1.5 pt-20 -175.62 151.77 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.329 -0.549 . . . . 0.0 112.329 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -110.33 154.56 23.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.859 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -150.99 152.17 33.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 111.719 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 60.28 24.35 13.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.932 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.411 HD12 ' HG3' ' A' ' 310' ' ' PRO . 48.8 mt -58.96 138.82 57.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.162 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.59 141.62 58.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.31 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -80.73 117.81 21.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.694 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.555 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.1 mmt -90.96 -19.03 23.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.343 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 49.2 m-20 -98.78 114.99 27.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.779 0.323 . . . . 0.0 110.524 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 26.3 t -48.84 116.38 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.45 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 62.11 15.44 50.38 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.369 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.29 -157.25 9.39 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.727 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.3 mt -100.34 -161.24 0.85 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 0.0 110.784 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.44 ' HB2' HD23 ' A' ' 335' ' ' LEU . 66.5 m -139.39 172.01 13.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.309 0.576 . . . . 0.0 111.103 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.409 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 15.3 m-20 -131.24 57.13 29.05 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.825 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.411 ' HG3' HD12 ' A' ' 299' ' ' LEU . 50.2 Cg_endo -70.56 148.56 60.13 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.096 2.531 . . . . 0.0 114.82 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.517 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 33.8 p90 -150.35 161.25 42.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.266 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.447 HG12 ' CG1' ' A' ' 359' ' ' VAL . 38.9 t -110.41 150.0 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -132.41 134.95 45.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.215 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.426 HG21 ' CZ ' ' A' ' 345' ' ' PHE . 5.3 mp -108.79 131.57 59.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.954 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -127.01 142.5 51.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.877 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 28.9 tp -113.31 106.01 14.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.527 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.5 mtm -106.79 131.17 54.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.311 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' A' ' 318' ' ' GLN . 0.4 OUTLIER -99.62 99.54 10.41 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.248 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 59.94 36.92 21.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.731 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 88.3 26.52 27.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.714 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.42 109.4 11.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.785 0.326 . . . . 0.0 110.883 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.79 129.24 25.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.184 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.401 ' CD1' ' CB ' ' A' ' 318' ' ' GLN . 10.0 mt -123.21 -41.38 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.47 147.74 49.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.897 0.38 . . . . 0.0 111.371 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -135.56 117.51 15.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 15.9 mmtp -124.26 160.85 27.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.927 0.394 . . . . 0.0 111.384 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.93 148.27 33.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.716 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 20.5 p -106.37 176.04 5.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.33 158.66 5.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.703 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.517 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.0 mt -102.13 126.08 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.979 0.418 . . . . 0.0 111.383 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.4 ' HG3' ' CG ' ' A' ' 337' ' ' PRO . 3.7 mmpt? -90.64 88.78 7.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.132 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -56.18 136.62 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.877 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 43.9 84.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.285 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 4.8 t -177.61 174.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.947 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 308' ' ' SER . 4.4 mt -145.95 -16.57 0.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.149 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.445 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.4 m-80 -132.29 56.99 26.13 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-O 120.765 0.317 . . . . 0.0 110.348 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 59.1 Cg_endo -88.33 167.69 6.41 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.18 2.587 . . . . 0.0 113.707 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.442 ' CE2' HD21 ' A' ' 294' ' ' LEU . 0.4 OUTLIER -111.31 159.29 18.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.302 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.443 ' HB2' HG22 ' A' ' 293' ' ' ILE . 83.6 m-85 -134.76 -62.25 0.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.792 0.329 . . . . 0.0 111.241 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.3 t30 57.87 37.58 26.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 293' ' ' ILE . 61.9 mt-10 -92.66 141.47 28.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 91.0 p -110.64 120.27 41.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.888 0.375 . . . . 0.0 111.544 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -113.34 147.91 36.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.361 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 83.0 p -123.09 140.5 52.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.972 0.415 . . . . 0.0 111.443 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.426 ' CZ ' HG21 ' A' ' 314' ' ' ILE . 63.1 m-85 -127.24 165.88 18.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.583 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.63 78.1 1.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.817 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.413 HG13 HG22 ' A' ' 355' ' ' VAL . 46.0 t -111.62 120.67 41.93 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.094 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.466 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.7 Cg_endo -72.07 156.97 55.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.468 2.112 . . . . 0.0 111.619 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -51.89 -22.94 4.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.54 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -85.72 -8.55 58.1 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.466 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.9 OUTLIER -109.96 -35.09 6.23 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.521 0.201 . . . . 0.0 111.473 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.513 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 5.9 tp -49.24 -26.72 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.651 0.263 . . . . 0.0 111.478 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . 0.413 ' O ' ' CD1' ' A' ' 380' ' ' TYR . 17.7 mt-30 -93.27 -7.92 43.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.771 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.403 ' HA ' ' CG ' ' A' ' 380' ' ' TYR . 38.8 mttp -116.41 -23.54 8.27 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.413 HG22 HG13 ' A' ' 347' ' ' VAL . 35.0 m -88.69 168.03 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.908 0.385 . . . . 0.0 111.428 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -143.29 133.48 24.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.1 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.1 t -87.0 101.98 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.443 ' CG1' ' HE2' ' A' ' 375' ' ' LYS . 0.8 OUTLIER -86.45 114.18 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.969 -178.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.596 ' HB ' HG23 ' A' ' 376' ' ' VAL . 40.4 t -99.75 107.85 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.92 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 375' ' ' LYS . 7.4 m -110.93 134.73 52.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 111.628 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 45.9 t -109.29 121.37 62.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.4 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.443 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.6 mp -123.07 147.55 46.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.918 0.389 . . . . 0.0 111.353 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.555 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.3 OUTLIER -96.54 125.19 40.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.601 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.5 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 20.3 t80 -75.8 139.45 41.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.818 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 367' ' ' ILE . 14.2 m-20 -126.22 70.72 1.24 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.871 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.5 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 0.3 OUTLIER 30.36 -89.35 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.075 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.402 ' N ' ' O ' ' A' ' 365' ' ' ASP . 5.1 mp -87.37 -69.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.72 0.295 . . . . 0.0 111.649 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -45.67 175.07 0.01 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.258 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.44 165.64 11.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.721 0.296 . . . . 0.0 110.708 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . 0.407 ' OD1' ' CD2' ' A' ' 364' ' ' TYR . 0.4 OUTLIER -93.36 127.56 39.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.701 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.99 150.94 43.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.548 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -97.32 111.63 23.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.608 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.496 HG21 HD12 ' A' ' 373' ' ' ILE . 30.0 mt -80.99 -33.12 12.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.386 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 168.13 -179.22 41.43 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.162 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.503 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 14.8 ptmt -164.67 140.92 5.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.175 0.512 . . . . 0.0 111.791 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.596 HG23 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -114.35 158.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.176 179.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -142.23 132.03 24.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 111.179 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.466 ' CG1' ' CE1' ' A' ' 405' ' ' HIS . 15.8 m -124.97 103.91 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.962 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.474 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 161.72 -165.2 35.59 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.042 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 353' ' ' GLN . 0.0 OUTLIER -44.17 150.18 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 111.465 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 14.0 m120 65.45 29.02 11.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.159 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 50.8 m -122.68 164.34 18.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.677 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 43.6 p -154.77 147.94 24.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.815 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.402 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 95.3 -157.8 22.08 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.42 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -49.24 -31.49 8.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -63.21 -51.08 67.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.155 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.36 -33.53 71.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.551 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 1.0 OUTLIER -61.8 -49.83 74.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.54 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.45 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 17.4 t-160 -57.91 -58.39 8.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.967 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.474 ' CD1' ' HA2' ' A' ' 379' ' ' GLY . 64.0 t-105 -50.83 -46.11 59.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.217 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.5 t -67.75 -35.82 79.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.233 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.421 ' HB3' HD12 ' A' ' 401' ' ' ILE . 4.4 t0 -64.08 -34.92 79.13 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.467 ' HE3' ' CZ3' ' A' ' 390' ' ' TRP . 26.6 ttp -64.5 -58.0 7.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.552 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.403 HD22 ' CG2' ' A' ' 352' ' ' ILE . 1.5 mt -55.22 -31.93 61.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.399 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.52 -30.64 69.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.786 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.9 m-80 -114.27 70.66 2.06 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.629 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.543 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 42.8 Cg_endo -68.77 37.67 0.21 Allowed 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.203 2.602 . . . . 0.0 113.479 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . 0.543 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 10.6 mmm180 -160.0 -45.69 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.918 0.39 . . . . 0.0 110.86 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.403 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 5.8 tpt180 -93.87 141.82 24.23 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.198 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.7 Cg_endo -75.37 156.31 41.34 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.585 2.19 . . . . 0.0 112.807 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.45 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.2 mm -126.53 119.32 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -111.86 144.53 41.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.721 0.296 . . . . 0.0 110.693 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.31 155.68 11.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.976 0.417 . . . . 0.0 111.378 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -81.69 119.17 23.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.79 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.618 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 47.1 m-70 -106.81 122.34 46.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.557 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -78.19 117.09 19.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.672 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.481 ' CD2' HG21 ' A' ' 376' ' ' VAL . 55.9 mt -62.44 128.37 35.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.194 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -114.46 171.98 7.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.756 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.409 ' HB ' ' CG ' ' A' ' 412' ' ' GLU . 3.6 t -59.46 122.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.503 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 5.4 mt-10 -51.09 -38.37 51.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.325 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -52.64 63.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.651 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.409 ' CG ' ' HB ' ' A' ' 409' ' ' VAL . 3.0 mm-40 -60.79 -41.13 95.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.455 HG21 ' HG2' ' A' ' 375' ' ' LYS . 61.7 t -56.22 -52.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.251 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.73 -31.32 72.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.597 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -71.64 -34.59 69.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.872 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 40.7 mtm -72.92 -36.88 67.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.769 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.58 -29.23 65.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.79 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -73.67 141.91 46.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.073 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.109 179.955 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.806 0.336 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.408 ' HB3' ' O ' ' A' ' 373' ' ' ILE . 46.7 mt -95.87 -32.04 12.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.818 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 116.24 -166.82 12.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.946 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -141.08 136.23 31.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.819 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.1 OUTLIER -125.09 125.4 69.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.207 0.527 . . . . 0.0 110.885 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.52 126.72 39.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.741 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.626 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 19.2 p90 -142.37 150.18 40.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.57 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.1 OUTLIER -103.87 160.36 14.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.05 -178.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 400' ' ' PRO . 10.6 mt -133.34 150.51 51.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.866 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.405 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.6 OUTLIER -158.97 105.08 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.552 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.528 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 28.4 t80 -99.14 138.66 35.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.08 95.28 44.17 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.403 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.515 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 6.9 Cg_exo -70.53 -31.06 17.76 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.844 2.362 . . . . 0.0 112.265 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.26 -32.07 15.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.147 0.499 . . . . 0.0 109.844 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.12 -18.71 9.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.816 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 78.77 47.58 7.73 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.617 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.97 129.46 51.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.04 0.447 . . . . 0.0 111.834 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 33.1 tp -96.55 147.56 23.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.932 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 4.3 m -137.63 139.53 40.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.235 0.541 . . . . 0.0 111.995 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.3 t -132.86 123.35 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.529 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.89 116.21 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 341' ' ' GLU . 36.5 mm -74.64 135.95 26.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.79 -64.98 1.22 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 338' ' ' TYR . 0.3 OUTLIER -174.67 148.62 1.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.524 -179.315 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -107.76 154.19 21.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.982 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -150.96 151.86 32.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 111.652 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 62.68 22.81 13.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.843 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 47.8 mt -57.02 138.53 54.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.163 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.35 142.97 58.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.588 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.408 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 14.1 mttt -82.64 113.06 20.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.444 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.415 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 8.2 mmm -91.6 -20.44 21.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.642 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 42.6 m-20 -92.28 118.86 31.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 110.527 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -48.04 115.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.611 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 57.5 17.95 28.16 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.264 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.97 -157.47 9.6 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.001 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.1 mt -99.27 -161.12 0.85 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 0.0 110.54 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.408 ' OG ' ' HA ' ' A' ' 301' ' ' LYS . 14.8 m -135.68 171.8 13.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.178 0.513 . . . . 0.0 111.017 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.414 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 6.5 m-20 -135.69 56.95 16.71 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 363' ' ' ASP . 73.3 Cg_endo -77.91 144.21 21.39 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.902 2.402 . . . . 0.0 114.891 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 10.9 p90 -139.12 167.73 21.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.025 177.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.432 ' CG1' ' CG1' ' A' ' 359' ' ' VAL . 47.6 t -116.85 149.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.325 0.584 . . . . 0.0 112.572 -179.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -132.38 155.78 47.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.434 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.411 HG22 ' CZ ' ' A' ' 345' ' ' PHE . 5.4 mp -124.51 134.19 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.417 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -128.93 127.74 42.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.013 0.435 . . . . 0.0 111.049 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.478 HD22 ' HD3' ' A' ' 324' ' ' LYS . 28.8 tp -99.32 114.27 27.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.288 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.9 mtm -122.05 133.62 54.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 111.441 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.77 99.49 10.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.02 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 59.95 36.68 21.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.38 25.61 32.89 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.853 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -122.06 117.46 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.7 0.286 . . . . 0.0 110.9 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -51.72 128.21 22.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.219 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.406 ' HB3' ' CE ' ' A' ' 324' ' ' LYS . 18.1 mt -125.5 -58.86 1.41 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.251 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.478 ' HD3' HD22 ' A' ' 316' ' ' LEU . 0.1 OUTLIER -129.93 159.94 35.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.179 0.514 . . . . 0.0 111.743 -179.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 325' ' ' LYS . 0.3 OUTLIER -139.7 138.07 35.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.721 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -143.98 158.62 43.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 111.157 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.93 145.3 26.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.948 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.432 HG22 ' CE1' ' A' ' 343' ' ' PHE . 12.9 p -102.0 -178.93 3.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.846 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 10.1 t -60.2 172.05 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.463 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 5.6 mt -113.44 121.54 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 111.454 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.404 ' HG3' ' CG ' ' A' ' 337' ' ' PRO . 7.1 mmpt? -86.43 85.73 7.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.997 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -56.45 136.77 53.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.981 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.19 83.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.255 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 4.8 t -176.99 174.0 1.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.76 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 4.0 mt -145.25 -15.8 0.5 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.378 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.471 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.79 56.09 20.64 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 120.75 0.309 . . . . 0.0 110.516 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 61.3 Cg_endo -89.04 167.69 5.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.15 2.567 . . . . 0.0 113.723 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.426 ' CG ' ' HB3' ' A' ' 295' ' ' GLU . 0.2 OUTLIER -110.03 160.4 16.47 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.456 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.449 ' C ' ' ND2' ' A' ' 340' ' ' ASN . 7.9 m-85 -135.17 -50.3 0.75 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.692 0.282 . . . . 0.0 111.192 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . 0.449 ' ND2' ' C ' ' A' ' 339' ' ' TYR . 1.7 p30 44.41 36.7 1.73 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.029 0.442 . . . . 0.0 110.976 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 293' ' ' ILE . 44.3 mt-10 -90.91 141.25 29.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.816 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 88.0 p -111.24 121.2 44.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.932 0.396 . . . . 0.0 111.558 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . 0.432 ' CE1' HG22 ' A' ' 328' ' ' THR . 67.6 m-85 -111.78 155.21 23.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.058 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 59.6 p -130.91 139.59 50.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.115 0.483 . . . . 0.0 111.692 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.411 ' CZ ' HG22 ' A' ' 314' ' ' ILE . 55.5 m-85 -126.41 165.97 18.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.581 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -113.16 76.94 1.01 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.546 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 49.4 t -109.84 122.21 39.76 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.322 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.493 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 63.2 Cg_endo -73.42 158.97 47.43 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.453 2.102 . . . . 0.0 111.492 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -52.06 -20.67 2.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.857 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -90.45 -8.7 49.83 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.493 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -110.47 -29.73 7.96 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.528 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 6.3 tp -47.09 -28.6 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.829 0.347 . . . . 0.0 111.059 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . 0.448 ' O ' ' CD2' ' A' ' 380' ' ' TYR . 2.8 mm-40 -95.11 -27.77 15.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.058 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -91.33 -3.94 56.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.875 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 29.9 m -106.96 166.3 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 111.278 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -141.65 126.23 17.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.658 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.453 HG21 ' CH2' ' A' ' 390' ' ' TRP . 64.9 t -90.77 105.01 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.145 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.98 111.34 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.811 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.596 ' HB ' HG21 ' A' ' 376' ' ' VAL . 48.2 t -91.52 108.0 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.421 ' CG2' ' HB3' ' A' ' 375' ' ' LYS . 2.6 m -110.26 131.93 54.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.061 0.457 . . . . 0.0 111.923 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 58.2 t -107.05 119.67 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.926 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.432 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.6 mp -119.94 141.88 49.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.992 0.425 . . . . 0.0 111.722 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 310' ' ' PRO . 6.3 t70 -90.09 125.94 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.585 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.526 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 24.6 t80 -80.06 145.98 32.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.593 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 367' ' ' ILE . 62.1 m-20 -139.43 64.78 1.45 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.554 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.526 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 1.9 tpmt? 27.85 -90.1 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 365' ' ' ASP . 4.6 mp -82.74 -66.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.726 0.298 . . . . 0.0 111.127 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -47.37 166.43 0.12 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.716 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.84 161.45 21.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.729 0.3 . . . . 0.0 110.658 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.89 120.93 28.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.496 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.16 149.86 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.915 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -91.0 112.03 23.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.019 0.438 . . . . 0.0 111.119 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.408 ' O ' ' HB3' ' A' ' 273' ' ' LEU . 1.3 mm -73.26 -33.88 42.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.997 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 155.61 -178.37 32.25 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.258 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.421 ' HB3' ' CG2' ' A' ' 360' ' ' THR . 12.2 ptmt -162.16 140.59 9.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.294 0.569 . . . . 0.0 112.017 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.596 HG21 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -112.98 158.79 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.155 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.405 ' CZ ' ' OE1' ' A' ' 386' ' ' GLU . 9.4 p90 -139.53 142.95 37.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.933 0.397 . . . . 0.0 111.121 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 12.1 m -132.85 87.94 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.066 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.489 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . -178.26 -160.47 24.61 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.267 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . 0.448 ' CD2' ' O ' ' A' ' 353' ' ' GLN . 0.2 OUTLIER -52.0 166.55 0.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.703 0.287 . . . . 0.0 110.981 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 57.15 25.68 11.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.958 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 7.3 m -126.31 162.02 26.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 73.2 p -155.77 148.44 24.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.927 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 97.8 -146.08 18.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.649 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -58.99 -30.12 67.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.749 0.309 . . . . 0.0 111.306 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.405 ' OE1' ' CZ ' ' A' ' 377' ' ' PHE . 14.4 mt-10 -65.05 -59.12 4.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.19 -32.06 71.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.501 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 2.6 ptt180 -64.94 -31.7 73.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.324 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.456 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 17.5 t-160 -77.29 -57.33 3.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.489 ' CD1' ' HA2' ' A' ' 379' ' ' GLY . 50.4 t-105 -49.47 -44.95 46.21 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.093 0.473 . . . . 0.0 109.901 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.0 t -69.06 -30.67 69.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.739 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.489 ' HB3' HD13 ' A' ' 401' ' ' ILE . 0.3 OUTLIER -63.14 -42.25 99.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.923 179.119 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.441 ' HE1' ' CH2' ' A' ' 390' ' ' TRP . 31.9 ttp -59.96 -54.83 41.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.971 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.4 mt -56.46 -31.57 64.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.417 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.2 -31.61 71.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.529 . . . . 0.0 109.691 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 398' ' ' ARG . 36.0 m-80 -115.17 71.17 2.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.55 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.522 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 39.6 Cg_endo -68.34 35.29 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.249 2.632 . . . . 0.0 113.443 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . 0.522 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 11.3 mmm180 -159.26 -45.23 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.0 0.428 . . . . 0.0 110.578 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.409 ' NH1' ' HB2' ' A' ' 399' ' ' ARG . 0.2 OUTLIER -94.04 140.75 23.01 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.037 -179.19 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 72.3 Cg_endo -75.02 156.3 42.89 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.52 2.147 . . . . 0.0 112.839 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.489 HD13 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -124.99 117.95 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.578 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -110.13 144.57 38.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.677 0.275 . . . . 0.0 110.763 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.77 155.57 10.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.965 0.412 . . . . 0.0 111.246 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -82.23 121.63 26.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.753 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.626 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 54.3 m-70 -109.46 122.68 47.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.593 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 90.4 m -78.28 117.11 19.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.542 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.453 HD21 HG21 ' A' ' 361' ' ' VAL . 61.8 mt -62.16 128.09 34.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.253 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -114.44 173.29 6.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.672 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.404 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 4.6 t -58.54 115.77 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.818 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.421 ' CG ' ' HD2' ' A' ' 375' ' ' LYS . 4.6 mp0 -52.42 -25.52 10.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.42 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.94 -51.18 19.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.481 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.404 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 2.6 mm-40 -64.35 -38.8 92.33 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 59.6 t -56.8 -50.63 74.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.363 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -30.9 71.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.495 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.49 67.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.943 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 42.2 mtm -70.55 -38.55 74.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.777 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 9.7 mt -68.01 -29.95 69.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -88.25 126.4 35.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.078 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 20.7 t . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.176 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.762 0.315 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 72.3 mt -86.34 -33.89 20.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.777 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 124.12 -166.07 16.82 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.307 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -140.91 132.55 27.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.75 0.31 . . . . 0.0 110.709 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.494 HG13 HG21 ' A' ' 312' ' ' VAL . 0.0 OUTLIER -123.14 130.17 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.165 0.507 . . . . 0.0 111.013 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.71 126.38 44.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.67 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.611 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.3 p90 -142.2 150.0 40.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.399 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.9 159.65 15.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.21 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 400' ' ' PRO . 31.8 mt -130.7 149.39 52.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.798 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.412 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 16.2 ttp180 -158.95 106.47 1.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.611 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.494 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 27.7 t80 -101.49 137.91 39.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.14 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 44.2 t -123.5 95.81 44.58 Favored Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.522 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.3 Cg_exo -70.54 -34.38 12.06 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.931 2.421 . . . . 0.0 112.733 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.25 -30.71 5.02 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.16 0.505 . . . . 0.0 109.957 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -116.64 -21.72 8.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.844 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.26 48.87 6.17 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.642 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -124.15 129.74 51.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.073 0.463 . . . . 0.0 111.891 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 39.2 tp -95.43 147.63 23.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.867 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 8.3 m -139.33 138.7 36.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 112.06 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.5 124.41 57.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.316 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 25.3 t -117.16 114.67 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.028 0.442 . . . . 0.0 111.852 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.438 HG13 ' CG2' ' A' ' 328' ' ' THR . 26.1 mm -74.68 137.01 23.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.446 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.29 -60.49 1.87 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.421 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 2.4 pt-20 -175.81 159.28 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.243 0.544 . . . . 0.0 112.24 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -123.64 149.5 45.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.853 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -145.55 153.68 41.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.987 0.423 . . . . 0.0 111.375 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 60.54 29.02 18.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.495 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.401 HD12 ' HG3' ' A' ' 310' ' ' PRO . 91.8 mt -66.01 138.79 58.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.951 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -58.41 148.59 27.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.59 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.45 121.9 32.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.465 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.502 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.8 mmt -96.48 -16.67 21.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.316 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 33.1 m-20 -106.97 101.3 10.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.767 0.318 . . . . 0.0 110.504 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.07 116.61 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.54 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.04 87.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.907 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -124.93 -139.47 5.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.85 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 34.1 mt -119.46 -159.21 0.76 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.01 0.433 . . . . 0.0 110.566 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.443 ' HB2' HD21 ' A' ' 335' ' ' LEU . 66.5 m -135.68 172.06 13.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.222 0.534 . . . . 0.0 110.638 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.407 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -131.44 57.57 31.91 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.037 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 309' ' ' ASP . 38.3 Cg_endo -67.66 153.85 74.97 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.136 2.557 . . . . 0.0 114.51 -177.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.516 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 25.1 p90 -156.82 148.3 22.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.355 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.494 HG21 HG13 ' A' ' 276' ' ' ILE . 39.8 t -102.99 143.59 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 327' ' ' LYS . 17.7 mttt -122.08 157.43 31.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.278 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.429 HG21 ' CZ ' ' A' ' 345' ' ' PHE . 5.4 mp -131.51 124.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.651 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -123.5 133.25 54.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 111.157 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 22.5 tp -102.15 105.83 16.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.285 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 0.9 OUTLIER -107.2 143.6 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.245 -179.47 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.58 99.56 9.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.416 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 59.84 37.75 21.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.937 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 90.16 25.56 26.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.902 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 317' ' ' MET . 7.8 mmtm -128.88 109.47 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -52.84 130.81 34.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.227 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 8.3 mt -126.26 -43.21 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.241 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -130.62 158.08 41.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.921 0.391 . . . . 0.0 111.341 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.59 134.21 23.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.837 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -142.3 159.11 42.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.916 0.388 . . . . 0.0 111.247 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 2.9 mttt -142.75 154.65 44.46 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.601 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.438 ' CG2' HG13 ' A' ' 293' ' ' ILE . 13.4 p -111.12 177.22 4.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.847 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.4 142.99 36.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.693 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.516 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.2 mt -90.55 119.17 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.109 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -83.56 89.47 7.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.3 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -57.42 137.4 56.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.799 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 43.91 83.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.365 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 308' ' ' SER . 4.5 t -176.82 174.78 1.73 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.803 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' A' ' 308' ' ' SER . 5.1 mt -146.65 -16.96 0.42 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.223 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.447 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.7 m-80 -132.6 59.26 42.11 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.387 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 44.5 Cg_endo -92.47 167.66 2.79 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.301 2.667 . . . . 0.0 113.756 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.446 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.4 OUTLIER -107.82 160.82 15.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.053 179.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -133.93 -61.62 0.79 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.857 0.361 . . . . 0.0 111.236 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 54.76 36.9 27.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 292' ' ' VAL . 51.6 mt-10 -92.33 142.44 27.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 14.9 m -112.67 117.22 31.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.442 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . 0.404 ' CE1' HG21 ' A' ' 328' ' ' THR . 81.2 m-85 -109.72 156.93 19.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.276 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 17.4 p -129.67 142.67 50.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 111.683 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.429 ' CZ ' HG21 ' A' ' 314' ' ' ILE . 45.0 m-85 -128.59 165.96 19.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.539 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -112.88 78.31 1.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.78 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.425 HG12 HG22 ' A' ' 355' ' ' VAL . 44.0 t -112.95 118.47 44.52 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.49 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 43.2 Cg_endo -68.7 151.87 74.52 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.286 1.991 . . . . 0.0 111.113 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -47.5 -24.39 0.83 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 354' ' ' LYS . 47.3 mt-10 -83.02 -20.7 34.53 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.49 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -93.67 -39.36 10.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.494 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 3.8 tp -45.62 -28.12 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.911 0.386 . . . . 0.0 110.994 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -86.41 -31.11 21.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.806 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 350' ' ' GLU . 3.2 pttm -105.34 11.37 32.87 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.425 HG22 HG12 ' A' ' 347' ' ' VAL . 32.6 m -112.98 163.61 9.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.733 0.302 . . . . 0.0 110.883 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.2 126.51 18.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.222 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.44 HG21 ' CH2' ' A' ' 390' ' ' TRP . 86.5 t -89.56 134.06 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.195 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.52 116.93 53.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.96 0.409 . . . . 0.0 111.692 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.603 ' HB ' HG22 ' A' ' 376' ' ' VAL . 46.0 t -97.67 108.11 21.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.834 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.425 ' CG2' ' HB3' ' A' ' 375' ' ' LYS . 2.2 m -111.65 132.09 54.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.945 0.403 . . . . 0.0 111.978 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.412 HG21 HD22 ' A' ' 407' ' ' LEU . 52.7 t -106.59 113.8 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.906 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.466 ' HB2' ' CE1' ' A' ' 311' ' ' TYR . 3.1 mp -118.6 146.92 44.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.046 0.451 . . . . 0.0 111.69 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.502 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -92.9 134.33 35.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.443 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 365' ' ' ASP . 6.9 t80 -90.29 144.28 25.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.064 0.459 . . . . 0.0 110.911 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.51 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 19.8 m-20 -128.61 105.68 8.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.018 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.495 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 1.4 pttt -29.9 -56.07 0.17 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.024 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.419 ' N ' ' CD1' ' A' ' 367' ' ' ILE . 1.4 mm -91.01 -77.75 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.429 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -53.13 -175.46 0.06 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.087 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.01 165.97 17.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 111.095 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.13 145.7 47.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.077 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -106.11 151.56 24.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.68 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -98.35 110.32 22.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.04 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.477 HG22 HD11 ' A' ' 373' ' ' ILE . 36.9 mt -81.26 -34.17 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.196 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 170.63 178.01 41.05 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.098 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.454 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 16.9 ptmt -164.44 140.47 6.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.192 0.52 . . . . 0.0 111.729 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.603 HG22 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -113.24 158.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.116 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -140.68 150.63 43.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 111.345 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.433 HG23 ' CE3' ' A' ' 390' ' ' TRP . 15.4 m -142.46 111.11 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.997 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 173.34 -154.28 19.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.908 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 382' ' ' SER . 0.2 OUTLIER -53.21 -70.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.744 0.307 . . . . 0.0 111.41 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -66.41 68.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.966 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 380' ' ' TYR . 0.7 OUTLIER -164.65 165.49 20.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.733 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 34.5 p -158.03 148.26 20.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 95.74 -143.0 16.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.705 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -57.43 -30.2 64.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.382 . . . . 0.0 111.332 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -68.22 -52.59 32.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.089 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 31.0 tp -68.94 -32.82 72.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 110.336 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.431 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -66.93 -30.07 70.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.253 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.454 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 20.1 t-160 -77.9 -52.77 8.32 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.646 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.45 ' CZ2' HD11 ' A' ' 352' ' ' ILE . 65.0 t-105 -51.57 -49.02 62.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.074 0.464 . . . . 0.0 109.764 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.2 t -65.69 -29.99 70.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.721 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.466 ' HB3' HD11 ' A' ' 401' ' ' ILE . 0.4 OUTLIER -62.54 -43.76 98.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.753 179.037 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.438 ' HE1' ' CZ3' ' A' ' 390' ' ' TRP . 29.8 ttp -60.39 -52.48 65.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.665 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.7 mt -57.96 -33.37 68.79 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.36 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -67.89 -30.52 69.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.305 0.574 . . . . 0.0 109.692 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.453 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.3 m-80 -114.92 71.41 2.63 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.591 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.546 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 41.4 Cg_endo -68.7 32.95 0.16 Allowed 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.23 2.62 . . . . 0.0 113.534 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . 0.546 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 0.5 OUTLIER -158.77 -44.56 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.933 0.397 . . . . 0.0 110.77 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.439 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.0 OUTLIER -93.84 137.6 23.07 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.154 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.439 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 58.3 Cg_endo -71.43 156.37 58.51 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.571 2.181 . . . . 0.0 112.902 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -126.14 116.11 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.786 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.85 144.71 34.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.312 . . . . 0.0 110.828 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.34 154.25 10.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.37 . . . . 0.0 111.344 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -81.97 120.9 25.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.611 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 55.2 m-70 -109.61 122.36 47.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 85.4 m -78.26 117.27 19.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.674 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.431 ' CD2' HG23 ' A' ' 376' ' ' VAL . 45.2 mt -61.73 127.81 33.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.013 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -115.32 169.58 9.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.888 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.465 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 41.1 t -55.59 121.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.973 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.454 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 6.7 mt-10 -55.17 -40.6 70.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.451 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.75 -51.13 71.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.469 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.465 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.1 mt-10 -63.57 -40.13 96.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.413 ' HB ' ' HD3' ' A' ' 375' ' ' LYS . 98.6 t -56.45 -48.03 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.295 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -63.13 -40.19 96.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.745 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.98 81.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.039 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 40.6 mtm -68.99 -32.81 72.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.756 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 10.9 mt -70.84 -31.16 67.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.811 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -84.51 156.12 21.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.094 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.817 0.341 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 47.9 mt -90.2 -35.97 15.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.798 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 127.57 -162.52 21.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.335 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.32 133.37 22.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.691 0.281 . . . . 0.0 110.731 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.551 HG13 HG21 ' A' ' 312' ' ' VAL . 0.1 OUTLIER -123.04 128.98 75.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.302 0.573 . . . . 0.0 111.165 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.26 126.71 41.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.556 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.622 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.2 p90 -142.16 149.51 39.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.474 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -100.94 160.47 14.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.04 -178.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.462 ' CD1' ' CD2' ' A' ' 389' ' ' HIS . 67.0 mt -130.21 147.05 51.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.162 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 290' ' ' THR . 0.7 OUTLIER -158.86 106.48 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 0.0 111.141 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.524 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 38.0 t80 -99.12 139.4 34.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.549 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 287' ' ' GLY . 98.9 t -114.89 93.8 35.54 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.97 0.414 . . . . 0.0 109.956 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 397' ' ' PRO . 16.7 Cg_exo -66.33 -31.38 43.52 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.916 2.411 . . . . 0.0 112.343 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -28.39 67.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.807 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -123.66 -2.92 8.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.677 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 62.97 46.55 93.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.09 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -121.98 128.83 51.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.059 0.457 . . . . 0.0 111.338 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 345' ' ' PHE . 32.8 tp -93.08 147.64 22.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.332 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.402 ' CB ' ' O ' ' A' ' 281' ' ' ARG . 1.8 m -136.0 137.34 41.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.344 0.592 . . . . 0.0 111.857 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.1 t -129.95 122.98 55.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.439 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 24.0 t -116.21 116.12 51.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.979 0.418 . . . . 0.0 111.788 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 339' ' ' TYR . 34.8 mm -76.09 136.89 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.443 HD22 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.21 -59.62 1.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -177.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.457 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 2.2 pt-20 -175.64 156.79 1.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.479 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -117.59 150.63 38.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.766 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.3 pttp -147.73 152.36 37.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 111.507 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 62.92 24.24 14.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.833 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.4 HD12 ' CB ' ' A' ' 310' ' ' PRO . 60.7 mt -59.79 138.68 57.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.997 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -67.01 147.99 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.705 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.427 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 20.0 mttp -81.11 120.9 25.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.581 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.442 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 4.5 mmm -101.13 -15.38 17.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.644 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 52.9 m-20 -98.52 123.05 42.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.839 0.352 . . . . 0.0 110.548 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.0 t -48.07 114.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.627 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 56.77 17.89 22.86 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.274 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.13 -159.72 10.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.06 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 6.6 mt -95.56 -161.67 0.88 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 110.466 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 301' ' ' LYS . 14.4 m -133.99 171.81 13.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.278 0.561 . . . . 0.0 111.181 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.418 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 13.7 m-20 -131.87 56.11 21.99 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 309' ' ' ASP . 58.5 Cg_endo -73.01 146.28 41.29 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.047 2.498 . . . . 0.0 114.842 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.501 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 42.2 p90 -146.2 165.85 27.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.171 -1.377 . . . . 0.0 107.948 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.551 HG21 HG13 ' A' ' 276' ' ' ILE . 48.1 t -115.11 149.95 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.4 ' HG2' ' CB ' ' A' ' 327' ' ' LYS . 13.0 mttt -129.44 164.48 23.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.042 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.433 HG22 ' CE1' ' A' ' 345' ' ' PHE . 4.8 mp -137.86 124.97 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.689 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -119.46 135.56 54.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.89 0.376 . . . . 0.0 111.313 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 345' ' ' PHE . 20.5 tp -103.92 105.55 15.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.457 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.1 mtm -111.04 127.9 55.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.408 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.38 99.6 12.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.283 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 55.16 38.1 29.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.024 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 91.79 27.48 16.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.867 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 317' ' ' MET . 2.3 mptt -130.71 109.39 10.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.732 0.301 . . . . 0.0 110.843 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.35 130.42 27.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.364 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 15.9 mt -124.58 -58.93 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.132 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.66 152.06 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.8 128.86 20.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.709 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -125.71 167.31 15.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.98 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.4 ' CB ' ' HG2' ' A' ' 313' ' ' LYS . 36.6 pttt -147.54 148.66 31.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.142 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.423 ' CG2' HG13 ' A' ' 293' ' ' ILE . 9.7 p -104.7 179.83 4.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.749 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 10.1 t -59.15 172.28 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.501 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.4 mt -116.96 125.1 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.955 0.407 . . . . 0.0 111.377 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.423 ' HG3' ' HB2' ' A' ' 337' ' ' PRO . 0.2 OUTLIER -91.08 91.45 8.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.281 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -58.83 137.09 57.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.833 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 44.54 80.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.413 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 4.7 t -172.98 173.49 3.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.556 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 3.2 mt -146.99 -14.75 0.41 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.391 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.466 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.8 m-80 -135.81 57.63 19.78 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 120.704 0.288 . . . . 0.0 110.506 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.466 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 45.5 Cg_endo -92.79 167.82 2.58 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.155 2.57 . . . . 0.0 113.721 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.443 ' CE2' HD22 ' A' ' 294' ' ' LEU . 0.6 OUTLIER -106.31 160.76 15.12 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.192 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.533 ' HB2' HG23 ' A' ' 293' ' ' ILE . 66.1 m-85 -132.65 -66.83 0.67 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.916 0.388 . . . . 0.0 110.982 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 60.72 37.35 19.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.843 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' A' ' 293' ' ' ILE . 29.9 mt-10 -93.65 143.91 25.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 93.1 p -113.21 121.92 45.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.007 0.432 . . . . 0.0 111.481 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . 0.421 ' CZ ' HG23 ' A' ' 328' ' ' THR . 36.7 m-85 -110.42 164.85 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.321 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 21.6 m -137.49 140.1 40.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.092 0.472 . . . . 0.0 111.679 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.433 ' CE1' HG22 ' A' ' 314' ' ' ILE . 38.3 m-85 -126.88 166.0 18.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.503 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.33 72.99 0.79 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.727 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.419 ' CG2' HD21 ' A' ' 316' ' ' LEU . 46.9 t -108.38 121.08 44.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.135 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.539 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 68.5 Cg_endo -74.4 157.84 44.93 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.358 2.038 . . . . 0.0 111.247 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -50.9 -22.23 2.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -89.15 -8.46 53.65 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.539 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -111.98 -27.19 8.52 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.524 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 4.5 tp -48.37 -26.92 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.741 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . 0.404 ' O ' ' CD2' ' A' ' 380' ' ' TYR . 3.6 mm-40 -95.09 -26.58 15.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.618 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -92.32 -0.66 57.37 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.883 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 24.8 m -110.24 163.18 7.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.92 0.39 . . . . 0.0 111.317 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -139.24 126.33 21.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.62 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.428 HG22 ' CZ3' ' A' ' 390' ' ' TRP . 98.9 t -90.88 111.81 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.533 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.95 109.39 24.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.399 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.612 ' HB ' HG22 ' A' ' 376' ' ' VAL . 48.8 t -90.48 108.0 19.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.442 ' CG2' ' HB3' ' A' ' 375' ' ' LYS . 1.5 m -108.25 133.43 52.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.02 0.438 . . . . 0.0 111.894 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 51.1 t -108.3 114.8 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.839 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.437 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.5 mp -118.3 150.05 40.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.063 0.458 . . . . 0.0 111.838 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.442 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 1.3 t70 -95.53 132.36 40.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.679 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.511 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 26.8 t80 -83.74 146.2 28.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.538 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -141.2 64.28 1.42 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.7 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.511 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 0.0 OUTLIER 33.2 -92.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.212 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 47.5 mm -81.11 -71.38 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.668 0.271 . . . . 0.0 111.409 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -42.91 163.81 0.03 OUTLIER Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.969 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 165.49 12.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 0.0 110.886 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.93 130.98 34.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.94 139.38 35.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -87.71 111.57 21.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.882 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.439 HD13 HG21 ' A' ' 373' ' ' ILE . 37.2 mt -79.78 -34.42 15.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.01 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.92 -179.81 40.97 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.961 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.442 ' HB3' ' CG2' ' A' ' 360' ' ' THR . 9.6 ptmt -164.6 140.62 5.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.513 . . . . 0.0 111.81 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.618 HG12 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -109.47 158.89 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.128 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.425 ' CE2' ' OG ' ' A' ' 382' ' ' SER . 17.6 p90 -139.58 151.4 46.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 0.0 111.813 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.414 HG23 ' CE3' ' A' ' 390' ' ' TRP . 17.0 m -148.39 121.4 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.03 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.43 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 169.57 -151.35 17.02 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.371 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 353' ' ' GLN . 0.2 OUTLIER -43.2 -69.83 0.12 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.863 0.364 . . . . 0.0 111.233 179.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -60.97 -155.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.186 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' SER . . . . . 0.425 ' OG ' ' CE2' ' A' ' 377' ' ' PHE . 0.7 OUTLIER 70.21 166.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 110.86 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 50.0 p -158.12 146.86 19.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.802 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 92.93 -154.66 22.07 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.825 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . 0.459 ' HA ' ' HG3' ' A' ' 388' ' ' ARG . . . -43.35 -34.26 1.2 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.8 -56.08 18.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.729 0.299 . . . . 0.0 110.797 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.76 -35.96 79.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.463 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.459 ' HG3' ' HA ' ' A' ' 385' ' ' ALA . 4.0 mtt85 -61.77 -41.37 97.62 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.978 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.471 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 13.9 t-160 -60.99 -55.69 29.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.738 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.449 ' CZ3' ' HE1' ' A' ' 393' ' ' MET . 62.5 t-105 -55.44 -50.99 68.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.462 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -37.26 86.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.312 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.514 ' HB3' HD11 ' A' ' 401' ' ' ILE . 14.8 m-20 -63.07 -32.83 74.29 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.48 ' HA ' HG13 ' A' ' 401' ' ' ILE . 26.0 ttp -63.42 -56.4 16.54 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.426 HD23 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -56.38 -23.26 36.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.715 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -78.99 -33.63 44.87 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.372 0.606 . . . . 0.0 109.374 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.408 ' N ' ' HD3' ' A' ' 397' ' ' PRO . 28.6 m-80 -130.1 59.76 47.45 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.459 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.627 ' HB3' ' HD3' ' A' ' 284' ' ' PRO . 65.5 Cg_exo -46.28 -76.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.921 2.414 . . . . 0.0 112.992 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -49.45 -21.94 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.87 133.49 27.67 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 110.881 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.3 Cg_endo -75.21 133.76 16.66 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.492 2.128 . . . . 0.0 112.614 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' ' 392' ' ' ASP . 1.1 mm -111.68 110.75 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.803 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.18 143.96 34.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.783 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.43 152.39 7.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.874 0.369 . . . . 0.0 111.378 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -80.12 124.09 28.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.686 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.622 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 61.0 m-70 -112.31 123.0 49.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.628 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 91.5 m -78.36 117.08 19.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.653 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.401 ' CD2' HG23 ' A' ' 276' ' ' ILE . 80.9 mt -62.45 127.73 32.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.077 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -115.85 170.26 8.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.791 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.465 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 61.1 t -55.22 117.39 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.812 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -52.01 -43.09 63.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.832 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -58.06 -50.16 74.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.738 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.465 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 23.0 mt-10 -64.04 -38.8 92.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 89.0 t -57.43 -48.32 83.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.286 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -64.42 -30.6 71.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.468 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.37 -39.66 85.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.611 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' MET . . . . . 0.409 ' SD ' ' CZ ' ' A' ' 377' ' ' PHE . 11.0 mtt -60.66 -41.6 95.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.532 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 5.2 mt -73.57 -30.57 63.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.934 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -93.36 113.72 25.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.075 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.163 179.933 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.8 0.333 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 55.0 mt -89.73 -48.43 7.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 135.16 -170.16 23.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.19 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -136.74 135.15 37.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.719 0.295 . . . . 0.0 111.01 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -125.37 128.7 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.03 0.443 . . . . 0.0 110.875 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.37 126.6 42.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.826 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.612 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.0 p90 -142.22 152.15 42.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.406 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.49 163.4 12.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.005 -178.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.485 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 96.1 mt -136.81 143.43 43.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.281 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.408 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 7.3 ttm180 -159.13 110.76 2.11 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.884 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.504 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 26.9 t80 -104.42 139.15 39.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.802 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.54 97.22 42.48 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.5 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.84 -33.47 7.9 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.669 2.246 . . . . 0.0 112.632 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -29.36 6.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.165 0.507 . . . . 0.0 109.983 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.29 -18.16 8.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.945 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.79 48.87 8.29 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.548 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -123.69 129.9 51.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.986 0.422 . . . . 0.0 111.621 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.411 ' CD1' ' HE3' ' A' ' 393' ' ' MET . 38.5 tp -97.42 147.49 24.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.977 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 2.8 m -137.61 137.21 38.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.429 0.633 . . . . 0.0 111.965 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.7 t -130.92 123.6 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.162 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 23.9 t -117.9 115.13 47.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.057 0.456 . . . . 0.0 111.794 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 339' ' ' TYR . 40.0 mm -74.83 137.11 23.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.02 -59.4 2.02 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.426 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 4.7 pt-20 -175.75 162.89 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.415 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -122.31 153.06 39.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.897 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -149.61 150.02 31.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.104 0.478 . . . . 0.0 111.534 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 60.38 26.27 15.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.878 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.417 HD12 ' CB ' ' A' ' 310' ' ' PRO . 94.2 mt -62.08 138.75 58.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.832 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.81 150.7 23.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.57 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -91.58 115.84 28.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.423 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.484 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.5 mmt -88.56 -19.26 26.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.541 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 50.1 m-20 -99.26 112.16 24.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.512 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -49.27 116.37 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.476 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 65.69 12.74 57.5 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.536 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.17 -151.01 7.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.75 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 10.6 mt -108.29 -161.51 0.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.697 0.284 . . . . 0.0 110.68 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.425 ' HB2' HD21 ' A' ' 335' ' ' LEU . 49.8 m -137.68 172.04 13.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.369 0.604 . . . . 0.0 111.276 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.407 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 8.7 m-20 -131.38 57.86 34.13 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.735 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.417 ' CB ' HD12 ' A' ' 299' ' ' LEU . 45.0 Cg_endo -69.74 151.92 69.32 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.196 2.597 . . . . 0.0 114.729 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 35.0 p90 -154.35 155.44 35.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.108 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.449 ' CG1' ' CG1' ' A' ' 359' ' ' VAL . 47.1 t -106.38 149.79 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 360' ' ' THR . 9.9 mtmt -131.93 140.99 49.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.307 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.42 HG23 ' CZ ' ' A' ' 345' ' ' PHE . 5.3 mp -115.79 127.74 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.556 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . 0.421 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 57.7 m80 -122.39 133.4 54.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.369 . . . . 0.0 111.378 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.404 HD22 HG21 ' A' ' 347' ' ' VAL . 38.7 tp -106.39 107.53 18.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.095 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.1 mtm -116.12 147.82 40.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.391 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.411 ' NE2' ' CD ' ' A' ' 354' ' ' LYS . 1.4 mt-30 -107.0 99.47 9.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.521 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 56.55 37.83 29.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 96.6 13.82 46.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.166 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 317' ' ' MET . 32.3 mmtt -119.18 109.12 15.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.808 0.304 . . . . 0.0 110.734 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.48 135.37 56.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.4 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.401 ' CD1' ' HG3' ' A' ' 318' ' ' GLN . 3.3 mt -127.08 -49.36 1.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.849 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.487 ' HB2' ' HE2' ' A' ' 345' ' ' PHE . 2.5 mttt -130.53 148.97 52.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.962 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . 0.421 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -144.25 119.54 10.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.753 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -122.96 155.88 35.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -137.58 148.58 45.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.842 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.412 ' CG2' HG13 ' A' ' 293' ' ' ILE . 4.3 p -101.71 -179.0 3.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.844 0.354 . . . . 0.0 110.712 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.0 t -60.45 162.2 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.468 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.483 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.6 mt -105.07 121.92 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.921 0.391 . . . . 0.0 111.219 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.6 94.65 9.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.109 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -60.8 136.8 58.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.928 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 43.83 83.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.51 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.5 t -177.06 174.5 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.879 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 308' ' ' SER . 4.3 mt -145.26 -16.86 0.49 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.294 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -131.42 61.68 60.41 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.862 0.363 . . . . 0.0 110.05 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -88.57 167.63 6.11 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.145 2.564 . . . . 0.0 114.045 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 58.8 t80 -114.09 153.18 29.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.846 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.474 ' HB2' HG21 ' A' ' 293' ' ' ILE . 83.9 m-85 -132.98 -69.83 0.55 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.85 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . 0.481 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 26.2 t-20 64.45 37.21 8.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.505 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 293' ' ' ILE . 31.3 mt-10 -91.42 142.9 27.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.787 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 13.7 m -110.28 122.18 47.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 0.0 111.581 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -113.2 148.36 35.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.091 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 3.0 m -120.8 140.0 52.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.1 0.476 . . . . 0.0 111.554 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.487 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 45.0 m-85 -126.88 165.87 18.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.437 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -116.62 76.1 1.01 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.958 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.461 HG13 HG23 ' A' ' 355' ' ' VAL . 55.7 t -109.16 122.92 38.31 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.209 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.514 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.4 Cg_endo -72.3 156.43 54.93 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.293 1.996 . . . . 0.0 111.3 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -50.68 -21.92 1.82 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.67 -8.5 52.27 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.514 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -107.88 -31.36 8.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.504 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 6.4 tp -46.81 -27.28 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 111.319 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -90.02 -47.54 7.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.627 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.43 ' CG ' ' HA ' ' A' ' 351' ' ' GLN . 5.9 ptpt -80.72 2.18 27.1 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.461 HG23 HG13 ' A' ' 347' ' ' VAL . 33.1 m -107.66 165.38 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.729 0.299 . . . . 0.0 110.872 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.67 126.46 15.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.087 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.426 HG22 ' CH2' ' A' ' 390' ' ' TRP . 61.4 t -88.54 114.14 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.276 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.16 116.29 43.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.756 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.596 ' HB ' HG23 ' A' ' 376' ' ' VAL . 58.3 t -98.46 108.11 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.856 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 313' ' ' LYS . 1.6 m -108.73 132.68 53.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.998 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 54.6 t -105.93 114.96 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.636 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 311' ' ' TYR . 3.3 mp -118.71 147.84 43.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.096 0.474 . . . . 0.0 111.895 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.484 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.8 t70 -93.8 137.36 33.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.744 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.492 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 30.7 t80 -90.09 145.62 24.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.376 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 367' ' ' ILE . 48.3 m-20 -142.53 66.22 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.492 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 0.0 OUTLIER 35.77 -92.24 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.312 179.157 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.404 ' N ' ' O ' ' A' ' 365' ' ' ASP . 4.6 mp -86.48 -65.44 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.792 0.329 . . . . 0.0 111.238 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -41.84 159.47 0.04 OUTLIER Glycine 0 C--N 1.332 0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.178 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.86 149.79 49.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.31 . . . . 0.0 110.889 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.03 126.41 29.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.781 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.01 148.9 37.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.15 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -95.4 110.89 22.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 373' ' ' ILE . 23.9 mt -79.59 -32.88 14.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.316 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 166.48 -178.87 40.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.746 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.471 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 10.9 ptmt -164.54 141.04 6.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.181 0.515 . . . . 0.0 111.686 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.61 HG13 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.86 158.79 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.226 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.409 ' CZ ' ' OE1' ' A' ' 386' ' ' GLU . 8.3 p90 -141.78 143.03 33.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.374 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.6 m -131.86 90.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.082 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.438 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . -177.64 -158.0 19.71 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.45 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -56.73 173.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 110.803 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 23.5 m120 51.18 26.55 2.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.273 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.19 165.53 23.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 34.1 p -158.02 150.65 22.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 97.97 -147.54 18.62 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.434 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -55.37 -30.4 60.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 111.379 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.409 ' OE1' ' CZ ' ' A' ' 377' ' ' PHE . 0.3 OUTLIER -68.53 -54.42 16.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.984 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.9 tp -67.96 -30.91 70.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.781 0.324 . . . . 0.0 110.43 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 5.1 ptt180 -68.23 -28.21 67.03 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.329 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.444 ' CD2' HG21 ' A' ' 401' ' ' ILE . 18.4 t-160 -81.33 -54.48 5.44 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.456 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.438 ' CD1' ' HA2' ' A' ' 379' ' ' GLY . 48.2 t-105 -49.96 -43.97 50.44 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.008 0.432 . . . . 0.0 109.863 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 31.3 t -69.72 -34.1 73.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.694 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 0.5 OUTLIER -61.08 -39.57 90.4 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.485 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 19.8 ttm -59.42 -53.79 54.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.115 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.9 mt -63.81 -29.74 70.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.374 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.82 -31.02 71.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.226 0.536 . . . . 0.0 109.694 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -125.3 77.86 67.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.329 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.505 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 6.0 Cg_exo -77.8 42.76 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.145 2.564 . . . . 0.0 113.162 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . 0.505 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 16.2 mmm-85 -158.98 -46.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.069 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.21 142.84 25.45 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.925 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.01 156.27 52.2 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.654 2.236 . . . . 0.0 112.904 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.448 HD13 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.81 114.69 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.749 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.91 144.21 35.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.759 0.314 . . . . 0.0 110.832 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.43 154.68 10.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.959 0.409 . . . . 0.0 111.291 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -81.38 120.35 24.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.959 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.612 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 48.3 m-70 -109.56 117.72 34.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.459 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 89.8 m -78.43 116.22 18.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.792 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.469 HD21 HG21 ' A' ' 376' ' ' VAL . 93.7 mt -61.09 128.12 34.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.347 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -115.47 171.96 7.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.558 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.494 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 44.2 t -54.59 120.72 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.471 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 14.8 mt-10 -54.29 -41.56 69.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.815 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.16 -51.33 70.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 0.0 110.539 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.494 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 24.6 mt-10 -62.49 -39.83 94.73 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 75.6 t -57.64 -50.11 78.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.378 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -60.08 -37.79 80.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.64 76.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.058 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 51.0 mtm -69.19 -31.62 70.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 9.0 mt -79.14 -34.18 43.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -70.62 174.7 5.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.099 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.057 179.987 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.819 0.343 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 22.0 mt -94.78 -33.95 12.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.811 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 117.75 -163.98 12.73 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.177 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -143.6 132.18 22.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.731 0.301 . . . . 0.0 110.589 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -121.04 131.57 72.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.184 0.516 . . . . 0.0 111.184 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.407 ' N ' ' CD1' ' A' ' 276' ' ' ILE . 0.1 OUTLIER -99.59 125.08 45.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.709 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.626 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 16.0 p90 -139.91 150.69 44.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.24 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.0 OUTLIER -99.62 158.03 16.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.056 -178.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.492 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 77.3 mt -129.44 144.87 51.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.018 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.437 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 22.7 ttp85 -158.89 109.22 2.02 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.702 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.5 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 26.1 t80 -103.39 137.98 40.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.93 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.0 t -122.29 94.6 47.78 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.523 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.5 Cg_exo -70.04 -32.63 17.06 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.939 2.426 . . . . 0.0 112.44 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.44 -30.03 7.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.184 0.516 . . . . 0.0 110.015 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.53 -21.45 7.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.962 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.92 48.44 6.11 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.549 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -124.04 130.18 52.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.983 0.421 . . . . 0.0 111.803 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 33.2 tp -95.66 147.5 23.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.74 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 7.1 m -138.19 136.58 36.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.31 0.576 . . . . 0.0 112.001 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.36 123.92 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.297 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 34.8 t -118.06 115.44 48.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.976 0.417 . . . . 0.0 112.006 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.439 HG21 ' HB2' ' A' ' 339' ' ' TYR . 31.3 mm -73.85 135.34 27.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.41 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.7 OUTLIER -112.62 -62.76 1.53 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.459 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 1.6 pt-20 -175.55 150.15 1.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.247 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -110.46 157.77 19.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.168 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -150.98 153.41 35.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.014 0.435 . . . . 0.0 111.724 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 59.08 25.2 13.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.93 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 335' ' ' LEU . 49.6 mt -59.04 138.63 57.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.168 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.83 144.78 47.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.406 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 25.5 mttp -85.69 109.64 18.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.406 ' HG2' ' CB ' ' A' ' 363' ' ' ASP . 0.0 OUTLIER -86.13 -21.62 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.872 -179.404 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 50.5 m-20 -95.39 123.56 38.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 20.5 t -54.19 117.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.546 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.11 16.74 34.61 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.407 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.84 -154.92 8.71 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.679 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 15.1 mt -102.26 -161.36 0.84 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.788 0.327 . . . . 0.0 110.43 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 334' ' ' THR . 68.8 m -135.32 172.05 13.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.231 0.539 . . . . 0.0 110.972 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.419 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -133.53 55.86 18.09 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 363' ' ' ASP . 69.5 Cg_endo -76.71 142.58 23.02 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.944 2.429 . . . . 0.0 114.93 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.577 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 14.7 p90 -137.46 167.05 22.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.36 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 276' ' ' ILE . 43.1 t -113.05 150.07 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -133.41 139.91 47.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.189 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.4 mp -114.63 131.01 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.685 0.279 . . . . 0.0 111.03 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -127.37 134.08 49.97 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.863 0.363 . . . . 0.0 111.015 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.429 HD23 ' CG2' ' A' ' 347' ' ' VAL . 22.5 tp -103.99 106.47 16.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.409 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' MET . . . . . 0.423 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.6 mtm -110.7 135.33 51.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.138 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.48 99.46 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.546 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 59.58 35.66 22.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.301 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 98.21 7.99 55.56 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.676 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 317' ' ' MET . 0.0 OUTLIER -115.47 112.74 22.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.387 0.593 . . . . 0.0 110.94 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.25 134.19 33.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.526 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 13.4 mt -125.91 -45.95 1.71 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 9.5 mmtp -130.59 153.63 48.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.364 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 117.31 10.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.903 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 3.4 mmtm -123.63 164.68 18.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.104 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.52 152.68 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.97 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.42 HG22 ' CE1' ' A' ' 343' ' ' PHE . 16.1 p -109.83 -178.89 3.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 11.3 t -63.0 165.85 6.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.577 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.9 mt -108.49 117.29 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 111.509 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.4 ' CD ' ' HB2' ' A' ' 337' ' ' PRO . 8.3 mmpt? -80.07 85.95 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.875 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -55.12 135.84 48.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.021 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.32 83.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.49 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 308' ' ' SER . 4.5 t -175.63 174.39 2.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.681 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.408 ' O ' ' HG ' ' A' ' 299' ' ' LEU . 5.2 mt -145.59 -17.16 0.48 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.185 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.467 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.72 56.53 22.98 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.908 0.385 . . . . 0.0 110.123 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 42.7 Cg_endo -90.1 167.79 4.51 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.203 2.602 . . . . 0.0 113.746 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -109.63 159.6 16.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.167 179.244 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.459 ' CD2' ' HA ' ' A' ' 295' ' ' GLU . 51.1 m-85 -132.48 -62.32 0.83 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.68 37.42 25.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 293' ' ' ILE . 30.1 mt-10 -92.47 144.47 25.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.706 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 51.6 p -115.48 120.76 40.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.393 . . . . 0.0 111.749 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . 0.42 ' CE1' HG22 ' A' ' 328' ' ' THR . 80.8 m-85 -112.38 155.06 24.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.11 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 83.4 p -127.16 139.62 52.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.083 0.468 . . . . 0.0 111.591 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 66.3 m-85 -127.89 165.86 19.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.545 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.56 79.93 1.33 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.998 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.429 ' CG2' HD23 ' A' ' 316' ' ' LEU . 47.9 t -112.16 118.99 45.04 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.991 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.465 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 37.2 Cg_endo -66.52 154.02 75.88 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.321 2.014 . . . . 0.0 111.353 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -51.9 -24.74 6.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.752 0.31 . . . . 0.0 111.444 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.27 -8.57 57.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.54 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.465 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 31.2 mt-30 -105.99 -37.14 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.667 0.27 . . . . 0.0 111.329 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.5 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 4.7 tp -47.13 -25.52 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 111.195 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . 0.409 ' O ' ' CD1' ' A' ' 380' ' ' TYR . 3.0 mt-30 -88.99 -24.86 22.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.831 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.477 ' HA ' ' CD1' ' A' ' 380' ' ' TYR . 0.6 OUTLIER -111.69 2.14 17.08 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.012 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.416 HG22 ' CZ2' ' A' ' 390' ' ' TRP . 33.8 m -96.77 167.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.766 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . 0.415 ' HA ' ' HA3' ' A' ' 379' ' ' GLY . 7.4 mt-30 -141.28 126.33 18.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.928 0.394 . . . . 0.0 111.472 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.405 HG22 ' CZ3' ' A' ' 390' ' ' TRP . 99.6 t -96.93 115.33 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.833 178.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.442 ' CG1' ' HE2' ' A' ' 375' ' ' LYS . 0.4 OUTLIER -101.22 117.17 46.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.605 ' HB ' HG21 ' A' ' 376' ' ' VAL . 45.9 t -98.22 107.85 20.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.435 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 4.7 m -111.28 129.58 55.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.054 0.454 . . . . 0.0 111.9 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 58.5 t -103.81 121.1 54.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.074 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.444 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 2.8 mp -123.18 146.26 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 111.816 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 310' ' ' PRO . 5.0 t70 -90.17 137.62 32.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.642 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.578 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 25.0 t80 -94.14 142.52 27.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.425 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 367' ' ' ILE . 1.2 m-20 -139.08 68.9 1.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.584 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.578 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 0.0 OUTLIER 27.91 -86.54 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 365' ' ' ASP . 42.7 mm -87.52 -67.15 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.75 0.309 . . . . 0.0 111.129 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -43.06 165.01 0.02 OUTLIER Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.091 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.8 165.56 12.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.848 0.356 . . . . 0.0 111.007 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.25 121.32 31.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.23 147.25 48.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.51 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -91.7 110.22 21.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.094 0.473 . . . . 0.0 111.373 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 2.4 mm -71.95 -35.57 54.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.783 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 157.38 -175.16 34.84 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.117 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.484 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 9.9 ptmt -164.1 140.5 6.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.287 0.565 . . . . 0.0 111.906 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.605 HG21 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -113.71 158.85 13.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.219 179.375 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 377' ' ' PHE . 2.6 p90 -140.45 150.85 44.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.563 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 17.1 m -151.31 127.96 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.151 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 133.81 126.45 2.67 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.953 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . 0.477 ' CD1' ' HA ' ' A' ' 354' ' ' LYS . 0.0 OUTLIER 58.97 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.649 0.261 . . . . 0.0 111.104 179.746 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 379' ' ' GLY . 0.3 OUTLIER -71.72 -161.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.313 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 69.8 166.8 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 110.93 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 42.2 p -158.09 147.33 19.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.867 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 90.14 -139.85 15.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.813 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -49.53 -31.9 11.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.701 0.286 . . . . 0.0 111.766 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -68.59 -58.88 3.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.903 0.382 . . . . 0.0 110.206 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.45 -30.91 71.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.368 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 4.7 ptt180 -65.52 -28.63 69.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.312 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.47 ' CD2' HG23 ' A' ' 401' ' ' ILE . 19.7 t-160 -81.56 -58.13 3.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.715 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.493 ' CD1' ' HA2' ' A' ' 379' ' ' GLY . 73.9 t-105 -49.82 -46.32 50.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.07 0.462 . . . . 0.0 109.979 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 5.4 t -64.49 -32.94 74.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.593 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.486 ' HB3' HD11 ' A' ' 401' ' ' ILE . 0.6 OUTLIER -65.47 -40.46 93.19 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.492 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 7.1 ttm -57.86 -53.06 62.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.378 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.8 mt -61.94 -34.37 75.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.359 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.65 -29.71 69.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.181 0.515 . . . . 0.0 109.943 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.425 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.7 m-80 -114.1 71.04 2.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.754 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.55 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 48.6 Cg_endo -70.07 33.98 0.21 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.167 2.578 . . . . 0.0 113.486 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . 0.55 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 10.2 mmm180 -159.25 -47.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.952 0.406 . . . . 0.0 110.952 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.482 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 36.1 ttt180 -93.94 136.66 23.55 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.385 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.482 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 48.6 Cg_endo -68.48 156.41 65.71 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.601 2.201 . . . . 0.0 112.939 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.37 118.72 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.797 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -105.64 144.58 32.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.839 0.352 . . . . 0.0 110.729 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.07 154.51 15.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.159 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -85.81 119.28 25.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.774 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.626 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 58.4 m-70 -108.56 122.16 46.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.251 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 89.9 m -78.08 117.41 19.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.721 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 67.5 mt -61.66 127.57 32.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.2 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -115.0 169.07 9.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.755 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.453 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 45.0 t -56.76 121.25 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.484 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 5.7 mt-10 -52.2 -44.83 64.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.993 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.06 -49.66 75.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 110.74 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.453 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 29.8 mt-10 -64.59 -38.76 92.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.414 HG23 ' HG2' ' A' ' 375' ' ' LYS . 96.3 t -58.24 -49.49 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.381 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.57 -34.07 72.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.829 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -72.58 -36.72 68.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.028 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 59.8 mtm -70.84 -32.8 69.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 12.0 mt -70.69 -30.77 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.914 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -79.03 116.8 19.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.092 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.143 179.986 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.819 0.342 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 60.8 mt -89.14 -31.57 17.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.942 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.24 -165.73 13.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.233 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.18 133.06 27.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -121.94 129.56 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.088 0.47 . . . . 0.0 110.914 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.86 125.35 41.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.668 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.609 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.6 p90 -142.08 149.29 39.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.406 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.97 161.31 13.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.269 -178.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.438 HD11 ' CE1' ' A' ' 389' ' ' HIS . 11.3 mt -133.27 149.67 51.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.942 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.44 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.1 OUTLIER -158.92 105.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.446 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.515 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 30.7 t80 -98.19 134.87 40.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.832 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.51 97.88 48.56 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.493 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.9 Cg_exo -72.46 -31.49 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.691 2.261 . . . . 0.0 112.377 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.26 -30.26 6.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.294 0.569 . . . . 0.0 109.715 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.16 -17.38 8.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.767 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.11 47.94 10.46 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.689 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -123.31 129.38 51.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.934 0.397 . . . . 0.0 111.853 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 36.5 tp -92.59 147.66 22.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.796 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 2.9 m -137.16 138.54 40.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.323 0.582 . . . . 0.0 112.091 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.1 t -131.42 123.91 53.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.449 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 29.0 t -116.74 115.3 48.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.942 0.401 . . . . 0.0 111.848 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 339' ' ' TYR . 31.6 mm -75.83 133.7 30.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.57 -59.86 1.89 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 7.3 pt-20 -175.72 165.17 3.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.241 0.543 . . . . 0.0 112.081 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -127.84 155.35 44.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.258 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -149.7 150.2 31.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 111.5 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 59.87 26.34 15.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.735 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.449 HD11 ' CG ' ' A' ' 310' ' ' PRO . 87.5 mt -64.83 139.0 58.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.108 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -57.62 145.61 33.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.381 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 127.77 41.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.405 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.479 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 14.7 mmt -97.78 -9.82 25.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.405 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 25.4 m-20 -108.52 119.17 38.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.718 0.294 . . . . 0.0 110.445 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.32 118.77 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.576 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 76.86 2.18 75.83 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.195 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -120.82 -123.26 3.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.932 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 44.0 mt -137.32 -159.28 0.94 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.906 0.384 . . . . 0.0 110.071 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.492 ' HB3' ' HD3' ' A' ' 310' ' ' PRO . 0.2 OUTLIER -140.13 167.98 20.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.933 0.397 . . . . 0.0 110.255 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.08 64.43 52.8 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 308' ' ' SER . 60.7 Cg_endo -74.03 142.68 31.49 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.827 2.351 . . . . 0.0 114.697 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.539 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 43.1 p90 -144.25 158.52 43.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.212 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.447 ' CG1' ' CG1' ' A' ' 359' ' ' VAL . 44.2 t -107.82 149.91 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.409 0.623 . . . . 0.0 112.625 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 360' ' ' THR . 9.7 mtmt -132.85 136.94 46.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.517 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.418 HG22 ' CZ ' ' A' ' 345' ' ' PHE . 5.4 mp -107.97 136.97 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.513 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . 0.431 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 77.9 m80 -130.89 133.6 46.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.379 . . . . 0.0 111.131 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.79 110.23 22.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.376 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.7 mtm -118.99 139.73 51.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.939 0.4 . . . . 0.0 111.378 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.63 99.44 10.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.411 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 53.02 38.1 26.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.4 26.82 12.83 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.87 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.8 mptt -129.23 109.3 11.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.706 0.288 . . . . 0.0 110.779 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.14 130.0 29.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.52 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 11.5 mt -125.86 -55.04 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.973 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -130.62 150.71 51.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.319 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . 0.431 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -144.45 123.41 12.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.422 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 21.6 mmtt -125.19 170.79 10.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.25 147.01 27.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.418 ' CG2' HG13 ' A' ' 293' ' ' ILE . 5.5 p -104.27 -178.71 3.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.758 0.313 . . . . 0.0 110.782 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 13.9 t -60.33 164.02 4.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.432 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.539 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.9 mt -108.11 116.87 52.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.973 0.416 . . . . 0.0 111.379 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.405 ' HG3' ' CG ' ' A' ' 337' ' ' PRO . 0.7 OUTLIER -78.81 85.93 4.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.034 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -53.51 136.45 38.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.167 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 43.6 86.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.277 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 308' ' ' SER . 5.0 t 177.31 173.16 0.5 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.52 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.448 ' CD2' ' HB2' ' A' ' 308' ' ' SER . 2.8 mt -144.28 -15.29 0.58 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.357 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.418 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.0 OUTLIER -132.6 61.14 55.11 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-O 120.857 0.361 . . . . 0.0 110.039 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 52.0 Cg_endo -91.21 167.71 3.55 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.196 2.597 . . . . 0.0 114.028 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.463 ' CD1' ' HB3' ' A' ' 295' ' ' GLU . 20.7 t80 -110.76 154.09 24.41 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.748 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.489 ' HB2' HG22 ' A' ' 293' ' ' ILE . 75.8 m-85 -131.39 -68.93 0.64 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.855 0.36 . . . . 0.0 111.727 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . 0.424 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 0.1 OUTLIER 63.71 36.65 10.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.703 -179.4 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 293' ' ' ILE . 37.4 mt-10 -91.8 144.68 25.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.6 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 51.5 p -114.87 121.81 44.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.934 0.397 . . . . 0.0 111.656 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -113.75 151.84 31.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.163 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 87.9 p -125.97 138.89 53.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.155 0.502 . . . . 0.0 111.789 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.418 ' CZ ' HG22 ' A' ' 314' ' ' ILE . 56.9 m-85 -125.42 166.05 17.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.585 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -113.27 78.21 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.913 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.414 ' O ' ' OH ' ' A' ' 282' ' ' TYR . 48.6 t -110.6 122.12 39.25 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.82 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.4 Cg_endo -72.54 157.55 52.51 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.352 2.035 . . . . 0.0 111.657 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -51.46 -21.89 2.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.841 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.33 -8.54 53.04 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.526 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -109.86 -30.31 7.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.515 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 6.4 tp -47.4 -28.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.811 0.338 . . . . 0.0 111.026 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . 0.438 ' O ' ' CD2' ' A' ' 380' ' ' TYR . 2.9 mm-40 -95.0 -25.82 16.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.897 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -95.1 0.84 54.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.875 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 17.2 m -113.18 161.11 12.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.833 0.349 . . . . 0.0 111.302 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -137.1 126.34 24.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.713 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.433 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 91.6 t -87.08 107.43 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.402 . . . . 0.0 110.248 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.411 ' CG1' ' HE2' ' A' ' 375' ' ' LYS . 0.7 OUTLIER -93.36 113.68 28.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.592 -179.29 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.602 ' HB ' HG21 ' A' ' 376' ' ' VAL . 41.7 t -96.69 107.74 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.915 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 313' ' ' LYS . 1.7 m -109.01 131.34 55.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.966 0.412 . . . . 0.0 111.774 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 50.5 t -106.16 114.95 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.946 178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 311' ' ' TYR . 3.5 mp -118.3 150.54 39.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.025 0.44 . . . . 0.0 111.885 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.479 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.1 t70 -94.76 131.37 40.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.361 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.583 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 25.1 t80 -85.67 146.91 26.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.759 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 367' ' ' ILE . 75.1 m-20 -140.29 62.86 1.49 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.321 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.583 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 0.0 OUTLIER 29.09 -87.62 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 179.477 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 365' ' ' ASP . 46.2 mm -81.79 -71.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.745 0.307 . . . . 0.0 111.186 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -43.85 164.9 0.03 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.037 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.94 165.61 12.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.935 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.83 134.92 33.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.947 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . 0.427 ' HB2' ' HG3' ' A' ' 302' ' ' MET . 1.8 m-20 -85.8 151.3 23.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.035 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -98.07 111.34 23.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.974 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.419 HG22 HD13 ' A' ' 373' ' ' ILE . 31.3 mt -80.97 -34.08 13.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.086 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.29 -178.96 41.16 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.88 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.471 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 14.7 ptmt -164.59 141.07 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.196 0.522 . . . . 0.0 111.792 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.602 HG21 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -113.78 158.99 13.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.189 179.516 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.423 ' CD2' ' OG ' ' A' ' 382' ' ' SER . 2.8 p90 -141.04 144.77 35.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 0.0 111.266 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 13.5 m -134.87 104.43 5.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.115 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.472 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 169.18 -161.18 34.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.369 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . 0.438 ' CD2' ' O ' ' A' ' 353' ' ' GLN . 0.2 OUTLIER -48.64 170.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.531 0.205 . . . . 0.0 110.749 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 380' ' ' TYR . 2.4 m-80 67.44 -63.1 0.31 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.086 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' SER . . . . . 0.423 ' OG ' ' CD2' ' A' ' 377' ' ' PHE . 0.8 OUTLIER -45.75 165.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.888 0.375 . . . . 0.0 111.355 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 42.9 p -158.09 151.23 23.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 98.93 -143.92 16.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.658 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -57.47 -31.17 65.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.838 0.352 . . . . 0.0 111.307 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -68.09 -52.81 30.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.003 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 20.5 tp -66.13 -31.75 72.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.867 0.365 . . . . 0.0 110.387 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -65.12 -29.69 70.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.456 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.463 ' CD2' HG21 ' A' ' 401' ' ' ILE . 20.3 t-160 -77.99 -53.07 7.84 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.472 ' CD1' ' HA2' ' A' ' 379' ' ' GLY . 55.7 t-105 -51.36 -49.23 61.89 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.177 0.513 . . . . 0.0 109.993 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -29.32 69.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.696 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 0.5 OUTLIER -61.98 -42.54 99.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.672 178.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.425 ' HE2' ' CH2' ' A' ' 390' ' ' TRP . 27.9 ttp -59.53 -52.61 64.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.58 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.403 ' O ' ' HG3' ' A' ' 397' ' ' PRO . 2.9 mt -60.87 -30.01 69.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.361 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.98 -33.02 75.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.218 0.532 . . . . 0.0 109.584 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -126.24 77.9 71.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.278 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.544 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 2.7 Cg_exo -75.79 44.37 1.27 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.238 2.625 . . . . 0.0 113.258 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . 0.544 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 0.4 OUTLIER -158.12 -46.52 0.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.231 179.675 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.452 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.3 OUTLIER -94.15 139.43 22.53 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.721 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.452 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 56.7 Cg_endo -70.48 156.16 62.05 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.548 2.165 . . . . 0.0 113.015 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.463 HG21 ' CD2' ' A' ' 389' ' ' HIS . 1.2 mm -127.02 113.73 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.603 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.24 145.01 32.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.731 0.301 . . . . 0.0 110.801 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.95 154.39 11.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.912 0.386 . . . . 0.0 111.195 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -81.6 120.52 25.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.609 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 49.1 m-70 -108.86 121.87 45.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.427 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.0 m -78.3 116.44 18.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.444 HD23 HG22 ' A' ' 376' ' ' VAL . 96.6 mt -62.45 128.1 34.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.004 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -116.9 171.64 7.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.778 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.455 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 43.5 t -56.57 120.81 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.471 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 19.0 mt-10 -53.73 -43.25 68.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.857 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -57.31 -49.52 75.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 0.0 110.602 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.455 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 30.7 mt-10 -64.55 -39.28 93.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 178.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 74.8 t -58.57 -49.93 80.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.258 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -59.59 -38.32 80.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.2 84.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 51.6 mtm -67.08 -31.02 71.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.921 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 12.6 mt -78.53 -34.8 46.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -63.62 139.08 58.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.071 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.125 179.967 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.868 0.366 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 42.5 mt -98.9 -38.88 8.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 125.17 -160.63 19.77 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.271 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -147.13 131.93 17.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.733 0.301 . . . . 0.0 110.75 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 296' ' ' ALA . 0.0 OUTLIER -119.97 132.2 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.144 0.497 . . . . 0.0 111.174 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.407 ' HB2' ' CE3' ' A' ' 404' ' ' TRP . 0.1 OUTLIER -99.48 126.01 45.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.758 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.617 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.7 p90 -141.94 151.53 42.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.303 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.68 160.75 14.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.987 -178.451 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.487 ' HB3' ' CE ' ' A' ' 393' ' ' MET . 98.2 mt -134.44 144.18 47.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.318 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.409 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 6.4 ttp180 -159.02 111.19 2.18 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.909 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 352' ' ' ILE . 25.1 t80 -104.45 138.85 40.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.977 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.04 94.29 47.37 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.526 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.5 Cg_exo -70.24 -33.86 14.01 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.916 2.411 . . . . 0.0 112.385 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -30.23 5.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.157 0.503 . . . . 0.0 110.019 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.72 -20.0 8.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.985 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.75 48.16 6.8 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.639 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.57 130.27 52.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.008 0.433 . . . . 0.0 111.703 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.401 ' CD1' ' HE3' ' A' ' 393' ' ' MET . 28.7 tp -97.82 147.53 24.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.868 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 12.2 m -138.82 136.67 35.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.272 0.558 . . . . 0.0 112.002 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 11.9 t -129.15 125.36 62.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.372 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 341' ' ' GLU . 24.5 t -119.2 115.34 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.965 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.447 HG23 ' HB2' ' A' ' 339' ' ' TYR . 34.3 mm -74.69 137.02 23.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.444 HD21 ' CE2' ' A' ' 338' ' ' TYR . 0.6 OUTLIER -114.22 -62.22 1.63 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 1.9 pt-20 -175.02 150.27 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.568 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 276' ' ' ILE . . . -109.5 154.65 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.931 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.92 152.42 33.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.045 0.45 . . . . 0.0 111.552 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 61.29 24.19 14.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.853 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 66.5 mt -59.14 141.23 54.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.109 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -63.69 146.4 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.424 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.41 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 17.8 mttt -84.91 116.99 23.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.522 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' MET . . . . . 0.493 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.5 mmt -93.46 -18.89 21.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.488 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 35.7 m-20 -103.98 102.65 12.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.852 0.358 . . . . 0.0 110.573 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.14 116.46 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.445 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 83.98 -4.34 83.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.811 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.53 -149.1 7.23 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.881 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 60.3 mt -107.49 -159.97 0.71 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.01 0.433 . . . . 0.0 110.79 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 334' ' ' THR . 73.4 m -132.9 172.22 12.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.252 0.549 . . . . 0.0 110.725 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.92 57.58 32.71 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 363' ' ' ASP . 74.2 Cg_endo -76.23 143.42 25.29 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.02 2.48 . . . . 0.0 114.901 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.593 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 8.5 p90 -140.48 168.12 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.124 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.455 HG22 HG13 ' A' ' 276' ' ' ILE . 42.5 t -116.36 149.96 18.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.371 0.605 . . . . 0.0 112.508 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -131.0 152.76 49.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.383 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.18 135.09 64.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.763 0.316 . . . . 0.0 110.579 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 79.9 m80 -130.98 132.54 45.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.35 . . . . 0.0 110.994 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.3 tp -105.79 106.67 17.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.407 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.8 mtm -111.58 126.78 55.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.131 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' A' ' 318' ' ' GLN . 0.4 OUTLIER -95.77 99.56 11.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.477 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 59.91 37.76 21.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.706 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.09 21.43 49.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.675 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -121.65 109.65 15.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.745 0.307 . . . . 0.0 110.806 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 10.8 ptt85 -51.25 128.07 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.351 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.415 ' CD1' ' CB ' ' A' ' 318' ' ' GLN . 9.3 mt -123.6 -49.53 1.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -135.03 147.92 49.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . 0.425 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.4 OUTLIER -144.09 120.56 11.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.584 179.616 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -125.5 166.43 16.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.231 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -142.87 149.92 39.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.793 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.422 ' CG2' HG13 ' A' ' 293' ' ' ILE . 20.7 p -104.75 176.52 5.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.029 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.2 p -59.6 162.43 5.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.577 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.593 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.2 mt -105.84 123.88 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 111.434 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -89.16 88.17 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.049 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -55.1 136.3 48.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.987 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 43.91 87.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.311 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 308' ' ' SER . 3.9 t -179.11 174.55 1.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.518 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 308' ' ' SER . 4.7 mt -145.96 -16.91 0.46 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.203 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' ASN . . . . . 0.453 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.5 m-80 -133.46 57.77 28.85 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.774 0.321 . . . . 0.0 110.283 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 53.3 Cg_endo -90.16 167.76 4.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.204 2.602 . . . . 0.0 113.738 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' TYR . . . . . 0.444 ' CE2' HD21 ' A' ' 294' ' ' LEU . 0.5 OUTLIER -110.15 159.07 17.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.305 179.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' TYR . . . . . 0.447 ' HB2' HG23 ' A' ' 293' ' ' ILE . 6.1 m-85 -134.25 -62.29 0.76 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.31 38.65 23.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.669 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 293' ' ' ILE . 32.1 mt-10 -91.91 143.2 26.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.77 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 4.2 m -114.03 119.51 37.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 111.656 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -111.02 153.77 25.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.248 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 73.5 m -128.38 142.29 51.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.012 0.434 . . . . 0.0 111.408 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -130.85 165.87 22.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -114.02 76.22 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 48.2 t -109.04 125.27 31.93 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.017 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.528 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 73.9 Cg_endo -76.67 155.42 35.35 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.499 2.132 . . . . 0.0 111.678 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -50.95 -23.13 2.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.839 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.23 -8.6 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' GLN . . . . . 0.528 ' HB2' ' HG2' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -112.69 -31.69 6.67 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.696 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.498 ' HB ' ' CZ ' ' A' ' 282' ' ' TYR . 4.0 tp -47.98 -27.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 111.134 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -92.14 -20.69 20.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.616 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -99.92 -21.32 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.679 0.276 . . . . 0.0 111.638 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.92 167.88 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.919 0.39 . . . . 0.0 111.222 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . 0.466 ' HA ' ' HA3' ' A' ' 379' ' ' GLY . 4.2 pt20 -148.59 126.95 12.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.028 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.415 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 47.7 t -86.9 114.19 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.637 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.63 109.68 23.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.205 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.59 ' HB ' HG23 ' A' ' 376' ' ' VAL . 26.8 t -93.48 107.76 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.425 ' CG2' ' HB3' ' A' ' 375' ' ' LYS . 11.0 m -109.33 141.08 42.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.91 0.386 . . . . 0.0 111.575 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 311' ' ' TYR . 41.8 t -115.46 120.2 64.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.072 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.452 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.5 mp -124.62 147.21 48.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.058 0.456 . . . . 0.0 111.679 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.493 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.9 OUTLIER -91.96 134.47 34.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.328 179.552 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 365' ' ' ASP . 7.0 t80 -90.83 141.73 28.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.0 110.831 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.463 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 14.0 m-20 -126.16 117.13 22.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.89 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.451 ' HG3' ' CD1' ' A' ' 367' ' ' ILE . 0.0 OUTLIER -34.24 -54.08 0.5 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.955 -179.215 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.451 ' CD1' ' HG3' ' A' ' 366' ' ' LYS . 5.2 mp -100.82 -73.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.364 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -50.79 165.79 0.65 Allowed Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.887 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -68.29 165.68 18.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 110.963 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.21 138.42 47.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.81 149.39 21.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -98.3 110.99 23.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.12 0.486 . . . . 0.0 110.977 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.475 HG22 HD11 ' A' ' 373' ' ' ILE . 43.6 mt -83.44 -34.54 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.192 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.57 175.02 37.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.037 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.44 ' HD2' ' HG2' ' A' ' 410' ' ' GLU . 11.6 ptmt -160.47 140.96 11.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.217 0.532 . . . . 0.0 111.779 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.59 HG23 ' HB ' ' A' ' 359' ' ' VAL . 0.1 OUTLIER -111.61 159.21 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.472 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -143.1 131.98 22.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.985 0.422 . . . . 0.0 111.133 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.435 ' CG1' ' CE1' ' A' ' 405' ' ' HIS . 19.6 m -126.55 100.77 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.045 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.502 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 165.13 -155.0 26.12 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.27 -0.967 . . . . 0.0 113.122 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.27 158.06 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.848 0.356 . . . . 0.0 111.233 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.18 29.99 15.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.236 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 7.2 m -124.96 160.91 27.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.83 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 32.4 p -153.86 148.29 26.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.725 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 96.73 -156.0 20.94 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.477 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -48.34 -32.13 7.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -63.96 -51.14 65.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.173 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 42.0 tp -59.38 -33.95 71.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 0.0 110.582 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 23.6 mtm180 -61.46 -49.34 77.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.343 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.45 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 14.8 t-160 -60.76 -57.93 10.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.792 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' TRP . . . . . 0.502 ' CD1' ' HA2' ' A' ' 379' ' ' GLY . 58.0 t-105 -49.52 -44.29 46.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.05 0.452 . . . . 0.0 110.004 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 4.7 t -68.57 -36.81 79.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.803 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.418 ' HB3' HD13 ' A' ' 401' ' ' ILE . 1.9 t0 -63.08 -36.22 82.85 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.487 ' CE ' ' HB3' ' A' ' 280' ' ' LEU . 10.2 ttm -61.84 -55.09 33.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.189 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.1 mt -60.85 -33.26 72.79 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.331 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.37 -29.81 70.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.276 0.56 . . . . 0.0 109.84 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.9 m-80 -114.97 71.68 2.73 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.596 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.528 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 50.4 Cg_endo -70.47 33.88 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.186 2.59 . . . . 0.0 113.616 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . 0.528 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 23.7 mmm-85 -159.51 -44.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.922 0.391 . . . . 0.0 110.972 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.429 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 1.7 tpp180 -93.96 140.48 22.96 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.455 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.429 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 57.0 Cg_endo -70.43 156.47 61.53 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.742 2.295 . . . . 0.0 112.751 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -128.15 113.45 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.818 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.27 144.46 32.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 110.82 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.67 153.71 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.963 0.411 . . . . 0.0 111.235 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . 0.407 ' CE3' ' HB2' ' A' ' 277' ' ' CYS . 55.8 m95 -83.02 120.01 25.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . 0.617 ' CD2' ' CZ ' ' A' ' 278' ' ' PHE . 45.4 m-70 -108.21 120.82 43.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.576 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 89.2 m -78.36 116.21 18.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.024 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.465 ' CD2' HG21 ' A' ' 376' ' ' VAL . 84.8 mt -62.47 128.2 34.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.288 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -114.82 170.9 7.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.512 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.451 ' HB ' ' HG3' ' A' ' 412' ' ' GLU . 47.0 t -52.71 115.77 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.44 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 4.1 mp0 -54.77 -43.07 72.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.79 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -55.35 -47.55 75.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.802 0.334 . . . . 0.0 110.537 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.451 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 35.2 mt-10 -64.24 -48.71 74.74 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.411 HG13 ' HG3' ' A' ' 375' ' ' LYS . 92.0 t -48.86 -45.41 15.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.771 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -52.99 -38.28 62.11 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.837 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -69.22 -44.28 72.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.749 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -56.96 -31.44 65.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.644 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.84 -33.52 16.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.915 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -56.19 137.67 51.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.262 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.226 -0.893 . . . . 0.0 111.087 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 373' ' ' ILE . 34.8 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.879 0.371 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.92 -162.71 16.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.266 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -144.01 135.41 25.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.77 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.875 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -124.46 128.95 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.097 0.475 . . . . 0.0 110.914 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.875 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -98.03 127.15 43.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.717 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.615 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.5 p90 -141.85 150.26 41.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.012 0.434 . . . . 0.0 110.341 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.62 161.67 13.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.018 -178.603 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.746 HD12 ' CD2' ' A' ' 389' ' ' HIS . 94.8 mt -133.57 143.9 48.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.15 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.94 106.82 1.84 Allowed 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.972 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.918 ' CD1' HD13 ' A' ' 352' ' ' ILE . 25.7 t80 -100.68 137.44 39.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.986 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.61 94.76 48.38 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.547 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 8.1 Cg_exo -69.89 -33.9 15.21 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.937 2.425 . . . . 0.0 112.425 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.51 -30.19 4.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.196 0.522 . . . . 0.0 110.042 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.44 -20.29 8.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.967 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.31 48.65 6.7 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.542 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -124.58 129.8 51.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 0.0 111.792 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.791 HD11 ' HE1' ' A' ' 393' ' ' MET . 33.2 tp -95.42 147.6 23.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.805 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 7.4 m -138.48 134.52 34.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.385 0.612 . . . . 0.0 111.936 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 8.7 t -127.24 123.13 61.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.206 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 341' ' ' GLU . 22.1 t -117.24 114.95 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.912 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.688 HG13 HG21 ' A' ' 328' ' ' THR . 35.9 mm -74.59 136.95 24.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.424 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.02 -60.9 1.82 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.732 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.44 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 0.9 OUTLIER -175.61 157.42 2.05 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.488 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.833 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -117.12 151.73 36.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.773 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -148.08 153.54 39.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.612 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 60.98 23.98 14.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.872 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.833 HD21 ' HB1' ' A' ' 296' ' ' ALA . 50.3 mt -58.92 138.79 57.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.07 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.04 146.9 53.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.504 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.43 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 16.0 mttt -85.41 114.39 22.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.581 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.458 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 9.9 mmm -92.93 -18.81 22.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.729 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 46.7 m-20 -96.17 118.35 32.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.844 0.355 . . . . 0.0 110.635 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.15 116.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.426 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 60.05 16.57 41.14 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.334 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.59 -157.08 9.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.8 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 16.5 mt -100.82 -160.38 0.79 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 110.492 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.542 ' HB2' HD23 ' A' ' 335' ' ' LEU . 15.2 m -135.07 172.03 13.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.239 0.542 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.419 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 8.9 m-20 -133.69 56.36 19.89 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.738 ' CG ' HD13 ' A' ' 299' ' ' LEU . 64.6 Cg_endo -75.39 141.71 25.86 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.044 2.496 . . . . 0.0 114.75 -177.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.568 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 17.1 p90 -139.85 165.31 27.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.424 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.849 HG22 HG22 ' A' ' 361' ' ' VAL . 42.4 t -112.81 149.98 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.822 ' HE2' HD13 ' A' ' 362' ' ' LEU . 6.6 mttm -132.02 151.92 51.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.197 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.469 HG23 HG13 ' A' ' 357' ' ' VAL . 5.2 mp -125.51 133.96 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.763 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.44 125.69 37.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.815 0.34 . . . . 0.0 111.181 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.499 HD23 ' HG3' ' A' ' 324' ' ' LYS . 27.5 tp -96.01 106.68 18.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.312 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.4 mtm -112.68 145.6 40.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 111.467 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.729 ' CG ' HD11 ' A' ' 323' ' ' LEU . 0.9 OUTLIER -99.44 99.73 10.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.066 179.299 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 10.9 p30 42.83 37.45 1.08 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.386 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 104.46 28.85 5.59 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.982 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 317' ' ' MET . 0.2 OUTLIER -136.99 109.38 7.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.725 0.298 . . . . 0.0 110.885 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.407 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.1 OUTLIER -54.13 130.84 39.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.729 HD11 ' CG ' ' A' ' 318' ' ' GLN . 7.6 mt -125.0 -51.66 1.67 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.202 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.499 ' HG3' HD23 ' A' ' 316' ' ' LEU . 2.2 mttt -130.62 153.42 48.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.037 0.446 . . . . 0.0 111.516 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.11 130.5 33.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.431 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.447 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 44.6 mmtt -135.44 160.38 38.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.96 0.409 . . . . 0.0 111.314 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 0.0 OUTLIER -148.68 143.52 26.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.796 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.739 HG22 ' CE1' ' A' ' 343' ' ' PHE . 14.5 p -101.22 176.63 5.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.95 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 10.1 t -56.96 169.88 0.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.504 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.568 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.3 mt -112.39 120.59 62.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.948 0.404 . . . . 0.0 111.465 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.662 ' O ' HG22 ' A' ' 334' ' ' THR . 3.7 mmpt? -82.74 84.59 7.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.762 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.23 135.45 44.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.082 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.3 83.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.39 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.695 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.8 t -176.86 174.08 1.82 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.748 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 334' ' ' THR . 4.3 mt -145.06 -16.33 0.51 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.322 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.49 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 4.9 m-80 -132.9 55.63 18.19 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.863 0.364 . . . . 0.0 110.213 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 51.4 Cg_endo -88.64 167.64 6.02 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.137 2.558 . . . . 0.0 113.636 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.44 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -110.9 160.02 17.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.3 179.181 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.626 ' HB2' HG22 ' A' ' 293' ' ' ILE . 86.6 m-85 -133.45 -63.63 0.75 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 111.325 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 58.36 37.55 25.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.753 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.545 ' O ' HG13 ' A' ' 292' ' ' VAL . 41.9 mt-10 -91.39 142.99 27.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.808 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.94 120.08 40.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.416 . . . . 0.0 111.566 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.739 ' CE1' HG22 ' A' ' 328' ' ' THR . 52.2 m-85 -112.58 146.74 38.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.208 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 18.1 p -118.97 142.2 47.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 0.0 111.457 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.447 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 40.0 m-85 -129.63 165.83 20.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.517 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -116.57 79.81 1.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.512 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.656 HG11 ' HA ' ' A' ' 352' ' ' ILE . 24.7 t -110.11 122.74 37.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.438 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 24.4 Cg_exo -62.19 147.92 94.15 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.51 2.14 . . . . 0.0 111.464 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -53.95 -24.02 15.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 111.336 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -91.64 -8.66 46.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.564 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.431 ' CB ' ' HD2' ' A' ' 348' ' ' PRO . 1.1 tt0 -106.52 -25.54 11.8 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.918 HD13 ' CD1' ' A' ' 282' ' ' TYR . 2.1 tp -48.68 -27.68 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 110.66 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' GLN . . . . . 0.458 HE21 HD22 ' A' ' 394' ' ' LEU . 20.2 mt-30 -90.57 -23.08 20.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.107 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -95.58 -4.83 43.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 31.3 m -106.61 167.77 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.881 0.372 . . . . 0.0 111.306 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -144.49 126.49 15.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.039 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.639 ' O ' HG22 ' A' ' 378' ' ' VAL . 66.8 t -90.83 115.64 30.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.268 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.3 OUTLIER -101.29 116.83 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.755 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.549 ' HB ' HG23 ' A' ' 376' ' ' VAL . 48.3 t -97.33 108.06 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.939 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.96 HG23 ' HB3' ' A' ' 375' ' ' LYS . 6.5 m -110.68 133.81 53.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.027 0.442 . . . . 0.0 111.801 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.849 HG22 HG22 ' A' ' 312' ' ' VAL . 42.9 t -107.57 119.8 57.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.13 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.822 HD13 ' HE2' ' A' ' 313' ' ' LYS . 3.5 mp -121.46 148.0 45.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.978 0.418 . . . . 0.0 111.741 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.458 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 4.1 t70 -92.8 131.97 37.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.358 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -87.97 146.95 25.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.66 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.462 -179.507 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.917 0.389 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.17 151.02 44.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.431 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.836 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -95.89 109.8 22.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 0.0 111.352 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.466 ' O ' HD22 ' A' ' 273' ' ' LEU . 0.9 OUTLIER -73.34 -35.25 45.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.78 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 156.13 179.05 30.88 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.059 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.96 ' HB3' HG23 ' A' ' 360' ' ' THR . 0.0 OUTLIER -160.23 142.32 12.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.363 0.601 . . . . 0.0 112.029 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.913 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -109.22 158.67 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.879 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.591 ' HB3' HG13 ' A' ' 358' ' ' VAL . 19.7 p90 -141.41 141.96 33.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.059 0.457 . . . . 0.0 111.721 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 357' ' ' VAL . 17.1 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.791 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.754 0.311 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.47 -34.62 78.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.569 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 4.5 ptm180 -64.18 -35.78 81.89 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.269 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.746 ' CD2' HD12 ' A' ' 280' ' ' LEU . 18.8 t-160 -67.43 -53.56 28.03 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.163 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.537 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 68.2 t-105 -54.99 -40.62 70.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.017 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -42.13 76.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.989 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 7.7 t0 -59.86 -34.31 72.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.638 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.791 ' HE1' HD11 ' A' ' 289' ' ' LEU . 8.4 ttm -60.36 -56.65 18.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.405 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.768 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.0 OUTLIER -58.82 -29.96 67.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.472 178.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.55 -31.49 70.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.188 0.518 . . . . 0.0 109.942 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -114.29 70.79 2.09 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.639 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.55 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 43.4 Cg_endo -69.08 35.37 0.19 Allowed 'Trans proline' 0 N--CA 1.474 0.364 0 C-N-CA 123.291 2.661 . . . . 0.0 113.642 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 398' ' ' ARG . . . . . 0.55 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 19.8 mmt85 -159.95 -44.35 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.955 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.91 142.17 24.68 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.57 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 58.3 Cg_endo -71.18 156.38 59.48 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.661 2.241 . . . . 0.0 112.953 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -127.74 110.26 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.664 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -103.73 144.36 31.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.844 0.354 . . . . 0.0 110.833 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.25 153.21 11.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.29 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -81.95 120.72 25.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.736 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.913 ' HB3' HG11 ' A' ' 376' ' ' VAL . 60.5 m-70 -111.28 118.37 35.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 85.0 m -78.24 116.7 18.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.946 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.791 HD23 HG22 ' A' ' 376' ' ' VAL . 95.9 mt -61.59 127.35 31.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.313 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -113.42 167.17 10.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.54 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 413' ' ' VAL . 90.5 t -52.58 117.85 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.836 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 8.6 mt-10 -50.48 -45.79 56.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.153 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -55.34 -45.96 76.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 0.0 110.947 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.499 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 16.5 mt-10 -66.71 -38.58 87.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 409' ' ' VAL . 73.4 t -58.39 -48.15 85.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.255 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.537 179.713 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 373' ' ' ILE . 63.8 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.914 0.388 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 118.2 -166.08 12.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.231 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ASP . . . . . 0.533 ' OD1' HG23 ' A' ' 406' ' ' THR . 12.3 m-20 -142.86 132.53 23.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.776 0.322 . . . . 0.0 110.63 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.846 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -120.17 130.75 73.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.163 0.506 . . . . 0.0 111.03 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.846 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.84 124.7 42.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.732 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.659 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 19.1 p90 -141.96 148.22 38.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.436 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 292' ' ' VAL . 0.0 OUTLIER -101.04 160.9 13.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.175 -178.6 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.609 HD12 ' CD2' ' A' ' 389' ' ' HIS . 9.2 mt -133.66 150.25 51.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.03 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -158.81 112.14 2.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.243 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.92 ' CD1' HD13 ' A' ' 352' ' ' ILE . 32.7 t80 -106.14 131.66 53.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.766 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.46 98.04 50.94 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.501 ' CG ' ' CB ' ' A' ' 397' ' ' PRO . 6.4 Cg_exo -71.06 -33.26 12.02 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.673 2.249 . . . . 0.0 112.67 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.2 -29.76 6.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.181 0.515 . . . . 0.0 110.058 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.81 -21.67 8.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.957 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.81 48.78 6.41 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.747 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -124.98 130.05 51.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.994 0.426 . . . . 0.0 111.68 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.469 HD21 ' CG2' ' A' ' 357' ' ' VAL . 30.5 tp -93.79 147.89 22.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.092 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.9 m -135.16 140.66 45.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.305 0.574 . . . . 0.0 112.022 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 18.2 t -134.01 120.91 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.357 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 341' ' ' GLU . 32.3 t -116.19 116.3 51.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.012 0.434 . . . . 0.0 112.057 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.683 HG22 ' HB2' ' A' ' 339' ' ' TYR . 40.1 mm -74.96 135.69 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.649 HD22 ' OE1' ' A' ' 295' ' ' GLU . 0.7 OUTLIER -113.47 -61.89 1.67 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.649 ' OE1' HD22 ' A' ' 294' ' ' LEU . 11.1 pm0 -174.16 148.16 1.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.512 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.808 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -108.38 153.63 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.006 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.84 152.49 33.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.077 0.465 . . . . 0.0 111.488 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.7 m120 61.02 24.75 14.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.808 HD21 ' HB1' ' A' ' 296' ' ' ALA . 60.3 mt -59.66 139.01 57.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.222 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.68 143.77 53.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.404 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.427 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 15.9 mttp -84.61 115.18 22.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.601 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.52 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.6 mmt -90.74 -20.0 22.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.408 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 41.9 m-20 -99.81 123.79 44.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.876 0.369 . . . . 0.0 110.709 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 48.8 t -60.56 118.83 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.215 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 64.0 13.51 53.04 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.718 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.89 -144.46 6.19 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.694 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' A' ' 333' ' ' ASN . 19.9 mt -115.46 -159.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.848 0.356 . . . . 0.0 110.511 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 334' ' ' THR . 5.6 m -138.26 172.01 13.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.314 0.578 . . . . 0.0 110.92 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.96 71.5 77.9 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.616 ' CG ' HD13 ' A' ' 299' ' ' LEU . 95.3 Cg_endo -87.73 143.27 6.07 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.526 2.151 . . . . 0.0 115.351 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.581 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 9.8 p90 -139.49 167.65 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.039 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.802 HG22 HG22 ' A' ' 361' ' ' VAL . 42.7 t -118.0 149.56 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.386 0.612 . . . . 0.0 112.504 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.827 ' HE3' HD13 ' A' ' 362' ' ' LEU . 13.8 mttt -131.09 146.97 52.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.292 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.475 ' N ' HD12 ' A' ' 314' ' ' ILE . 4.6 mp -122.6 131.87 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.622 0.248 . . . . 0.0 111.089 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -130.17 134.89 47.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.93 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 347' ' ' VAL . 26.7 tp -104.14 107.17 17.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.612 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.74 126.67 52.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.904 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.4 OUTLIER -95.16 99.8 11.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.499 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 3.4 m120 60.15 37.92 20.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.727 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.03 22.35 45.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.78 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt -123.85 109.56 13.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.452 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -54.19 130.7 39.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.904 HD11 ' CB ' ' A' ' 318' ' ' GLN . 6.9 mt -126.71 -42.21 1.79 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.234 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -130.6 147.69 52.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.212 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 115.61 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.954 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -124.09 166.51 15.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.48 149.51 30.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.07 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.662 HG21 HG13 ' A' ' 293' ' ' ILE . 21.2 p -106.11 174.05 6.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.736 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.76 174.07 0.37 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.43 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.581 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.7 mt -119.87 118.96 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.051 0.453 . . . . 0.0 111.688 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.732 ' HB3' HG21 ' A' ' 334' ' ' THR . 0.0 OUTLIER -82.57 91.19 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.249 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -56.88 137.21 55.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.885 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' ASN . . . . . 0.51 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.0 OUTLIER 46.85 83.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.592 179.214 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.749 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.5 t -177.2 174.05 1.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.486 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.749 HD23 ' O ' ' A' ' 334' ' ' THR . 4.0 mt -146.17 -16.22 0.45 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.401 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.478 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.9 m-80 -133.97 57.18 22.97 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.486 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 59.2 Cg_endo -90.41 167.74 4.23 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.095 2.53 . . . . 0.0 113.662 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.411 ' CZ ' ' OE1' ' A' ' 295' ' ' GLU . 1.3 t80 -105.26 160.68 14.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.201 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.683 ' HB2' HG22 ' A' ' 293' ' ' ILE . 9.3 m-85 -131.72 -65.38 0.76 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.963 0.411 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 59.11 36.85 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.946 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.559 ' O ' HG13 ' A' ' 292' ' ' VAL . 41.8 mt-10 -93.92 144.79 25.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.78 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 98.5 p -116.56 123.07 46.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 0.0 111.375 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.61 ' CE1' HG22 ' A' ' 328' ' ' THR . 66.0 m-85 -116.35 150.61 37.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.192 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 41.8 p -121.53 143.16 49.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.119 0.485 . . . . 0.0 111.462 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -129.58 164.95 22.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.572 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.71 80.32 1.36 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.637 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 351' ' ' GLN . 71.0 t -113.09 123.77 32.88 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.117 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 351' ' ' GLN . 56.1 Cg_endo -70.69 153.4 64.66 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.491 2.127 . . . . 0.0 111.523 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -51.21 -24.14 4.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.489 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -85.42 -8.6 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.823 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.753 ' O ' HG22 ' A' ' 355' ' ' VAL . 24.5 mt-30 -107.21 -36.79 6.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.653 0.264 . . . . 0.0 111.62 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.92 HD13 ' CD1' ' A' ' 282' ' ' TYR . 6.1 tp -46.45 -27.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.846 0.355 . . . . 0.0 111.118 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.77 -27.79 18.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.678 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 351' ' ' GLN . 14.9 ptmt -109.95 15.67 22.44 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 351' ' ' GLN . 31.1 m -116.09 167.91 8.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.766 0.317 . . . . 0.0 110.64 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' GLN . . . . . 0.408 ' HG3' ' C ' ' A' ' 355' ' ' VAL . 3.0 mt-30 -140.11 138.65 35.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.0 0.429 . . . . 0.0 111.447 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.511 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 91.9 t -104.39 106.96 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.903 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.506 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.3 OUTLIER -91.01 114.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.98 0.419 . . . . 0.0 112.033 -178.73 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.533 ' HB ' HG23 ' A' ' 376' ' ' VAL . 43.9 t -98.73 108.08 21.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.637 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.969 HG23 ' HB3' ' A' ' 375' ' ' LYS . 3.5 m -109.27 136.11 49.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 0.0 111.995 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.802 HG22 HG22 ' A' ' 312' ' ' VAL . 47.2 t -111.1 120.25 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.913 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.827 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.6 mp -122.45 150.22 42.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.032 0.444 . . . . 0.0 111.718 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.52 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.9 t70 -96.4 131.26 43.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.586 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.478 ' HB2' HG21 ' A' ' 330' ' ' ILE . 27.3 t80 -83.96 146.82 27.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.535 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.323 -179.526 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 CA-C-O 120.945 0.403 . . . . 0.0 110.811 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.78 139.94 30.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.54 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -86.91 110.87 20.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.111 0.481 . . . . 0.0 110.899 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.806 ' O ' HD22 ' A' ' 273' ' ' LEU . 33.4 mt -80.34 -34.64 14.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.073 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.22 178.92 39.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.303 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.969 ' HB3' HG23 ' A' ' 360' ' ' THR . 17.2 ptmt -162.75 141.27 8.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.179 0.514 . . . . 0.0 111.604 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.848 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.24 158.77 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.103 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.505 ' HB3' HG13 ' A' ' 358' ' ' VAL . 13.3 p90 -141.77 145.2 34.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.801 0.334 . . . . 0.0 111.039 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 378' ' ' VAL . 20.4 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.166 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.756 0.313 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 48.6 tp -57.56 -36.62 71.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.625 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 5.1 mtp85 -60.6 -46.75 89.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.384 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.609 ' CD2' HD12 ' A' ' 280' ' ' LEU . 18.6 t-160 -61.76 -56.22 21.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.511 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 63.5 t-105 -50.91 -49.64 59.17 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.153 0.501 . . . . 0.0 109.723 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.9 t -65.03 -30.39 71.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.606 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.455 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.6 OUTLIER -62.36 -42.32 99.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.968 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.42 ' CE ' ' CZ3' ' A' ' 390' ' ' TRP . 22.3 ttp -58.66 -55.58 33.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.68 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.807 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.8 mt -59.21 -24.63 63.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.567 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 392' ' ' ASP . . . -67.65 -34.95 77.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -126.96 74.03 76.48 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.466 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.501 ' CB ' ' CG ' ' A' ' 284' ' ' PRO . 8.4 Cg_exo -72.38 50.4 1.59 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.997 2.465 . . . . 0.0 113.032 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' ARG . . . . . 0.485 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 4.5 mmm180 -158.37 -45.69 0.06 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.178 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -94.27 158.48 35.79 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.353 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 90.5 Cg_endo -87.56 138.71 4.63 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.012 2.475 . . . . 0.0 112.815 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.461 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.1 mm -112.14 120.16 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.587 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -112.07 145.23 40.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.758 0.313 . . . . 0.0 110.938 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -163.04 155.26 18.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 0.0 111.349 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -83.13 116.38 22.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.697 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.848 ' HB3' HG11 ' A' ' 376' ' ' VAL . 29.3 m-70 -103.81 120.75 41.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.78 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.533 HG23 ' OD1' ' A' ' 275' ' ' ASP . 86.9 m -78.18 116.44 18.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.226 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.73 HD23 HG22 ' A' ' 376' ' ' VAL . 67.3 mt -61.64 127.44 31.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.218 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -114.16 168.82 9.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.878 ' O ' HG23 ' A' ' 413' ' ' VAL . 61.2 t -55.73 119.93 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.54 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 19.4 mt-10 -53.52 -42.34 67.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.756 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.58 -50.06 74.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.332 . . . . 0.0 110.613 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.462 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.1 mt-10 -64.52 -38.27 90.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 409' ' ' VAL . 81.0 t -59.06 -49.96 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.351 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.926 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.789 HD22 ' O ' ' A' ' 373' ' ' ILE . 68.6 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.983 0.421 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.09 -165.63 13.61 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.036 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ASP . . . . . 0.549 ' OD1' HG23 ' A' ' 406' ' ' THR . 14.6 m-20 -141.94 136.95 30.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.332 . . . . 0.0 110.827 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.893 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -124.11 130.22 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.139 0.495 . . . . 0.0 110.919 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.893 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.2 126.23 42.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.76 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.622 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.7 p90 -142.08 151.19 42.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.331 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.1 OUTLIER -99.67 162.25 13.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.027 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.603 HD12 ' CD2' ' A' ' 389' ' ' HIS . 94.4 mt -134.74 144.15 47.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.085 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.4 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 9.7 ttm180 -159.13 106.55 1.79 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.966 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.896 ' CD1' HD13 ' A' ' 352' ' ' ILE . 28.9 t80 -101.22 137.21 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.845 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 44.9 t -122.31 97.79 44.79 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.524 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.53 -32.62 9.59 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.687 2.258 . . . . 0.0 112.612 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.04 -30.12 5.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.193 0.521 . . . . 0.0 109.919 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.52 -18.95 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.909 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 77.48 48.59 7.95 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.692 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -123.79 130.14 52.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 111.745 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.799 HD11 ' HE1' ' A' ' 393' ' ' MET . 34.8 tp -96.09 147.63 23.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.924 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 343' ' ' PHE . 4.9 m -136.35 138.42 41.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.356 0.598 . . . . 0.0 112.045 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.486 HG21 HG11 ' A' ' 357' ' ' VAL . 17.1 t -131.95 120.97 45.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.312 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 341' ' ' GLU . 30.5 t -116.97 115.56 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.08 0.467 . . . . 0.0 111.938 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.832 HG22 ' HB2' ' A' ' 339' ' ' TYR . 37.0 mm -74.17 136.98 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 277' ' ' CYS . 0.3 OUTLIER -112.44 -61.48 1.72 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.028 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.443 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 0.3 OUTLIER -175.71 151.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.24 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.74 ' HB3' HD11 ' A' ' 299' ' ' LEU . . . -112.48 152.66 28.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.849 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.426 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 7.8 pttt -149.07 152.64 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.478 . . . . 0.0 111.458 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 60.04 27.09 16.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.565 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' ' 296' ' ' ALA . 87.1 mt -63.97 139.21 58.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.951 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -60.59 149.61 34.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.514 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.403 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 8.4 mttp -90.03 119.32 30.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.573 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.508 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.7 mmt -92.26 -17.24 25.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.402 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 54.4 m-20 -99.66 115.77 30.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.849 0.357 . . . . 0.0 110.601 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.58 116.06 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.445 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.09 47.27 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.45 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.6 -156.89 9.35 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.704 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 307' ' ' LEU . 7.9 mt -101.43 -161.05 0.83 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.837 0.351 . . . . 0.0 110.789 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.614 ' HB2' HD23 ' A' ' 335' ' ' LEU . 66.6 m -139.51 172.19 13.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.302 0.573 . . . . 0.0 111.11 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.411 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -129.73 57.49 31.02 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.455 ' CB ' HD13 ' A' ' 299' ' ' LEU . 37.5 Cg_endo -68.29 150.82 76.65 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.146 2.564 . . . . 0.0 114.688 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.571 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 53.0 p90 -154.36 156.7 37.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.249 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.834 HG22 HG22 ' A' ' 361' ' ' VAL . 36.6 t -106.73 149.8 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.834 ' HE3' HD13 ' A' ' 362' ' ' LEU . 12.1 mtmt -130.39 152.81 49.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.253 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.421 ' CG2' HG13 ' A' ' 357' ' ' VAL . 5.4 mp -126.51 133.35 68.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.521 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' A' ' 325' ' ' LYS . 13.3 m80 -129.85 127.35 40.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.143 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.48 HD21 HG22 ' A' ' 347' ' ' VAL . 22.0 tp -100.04 105.1 16.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.453 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.2 mtm -108.06 138.86 43.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.28 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.821 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -100.56 99.58 10.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.364 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.7 m120 57.21 37.36 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.82 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 91.18 28.72 14.17 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.804 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.31 109.58 9.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.762 0.315 . . . . 0.0 110.988 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 13.3 mtm-85 -49.77 128.5 18.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.292 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.821 HD11 ' CB ' ' A' ' 318' ' ' GLN . 11.4 mt -123.31 -49.63 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.232 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -130.59 150.93 51.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.345 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' LYS . . . . . 0.422 ' HA ' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -134.92 132.33 38.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.678 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.461 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 14.5 mmtt -138.25 159.53 41.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.889 0.376 . . . . 0.0 111.133 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -148.15 143.38 27.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.81 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.776 HG22 ' CE1' ' A' ' 343' ' ' PHE . 5.1 p -99.46 178.89 4.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.331 . . . . 0.0 110.689 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.2 t -59.81 162.61 5.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.264 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.571 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -106.27 122.28 59.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.884 0.373 . . . . 0.0 111.273 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.659 ' O ' HG22 ' A' ' 334' ' ' THR . 2.2 mmpt? -85.4 89.86 7.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.075 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -55.39 136.53 49.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.857 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 43.68 84.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.316 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.758 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.9 t -177.21 174.01 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.814 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 334' ' ' THR . 4.4 mt -146.42 -16.27 0.44 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.258 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.0 m-80 -132.24 57.69 31.31 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 120.72 0.295 . . . . 0.0 110.446 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 43.5 Cg_endo -92.4 167.79 2.82 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.26 2.64 . . . . 0.0 113.73 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.438 ' CG ' ' HB3' ' A' ' 295' ' ' GLU . 0.2 OUTLIER -106.99 160.81 15.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.235 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.832 ' HB2' HG22 ' A' ' 293' ' ' ILE . 47.7 m-85 -134.84 -51.62 0.79 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.689 0.281 . . . . 0.0 111.269 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 44.45 36.12 1.56 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.105 0.479 . . . . 0.0 110.975 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.544 ' O ' HG13 ' A' ' 292' ' ' VAL . 28.0 mt-10 -91.02 140.68 29.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 80.6 p -110.85 121.36 45.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.936 0.398 . . . . 0.0 111.667 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.776 ' CE1' HG22 ' A' ' 328' ' ' THR . 82.9 m-85 -111.31 156.65 21.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.01 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 56.5 m -130.91 138.65 49.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.449 . . . . 0.0 111.698 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.461 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 63.8 m-85 -127.91 165.92 19.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.604 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -115.5 79.12 1.25 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.247 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.535 HG13 ' HB3' ' A' ' 351' ' ' GLN . 37.3 t -106.44 123.19 39.58 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.268 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 35.5 Cg_exo -60.28 150.89 77.56 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.576 2.184 . . . . 0.0 111.855 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -57.16 -23.83 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -91.53 -8.59 47.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.491 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.535 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -105.2 -24.41 12.74 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.896 HD13 ' CD1' ' A' ' 282' ' ' TYR . 3.2 tp -53.0 -27.61 13.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 0.0 110.759 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -95.01 3.05 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.378 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -122.27 -20.78 6.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.6 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.652 HG12 ' HG2' ' A' ' 318' ' ' GLN . 34.4 m -87.87 167.9 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 111.483 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -139.92 126.55 20.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.291 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.522 ' CG2' HD21 ' A' ' 289' ' ' LEU . 52.4 t -95.17 103.68 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.099 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.609 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.4 OUTLIER -92.04 115.55 31.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.903 -179.007 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.559 ' HB ' HG23 ' A' ' 376' ' ' VAL . 56.7 t -94.92 108.18 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.463 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' THR . . . . . 1.006 HG23 ' HB3' ' A' ' 375' ' ' LYS . 2.3 m -110.59 134.43 52.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 0.0 112.014 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.834 HG22 HG22 ' A' ' 312' ' ' VAL . 48.6 t -109.58 115.12 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.276 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.834 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.9 mp -118.28 148.61 42.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 111.467 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.508 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.1 OUTLIER -98.43 125.02 43.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -72.45 144.56 48.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.875 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.071 -179.954 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 370' ' ' ASN . . . . . 0.421 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.761 0.315 . . . . 0.0 110.842 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.59 149.33 25.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.3 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.792 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.29 111.49 23.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.789 ' O ' HD22 ' A' ' 273' ' ' LEU . 32.8 mt -79.62 -33.99 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.186 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 169.01 179.2 40.92 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.08 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 1.006 ' HB3' HG23 ' A' ' 360' ' ' THR . 15.6 ptmt -164.56 141.34 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.109 0.481 . . . . 0.0 111.794 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.909 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.67 158.81 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.29 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.549 ' HB3' HG13 ' A' ' 358' ' ' VAL . 6.7 p90 -138.32 140.97 39.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 111.334 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 378' ' ' VAL . 28.0 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.914 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 . . . . . 0 CA--C 1.52 -0.203 0 CA-C-O 120.823 0.344 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.68 -32.56 71.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.269 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.1 OUTLIER -61.54 -41.9 98.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.203 179.513 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.603 ' CD2' HD12 ' A' ' 280' ' ' LEU . 16.5 t-160 -65.43 -58.0 6.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.619 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.488 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 62.9 t-105 -49.71 -44.68 48.4 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.136 0.493 . . . . 0.0 109.927 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.21 -34.29 77.17 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.553 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.465 ' HB3' HD12 ' A' ' 401' ' ' ILE . 1.8 t0 -65.17 -36.39 84.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.8 ' SD ' HD11 ' A' ' 352' ' ' ILE . 14.0 ttm -61.36 -57.57 11.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.119 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.771 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -61.05 -29.25 69.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.439 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.03 73.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.209 0.528 . . . . 0.0 109.843 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -125.46 77.74 68.52 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.374 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.53 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 5.8 Cg_exo -76.98 44.93 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.131 2.554 . . . . 0.0 113.002 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 398' ' ' ARG . . . . . 0.53 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 9.9 mmm180 -159.94 -46.74 0.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.908 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.26 137.4 22.82 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.961 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 56.6 Cg_endo -70.41 156.24 62.07 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.553 2.169 . . . . 0.0 112.747 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.26 117.13 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.971 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -108.82 144.36 36.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.716 0.293 . . . . 0.0 110.731 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -166.49 156.9 12.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.918 0.39 . . . . 0.0 111.376 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' TRP . . . . . 0.426 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 57.9 m95 -84.38 121.48 27.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.84 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.909 ' HB3' HG11 ' A' ' 376' ' ' VAL . 53.4 m-70 -110.09 122.62 48.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.405 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.549 HG23 ' OD1' ' A' ' 275' ' ' ASP . 88.6 m -78.29 118.21 20.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.751 HD23 HG22 ' A' ' 376' ' ' VAL . 67.3 mt -64.02 128.16 34.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.178 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -116.75 169.97 8.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.73 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.893 ' O ' HG23 ' A' ' 413' ' ' VAL . 58.8 t -53.96 119.44 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.792 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 36.8 mt-10 -54.57 -43.67 72.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.993 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -56.33 -47.65 78.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 110.721 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.6 mt-10 -66.54 -38.07 86.37 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 409' ' ' VAL . 57.4 t -60.15 -50.73 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.335 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.167 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.703 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 408' ' ' GLN . 18.3 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.815 0.341 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 119.41 -169.17 13.62 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.255 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ASP . . . . . 0.772 ' OD1' HG23 ' A' ' 406' ' ' THR . 2.8 m-20 -138.76 134.24 33.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.745 0.307 . . . . 0.0 110.818 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.898 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -125.11 130.67 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.2 0.524 . . . . 0.0 111.013 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.898 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -99.11 126.93 44.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.725 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.605 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.4 p90 -142.04 151.83 42.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.324 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.42 161.44 13.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.965 -178.503 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.559 HD12 ' CD2' ' A' ' 389' ' ' HIS . 83.9 mt -135.65 141.74 45.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.486 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -158.94 114.7 2.59 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.856 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.937 ' CD1' HD13 ' A' ' 352' ' ' ILE . 25.0 t80 -105.98 138.87 41.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.64 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.35 97.51 45.0 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.531 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.4 -32.0 10.68 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.552 2.168 . . . . 0.0 112.472 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.6 -29.84 7.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.229 0.538 . . . . 0.0 109.941 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.28 -17.5 8.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.052 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.72 48.44 8.83 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.587 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -123.62 130.45 52.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.441 . . . . 0.0 111.834 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.887 HD11 ' HE1' ' A' ' 393' ' ' MET . 28.7 tp -95.76 147.56 23.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.793 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 3.1 m -137.39 134.29 35.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.331 0.586 . . . . 0.0 112.062 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 3.3 t -127.29 123.67 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.146 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 341' ' ' GLU . 39.7 t -118.17 115.26 47.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.062 0.458 . . . . 0.0 111.848 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.741 HG22 ' HB2' ' A' ' 339' ' ' TYR . 34.2 mm -74.55 137.04 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.437 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.5 OUTLIER -113.86 -60.64 1.86 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.798 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.456 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 2.6 pt-20 -175.63 157.8 2.1 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.296 -0.561 . . . . 0.0 112.448 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.811 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -115.98 154.04 30.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.897 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.0 ptmm? -150.93 151.97 32.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.037 0.446 . . . . 0.0 111.614 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 59.58 23.95 12.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.986 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.811 HD21 ' HB1' ' A' ' 296' ' ' ALA . 55.2 mt -58.14 138.91 55.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.077 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -62.6 144.44 56.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.472 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.426 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 11.2 mttt -83.46 114.63 21.61 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.449 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.451 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 5.8 mmm -93.79 -17.75 22.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.739 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 45.6 m-20 -96.03 117.89 31.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.4 116.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.643 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.39 16.32 35.02 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.423 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.27 -156.26 9.19 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.938 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 307' ' ' LEU . 8.3 mt -100.63 -160.43 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 110.305 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.663 ' HB2' HD23 ' A' ' 335' ' ' LEU . 65.3 m -135.98 171.77 13.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.231 0.539 . . . . 0.0 111.122 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.427 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 5.9 m-20 -134.47 56.5 18.36 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.729 ' CG ' HD13 ' A' ' 299' ' ' LEU . 72.4 Cg_endo -77.27 144.72 23.5 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.886 2.39 . . . . 0.0 115.043 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.548 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 11.3 p90 -139.07 167.9 21.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.185 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 361' ' ' VAL . 47.4 t -114.08 150.08 16.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.432 0.634 . . . . 0.0 112.663 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.656 ' CE ' HD13 ' A' ' 362' ' ' LEU . 7.0 mtmm -134.14 156.79 47.68 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.186 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.625 ' CG2' HG13 ' A' ' 357' ' ' VAL . 5.4 mp -129.96 138.44 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.707 0.289 . . . . 0.0 111.061 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' HIS . . . . . 0.412 ' O ' HG23 ' A' ' 358' ' ' VAL . 2.2 m170 -130.66 121.59 25.83 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.462 HD21 HG22 ' A' ' 347' ' ' VAL . 36.3 tp -87.96 106.78 18.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.804 0.335 . . . . 0.0 110.117 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 31.7 mtp -109.26 128.59 55.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.299 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.793 ' CB ' HD11 ' A' ' 323' ' ' LEU . 7.7 tp60 -104.93 103.31 12.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.991 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ASN . . . . . 0.478 ' HB2' ' NE2' ' A' ' 318' ' ' GLN . 2.5 m120 61.31 37.67 16.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.782 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 83.79 25.04 47.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.565 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -129.3 110.07 11.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 110.847 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -56.68 135.55 55.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.793 HD11 ' CB ' ' A' ' 318' ' ' GLN . 5.7 mt -125.01 -48.13 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.29 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 345' ' ' PHE . 0.4 OUTLIER -130.54 147.22 52.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.961 0.41 . . . . 0.0 111.353 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.39 140.6 52.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.515 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 1.7 mmpt? -139.79 162.61 34.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 0.0 111.153 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.404 ' CB ' ' HG2' ' A' ' 313' ' ' LYS . 0.0 OUTLIER -152.21 149.85 29.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.889 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.713 HG22 ' CE1' ' A' ' 343' ' ' PHE . 15.6 p -110.29 179.47 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.943 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.457 HG23 ' HE3' ' A' ' 331' ' ' LYS . 12.6 t -59.03 167.21 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.518 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.548 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.2 mt -110.74 122.4 65.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.928 0.394 . . . . 0.0 111.338 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.457 ' HE3' HG23 ' A' ' 329' ' ' THR . 9.0 mmpt? -86.95 93.06 9.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.854 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -60.71 136.69 58.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.238 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 43.94 84.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.537 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.568 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.7 t -179.38 171.02 1.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.434 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.663 HD23 ' HB2' ' A' ' 308' ' ' SER . 1.6 mt -140.73 -14.36 0.94 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.495 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.45 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.1 m-80 -133.53 58.52 33.93 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-O 120.692 0.282 . . . . 0.0 110.378 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 52.0 Cg_endo -90.49 167.69 4.16 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.146 2.564 . . . . 0.0 113.686 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.45 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.4 OUTLIER -109.53 160.72 16.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.329 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.741 ' HB2' HG22 ' A' ' 293' ' ' ILE . 63.9 m-85 -133.99 -63.43 0.73 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.826 0.346 . . . . 0.0 111.243 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.15 37.96 26.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.579 ' O ' HG13 ' A' ' 292' ' ' VAL . 31.2 mt-10 -93.3 145.51 24.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.711 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 78.0 p -116.07 121.5 42.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.927 0.394 . . . . 0.0 111.586 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.713 ' CE1' HG22 ' A' ' 328' ' ' THR . 70.2 m-85 -113.05 151.33 30.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.349 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 15.1 m -121.88 138.44 54.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.083 0.468 . . . . 0.0 111.546 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 289' ' ' LEU . 34.2 m-85 -124.36 165.93 16.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.547 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.21 73.55 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.799 HG13 ' HB3' ' A' ' 351' ' ' GLN . 74.1 t -108.01 131.75 21.53 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.159 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 84.4 Cg_endo -82.24 154.94 16.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.778 2.319 . . . . 0.0 111.715 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -51.26 -22.71 2.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.829 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -86.42 -8.6 57.5 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.799 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -112.71 -29.86 7.28 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.596 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.937 HD13 ' CD1' ' A' ' 282' ' ' TYR . 3.9 tp -51.14 -33.67 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.665 0.269 . . . . 0.0 111.034 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -88.47 1.48 54.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.699 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -122.73 -20.65 5.85 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.511 HG23 ' CZ2' ' A' ' 390' ' ' TRP . 36.0 m -91.65 167.99 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.968 0.413 . . . . 0.0 111.386 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.49 127.83 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.775 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.625 HG13 ' CG2' ' A' ' 314' ' ' ILE . 98.9 t -86.86 104.77 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.439 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.5 OUTLIER -90.23 109.67 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.618 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.584 ' HB ' HG23 ' A' ' 376' ' ' VAL . 43.9 t -90.53 108.02 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.788 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.891 HG23 ' HB3' ' A' ' 375' ' ' LYS . 11.8 m -110.96 129.74 55.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 111.949 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 312' ' ' VAL . 48.7 t -104.12 131.0 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.114 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.656 HD13 ' CE ' ' A' ' 313' ' ' LYS . 3.9 mp -129.93 145.6 51.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.925 0.393 . . . . 0.0 111.481 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.451 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 9.1 t70 -90.08 126.81 35.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -79.42 146.97 32.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.562 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.33 . . . . 0.0 111.745 -179.442 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.837 0.351 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.09 157.25 38.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.914 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.466 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.68 109.45 22.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.08 0.467 . . . . 0.0 111.216 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.424 HG21 HD22 ' A' ' 299' ' ' LEU . 2.0 mm -71.4 -35.08 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.941 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' GLY . . . . . 0.407 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 157.47 -174.1 34.93 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.154 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.891 ' HB3' HG23 ' A' ' 360' ' ' THR . 18.2 ptmt -162.47 140.7 8.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.394 0.597 . . . . 0.0 112.058 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.985 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.9 158.9 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.174 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.538 ' HB3' HG13 ' A' ' 358' ' ' VAL . 25.7 p90 -139.54 140.57 37.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.954 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 357' ' ' VAL . 11.5 m . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.474 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.442 0.163 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 26.2 tp -71.32 -35.64 71.3 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.369 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 7.7 ptt180 -62.85 -33.58 75.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.345 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.559 ' CD2' HD12 ' A' ' 280' ' ' LEU . 18.5 t-160 -70.27 -55.44 9.23 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.321 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.585 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 58.4 t-105 -50.12 -45.13 52.68 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.092 0.472 . . . . 0.0 109.907 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.54 -33.21 73.71 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.614 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.47 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.5 OUTLIER -62.11 -39.38 92.29 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.552 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.887 ' HE1' HD11 ' A' ' 289' ' ' LEU . 20.1 ttm -59.18 -53.03 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.978 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.79 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -64.26 -30.7 71.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.244 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.68 -31.56 72.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.184 0.516 . . . . 0.0 109.668 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -125.49 77.92 68.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.337 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.546 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 5.9 Cg_exo -76.87 42.88 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.111 2.541 . . . . 0.0 113.061 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 398' ' ' ARG . . . . . 0.546 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 20.4 mmt180 -158.88 -47.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.093 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.41 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.1 OUTLIER -94.27 140.26 22.74 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.167 -179.341 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.41 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 57.9 Cg_endo -70.73 156.32 61.05 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.677 2.251 . . . . 0.0 112.885 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -127.76 115.35 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.745 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.56 144.44 33.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.808 0.337 . . . . 0.0 111.039 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.5 153.95 11.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.124 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' TRP . . . . . 0.406 ' CZ3' ' HB2' ' A' ' 277' ' ' CYS . 33.4 m95 -81.83 121.75 26.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.906 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.985 ' HB3' HG11 ' A' ' 376' ' ' VAL . 56.7 m-70 -111.98 117.61 33.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.551 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.772 HG23 ' OD1' ' A' ' 275' ' ' ASP . 89.6 m -78.44 116.46 18.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.859 HD23 HG22 ' A' ' 376' ' ' VAL . 95.0 mt -60.53 127.61 32.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.134 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.515 ' C ' HD12 ' A' ' 273' ' ' LEU . 5.2 mt-30 -115.06 168.8 9.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.605 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.825 ' O ' HG23 ' A' ' 413' ' ' VAL . 91.8 t -55.3 120.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.466 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 14.8 mt-10 -52.35 -41.13 62.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.774 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.62 -51.08 71.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.638 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.509 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 19.7 mt-10 -63.76 -38.8 92.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 409' ' ' VAL . 97.5 t -57.36 -49.15 81.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.147 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.471 179.583 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.796 HD22 ' O ' ' A' ' 373' ' ' ILE . 55.5 mt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.36 -166.08 15.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.247 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ASP . . . . . 0.744 ' OD1' HG23 ' A' ' 406' ' ' THR . 27.6 m-20 -142.12 130.7 22.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.897 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.809 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -120.04 131.01 73.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.809 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.5 OUTLIER -99.99 126.02 46.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.898 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.634 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.4 p90 -142.32 152.59 43.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.345 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.49 161.3 13.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.134 -178.573 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.552 HD12 ' CD2' ' A' ' 389' ' ' HIS . 95.4 mt -135.08 142.82 46.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.053 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -158.85 110.89 2.19 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.092 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.842 ' CD1' HD13 ' A' ' 352' ' ' ILE . 22.0 t80 -102.87 139.36 38.55 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.896 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.04 94.18 47.49 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.542 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 8.0 Cg_exo -69.86 -32.72 17.6 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.914 2.41 . . . . 0.0 112.337 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -29.79 8.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.089 0.471 . . . . 0.0 109.96 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.73 -20.22 7.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.073 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.14 48.02 6.7 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.585 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -123.08 129.87 52.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.029 0.443 . . . . 0.0 111.802 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.893 HD11 ' HE1' ' A' ' 393' ' ' MET . 36.6 tp -96.88 147.55 23.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.991 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 8.7 m -138.25 137.01 37.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.444 0.64 . . . . 0.0 111.993 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.7 t -129.88 124.06 57.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.238 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 341' ' ' GLU . 24.5 t -119.69 115.43 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.094 0.473 . . . . 0.0 111.902 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.671 HG13 HG21 ' A' ' 328' ' ' THR . 44.2 mm -74.52 137.2 23.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.17 -58.64 2.12 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 16.8 pt-20 -175.74 162.1 2.65 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.537 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.767 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -119.06 152.41 36.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.647 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.438 ' HD2' ' CH2' ' A' ' 404' ' ' TRP . 0.4 OUTLIER -150.65 150.19 30.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.124 0.488 . . . . 0.0 111.572 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 61.61 24.02 14.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.996 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.767 HD21 ' HB1' ' A' ' 296' ' ' ALA . 53.4 mt -57.7 138.31 55.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 110.796 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.54 129.35 39.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.475 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.449 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 14.9 mttt -63.44 112.11 2.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.279 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' A' ' 371' ' ' ASP . 0.2 OUTLIER -85.06 -19.85 31.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.8 -179.169 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 28.7 m-20 -99.34 117.2 33.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.652 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 23.8 t -50.06 116.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.268 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 63.93 14.12 54.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.428 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -129.03 -159.88 10.09 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.677 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.1 mt -98.13 -162.87 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.792 0.33 . . . . 0.0 110.66 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.521 ' HB2' HD23 ' A' ' 335' ' ' LEU . 13.0 m -135.69 172.02 13.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.38 0.609 . . . . 0.0 111.205 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.422 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -134.16 56.18 17.96 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.829 178.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.712 ' CG ' HD13 ' A' ' 299' ' ' LEU . 66.7 Cg_endo -75.58 142.66 26.43 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.114 2.542 . . . . 0.0 115.034 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.625 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 7.1 p90 -140.57 168.17 20.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.006 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 361' ' ' VAL . 41.3 t -117.02 149.83 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.442 ' CE ' HD13 ' A' ' 362' ' ' LEU . 9.2 mttm -130.7 160.19 35.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.316 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.438 HG23 HG13 ' A' ' 357' ' ' VAL . 5.3 mp -128.82 136.42 59.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.526 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 79.1 m80 -130.83 130.84 44.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.884 0.373 . . . . 0.0 110.987 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 324' ' ' LYS . 41.1 tp -108.94 108.12 18.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.376 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 3.4 mtm -117.79 134.55 54.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.438 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.591 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.0 OUTLIER -95.4 99.62 11.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.414 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.8 m120 59.44 37.69 22.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.08 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 92.73 17.15 45.86 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.181 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 317' ' ' MET . 10.6 mmmm -120.33 109.06 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.841 0.32 . . . . 0.0 110.805 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.39 132.02 38.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.615 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 318' ' ' GLN . 5.0 mt -125.89 -50.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.85 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 12.1 mmtm -130.7 146.04 52.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.959 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' LYS . . . . . 0.417 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -143.5 116.4 8.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.613 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -118.87 168.58 10.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.966 0.412 . . . . 0.0 111.291 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 15.2 ptpt -148.71 145.27 27.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.836 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.671 HG21 HG13 ' A' ' 293' ' ' ILE . 14.4 p -102.15 173.76 6.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.829 0.347 . . . . 0.0 110.924 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.492 HG22 ' OE2' ' A' ' 341' ' ' GLU . 6.3 t -54.68 175.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.675 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.625 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -118.5 124.08 72.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 111.432 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.665 ' O ' HG22 ' A' ' 334' ' ' THR . 0.1 OUTLIER -87.73 87.08 7.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.981 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -54.93 136.21 47.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.96 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 44.81 84.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.401 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 331' ' ' LYS . 4.9 t -178.02 173.66 1.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.784 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.658 HD23 ' O ' ' A' ' 334' ' ' THR . 3.8 mt -144.94 -15.94 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.373 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.433 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.32 57.61 30.61 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.843 0.354 . . . . 0.0 110.106 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 66.3 Cg_endo -86.27 167.62 9.13 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.133 2.555 . . . . 0.0 113.891 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 50.7 t80 -112.48 155.48 24.19 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.95 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.512 ' HB2' HG22 ' A' ' 293' ' ' ILE . 76.0 m-85 -133.2 -71.61 0.52 Allowed 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.817 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ASN . . . . . 0.537 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 24.2 t-20 66.16 37.54 5.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.542 ' O ' HG13 ' A' ' 292' ' ' VAL . 38.4 mt-10 -91.15 142.27 27.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.52 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 94.5 p -112.63 121.7 45.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.023 0.439 . . . . 0.0 111.757 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.671 ' HE1' HG22 ' A' ' 328' ' ' THR . 64.8 m-85 -113.85 148.53 36.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.014 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 52.1 p -122.99 140.47 52.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.043 0.449 . . . . 0.0 111.532 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -129.51 165.85 20.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.493 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -115.78 80.67 1.48 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.416 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.564 HG11 ' HA ' ' A' ' 352' ' ' ILE . 33.3 t -108.19 122.81 39.43 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.287 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.427 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 27.7 Cg_exo -60.84 149.43 88.29 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.578 2.185 . . . . 0.0 111.8 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -55.2 -23.91 24.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.138 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -91.48 -8.7 46.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.522 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.563 ' HB3' HG13 ' A' ' 347' ' ' VAL . 1.4 tt0 -105.53 -25.93 12.11 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.842 HD13 ' CD1' ' A' ' 282' ' ' TYR . 3.1 tp -50.15 -25.66 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.727 0.299 . . . . 0.0 110.874 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -93.45 -17.06 23.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.359 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -102.6 -17.28 15.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.635 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.591 HG12 ' HG2' ' A' ' 318' ' ' GLN . 30.9 m -89.47 168.04 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.827 0.346 . . . . 0.0 111.17 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -142.99 126.36 16.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.282 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.523 ' CG2' HD21 ' A' ' 289' ' ' LEU . 74.2 t -92.16 101.37 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.036 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.7 OUTLIER -89.18 112.04 23.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.863 -178.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.535 HG11 ' CD2' ' A' ' 278' ' ' PHE . 16.2 t -95.57 107.86 20.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.813 HG23 ' HB3' ' A' ' 375' ' ' LYS . 8.7 m -108.31 142.95 37.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 111.697 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 312' ' ' VAL . 60.3 t -118.5 115.77 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.203 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.465 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.7 mp -119.42 149.91 41.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 111.191 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.48 ' HB3' ' SD ' ' A' ' 302' ' ' MET . 0.1 OUTLIER -97.88 131.64 44.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.699 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -80.98 140.84 34.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.683 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.314 -179.666 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 370' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.728 0.299 . . . . 0.0 110.533 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' ASP . . . . . 0.507 ' HB2' ' SD ' ' A' ' 302' ' ' MET . 0.0 OUTLIER -98.01 142.45 29.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.967 0.413 . . . . 0.0 110.685 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.604 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -82.65 122.51 28.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.26 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.796 ' O ' HD22 ' A' ' 273' ' ' LEU . 13.0 mt -82.43 -30.08 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.787 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' GLY . . . . . 0.491 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 169.41 -179.3 42.05 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.74 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.813 ' HB3' HG23 ' A' ' 360' ' ' THR . 17.7 ptmt -164.61 140.93 6.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 111.934 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.821 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.37 158.6 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.098 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.56 ' CD1' HG13 ' A' ' 413' ' ' VAL . 53.0 p90 -143.26 144.37 32.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.849 0.357 . . . . 0.0 111.055 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 378' ' ' VAL . 25.3 m . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.214 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.822 0.344 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 21.3 tp -62.21 -28.19 69.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.549 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -69.06 -32.44 71.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.382 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.552 ' CD2' HD12 ' A' ' 280' ' ' LEU . 20.8 t-160 -78.88 -51.27 9.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.687 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.488 ' CH2' HG23 ' A' ' 357' ' ' VAL . 63.4 t-105 -51.84 -46.9 64.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.042 0.449 . . . . 0.0 110.051 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -33.61 76.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.607 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.478 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.8 OUTLIER -62.48 -38.33 89.42 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.893 ' HE1' HD11 ' A' ' 289' ' ' LEU . 11.5 ttm -61.35 -52.61 63.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.067 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.751 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.4 mt -61.88 -35.88 79.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.407 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.85 -29.64 70.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.205 0.526 . . . . 0.0 109.851 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 398' ' ' ARG . 11.3 m-80 -114.79 71.91 2.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.537 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.542 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 48.2 Cg_endo -70.42 32.9 0.21 Allowed 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.219 2.613 . . . . 0.0 113.552 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' ARG . . . . . 0.527 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 3.1 mmm180 -159.08 -46.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.013 0.435 . . . . 0.0 110.981 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.466 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 17.2 ttp180 -94.03 134.92 25.24 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.352 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.466 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 39.5 Cg_endo -66.41 156.35 65.68 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.7 2.266 . . . . 0.0 112.84 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -126.14 115.93 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.651 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.63 144.38 32.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.791 0.329 . . . . 0.0 110.853 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -166.6 152.1 8.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.16 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' TRP . . . . . 0.438 ' CH2' ' HD2' ' A' ' 297' ' ' LYS . 61.2 m95 -80.34 118.1 21.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.885 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.821 ' HB3' HG11 ' A' ' 376' ' ' VAL . 28.9 m-70 -105.01 117.01 32.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.572 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.744 HG23 ' OD1' ' A' ' 275' ' ' ASP . 88.7 m -78.32 115.42 18.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.781 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.819 HD23 HG22 ' A' ' 376' ' ' VAL . 89.7 mt -60.23 127.12 30.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.359 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.459 ' C ' HD12 ' A' ' 273' ' ' LEU . 4.0 mt-30 -112.94 171.63 7.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.582 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.877 ' O ' HG23 ' A' ' 413' ' ' VAL . 59.0 t -55.8 123.36 6.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.991 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.604 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 6.8 mt-10 -55.32 -42.3 73.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.704 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.16 -50.32 73.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.79 0.329 . . . . 0.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.461 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.2 mt-10 -62.89 -39.42 94.42 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 409' ' ' VAL . 89.4 t -56.08 -48.65 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.372 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.781 HD22 ' O ' ' A' ' 373' ' ' ILE . 42.7 mt . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.804 0.335 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 121.68 -164.54 14.8 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.185 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ASP . . . . . 0.624 ' OD1' HG23 ' A' ' 406' ' ' THR . 30.0 m-20 -143.3 130.94 21.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.812 0.339 . . . . 0.0 110.844 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.783 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -120.34 128.85 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.061 0.458 . . . . 0.0 110.804 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.783 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -96.91 126.53 42.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.948 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.635 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.6 p90 -142.15 150.64 41.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.267 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.3 OUTLIER -99.43 163.21 12.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.281 0.562 . . . . 0.0 112.084 -178.704 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.835 HD12 ' CD2' ' A' ' 389' ' ' HIS . 76.6 mt -133.44 144.26 49.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.213 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 7.8 ttp85 -159.19 106.82 1.79 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.82 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.938 ' CD1' HD13 ' A' ' 352' ' ' ILE . 27.6 t80 -98.25 139.57 33.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.481 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 287' ' ' GLY . 44.4 t -116.14 92.98 37.46 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 16.4 Cg_exo -66.03 -31.8 45.49 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.94 2.426 . . . . 0.0 112.501 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -30.96 62.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.921 0.391 . . . . 0.0 110.751 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -121.54 -12.06 8.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.717 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 74.07 45.53 25.63 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.992 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -120.03 130.06 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 111.464 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.96 HD11 ' HE1' ' A' ' 393' ' ' MET . 33.1 tp -94.3 147.58 23.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.225 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 3.9 m -136.26 137.6 40.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.276 0.56 . . . . 0.0 111.924 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 15.1 t -131.78 121.82 48.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.369 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 341' ' ' GLU . 20.5 t -116.9 115.14 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.967 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.664 HG13 HG21 ' A' ' 328' ' ' THR . 41.6 mm -74.17 137.09 23.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.45 HD22 ' OE1' ' A' ' 295' ' ' GLU . 0.5 OUTLIER -113.38 -58.2 2.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.47 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 0.3 OUTLIER -175.73 164.42 2.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.391 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.777 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -123.94 153.35 41.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.798 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.48 150.93 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.693 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 25.9 m120 61.24 24.32 14.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.915 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.777 HD21 ' HB1' ' A' ' 296' ' ' ALA . 58.9 mt -58.84 138.38 57.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.079 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -61.01 142.79 56.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.492 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.403 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 4.8 mttp -82.0 118.6 23.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.539 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.517 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.5 mmt -93.75 -18.93 21.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.395 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 44.6 m-20 -99.65 117.04 33.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.911 0.386 . . . . 0.0 110.745 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.01 116.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.438 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 61.33 15.41 45.16 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.354 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.34 -156.46 9.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.8 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 307' ' ' LEU . 7.7 mt -100.78 -161.18 0.84 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.847 0.356 . . . . 0.0 110.741 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.633 ' HB2' HD23 ' A' ' 335' ' ' LEU . 58.5 m -138.15 172.13 13.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.313 0.577 . . . . 0.0 111.066 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -131.77 57.73 32.5 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.557 ' CB ' HD13 ' A' ' 299' ' ' LEU . 60.3 Cg_endo -74.33 143.2 31.18 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.987 2.458 . . . . 0.0 114.707 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.547 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 31.6 p90 -143.71 162.16 36.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.363 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 361' ' ' VAL . 39.7 t -109.37 149.9 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.425 0.631 . . . . 0.0 112.461 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.827 ' HE3' HD13 ' A' ' 362' ' ' LEU . 10.5 mtmt -132.38 134.81 45.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.388 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.484 HG23 HG13 ' A' ' 357' ' ' VAL . 4.7 mp -101.43 145.4 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.802 0.334 . . . . 0.0 110.65 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' HIS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 358' ' ' VAL . 0.5 OUTLIER -135.43 133.9 39.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.069 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.0 tp -117.95 109.18 16.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.514 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 0.0 OUTLIER -117.31 148.01 42.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.395 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.545 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.2 OUTLIER -105.74 99.63 9.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.294 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 10.7 m120 59.51 38.15 22.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.082 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.8 10.75 57.45 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.226 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 317' ' ' MET . 4.5 mmtt -117.61 109.33 16.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.878 0.339 . . . . 0.0 110.849 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.66 136.92 54.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.294 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 318' ' ' GLN . 1.7 mt -128.71 -45.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.117 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 148.8 52.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.287 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' LYS . . . . . 0.45 ' CG ' ' CD2' ' A' ' 315' ' ' HIS . 0.5 OUTLIER -142.51 125.61 16.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.456 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.03 165.44 17.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.976 0.417 . . . . 0.0 111.248 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -146.16 142.0 28.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.538 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.669 HG22 ' CE2' ' A' ' 343' ' ' PHE . 5.8 p -98.57 -179.63 4.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.868 0.366 . . . . 0.0 111.026 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.4 p -60.02 159.41 9.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.537 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.2 mt -102.71 122.12 54.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.894 0.378 . . . . 0.0 111.38 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.477 ' HB3' HG21 ' A' ' 334' ' ' THR . 2.3 mmtt -87.4 92.14 8.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.956 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -61.47 136.83 58.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.168 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' ASN . . . . . 0.436 ' C ' HD13 ' A' ' 307' ' ' LEU . 1.0 OUTLIER 44.76 82.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.464 179.055 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.728 ' O ' HD23 ' A' ' 335' ' ' LEU . 3.7 t -175.92 174.37 2.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.791 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.728 HD23 ' O ' ' A' ' 334' ' ' THR . 4.5 mt -144.95 -16.86 0.51 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.264 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.435 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.5 m-80 -132.54 58.87 39.4 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 60.3 Cg_endo -88.26 167.6 6.51 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.174 2.582 . . . . 0.0 113.867 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.483 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 12.6 t80 -107.39 158.03 17.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.907 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.582 ' HB2' HG22 ' A' ' 293' ' ' ILE . 63.7 m-85 -132.37 -71.73 0.53 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.88 0.372 . . . . 0.0 111.28 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' ASN . . . . . 0.483 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 9.6 t-20 63.87 34.98 11.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.019 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.491 ' O ' HG13 ' A' ' 292' ' ' VAL . 37.9 mt-10 -91.15 140.39 29.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.718 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.2 m -111.21 121.32 44.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.97 0.414 . . . . 0.0 111.66 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.669 ' CE2' HG22 ' A' ' 328' ' ' THR . 67.3 m-85 -113.34 148.34 35.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.101 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 23.9 m -127.02 138.21 53.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.028 0.442 . . . . 0.0 111.533 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -127.06 165.82 18.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.596 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -110.44 77.14 1.02 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.719 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.885 HG13 ' HB3' ' A' ' 351' ' ' GLN . 40.5 t -108.04 114.17 60.09 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.983 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.439 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 32.9 Cg_endo -65.49 157.43 58.26 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.338 2.026 . . . . 0.0 111.395 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -51.42 -25.24 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.482 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -85.23 -11.55 54.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.576 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.885 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.6 OUTLIER -102.08 -36.38 8.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.575 0.226 . . . . 0.0 111.187 -179.717 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.938 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.9 tp -50.81 -28.61 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.32 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -95.0 0.82 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.677 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -125.64 -13.83 6.4 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.545 HG12 ' HG2' ' A' ' 318' ' ' GLN . 26.5 m -94.09 166.84 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 111.271 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -143.2 126.38 16.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.518 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 85.9 t -89.09 115.61 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.205 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.616 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.2 OUTLIER -101.54 109.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.584 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.562 ' HB ' HG23 ' A' ' 376' ' ' VAL . 42.9 t -93.69 107.84 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.961 HG23 ' HB3' ' A' ' 375' ' ' LYS . 3.6 m -110.74 134.21 52.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.964 0.412 . . . . 0.0 111.587 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 312' ' ' VAL . 40.9 t -108.19 117.22 53.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.223 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.827 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.4 mp -120.63 148.16 44.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.013 0.435 . . . . 0.0 111.604 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.517 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -96.01 131.95 41.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.46 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 365' ' ' ASP . 8.5 t80 -87.04 142.63 27.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.736 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' ASP . . . . . 0.448 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 22.9 m-20 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.639 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.829 0.347 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -98.94 139.82 34.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.013 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.673 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -87.15 110.84 20.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.176 0.513 . . . . 0.0 110.852 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.781 ' O ' HD22 ' A' ' 273' ' ' LEU . 37.3 mt -79.83 -34.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.285 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' GLY . . . . . 0.542 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 168.71 -178.51 42.09 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.746 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.961 ' HB3' HG23 ' A' ' 360' ' ' THR . 11.0 ptmt -164.83 140.74 5.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.336 0.589 . . . . 0.0 112.275 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.908 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.81 159.15 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.746 178.707 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.622 ' CD1' HG13 ' A' ' 413' ' ' VAL . 27.5 p90 -146.44 131.99 18.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 0.0 111.756 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 378' ' ' VAL . 26.5 m . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.787 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.693 0.282 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 39.5 tp -72.24 -36.09 68.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 0.0 110.298 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 9.8 ptt180 -62.45 -32.04 72.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.235 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.835 ' CD2' HD12 ' A' ' 280' ' ' LEU . 17.7 t-160 -74.26 -52.08 13.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.42 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.518 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 70.0 t-105 -54.91 -45.28 74.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.53 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -37.86 84.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 13.0 t0 -61.2 -35.64 77.72 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.96 ' HE1' HD11 ' A' ' 289' ' ' LEU . 10.9 ttm -59.68 -52.82 63.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.174 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.768 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.3 mt -61.75 -25.83 67.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.964 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -76.72 -44.77 32.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.255 0.55 . . . . 0.0 109.594 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.441 ' HB2' HD11 ' A' ' 401' ' ' ILE . 21.9 m-80 -119.33 64.39 7.6 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.489 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.517 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 5.0 Cg_endo -45.67 -80.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.498 2.799 . . . . 0.0 113.23 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.51 -17.56 2.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.421 ' HB3' ' HB3' ' A' ' 396' ' ' ASN . 0.0 OUTLIER -93.79 116.72 66.83 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.818 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 34.6 Cg_exo -57.5 136.83 78.28 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.472 2.115 . . . . 0.0 112.691 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.47 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.2 mm -116.75 107.38 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.327 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.81 143.62 36.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.858 0.361 . . . . 0.0 110.829 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.52 152.33 10.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.321 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -79.13 116.31 19.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.582 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.908 ' HB3' HG11 ' A' ' 376' ' ' VAL . 33.5 m-70 -102.87 119.88 39.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.685 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.624 HG23 ' OD1' ' A' ' 275' ' ' ASP . 74.4 m -78.33 116.01 18.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.4 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.865 HD23 HG22 ' A' ' 376' ' ' VAL . 93.4 mt -62.38 127.78 32.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.252 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.425 ' C ' HD12 ' A' ' 273' ' ' LEU . 7.2 mt-30 -115.88 172.57 7.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.856 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.887 ' O ' HG23 ' A' ' 413' ' ' VAL . 41.3 t -56.18 121.82 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.002 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.673 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 12.2 mt-10 -54.23 -43.65 71.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.101 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.5 -50.4 73.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.886 0.374 . . . . 0.0 110.795 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.447 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.4 mt-10 -63.38 -37.8 88.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 409' ' ' VAL . 99.6 t -57.61 -48.09 83.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.715 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.777 HD22 ' O ' ' A' ' 373' ' ' ILE . 62.5 mt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.919 0.39 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.63 -163.2 16.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.255 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ASP . . . . . 0.632 ' OD1' HG23 ' A' ' 406' ' ' THR . 8.4 m-20 -143.44 135.87 27.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.71 0.291 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.796 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -123.63 129.43 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.057 0.456 . . . . 0.0 110.822 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.796 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.4 OUTLIER -97.35 124.96 41.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.017 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.606 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 20.3 p90 -142.26 149.73 39.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.802 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.755 ' OG ' ' HB ' ' A' ' 292' ' ' VAL . 16.1 p -110.83 168.0 9.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.197 0.522 . . . . 0.0 111.892 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.553 HD12 ' NE2' ' A' ' 389' ' ' HIS . 1.2 mt -137.67 160.09 40.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.78 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.488 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.9 OUTLIER -159.14 102.47 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.767 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.961 ' CD1' HD13 ' A' ' 352' ' ' ILE . 39.7 t80 -100.14 130.82 46.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.944 0.402 . . . . 0.0 111.878 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.48 97.82 51.16 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.508 ' CG ' ' CB ' ' A' ' 397' ' ' PRO . 6.0 Cg_exo -71.13 -29.93 16.88 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.643 2.229 . . . . 0.0 112.299 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -30.56 11.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.187 0.518 . . . . 0.0 109.774 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.76 -20.83 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.822 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.44 47.17 7.01 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.908 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -123.98 129.66 51.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 111.482 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.404 HD21 ' CG2' ' A' ' 357' ' ' VAL . 33.5 tp -96.36 147.63 23.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.26 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 343' ' ' PHE . 6.0 m -135.28 137.24 42.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.287 0.565 . . . . 0.0 112.003 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.8 t -130.33 123.07 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.412 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.755 ' HB ' ' OG ' ' A' ' 279' ' ' SER . 5.0 t -118.54 116.32 50.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.664 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.652 HG13 HG21 ' A' ' 328' ' ' THR . 44.1 mm -75.65 137.15 23.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.569 HD22 ' OE1' ' A' ' 295' ' ' GLU . 0.8 OUTLIER -114.16 -57.94 2.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.742 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.569 ' OE1' HD22 ' A' ' 294' ' ' LEU . 1.2 pt-20 -175.54 162.43 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.422 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.754 ' CB ' HD11 ' A' ' 299' ' ' LEU . . . -122.33 154.81 37.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.933 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.421 ' HD3' ' CZ3' ' A' ' 404' ' ' TRP . 4.0 ptmt -150.79 150.4 30.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 111.519 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.0 m120 59.62 25.54 14.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.754 HD11 ' CB ' ' A' ' 296' ' ' ALA . 89.3 mt -61.43 138.95 58.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.813 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -58.25 151.48 19.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.546 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.452 ' HE3' HD11 ' A' ' 335' ' ' LEU . 13.7 mttp -91.46 118.13 30.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.547 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.547 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.6 mmt -91.48 -18.57 23.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.341 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 30.6 m-20 -104.46 98.18 7.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.729 0.3 . . . . 0.0 110.408 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.22 114.73 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 111.44 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.95 -3.52 84.68 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.681 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -129.36 -143.17 5.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.87 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.492 HD12 ' HB2' ' A' ' 333' ' ' ASN . 34.6 mt -113.63 -159.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.909 0.385 . . . . 0.0 110.842 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.638 ' HB2' HD23 ' A' ' 335' ' ' LEU . 74.2 m -134.74 172.24 13.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.307 0.575 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.405 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -129.13 58.07 34.59 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.443 ' CB ' HD13 ' A' ' 299' ' ' LEU . 47.6 Cg_endo -70.15 150.64 66.13 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.13 2.554 . . . . 0.0 114.974 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.557 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 51.4 p90 -153.51 156.54 38.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.169 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.888 HG22 HG22 ' A' ' 361' ' ' VAL . 42.7 t -107.6 149.97 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.823 ' HE3' HD13 ' A' ' 362' ' ' LEU . 12.8 mtmt -131.09 139.21 49.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.313 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.411 HD11 ' CG1' ' A' ' 293' ' ' ILE . 5.2 mp -114.77 130.31 69.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.296 . . . . 0.0 110.963 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -126.17 136.76 53.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 0.0 111.042 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.443 HD23 ' HG3' ' A' ' 324' ' ' LYS . 21.8 tp -105.51 105.25 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.594 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 1.4 mtm -107.69 144.18 35.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.716 ' CG ' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -104.38 99.68 9.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.572 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.6 m120 57.68 35.48 25.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.352 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 100.56 11.77 40.18 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.753 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.01 110.73 14.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.377 0.589 . . . . 0.0 110.921 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.401 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.6 OUTLIER -53.82 137.85 37.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.688 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.716 HD11 ' CG ' ' A' ' 318' ' ' GLN . 5.8 mt -126.8 -43.16 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.079 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.443 ' HG3' HD23 ' A' ' 316' ' ' LEU . 0.8 OUTLIER -130.46 151.57 50.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.34 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.0 133.68 41.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.836 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -136.35 160.25 39.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.032 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -147.8 144.22 28.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.825 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.67 HG22 ' CE1' ' A' ' 343' ' ' PHE . 18.0 p -103.78 174.0 6.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.695 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.2 t -55.02 162.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.682 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.557 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.0 mt -108.8 128.55 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.949 0.404 . . . . 0.0 111.245 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.638 ' O ' HG22 ' A' ' 334' ' ' THR . 2.1 mmtt -94.99 93.14 7.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.46 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -57.79 137.38 56.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.693 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' ASN . . . . . 0.492 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.2 p-10 44.79 83.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.401 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.779 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.9 t -175.87 173.33 2.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.685 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 334' ' ' THR . 4.1 mt -146.9 -15.97 0.41 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.264 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.411 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.9 m-80 -131.48 60.26 51.14 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.86 0.362 . . . . 0.0 110.08 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.455 ' HB2' ' HG3' ' A' ' 331' ' ' LYS . 73.5 Cg_endo -86.79 167.59 8.4 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.081 2.521 . . . . 0.0 114.106 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 74.0 t80 -119.95 149.46 42.08 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.605 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -132.46 -67.73 0.64 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.909 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' ASN . . . . . 0.487 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 11.6 t-20 67.85 36.53 3.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.688 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 293' ' ' ILE . 46.3 mt-10 -91.04 135.0 34.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' SER . . . . . 0.519 ' HA ' HG13 ' A' ' 292' ' ' VAL . 1.4 m -104.72 121.69 44.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.836 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.67 ' CE1' HG22 ' A' ' 328' ' ' THR . 60.9 m-85 -109.08 164.72 12.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.891 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 18.3 m -134.7 142.65 46.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.05 0.452 . . . . 0.0 111.73 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.407 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 50.3 m-85 -132.14 162.1 31.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -112.5 77.69 1.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.562 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 351' ' ' GLN . 38.3 t -105.26 122.13 43.98 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.323 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 27.1 Cg_exo -60.85 146.66 97.18 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.571 2.181 . . . . 0.0 111.564 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.44 ' CD1' ' HB3' ' A' ' 284' ' ' PRO . 11.3 t80 -54.08 -23.74 14.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 111.243 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 15.1 pm0 -91.5 -8.59 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.372 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.486 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.1 OUTLIER -104.45 -24.58 13.03 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.961 HD13 ' CD1' ' A' ' 282' ' ' TYR . 1.7 tp -52.4 -32.59 16.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.879 0.371 . . . . 0.0 110.547 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -87.58 3.33 47.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.338 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -124.29 -21.25 5.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.503 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.615 HG12 ' HG2' ' A' ' 318' ' ' GLN . 24.0 m -87.88 166.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.879 0.371 . . . . 0.0 111.285 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -143.47 126.28 16.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.778 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.508 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 64.5 t -88.26 119.55 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.287 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.5 OUTLIER -102.46 111.65 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.74 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 376' ' ' VAL . 46.6 t -97.52 107.91 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.674 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.979 HG23 ' HB3' ' A' ' 375' ' ' LYS . 3.1 m -110.59 134.41 52.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.011 0.434 . . . . 0.0 111.859 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.888 HG22 HG22 ' A' ' 312' ' ' VAL . 55.5 t -108.37 115.02 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.128 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.823 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.8 mp -118.87 150.31 40.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 111.506 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.547 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.4 OUTLIER -97.22 129.94 44.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.638 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -78.99 146.86 33.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.652 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.542 -179.527 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.802 0.334 . . . . 0.0 110.5 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.89 153.64 40.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.522 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.663 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -100.86 111.74 24.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.616 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.777 ' O ' HD22 ' A' ' 273' ' ' LEU . 25.5 mt -79.66 -33.23 14.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.317 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.13 -178.24 41.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.854 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.979 ' HB3' HG23 ' A' ' 360' ' ' THR . 17.1 ptmt -164.66 140.61 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.292 0.568 . . . . 0.0 111.967 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.9 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.77 159.07 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.01 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.437 ' HB3' HG13 ' A' ' 358' ' ' VAL . 9.4 p90 -143.82 131.98 21.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.417 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 378' ' ' VAL . 30.1 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.793 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.417 ' OE1' ' CE1' ' A' ' 377' ' ' PHE . 13.2 mt-10 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.749 0.309 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.0 tp -56.99 -34.44 68.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.58 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 6.0 mtt180 -61.82 -48.52 80.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.359 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.553 ' NE2' HD12 ' A' ' 280' ' ' LEU . 19.6 t-160 -60.27 -57.53 12.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.508 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 65.2 t-105 -51.41 -44.96 62.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.963 0.411 . . . . 0.0 110.203 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.0 t -68.86 -34.79 76.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.932 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 4.4 t0 -62.04 -31.67 72.1 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.458 ' HA ' HG13 ' A' ' 401' ' ' ILE . 5.7 tpt -66.61 -56.42 10.78 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.74 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.825 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.3 mt -58.42 -21.45 50.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.665 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.421 ' C ' ' HD3' ' A' ' 397' ' ' PRO . . . -70.39 -34.08 72.14 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -127.96 70.52 78.03 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.669 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.52 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 11.2 Cg_exo -71.59 51.65 1.52 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.101 2.534 . . . . 0.0 112.954 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' ARG . . . . . 0.52 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 4.7 mmm180 -158.99 -40.89 0.06 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.351 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.417 ' O ' ' HE1' ' A' ' 393' ' ' MET . 0.3 OUTLIER -94.0 160.72 31.73 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.491 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 82.2 Cg_endo -89.87 123.23 1.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.131 2.554 . . . . 0.0 112.664 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.458 HG13 ' HA ' ' A' ' 393' ' ' MET . 1.1 mm -98.38 130.44 47.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.717 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 279' ' ' SER . . . -124.57 146.01 49.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.701 0.286 . . . . 0.0 110.809 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.29 155.78 9.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 111.411 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' TRP . . . . . 0.421 ' CZ3' ' HD3' ' A' ' 297' ' ' LYS . 54.1 m95 -83.63 123.38 29.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.776 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.9 ' HB3' HG11 ' A' ' 376' ' ' VAL . 47.5 m-70 -111.05 119.21 38.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.632 HG23 ' OD1' ' A' ' 275' ' ' ASP . 87.8 m -78.34 116.52 18.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.811 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.836 HD23 HG22 ' A' ' 376' ' ' VAL . 94.9 mt -61.89 127.66 32.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.352 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -114.97 171.59 7.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.561 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 413' ' ' VAL . 60.5 t -54.17 120.25 2.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.663 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 10.6 mt-10 -54.57 -42.37 70.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.879 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -48.87 77.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.36 . . . . 0.0 110.74 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.469 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.5 mt-10 -64.67 -38.84 92.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.349 0.595 . . . . 0.0 109.417 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 375' ' ' LYS . 95.2 t -58.44 -49.27 82.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.544 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.936 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.785 HD22 ' O ' ' A' ' 373' ' ' ILE . 48.4 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.791 0.329 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 117.41 -168.47 12.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.225 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.11 132.42 32.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.707 0.289 . . . . 0.0 110.987 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.821 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -118.58 129.29 75.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.058 0.456 . . . . 0.0 110.964 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.821 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.52 124.87 41.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.828 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.608 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 20.5 p90 -142.3 149.67 39.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.691 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.783 ' OG ' ' HB ' ' A' ' 292' ' ' VAL . 13.2 p -109.78 160.65 16.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.233 0.54 . . . . 0.0 112.214 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.74 HD12 ' CD2' ' A' ' 389' ' ' HIS . 6.8 mt -128.69 153.82 46.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.806 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.418 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 9.8 ttp180 -159.27 107.28 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.86 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.959 ' CD1' HD13 ' A' ' 352' ' ' ILE . 31.3 t80 -99.04 139.48 34.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.721 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 287' ' ' GLY . 60.1 t -116.54 92.83 38.55 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 17.1 Cg_exo -65.14 -30.88 55.28 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.891 2.394 . . . . 0.0 112.322 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -31.54 63.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.732 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.84 -11.9 8.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.637 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 73.5 45.41 29.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.059 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -120.08 130.06 54.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 111.447 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.492 HD21 ' CG2' ' A' ' 357' ' ' VAL . 25.0 tp -94.34 148.02 22.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.381 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 3.6 m -136.82 134.3 36.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.254 0.55 . . . . 0.0 111.903 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.47 HG21 HG11 ' A' ' 357' ' ' VAL . 21.5 t -127.81 122.65 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.363 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.783 ' HB ' ' OG ' ' A' ' 279' ' ' SER . 4.3 t -117.68 115.48 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.758 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.704 HG13 HG21 ' A' ' 328' ' ' THR . 40.8 mm -74.6 137.14 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 277' ' ' CYS . 0.6 OUTLIER -113.45 -58.3 2.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.5 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 11.4 pt-20 -175.72 163.77 2.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.665 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.699 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -125.24 149.01 48.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.677 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.421 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 17.7 pttt -146.17 153.29 40.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.104 0.478 . . . . 0.0 111.549 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.0 m120 60.1 27.1 16.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.621 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.699 HD21 ' HB1' ' A' ' 296' ' ' ALA . 91.7 mt -63.36 138.55 58.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.599 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.71 136.73 53.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.689 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.4 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 7.1 mttt -69.51 123.54 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.185 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 363' ' ' ASP . 0.1 OUTLIER -100.49 -11.58 20.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.687 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 53.1 m-20 -103.05 121.94 43.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.807 0.337 . . . . 0.0 110.284 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -47.02 115.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 111.664 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 57.37 17.27 24.55 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.405 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.97 -160.43 10.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.956 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.491 HD13 ' C ' ' A' ' 333' ' ' ASN . 6.3 mt -94.84 -160.86 0.81 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.449 0.3 . . . . 0.0 110.27 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.66 ' HB2' HD23 ' A' ' 335' ' ' LEU . 67.3 m -136.68 171.86 13.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.344 0.592 . . . . 0.0 111.105 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.448 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -132.12 55.12 16.23 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.819 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 309' ' ' ASP . 35.4 Cg_endo -65.97 149.94 85.85 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.168 2.578 . . . . 0.0 114.551 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.539 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 48.1 p90 -154.18 150.09 27.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.401 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.833 HG22 HG22 ' A' ' 361' ' ' VAL . 39.3 t -101.23 148.96 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.836 ' HE3' HD13 ' A' ' 362' ' ' LEU . 11.7 mtmt -130.33 138.54 50.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.154 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.514 HG23 HG13 ' A' ' 357' ' ' VAL . 5.3 mp -115.66 131.06 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.774 0.321 . . . . 0.0 110.771 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -129.13 133.38 47.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.491 HD21 ' CG2' ' A' ' 347' ' ' VAL . 18.9 tp -106.06 104.97 14.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.638 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 3.5 mtm -106.57 142.79 35.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.747 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.2 OUTLIER -102.21 99.77 9.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.48 179.482 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 58.65 38.3 25.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 92.18 22.52 29.65 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.027 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.5 mtpm? -128.86 109.3 11.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.741 0.305 . . . . 0.0 110.805 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.88 131.59 40.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.26 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.747 HD11 ' CB ' ' A' ' 318' ' ' GLN . 4.9 mt -126.01 -42.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.131 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -130.72 151.32 51.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.502 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 132.1 32.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.582 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.441 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 53.2 mmtt -139.34 155.27 47.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.236 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -141.31 149.47 41.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.72 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.765 HG22 ' CE1' ' A' ' 343' ' ' PHE . 21.2 p -106.17 175.51 5.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.826 0.346 . . . . 0.0 111.031 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -57.24 148.7 21.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.69 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.539 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -92.12 122.49 43.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.514 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.661 ' O ' HG22 ' A' ' 334' ' ' THR . 20.3 mmmt -86.67 85.87 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.016 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.68 139.29 50.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.99 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' ASN . . . . . 0.491 ' C ' HD13 ' A' ' 307' ' ' LEU . 0.9 OUTLIER 42.81 79.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.496 179.009 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.758 ' O ' HD23 ' A' ' 335' ' ' LEU . 5.1 t -173.44 173.48 3.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.165 0.507 . . . . 0.0 110.911 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 334' ' ' THR . 4.0 mt -146.19 -16.09 0.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.186 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.492 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.57 58.5 36.64 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 110.217 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 84.6 Cg_endo -90.39 167.79 4.24 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.175 2.583 . . . . 0.0 114.076 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.524 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 35.9 t80 -114.1 152.48 31.02 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.067 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.495 ' HB2' HG22 ' A' ' 293' ' ' ILE . 2.2 m-85 -130.03 -70.53 0.63 Allowed 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.921 0.391 . . . . 0.0 111.519 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' ASN . . . . . 0.524 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 24.3 t-20 66.67 35.14 5.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.714 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 293' ' ' ILE . 52.1 mt-10 -91.11 133.81 35.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.973 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' SER . . . . . 0.53 ' HA ' HG13 ' A' ' 292' ' ' VAL . 1.2 m -104.07 121.25 42.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.695 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.765 ' CE1' HG22 ' A' ' 328' ' ' THR . 69.2 m-85 -110.08 156.5 20.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.022 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 57.9 p -130.65 140.54 50.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.088 0.47 . . . . 0.0 111.588 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.441 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 62.7 m-85 -128.54 165.91 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.58 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -111.6 78.48 1.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.86 HG13 ' HB3' ' A' ' 351' ' ' GLN . 41.4 t -111.72 117.81 47.96 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.059 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.486 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 48.3 Cg_endo -69.52 157.47 60.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.383 2.055 . . . . 0.0 111.434 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -51.3 -23.02 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -86.7 -10.23 54.19 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.86 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -107.8 -33.16 7.34 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.537 0.208 . . . . 0.0 111.544 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.959 HD13 ' CD1' ' A' ' 282' ' ' TYR . 5.1 tp -49.26 -27.21 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.638 0.256 . . . . 0.0 111.136 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' GLN . . . . . 0.424 HE21 ' HB3' ' A' ' 353' ' ' GLN . 0.0 OUTLIER -95.17 -9.42 33.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.842 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -113.29 -18.62 12.02 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.587 HG12 ' HG2' ' A' ' 318' ' ' GLN . 23.7 m -87.92 167.89 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 111.377 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -143.81 126.34 15.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.824 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.544 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 53.9 t -89.87 104.83 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.497 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.5 OUTLIER -90.69 110.78 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.615 -179.293 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 376' ' ' VAL . 44.3 t -93.81 107.85 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.981 HG23 ' HB3' ' A' ' 375' ' ' LYS . 5.2 m -111.55 131.77 55.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 0.0 111.968 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.833 HG22 HG22 ' A' ' 312' ' ' VAL . 42.5 t -105.03 119.47 54.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.163 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.836 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.5 mp -124.73 147.61 48.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.134 0.492 . . . . 0.0 111.797 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.455 ' HB3' ' SD ' ' A' ' 302' ' ' MET . 3.4 t70 -91.13 129.87 37.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.012 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.462 ' CB ' HG21 ' A' ' 330' ' ' ILE . 21.7 t80 -79.63 141.95 36.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.232 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.496 -179.442 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 370' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.91 0.386 . . . . 0.0 110.834 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -72.68 145.01 47.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.291 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.711 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -101.1 112.44 24.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.135 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.785 ' O ' HD22 ' A' ' 273' ' ' LEU . 12.3 mt -79.98 -33.37 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.336 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 166.35 179.21 39.57 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.945 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.981 ' HB3' HG23 ' A' ' 360' ' ' THR . 13.3 ptmt -161.2 140.37 10.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.24 0.543 . . . . 0.0 112.075 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.913 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -111.84 159.06 12.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.21 179.324 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.468 ' HB3' HG13 ' A' ' 358' ' ' VAL . 14.8 p90 -142.98 135.17 27.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 0.0 111.546 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 378' ' ' VAL . 18.8 m . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.986 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.527 0.203 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.02 -32.42 69.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.571 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 31.7 mtt180 -63.55 -50.88 67.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.619 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.74 ' CD2' HD12 ' A' ' 280' ' ' LEU . 16.2 t-160 -56.82 -54.14 49.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.544 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 61.1 t-105 -54.06 -50.67 66.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.091 0.472 . . . . 0.0 110.335 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.4 t -63.69 -34.94 78.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.345 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 8.2 t0 -62.74 -36.57 83.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.047 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.762 ' CE ' HD11 ' A' ' 352' ' ' ILE . 31.2 ttp -62.96 -55.32 26.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.724 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.796 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -57.52 -24.68 57.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.662 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -79.94 -37.75 33.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.299 0.571 . . . . 0.0 109.526 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 399' ' ' ARG . 13.6 m-80 -126.82 60.99 43.61 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.646 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.523 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 3.9 Cg_endo -45.11 -79.32 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.791 2.994 . . . . 0.0 113.266 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -48.51 -21.8 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.126 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' A' ' 396' ' ' ASN . 1.1 tpt180 -93.73 126.71 48.59 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.826 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.34 131.39 21.72 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.46 2.106 . . . . 0.0 112.547 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.456 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.1 mm -110.46 112.06 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.093 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 279' ' ' SER . . . -108.95 145.65 35.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.687 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.95 152.7 6.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.927 0.394 . . . . 0.0 111.322 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' TRP . . . . . 0.43 ' CH2' ' HG3' ' A' ' 295' ' ' GLU . 64.2 m95 -80.89 118.74 22.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.823 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.913 ' HB3' HG11 ' A' ' 376' ' ' VAL . 46.3 m-70 -107.17 119.77 40.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 86.6 m -78.29 116.26 18.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.091 0.472 . . . . 0.0 110.961 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.832 HD23 HG22 ' A' ' 376' ' ' VAL . 94.9 mt -61.75 127.55 31.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.28 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -114.42 171.9 7.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.491 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 413' ' ' VAL . 57.1 t -54.58 115.65 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.711 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 3.6 mp0 -52.05 -41.16 62.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.803 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -57.21 -48.91 77.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 110.622 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.467 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 24.4 mt-10 -65.04 -39.91 94.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.845 HG11 ' HG3' ' A' ' 375' ' ' LYS . 70.5 t -59.5 -49.54 83.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.158 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.741 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.716 HD22 ' O ' ' A' ' 373' ' ' ILE . 44.6 mt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.896 0.379 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.12 -159.63 16.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.192 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ASP . . . . . 0.52 ' OD1' HG23 ' A' ' 406' ' ' THR . 28.3 m-20 -148.17 131.12 16.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.787 0.327 . . . . 0.0 110.56 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.898 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -120.63 130.14 74.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 110.935 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.898 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.21 126.22 42.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.736 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.619 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.5 p90 -141.94 149.33 39.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.321 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.0 OUTLIER -99.75 159.37 15.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.045 -178.62 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.606 HD13 ' HE3' ' A' ' 393' ' ' MET . 85.2 mt -130.49 144.99 51.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.855 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.406 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 7.2 ttm180 -158.86 103.94 1.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.781 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.905 ' CD1' HD13 ' A' ' 352' ' ' ILE . 27.8 t80 -99.22 138.86 35.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.241 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.8 t -123.55 94.59 46.16 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.394 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.537 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.15 -32.57 16.71 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.927 2.418 . . . . 0.0 112.325 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.53 -29.8 7.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.176 0.512 . . . . 0.0 110.07 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.95 -21.1 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.117 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 81.06 48.03 6.26 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.538 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -123.76 129.32 50.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.058 0.456 . . . . 0.0 111.626 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.711 HD11 ' HE1' ' A' ' 393' ' ' MET . 33.7 tp -96.08 147.74 23.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.9 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 2.6 m -136.05 135.99 39.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.319 0.58 . . . . 0.0 111.998 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.43 118.19 44.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.12 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 341' ' ' GLU . 23.1 t -113.92 115.74 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.058 0.456 . . . . 0.0 111.961 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.718 HG22 ' HB2' ' A' ' 339' ' ' TYR . 34.2 mm -74.75 137.02 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.49 -60.34 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 4.9 pt-20 -175.73 155.89 1.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.357 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.771 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -112.03 153.3 27.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.724 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -150.95 150.71 31.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.148 0.499 . . . . 0.0 111.614 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 61.38 22.74 13.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.005 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.782 HD13 ' CG ' ' A' ' 310' ' ' PRO . 52.0 mt -57.8 138.46 55.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.109 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -64.09 149.88 46.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.502 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.507 ' HE3' HD11 ' A' ' 335' ' ' LEU . 11.1 mttt -88.32 116.22 26.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.54 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.427 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 9.0 mmm -95.93 -19.98 19.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.486 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 48.6 m-20 -91.91 121.57 33.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.543 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -48.35 115.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.648 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 56.17 18.56 20.81 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.304 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.42 -157.74 9.75 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.005 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 307' ' ' LEU . 7.0 mt -98.53 -161.38 0.87 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.781 0.324 . . . . 0.0 110.529 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.54 ' HB2' HD23 ' A' ' 335' ' ' LEU . 15.1 m -134.91 171.89 13.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.246 0.546 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.422 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -135.16 56.61 16.91 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.782 ' CG ' HD13 ' A' ' 299' ' ' LEU . 73.7 Cg_endo -77.57 143.68 21.78 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.963 2.442 . . . . 0.0 114.805 -177.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.575 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 10.6 p90 -138.8 166.94 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.242 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.802 HG22 HG22 ' A' ' 361' ' ' VAL . 24.4 t -112.73 149.96 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.665 ' CE ' HD13 ' A' ' 362' ' ' LEU . 7.0 mttm -133.97 144.05 48.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.871 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.478 HD11 HD11 ' A' ' 293' ' ' ILE . 5.4 mp -118.86 124.09 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 111.201 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -117.98 130.98 56.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.597 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.567 ' HG ' HD12 ' A' ' 323' ' ' LEU . 22.5 tp -102.82 104.64 14.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 0.0 OUTLIER -127.59 129.09 46.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.408 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.764 ' HB3' HG12 ' A' ' 355' ' ' VAL . 1.2 pt20 -105.53 103.15 12.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 110.372 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 318' ' ' GLN . 83.2 m-20 71.15 36.43 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.199 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 82.12 21.22 61.3 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.175 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.6 mtpm? -113.34 109.07 18.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.837 0.318 . . . . 0.0 110.628 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -56.92 127.2 30.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.221 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.757 HD11 ' HG2' ' A' ' 318' ' ' GLN . 11.9 mt -122.7 -56.01 1.79 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.914 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.506 ' HB2' ' HE2' ' A' ' 345' ' ' PHE . 11.7 mttp -137.85 153.98 49.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.944 0.402 . . . . 0.0 111.256 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.57 129.42 20.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.435 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.407 ' HD3' ' CD2' ' A' ' 343' ' ' PHE . 1.2 mttt -127.37 167.88 15.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 111.269 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.55 144.87 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.713 HG22 ' CE1' ' A' ' 343' ' ' PHE . 17.3 p -104.21 178.35 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 7.2 p -57.52 176.5 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.502 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.575 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.4 mt -118.21 118.39 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.97 0.414 . . . . 0.0 111.329 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.645 ' O ' HG22 ' A' ' 334' ' ' THR . 8.8 mmtt -82.95 84.86 7.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.978 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -55.96 136.86 51.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.015 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.45 82.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.294 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.698 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.9 t -176.45 173.86 2.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.725 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 334' ' ' THR . 4.3 mt -145.13 -16.31 0.5 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.219 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.487 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.6 m-80 -132.9 56.05 20.3 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 120.796 0.332 . . . . 0.0 110.117 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 55.8 Cg_endo -88.32 167.67 6.43 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.199 2.599 . . . . 0.0 113.79 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.435 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 1.1 t80 -107.04 160.83 15.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.327 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.718 ' HB2' HG22 ' A' ' 293' ' ' ILE . 70.9 m-85 -134.01 -64.49 0.7 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.865 0.364 . . . . 0.0 111.075 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 56.99 36.95 28.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.976 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.529 ' O ' HG13 ' A' ' 292' ' ' VAL . 47.5 mt-10 -92.97 142.13 27.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.778 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 12.7 m -114.0 120.56 41.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.44 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.713 ' CE1' HG22 ' A' ' 328' ' ' THR . 79.4 m-85 -112.97 153.42 28.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.252 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 9.7 m -123.74 137.73 54.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.152 0.501 . . . . 0.0 111.675 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.506 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 32.2 m-85 -120.88 165.96 14.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.584 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -116.43 72.43 0.82 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.85 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.92 HG13 ' HB3' ' A' ' 351' ' ' GLN . 40.0 t -108.97 117.53 53.53 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.236 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 38.4 Cg_endo -67.61 153.33 76.53 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.113 1.875 . . . . 0.0 111.104 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -48.19 -24.58 1.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.38 -18.02 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.925 0.342 . . . . 0.0 111.925 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.92 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.1 OUTLIER -96.0 -36.56 11.0 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.905 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.3 tp -48.36 -27.12 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 111.243 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -89.16 -17.77 28.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.987 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 351' ' ' GLN . 0.0 OUTLIER -119.06 10.52 12.16 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.764 HG12 ' HB3' ' A' ' 318' ' ' GLN . 31.0 m -108.36 167.71 3.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -141.22 126.45 18.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.922 0.392 . . . . 0.0 111.224 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.516 ' CG2' HD21 ' A' ' 289' ' ' LEU . 85.4 t -97.25 117.66 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.13 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.632 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.2 OUTLIER -105.22 116.13 48.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.085 -178.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.544 ' HB ' HG23 ' A' ' 376' ' ' VAL . 47.7 t -94.66 107.77 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.976 HG23 ' HB3' ' A' ' 375' ' ' LYS . 5.2 m -109.76 134.74 51.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.062 0.458 . . . . 0.0 111.993 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.802 HG22 HG22 ' A' ' 312' ' ' VAL . 47.5 t -110.88 118.88 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.237 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.665 HD13 ' CE ' ' A' ' 313' ' ' LYS . 3.7 mp -119.8 143.49 47.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.975 0.417 . . . . 0.0 111.43 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.427 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 3.4 t70 -90.37 126.44 35.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.716 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -81.94 141.82 32.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.782 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.983 -179.963 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 370' ' ' ASN . . . . . 0.503 ' ND2' ' N ' ' A' ' 370' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.775 0.322 . . . . 0.0 110.907 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.01 157.28 20.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.714 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -100.9 111.29 23.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.076 0.465 . . . . 0.0 111.269 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.716 ' O ' HD22 ' A' ' 273' ' ' LEU . 1.4 mm -75.61 -35.64 32.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.817 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' GLY . . . . . 0.521 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 157.29 -174.6 34.81 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.44 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.976 ' HB3' HG23 ' A' ' 360' ' ' THR . 15.9 ptmt -164.31 141.03 6.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.195 0.521 . . . . 0.0 111.851 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.952 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -111.93 158.63 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.167 179.31 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.632 ' HB3' HG13 ' A' ' 358' ' ' VAL . 5.4 p90 -142.1 148.25 38.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.006 0.431 . . . . 0.0 111.593 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 19.8 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.857 179.933 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.736 0.303 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 32.9 tp -57.12 -36.57 70.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.67 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 2.6 mtt180 -59.11 -44.77 92.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.129 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.471 ' CD2' HD12 ' A' ' 280' ' ' LEU . 16.6 t-160 -59.95 -57.43 12.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.93 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.516 ' CZ3' ' HE1' ' A' ' 393' ' ' MET . 71.3 t-105 -50.51 -46.43 57.15 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.174 0.512 . . . . 0.0 109.954 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.6 t -67.04 -33.44 75.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.597 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.531 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.8 OUTLIER -64.65 -38.0 89.49 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.565 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.756 ' SD ' HD11 ' A' ' 352' ' ' ILE . 7.6 ttm -62.21 -53.61 52.73 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.88 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.704 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.6 mt -61.64 -35.9 79.24 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.338 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.1 -29.55 69.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.865 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.407 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.3 m-80 -114.28 71.48 2.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.66 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.537 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 52.6 Cg_endo -70.28 32.88 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.249 2.633 . . . . 0.0 113.594 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 398' ' ' ARG . . . . . 0.515 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 16.5 mmm180 -159.33 -44.31 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.979 0.419 . . . . 0.0 110.854 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.444 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.0 OUTLIER -93.92 136.95 23.27 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.314 -178.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 58.9 Cg_endo -71.34 156.46 58.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.52 2.147 . . . . 0.0 112.814 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.531 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.89 116.92 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.61 144.1 35.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.702 0.287 . . . . 0.0 110.822 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.56 153.09 10.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.972 0.415 . . . . 0.0 111.388 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' TRP . . . . . 0.414 ' CH2' ' HG3' ' A' ' 295' ' ' GLU . 59.0 m95 -82.24 118.71 23.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.952 ' HB3' HG11 ' A' ' 376' ' ' VAL . 55.9 m-70 -106.74 123.68 48.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.52 HG23 ' OD1' ' A' ' 275' ' ' ASP . 88.6 m -78.29 118.56 20.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.783 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.736 HD23 HG22 ' A' ' 376' ' ' VAL . 58.7 mt -64.5 127.98 33.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.102 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.483 ' C ' HD12 ' A' ' 273' ' ' LEU . 7.2 mt-30 -117.9 170.89 8.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.893 ' O ' HG23 ' A' ' 413' ' ' VAL . 60.8 t -55.64 119.91 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.863 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.469 ' CG ' ' HD2' ' A' ' 375' ' ' LYS . 26.9 mt-10 -53.74 -42.54 68.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.969 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -49.36 76.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.759 0.314 . . . . 0.0 110.64 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.464 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 22.2 mt-10 -65.06 -37.96 89.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 409' ' ' VAL . 63.8 t -59.33 -50.18 80.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.463 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.776 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.505 HD12 ' C ' ' A' ' 408' ' ' GLN . 18.7 mt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.846 0.355 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 114.31 -166.38 12.15 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.319 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.26 132.48 23.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.722 0.296 . . . . 0.0 110.771 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.834 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -121.78 131.51 72.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.074 0.464 . . . . 0.0 111.043 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.834 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -98.84 125.42 44.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.938 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.611 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.7 p90 -142.11 150.47 41.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.439 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -103.75 161.17 14.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.395 0.617 . . . . 0.0 112.356 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.602 HD12 ' CD2' ' A' ' 389' ' ' HIS . 10.9 mt -133.39 150.26 51.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.857 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.8 106.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.928 0.395 . . . . 0.0 111.362 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.901 ' CD1' HD13 ' A' ' 352' ' ' ILE . 27.7 t80 -99.93 138.12 37.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.211 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.29 95.03 46.11 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.431 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.506 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.24 -32.13 17.12 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.853 2.369 . . . . 0.0 112.238 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -30.65 7.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.155 0.502 . . . . 0.0 109.887 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.34 -20.55 8.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.918 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.15 48.24 6.57 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.565 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -123.86 129.97 51.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.842 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.438 HD21 ' CG2' ' A' ' 357' ' ' VAL . 40.6 tp -95.67 147.54 23.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.968 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 343' ' ' PHE . 5.4 m -137.85 140.16 40.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.551 . . . . 0.0 111.98 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.462 HG21 HG11 ' A' ' 357' ' ' VAL . 23.6 t -132.49 125.33 53.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.451 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 341' ' ' GLU . 21.7 t -118.68 115.41 47.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.904 0.383 . . . . 0.0 111.997 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 314' ' ' ILE . 38.7 mm -74.51 136.99 24.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.56 -58.62 2.12 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.429 ' HG3' ' CH2' ' A' ' 404' ' ' TRP . 8.7 pt-20 -175.59 162.01 2.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.139 -0.625 . . . . 0.0 112.335 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.787 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -118.43 153.58 33.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.764 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.435 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 11.8 pttt -150.93 148.52 28.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.11 0.481 . . . . 0.0 111.705 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 60.65 23.85 13.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.067 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.787 HD21 ' HB1' ' A' ' 296' ' ' ALA . 52.1 mt -56.88 138.09 54.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.083 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 143.33 51.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.322 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.431 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 35.3 mttt -85.14 108.39 17.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.644 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.515 ' HG2' ' HB3' ' A' ' 363' ' ' ASP . 0.0 OUTLIER -83.02 -20.94 34.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.958 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 56.0 m-20 -96.16 116.25 28.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.838 0.351 . . . . 0.0 110.718 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.3 t -49.95 116.11 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.444 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 63.26 14.28 53.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.419 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.32 -156.75 9.22 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.79 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.7 mt -100.8 -162.26 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.658 ' HB2' HD23 ' A' ' 335' ' ' LEU . 67.3 m -135.61 172.07 13.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.139 0.495 . . . . 0.0 110.927 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.423 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -133.73 56.02 18.33 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.708 ' CG ' HD13 ' A' ' 299' ' ' LEU . 72.8 Cg_endo -77.11 147.08 26.06 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.88 2.387 . . . . 0.0 114.969 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.562 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 11.5 p90 -141.53 167.74 21.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.069 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.926 HG22 HG22 ' A' ' 361' ' ' VAL . 29.4 t -116.89 148.18 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.844 ' HE3' HD13 ' A' ' 362' ' ' LEU . 17.3 mttt -129.84 157.13 43.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.968 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 293' ' ' ILE . 5.3 mp -132.74 128.48 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.647 0.261 . . . . 0.0 110.819 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -126.4 138.46 53.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.887 0.375 . . . . 0.0 111.077 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.448 ' HB2' ' CE2' ' A' ' 345' ' ' PHE . 29.7 tp -99.36 108.38 20.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -107.45 121.11 43.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.162 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.954 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -92.24 100.17 12.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 57.84 38.37 27.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.834 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.01 28.84 24.69 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.668 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.24 109.48 9.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.357 . . . . 0.0 110.918 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -53.31 129.65 32.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.155 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.954 HD11 ' CB ' ' A' ' 318' ' ' GLN . 10.5 mt -123.52 -46.06 2.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.063 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -130.56 151.37 51.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.85 132.79 40.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.763 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -136.97 156.52 48.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.881 0.372 . . . . 0.0 111.117 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 0.5 OUTLIER -146.87 143.85 28.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.9 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.643 HG21 HG13 ' A' ' 293' ' ' ILE . 13.7 p -101.49 177.46 4.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.757 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 11.1 t -59.49 166.14 2.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.582 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.562 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 5.5 mt -108.15 130.21 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.005 0.431 . . . . 0.0 111.246 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.629 ' O ' HG22 ' A' ' 334' ' ' THR . 22.3 mmmt -97.67 89.92 4.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.378 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -57.57 137.58 56.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.756 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 44.9 85.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.366 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.759 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.5 t -176.72 173.47 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.696 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.759 HD23 ' O ' ' A' ' 334' ' ' THR . 4.6 mt -147.14 -16.1 0.4 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.425 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.2 m-80 -134.07 58.94 34.68 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.817 0.341 . . . . 0.0 110.158 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.461 ' HB2' ' HG3' ' A' ' 331' ' ' LYS . 80.9 Cg_endo -86.63 167.59 8.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.076 2.517 . . . . 0.0 113.952 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 68.1 t80 -116.86 152.04 35.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.995 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.425 ' HB2' HG22 ' A' ' 293' ' ' ILE . 92.9 m-85 -133.19 -68.73 0.57 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 340' ' ' ASN . . . . . 0.519 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 14.5 t-20 66.24 38.29 4.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.812 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 292' ' ' VAL . 52.0 mt-10 -91.02 141.9 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.663 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 85.5 p -110.09 121.92 46.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 111.662 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.638 ' CE1' HG22 ' A' ' 328' ' ' THR . 58.0 m-85 -111.71 163.1 14.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.032 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 13.2 m -133.8 145.14 49.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.139 0.495 . . . . 0.0 111.643 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' A' ' 316' ' ' LEU . 35.1 m-85 -131.26 165.79 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.436 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -114.57 79.45 1.27 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.006 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.901 HG13 ' HB3' ' A' ' 351' ' ' GLN . 50.4 t -115.27 123.58 31.43 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.352 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.524 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 73.8 Cg_endo -75.2 158.91 41.17 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.529 2.153 . . . . 0.0 111.376 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -51.37 -21.13 2.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -90.66 -8.68 49.35 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.901 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.6 OUTLIER -111.75 -27.23 8.59 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.901 HD13 ' CD1' ' A' ' 282' ' ' TYR . 5.7 tp -47.47 -28.66 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -95.09 -25.14 16.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -91.45 -4.91 55.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.872 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 351' ' ' GLN . 31.4 m -108.92 167.84 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 111.388 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -144.73 126.44 15.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.655 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.556 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 58.9 t -87.17 109.41 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.379 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.6 OUTLIER -94.63 111.85 26.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.15 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.521 ' HB ' HG23 ' A' ' 376' ' ' VAL . 39.7 t -95.62 107.87 20.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.769 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.973 HG23 ' HB3' ' A' ' 375' ' ' LYS . 6.3 m -109.39 139.32 44.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.064 0.459 . . . . 0.0 111.845 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.926 HG22 HG22 ' A' ' 312' ' ' VAL . 59.9 t -115.56 120.58 65.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.03 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.844 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.6 mp -120.89 142.92 49.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.363 . . . . 0.0 111.755 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 302' ' ' MET . 2.6 t70 -90.15 124.43 34.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.511 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -76.01 146.77 39.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.786 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 . . . . . 0 CA--C 1.53 0.208 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.505 -179.535 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.844 0.354 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' ASP . . . . . 0.446 ' HB2' ' HG2' ' A' ' 302' ' ' MET . 2.5 m-20 -71.05 152.05 43.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.893 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.731 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -100.88 111.44 23.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.063 0.459 . . . . 0.0 111.003 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.507 HG21 HD22 ' A' ' 299' ' ' LEU . 2.3 mm -72.06 -32.22 42.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.072 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 152.1 -178.81 29.12 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.973 ' HB3' HG23 ' A' ' 360' ' ' THR . 15.4 ptmt -160.55 140.78 11.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.34 0.591 . . . . 0.0 111.864 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.932 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.52 158.9 12.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.158 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.505 ' HB3' HG13 ' A' ' 358' ' ' VAL . 2.6 p90 -141.58 145.2 34.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.918 0.39 . . . . 0.0 111.224 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 378' ' ' VAL . 15.3 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.146 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.644 0.259 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 22.3 tp -64.66 -32.64 74.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.352 . . . . 0.0 110.332 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -65.39 -28.5 69.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.371 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.602 ' CD2' HD12 ' A' ' 280' ' ' LEU . 20.6 t-160 -79.89 -54.05 6.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.815 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.556 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 51.2 t-105 -51.27 -47.22 62.54 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.048 0.451 . . . . 0.0 109.944 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 15.0 t -67.81 -29.28 68.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.722 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.505 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.3 OUTLIER -62.98 -42.9 99.96 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.789 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.81 ' CE ' HD11 ' A' ' 352' ' ' ILE . 30.4 ttp -59.61 -52.49 65.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.671 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.804 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.6 mt -56.66 -31.74 64.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.329 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.46 -30.19 69.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 109.722 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 398' ' ' ARG . 17.1 m-80 -115.26 71.12 2.99 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.614 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.535 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 39.9 Cg_endo -68.07 31.37 0.14 Allowed 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.225 2.616 . . . . 0.0 113.396 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 398' ' ' ARG . . . . . 0.535 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 2.5 mmt180 -158.2 -42.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.092 0.472 . . . . 0.0 110.34 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.633 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 38.8 ttt85 -93.86 145.73 30.4 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.858 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.633 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 84.4 Cg_endo -81.03 156.24 20.09 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.457 2.105 . . . . 0.0 112.925 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -125.5 116.44 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.778 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -108.33 144.9 35.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.685 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.39 154.88 10.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.916 0.389 . . . . 0.0 111.298 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' TRP . . . . . 0.435 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 49.8 m95 -81.35 120.79 25.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.932 ' HB3' HG11 ' A' ' 376' ' ' VAL . 46.1 m-70 -108.54 122.7 47.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.516 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -78.24 117.19 19.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.746 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.787 HD23 HG22 ' A' ' 376' ' ' VAL . 79.9 mt -62.61 127.67 32.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.086 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.505 ' C ' HD12 ' A' ' 273' ' ' LEU . 6.3 mt-30 -116.06 168.94 9.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.828 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.853 ' O ' HG23 ' A' ' 413' ' ' VAL . 59.6 t -55.7 119.34 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.798 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.731 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 20.0 mt-10 -52.7 -43.63 65.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.911 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -56.52 -48.8 76.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.34 . . . . 0.0 110.657 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.461 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.0 mt-10 -65.52 -38.51 89.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 375' ' ' LYS . 73.4 t -59.43 -49.91 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.229 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.888 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.794 HD22 ' O ' ' A' ' 373' ' ' ILE . 33.9 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.898 0.38 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.06 -165.67 13.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.215 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ASP . . . . . 0.632 ' OD1' HG23 ' A' ' 406' ' ' THR . 9.7 m-20 -142.33 133.23 25.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 110.875 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.862 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -121.87 131.07 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 0.0 111.026 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.862 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -98.38 126.02 43.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.831 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.618 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.7 p90 -141.89 149.94 40.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.202 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.38 159.53 15.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.085 -178.543 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.878 HD12 ' CD2' ' A' ' 389' ' ' HIS . 75.4 mt -128.9 148.34 50.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.177 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -158.81 104.58 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 111.597 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.992 ' CD1' HD13 ' A' ' 352' ' ' ILE . 29.9 t80 -96.65 139.54 32.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.385 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 287' ' ' GLY . 61.1 t -116.12 92.96 37.29 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 17.1 Cg_exo -65.27 -32.49 51.27 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.941 2.427 . . . . 0.0 112.366 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -31.62 62.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.872 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.6 -10.08 9.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.639 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 71.86 45.56 42.3 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.036 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -120.91 130.18 53.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.926 0.393 . . . . 0.0 111.55 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.492 HD21 ' CG2' ' A' ' 357' ' ' VAL . 32.7 tp -93.75 147.58 22.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.135 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.9 m -136.69 136.99 39.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.32 0.581 . . . . 0.0 112.122 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.09 123.8 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.455 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 341' ' ' GLU . 27.1 t -118.04 115.08 47.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.03 0.443 . . . . 0.0 111.767 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.682 HG13 HG21 ' A' ' 328' ' ' THR . 38.8 mm -74.7 137.04 23.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.429 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.5 OUTLIER -113.74 -59.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -177.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.447 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 2.4 pt-20 -175.7 159.48 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.362 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.815 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -118.73 154.01 33.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.873 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -150.87 151.89 32.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.968 0.414 . . . . 0.0 111.679 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 25.8 m120 60.91 24.76 14.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.796 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.815 HD21 ' HB1' ' A' ' 296' ' ' ALA . 54.8 mt -59.69 139.38 57.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.282 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -62.17 144.49 55.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.483 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.416 ' HE3' HD11 ' A' ' 335' ' ' LEU . 9.5 mttp -84.19 118.73 24.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.548 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.567 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.7 mmt -93.91 -18.78 21.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.334 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 49.5 m-20 -98.39 116.97 31.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.841 0.353 . . . . 0.0 110.619 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -48.95 116.68 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.443 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.8 16.59 39.29 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.287 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.79 -157.58 9.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.804 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 307' ' ' LEU . 7.6 mt -100.33 -161.08 0.84 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.83 0.348 . . . . 0.0 110.702 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.618 ' HB2' HD23 ' A' ' 335' ' ' LEU . 70.9 m -139.39 172.13 13.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.33 0.586 . . . . 0.0 111.077 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.401 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -131.99 57.44 29.93 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.593 ' CG ' HD13 ' A' ' 299' ' ' LEU . 57.7 Cg_endo -72.75 144.65 39.67 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.132 2.555 . . . . 0.0 114.682 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.553 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 38.4 p90 -143.61 163.47 33.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.252 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.753 HG22 HG22 ' A' ' 361' ' ' VAL . 38.0 t -111.6 149.97 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.43 0.633 . . . . 0.0 112.577 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.841 ' HE3' HD13 ' A' ' 362' ' ' LEU . 11.1 mtmt -131.4 138.49 49.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.378 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.462 HG23 HG13 ' A' ' 357' ' ' VAL . 5.2 mp -111.69 132.44 60.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 0.0 110.8 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 358' ' ' VAL . 18.8 m80 -127.76 135.32 49.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 0.0 110.975 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.923 HD23 ' HD3' ' A' ' 324' ' ' LYS . 51.5 tp -103.76 110.84 23.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' MET . . . . . 0.404 ' HA ' ' HG ' ' A' ' 323' ' ' LEU . 2.9 mtm -117.0 134.96 54.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.539 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.822 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.0 OUTLIER -93.65 99.49 11.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.29 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 59.52 37.7 22.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.36 7.43 60.63 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.224 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 317' ' ' MET . 5.5 mptt -111.02 109.76 20.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.834 0.317 . . . . 0.0 110.975 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.39 131.59 33.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.377 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.723 HD11 ' CB ' ' A' ' 318' ' ' GLN . 5.9 mt -125.35 -47.72 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.261 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.923 ' HD3' HD23 ' A' ' 316' ' ' LEU . 0.1 OUTLIER -129.89 160.59 33.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.085 0.469 . . . . 0.0 111.448 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.31 143.74 37.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.881 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 314' ' ' ILE . 20.9 mmtm -145.78 162.13 38.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.943 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.6 146.75 27.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.701 HG22 ' CE1' ' A' ' 343' ' ' PHE . 14.6 p -106.11 176.73 5.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 13.3 t -58.09 164.61 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.514 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.553 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.4 mt -107.83 123.55 63.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.938 0.399 . . . . 0.0 111.39 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.643 ' O ' HG22 ' A' ' 334' ' ' THR . 4.5 mmpt? -86.28 87.45 7.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.953 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -55.14 136.42 48.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.987 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 44.22 85.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.33 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.752 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.9 t -178.55 174.21 1.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.808 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 334' ' ' THR . 4.4 mt -145.59 -16.71 0.48 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.176 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.3 m-80 -132.65 56.36 22.17 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.318 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 46.8 Cg_endo -89.54 167.76 5.04 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.165 2.577 . . . . 0.0 113.628 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.447 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -108.97 160.67 15.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.299 179.302 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.636 ' HB2' HG22 ' A' ' 293' ' ' ILE . 81.6 m-85 -133.96 -63.97 0.71 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.755 0.312 . . . . 0.0 111.224 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.5 t30 59.12 38.52 23.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.956 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.547 ' O ' HG13 ' A' ' 292' ' ' VAL . 31.7 mt-10 -93.4 144.69 25.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.679 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 99.3 p -114.67 122.5 46.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 111.718 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.701 ' CE1' HG22 ' A' ' 328' ' ' THR . 76.3 m-85 -114.87 152.85 31.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.156 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 64.4 p -129.37 138.93 51.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.116 0.484 . . . . 0.0 111.763 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -125.13 166.01 17.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.569 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -111.02 76.84 1.0 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.829 HG13 ' HB3' ' A' ' 351' ' ' GLN . 50.0 t -110.0 122.2 39.62 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.035 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.53 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 71.0 Cg_endo -75.28 157.83 41.39 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.418 2.079 . . . . 0.0 111.64 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -51.72 -22.68 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.702 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -87.27 -8.55 56.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.829 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -111.97 -28.4 8.04 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.641 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.992 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.4 tp -52.2 -29.94 12.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.767 0.318 . . . . 0.0 110.864 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.67 3.31 55.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.411 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -124.1 -21.78 4.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.471 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.822 HG12 ' HG2' ' A' ' 318' ' ' GLN . 32.4 m -88.04 163.28 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.002 0.429 . . . . 0.0 111.485 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -137.88 126.28 23.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.5 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.511 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 88.9 t -88.3 116.2 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 0.0 110.28 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.4 OUTLIER -100.28 113.8 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.758 -179.157 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.569 ' HB ' HG23 ' A' ' 376' ' ' VAL . 47.8 t -99.09 107.79 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.97 HG23 ' HB3' ' A' ' 375' ' ' LYS . 3.7 m -110.4 135.38 51.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.964 0.411 . . . . 0.0 111.825 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.753 HG22 HG22 ' A' ' 312' ' ' VAL . 45.7 t -109.38 118.74 57.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.228 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.841 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.8 mp -121.28 145.76 47.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.502 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.567 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -94.57 125.16 39.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.664 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -75.75 146.91 39.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.899 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.596 -179.576 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.791 0.329 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.92 149.76 30.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.055 0.455 . . . . 0.0 111.57 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.549 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -100.95 111.11 23.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.72 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.794 ' O ' HD22 ' A' ' 273' ' ' LEU . 33.3 mt -82.39 -32.73 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.491 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' GLY . . . . . 0.502 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 167.05 -178.5 41.24 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.034 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.97 ' HB3' HG23 ' A' ' 360' ' ' THR . 17.5 ptmt -164.72 140.98 5.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.221 0.534 . . . . 0.0 112.041 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.925 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.53 159.27 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.048 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.458 ' HB3' HG13 ' A' ' 358' ' ' VAL . 22.1 p90 -144.85 132.0 20.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.055 0.455 . . . . 0.0 111.79 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 378' ' ' VAL . 22.9 m . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.756 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.897 0.38 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 23.8 tp -56.4 -34.4 66.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.728 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -62.0 -46.84 87.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.523 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.878 ' CD2' HD12 ' A' ' 280' ' ' LEU . 15.2 t-160 -62.58 -53.84 48.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.148 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.511 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 68.1 t-105 -54.83 -51.44 65.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.952 0.406 . . . . 0.0 110.461 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.5 t -66.25 -32.61 74.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.144 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.575 ' HB3' HD12 ' A' ' 401' ' ' ILE . 6.4 m-20 -64.87 -31.59 72.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.79 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.668 ' CE ' HD11 ' A' ' 352' ' ' ILE . 25.8 ttp -65.88 -54.27 28.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.91 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.807 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.5 mt -55.76 -22.79 25.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.124 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -80.8 -38.45 28.44 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 399' ' ' ARG . 40.0 m-80 -125.01 60.37 27.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.563 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.523 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 2.4 Cg_endo -44.06 -77.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.759 2.973 . . . . 0.0 113.356 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -51.38 -17.85 0.86 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.406 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' A' ' 396' ' ' ASN . 0.9 OUTLIER -93.67 133.47 27.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.906 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 74.1 Cg_endo -75.41 115.41 4.22 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.435 2.09 . . . . 0.0 112.548 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -93.62 108.39 20.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.881 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.57 144.0 32.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.737 0.303 . . . . 0.0 110.623 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.44 154.38 12.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.406 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -82.46 117.12 22.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.925 ' HB3' HG11 ' A' ' 376' ' ' VAL . 48.9 m-70 -106.68 118.38 36.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.576 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.632 HG23 ' OD1' ' A' ' 275' ' ' ASP . 91.6 m -78.33 116.25 18.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.952 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.841 HD23 HG22 ' A' ' 376' ' ' VAL . 93.5 mt -61.29 127.94 33.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.405 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.466 ' C ' HD12 ' A' ' 273' ' ' LEU . 6.6 mt-30 -116.04 172.25 7.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.497 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.832 ' O ' HG23 ' A' ' 413' ' ' VAL . 61.2 t -54.98 121.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.549 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 23.9 mt-10 -55.16 -42.47 73.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.88 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.16 -49.11 76.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.458 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.7 mt-10 -64.89 -38.17 90.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.371 0.605 . . . . 0.0 109.418 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 409' ' ' VAL . 94.9 t -57.28 -47.29 84.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.534 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.979 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.653 HD22 ' O ' ' A' ' 373' ' ' ILE . 41.4 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.943 0.402 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 124.11 -164.35 17.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.162 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.04 132.53 22.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.703 0.287 . . . . 0.0 110.72 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.701 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -122.71 122.43 65.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.161 0.505 . . . . 0.0 110.821 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.701 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -92.01 126.17 36.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.786 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.616 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.0 p90 -142.22 148.94 38.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.383 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -101.92 160.61 14.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.064 -178.685 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.831 HD12 ' CD2' ' A' ' 389' ' ' HIS . 73.0 mt -128.81 147.81 50.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.214 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 290' ' ' THR . 1.6 ttm180 -158.92 106.7 1.84 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.579 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.979 ' CD1' HD13 ' A' ' 352' ' ' ILE . 30.0 t80 -98.25 139.52 33.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.599 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 287' ' ' GLY . 83.1 t -116.37 93.11 38.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 16.5 Cg_exo -65.65 -30.94 50.58 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.892 2.394 . . . . 0.0 112.211 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -30.67 65.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.699 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -122.4 -5.3 8.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.643 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 66.49 45.98 80.97 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.629 -0.795 . . . . 0.0 112.033 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -121.36 129.32 53.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 111.493 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.446 HD21 ' CG2' ' A' ' 357' ' ' VAL . 34.2 tp -93.05 147.64 22.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.068 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 343' ' ' PHE . 1.6 m -136.68 136.7 39.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.347 0.594 . . . . 0.0 112.177 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.404 HG21 HG11 ' A' ' 357' ' ' VAL . 15.1 t -128.36 123.53 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.306 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 341' ' ' GLU . 38.1 t -117.25 116.04 50.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.995 0.426 . . . . 0.0 111.942 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.71 HG13 HG21 ' A' ' 328' ' ' THR . 26.6 mm -74.55 137.05 23.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 277' ' ' CYS . 0.7 OUTLIER -113.46 -57.44 2.28 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 4.9 pt-20 -175.96 158.53 2.05 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.131 -0.628 . . . . 0.0 112.444 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.787 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -117.98 145.56 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.497 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.427 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 10.7 pttt -145.68 151.04 37.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 111.542 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 30.8 m120 61.47 23.01 13.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.072 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.787 HD21 ' HB1' ' A' ' 296' ' ' ALA . 58.2 mt -56.79 138.27 53.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.901 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -66.34 150.67 48.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.562 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.44 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 25.1 mttt -86.43 115.59 24.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.614 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.471 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 6.9 mmm -94.12 -18.37 21.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.563 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 55.6 m-20 -94.88 118.56 31.98 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.764 0.316 . . . . 0.0 110.332 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -47.61 115.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.02 0.438 . . . . 0.0 111.598 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.5 16.83 37.98 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.433 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.37 -159.26 10.07 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.961 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' A' ' 307' ' ' LEU . 6.6 mt -96.67 -161.55 0.88 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.72 0.295 . . . . 0.0 110.292 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.479 ' HB2' HD23 ' A' ' 335' ' ' LEU . 5.5 m -134.97 170.66 15.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.228 0.537 . . . . 0.0 111.166 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.453 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 6.8 m-20 -135.72 55.44 12.53 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.586 ' CG ' HD13 ' A' ' 299' ' ' LEU . 34.4 Cg_endo -66.88 154.81 73.32 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.233 2.622 . . . . 0.0 114.697 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.517 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 48.6 p90 -153.06 149.55 28.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.503 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.958 HG22 HG22 ' A' ' 361' ' ' VAL . 41.0 t -99.98 150.14 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.872 ' HE2' HD13 ' A' ' 362' ' ' LEU . 5.6 mtmm -133.08 136.16 45.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.219 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.639 HG23 HG13 ' A' ' 357' ' ' VAL . 5.1 mp -107.72 137.27 39.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.251 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -131.45 128.45 39.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.388 . . . . 0.0 111.21 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 324' ' ' LYS . 28.6 tp -104.64 106.64 17.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.464 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.6 mtm -112.87 140.65 47.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.912 0.387 . . . . 0.0 111.243 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.72 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.0 OUTLIER -101.38 99.48 9.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.324 179.435 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 30.0 m120 55.46 38.14 29.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 93.22 25.8 18.08 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.866 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 317' ' ' MET . 3.8 mptt -130.67 109.26 10.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.888 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.406 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -52.22 130.78 31.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.449 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.685 HD11 ' CG ' ' A' ' 318' ' ' GLN . 8.9 mt -124.34 -53.56 1.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.969 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 18.7 mmtt -130.64 150.2 51.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.06 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 314' ' ' ILE . 0.6 OUTLIER -143.44 120.1 11.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.815 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.467 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 7.8 mmtm -118.39 172.75 7.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.995 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.415 ' HB3' ' HG2' ' A' ' 313' ' ' LYS . 0.0 OUTLIER -155.15 138.5 15.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.261 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.71 HG21 HG13 ' A' ' 293' ' ' ILE . 25.1 p -92.06 -171.65 2.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.855 0.36 . . . . 0.0 110.47 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.407 HG22 ' HE1' ' A' ' 339' ' ' TYR . 9.8 t -70.54 171.71 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.064 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.535 HG21 ' CB ' ' A' ' 364' ' ' TYR . 2.3 mp -110.3 114.35 46.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.078 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 310' ' ' PRO . 0.0 OUTLIER -75.08 90.78 2.51 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.336 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -58.42 135.96 57.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.404 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 333' ' ' ASN . . . . . 0.41 ' C ' HD13 ' A' ' 307' ' ' LEU . 1.3 p-10 41.29 80.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.528 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.6 ' O ' HD23 ' A' ' 335' ' ' LEU . 3.5 t -179.06 173.64 1.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.963 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 334' ' ' THR . 0.9 OUTLIER -145.49 -11.46 0.53 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.224 -178.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.478 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.3 m-80 -137.84 59.33 19.08 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.733 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.536 ' HG3' ' HG3' ' A' ' 331' ' ' LYS . 54.8 Cg_endo -98.48 167.91 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.532 2.822 . . . . 0.0 113.509 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.435 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.6 OUTLIER -104.12 160.79 14.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.729 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.48 ' CB ' HG22 ' A' ' 293' ' ' ILE . 6.7 m-85 -129.73 -75.71 0.55 Allowed 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.981 0.42 . . . . 0.0 111.778 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 69.93 35.4 2.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.491 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.571 ' O ' HG13 ' A' ' 292' ' ' VAL . 29.3 mt-10 -91.12 143.11 27.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.584 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 26.5 p -115.41 121.29 42.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.0 111.765 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.703 ' CE1' HG22 ' A' ' 328' ' ' THR . 71.7 m-85 -110.49 159.98 17.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.977 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 6.2 m -135.72 137.97 42.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.118 0.485 . . . . 0.0 111.828 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.467 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 57.1 m-85 -125.25 166.07 17.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.609 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -112.29 74.49 0.87 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.866 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 351' ' ' GLN . 47.7 t -108.31 122.75 39.53 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.534 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 74.5 Cg_endo -75.76 158.06 39.36 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.418 2.079 . . . . 0.0 111.547 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -51.71 -22.43 3.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.629 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -87.82 -8.56 55.74 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.825 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.2 OUTLIER -112.59 -28.2 7.92 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.696 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.979 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.0 tp -51.44 -34.89 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.79 0.329 . . . . 0.0 110.779 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.99 3.07 54.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.374 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -123.06 -15.99 7.14 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.72 HG12 ' HG2' ' A' ' 318' ' ' GLN . 33.7 m -95.63 165.15 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.858 0.361 . . . . 0.0 111.469 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.85 126.49 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.989 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.639 HG13 HG23 ' A' ' 314' ' ' ILE . 47.7 t -89.11 110.18 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.442 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.5 OUTLIER -95.83 110.01 23.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.503 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.584 ' HB ' HG23 ' A' ' 376' ' ' VAL . 43.1 t -91.9 107.89 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.868 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.976 HG23 ' HB3' ' A' ' 375' ' ' LYS . 4.3 m -112.68 126.93 55.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.021 0.439 . . . . 0.0 111.949 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.958 HG22 HG22 ' A' ' 312' ' ' VAL . 46.7 t -101.98 118.37 48.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.216 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.872 HD13 ' HE2' ' A' ' 313' ' ' LYS . 2.7 mp -119.44 147.33 44.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 0.0 111.529 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 310' ' ' PRO . 5.2 t70 -90.02 130.19 36.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.821 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.535 ' CB ' HG21 ' A' ' 330' ' ' ILE . 8.9 t80 -81.95 141.45 33.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.584 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.157 -179.72 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.128 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 363' ' ' ASP . 5.7 m-20 -71.27 152.1 43.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.067 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.769 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -100.84 112.62 25.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.392 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.653 ' O ' HD22 ' A' ' 273' ' ' LEU . 1.3 mm -74.31 -34.28 36.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.751 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 155.98 -178.27 32.61 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.32 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.976 ' HB3' HG23 ' A' ' 360' ' ' THR . 11.9 ptmt -161.9 139.64 8.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.351 0.596 . . . . 0.0 112.303 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.919 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.18 158.93 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.077 179.264 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.496 ' HB3' HG13 ' A' ' 358' ' ' VAL . 25.5 p90 -141.2 135.48 30.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.906 0.384 . . . . 0.0 111.6 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 378' ' ' VAL . 15.5 m . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.898 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 120.658 0.266 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 46.4 tp -65.11 -37.15 86.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.623 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -62.58 -37.59 86.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.207 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.831 ' CD2' HD12 ' A' ' 280' ' ' LEU . 16.9 t-160 -65.54 -55.48 17.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 110.448 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.575 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 69.1 t-105 -53.83 -50.03 67.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.039 0.447 . . . . 0.0 110.262 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.42 -29.76 69.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.479 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.593 ' HB3' HD12 ' A' ' 401' ' ' ILE . 5.4 m-20 -67.86 -33.02 73.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.714 ' CE ' HD11 ' A' ' 352' ' ' ILE . 27.6 ttp -63.73 -52.61 59.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.695 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.785 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.6 mt -57.02 -22.9 42.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.91 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -81.16 -36.25 30.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.309 0.576 . . . . 0.0 109.483 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.471 ' HB2' HD11 ' A' ' 401' ' ' ILE . 22.7 m-80 -126.11 60.2 34.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.555 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.508 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 3.2 Cg_endo -44.67 -78.69 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.595 2.863 . . . . 0.0 112.91 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -51.24 -18.88 1.03 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.133 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -93.74 132.63 29.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.596 0.236 . . . . 0.0 110.813 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.7 Cg_endo -75.6 124.35 8.18 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.44 2.094 . . . . 0.0 112.712 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.593 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -102.59 107.63 22.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.761 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.28 144.26 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.858 0.361 . . . . 0.0 110.891 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.1 151.22 10.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.375 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 404' ' ' TRP . . . . . 0.427 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 36.4 m95 -78.17 115.77 18.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.688 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.919 ' HB3' HG11 ' A' ' 376' ' ' VAL . 51.0 m-70 -104.15 119.96 40.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.389 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 90.6 m -78.2 116.47 18.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.437 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.743 HD23 HG22 ' A' ' 376' ' ' VAL . 64.2 mt -61.63 126.9 28.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.038 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.44 ' C ' HD12 ' A' ' 273' ' ' LEU . 5.9 mt-30 -115.72 170.08 8.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.944 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.804 ' O ' HG23 ' A' ' 413' ' ' VAL . 55.5 t -54.83 117.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.725 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.769 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 9.0 mp0 -55.4 -41.22 72.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.642 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -56.83 -48.63 77.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 110.58 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.439 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.0 mt-10 -65.7 -40.07 91.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 409' ' ' VAL . 97.9 t -58.59 -48.79 84.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.17 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.499 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.789 HD22 ' O ' ' A' ' 373' ' ' ILE . 47.6 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.914 0.388 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 116.97 -168.1 12.73 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.234 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.18 132.28 26.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 0.0 110.723 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.882 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -120.99 129.93 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.171 0.51 . . . . 0.0 110.983 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.882 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.14 125.38 41.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.829 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.618 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 21.2 p90 -142.29 149.88 40.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.321 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.1 OUTLIER -102.54 161.31 13.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.362 0.601 . . . . 0.0 112.268 -178.584 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.659 HD12 ' CD2' ' A' ' 389' ' ' HIS . 27.7 mt -132.2 149.93 52.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.958 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.413 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.3 OUTLIER -158.92 102.8 1.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.443 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.936 ' CD1' HD13 ' A' ' 352' ' ' ILE . 29.6 t80 -98.57 136.69 38.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 43.0 t -122.8 95.88 45.92 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.535 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.57 -32.2 15.61 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.881 2.387 . . . . 0.0 112.317 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -31.17 6.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.191 0.52 . . . . 0.0 109.957 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.39 -21.15 8.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.813 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 81.16 47.6 6.43 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.778 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -123.65 129.74 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.97 0.414 . . . . 0.0 111.798 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.635 HD21 ' CG2' ' A' ' 357' ' ' VAL . 31.4 tp -95.48 147.67 23.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.994 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 3.4 m -134.73 137.64 43.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 112.0 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.41 ' CG2' HG11 ' A' ' 357' ' ' VAL . 21.6 t -130.87 120.28 47.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.32 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 341' ' ' GLU . 21.7 t -116.2 115.45 49.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.039 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.682 HG22 ' HB2' ' A' ' 339' ' ' TYR . 42.1 mm -75.05 137.13 23.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.446 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.98 -61.97 1.67 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -177.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.438 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 1.5 pt-20 -175.62 151.77 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.329 -0.549 . . . . 0.0 112.329 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.825 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -110.33 154.56 23.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.859 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -150.99 152.17 33.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 111.719 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 60.28 24.35 13.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.932 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.825 HD21 ' HB1' ' A' ' 296' ' ' ALA . 48.8 mt -58.96 138.82 57.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.162 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.463 ' HD2' ' HE2' ' A' ' 302' ' ' MET . 1.0 OUTLIER -62.59 141.62 58.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.31 -179.531 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.401 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 7.7 mttt -80.73 117.81 21.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.694 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.583 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.1 mmt -90.96 -19.03 23.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.343 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 49.2 m-20 -98.78 114.99 27.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.779 0.323 . . . . 0.0 110.524 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 26.3 t -48.84 116.38 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.45 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 62.11 15.44 50.38 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.369 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.29 -157.25 9.39 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.727 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.3 mt -100.34 -161.24 0.85 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 0.0 110.784 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.64 ' HB2' HD23 ' A' ' 335' ' ' LEU . 66.5 m -139.39 172.01 13.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.309 0.576 . . . . 0.0 111.103 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.409 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 15.3 m-20 -131.24 57.13 29.05 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.825 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.566 ' CB ' HD13 ' A' ' 299' ' ' LEU . 50.2 Cg_endo -70.56 148.56 60.13 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.096 2.531 . . . . 0.0 114.82 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.546 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 33.8 p90 -150.35 161.25 42.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.266 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.791 HG22 HG22 ' A' ' 361' ' ' VAL . 38.9 t -110.41 150.0 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.816 ' HE3' HD13 ' A' ' 362' ' ' LEU . 10.3 mtmt -132.41 134.95 45.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.215 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.536 HG23 HG13 ' A' ' 357' ' ' VAL . 5.3 mp -108.79 131.57 59.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.954 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -127.01 142.5 51.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.877 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.417 HD21 HG22 ' A' ' 347' ' ' VAL . 28.9 tp -113.31 106.01 14.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.527 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.5 mtm -106.79 131.17 54.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.311 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.939 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.4 OUTLIER -99.62 99.54 10.41 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.248 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 59.94 36.92 21.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.731 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 88.3 26.52 27.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.714 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.42 109.4 11.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.785 0.326 . . . . 0.0 110.883 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.79 129.24 25.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.184 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.939 HD11 ' CB ' ' A' ' 318' ' ' GLN . 10.0 mt -123.21 -41.38 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.47 147.74 49.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.897 0.38 . . . . 0.0 111.371 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -135.56 117.51 15.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.433 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 15.9 mmtp -124.26 160.85 27.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.927 0.394 . . . . 0.0 111.384 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.93 148.27 33.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.716 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.672 HG21 HG13 ' A' ' 293' ' ' ILE . 20.5 p -106.37 176.04 5.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.956 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.33 158.66 5.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.703 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.546 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.0 mt -102.13 126.08 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.979 0.418 . . . . 0.0 111.383 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.64 ' O ' HG22 ' A' ' 334' ' ' THR . 3.7 mmpt? -90.64 88.78 7.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.132 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -56.18 136.62 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.877 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 43.9 84.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.285 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.721 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.8 t -177.61 174.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.947 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.721 HD23 ' O ' ' A' ' 334' ' ' THR . 4.4 mt -145.95 -16.57 0.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.149 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.462 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.4 m-80 -132.29 56.99 26.13 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-O 120.765 0.317 . . . . 0.0 110.348 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 59.1 Cg_endo -88.33 167.69 6.41 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.18 2.587 . . . . 0.0 113.707 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.446 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.4 OUTLIER -111.31 159.29 18.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.302 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.682 ' HB2' HG22 ' A' ' 293' ' ' ILE . 83.6 m-85 -134.76 -62.25 0.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.792 0.329 . . . . 0.0 111.241 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.3 t30 57.87 37.58 26.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 292' ' ' VAL . 61.9 mt-10 -92.66 141.47 28.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 91.0 p -110.64 120.27 41.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.888 0.375 . . . . 0.0 111.544 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.639 ' CE1' HG22 ' A' ' 328' ' ' THR . 65.1 m-85 -113.34 147.91 36.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.361 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 83.0 p -123.09 140.5 52.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.972 0.415 . . . . 0.0 111.443 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.433 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 63.1 m-85 -127.24 165.88 18.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.583 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.63 78.1 1.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.817 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 351' ' ' GLN . 46.0 t -111.62 120.67 41.93 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.094 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.7 Cg_endo -72.07 156.97 55.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.468 2.112 . . . . 0.0 111.619 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -51.89 -22.94 4.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.54 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -85.72 -8.55 58.1 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.825 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.9 OUTLIER -109.96 -35.09 6.23 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.521 0.201 . . . . 0.0 111.473 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.936 HD13 ' CD1' ' A' ' 282' ' ' TYR . 5.9 tp -49.24 -26.72 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.651 0.263 . . . . 0.0 111.478 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -93.27 -7.92 43.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.771 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -116.41 -23.54 8.27 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 351' ' ' GLN . 35.0 m -88.69 168.03 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.908 0.385 . . . . 0.0 111.428 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -143.29 133.48 24.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.1 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.635 ' CG2' HD21 ' A' ' 289' ' ' LEU . 53.1 t -87.0 101.98 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.465 ' CG1' ' HE2' ' A' ' 375' ' ' LYS . 0.8 OUTLIER -86.45 114.18 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.969 -178.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.525 ' HB ' HG23 ' A' ' 376' ' ' VAL . 40.4 t -99.75 107.85 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.92 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.957 HG23 ' HB3' ' A' ' 375' ' ' LYS . 7.4 m -110.93 134.73 52.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 111.628 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.791 HG22 HG22 ' A' ' 312' ' ' VAL . 45.9 t -109.29 121.37 62.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.4 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.816 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.6 mp -123.07 147.55 46.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.918 0.389 . . . . 0.0 111.353 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.583 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.3 OUTLIER -96.54 125.19 40.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.601 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.407 ' CD2' ' OD1' ' A' ' 370' ' ' ASN . 20.3 t80 -75.8 139.45 41.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.818 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.871 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 370' ' ' ASN . . . . . 0.407 ' OD1' ' CD2' ' A' ' 364' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.8 0.333 . . . . 0.0 110.701 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.99 150.94 43.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.548 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.454 ' HB1' ' OE1' ' A' ' 410' ' ' GLU . . . -97.32 111.63 23.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.608 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.789 ' O ' HD22 ' A' ' 273' ' ' LEU . 30.0 mt -80.99 -33.12 12.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.386 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 168.13 -179.22 41.43 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.162 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.957 ' HB3' HG23 ' A' ' 360' ' ' THR . 14.8 ptmt -164.67 140.92 5.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.175 0.512 . . . . 0.0 111.791 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.936 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -114.35 158.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.176 179.245 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.568 ' CD1' HG13 ' A' ' 413' ' ' VAL . 43.0 p90 -142.23 132.03 24.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 111.179 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 378' ' ' VAL . 15.8 m . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.962 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.627 0.251 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.36 -33.53 71.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.551 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 1.0 OUTLIER -61.8 -49.83 74.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.54 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.659 ' CD2' HD12 ' A' ' 280' ' ' LEU . 17.4 t-160 -57.91 -58.39 8.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.967 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.481 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 64.0 t-105 -50.83 -46.11 59.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.217 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.5 t -67.75 -35.82 79.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.233 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.438 ' HB3' HD12 ' A' ' 401' ' ' ILE . 4.4 t0 -64.08 -34.92 79.13 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.759 ' CE ' HD11 ' A' ' 352' ' ' ILE . 26.6 ttp -64.5 -58.0 7.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.552 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.761 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.5 mt -55.22 -31.93 61.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.399 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.52 -30.64 69.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.786 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -114.27 70.66 2.06 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.629 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.535 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 42.8 Cg_endo -68.77 37.67 0.21 Allowed 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.203 2.602 . . . . 0.0 113.479 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 398' ' ' ARG . . . . . 0.533 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 10.6 mmm180 -160.0 -45.69 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.918 0.39 . . . . 0.0 110.86 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -93.87 141.82 24.23 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.198 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.7 Cg_endo -75.37 156.31 41.34 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.585 2.19 . . . . 0.0 112.807 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.45 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.2 mm -126.53 119.32 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -111.86 144.53 41.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.721 0.296 . . . . 0.0 110.693 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.31 155.68 11.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.976 0.417 . . . . 0.0 111.378 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -81.69 119.17 23.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.79 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.936 ' HB3' HG11 ' A' ' 376' ' ' VAL . 47.1 m-70 -106.81 122.34 46.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.557 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -78.19 117.09 19.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.672 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.803 HD23 HG22 ' A' ' 376' ' ' VAL . 55.9 mt -62.44 128.37 35.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.194 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.467 ' C ' HD12 ' A' ' 273' ' ' LEU . 5.3 mt-30 -114.46 171.98 7.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.756 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.85 ' O ' HG23 ' A' ' 413' ' ' VAL . 3.6 t -59.46 122.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.509 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 5.4 mt-10 -51.09 -38.37 51.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.325 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -52.64 63.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.651 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.429 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 3.0 mm-40 -60.79 -41.13 95.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 409' ' ' VAL . 61.7 t -56.22 -52.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.251 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.597 179.812 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 373' ' ' ILE . 46.7 mt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.788 0.328 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 116.24 -166.82 12.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.946 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -141.08 136.23 31.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.819 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.814 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -125.09 125.4 69.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.207 0.527 . . . . 0.0 110.885 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.814 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.5 OUTLIER -94.52 126.72 39.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.741 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.626 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 19.2 p90 -142.37 150.18 40.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.57 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.1 OUTLIER -103.87 160.36 14.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.05 -178.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.635 HD12 ' CD2' ' A' ' 389' ' ' HIS . 10.6 mt -133.34 150.51 51.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.866 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.97 105.08 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.552 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.946 ' CD1' HD13 ' A' ' 352' ' ' ILE . 28.4 t80 -99.14 138.66 35.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.08 95.28 44.17 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.403 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.532 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 6.9 Cg_exo -70.53 -31.06 17.76 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.844 2.362 . . . . 0.0 112.265 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.26 -32.07 15.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.147 0.499 . . . . 0.0 109.844 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.12 -18.71 9.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.816 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 78.77 47.58 7.73 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.617 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.97 129.46 51.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.04 0.447 . . . . 0.0 111.834 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 33.1 tp -96.55 147.56 23.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.932 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 343' ' ' PHE . 4.3 m -137.63 139.53 40.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.235 0.541 . . . . 0.0 111.995 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.3 t -132.86 123.35 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.529 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 341' ' ' GLU . 21.8 t -116.89 116.21 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.837 HG22 ' HB2' ' A' ' 339' ' ' TYR . 36.5 mm -74.64 135.95 26.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.79 -64.98 1.22 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.443 ' HB3' ' CG ' ' A' ' 338' ' ' TYR . 0.3 OUTLIER -174.67 148.62 1.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.524 -179.315 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.843 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -107.76 154.19 21.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.982 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -150.96 151.86 32.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 111.652 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 62.68 22.81 13.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.843 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.843 HD21 ' HB1' ' A' ' 296' ' ' ALA . 47.8 mt -57.02 138.53 54.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.163 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.35 142.97 58.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.588 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.419 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 14.1 mttt -82.64 113.06 20.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.444 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.44 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 8.2 mmm -91.6 -20.44 21.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.642 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 42.6 m-20 -92.28 118.86 31.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 110.527 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -48.04 115.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.611 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 57.5 17.95 28.16 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.264 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.97 -157.47 9.6 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.001 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.1 mt -99.27 -161.12 0.85 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 0.0 110.54 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.545 ' HB2' HD23 ' A' ' 335' ' ' LEU . 14.8 m -135.68 171.8 13.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.178 0.513 . . . . 0.0 111.017 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.43 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 6.5 m-20 -135.69 56.95 16.71 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.75 ' CG ' HD13 ' A' ' 299' ' ' LEU . 73.3 Cg_endo -77.91 144.21 21.39 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.902 2.402 . . . . 0.0 114.891 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.549 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 10.9 p90 -139.12 167.73 21.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.025 177.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 361' ' ' VAL . 47.6 t -116.85 149.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.325 0.584 . . . . 0.0 112.572 -179.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.853 ' HE3' HD13 ' A' ' 362' ' ' LEU . 13.8 mttt -132.38 155.78 47.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.434 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.519 HG23 HG13 ' A' ' 357' ' ' VAL . 5.4 mp -124.51 134.19 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.417 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -128.93 127.74 42.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.013 0.435 . . . . 0.0 111.049 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' A' ' 324' ' ' LYS . 28.8 tp -99.32 114.27 27.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.288 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.9 mtm -122.05 133.62 54.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 111.441 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.791 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.0 OUTLIER -98.77 99.49 10.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.02 179.205 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 59.95 36.68 21.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.38 25.61 32.89 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.853 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -122.06 117.46 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.7 0.286 . . . . 0.0 110.9 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.584 ' O ' HD23 ' A' ' 323' ' ' LEU . 14.9 mmt180 -51.72 128.21 22.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.219 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.765 HD11 ' HB2' ' A' ' 318' ' ' GLN . 18.1 mt -125.5 -58.86 1.41 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.251 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.907 ' HD3' HD23 ' A' ' 316' ' ' LEU . 0.1 OUTLIER -129.93 159.94 35.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.179 0.514 . . . . 0.0 111.743 -179.167 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 325' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 325' ' ' LYS . 0.3 OUTLIER -139.7 138.07 35.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.721 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.403 ' HB2' ' HB ' ' A' ' 314' ' ' ILE . 1.2 mmtm -143.98 158.62 43.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 111.157 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 0.1 OUTLIER -149.93 145.3 26.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.948 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.714 HG22 ' CE1' ' A' ' 343' ' ' PHE . 12.9 p -102.0 -178.93 3.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.846 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.637 HG23 ' HE3' ' A' ' 331' ' ' LYS . 10.1 t -60.2 172.05 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.463 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.549 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 5.6 mt -113.44 121.54 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 111.454 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.637 ' HE3' HG23 ' A' ' 329' ' ' THR . 7.1 mmpt? -86.43 85.73 7.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.997 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -56.45 136.77 53.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.981 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.19 83.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.255 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.688 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.8 t -176.99 174.0 1.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.76 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 334' ' ' THR . 4.0 mt -145.25 -15.8 0.5 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.378 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.486 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.79 56.09 20.64 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 120.75 0.309 . . . . 0.0 110.516 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 61.3 Cg_endo -89.04 167.69 5.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.15 2.567 . . . . 0.0 113.723 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.443 ' CG ' ' HB3' ' A' ' 295' ' ' GLU . 0.2 OUTLIER -110.03 160.4 16.47 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.456 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.837 ' HB2' HG22 ' A' ' 293' ' ' ILE . 7.9 m-85 -135.17 -50.3 0.75 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.692 0.282 . . . . 0.0 111.192 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 44.41 36.7 1.73 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.029 0.442 . . . . 0.0 110.976 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.526 ' O ' HG13 ' A' ' 292' ' ' VAL . 44.3 mt-10 -90.91 141.25 29.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.816 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 88.0 p -111.24 121.2 44.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.932 0.396 . . . . 0.0 111.558 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.714 ' CE1' HG22 ' A' ' 328' ' ' THR . 67.6 m-85 -111.78 155.21 23.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.058 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 59.6 p -130.91 139.59 50.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.115 0.483 . . . . 0.0 111.692 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -126.41 165.97 18.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.581 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -113.16 76.94 1.01 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.546 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.902 HG13 ' HB3' ' A' ' 351' ' ' GLN . 49.4 t -109.84 122.21 39.76 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.322 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.501 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 63.2 Cg_endo -73.42 158.97 47.43 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.453 2.102 . . . . 0.0 111.492 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -52.06 -20.67 2.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.857 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -90.45 -8.7 49.83 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.902 ' HB3' HG13 ' A' ' 347' ' ' VAL . 1.0 OUTLIER -110.47 -29.73 7.96 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.946 HD13 ' CD1' ' A' ' 282' ' ' TYR . 6.3 tp -47.09 -28.6 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.829 0.347 . . . . 0.0 111.059 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -95.11 -27.77 15.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.058 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -91.33 -3.94 56.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.875 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.791 HG12 ' HG2' ' A' ' 318' ' ' GLN . 29.9 m -106.96 166.3 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 111.278 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -141.65 126.23 17.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.658 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.519 HG13 HG23 ' A' ' 314' ' ' ILE . 64.9 t -90.77 105.01 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.145 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.3 OUTLIER -93.98 111.34 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.811 -179.008 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.532 ' HB ' HG23 ' A' ' 376' ' ' VAL . 48.2 t -91.52 108.0 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.99 HG23 ' HB3' ' A' ' 375' ' ' LYS . 2.6 m -110.26 131.93 54.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.061 0.457 . . . . 0.0 111.923 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 312' ' ' VAL . 58.2 t -107.05 119.67 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.926 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.853 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.6 mp -119.94 141.88 49.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.992 0.425 . . . . 0.0 111.722 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.44 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 6.3 t70 -90.09 125.94 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.585 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -80.06 145.98 32.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.593 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.554 -179.481 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.889 0.376 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.16 149.86 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.915 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.762 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -91.0 112.03 23.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.019 0.438 . . . . 0.0 111.119 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.433 ' O ' HD22 ' A' ' 273' ' ' LEU . 1.3 mm -73.26 -33.88 42.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.997 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 155.61 -178.37 32.25 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.258 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.99 ' HB3' HG23 ' A' ' 360' ' ' THR . 12.2 ptmt -162.16 140.59 9.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.294 0.569 . . . . 0.0 112.017 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.936 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.98 158.79 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.155 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.556 ' HB3' HG13 ' A' ' 358' ' ' VAL . 9.4 p90 -139.53 142.95 37.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.933 0.397 . . . . 0.0 111.121 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 378' ' ' VAL . 12.1 m . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.066 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.405 ' OE1' ' CZ ' ' A' ' 377' ' ' PHE . 14.4 mt-10 . . . . . 0 CA--C 1.522 -0.101 0 CA-C-O 120.808 0.337 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.19 -32.06 71.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.501 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 2.6 ptt180 -64.94 -31.7 73.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.324 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.635 ' CD2' HD12 ' A' ' 280' ' ' LEU . 17.5 t-160 -77.29 -57.33 3.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.513 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 50.4 t-105 -49.47 -44.95 46.21 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.093 0.473 . . . . 0.0 109.901 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.0 t -69.06 -30.67 69.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.739 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.528 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.3 OUTLIER -63.14 -42.25 99.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.923 179.119 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.803 ' CE ' HD11 ' A' ' 352' ' ' ILE . 31.9 ttp -59.96 -54.83 41.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.971 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.797 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.4 mt -56.46 -31.57 64.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.417 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.2 -31.61 71.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.529 . . . . 0.0 109.691 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' A' ' 398' ' ' ARG . 36.0 m-80 -115.17 71.17 2.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.55 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.532 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 39.6 Cg_endo -68.34 35.29 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.249 2.632 . . . . 0.0 113.443 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 398' ' ' ARG . . . . . 0.51 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 11.3 mmm180 -159.26 -45.23 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.0 0.428 . . . . 0.0 110.578 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.405 ' NH1' ' HB2' ' A' ' 399' ' ' ARG . 0.2 OUTLIER -94.04 140.75 23.01 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.037 -179.19 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 72.3 Cg_endo -75.02 156.3 42.89 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.52 2.147 . . . . 0.0 112.839 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -124.99 117.95 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.578 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -110.13 144.57 38.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.677 0.275 . . . . 0.0 110.763 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.77 155.57 10.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.965 0.412 . . . . 0.0 111.246 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -82.23 121.63 26.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.753 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.936 ' HB3' HG11 ' A' ' 376' ' ' VAL . 54.3 m-70 -109.46 122.68 47.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.593 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 90.4 m -78.28 117.11 19.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.542 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.768 HD23 HG22 ' A' ' 376' ' ' VAL . 61.8 mt -62.16 128.09 34.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.253 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -114.44 173.29 6.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.672 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.812 ' O ' HG23 ' A' ' 413' ' ' VAL . 4.6 t -58.54 115.77 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.818 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.762 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 4.6 mp0 -52.42 -25.52 10.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.42 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.424 ' H ' HG12 ' A' ' 409' ' ' VAL . 2.3 mt-10 -72.94 -51.18 19.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.481 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.434 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 2.6 mm-40 -64.35 -38.8 92.33 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.897 HG11 ' HG3' ' A' ' 375' ' ' LYS . 59.6 t -56.8 -50.63 74.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.363 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.495 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.818 HD22 ' O ' ' A' ' 373' ' ' ILE . 72.3 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.918 0.39 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 124.12 -166.07 16.82 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.307 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ASP . . . . . 0.457 ' OD1' HG23 ' A' ' 406' ' ' THR . 36.0 m-20 -140.91 132.55 27.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.75 0.31 . . . . 0.0 110.709 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.849 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -123.14 130.17 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.165 0.507 . . . . 0.0 111.013 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.849 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -98.71 126.38 44.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.67 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.611 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.3 p90 -142.2 150.0 40.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.399 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.9 159.65 15.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.21 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.58 HD12 ' CD2' ' A' ' 389' ' ' HIS . 31.8 mt -130.7 149.39 52.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.798 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -158.95 106.47 1.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.611 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.967 ' CD1' HD13 ' A' ' 352' ' ' ILE . 27.7 t80 -101.49 137.91 39.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.14 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 44.2 t -123.5 95.81 44.58 Favored Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.539 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.3 Cg_exo -70.54 -34.38 12.06 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.931 2.421 . . . . 0.0 112.733 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.25 -30.71 5.02 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.16 0.505 . . . . 0.0 109.957 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -116.64 -21.72 8.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.844 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.26 48.87 6.17 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.642 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -124.15 129.74 51.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.073 0.463 . . . . 0.0 111.891 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 352' ' ' ILE . 39.2 tp -95.43 147.63 23.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.867 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 343' ' ' PHE . 8.3 m -139.33 138.7 36.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 112.06 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.5 124.41 57.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.316 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 341' ' ' GLU . 25.3 t -117.16 114.67 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.028 0.442 . . . . 0.0 111.852 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.788 HG22 ' HB2' ' A' ' 339' ' ' TYR . 26.1 mm -74.68 137.01 23.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.453 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.29 -60.49 1.87 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.956 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 2.4 pt-20 -175.81 159.28 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.243 0.544 . . . . 0.0 112.24 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.769 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -123.64 149.5 45.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.853 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -145.55 153.68 41.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.987 0.423 . . . . 0.0 111.375 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 60.54 29.02 18.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.495 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.769 HD21 ' HB1' ' A' ' 296' ' ' ALA . 91.8 mt -66.01 138.79 58.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.951 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -58.41 148.59 27.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.59 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.404 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 0.1 OUTLIER -89.45 121.9 32.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.465 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.53 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.8 mmt -96.48 -16.67 21.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.316 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 33.1 m-20 -106.97 101.3 10.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.767 0.318 . . . . 0.0 110.504 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.07 116.61 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.54 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.04 87.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.907 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -124.93 -139.47 5.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.85 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.505 HD12 ' HB2' ' A' ' 333' ' ' ASN . 34.1 mt -119.46 -159.21 0.76 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.01 0.433 . . . . 0.0 110.566 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.666 ' HB2' HD23 ' A' ' 335' ' ' LEU . 66.5 m -135.68 172.06 13.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.222 0.534 . . . . 0.0 110.638 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.407 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -131.44 57.57 31.91 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.037 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 363' ' ' ASP . 38.3 Cg_endo -67.66 153.85 74.97 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.136 2.557 . . . . 0.0 114.51 -177.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.548 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 25.1 p90 -156.82 148.3 22.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.355 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 1.009 HG22 HG22 ' A' ' 361' ' ' VAL . 39.8 t -102.99 143.59 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.701 ' HE3' HD13 ' A' ' 362' ' ' LEU . 17.7 mttt -122.08 157.43 31.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.278 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.405 HG23 HG13 ' A' ' 357' ' ' VAL . 5.4 mp -131.51 124.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.651 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -123.5 133.25 54.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 111.157 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.416 HD21 HG22 ' A' ' 347' ' ' VAL . 22.5 tp -102.15 105.83 16.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.285 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 317' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 0.9 OUTLIER -107.2 143.6 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.245 -179.47 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.794 ' HB2' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -105.58 99.56 9.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.416 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 59.84 37.75 21.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.937 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 90.16 25.56 26.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.902 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 317' ' ' MET . 7.8 mmtm -128.88 109.47 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.451 ' O ' HD23 ' A' ' 323' ' ' LEU . 7.9 ptt180 -52.84 130.81 34.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.227 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.794 HD11 ' HB2' ' A' ' 318' ' ' GLN . 8.3 mt -126.26 -43.21 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.241 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 3.2 mmpt? -130.62 158.08 41.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.921 0.391 . . . . 0.0 111.341 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.59 134.21 23.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.837 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -142.3 159.11 42.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.916 0.388 . . . . 0.0 111.247 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 2.9 mttt -142.75 154.65 44.46 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.601 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.795 HG22 ' CE1' ' A' ' 343' ' ' PHE . 13.4 p -111.12 177.22 4.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.847 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.4 142.99 36.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.693 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.548 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.2 mt -90.55 119.17 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.109 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.614 ' O ' HG22 ' A' ' 334' ' ' THR . 1.1 mmpt? -83.56 89.47 7.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.3 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -57.42 137.4 56.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.799 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 333' ' ' ASN . . . . . 0.505 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.2 p-10 43.91 83.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.365 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.756 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.5 t -176.82 174.78 1.73 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.803 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 334' ' ' THR . 5.1 mt -146.65 -16.96 0.42 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.223 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.464 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.7 m-80 -132.6 59.26 42.11 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.387 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 44.5 Cg_endo -92.47 167.66 2.79 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.301 2.667 . . . . 0.0 113.756 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.453 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.4 OUTLIER -107.82 160.82 15.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.053 179.153 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.788 ' HB2' HG22 ' A' ' 293' ' ' ILE . 78.8 m-85 -133.93 -61.62 0.79 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.857 0.361 . . . . 0.0 111.236 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 54.76 36.9 27.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.536 ' O ' HG13 ' A' ' 292' ' ' VAL . 51.6 mt-10 -92.33 142.44 27.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 14.9 m -112.67 117.22 31.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.442 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.795 ' CE1' HG22 ' A' ' 328' ' ' THR . 81.2 m-85 -109.72 156.93 19.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.276 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 17.4 p -129.67 142.67 50.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 111.683 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -128.59 165.96 19.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.539 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -112.88 78.31 1.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.78 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.903 HG13 ' HB3' ' A' ' 351' ' ' GLN . 44.0 t -112.95 118.47 44.52 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.499 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 43.2 Cg_endo -68.7 151.87 74.52 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.286 1.991 . . . . 0.0 111.113 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -47.5 -24.39 0.83 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 354' ' ' LYS . 47.3 mt-10 -83.02 -20.7 34.53 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.903 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -93.67 -39.36 10.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.967 HD13 ' CD1' ' A' ' 282' ' ' TYR . 3.8 tp -45.62 -28.12 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.911 0.386 . . . . 0.0 110.994 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 353' ' ' GLN . . . . . 0.458 HE21 HD22 ' A' ' 394' ' ' LEU . 14.9 mm-40 -86.41 -31.11 21.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.806 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 350' ' ' GLU . 3.2 pttm -105.34 11.37 32.87 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.701 HG12 ' HG2' ' A' ' 318' ' ' GLN . 32.6 m -112.98 163.61 9.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.733 0.302 . . . . 0.0 110.883 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.2 126.51 18.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.222 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.527 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 86.5 t -89.56 134.06 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.195 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.527 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.5 OUTLIER -117.52 116.93 53.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.96 0.409 . . . . 0.0 111.692 -179.323 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.541 HG11 ' CD2' ' A' ' 278' ' ' PHE . 46.0 t -97.67 108.11 21.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.834 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.982 HG23 ' HB3' ' A' ' 375' ' ' LYS . 2.2 m -111.65 132.09 54.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.945 0.403 . . . . 0.0 111.978 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 1.009 HG22 HG22 ' A' ' 312' ' ' VAL . 52.7 t -106.59 113.8 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.906 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.701 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.1 mp -118.6 146.92 44.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.046 0.451 . . . . 0.0 111.69 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.53 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -92.9 134.33 35.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.443 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 365' ' ' ASP . 6.9 t80 -90.29 144.28 25.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.064 0.459 . . . . 0.0 110.911 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' ASP . . . . . 0.51 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 19.8 m-20 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.018 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.89 0.376 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -106.11 151.56 24.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.68 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.619 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.35 110.32 22.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.04 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.818 ' O ' HD22 ' A' ' 273' ' ' LEU . 36.9 mt -81.26 -34.17 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.196 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 170.63 178.01 41.05 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.098 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.982 ' HB3' HG23 ' A' ' 360' ' ' THR . 16.9 ptmt -164.44 140.47 6.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.192 0.52 . . . . 0.0 111.729 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.921 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.24 158.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.116 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.501 ' HB3' HG13 ' A' ' 358' ' ' VAL . 44.1 p90 -140.68 150.63 43.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 111.345 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 378' ' ' VAL . 15.4 m . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.997 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.485 0.183 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 31.0 tp -68.94 -32.82 72.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 110.336 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -66.93 -30.07 70.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.253 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.58 ' CD2' HD12 ' A' ' 280' ' ' LEU . 20.1 t-160 -77.9 -52.77 8.32 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.646 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.527 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 65.0 t-105 -51.57 -49.02 62.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.074 0.464 . . . . 0.0 109.764 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.2 t -65.69 -29.99 70.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.721 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.516 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.4 OUTLIER -62.54 -43.76 98.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.753 179.037 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.851 ' CE ' HD11 ' A' ' 352' ' ' ILE . 29.8 ttp -60.39 -52.48 65.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.665 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.739 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.7 mt -57.96 -33.37 68.79 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.36 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -67.89 -30.52 69.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.305 0.574 . . . . 0.0 109.692 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.3 m-80 -114.92 71.41 2.63 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.591 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.541 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 41.4 Cg_endo -68.7 32.95 0.16 Allowed 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.23 2.62 . . . . 0.0 113.534 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 398' ' ' ARG . . . . . 0.541 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 0.5 OUTLIER -158.77 -44.56 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.933 0.397 . . . . 0.0 110.77 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.417 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.0 OUTLIER -93.84 137.6 23.07 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.154 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 58.3 Cg_endo -71.43 156.37 58.51 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.571 2.181 . . . . 0.0 112.902 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -126.14 116.11 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.786 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.85 144.71 34.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.312 . . . . 0.0 110.828 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.34 154.25 10.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.37 . . . . 0.0 111.344 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -81.97 120.9 25.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.921 ' HB3' HG11 ' A' ' 376' ' ' VAL . 55.2 m-70 -109.61 122.36 47.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.457 HG23 ' OD1' ' A' ' 275' ' ' ASP . 85.4 m -78.26 117.27 19.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.674 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.761 HD23 HG22 ' A' ' 376' ' ' VAL . 45.2 mt -61.73 127.81 33.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.013 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -115.32 169.58 9.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.888 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.877 ' O ' HG23 ' A' ' 413' ' ' VAL . 41.1 t -55.59 121.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.973 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.619 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 6.7 mt-10 -55.17 -40.6 70.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.451 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.75 -51.13 71.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.469 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.456 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.1 mt-10 -63.57 -40.13 96.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 375' ' ' LYS . 98.6 t -56.45 -48.03 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.295 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 24.0 t0 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.745 179.89 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.772 HD22 ' O ' ' A' ' 373' ' ' ILE . 47.9 mt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.911 0.386 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 127.57 -162.52 21.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.335 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.32 133.37 22.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.691 0.281 . . . . 0.0 110.731 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.873 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -123.04 128.98 75.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.302 0.573 . . . . 0.0 111.165 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.873 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -96.26 126.71 41.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.556 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.622 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.2 p90 -142.16 149.51 39.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.474 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -100.94 160.47 14.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.04 -178.767 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.89 HD12 ' CD2' ' A' ' 389' ' ' HIS . 67.0 mt -130.21 147.05 51.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.162 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 290' ' ' THR . 0.7 OUTLIER -158.86 106.48 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 0.0 111.141 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 1.0 ' CD1' HD13 ' A' ' 352' ' ' ILE . 38.0 t80 -99.12 139.4 34.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.549 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 287' ' ' GLY . 98.9 t -114.89 93.8 35.54 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.97 0.414 . . . . 0.0 109.956 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.669 ' HD3' ' HB3' ' A' ' 397' ' ' PRO . 16.7 Cg_exo -66.33 -31.38 43.52 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.916 2.411 . . . . 0.0 112.343 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -28.39 67.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.807 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -123.66 -2.92 8.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.677 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 62.97 46.55 93.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.09 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -121.98 128.83 51.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.059 0.457 . . . . 0.0 111.338 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.462 HD21 ' CG2' ' A' ' 357' ' ' VAL . 32.8 tp -93.08 147.64 22.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.332 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 343' ' ' PHE . 1.8 m -136.0 137.34 41.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.344 0.592 . . . . 0.0 111.857 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.1 t -129.95 122.98 55.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.439 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 341' ' ' GLU . 24.0 t -116.21 116.12 51.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.979 0.418 . . . . 0.0 111.788 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.702 HG13 HG21 ' A' ' 328' ' ' THR . 34.8 mm -76.09 136.89 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.447 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.21 -59.62 1.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -177.728 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.486 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 2.2 pt-20 -175.64 156.79 1.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.479 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.793 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -117.59 150.63 38.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.766 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.405 ' HE3' ' CE3' ' A' ' 404' ' ' TRP . 11.3 pttp -147.73 152.36 37.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 111.507 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 62.92 24.24 14.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.833 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.793 HD21 ' HB1' ' A' ' 296' ' ' ALA . 60.7 mt -59.79 138.68 57.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.997 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -67.01 147.99 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.705 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.438 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 20.0 mttp -81.11 120.9 25.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.581 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.465 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 4.5 mmm -101.13 -15.38 17.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.644 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 52.9 m-20 -98.52 123.05 42.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.839 0.352 . . . . 0.0 110.548 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.0 t -48.07 114.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.627 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 56.77 17.89 22.86 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.274 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.13 -159.72 10.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.06 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 6.6 mt -95.56 -161.67 0.88 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 110.466 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.527 ' HB2' HD23 ' A' ' 335' ' ' LEU . 14.4 m -133.99 171.81 13.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.278 0.561 . . . . 0.0 111.181 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.418 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 13.7 m-20 -131.87 56.11 21.99 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.627 ' CG ' HD13 ' A' ' 299' ' ' LEU . 58.5 Cg_endo -73.01 146.28 41.29 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.047 2.498 . . . . 0.0 114.842 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.53 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 42.2 p90 -146.2 165.85 27.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.171 -1.377 . . . . 0.0 107.948 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.897 HG22 HG22 ' A' ' 361' ' ' VAL . 48.1 t -115.11 149.95 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.84 ' HE3' HD13 ' A' ' 362' ' ' LEU . 13.0 mttt -129.44 164.48 23.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.042 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.542 HG23 HG13 ' A' ' 357' ' ' VAL . 4.8 mp -137.86 124.97 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.689 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -119.46 135.56 54.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.89 0.376 . . . . 0.0 111.313 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 345' ' ' PHE . 20.5 tp -103.92 105.55 15.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.457 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.1 mtm -111.04 127.9 55.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.408 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.771 ' HB2' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -91.38 99.6 12.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.283 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 3.7 m120 55.16 38.1 29.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.024 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 91.79 27.48 16.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.867 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 317' ' ' MET . 2.3 mptt -130.71 109.39 10.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.732 0.301 . . . . 0.0 110.843 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.503 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.9 OUTLIER -51.35 130.42 27.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.364 -179.793 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 318' ' ' GLN . 15.9 mt -124.58 -58.93 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.132 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.66 152.06 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.8 128.86 20.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.709 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -125.71 167.31 15.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.98 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.418 ' CB ' ' HG2' ' A' ' 313' ' ' LYS . 36.6 pttt -147.54 148.66 31.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.142 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.784 HG22 ' CE1' ' A' ' 343' ' ' PHE . 9.7 p -104.7 179.83 4.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.749 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.581 HG22 ' OE2' ' A' ' 341' ' ' GLU . 10.1 t -59.15 172.28 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.53 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.4 mt -116.96 125.1 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.955 0.407 . . . . 0.0 111.377 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.62 ' O ' HG22 ' A' ' 334' ' ' THR . 0.2 OUTLIER -91.08 91.45 8.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.281 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -58.83 137.09 57.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.833 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 333' ' ' ASN . . . . . 0.454 ' C ' HD13 ' A' ' 307' ' ' LEU . 0.9 OUTLIER 44.54 80.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.413 179.106 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.706 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.7 t -172.98 173.49 3.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.556 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 334' ' ' THR . 3.2 mt -146.99 -14.75 0.41 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.391 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.486 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.8 m-80 -135.81 57.63 19.78 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 120.704 0.288 . . . . 0.0 110.506 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 45.5 Cg_endo -92.79 167.82 2.58 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.155 2.57 . . . . 0.0 113.721 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.447 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.6 OUTLIER -106.31 160.76 15.12 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.192 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.623 ' HB2' HG22 ' A' ' 293' ' ' ILE . 66.1 m-85 -132.65 -66.83 0.67 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.916 0.388 . . . . 0.0 110.982 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 60.72 37.35 19.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.843 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.581 ' OE2' HG22 ' A' ' 329' ' ' THR . 29.9 mt-10 -93.65 143.91 25.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 93.1 p -113.21 121.92 45.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.007 0.432 . . . . 0.0 111.481 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.784 ' CE1' HG22 ' A' ' 328' ' ' THR . 36.7 m-85 -110.42 164.85 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.321 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 21.6 m -137.49 140.1 40.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.092 0.472 . . . . 0.0 111.679 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 316' ' ' LEU . 38.3 m-85 -126.88 166.0 18.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.503 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.33 72.99 0.79 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.727 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.824 HG13 ' HB3' ' A' ' 351' ' ' GLN . 46.9 t -108.38 121.08 44.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.135 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.562 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 68.5 Cg_endo -74.4 157.84 44.93 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.358 2.038 . . . . 0.0 111.247 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -50.9 -22.23 2.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -89.15 -8.46 53.65 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.824 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -111.98 -27.19 8.52 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 1.0 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.5 tp -48.37 -26.92 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.741 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 353' ' ' GLN . . . . . 0.544 ' NE2' HD13 ' A' ' 394' ' ' LEU . 3.6 mm-40 -95.09 -26.58 15.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.618 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -92.32 -0.66 57.37 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.883 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 351' ' ' GLN . 24.8 m -110.24 163.18 7.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.92 0.39 . . . . 0.0 111.317 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.24 126.33 21.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.62 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.542 HG13 HG23 ' A' ' 314' ' ' ILE . 98.9 t -90.88 111.81 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.533 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.529 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.6 OUTLIER -99.95 109.39 24.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.399 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.553 ' HB ' HG23 ' A' ' 376' ' ' VAL . 48.8 t -90.48 108.0 19.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.978 HG23 ' HB3' ' A' ' 375' ' ' LYS . 1.5 m -108.25 133.43 52.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.02 0.438 . . . . 0.0 111.894 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.897 HG22 HG22 ' A' ' 312' ' ' VAL . 51.1 t -108.3 114.8 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.839 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.84 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.5 mp -118.3 150.05 40.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.063 0.458 . . . . 0.0 111.838 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.465 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 1.3 t70 -95.53 132.36 40.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.679 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -83.74 146.2 28.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.538 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 . . . . . 0 CA--C 1.531 0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.7 -179.372 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.523 -0.068 0 CA-C-O 120.94 0.4 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.94 139.38 35.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.675 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -87.71 111.57 21.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.882 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.772 ' O ' HD22 ' A' ' 273' ' ' LEU . 37.2 mt -79.78 -34.42 15.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.01 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.92 -179.81 40.97 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.961 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.978 ' HB3' HG23 ' A' ' 360' ' ' THR . 9.6 ptmt -164.6 140.62 5.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.513 . . . . 0.0 111.81 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.957 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -109.47 158.89 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.128 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.471 ' CD1' HG13 ' A' ' 413' ' ' VAL . 17.6 p90 -139.58 151.4 46.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 0.0 111.813 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 378' ' ' VAL . 17.0 m . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.03 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.729 0.299 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.76 -35.96 79.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.463 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 392' ' ' ASP . 4.0 mtt85 -61.77 -41.37 97.62 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.978 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.89 ' CD2' HD12 ' A' ' 280' ' ' LEU . 13.9 t-160 -60.99 -55.69 29.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.738 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.469 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 62.5 t-105 -55.44 -50.99 68.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.462 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -37.26 86.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.312 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.554 ' HB3' HD12 ' A' ' 401' ' ' ILE . 14.8 m-20 -63.07 -32.83 74.29 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.712 ' CE ' HD11 ' A' ' 352' ' ' ILE . 26.0 ttp -63.42 -56.4 16.54 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.776 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -56.38 -23.26 36.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.715 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.4 ' C ' ' HD3' ' A' ' 397' ' ' PRO . . . -78.99 -33.63 44.87 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.372 0.606 . . . . 0.0 109.374 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.426 ' N ' ' HD3' ' A' ' 397' ' ' PRO . 28.6 m-80 -130.1 59.76 47.45 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.459 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.669 ' HB3' ' HD3' ' A' ' 284' ' ' PRO . 65.5 Cg_exo -46.28 -76.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.921 2.414 . . . . 0.0 112.992 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -49.45 -21.94 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.87 133.49 27.67 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 110.881 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.3 Cg_endo -75.21 133.76 16.66 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.492 2.128 . . . . 0.0 112.614 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.1 mm -111.68 110.75 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.803 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.18 143.96 34.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.783 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.43 152.39 7.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.874 0.369 . . . . 0.0 111.378 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' TRP . . . . . 0.405 ' CE3' ' HE3' ' A' ' 297' ' ' LYS . 63.3 m95 -80.12 124.09 28.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.686 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.957 ' HB3' HG11 ' A' ' 376' ' ' VAL . 61.0 m-70 -112.31 123.0 49.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.628 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 91.5 m -78.36 117.08 19.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.653 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.755 HD23 HG22 ' A' ' 376' ' ' VAL . 80.9 mt -62.45 127.73 32.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.077 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -115.85 170.26 8.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.791 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.857 ' O ' HG23 ' A' ' 413' ' ' VAL . 61.1 t -55.22 117.39 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.812 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.675 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 6.3 mp0 -52.01 -43.09 63.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.832 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -58.06 -50.16 74.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.738 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.455 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 23.0 mt-10 -64.04 -38.8 92.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 409' ' ' VAL . 89.0 t -57.43 -48.32 83.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.286 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 33.1 t0 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.468 179.504 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.792 HD22 ' O ' ' A' ' 373' ' ' ILE . 55.0 mt . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.922 0.391 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 135.16 -170.16 23.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.19 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ASP . . . . . 0.64 ' OD1' HG23 ' A' ' 406' ' ' THR . 3.2 m-20 -136.74 135.15 37.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.719 0.295 . . . . 0.0 111.01 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.795 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -125.37 128.7 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.03 0.443 . . . . 0.0 110.875 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.795 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.5 OUTLIER -97.37 126.6 42.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.826 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.612 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.0 p90 -142.22 152.15 42.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.406 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.49 163.4 12.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.005 -178.786 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.673 HD12 ' CD2' ' A' ' 389' ' ' HIS . 96.1 mt -136.81 143.43 43.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.281 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -159.13 110.76 2.11 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.884 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.858 ' CD1' HD13 ' A' ' 352' ' ' ILE . 26.9 t80 -104.42 139.15 39.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.802 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.54 97.22 42.48 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.537 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.84 -33.47 7.9 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.669 2.246 . . . . 0.0 112.632 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -29.36 6.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.165 0.507 . . . . 0.0 109.983 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.29 -18.16 8.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.945 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.79 48.87 8.29 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.548 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -123.69 129.9 51.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.986 0.422 . . . . 0.0 111.621 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.904 HD11 ' HE1' ' A' ' 393' ' ' MET . 38.5 tp -97.42 147.49 24.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.977 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 2.8 m -137.61 137.21 38.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.429 0.633 . . . . 0.0 111.965 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.7 t -130.92 123.6 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.162 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 341' ' ' GLU . 23.9 t -117.9 115.13 47.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.057 0.456 . . . . 0.0 111.794 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.622 HG13 HG21 ' A' ' 328' ' ' THR . 40.0 mm -74.83 137.11 23.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.02 -59.4 2.02 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 4.7 pt-20 -175.75 162.89 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.415 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.739 ' CB ' HD11 ' A' ' 299' ' ' LEU . . . -122.31 153.06 39.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.897 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -149.61 150.02 31.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.104 0.478 . . . . 0.0 111.534 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 60.38 26.27 15.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.878 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.739 HD11 ' CB ' ' A' ' 296' ' ' ALA . 94.2 mt -62.08 138.75 58.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.832 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.81 150.7 23.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.57 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.409 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 23.6 mttt -91.58 115.84 28.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.423 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.516 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.5 mmt -88.56 -19.26 26.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.541 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 50.1 m-20 -99.26 112.16 24.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.512 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -49.27 116.37 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.476 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 65.69 12.74 57.5 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.536 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.17 -151.01 7.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.75 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 307' ' ' LEU . 10.6 mt -108.29 -161.51 0.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.697 0.284 . . . . 0.0 110.68 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.622 ' HB2' HD23 ' A' ' 335' ' ' LEU . 49.8 m -137.68 172.04 13.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.369 0.604 . . . . 0.0 111.276 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.407 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 8.7 m-20 -131.38 57.86 34.13 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.735 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.44 ' CB ' HD13 ' A' ' 299' ' ' LEU . 45.0 Cg_endo -69.74 151.92 69.32 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.196 2.597 . . . . 0.0 114.729 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.513 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 35.0 p90 -154.35 155.44 35.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.108 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.871 HG22 HG22 ' A' ' 361' ' ' VAL . 47.1 t -106.38 149.79 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.762 ' HE3' HD13 ' A' ' 362' ' ' LEU . 9.9 mtmt -131.93 140.99 49.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.307 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.551 HD11 HD11 ' A' ' 293' ' ' ILE . 5.3 mp -115.79 127.74 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.556 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -122.39 133.4 54.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.369 . . . . 0.0 111.378 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.661 HD23 ' HG3' ' A' ' 324' ' ' LYS . 38.7 tp -106.39 107.53 18.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.095 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.1 mtm -116.12 147.82 40.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.391 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.67 ' HG3' HD11 ' A' ' 323' ' ' LEU . 0.1 OUTLIER -107.0 99.47 9.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.521 179.535 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 56.55 37.83 29.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 96.6 13.82 46.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.166 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 317' ' ' MET . 32.3 mmtt -119.18 109.12 15.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.808 0.304 . . . . 0.0 110.734 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.48 135.37 56.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.4 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.67 HD11 ' HG3' ' A' ' 318' ' ' GLN . 3.3 mt -127.08 -49.36 1.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.849 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.661 ' HG3' HD23 ' A' ' 316' ' ' LEU . 2.5 mttt -130.53 148.97 52.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.962 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.25 119.54 10.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.753 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -122.96 155.88 35.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.423 ' HB3' ' HG2' ' A' ' 313' ' ' LYS . 14.6 ptmt -137.58 148.58 45.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.842 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.73 HG22 ' CE1' ' A' ' 343' ' ' PHE . 4.3 p -101.71 -179.0 3.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.844 0.354 . . . . 0.0 110.712 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.0 t -60.45 162.2 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.468 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.513 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.6 mt -105.07 121.92 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.921 0.391 . . . . 0.0 111.219 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.479 ' HB3' HG21 ' A' ' 334' ' ' THR . 0.7 OUTLIER -85.6 94.65 9.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.109 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -60.8 136.8 58.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.928 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 43.83 83.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.51 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.738 ' O ' HD23 ' A' ' 335' ' ' LEU . 3.5 t -177.06 174.5 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.879 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 334' ' ' THR . 4.3 mt -145.26 -16.86 0.49 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.294 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 296' ' ' ALA . 1.1 m-80 -131.42 61.68 60.41 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.862 0.363 . . . . 0.0 110.05 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.413 ' HB2' ' CD ' ' A' ' 331' ' ' LYS . 64.6 Cg_endo -88.57 167.63 6.11 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.145 2.564 . . . . 0.0 114.045 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 58.8 t80 -114.09 153.18 29.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.846 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.538 ' HB2' HG22 ' A' ' 293' ' ' ILE . 83.9 m-85 -132.98 -69.83 0.55 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.85 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 340' ' ' ASN . . . . . 0.505 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 26.2 t-20 64.45 37.21 8.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.505 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.541 ' O ' HG13 ' A' ' 292' ' ' VAL . 31.3 mt-10 -91.42 142.9 27.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.787 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 13.7 m -110.28 122.18 47.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 0.0 111.581 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.73 ' CE1' HG22 ' A' ' 328' ' ' THR . 65.6 m-85 -113.2 148.36 35.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.091 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 3.0 m -120.8 140.0 52.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.1 0.476 . . . . 0.0 111.554 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.511 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 45.0 m-85 -126.88 165.87 18.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.437 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -116.62 76.1 1.01 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.958 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.907 HG13 ' HB3' ' A' ' 351' ' ' GLN . 55.7 t -109.16 122.92 38.31 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.209 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.529 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.4 Cg_endo -72.3 156.43 54.93 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.293 1.996 . . . . 0.0 111.3 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -50.68 -21.92 1.82 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.67 -8.5 52.27 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.907 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -107.88 -31.36 8.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.858 HD13 ' CD1' ' A' ' 282' ' ' TYR . 6.4 tp -46.81 -27.28 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 111.319 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -90.02 -47.54 7.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.627 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.446 ' CG ' ' HA ' ' A' ' 351' ' ' GLN . 5.9 ptpt -80.72 2.18 27.1 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 351' ' ' GLN . 33.1 m -107.66 165.38 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.729 0.299 . . . . 0.0 110.872 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.67 126.46 15.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.087 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.561 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 61.4 t -88.54 114.14 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.276 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.498 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.4 OUTLIER -100.16 116.29 43.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.756 -179.169 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.553 HG13 ' CG1' ' A' ' 312' ' ' VAL . 58.3 t -98.46 108.11 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.856 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.932 HG23 ' HB3' ' A' ' 375' ' ' LYS . 1.6 m -108.73 132.68 53.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.998 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.871 HG22 HG22 ' A' ' 312' ' ' VAL . 54.6 t -105.93 114.96 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.636 178.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.762 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.3 mp -118.71 147.84 43.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.096 0.474 . . . . 0.0 111.895 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.516 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.8 t70 -93.8 137.36 33.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.744 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -90.09 145.62 24.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.376 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 . . . . . 0 C--N 1.33 -0.268 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.288 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.916 0.388 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.01 148.9 37.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.15 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.65 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -95.4 110.89 22.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.792 ' O ' HD22 ' A' ' 273' ' ' LEU . 23.9 mt -79.59 -32.88 14.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.316 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 374' ' ' GLY . . . . . 0.44 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 166.48 -178.87 40.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.746 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.932 ' HB3' HG23 ' A' ' 360' ' ' THR . 10.9 ptmt -164.54 141.04 6.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.181 0.515 . . . . 0.0 111.686 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.899 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.86 158.79 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.226 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.498 ' HB3' HG13 ' A' ' 358' ' ' VAL . 8.3 p90 -141.78 143.03 33.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.374 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 378' ' ' VAL . 7.6 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.082 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.409 ' OE1' ' CZ ' ' A' ' 377' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.57 0.224 . . . . 0.0 110.984 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.9 tp -67.96 -30.91 70.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.781 0.324 . . . . 0.0 110.43 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 5.1 ptt180 -68.23 -28.21 67.03 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.329 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.673 ' CD2' HD12 ' A' ' 280' ' ' LEU . 18.4 t-160 -81.33 -54.48 5.44 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.456 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.561 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 48.2 t-105 -49.96 -43.97 50.44 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.008 0.432 . . . . 0.0 109.863 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 31.3 t -69.72 -34.1 73.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.694 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.467 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.5 OUTLIER -61.08 -39.57 90.4 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.664 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.904 ' HE1' HD11 ' A' ' 289' ' ' LEU . 19.8 ttm -59.42 -53.79 54.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.115 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.798 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.9 mt -63.81 -29.74 70.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.374 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.82 -31.02 71.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.226 0.536 . . . . 0.0 109.694 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -125.3 77.86 67.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.329 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.537 ' HB3' ' CG ' ' A' ' 284' ' ' PRO . 6.0 Cg_exo -77.8 42.76 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.145 2.564 . . . . 0.0 113.162 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 398' ' ' ARG . . . . . 0.505 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 16.2 mmm-85 -158.98 -46.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.069 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.21 142.84 25.45 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.925 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 63.4 Cg_endo -73.01 156.27 52.2 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.654 2.236 . . . . 0.0 112.904 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.81 114.69 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.749 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.91 144.21 35.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.759 0.314 . . . . 0.0 110.832 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.43 154.68 10.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.959 0.409 . . . . 0.0 111.291 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -81.38 120.35 24.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.959 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.899 ' HB3' HG11 ' A' ' 376' ' ' VAL . 48.3 m-70 -109.56 117.72 34.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.459 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.64 HG23 ' OD1' ' A' ' 275' ' ' ASP . 89.8 m -78.43 116.22 18.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.792 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.825 HD23 HG22 ' A' ' 376' ' ' VAL . 93.7 mt -61.09 128.12 34.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.347 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.417 ' C ' HD12 ' A' ' 273' ' ' LEU . 5.2 mt-30 -115.47 171.96 7.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.558 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.888 ' O ' HG23 ' A' ' 413' ' ' VAL . 44.2 t -54.59 120.72 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.65 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 14.8 mt-10 -54.29 -41.56 69.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.815 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.16 -51.33 70.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 0.0 110.539 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.49 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 24.6 mt-10 -62.49 -39.83 94.73 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.889 HG11 ' HG3' ' A' ' 375' ' ' LYS . 75.6 t -57.64 -50.11 78.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.378 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 58.2 t0 . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.887 179.982 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 373' ' ' ILE . 22.0 mt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.827 0.346 . . . . 0.0 110.811 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 117.75 -163.98 12.73 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.177 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ASP . . . . . 0.49 ' OD1' HG23 ' A' ' 406' ' ' THR . 28.3 m-20 -143.6 132.18 22.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.731 0.301 . . . . 0.0 110.589 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.912 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -121.04 131.57 72.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.184 0.516 . . . . 0.0 111.184 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.912 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -99.59 125.08 45.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.709 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.626 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 16.0 p90 -139.91 150.69 44.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.24 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.0 OUTLIER -99.62 158.03 16.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.056 -178.473 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.555 HD13 ' HE3' ' A' ' 393' ' ' MET . 77.3 mt -129.44 144.87 51.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.018 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.416 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 22.7 ttp85 -158.89 109.22 2.02 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.702 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.834 ' CD1' HD13 ' A' ' 352' ' ' ILE . 26.1 t80 -103.39 137.98 40.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.93 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.0 t -122.29 94.6 47.78 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.541 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.5 Cg_exo -70.04 -32.63 17.06 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.939 2.426 . . . . 0.0 112.44 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.44 -30.03 7.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.184 0.516 . . . . 0.0 110.015 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.53 -21.45 7.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.962 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.92 48.44 6.11 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.549 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -124.04 130.18 52.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.983 0.421 . . . . 0.0 111.803 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.754 HD11 ' HE1' ' A' ' 393' ' ' MET . 33.2 tp -95.66 147.5 23.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.74 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 343' ' ' PHE . 7.1 m -138.19 136.58 36.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.31 0.576 . . . . 0.0 112.001 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.36 123.92 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.297 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 341' ' ' GLU . 34.8 t -118.06 115.44 48.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.976 0.417 . . . . 0.0 112.006 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.712 HG22 ' HB2' ' A' ' 339' ' ' TYR . 31.3 mm -73.85 135.34 27.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.62 -62.76 1.53 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.486 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 1.6 pt-20 -175.55 150.15 1.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.247 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.87 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -110.46 157.77 19.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.168 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -150.98 153.41 35.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.014 0.435 . . . . 0.0 111.724 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 59.08 25.2 13.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.93 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.87 HD21 ' HB1' ' A' ' 296' ' ' ALA . 49.6 mt -59.04 138.63 57.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.168 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.83 144.78 47.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.415 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 25.5 mttp -85.69 109.64 18.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.42 ' HG2' ' HB3' ' A' ' 363' ' ' ASP . 0.0 OUTLIER -86.13 -21.62 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.872 -179.404 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 50.5 m-20 -95.39 123.56 38.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 20.5 t -54.19 117.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.546 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.11 16.74 34.61 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.407 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.84 -154.92 8.71 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.679 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 15.1 mt -102.26 -161.36 0.84 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.788 0.327 . . . . 0.0 110.43 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.646 ' HB2' HD23 ' A' ' 335' ' ' LEU . 68.8 m -135.32 172.05 13.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.231 0.539 . . . . 0.0 110.972 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -133.53 55.86 18.09 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.738 ' CG ' HD13 ' A' ' 299' ' ' LEU . 69.5 Cg_endo -76.71 142.58 23.02 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.944 2.429 . . . . 0.0 114.93 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.604 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 14.7 p90 -137.46 167.05 22.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.36 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.906 HG22 HG22 ' A' ' 361' ' ' VAL . 43.1 t -113.05 150.07 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.837 ' HE2' HD13 ' A' ' 362' ' ' LEU . 7.5 mttm -133.41 139.91 47.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.189 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 293' ' ' ILE . 5.4 mp -114.63 131.01 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.685 0.279 . . . . 0.0 111.03 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -127.37 134.08 49.97 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.863 0.363 . . . . 0.0 111.015 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 324' ' ' LYS . 22.5 tp -103.99 106.47 16.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.409 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.6 mtm -110.7 135.33 51.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.138 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.721 ' HB2' HD11 ' A' ' 323' ' ' LEU . 0.5 OUTLIER -95.48 99.46 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.546 179.628 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 59.58 35.66 22.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.301 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 98.21 7.99 55.56 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.676 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.712 ' HG3' HD21 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -115.47 112.74 22.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.387 0.593 . . . . 0.0 110.94 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.513 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.4 OUTLIER -52.25 134.19 33.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.526 -179.581 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.721 HD11 ' HB2' ' A' ' 318' ' ' GLN . 13.4 mt -125.91 -45.95 1.71 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.104 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 9.5 mmtp -130.59 153.63 48.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.364 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 117.31 10.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.903 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.451 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 3.4 mmtm -123.63 164.68 18.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.104 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.52 152.68 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.97 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.727 HG22 ' CE1' ' A' ' 343' ' ' PHE . 16.1 p -109.83 -178.89 3.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 11.3 t -63.0 165.85 6.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.604 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.9 mt -108.49 117.29 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 111.509 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.659 ' O ' HG22 ' A' ' 334' ' ' THR . 8.3 mmpt? -80.07 85.95 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.875 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -55.12 135.84 48.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.021 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.32 83.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.49 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.773 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.5 t -175.63 174.39 2.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.681 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.773 HD23 ' O ' ' A' ' 334' ' ' THR . 5.2 mt -145.59 -17.16 0.48 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.185 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.486 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.72 56.53 22.98 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.908 0.385 . . . . 0.0 110.123 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 42.7 Cg_endo -90.1 167.79 4.51 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.203 2.602 . . . . 0.0 113.746 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -109.63 159.6 16.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.167 179.244 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.712 ' HB2' HG22 ' A' ' 293' ' ' ILE . 51.1 m-85 -132.48 -62.32 0.83 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.68 37.42 25.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.564 ' O ' HG13 ' A' ' 292' ' ' VAL . 30.1 mt-10 -92.47 144.47 25.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.706 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 51.6 p -115.48 120.76 40.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.393 . . . . 0.0 111.749 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.727 ' CE1' HG22 ' A' ' 328' ' ' THR . 80.8 m-85 -112.38 155.06 24.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.11 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 83.4 p -127.16 139.62 52.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.083 0.468 . . . . 0.0 111.591 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.451 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 66.3 m-85 -127.89 165.86 19.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.545 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.56 79.93 1.33 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.998 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' A' ' 351' ' ' GLN . 47.9 t -112.16 118.99 45.04 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.991 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.449 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 37.2 Cg_endo -66.52 154.02 75.88 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.321 2.014 . . . . 0.0 111.353 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -51.9 -24.74 6.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.752 0.31 . . . . 0.0 111.444 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.27 -8.57 57.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.54 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.551 ' HB3' HG13 ' A' ' 347' ' ' VAL . 31.2 mt-30 -105.99 -37.14 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.667 0.27 . . . . 0.0 111.329 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.834 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.7 tp -47.13 -25.52 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 111.195 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -88.99 -24.86 22.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.831 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.41 ' HG3' ' HA ' ' A' ' 351' ' ' GLN . 0.6 OUTLIER -111.69 2.14 17.08 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.012 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 351' ' ' GLN . 33.8 m -96.77 167.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.766 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -141.28 126.33 18.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.928 0.394 . . . . 0.0 111.472 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.571 ' CG2' HD21 ' A' ' 289' ' ' LEU . 99.6 t -96.93 115.33 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.833 178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.4 OUTLIER -101.22 117.17 46.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.529 ' HB ' HG23 ' A' ' 376' ' ' VAL . 45.9 t -98.22 107.85 20.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.435 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.966 HG23 ' HB3' ' A' ' 375' ' ' LYS . 4.7 m -111.28 129.58 55.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.054 0.454 . . . . 0.0 111.9 -178.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.906 HG22 HG22 ' A' ' 312' ' ' VAL . 58.5 t -103.81 121.1 54.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.074 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.837 HD13 ' HE2' ' A' ' 313' ' ' LYS . 2.8 mp -123.18 146.26 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 111.816 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 310' ' ' PRO . 5.0 t70 -90.17 137.62 32.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.642 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.405 ' CB ' HG21 ' A' ' 330' ' ' ILE . 25.0 t80 -94.14 142.52 27.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.425 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.584 -179.488 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.902 0.382 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' ASP . . . . . 0.415 ' HB2' ' HG2' ' A' ' 302' ' ' MET . 1.3 m-20 -71.23 147.25 48.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.51 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -91.7 110.22 21.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.094 0.473 . . . . 0.0 111.373 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.589 ' O ' HD22 ' A' ' 273' ' ' LEU . 2.4 mm -71.95 -35.57 54.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.783 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 374' ' ' GLY . . . . . 0.426 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 157.38 -175.16 34.84 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.117 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.966 ' HB3' HG23 ' A' ' 360' ' ' THR . 9.9 ptmt -164.1 140.5 6.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.287 0.565 . . . . 0.0 111.906 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.944 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.71 158.85 13.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.219 179.375 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.513 ' HB3' HG13 ' A' ' 358' ' ' VAL . 2.6 p90 -140.45 150.85 44.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.563 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.151 179.837 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 . . . . . 0 CA--C 1.52 -0.197 0 CA-C-O 120.903 0.382 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.45 -30.91 71.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.368 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 4.7 ptt180 -65.52 -28.63 69.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.312 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.441 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 19.7 t-160 -81.56 -58.13 3.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.715 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.561 ' CZ3' ' HE1' ' A' ' 393' ' ' MET . 73.9 t-105 -49.82 -46.32 50.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.07 0.462 . . . . 0.0 109.979 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 5.4 t -64.49 -32.94 74.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.593 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.54 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.6 OUTLIER -65.47 -40.46 93.19 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.639 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.776 ' SD ' HD11 ' A' ' 352' ' ' ILE . 7.1 ttm -57.86 -53.06 62.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.378 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.724 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.8 mt -61.94 -34.37 75.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.359 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.65 -29.71 69.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.181 0.515 . . . . 0.0 109.943 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -114.1 71.04 2.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.754 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.543 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 48.6 Cg_endo -70.07 33.98 0.21 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.167 2.578 . . . . 0.0 113.486 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 398' ' ' ARG . . . . . 0.543 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 10.2 mmm180 -159.25 -47.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.952 0.406 . . . . 0.0 110.952 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.486 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 36.1 ttt180 -93.94 136.66 23.55 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.385 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.486 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 48.6 Cg_endo -68.48 156.41 65.71 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.601 2.201 . . . . 0.0 112.939 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.54 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.37 118.72 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.797 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -105.64 144.58 32.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.839 0.352 . . . . 0.0 110.729 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.07 154.51 15.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.159 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -85.81 119.28 25.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.774 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.944 ' HB3' HG11 ' A' ' 376' ' ' VAL . 58.4 m-70 -108.56 122.16 46.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.251 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.49 HG23 ' OD1' ' A' ' 275' ' ' ASP . 89.9 m -78.08 117.41 19.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.721 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.737 HD23 HG22 ' A' ' 376' ' ' VAL . 67.5 mt -61.66 127.57 32.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.2 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.477 ' C ' HD12 ' A' ' 273' ' ' LEU . 6.0 mt-30 -115.0 169.07 9.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.755 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.889 ' O ' HG23 ' A' ' 413' ' ' VAL . 45.0 t -56.76 121.25 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.479 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 5.7 mt-10 -52.2 -44.83 64.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.993 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.06 -49.66 75.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 110.74 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.444 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 29.8 mt-10 -64.59 -38.76 92.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 409' ' ' VAL . 96.3 t -58.24 -49.49 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.381 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 t70 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.829 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.793 HD22 ' O ' ' A' ' 373' ' ' ILE . 60.8 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.868 0.366 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.24 -165.73 13.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.233 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.18 133.06 27.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.806 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -121.94 129.56 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.088 0.47 . . . . 0.0 110.914 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.806 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -96.86 125.35 41.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.668 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.609 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.6 p90 -142.08 149.29 39.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.406 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.97 161.31 13.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.269 -178.632 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.635 HD12 ' CD2' ' A' ' 389' ' ' HIS . 11.3 mt -133.27 149.67 51.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.942 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.418 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.1 OUTLIER -158.92 105.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.446 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.908 ' CD1' HD13 ' A' ' 352' ' ' ILE . 30.7 t80 -98.19 134.87 40.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.832 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.51 97.88 48.56 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.526 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.9 Cg_exo -72.46 -31.49 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.691 2.261 . . . . 0.0 112.377 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.26 -30.26 6.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.294 0.569 . . . . 0.0 109.715 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.16 -17.38 8.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.767 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.11 47.94 10.46 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.689 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -123.31 129.38 51.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.934 0.397 . . . . 0.0 111.853 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.464 HD21 ' CG2' ' A' ' 357' ' ' VAL . 36.5 tp -92.59 147.66 22.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.796 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 2.9 m -137.16 138.54 40.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.323 0.582 . . . . 0.0 112.091 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.1 t -131.42 123.91 53.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.449 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 341' ' ' GLU . 29.0 t -116.74 115.3 48.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.942 0.401 . . . . 0.0 111.848 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.712 HG13 HG21 ' A' ' 328' ' ' THR . 31.6 mm -75.83 133.7 30.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.57 -59.86 1.89 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.476 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 7.3 pt-20 -175.72 165.17 3.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.241 0.543 . . . . 0.0 112.081 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.911 ' CB ' HD11 ' A' ' 299' ' ' LEU . . . -127.84 155.35 44.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.258 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.402 ' HD2' ' CH2' ' A' ' 404' ' ' TRP . 10.4 ptmt -149.7 150.2 31.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 111.5 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 59.87 26.34 15.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.735 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.911 HD11 ' CB ' ' A' ' 296' ' ' ALA . 87.5 mt -64.83 139.0 58.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.108 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -57.62 145.61 33.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.381 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.622 ' HG3' HD21 ' A' ' 335' ' ' LEU . 0.0 OUTLIER -94.94 127.77 41.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.405 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.509 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 14.7 mmt -97.78 -9.82 25.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.405 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 25.4 m-20 -108.52 119.17 38.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.718 0.294 . . . . 0.0 110.445 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.32 118.77 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.576 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 76.86 2.18 75.83 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.195 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' GLY . . . . . 0.407 ' O ' HD23 ' A' ' 307' ' ' LEU . . . -120.82 -123.26 3.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.932 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 333' ' ' ASN . 44.0 mt -137.32 -159.28 0.94 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.906 0.384 . . . . 0.0 110.071 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.506 ' HB3' ' HD3' ' A' ' 310' ' ' PRO . 0.2 OUTLIER -140.13 167.98 20.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.933 0.397 . . . . 0.0 110.255 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.08 64.43 52.8 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 308' ' ' SER . 60.7 Cg_endo -74.03 142.68 31.49 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.827 2.351 . . . . 0.0 114.697 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 43.1 p90 -144.25 158.52 43.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.212 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.838 HG22 HG22 ' A' ' 361' ' ' VAL . 44.2 t -107.82 149.91 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.409 0.623 . . . . 0.0 112.625 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.854 ' HE3' HD13 ' A' ' 362' ' ' LEU . 9.7 mtmt -132.85 136.94 46.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.517 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.576 HG23 HG13 ' A' ' 357' ' ' VAL . 5.4 mp -107.97 136.97 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.513 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 77.9 m80 -130.89 133.6 46.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.379 . . . . 0.0 111.131 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.474 HD21 HG22 ' A' ' 347' ' ' VAL . 35.0 tp -106.79 110.23 22.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.376 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.7 mtm -118.99 139.73 51.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.939 0.4 . . . . 0.0 111.378 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.551 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -99.63 99.44 10.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.411 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 13.8 m120 53.02 38.1 26.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.4 26.82 12.83 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.87 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.8 mptt -129.23 109.3 11.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.706 0.288 . . . . 0.0 110.779 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.501 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -52.14 130.0 29.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.52 -179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.551 HD11 ' CB ' ' A' ' 318' ' ' GLN . 11.5 mt -125.86 -55.04 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.973 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -130.62 150.71 51.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.319 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' LYS . . . . . 0.422 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -144.45 123.41 12.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.422 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 21.6 mmtt -125.19 170.79 10.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.407 ' HB3' ' HG2' ' A' ' 313' ' ' LYS . 0.5 OUTLIER -150.25 147.01 27.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.897 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.755 HG22 ' CE1' ' A' ' 343' ' ' PHE . 5.5 p -104.27 -178.71 3.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.758 0.313 . . . . 0.0 110.782 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 13.9 t -60.33 164.02 4.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.432 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.569 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.9 mt -108.11 116.87 52.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.973 0.416 . . . . 0.0 111.379 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.612 ' O ' HG22 ' A' ' 334' ' ' THR . 0.7 OUTLIER -78.81 85.93 4.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.034 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -53.51 136.45 38.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.167 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 333' ' ' ASN . . . . . 0.529 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.1 p-10 43.6 86.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.277 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.627 ' O ' HD23 ' A' ' 335' ' ' LEU . 5.0 t 177.31 173.16 0.5 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.52 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.627 HD23 ' O ' ' A' ' 334' ' ' THR . 2.8 mt -144.28 -15.29 0.58 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.357 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.434 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.0 OUTLIER -132.6 61.14 55.11 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-O 120.857 0.361 . . . . 0.0 110.039 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 52.0 Cg_endo -91.21 167.71 3.55 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.196 2.597 . . . . 0.0 114.028 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.476 ' CD1' ' HB3' ' A' ' 295' ' ' GLU . 20.7 t80 -110.76 154.09 24.41 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.748 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.553 ' HB2' HG22 ' A' ' 293' ' ' ILE . 75.8 m-85 -131.39 -68.93 0.64 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.855 0.36 . . . . 0.0 111.727 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 340' ' ' ASN . . . . . 0.421 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 0.1 OUTLIER 63.71 36.65 10.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.703 -179.4 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.551 ' O ' HG13 ' A' ' 292' ' ' VAL . 37.4 mt-10 -91.8 144.68 25.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.6 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 51.5 p -114.87 121.81 44.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.934 0.397 . . . . 0.0 111.656 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.755 ' CE1' HG22 ' A' ' 328' ' ' THR . 63.6 m-85 -113.75 151.84 31.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.163 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 87.9 p -125.97 138.89 53.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.155 0.502 . . . . 0.0 111.789 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.435 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 56.9 m-85 -125.42 166.05 17.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.585 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -113.27 78.21 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.913 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.89 HG13 ' HB3' ' A' ' 351' ' ' GLN . 48.6 t -110.6 122.12 39.25 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.82 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.525 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.4 Cg_endo -72.54 157.55 52.51 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.352 2.035 . . . . 0.0 111.657 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -51.46 -21.89 2.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.841 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.33 -8.54 53.04 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.89 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -109.86 -30.31 7.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.908 HD13 ' CD1' ' A' ' 282' ' ' TYR . 6.4 tp -47.4 -28.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.811 0.338 . . . . 0.0 111.026 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -95.0 -25.82 16.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.897 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -95.1 0.84 54.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.875 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 351' ' ' GLN . 17.2 m -113.18 161.11 12.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.833 0.349 . . . . 0.0 111.302 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -137.1 126.34 24.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.713 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 314' ' ' ILE . 91.6 t -87.08 107.43 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.402 . . . . 0.0 110.248 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.453 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.7 OUTLIER -93.36 113.68 28.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.592 -179.29 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.542 ' HB ' HG23 ' A' ' 376' ' ' VAL . 41.7 t -96.69 107.74 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.915 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.959 HG23 ' HB3' ' A' ' 375' ' ' LYS . 1.7 m -109.01 131.34 55.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.966 0.412 . . . . 0.0 111.774 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.838 HG22 HG22 ' A' ' 312' ' ' VAL . 50.5 t -106.16 114.95 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.946 178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.854 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.5 mp -118.3 150.54 39.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.025 0.44 . . . . 0.0 111.885 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.509 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.1 t70 -94.76 131.37 40.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.361 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.467 ' CB ' HG21 ' A' ' 330' ' ' ILE . 25.1 t80 -85.67 146.91 26.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.759 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.321 -179.553 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.874 0.369 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 371' ' ' ASP . . . . . 0.429 ' HB2' ' HG3' ' A' ' 302' ' ' MET . 1.8 m-20 -85.8 151.3 23.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.035 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.604 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.07 111.34 23.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.974 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.793 ' O ' HD22 ' A' ' 273' ' ' LEU . 31.3 mt -80.97 -34.08 13.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.086 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' GLY . . . . . 0.455 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 167.29 -178.96 41.16 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.88 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.959 ' HB3' HG23 ' A' ' 360' ' ' THR . 14.7 ptmt -164.59 141.07 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.196 0.522 . . . . 0.0 111.792 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.95 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.78 158.99 13.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.189 179.516 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.453 ' HB3' HG13 ' A' ' 358' ' ' VAL . 2.8 p90 -141.04 144.77 35.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 0.0 111.266 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 378' ' ' VAL . 13.5 m . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.115 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.567 0.223 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 20.5 tp -66.13 -31.75 72.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.867 0.365 . . . . 0.0 110.387 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -65.12 -29.69 70.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.456 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.635 ' CD2' HD12 ' A' ' 280' ' ' LEU . 20.3 t-160 -77.99 -53.07 7.84 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.535 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 55.7 t-105 -51.36 -49.23 61.89 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.177 0.513 . . . . 0.0 109.993 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -29.32 69.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.696 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.469 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.5 OUTLIER -61.98 -42.54 99.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.672 178.854 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.747 ' CE ' HD11 ' A' ' 352' ' ' ILE . 27.9 ttp -59.53 -52.61 64.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.58 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.771 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.9 mt -60.87 -30.01 69.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.361 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.98 -33.02 75.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.218 0.532 . . . . 0.0 109.584 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -126.24 77.9 71.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.278 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.539 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 2.7 Cg_exo -75.79 44.37 1.27 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.238 2.625 . . . . 0.0 113.258 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 398' ' ' ARG . . . . . 0.539 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 0.4 OUTLIER -158.12 -46.52 0.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.231 179.675 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.428 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.3 OUTLIER -94.15 139.43 22.53 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.721 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 56.7 Cg_endo -70.48 156.16 62.05 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.548 2.165 . . . . 0.0 113.015 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.02 113.73 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.603 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.24 145.01 32.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.731 0.301 . . . . 0.0 110.801 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.95 154.39 11.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.912 0.386 . . . . 0.0 111.195 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' TRP . . . . . 0.402 ' CH2' ' HD2' ' A' ' 297' ' ' LYS . 64.0 m95 -81.6 120.52 25.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.95 ' HB3' HG11 ' A' ' 376' ' ' VAL . 49.1 m-70 -108.86 121.87 45.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.427 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.0 m -78.3 116.44 18.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.89 HD23 HG22 ' A' ' 376' ' ' VAL . 96.6 mt -62.45 128.1 34.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.004 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.441 ' C ' HD12 ' A' ' 273' ' ' LEU . 7.6 mt-30 -116.9 171.64 7.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.778 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.897 ' O ' HG23 ' A' ' 413' ' ' VAL . 43.5 t -56.57 120.81 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.604 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 19.0 mt-10 -53.73 -43.25 68.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.857 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -57.31 -49.52 75.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 0.0 110.602 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.448 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 30.7 mt-10 -64.55 -39.28 93.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 409' ' ' VAL . 74.8 t -58.57 -49.93 80.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.258 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 18.3 t0 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.921 179.918 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.81 HD22 ' O ' ' A' ' 373' ' ' ILE . 42.5 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.83 0.347 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 125.17 -160.63 19.77 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.271 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ASP . . . . . 0.485 ' OD1' HG23 ' A' ' 406' ' ' THR . 11.9 m-20 -147.13 131.93 17.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.733 0.301 . . . . 0.0 110.75 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.796 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -119.97 132.2 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.144 0.497 . . . . 0.0 111.174 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.796 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -99.48 126.01 45.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.758 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.617 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.7 p90 -141.94 151.53 42.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.303 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.68 160.75 14.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.987 -178.451 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.674 HD12 ' CD2' ' A' ' 389' ' ' HIS . 98.2 mt -134.44 144.18 47.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.318 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -159.02 111.19 2.18 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.909 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' TYR . . . . . 0.923 ' CD1' HD13 ' A' ' 352' ' ' ILE . 25.1 t80 -104.45 138.85 40.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.977 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.04 94.29 47.37 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.544 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.5 Cg_exo -70.24 -33.86 14.01 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.916 2.411 . . . . 0.0 112.385 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -30.23 5.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.157 0.503 . . . . 0.0 110.019 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.72 -20.0 8.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.985 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.75 48.16 6.8 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.639 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.57 130.27 52.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.008 0.433 . . . . 0.0 111.703 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.967 HD11 ' HE1' ' A' ' 393' ' ' MET . 28.7 tp -97.82 147.53 24.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.868 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 343' ' ' PHE . 12.2 m -138.82 136.67 35.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.272 0.558 . . . . 0.0 112.002 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.411 HG21 HG11 ' A' ' 357' ' ' VAL . 11.9 t -129.15 125.36 62.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.372 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 341' ' ' GLU . 24.5 t -119.2 115.34 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.965 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.715 HG13 HG21 ' A' ' 328' ' ' THR . 34.3 mm -74.69 137.02 23.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.463 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.6 OUTLIER -114.22 -62.22 1.63 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.759 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.456 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 1.9 pt-20 -175.02 150.27 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.568 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.756 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -109.5 154.65 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.931 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.92 152.42 33.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.045 0.45 . . . . 0.0 111.552 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 61.29 24.19 14.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.853 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.756 HD21 ' HB1' ' A' ' 296' ' ' ALA . 66.5 mt -59.14 141.23 54.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.109 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.524 ' HD2' ' HE2' ' A' ' 302' ' ' MET . 3.5 ttmt -63.69 146.4 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.424 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.611 ' HE3' HD11 ' A' ' 335' ' ' LEU . 17.8 mttt -84.91 116.99 23.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.522 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' MET . . . . . 0.524 ' HE2' ' HD2' ' A' ' 300' ' ' LYS . 10.5 mmt -93.46 -18.89 21.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.488 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 35.7 m-20 -103.98 102.65 12.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.852 0.358 . . . . 0.0 110.573 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.14 116.46 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.445 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 83.98 -4.34 83.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.811 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.53 -149.1 7.23 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.881 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 60.3 mt -107.49 -159.97 0.71 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.01 0.433 . . . . 0.0 110.79 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.624 ' HB2' HD23 ' A' ' 335' ' ' LEU . 73.4 m -132.9 172.22 12.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.252 0.549 . . . . 0.0 110.725 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.92 57.58 32.71 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.673 ' CG ' HD13 ' A' ' 299' ' ' LEU . 74.2 Cg_endo -76.23 143.42 25.29 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.02 2.48 . . . . 0.0 114.901 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.619 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 8.5 p90 -140.48 168.12 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.124 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.858 HG22 HG22 ' A' ' 361' ' ' VAL . 42.5 t -116.36 149.96 18.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.371 0.605 . . . . 0.0 112.508 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.665 ' HE3' HD13 ' A' ' 362' ' ' LEU . 9.2 mttm -131.0 152.76 49.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.383 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.56 HG23 HG13 ' A' ' 357' ' ' VAL . 5.3 mp -123.18 135.09 64.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.763 0.316 . . . . 0.0 110.579 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 79.9 m80 -130.98 132.54 45.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.35 . . . . 0.0 110.994 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.3 tp -105.79 106.67 17.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.407 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.8 mtm -111.58 126.78 55.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.131 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.961 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.4 OUTLIER -95.77 99.56 11.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.477 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 59.91 37.76 21.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.706 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.09 21.43 49.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.675 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -121.65 109.65 15.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.745 0.307 . . . . 0.0 110.806 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 10.8 ptt85 -51.25 128.07 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.351 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.961 HD11 ' CB ' ' A' ' 318' ' ' GLN . 9.3 mt -123.6 -49.53 1.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -135.03 147.92 49.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 325' ' ' LYS . . . . . 0.42 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.4 OUTLIER -144.09 120.56 11.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.584 179.616 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -125.5 166.43 16.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.231 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -142.87 149.92 39.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.793 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.715 HG21 HG13 ' A' ' 293' ' ' ILE . 20.7 p -104.75 176.52 5.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.029 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.2 p -59.6 162.43 5.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.577 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.619 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.2 mt -105.84 123.88 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 111.434 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.619 ' O ' HG22 ' A' ' 334' ' ' THR . 9.7 mmtm -89.16 88.17 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.049 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -55.1 136.3 48.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.987 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 333' ' ' ASN . . . . . 0.409 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.3 p-10 43.91 87.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.311 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.772 ' O ' HD23 ' A' ' 335' ' ' LEU . 3.9 t -179.11 174.55 1.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.518 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.772 HD23 ' O ' ' A' ' 334' ' ' THR . 4.7 mt -145.96 -16.91 0.46 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.203 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 336' ' ' ASN . . . . . 0.467 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.5 m-80 -133.46 57.77 28.85 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.774 0.321 . . . . 0.0 110.283 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 53.3 Cg_endo -90.16 167.76 4.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.204 2.602 . . . . 0.0 113.738 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 338' ' ' TYR . . . . . 0.463 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.5 OUTLIER -110.15 159.07 17.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.305 179.549 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 339' ' ' TYR . . . . . 0.612 ' HB2' HG22 ' A' ' 293' ' ' ILE . 6.1 m-85 -134.25 -62.29 0.76 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.31 38.65 23.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.669 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.557 ' O ' HG13 ' A' ' 292' ' ' VAL . 32.1 mt-10 -91.91 143.2 26.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.77 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 4.2 m -114.03 119.51 37.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 111.656 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' PHE . . . . . 0.708 ' CE1' HG22 ' A' ' 328' ' ' THR . 78.3 m-85 -111.02 153.77 25.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.248 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 73.5 m -128.38 142.29 51.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.012 0.434 . . . . 0.0 111.408 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -130.85 165.87 22.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -114.02 76.22 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.675 HG13 ' HB3' ' A' ' 351' ' ' GLN . 48.2 t -109.04 125.27 31.93 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.017 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.537 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 73.9 Cg_endo -76.67 155.42 35.35 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.499 2.132 . . . . 0.0 111.678 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -50.95 -23.13 2.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.839 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.23 -8.6 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' GLN . . . . . 0.675 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -112.69 -31.69 6.67 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.696 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.923 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.0 tp -47.98 -27.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 111.134 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -92.14 -20.69 20.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.616 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -99.92 -21.32 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.679 0.276 . . . . 0.0 111.638 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.92 167.88 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.919 0.39 . . . . 0.0 111.222 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -148.59 126.95 12.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.028 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.584 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 47.7 t -86.9 114.19 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.637 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.636 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.2 OUTLIER -97.63 109.68 23.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.205 -179.514 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.526 ' HB ' HG23 ' A' ' 376' ' ' VAL . 26.8 t -93.48 107.76 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.979 HG23 ' HB3' ' A' ' 375' ' ' LYS . 11.0 m -109.33 141.08 42.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.91 0.386 . . . . 0.0 111.575 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.858 HG22 HG22 ' A' ' 312' ' ' VAL . 41.8 t -115.46 120.2 64.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.072 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.665 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.5 mp -124.62 147.21 48.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.058 0.456 . . . . 0.0 111.679 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.522 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.9 OUTLIER -91.96 134.47 34.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.328 179.552 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 365' ' ' ASP . 7.0 t80 -90.83 141.73 28.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.0 110.831 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' ASP . . . . . 0.463 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 14.0 m-20 . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.89 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.13 0 CA-C-O 120.85 0.357 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.81 149.39 21.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.52 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.3 110.99 23.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.12 0.486 . . . . 0.0 110.977 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.81 ' O ' HD22 ' A' ' 273' ' ' LEU . 43.6 mt -83.44 -34.54 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.192 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.57 175.02 37.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.037 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.979 ' HB3' HG23 ' A' ' 360' ' ' THR . 11.6 ptmt -160.47 140.96 11.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.217 0.532 . . . . 0.0 111.779 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.943 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -111.61 159.21 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.472 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.636 ' HB3' HG13 ' A' ' 358' ' ' VAL . 20.8 p90 -143.1 131.98 22.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.985 0.422 . . . . 0.0 111.133 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 378' ' ' VAL . 19.6 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.045 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.667 0.27 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 42.0 tp -59.38 -33.95 71.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 0.0 110.582 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 23.6 mtm180 -61.46 -49.34 77.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.343 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.674 ' CD2' HD12 ' A' ' 280' ' ' LEU . 14.8 t-160 -60.76 -57.93 10.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.792 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' TRP . . . . . 0.584 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 58.0 t-105 -49.52 -44.29 46.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.05 0.452 . . . . 0.0 110.004 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 4.7 t -68.57 -36.81 79.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.803 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' ASP . . . . . 0.437 ' HB3' HD12 ' A' ' 401' ' ' ILE . 1.9 t0 -63.08 -36.22 82.85 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' MET . . . . . 0.967 ' HE1' HD11 ' A' ' 289' ' ' LEU . 10.2 ttm -61.84 -55.09 33.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.189 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.752 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.1 mt -60.85 -33.26 72.79 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.331 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.37 -29.81 70.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.276 0.56 . . . . 0.0 109.84 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -114.97 71.68 2.73 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.596 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.544 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 50.4 Cg_endo -70.47 33.88 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.186 2.59 . . . . 0.0 113.616 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 398' ' ' ARG . . . . . 0.518 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 23.7 mmm-85 -159.51 -44.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.922 0.391 . . . . 0.0 110.972 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.4 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 1.7 tpp180 -93.96 140.48 22.96 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.455 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 57.0 Cg_endo -70.43 156.47 61.53 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.742 2.295 . . . . 0.0 112.751 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -128.15 113.45 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.818 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.27 144.46 32.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 110.82 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.67 153.71 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.963 0.411 . . . . 0.0 111.235 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 404' ' ' TRP . . . . . 0.413 ' CZ3' ' HB2' ' A' ' 277' ' ' CYS . 55.8 m95 -83.02 120.01 25.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.943 ' HB3' HG11 ' A' ' 376' ' ' VAL . 45.4 m-70 -108.21 120.82 43.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.576 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.485 HG23 ' OD1' ' A' ' 275' ' ' ASP . 89.2 m -78.36 116.21 18.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.024 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.879 HD23 HG22 ' A' ' 376' ' ' VAL . 84.8 mt -62.47 128.2 34.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.288 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -114.82 170.9 7.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.512 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 413' ' ' VAL . 47.0 t -52.71 115.77 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.52 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 4.1 mp0 -54.77 -43.07 72.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.79 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -55.35 -47.55 75.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.802 0.334 . . . . 0.0 110.537 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.441 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 35.2 mt-10 -64.24 -48.71 74.74 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 409' ' ' VAL . 92.0 t -48.86 -45.41 15.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.771 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.8 t70 . . . . . 0 C--N 1.333 -0.147 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.837 179.067 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.82 0.343 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 373' ' ' ILE . 34.8 mt -108.84 -40.16 5.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.92 -162.71 16.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.266 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -144.01 135.41 25.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.77 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.875 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -124.46 128.95 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.097 0.475 . . . . 0.0 110.914 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.875 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -98.03 127.15 43.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.717 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.615 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.5 p90 -141.85 150.26 41.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.012 0.434 . . . . 0.0 110.341 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.62 161.67 13.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.018 -178.603 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.746 HD12 ' CD2' ' A' ' 389' ' ' HIS . 94.8 mt -133.57 143.9 48.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.15 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.94 106.82 1.84 Allowed 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.972 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.918 ' CD1' HD13 ' A' ' 352' ' ' ILE . 25.7 t80 -100.68 137.44 39.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.986 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.61 94.76 48.38 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.547 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 8.1 Cg_exo -69.89 -33.9 15.21 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.937 2.425 . . . . 0.0 112.425 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.51 -30.19 4.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.196 0.522 . . . . 0.0 110.042 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.44 -20.29 8.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.967 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.31 48.65 6.7 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.542 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -124.58 129.8 51.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 0.0 111.792 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.791 HD11 ' HE1' ' A' ' 393' ' ' MET . 33.2 tp -95.42 147.6 23.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.805 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 7.4 m -138.48 134.52 34.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.385 0.612 . . . . 0.0 111.936 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 8.7 t -127.24 123.13 61.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.206 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 341' ' ' GLU . 22.1 t -117.24 114.95 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.912 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.688 HG13 HG21 ' A' ' 328' ' ' THR . 35.9 mm -74.59 136.95 24.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.424 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.02 -60.9 1.82 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.44 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 0.9 OUTLIER -175.61 157.42 2.05 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.488 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.833 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -117.12 151.73 36.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.773 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -148.08 153.54 39.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.612 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 60.98 23.98 14.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.872 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.833 HD21 ' HB1' ' A' ' 296' ' ' ALA . 50.3 mt -58.92 138.79 57.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.07 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.04 146.9 53.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.504 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.43 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 16.0 mttt -85.41 114.39 22.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.581 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.458 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 9.9 mmm -92.93 -18.81 22.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.729 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 46.7 m-20 -96.17 118.35 32.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.844 0.355 . . . . 0.0 110.635 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.15 116.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.426 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 60.05 16.57 41.14 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.334 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.59 -157.08 9.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.8 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 16.5 mt -100.82 -160.38 0.79 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 110.492 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.542 ' HB2' HD23 ' A' ' 335' ' ' LEU . 15.2 m -135.07 172.03 13.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.239 0.542 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.419 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 8.9 m-20 -133.69 56.36 19.89 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.738 ' CG ' HD13 ' A' ' 299' ' ' LEU . 64.6 Cg_endo -75.39 141.71 25.86 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.044 2.496 . . . . 0.0 114.75 -177.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.568 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 17.1 p90 -139.85 165.31 27.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.424 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.849 HG22 HG22 ' A' ' 361' ' ' VAL . 42.4 t -112.81 149.98 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.822 ' HE2' HD13 ' A' ' 362' ' ' LEU . 6.6 mttm -132.02 151.92 51.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.197 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.469 HG23 HG13 ' A' ' 357' ' ' VAL . 5.2 mp -125.51 133.96 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.763 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.44 125.69 37.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.815 0.34 . . . . 0.0 111.181 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.499 HD23 ' HG3' ' A' ' 324' ' ' LYS . 27.5 tp -96.01 106.68 18.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.312 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.4 mtm -112.68 145.6 40.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 111.467 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.729 ' CG ' HD11 ' A' ' 323' ' ' LEU . 0.9 OUTLIER -99.44 99.73 10.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.066 179.299 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 10.9 p30 42.83 37.45 1.08 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.386 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 104.46 28.85 5.59 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.982 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 317' ' ' MET . 0.2 OUTLIER -136.99 109.38 7.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.725 0.298 . . . . 0.0 110.885 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.407 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.1 OUTLIER -54.13 130.84 39.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.729 HD11 ' CG ' ' A' ' 318' ' ' GLN . 7.6 mt -125.0 -51.66 1.67 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.202 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.499 ' HG3' HD23 ' A' ' 316' ' ' LEU . 2.2 mttt -130.62 153.42 48.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.037 0.446 . . . . 0.0 111.516 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.11 130.5 33.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.431 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.447 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 44.6 mmtt -135.44 160.38 38.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.96 0.409 . . . . 0.0 111.314 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 0.0 OUTLIER -148.68 143.52 26.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.796 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.739 HG22 ' CE1' ' A' ' 343' ' ' PHE . 14.5 p -101.22 176.63 5.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.95 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 10.1 t -56.96 169.88 0.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.504 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.568 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.3 mt -112.39 120.59 62.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.948 0.404 . . . . 0.0 111.465 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.662 ' O ' HG22 ' A' ' 334' ' ' THR . 3.7 mmpt? -82.74 84.59 7.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.762 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.23 135.45 44.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.082 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.3 83.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.39 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.695 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.8 t -176.86 174.08 1.82 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.748 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 334' ' ' THR . 4.3 mt -145.06 -16.33 0.51 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.322 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.49 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 4.9 m-80 -132.9 55.63 18.19 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.863 0.364 . . . . 0.0 110.213 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 51.4 Cg_endo -88.64 167.64 6.02 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.137 2.558 . . . . 0.0 113.636 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.44 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -110.9 160.02 17.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.3 179.181 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.626 ' HB2' HG22 ' A' ' 293' ' ' ILE . 86.6 m-85 -133.45 -63.63 0.75 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 111.325 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 58.36 37.55 25.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.753 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.545 ' O ' HG13 ' A' ' 292' ' ' VAL . 41.9 mt-10 -91.39 142.99 27.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.808 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.94 120.08 40.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.416 . . . . 0.0 111.566 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.739 ' CE1' HG22 ' A' ' 328' ' ' THR . 52.2 m-85 -112.58 146.74 38.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.208 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 18.1 p -118.97 142.2 47.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 0.0 111.457 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.447 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 40.0 m-85 -129.63 165.83 20.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.517 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -116.57 79.81 1.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.512 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.656 HG11 ' HA ' ' A' ' 352' ' ' ILE . 24.7 t -110.11 122.74 37.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.438 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 24.4 Cg_exo -62.19 147.92 94.15 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.51 2.14 . . . . 0.0 111.464 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -53.95 -24.02 15.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 111.336 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -91.64 -8.66 46.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.564 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.431 ' CB ' ' HD2' ' A' ' 348' ' ' PRO . 1.1 tt0 -106.52 -25.54 11.8 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.918 HD13 ' CD1' ' A' ' 282' ' ' TYR . 2.1 tp -48.68 -27.68 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 110.66 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLN . . . . . 0.458 HE21 HD22 ' A' ' 394' ' ' LEU . 20.2 mt-30 -90.57 -23.08 20.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.107 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -95.58 -4.83 43.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 31.3 m -106.61 167.77 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.881 0.372 . . . . 0.0 111.306 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -144.49 126.49 15.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.039 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.639 ' O ' HG22 ' A' ' 378' ' ' VAL . 66.8 t -90.83 115.64 30.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.268 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.3 OUTLIER -101.29 116.83 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.755 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.549 ' HB ' HG23 ' A' ' 376' ' ' VAL . 48.3 t -97.33 108.06 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.939 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.96 HG23 ' HB3' ' A' ' 375' ' ' LYS . 6.5 m -110.68 133.81 53.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.027 0.442 . . . . 0.0 111.801 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.849 HG22 HG22 ' A' ' 312' ' ' VAL . 42.9 t -107.57 119.8 57.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.13 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.822 HD13 ' HE2' ' A' ' 313' ' ' LYS . 3.5 mp -121.46 148.0 45.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.978 0.418 . . . . 0.0 111.741 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.458 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 4.1 t70 -92.8 131.97 37.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.358 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.573 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 26.0 t80 -87.97 146.95 25.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.66 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 367' ' ' ILE . 23.2 m-20 -142.73 61.62 1.42 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.462 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.625 ' HG2' HD12 ' A' ' 367' ' ' ILE . 12.9 tttp 34.78 -89.66 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.625 HD12 ' HG2' ' A' ' 366' ' ' LYS . 4.5 mp -84.82 -66.42 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.694 0.283 . . . . 0.0 111.209 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -43.53 163.5 0.04 OUTLIER Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.925 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 31.2 tttp -65.79 159.34 25.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.22 122.15 28.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.17 151.02 44.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.431 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.836 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -95.89 109.8 22.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 0.0 111.352 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.466 ' O ' HD22 ' A' ' 273' ' ' LEU . 0.9 OUTLIER -73.34 -35.25 45.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.78 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 156.13 179.05 30.88 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.059 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.96 ' HB3' HG23 ' A' ' 360' ' ' THR . 0.0 OUTLIER -160.23 142.32 12.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.363 0.601 . . . . 0.0 112.029 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.913 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -109.22 158.67 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.879 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.591 ' HB3' HG13 ' A' ' 358' ' ' VAL . 19.7 p90 -141.41 141.96 33.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.059 0.457 . . . . 0.0 111.721 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 357' ' ' VAL . 17.1 m -132.29 135.72 57.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.791 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.453 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 144.14 -156.15 26.59 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.145 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -46.42 -73.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 416' ' ' MET . 3.5 m-20 -52.48 -23.66 6.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.032 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' SER . . . . . 0.413 ' O ' HG23 ' A' ' 383' ' ' THR . 12.1 m -65.19 159.81 22.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 110.857 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 382' ' ' SER . 39.3 p -158.04 155.08 28.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.002 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 78.6 -128.85 8.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.65 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -67.29 -29.91 69.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 111.264 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.404 ' HB2' ' HB3' ' A' ' 382' ' ' SER . 1.3 mt-10 -71.94 -49.02 41.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.614 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.47 -34.62 78.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.569 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 385' ' ' ALA . 4.5 ptm180 -64.18 -35.78 81.89 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.269 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.746 ' CD2' HD12 ' A' ' 280' ' ' LEU . 18.8 t-160 -67.43 -53.56 28.03 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.163 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.537 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 68.2 t-105 -54.99 -40.62 70.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.017 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -42.13 76.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.989 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 7.7 t0 -59.86 -34.31 72.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.638 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.791 ' HE1' HD11 ' A' ' 289' ' ' LEU . 8.4 ttm -60.36 -56.65 18.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.405 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.768 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.0 OUTLIER -58.82 -29.96 67.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.472 178.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.55 -31.49 70.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.188 0.518 . . . . 0.0 109.942 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -114.29 70.79 2.09 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.639 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.55 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 43.4 Cg_endo -69.08 35.37 0.19 Allowed 'Trans proline' 0 N--CA 1.474 0.364 0 C-N-CA 123.291 2.661 . . . . 0.0 113.642 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ARG . . . . . 0.55 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 19.8 mmt85 -159.95 -44.35 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.955 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.91 142.17 24.68 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.57 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 58.3 Cg_endo -71.18 156.38 59.48 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.661 2.241 . . . . 0.0 112.953 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -127.74 110.26 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.664 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -103.73 144.36 31.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.844 0.354 . . . . 0.0 110.833 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.25 153.21 11.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.29 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -81.95 120.72 25.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.736 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.913 ' HB3' HG11 ' A' ' 376' ' ' VAL . 60.5 m-70 -111.28 118.37 35.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 85.0 m -78.24 116.7 18.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.946 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.791 HD23 HG22 ' A' ' 376' ' ' VAL . 95.9 mt -61.59 127.35 31.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.313 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -113.42 167.17 10.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.54 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 413' ' ' VAL . 90.5 t -52.58 117.85 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.836 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 8.6 mt-10 -50.48 -45.79 56.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.153 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -55.34 -45.96 76.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 0.0 110.947 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.499 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 16.5 mt-10 -66.71 -38.58 87.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 409' ' ' VAL . 73.4 t -58.39 -48.15 85.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.255 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -65.73 -31.78 72.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.537 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.21 80.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.586 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' MET . . . . . 0.493 ' O ' ' ND2' ' A' ' 381' ' ' ASN . 15.0 mtt -65.33 -50.05 67.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.461 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.2 mt -58.17 -30.68 66.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.941 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.49 118.98 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.04 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.081 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.848 0.356 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 373' ' ' ILE . 63.8 mt -90.74 -32.79 16.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 118.2 -166.08 12.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.231 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.533 ' OD1' HG23 ' A' ' 406' ' ' THR . 12.3 m-20 -142.86 132.53 23.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.776 0.322 . . . . 0.0 110.63 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.846 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -120.17 130.75 73.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.163 0.506 . . . . 0.0 111.03 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.846 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.84 124.7 42.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.732 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.659 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 19.1 p90 -141.96 148.22 38.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.436 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 292' ' ' VAL . 0.0 OUTLIER -101.04 160.9 13.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.175 -178.6 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.609 HD12 ' CD2' ' A' ' 389' ' ' HIS . 9.2 mt -133.66 150.25 51.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.03 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -158.81 112.14 2.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.243 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.92 ' CD1' HD13 ' A' ' 352' ' ' ILE . 32.7 t80 -106.14 131.66 53.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.766 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.46 98.04 50.94 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.501 ' CG ' ' CB ' ' A' ' 397' ' ' PRO . 6.4 Cg_exo -71.06 -33.26 12.02 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.673 2.249 . . . . 0.0 112.67 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.2 -29.76 6.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.181 0.515 . . . . 0.0 110.058 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.81 -21.67 8.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.957 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.81 48.78 6.41 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.747 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -124.98 130.05 51.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.994 0.426 . . . . 0.0 111.68 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.469 HD21 ' CG2' ' A' ' 357' ' ' VAL . 30.5 tp -93.79 147.89 22.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.092 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.9 m -135.16 140.66 45.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.305 0.574 . . . . 0.0 112.022 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 18.2 t -134.01 120.91 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.357 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 341' ' ' GLU . 32.3 t -116.19 116.3 51.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.012 0.434 . . . . 0.0 112.057 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.683 HG22 ' HB2' ' A' ' 339' ' ' TYR . 40.1 mm -74.96 135.69 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.649 HD22 ' OE1' ' A' ' 295' ' ' GLU . 0.7 OUTLIER -113.47 -61.89 1.67 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.649 ' OE1' HD22 ' A' ' 294' ' ' LEU . 11.1 pm0 -174.16 148.16 1.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.512 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.808 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -108.38 153.63 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.006 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.84 152.49 33.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.077 0.465 . . . . 0.0 111.488 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.7 m120 61.02 24.75 14.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.808 HD21 ' HB1' ' A' ' 296' ' ' ALA . 60.3 mt -59.66 139.01 57.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.222 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.68 143.77 53.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.404 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.427 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 15.9 mttp -84.61 115.18 22.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.601 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.52 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.6 mmt -90.74 -20.0 22.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.408 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 41.9 m-20 -99.81 123.79 44.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.876 0.369 . . . . 0.0 110.709 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 48.8 t -60.56 118.83 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.215 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 64.0 13.51 53.04 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.718 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.89 -144.46 6.19 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.694 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' A' ' 333' ' ' ASN . 19.9 mt -115.46 -159.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.848 0.356 . . . . 0.0 110.511 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 334' ' ' THR . 5.6 m -138.26 172.01 13.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.314 0.578 . . . . 0.0 110.92 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.96 71.5 77.9 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.616 ' CG ' HD13 ' A' ' 299' ' ' LEU . 95.3 Cg_endo -87.73 143.27 6.07 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.526 2.151 . . . . 0.0 115.351 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.581 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 9.8 p90 -139.49 167.65 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.039 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.802 HG22 HG22 ' A' ' 361' ' ' VAL . 42.7 t -118.0 149.56 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.386 0.612 . . . . 0.0 112.504 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.827 ' HE3' HD13 ' A' ' 362' ' ' LEU . 13.8 mttt -131.09 146.97 52.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.292 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.475 ' N ' HD12 ' A' ' 314' ' ' ILE . 4.6 mp -122.6 131.87 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.622 0.248 . . . . 0.0 111.089 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -130.17 134.89 47.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.93 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 347' ' ' VAL . 26.7 tp -104.14 107.17 17.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.612 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.74 126.67 52.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.904 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.4 OUTLIER -95.16 99.8 11.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.499 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 3.4 m120 60.15 37.92 20.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.727 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.03 22.35 45.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.78 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt -123.85 109.56 13.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.452 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -54.19 130.7 39.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.904 HD11 ' CB ' ' A' ' 318' ' ' GLN . 6.9 mt -126.71 -42.21 1.79 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.234 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -130.6 147.69 52.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.212 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 115.61 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.954 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -124.09 166.51 15.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.48 149.51 30.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.07 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.662 HG21 HG13 ' A' ' 293' ' ' ILE . 21.2 p -106.11 174.05 6.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.736 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.76 174.07 0.37 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.43 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.581 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.7 mt -119.87 118.96 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.051 0.453 . . . . 0.0 111.688 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.732 ' HB3' HG21 ' A' ' 334' ' ' THR . 0.0 OUTLIER -82.57 91.19 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.249 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -56.88 137.21 55.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.885 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ASN . . . . . 0.51 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.0 OUTLIER 46.85 83.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.592 179.214 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.749 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.5 t -177.2 174.05 1.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.486 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.749 HD23 ' O ' ' A' ' 334' ' ' THR . 4.0 mt -146.17 -16.22 0.45 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.401 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.478 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.9 m-80 -133.97 57.18 22.97 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.486 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 59.2 Cg_endo -90.41 167.74 4.23 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.095 2.53 . . . . 0.0 113.662 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.411 ' CZ ' ' OE1' ' A' ' 295' ' ' GLU . 1.3 t80 -105.26 160.68 14.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.201 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.683 ' HB2' HG22 ' A' ' 293' ' ' ILE . 9.3 m-85 -131.72 -65.38 0.76 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.963 0.411 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 59.11 36.85 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.946 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.559 ' O ' HG13 ' A' ' 292' ' ' VAL . 41.8 mt-10 -93.92 144.79 25.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.78 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 98.5 p -116.56 123.07 46.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 0.0 111.375 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.61 ' CE1' HG22 ' A' ' 328' ' ' THR . 66.0 m-85 -116.35 150.61 37.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.192 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 41.8 p -121.53 143.16 49.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.119 0.485 . . . . 0.0 111.462 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -129.58 164.95 22.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.572 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.71 80.32 1.36 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.637 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 351' ' ' GLN . 71.0 t -113.09 123.77 32.88 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.117 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 351' ' ' GLN . 56.1 Cg_endo -70.69 153.4 64.66 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.491 2.127 . . . . 0.0 111.523 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -51.21 -24.14 4.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.489 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -85.42 -8.6 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.823 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.753 ' O ' HG22 ' A' ' 355' ' ' VAL . 24.5 mt-30 -107.21 -36.79 6.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.653 0.264 . . . . 0.0 111.62 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.92 HD13 ' CD1' ' A' ' 282' ' ' TYR . 6.1 tp -46.45 -27.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.846 0.355 . . . . 0.0 111.118 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLN . . . . . 0.441 ' O ' ' CD1' ' A' ' 380' ' ' TYR . 0.6 OUTLIER -90.77 -27.79 18.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.678 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.503 ' HA ' ' CD1' ' A' ' 380' ' ' TYR . 14.9 ptmt -109.95 15.67 22.44 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 351' ' ' GLN . 31.1 m -116.09 167.91 8.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.766 0.317 . . . . 0.0 110.64 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' GLN . . . . . 0.408 ' HG3' ' C ' ' A' ' 355' ' ' VAL . 6.2 mt-30 -140.11 138.65 35.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.0 0.429 . . . . 0.0 111.447 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.511 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 91.9 t -104.39 106.96 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.903 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.506 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.3 OUTLIER -91.01 114.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.98 0.419 . . . . 0.0 112.033 -178.73 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.533 ' HB ' HG23 ' A' ' 376' ' ' VAL . 43.9 t -98.73 108.08 21.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.637 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.969 HG23 ' HB3' ' A' ' 375' ' ' LYS . 3.5 m -109.27 136.11 49.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 0.0 111.995 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.802 HG22 HG22 ' A' ' 312' ' ' VAL . 47.2 t -111.1 120.25 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.913 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.827 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.6 mp -122.45 150.22 42.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.032 0.444 . . . . 0.0 111.718 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.52 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.9 t70 -96.4 131.26 43.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.586 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.572 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 27.3 t80 -83.96 146.82 27.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.535 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 367' ' ' ILE . 35.9 m-20 -140.36 65.55 1.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.323 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.666 ' HB2' HD12 ' A' ' 367' ' ' ILE . 18.4 mttt 28.12 -84.91 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.666 HD12 ' HB2' ' A' ' 366' ' ' LYS . 5.0 mp -86.38 -70.68 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.807 0.337 . . . . 0.0 111.26 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -44.12 164.28 0.04 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.149 -0.548 . . . . 0.0 113.024 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 40.6 tttt -66.01 161.34 21.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.9 134.03 35.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.811 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.78 139.94 30.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.54 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -86.91 110.87 20.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.111 0.481 . . . . 0.0 110.899 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.806 ' O ' HD22 ' A' ' 273' ' ' LEU . 33.4 mt -80.34 -34.64 14.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.073 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.22 178.92 39.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.303 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.969 ' HB3' HG23 ' A' ' 360' ' ' THR . 17.2 ptmt -162.75 141.27 8.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.179 0.514 . . . . 0.0 111.604 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.848 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.24 158.77 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.103 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.505 ' HB3' HG13 ' A' ' 358' ' ' VAL . 13.3 p90 -141.77 145.2 34.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.801 0.334 . . . . 0.0 111.039 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 378' ' ' VAL . 20.4 m -141.46 114.21 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.166 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.455 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 167.01 -148.89 13.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.049 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.503 ' CD1' ' HA ' ' A' ' 354' ' ' LYS . 0.0 OUTLIER -50.08 -75.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.76 0.314 . . . . 0.0 111.349 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -69.82 80.72 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.816 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 383' ' ' THR . 15.6 m -165.14 163.39 20.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.797 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 382' ' ' SER . 43.9 p -158.09 147.87 19.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.735 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 94.02 -157.75 22.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.618 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -45.46 -31.24 1.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -63.88 -55.06 25.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.858 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 48.6 tp -57.56 -36.62 71.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.625 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 5.1 mtp85 -60.6 -46.75 89.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.384 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.609 ' CD2' HD12 ' A' ' 280' ' ' LEU . 18.6 t-160 -61.76 -56.22 21.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.511 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 63.5 t-105 -50.91 -49.64 59.17 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.153 0.501 . . . . 0.0 109.723 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.9 t -65.03 -30.39 71.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.606 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.455 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.6 OUTLIER -62.36 -42.32 99.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.968 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.42 ' CE ' ' CZ3' ' A' ' 390' ' ' TRP . 22.3 ttp -58.66 -55.58 33.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.68 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.807 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.8 mt -59.21 -24.63 63.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.567 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 392' ' ' ASP . . . -67.65 -34.95 77.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -126.96 74.03 76.48 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.466 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.501 ' CB ' ' CG ' ' A' ' 284' ' ' PRO . 8.4 Cg_exo -72.38 50.4 1.59 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.997 2.465 . . . . 0.0 113.032 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ARG . . . . . 0.485 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 4.5 mmm180 -158.37 -45.69 0.06 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.178 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -94.27 158.48 35.79 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.353 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 90.5 Cg_endo -87.56 138.71 4.63 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.012 2.475 . . . . 0.0 112.815 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.461 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.1 mm -112.14 120.16 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.587 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -112.07 145.23 40.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.758 0.313 . . . . 0.0 110.938 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -163.04 155.26 18.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 0.0 111.349 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -83.13 116.38 22.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.697 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.848 ' HB3' HG11 ' A' ' 376' ' ' VAL . 29.3 m-70 -103.81 120.75 41.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.78 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.533 HG23 ' OD1' ' A' ' 275' ' ' ASP . 86.9 m -78.18 116.44 18.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.226 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.73 HD23 HG22 ' A' ' 376' ' ' VAL . 67.3 mt -61.64 127.44 31.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.218 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -114.16 168.82 9.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.878 ' O ' HG23 ' A' ' 413' ' ' VAL . 61.2 t -55.73 119.93 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.54 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 19.4 mt-10 -53.52 -42.34 67.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.756 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.58 -50.06 74.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.332 . . . . 0.0 110.613 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.462 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.1 mt-10 -64.52 -38.27 90.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 409' ' ' VAL . 81.0 t -59.06 -49.96 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.351 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.43 ' HA ' HD12 ' A' ' 417' ' ' LEU . 1.6 m-20 -61.16 -36.51 80.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.926 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -69.52 -36.07 76.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.067 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 44.6 mtm -70.2 -36.37 74.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.439 HD21 ' CB ' ' A' ' 377' ' ' PHE . 15.2 mt -69.27 -31.16 69.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.973 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -71.52 145.56 49.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 29.0 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.074 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.839 0.352 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.789 HD22 ' O ' ' A' ' 373' ' ' ILE . 68.6 mt -85.93 -31.89 21.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.09 -165.63 13.61 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.036 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.549 ' OD1' HG23 ' A' ' 406' ' ' THR . 14.6 m-20 -141.94 136.95 30.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.332 . . . . 0.0 110.827 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.893 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -124.11 130.22 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.139 0.495 . . . . 0.0 110.919 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.893 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.2 126.23 42.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.76 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.622 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.7 p90 -142.08 151.19 42.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.331 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.1 OUTLIER -99.67 162.25 13.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.027 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.603 HD12 ' CD2' ' A' ' 389' ' ' HIS . 94.4 mt -134.74 144.15 47.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.085 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.4 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 9.7 ttm180 -159.13 106.55 1.79 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.966 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.896 ' CD1' HD13 ' A' ' 352' ' ' ILE . 28.9 t80 -101.22 137.21 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.845 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 44.9 t -122.31 97.79 44.79 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.524 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.53 -32.62 9.59 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.687 2.258 . . . . 0.0 112.612 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.04 -30.12 5.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.193 0.521 . . . . 0.0 109.919 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.52 -18.95 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.909 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 77.48 48.59 7.95 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.692 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -123.79 130.14 52.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 111.745 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.799 HD11 ' HE1' ' A' ' 393' ' ' MET . 34.8 tp -96.09 147.63 23.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.924 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 343' ' ' PHE . 4.9 m -136.35 138.42 41.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.356 0.598 . . . . 0.0 112.045 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.486 HG21 HG11 ' A' ' 357' ' ' VAL . 17.1 t -131.95 120.97 45.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.312 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 341' ' ' GLU . 30.5 t -116.97 115.56 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.08 0.467 . . . . 0.0 111.938 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.832 HG22 ' HB2' ' A' ' 339' ' ' TYR . 37.0 mm -74.17 136.98 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 277' ' ' CYS . 0.3 OUTLIER -112.44 -61.48 1.72 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.028 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.443 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 0.3 OUTLIER -175.71 151.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.24 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.74 ' HB3' HD11 ' A' ' 299' ' ' LEU . . . -112.48 152.66 28.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.849 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.426 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 7.8 pttt -149.07 152.64 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.478 . . . . 0.0 111.458 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 60.04 27.09 16.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.565 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' ' 296' ' ' ALA . 87.1 mt -63.97 139.21 58.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.951 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -60.59 149.61 34.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.514 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.403 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 8.4 mttp -90.03 119.32 30.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.573 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.508 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.7 mmt -92.26 -17.24 25.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.402 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 54.4 m-20 -99.66 115.77 30.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.849 0.357 . . . . 0.0 110.601 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.58 116.06 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.445 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.09 47.27 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.45 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.6 -156.89 9.35 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.704 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 307' ' ' LEU . 7.9 mt -101.43 -161.05 0.83 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.837 0.351 . . . . 0.0 110.789 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.614 ' HB2' HD23 ' A' ' 335' ' ' LEU . 66.6 m -139.51 172.19 13.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.302 0.573 . . . . 0.0 111.11 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.411 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -129.73 57.49 31.02 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.455 ' CB ' HD13 ' A' ' 299' ' ' LEU . 37.5 Cg_endo -68.29 150.82 76.65 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.146 2.564 . . . . 0.0 114.688 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.571 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 53.0 p90 -154.36 156.7 37.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.249 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.834 HG22 HG22 ' A' ' 361' ' ' VAL . 36.6 t -106.73 149.8 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.834 ' HE3' HD13 ' A' ' 362' ' ' LEU . 12.1 mtmt -130.39 152.81 49.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.253 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.421 ' CG2' HG13 ' A' ' 357' ' ' VAL . 5.4 mp -126.51 133.35 68.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.521 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' A' ' 325' ' ' LYS . 13.3 m80 -129.85 127.35 40.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.143 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.48 HD21 HG22 ' A' ' 347' ' ' VAL . 22.0 tp -100.04 105.1 16.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.453 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.2 mtm -108.06 138.86 43.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.28 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.821 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -100.56 99.58 10.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.364 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 57.21 37.36 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.82 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 91.18 28.72 14.17 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.804 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.31 109.58 9.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.762 0.315 . . . . 0.0 110.988 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 13.3 mtm-85 -49.77 128.5 18.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.292 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.821 HD11 ' CB ' ' A' ' 318' ' ' GLN . 11.4 mt -123.31 -49.63 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.232 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -130.59 150.93 51.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.345 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' LYS . . . . . 0.422 ' HA ' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -134.92 132.33 38.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.678 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.461 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 14.5 mmtt -138.25 159.53 41.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.889 0.376 . . . . 0.0 111.133 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -148.15 143.38 27.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.81 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.776 HG22 ' CE1' ' A' ' 343' ' ' PHE . 5.1 p -99.46 178.89 4.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.331 . . . . 0.0 110.689 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.2 t -59.81 162.61 5.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.264 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.571 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -106.27 122.28 59.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.884 0.373 . . . . 0.0 111.273 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.659 ' O ' HG22 ' A' ' 334' ' ' THR . 2.2 mmpt? -85.4 89.86 7.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.075 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -55.39 136.53 49.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.857 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 43.68 84.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.316 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.758 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.9 t -177.21 174.01 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.814 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 334' ' ' THR . 4.4 mt -146.42 -16.27 0.44 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.258 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.0 m-80 -132.24 57.69 31.31 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 120.72 0.295 . . . . 0.0 110.446 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 43.5 Cg_endo -92.4 167.79 2.82 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.26 2.64 . . . . 0.0 113.73 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.438 ' CG ' ' HB3' ' A' ' 295' ' ' GLU . 0.2 OUTLIER -106.99 160.81 15.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.235 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.832 ' HB2' HG22 ' A' ' 293' ' ' ILE . 47.7 m-85 -134.84 -51.62 0.79 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.689 0.281 . . . . 0.0 111.269 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 44.45 36.12 1.56 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.105 0.479 . . . . 0.0 110.975 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.544 ' O ' HG13 ' A' ' 292' ' ' VAL . 28.0 mt-10 -91.02 140.68 29.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 80.6 p -110.85 121.36 45.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.936 0.398 . . . . 0.0 111.667 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.776 ' CE1' HG22 ' A' ' 328' ' ' THR . 82.9 m-85 -111.31 156.65 21.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.01 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 56.5 m -130.91 138.65 49.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.449 . . . . 0.0 111.698 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.461 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 63.8 m-85 -127.91 165.92 19.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.604 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -115.5 79.12 1.25 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.247 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.535 HG13 ' HB3' ' A' ' 351' ' ' GLN . 37.3 t -106.44 123.19 39.58 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.268 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 35.5 Cg_exo -60.28 150.89 77.56 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.576 2.184 . . . . 0.0 111.855 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -57.16 -23.83 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -91.53 -8.59 47.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.491 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.535 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -105.2 -24.41 12.74 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.896 HD13 ' CD1' ' A' ' 282' ' ' TYR . 3.2 tp -53.0 -27.61 13.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 0.0 110.759 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLN . . . . . 0.412 ' O ' ' CD1' ' A' ' 380' ' ' TYR . 14.1 mt-30 -95.01 3.05 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.378 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.469 ' HA ' ' CD1' ' A' ' 380' ' ' TYR . 24.2 mtpp -122.27 -20.78 6.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.6 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.652 HG12 ' HG2' ' A' ' 318' ' ' GLN . 34.4 m -87.87 167.9 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 111.483 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' GLN . . . . . 0.535 ' OE1' HD23 ' A' ' 417' ' ' LEU . 35.3 mt-30 -139.92 126.55 20.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.522 ' CG2' HD21 ' A' ' 289' ' ' LEU . 52.4 t -95.17 103.68 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.099 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.609 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.4 OUTLIER -92.04 115.55 31.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.903 -179.007 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.559 ' HB ' HG23 ' A' ' 376' ' ' VAL . 56.7 t -94.92 108.18 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.463 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' THR . . . . . 1.006 HG23 ' HB3' ' A' ' 375' ' ' LYS . 2.3 m -110.59 134.43 52.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 0.0 112.014 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.834 HG22 HG22 ' A' ' 312' ' ' VAL . 48.6 t -109.58 115.12 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.276 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.834 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.9 mp -118.28 148.61 42.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 111.467 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.508 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.1 OUTLIER -98.43 125.02 43.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.444 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 26.9 t80 -72.45 144.56 48.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 367' ' ' ILE . 19.8 m-20 -132.72 72.4 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.071 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.649 ' HG2' HD12 ' A' ' 367' ' ' ILE . 0.0 OUTLIER 32.96 -88.79 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.685 ' H ' HD12 ' A' ' 367' ' ' ILE . 5.2 mp -22.96 -86.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -161.47 -55.67 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.632 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -65.42 141.71 58.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.928 0.394 . . . . 0.0 110.616 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' ASN . . . . . 0.421 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 0.7 OUTLIER -120.98 148.85 43.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.842 -179.529 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.59 149.33 25.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.3 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.792 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.29 111.49 23.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.789 ' O ' HD22 ' A' ' 273' ' ' LEU . 32.8 mt -79.62 -33.99 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.186 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 169.01 179.2 40.92 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.08 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 1.006 ' HB3' HG23 ' A' ' 360' ' ' THR . 15.6 ptmt -164.56 141.34 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.109 0.481 . . . . 0.0 111.794 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.909 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.67 158.81 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.29 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.549 ' HB3' HG13 ' A' ' 358' ' ' VAL . 6.7 p90 -138.32 140.97 39.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 111.334 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 378' ' ' VAL . 28.0 m -139.85 104.85 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.914 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.514 ' HA2' ' CG ' ' A' ' 390' ' ' TRP . . . 166.56 -146.89 11.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.342 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 354' ' ' LYS . 0.0 OUTLIER -45.49 137.58 4.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.691 0.281 . . . . 0.0 110.43 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 72.84 -153.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' SER . . . . . 0.426 ' O ' HG23 ' A' ' 383' ' ' THR . 0.7 OUTLIER 64.22 165.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.726 0.298 . . . . 0.0 110.601 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 382' ' ' SER . 39.9 p -158.28 147.5 19.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.066 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 102.04 -145.43 16.64 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.951 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -57.4 -31.2 65.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.732 0.301 . . . . 0.0 111.648 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -64.91 -59.1 4.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.823 0.344 . . . . 0.0 110.706 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.68 -32.56 71.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.269 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.1 OUTLIER -61.54 -41.9 98.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.203 179.513 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.603 ' CD2' HD12 ' A' ' 280' ' ' LEU . 16.5 t-160 -65.43 -58.0 6.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.619 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.514 ' CG ' ' HA2' ' A' ' 379' ' ' GLY . 62.9 t-105 -49.71 -44.68 48.4 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.136 0.493 . . . . 0.0 109.927 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.21 -34.29 77.17 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.553 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.465 ' HB3' HD12 ' A' ' 401' ' ' ILE . 1.8 t0 -65.17 -36.39 84.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.8 ' SD ' HD11 ' A' ' 352' ' ' ILE . 14.0 ttm -61.36 -57.57 11.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.119 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.771 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -61.05 -29.25 69.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.439 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.03 73.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.209 0.528 . . . . 0.0 109.843 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -125.46 77.74 68.52 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.374 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.53 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 5.8 Cg_exo -76.98 44.93 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.131 2.554 . . . . 0.0 113.002 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ARG . . . . . 0.53 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 9.9 mmm180 -159.94 -46.74 0.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.908 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.26 137.4 22.82 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.961 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 56.6 Cg_endo -70.41 156.24 62.07 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.553 2.169 . . . . 0.0 112.747 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.26 117.13 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.971 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -108.82 144.36 36.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.716 0.293 . . . . 0.0 110.731 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -166.49 156.9 12.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.918 0.39 . . . . 0.0 111.376 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' TRP . . . . . 0.426 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 57.9 m95 -84.38 121.48 27.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.84 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.909 ' HB3' HG11 ' A' ' 376' ' ' VAL . 53.4 m-70 -110.09 122.62 48.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.405 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.549 HG23 ' OD1' ' A' ' 275' ' ' ASP . 88.6 m -78.29 118.21 20.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.751 HD23 HG22 ' A' ' 376' ' ' VAL . 67.3 mt -64.02 128.16 34.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.178 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -116.75 169.97 8.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.73 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.893 ' O ' HG23 ' A' ' 413' ' ' VAL . 58.8 t -53.96 119.44 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.792 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 36.8 mt-10 -54.57 -43.67 72.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.993 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -56.33 -47.65 78.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 110.721 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.6 mt-10 -66.54 -38.07 86.37 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 409' ' ' VAL . 57.4 t -60.15 -50.73 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.335 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.654 ' HA ' HD12 ' A' ' 417' ' ' LEU . 0.2 OUTLIER -62.77 -38.16 89.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.703 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.13 -31.87 72.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.017 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 45.4 mtm -72.16 -30.38 64.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.83 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' A' ' 414' ' ' ASP . 4.2 mt -77.49 -34.19 54.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -65.68 143.73 57.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.044 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 1.5 pttt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.823 0.345 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 408' ' ' GLN . 18.3 mt -78.65 -34.89 46.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 119.41 -169.17 13.62 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.255 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.772 ' OD1' HG23 ' A' ' 406' ' ' THR . 2.8 m-20 -138.76 134.24 33.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.745 0.307 . . . . 0.0 110.818 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.898 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -125.11 130.67 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.2 0.524 . . . . 0.0 111.013 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.898 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -99.11 126.93 44.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.725 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.605 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.4 p90 -142.04 151.83 42.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.324 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.42 161.44 13.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.965 -178.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.559 HD12 ' CD2' ' A' ' 389' ' ' HIS . 83.9 mt -135.65 141.74 45.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.486 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -158.94 114.7 2.59 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.856 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.937 ' CD1' HD13 ' A' ' 352' ' ' ILE . 25.0 t80 -105.98 138.87 41.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.64 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.35 97.51 45.0 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.531 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.4 -32.0 10.68 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.552 2.168 . . . . 0.0 112.472 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.6 -29.84 7.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.229 0.538 . . . . 0.0 109.941 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.28 -17.5 8.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.052 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.72 48.44 8.83 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.587 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -123.62 130.45 52.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.441 . . . . 0.0 111.834 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.887 HD11 ' HE1' ' A' ' 393' ' ' MET . 28.7 tp -95.76 147.56 23.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.793 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 3.1 m -137.39 134.29 35.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.331 0.586 . . . . 0.0 112.062 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 3.3 t -127.29 123.67 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.146 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 341' ' ' GLU . 39.7 t -118.17 115.26 47.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.062 0.458 . . . . 0.0 111.848 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.741 HG22 ' HB2' ' A' ' 339' ' ' TYR . 34.2 mm -74.55 137.04 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.437 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.5 OUTLIER -113.86 -60.64 1.86 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.456 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 2.6 pt-20 -175.63 157.8 2.1 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.296 -0.561 . . . . 0.0 112.448 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.811 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -115.98 154.04 30.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.897 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.0 ptmm? -150.93 151.97 32.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.037 0.446 . . . . 0.0 111.614 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 59.58 23.95 12.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.986 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.811 HD21 ' HB1' ' A' ' 296' ' ' ALA . 55.2 mt -58.14 138.91 55.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.077 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -62.6 144.44 56.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.472 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.426 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 11.2 mttt -83.46 114.63 21.61 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.449 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.451 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 5.8 mmm -93.79 -17.75 22.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.739 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 45.6 m-20 -96.03 117.89 31.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.4 116.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.643 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.39 16.32 35.02 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.423 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.27 -156.26 9.19 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.938 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 307' ' ' LEU . 8.3 mt -100.63 -160.43 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 110.305 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.663 ' HB2' HD23 ' A' ' 335' ' ' LEU . 65.3 m -135.98 171.77 13.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.231 0.539 . . . . 0.0 111.122 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.427 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 5.9 m-20 -134.47 56.5 18.36 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.729 ' CG ' HD13 ' A' ' 299' ' ' LEU . 72.4 Cg_endo -77.27 144.72 23.5 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.886 2.39 . . . . 0.0 115.043 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.548 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 11.3 p90 -139.07 167.9 21.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.185 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 361' ' ' VAL . 47.4 t -114.08 150.08 16.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.432 0.634 . . . . 0.0 112.663 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.656 ' CE ' HD13 ' A' ' 362' ' ' LEU . 7.0 mtmm -134.14 156.79 47.68 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.186 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.625 ' CG2' HG13 ' A' ' 357' ' ' VAL . 5.4 mp -129.96 138.44 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.707 0.289 . . . . 0.0 111.061 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' HIS . . . . . 0.412 ' O ' HG23 ' A' ' 358' ' ' VAL . 2.2 m170 -130.66 121.59 25.83 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.462 HD21 HG22 ' A' ' 347' ' ' VAL . 36.3 tp -87.96 106.78 18.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.804 0.335 . . . . 0.0 110.117 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' MET . . . . . 0.594 ' CE ' HD13 ' A' ' 417' ' ' LEU . 31.7 mtp -109.26 128.59 55.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.299 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.793 ' CB ' HD11 ' A' ' 323' ' ' LEU . 7.7 tp60 -104.93 103.31 12.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.991 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ASN . . . . . 0.478 ' HB2' ' NE2' ' A' ' 318' ' ' GLN . 2.5 m120 61.31 37.67 16.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.782 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 83.79 25.04 47.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.565 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -129.3 110.07 11.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 110.847 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -56.68 135.55 55.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.793 HD11 ' CB ' ' A' ' 318' ' ' GLN . 5.7 mt -125.01 -48.13 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.29 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 345' ' ' PHE . 0.4 OUTLIER -130.54 147.22 52.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.961 0.41 . . . . 0.0 111.353 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.39 140.6 52.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.515 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 1.7 mmpt? -139.79 162.61 34.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 0.0 111.153 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.404 ' CB ' ' HG2' ' A' ' 313' ' ' LYS . 0.0 OUTLIER -152.21 149.85 29.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.889 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.713 HG22 ' CE1' ' A' ' 343' ' ' PHE . 15.6 p -110.29 179.47 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.943 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.457 HG23 ' HE3' ' A' ' 331' ' ' LYS . 12.6 t -59.03 167.21 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.518 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.548 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.2 mt -110.74 122.4 65.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.928 0.394 . . . . 0.0 111.338 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.457 ' HE3' HG23 ' A' ' 329' ' ' THR . 9.0 mmpt? -86.95 93.06 9.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.854 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -60.71 136.69 58.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.238 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 43.94 84.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.537 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.568 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.7 t -179.38 171.02 1.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.434 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.663 HD23 ' HB2' ' A' ' 308' ' ' SER . 1.6 mt -140.73 -14.36 0.94 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.495 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.45 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.1 m-80 -133.53 58.52 33.93 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-O 120.692 0.282 . . . . 0.0 110.378 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 52.0 Cg_endo -90.49 167.69 4.16 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.146 2.564 . . . . 0.0 113.686 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.45 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.4 OUTLIER -109.53 160.72 16.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.329 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.741 ' HB2' HG22 ' A' ' 293' ' ' ILE . 63.9 m-85 -133.99 -63.43 0.73 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.826 0.346 . . . . 0.0 111.243 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.15 37.96 26.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.579 ' O ' HG13 ' A' ' 292' ' ' VAL . 31.2 mt-10 -93.3 145.51 24.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.711 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 78.0 p -116.07 121.5 42.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.927 0.394 . . . . 0.0 111.586 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.713 ' CE1' HG22 ' A' ' 328' ' ' THR . 70.2 m-85 -113.05 151.33 30.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.349 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 15.1 m -121.88 138.44 54.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.083 0.468 . . . . 0.0 111.546 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 289' ' ' LEU . 34.2 m-85 -124.36 165.93 16.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.547 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.21 73.55 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.799 HG13 ' HB3' ' A' ' 351' ' ' GLN . 74.1 t -108.01 131.75 21.53 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.159 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 84.4 Cg_endo -82.24 154.94 16.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.778 2.319 . . . . 0.0 111.715 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -51.26 -22.71 2.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.829 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -86.42 -8.6 57.5 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.799 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -112.71 -29.86 7.28 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.596 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.937 HD13 ' CD1' ' A' ' 282' ' ' TYR . 3.9 tp -51.14 -33.67 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.665 0.269 . . . . 0.0 111.034 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -88.47 1.48 54.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.699 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.463 ' HA ' ' CD1' ' A' ' 380' ' ' TYR . 23.9 mttm -122.73 -20.65 5.85 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.511 HG23 ' CZ2' ' A' ' 390' ' ' TRP . 36.0 m -91.65 167.99 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.968 0.413 . . . . 0.0 111.386 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.49 127.83 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.775 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.625 HG13 ' CG2' ' A' ' 314' ' ' ILE . 98.9 t -86.86 104.77 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.439 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.5 OUTLIER -90.23 109.67 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.618 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.584 ' HB ' HG23 ' A' ' 376' ' ' VAL . 43.9 t -90.53 108.02 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.788 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.891 HG23 ' HB3' ' A' ' 375' ' ' LYS . 11.8 m -110.96 129.74 55.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 111.949 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 312' ' ' VAL . 48.7 t -104.12 131.0 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.114 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.656 HD13 ' CE ' ' A' ' 313' ' ' LYS . 3.9 mp -129.93 145.6 51.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.925 0.393 . . . . 0.0 111.481 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.451 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 9.1 t70 -90.08 126.81 35.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.554 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 29.1 t80 -79.42 146.97 32.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.562 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -141.3 64.98 1.4 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.33 . . . . 0.0 111.745 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.69 ' HG2' HD12 ' A' ' 367' ' ' ILE . 1.7 tptt 31.39 -91.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.69 HD12 ' HG2' ' A' ' 366' ' ' LYS . 4.5 mp -84.77 -66.93 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-O 120.748 0.309 . . . . 0.0 111.361 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -45.87 168.25 0.04 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.761 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -65.7 164.29 14.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.728 0.299 . . . . 0.0 110.626 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.47 126.41 35.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.65 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.09 157.25 38.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.914 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.466 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.68 109.45 22.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.08 0.467 . . . . 0.0 111.216 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.424 HG21 HD22 ' A' ' 299' ' ' LEU . 2.0 mm -71.4 -35.08 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.941 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' GLY . . . . . 0.407 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 157.47 -174.1 34.93 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.154 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.891 ' HB3' HG23 ' A' ' 360' ' ' THR . 18.2 ptmt -162.47 140.7 8.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.394 0.597 . . . . 0.0 112.058 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.985 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.9 158.9 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.174 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.538 ' HB3' HG13 ' A' ' 358' ' ' VAL . 25.7 p90 -139.54 140.57 37.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.954 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 357' ' ' VAL . 11.5 m -130.19 110.53 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.474 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.583 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 141.2 -150.62 21.97 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.5 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.463 ' CD1' ' HA ' ' A' ' 354' ' ' LYS . 0.2 OUTLIER -44.09 156.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.871 0.367 . . . . 0.0 111.508 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.2 m120 55.13 36.23 26.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.004 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 3.1 m -138.75 161.51 37.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.977 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 52.0 p -157.94 148.03 20.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.911 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 101.16 -124.08 8.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.743 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -83.6 -28.54 28.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 111.495 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -70.91 -45.32 64.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.23 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 26.2 tp -71.32 -35.64 71.3 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.369 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 385' ' ' ALA . 7.7 ptt180 -62.85 -33.58 75.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.345 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.559 ' CD2' HD12 ' A' ' 280' ' ' LEU . 18.5 t-160 -70.27 -55.44 9.23 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.321 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.585 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 58.4 t-105 -50.12 -45.13 52.68 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.092 0.472 . . . . 0.0 109.907 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.54 -33.21 73.71 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.614 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.47 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.5 OUTLIER -62.11 -39.38 92.29 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.552 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.887 ' HE1' HD11 ' A' ' 289' ' ' LEU . 20.1 ttm -59.18 -53.03 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.978 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.79 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -64.26 -30.7 71.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.244 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.68 -31.56 72.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.184 0.516 . . . . 0.0 109.668 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -125.49 77.92 68.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.337 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.546 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 5.9 Cg_exo -76.87 42.88 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.111 2.541 . . . . 0.0 113.061 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ARG . . . . . 0.546 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 20.4 mmt180 -158.88 -47.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.093 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.41 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.1 OUTLIER -94.27 140.26 22.74 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.167 -179.341 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.41 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 57.9 Cg_endo -70.73 156.32 61.05 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.677 2.251 . . . . 0.0 112.885 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -127.76 115.35 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.745 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.56 144.44 33.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.808 0.337 . . . . 0.0 111.039 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.5 153.95 11.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.124 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' TRP . . . . . 0.406 ' CZ3' ' HB2' ' A' ' 277' ' ' CYS . 33.4 m95 -81.83 121.75 26.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.906 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.985 ' HB3' HG11 ' A' ' 376' ' ' VAL . 56.7 m-70 -111.98 117.61 33.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.551 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.772 HG23 ' OD1' ' A' ' 275' ' ' ASP . 89.6 m -78.44 116.46 18.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.859 HD23 HG22 ' A' ' 376' ' ' VAL . 95.0 mt -60.53 127.61 32.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.134 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.515 ' C ' HD12 ' A' ' 273' ' ' LEU . 5.2 mt-30 -115.06 168.8 9.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.605 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.825 ' O ' HG23 ' A' ' 413' ' ' VAL . 91.8 t -55.3 120.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.466 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 14.8 mt-10 -52.35 -41.13 62.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.774 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.62 -51.08 71.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.638 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.509 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 19.7 mt-10 -63.76 -38.8 92.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 409' ' ' VAL . 97.5 t -57.36 -49.15 81.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.147 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.41 -32.57 73.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.471 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.22 90.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.651 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' MET . . . . . 0.451 ' SD ' ' CE1' ' A' ' 377' ' ' PHE . 9.1 mtt -64.87 -50.84 64.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.497 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.594 HD13 ' CE ' ' A' ' 317' ' ' MET . 10.2 mt -59.87 -28.21 67.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.932 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -71.75 -175.26 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.998 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.102 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.788 0.328 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.796 HD22 ' O ' ' A' ' 373' ' ' ILE . 55.5 mt -75.63 -31.11 59.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.36 -166.08 15.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.247 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.744 ' OD1' HG23 ' A' ' 406' ' ' THR . 27.6 m-20 -142.12 130.7 22.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.897 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.809 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -120.04 131.01 73.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.809 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.5 OUTLIER -99.99 126.02 46.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.898 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.634 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.4 p90 -142.32 152.59 43.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.345 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.49 161.3 13.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.134 -178.573 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.552 HD12 ' CD2' ' A' ' 389' ' ' HIS . 95.4 mt -135.08 142.82 46.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.053 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -158.85 110.89 2.19 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.092 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.842 ' CD1' HD13 ' A' ' 352' ' ' ILE . 22.0 t80 -102.87 139.36 38.55 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.896 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.04 94.18 47.49 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.542 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 8.0 Cg_exo -69.86 -32.72 17.6 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.914 2.41 . . . . 0.0 112.337 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -29.79 8.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.089 0.471 . . . . 0.0 109.96 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.73 -20.22 7.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.073 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.14 48.02 6.7 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.585 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -123.08 129.87 52.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.029 0.443 . . . . 0.0 111.802 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.893 HD11 ' HE1' ' A' ' 393' ' ' MET . 36.6 tp -96.88 147.55 23.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.991 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 8.7 m -138.25 137.01 37.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.444 0.64 . . . . 0.0 111.993 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.7 t -129.88 124.06 57.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.238 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 341' ' ' GLU . 24.5 t -119.69 115.43 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.094 0.473 . . . . 0.0 111.902 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.671 HG13 HG21 ' A' ' 328' ' ' THR . 44.2 mm -74.52 137.2 23.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.17 -58.64 2.12 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 16.8 pt-20 -175.74 162.1 2.65 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.537 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.767 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -119.06 152.41 36.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.647 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.438 ' HD2' ' CH2' ' A' ' 404' ' ' TRP . 0.4 OUTLIER -150.65 150.19 30.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.124 0.488 . . . . 0.0 111.572 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 61.61 24.02 14.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.996 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.767 HD21 ' HB1' ' A' ' 296' ' ' ALA . 53.4 mt -57.7 138.31 55.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 110.796 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.54 129.35 39.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.475 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.449 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 14.9 mttt -63.44 112.11 2.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.279 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' A' ' 371' ' ' ASP . 0.2 OUTLIER -85.06 -19.85 31.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.8 -179.169 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 28.7 m-20 -99.34 117.2 33.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.652 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 23.8 t -50.06 116.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.268 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 63.93 14.12 54.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.428 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -129.03 -159.88 10.09 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.677 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.1 mt -98.13 -162.87 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.792 0.33 . . . . 0.0 110.66 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.521 ' HB2' HD23 ' A' ' 335' ' ' LEU . 13.0 m -135.69 172.02 13.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.38 0.609 . . . . 0.0 111.205 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.422 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -134.16 56.18 17.96 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.829 178.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.712 ' CG ' HD13 ' A' ' 299' ' ' LEU . 66.7 Cg_endo -75.58 142.66 26.43 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.114 2.542 . . . . 0.0 115.034 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.625 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 7.1 p90 -140.57 168.17 20.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.006 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 361' ' ' VAL . 41.3 t -117.02 149.83 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.442 ' CE ' HD13 ' A' ' 362' ' ' LEU . 9.2 mttm -130.7 160.19 35.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.316 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.438 HG23 HG13 ' A' ' 357' ' ' VAL . 5.3 mp -128.82 136.42 59.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.526 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 79.1 m80 -130.83 130.84 44.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.884 0.373 . . . . 0.0 110.987 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 324' ' ' LYS . 41.1 tp -108.94 108.12 18.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.376 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 3.4 mtm -117.79 134.55 54.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.438 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.591 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.0 OUTLIER -95.4 99.62 11.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.414 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 59.44 37.69 22.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.08 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 92.73 17.15 45.86 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.181 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 317' ' ' MET . 10.6 mmmm -120.33 109.06 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.841 0.32 . . . . 0.0 110.805 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.39 132.02 38.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.615 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 318' ' ' GLN . 5.0 mt -125.89 -50.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.85 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 12.1 mmtm -130.7 146.04 52.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.959 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' LYS . . . . . 0.417 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -143.5 116.4 8.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.613 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -118.87 168.58 10.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.966 0.412 . . . . 0.0 111.291 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 15.2 ptpt -148.71 145.27 27.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.836 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.671 HG21 HG13 ' A' ' 293' ' ' ILE . 14.4 p -102.15 173.76 6.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.829 0.347 . . . . 0.0 110.924 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.492 HG22 ' OE2' ' A' ' 341' ' ' GLU . 6.3 t -54.68 175.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.675 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.625 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -118.5 124.08 72.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 111.432 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.665 ' O ' HG22 ' A' ' 334' ' ' THR . 0.1 OUTLIER -87.73 87.08 7.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.981 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -54.93 136.21 47.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.96 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 44.81 84.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.401 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 331' ' ' LYS . 4.9 t -178.02 173.66 1.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.784 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.658 HD23 ' O ' ' A' ' 334' ' ' THR . 3.8 mt -144.94 -15.94 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.373 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.433 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.32 57.61 30.61 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.843 0.354 . . . . 0.0 110.106 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 66.3 Cg_endo -86.27 167.62 9.13 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.133 2.555 . . . . 0.0 113.891 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 50.7 t80 -112.48 155.48 24.19 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.95 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.512 ' HB2' HG22 ' A' ' 293' ' ' ILE . 76.0 m-85 -133.2 -71.61 0.52 Allowed 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.817 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ASN . . . . . 0.537 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 24.2 t-20 66.16 37.54 5.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.542 ' O ' HG13 ' A' ' 292' ' ' VAL . 38.4 mt-10 -91.15 142.27 27.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.52 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 94.5 p -112.63 121.7 45.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.023 0.439 . . . . 0.0 111.757 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.671 ' HE1' HG22 ' A' ' 328' ' ' THR . 64.8 m-85 -113.85 148.53 36.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.014 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 52.1 p -122.99 140.47 52.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.043 0.449 . . . . 0.0 111.532 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -129.51 165.85 20.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.493 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -115.78 80.67 1.48 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.416 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.564 HG11 ' HA ' ' A' ' 352' ' ' ILE . 33.3 t -108.19 122.81 39.43 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.287 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.427 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 27.7 Cg_exo -60.84 149.43 88.29 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.578 2.185 . . . . 0.0 111.8 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -55.2 -23.91 24.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.138 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -91.48 -8.7 46.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.522 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.563 ' HB3' HG13 ' A' ' 347' ' ' VAL . 1.4 tt0 -105.53 -25.93 12.11 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.842 HD13 ' CD1' ' A' ' 282' ' ' TYR . 3.1 tp -50.15 -25.66 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.727 0.299 . . . . 0.0 110.874 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -93.45 -17.06 23.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.359 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -102.6 -17.28 15.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.635 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.591 HG12 ' HG2' ' A' ' 318' ' ' GLN . 30.9 m -89.47 168.04 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.827 0.346 . . . . 0.0 111.17 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' GLN . . . . . 0.493 ' HA ' ' HA3' ' A' ' 379' ' ' GLY . 8.8 mt-30 -142.99 126.36 16.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.282 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.523 ' CG2' HD21 ' A' ' 289' ' ' LEU . 74.2 t -92.16 101.37 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.036 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.7 OUTLIER -89.18 112.04 23.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.863 -178.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.535 HG11 ' CD2' ' A' ' 278' ' ' PHE . 16.2 t -95.57 107.86 20.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.813 HG23 ' HB3' ' A' ' 375' ' ' LYS . 8.7 m -108.31 142.95 37.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 111.697 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 312' ' ' VAL . 60.3 t -118.5 115.77 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.203 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.465 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.7 mp -119.42 149.91 41.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 111.191 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.48 ' HB3' ' SD ' ' A' ' 302' ' ' MET . 0.1 OUTLIER -97.88 131.64 44.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.699 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.577 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 20.6 t80 -80.98 140.84 34.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.683 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 366' ' ' LYS . 69.9 m-20 -132.45 72.58 1.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.314 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.577 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 9.8 tttp 16.1 -86.79 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 33.0 mm -77.57 -77.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.495 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -46.09 165.26 0.08 OUTLIER Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.991 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -65.85 165.68 12.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.849 0.357 . . . . 0.0 111.04 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 0.1 OUTLIER -87.9 132.57 34.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.533 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ASP . . . . . 0.507 ' HB2' ' SD ' ' A' ' 302' ' ' MET . 0.0 OUTLIER -98.01 142.45 29.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.967 0.413 . . . . 0.0 110.685 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.604 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -82.65 122.51 28.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.26 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.796 ' O ' HD22 ' A' ' 273' ' ' LEU . 13.0 mt -82.43 -30.08 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.787 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' GLY . . . . . 0.491 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 169.41 -179.3 42.05 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.74 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.813 ' HB3' HG23 ' A' ' 360' ' ' THR . 17.7 ptmt -164.61 140.93 6.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 111.934 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.821 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.37 158.6 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.098 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.56 ' CD1' HG13 ' A' ' 413' ' ' VAL . 53.0 p90 -143.26 144.37 32.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.849 0.357 . . . . 0.0 111.055 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 378' ' ' VAL . 25.3 m -144.68 108.09 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.214 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 152.96 141.56 3.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.248 -0.977 . . . . 0.0 113.377 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 39.68 -85.97 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 379' ' ' GLY . 9.6 m120 -79.79 86.16 5.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.886 0.374 . . . . 0.0 111.02 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' SER . . . . . 0.489 ' HG ' ' HE2' ' A' ' 377' ' ' PHE . 38.3 m -164.54 159.22 19.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.942 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 58.0 p -152.73 147.96 26.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.765 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 90.01 -146.57 18.81 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.451 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -53.98 -30.76 48.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.319 . . . . 0.0 111.492 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.68 -60.07 3.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 21.3 tp -62.21 -28.19 69.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.549 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -69.06 -32.44 71.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.382 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.552 ' CD2' HD12 ' A' ' 280' ' ' LEU . 20.8 t-160 -78.88 -51.27 9.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.687 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.493 ' CD1' ' HA2' ' A' ' 379' ' ' GLY . 63.4 t-105 -51.84 -46.9 64.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.042 0.449 . . . . 0.0 110.051 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -33.61 76.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.607 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.478 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.8 OUTLIER -62.48 -38.33 89.42 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.893 ' HE1' HD11 ' A' ' 289' ' ' LEU . 11.5 ttm -61.35 -52.61 63.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.067 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.751 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.4 mt -61.88 -35.88 79.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.407 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.85 -29.64 70.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.205 0.526 . . . . 0.0 109.851 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 398' ' ' ARG . 11.3 m-80 -114.79 71.91 2.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.537 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.542 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 48.2 Cg_endo -70.42 32.9 0.21 Allowed 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.219 2.613 . . . . 0.0 113.552 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ARG . . . . . 0.527 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 3.1 mmm180 -159.08 -46.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.013 0.435 . . . . 0.0 110.981 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.466 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 17.2 ttp180 -94.03 134.92 25.24 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.352 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.466 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 39.5 Cg_endo -66.41 156.35 65.68 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.7 2.266 . . . . 0.0 112.84 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -126.14 115.93 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.651 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.63 144.38 32.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.791 0.329 . . . . 0.0 110.853 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -166.6 152.1 8.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.16 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' TRP . . . . . 0.438 ' CH2' ' HD2' ' A' ' 297' ' ' LYS . 61.2 m95 -80.34 118.1 21.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.885 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.821 ' HB3' HG11 ' A' ' 376' ' ' VAL . 28.9 m-70 -105.01 117.01 32.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.572 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.744 HG23 ' OD1' ' A' ' 275' ' ' ASP . 88.7 m -78.32 115.42 18.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.781 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.819 HD23 HG22 ' A' ' 376' ' ' VAL . 89.7 mt -60.23 127.12 30.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.359 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.459 ' C ' HD12 ' A' ' 273' ' ' LEU . 4.0 mt-30 -112.94 171.63 7.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.582 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.877 ' O ' HG23 ' A' ' 413' ' ' VAL . 59.0 t -55.8 123.36 6.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.991 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.604 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 6.8 mt-10 -55.32 -42.3 73.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.704 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.16 -50.32 73.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.79 0.329 . . . . 0.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.461 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.2 mt-10 -62.89 -39.42 94.42 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 409' ' ' VAL . 89.4 t -56.08 -48.65 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.372 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.42 ' HA ' HD12 ' A' ' 417' ' ' LEU . 1.0 OUTLIER -56.84 -33.89 67.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 179.691 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 412' ' ' GLU . . . -59.98 -48.46 81.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.568 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' MET . . . . . 0.489 ' HG2' ' CZ ' ' A' ' 377' ' ' PHE . 0.0 OUTLIER -55.05 -36.14 65.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.75 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.437 HD23 ' OE1' ' A' ' 356' ' ' GLN . 5.7 mt -82.57 -32.51 28.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.887 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -84.29 122.9 29.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.083 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 419' ' ' VAL . 21.6 t . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.126 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 11.1 tptt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.817 0.341 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.781 HD22 ' O ' ' A' ' 373' ' ' ILE . 42.7 mt -89.43 -30.81 18.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.045 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 121.68 -164.54 14.8 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.185 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.624 ' OD1' HG23 ' A' ' 406' ' ' THR . 30.0 m-20 -143.3 130.94 21.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.812 0.339 . . . . 0.0 110.844 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.783 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -120.34 128.85 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.061 0.458 . . . . 0.0 110.804 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.783 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -96.91 126.53 42.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.948 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.635 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.6 p90 -142.15 150.64 41.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.267 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.3 OUTLIER -99.43 163.21 12.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.281 0.562 . . . . 0.0 112.084 -178.704 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.835 HD12 ' CD2' ' A' ' 389' ' ' HIS . 76.6 mt -133.44 144.26 49.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.213 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 7.8 ttp85 -159.19 106.82 1.79 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.82 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.938 ' CD1' HD13 ' A' ' 352' ' ' ILE . 27.6 t80 -98.25 139.57 33.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.481 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 287' ' ' GLY . 44.4 t -116.14 92.98 37.46 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 16.4 Cg_exo -66.03 -31.8 45.49 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.94 2.426 . . . . 0.0 112.501 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -30.96 62.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.921 0.391 . . . . 0.0 110.751 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -121.54 -12.06 8.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.717 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 74.07 45.53 25.63 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.992 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -120.03 130.06 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 111.464 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.96 HD11 ' HE1' ' A' ' 393' ' ' MET . 33.1 tp -94.3 147.58 23.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.225 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 3.9 m -136.26 137.6 40.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.276 0.56 . . . . 0.0 111.924 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 15.1 t -131.78 121.82 48.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.369 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 341' ' ' GLU . 20.5 t -116.9 115.14 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.967 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.664 HG13 HG21 ' A' ' 328' ' ' THR . 41.6 mm -74.17 137.09 23.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.45 HD22 ' OE1' ' A' ' 295' ' ' GLU . 0.5 OUTLIER -113.38 -58.2 2.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.47 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 0.3 OUTLIER -175.73 164.42 2.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.391 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.777 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -123.94 153.35 41.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.798 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.48 150.93 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.693 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 25.9 m120 61.24 24.32 14.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.915 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.777 HD21 ' HB1' ' A' ' 296' ' ' ALA . 58.9 mt -58.84 138.38 57.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.079 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -61.01 142.79 56.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.492 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.403 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 4.8 mttp -82.0 118.6 23.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.539 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.517 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.5 mmt -93.75 -18.93 21.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.395 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 44.6 m-20 -99.65 117.04 33.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.911 0.386 . . . . 0.0 110.745 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.01 116.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.438 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 61.33 15.41 45.16 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.354 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.34 -156.46 9.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.8 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 307' ' ' LEU . 7.7 mt -100.78 -161.18 0.84 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.847 0.356 . . . . 0.0 110.741 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.633 ' HB2' HD23 ' A' ' 335' ' ' LEU . 58.5 m -138.15 172.13 13.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.313 0.577 . . . . 0.0 111.066 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -131.77 57.73 32.5 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.557 ' CB ' HD13 ' A' ' 299' ' ' LEU . 60.3 Cg_endo -74.33 143.2 31.18 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.987 2.458 . . . . 0.0 114.707 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.547 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 31.6 p90 -143.71 162.16 36.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.363 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 361' ' ' VAL . 39.7 t -109.37 149.9 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.425 0.631 . . . . 0.0 112.461 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.827 ' HE3' HD13 ' A' ' 362' ' ' LEU . 10.5 mtmt -132.38 134.81 45.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.388 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.484 HG23 HG13 ' A' ' 357' ' ' VAL . 4.7 mp -101.43 145.4 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.802 0.334 . . . . 0.0 110.65 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' HIS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 358' ' ' VAL . 0.5 OUTLIER -135.43 133.9 39.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.069 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.0 tp -117.95 109.18 16.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.514 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 0.0 OUTLIER -117.31 148.01 42.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.395 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.545 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.2 OUTLIER -105.74 99.63 9.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.294 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 10.7 m120 59.51 38.15 22.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.082 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.8 10.75 57.45 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.226 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 317' ' ' MET . 4.5 mmtt -117.61 109.33 16.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.878 0.339 . . . . 0.0 110.849 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.66 136.92 54.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.294 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 318' ' ' GLN . 1.7 mt -128.71 -45.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.117 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 148.8 52.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.287 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' LYS . . . . . 0.45 ' CG ' ' CD2' ' A' ' 315' ' ' HIS . 0.5 OUTLIER -142.51 125.61 16.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.456 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.03 165.44 17.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.976 0.417 . . . . 0.0 111.248 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -146.16 142.0 28.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.538 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.669 HG22 ' CE2' ' A' ' 343' ' ' PHE . 5.8 p -98.57 -179.63 4.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.868 0.366 . . . . 0.0 111.026 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.4 p -60.02 159.41 9.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.537 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.2 mt -102.71 122.12 54.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.894 0.378 . . . . 0.0 111.38 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.477 ' HB3' HG21 ' A' ' 334' ' ' THR . 2.3 mmtt -87.4 92.14 8.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.956 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -61.47 136.83 58.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.168 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ASN . . . . . 0.436 ' C ' HD13 ' A' ' 307' ' ' LEU . 1.0 OUTLIER 44.76 82.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.464 179.055 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.728 ' O ' HD23 ' A' ' 335' ' ' LEU . 3.7 t -175.92 174.37 2.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.791 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.728 HD23 ' O ' ' A' ' 334' ' ' THR . 4.5 mt -144.95 -16.86 0.51 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.264 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.435 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.5 m-80 -132.54 58.87 39.4 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 60.3 Cg_endo -88.26 167.6 6.51 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.174 2.582 . . . . 0.0 113.867 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.483 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 12.6 t80 -107.39 158.03 17.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.907 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.582 ' HB2' HG22 ' A' ' 293' ' ' ILE . 63.7 m-85 -132.37 -71.73 0.53 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.88 0.372 . . . . 0.0 111.28 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ASN . . . . . 0.483 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 9.6 t-20 63.87 34.98 11.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.019 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.491 ' O ' HG13 ' A' ' 292' ' ' VAL . 37.9 mt-10 -91.15 140.39 29.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.718 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.2 m -111.21 121.32 44.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.97 0.414 . . . . 0.0 111.66 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.669 ' CE2' HG22 ' A' ' 328' ' ' THR . 67.3 m-85 -113.34 148.34 35.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.101 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 23.9 m -127.02 138.21 53.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.028 0.442 . . . . 0.0 111.533 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -127.06 165.82 18.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.596 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -110.44 77.14 1.02 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.719 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.885 HG13 ' HB3' ' A' ' 351' ' ' GLN . 40.5 t -108.04 114.17 60.09 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.983 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.439 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 32.9 Cg_endo -65.49 157.43 58.26 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.338 2.026 . . . . 0.0 111.395 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -51.42 -25.24 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.482 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -85.23 -11.55 54.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.576 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.885 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.6 OUTLIER -102.08 -36.38 8.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.575 0.226 . . . . 0.0 111.187 -179.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.938 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.9 tp -50.81 -28.61 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.32 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -95.0 0.82 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.677 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -125.64 -13.83 6.4 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.545 HG12 ' HG2' ' A' ' 318' ' ' GLN . 26.5 m -94.09 166.84 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 111.271 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' GLN . . . . . 0.412 ' CG ' ' HA3' ' A' ' 379' ' ' GLY . 7.5 mp0 -143.2 126.38 16.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.518 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 85.9 t -89.09 115.61 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.205 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.616 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.2 OUTLIER -101.54 109.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.584 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.562 ' HB ' HG23 ' A' ' 376' ' ' VAL . 42.9 t -93.69 107.84 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.961 HG23 ' HB3' ' A' ' 375' ' ' LYS . 3.6 m -110.74 134.21 52.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.964 0.412 . . . . 0.0 111.587 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 312' ' ' VAL . 40.9 t -108.19 117.22 53.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.223 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.827 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.4 mp -120.63 148.16 44.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.013 0.435 . . . . 0.0 111.604 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.517 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -96.01 131.95 41.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.46 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 365' ' ' ASP . 8.5 t80 -87.04 142.63 27.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.736 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.448 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 22.9 m-20 -126.41 104.54 8.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.639 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.438 ' HD3' HG12 ' A' ' 367' ' ' ILE . 0.0 OUTLIER -29.18 -46.22 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.915 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.438 HG12 ' HD3' ' A' ' 366' ' ' LYS . 39.5 mm -107.15 -69.33 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.745 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -57.41 166.67 5.4 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.482 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.73 165.61 20.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.5 135.5 45.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.776 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -98.94 139.82 34.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.013 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.673 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -87.15 110.84 20.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.176 0.513 . . . . 0.0 110.852 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.781 ' O ' HD22 ' A' ' 273' ' ' LEU . 37.3 mt -79.83 -34.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.285 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' GLY . . . . . 0.542 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 168.71 -178.51 42.09 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.746 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.961 ' HB3' HG23 ' A' ' 360' ' ' THR . 11.0 ptmt -164.83 140.74 5.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.336 0.589 . . . . 0.0 112.275 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.908 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.81 159.15 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.746 178.707 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.622 ' CD1' HG13 ' A' ' 413' ' ' VAL . 27.5 p90 -146.44 131.99 18.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 0.0 111.756 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 378' ' ' VAL . 26.5 m -127.01 105.6 14.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.787 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.412 ' HA3' ' CG ' ' A' ' 356' ' ' GLN . . . -145.7 -149.42 5.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.775 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.84 -31.11 13.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.805 0.336 . . . . 0.0 110.727 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.6 -27.52 41.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.79 173.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 68.6 p -153.52 148.21 26.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 93.18 -147.09 18.43 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.702 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.514 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -57.44 -29.49 64.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.931 0.396 . . . . 0.0 111.245 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -72.29 -41.24 66.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.903 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 39.5 tp -72.24 -36.09 68.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 0.0 110.298 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 385' ' ' ALA . 9.8 ptt180 -62.45 -32.04 72.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.235 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.835 ' CD2' HD12 ' A' ' 280' ' ' LEU . 17.7 t-160 -74.26 -52.08 13.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.42 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.518 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 70.0 t-105 -54.91 -45.28 74.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.53 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -37.86 84.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 13.0 t0 -61.2 -35.64 77.72 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.96 ' HE1' HD11 ' A' ' 289' ' ' LEU . 10.9 ttm -59.68 -52.82 63.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.174 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.768 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.3 mt -61.75 -25.83 67.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.964 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -76.72 -44.77 32.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.255 0.55 . . . . 0.0 109.594 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.441 ' HB2' HD11 ' A' ' 401' ' ' ILE . 21.9 m-80 -119.33 64.39 7.6 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.489 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.517 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 5.0 Cg_endo -45.67 -80.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.498 2.799 . . . . 0.0 113.23 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.51 -17.56 2.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.421 ' HB3' ' HB3' ' A' ' 396' ' ' ASN . 0.0 OUTLIER -93.79 116.72 66.83 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.818 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 34.6 Cg_exo -57.5 136.83 78.28 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.472 2.115 . . . . 0.0 112.691 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.47 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.2 mm -116.75 107.38 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.327 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.81 143.62 36.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.858 0.361 . . . . 0.0 110.829 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.52 152.33 10.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.321 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -79.13 116.31 19.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.582 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.908 ' HB3' HG11 ' A' ' 376' ' ' VAL . 33.5 m-70 -102.87 119.88 39.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.685 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.624 HG23 ' OD1' ' A' ' 275' ' ' ASP . 74.4 m -78.33 116.01 18.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.4 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.865 HD23 HG22 ' A' ' 376' ' ' VAL . 93.4 mt -62.38 127.78 32.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.252 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.425 ' C ' HD12 ' A' ' 273' ' ' LEU . 7.2 mt-30 -115.88 172.57 7.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.856 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.887 ' O ' HG23 ' A' ' 413' ' ' VAL . 41.3 t -56.18 121.82 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.002 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.673 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 12.2 mt-10 -54.23 -43.65 71.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.101 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.5 -50.4 73.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.886 0.374 . . . . 0.0 110.795 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.447 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.4 mt-10 -63.38 -37.8 88.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 409' ' ' VAL . 99.6 t -57.61 -48.09 83.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.715 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -31.1 72.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -75.05 -30.95 61.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.075 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 28.7 mtm -72.15 -32.96 67.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.998 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 9.4 mt -78.16 -32.79 50.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -87.88 -177.07 5.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 28.6 t . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.037 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.777 HD22 ' O ' ' A' ' 373' ' ' ILE . 62.5 mt -75.13 -33.05 61.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.63 -163.2 16.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.255 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.632 ' OD1' HG23 ' A' ' 406' ' ' THR . 8.4 m-20 -143.44 135.87 27.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.71 0.291 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.796 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -123.63 129.43 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.057 0.456 . . . . 0.0 110.822 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.796 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.4 OUTLIER -97.35 124.96 41.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.017 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.606 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 20.3 p90 -142.26 149.73 39.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.802 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.755 ' OG ' ' HB ' ' A' ' 292' ' ' VAL . 16.1 p -110.83 168.0 9.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.197 0.522 . . . . 0.0 111.892 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.553 HD12 ' NE2' ' A' ' 389' ' ' HIS . 1.2 mt -137.67 160.09 40.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.78 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.488 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.9 OUTLIER -159.14 102.47 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.767 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.961 ' CD1' HD13 ' A' ' 352' ' ' ILE . 39.7 t80 -100.14 130.82 46.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.944 0.402 . . . . 0.0 111.878 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.48 97.82 51.16 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.508 ' CG ' ' CB ' ' A' ' 397' ' ' PRO . 6.0 Cg_exo -71.13 -29.93 16.88 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.643 2.229 . . . . 0.0 112.299 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -30.56 11.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.187 0.518 . . . . 0.0 109.774 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.76 -20.83 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.822 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.44 47.17 7.01 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.908 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -123.98 129.66 51.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 111.482 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.404 HD21 ' CG2' ' A' ' 357' ' ' VAL . 33.5 tp -96.36 147.63 23.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.26 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 343' ' ' PHE . 6.0 m -135.28 137.24 42.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.287 0.565 . . . . 0.0 112.003 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.8 t -130.33 123.07 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.412 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.755 ' HB ' ' OG ' ' A' ' 279' ' ' SER . 5.0 t -118.54 116.32 50.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.664 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.652 HG13 HG21 ' A' ' 328' ' ' THR . 44.1 mm -75.65 137.15 23.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.569 HD22 ' OE1' ' A' ' 295' ' ' GLU . 0.8 OUTLIER -114.16 -57.94 2.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.742 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.569 ' OE1' HD22 ' A' ' 294' ' ' LEU . 1.2 pt-20 -175.54 162.43 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.422 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.754 ' CB ' HD11 ' A' ' 299' ' ' LEU . . . -122.33 154.81 37.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.933 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.421 ' HD3' ' CZ3' ' A' ' 404' ' ' TRP . 4.0 ptmt -150.79 150.4 30.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 111.519 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.0 m120 59.62 25.54 14.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.754 HD11 ' CB ' ' A' ' 296' ' ' ALA . 89.3 mt -61.43 138.95 58.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.813 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -58.25 151.48 19.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.546 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.452 ' HE3' HD11 ' A' ' 335' ' ' LEU . 13.7 mttp -91.46 118.13 30.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.547 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.547 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.6 mmt -91.48 -18.57 23.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.341 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 30.6 m-20 -104.46 98.18 7.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.729 0.3 . . . . 0.0 110.408 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.22 114.73 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 111.44 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.95 -3.52 84.68 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.681 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -129.36 -143.17 5.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.87 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.492 HD12 ' HB2' ' A' ' 333' ' ' ASN . 34.6 mt -113.63 -159.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.909 0.385 . . . . 0.0 110.842 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.638 ' HB2' HD23 ' A' ' 335' ' ' LEU . 74.2 m -134.74 172.24 13.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.307 0.575 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.405 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -129.13 58.07 34.59 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.443 ' CB ' HD13 ' A' ' 299' ' ' LEU . 47.6 Cg_endo -70.15 150.64 66.13 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.13 2.554 . . . . 0.0 114.974 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.557 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 51.4 p90 -153.51 156.54 38.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.169 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.888 HG22 HG22 ' A' ' 361' ' ' VAL . 42.7 t -107.6 149.97 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.823 ' HE3' HD13 ' A' ' 362' ' ' LEU . 12.8 mtmt -131.09 139.21 49.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.313 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.411 HD11 ' CG1' ' A' ' 293' ' ' ILE . 5.2 mp -114.77 130.31 69.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.296 . . . . 0.0 110.963 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -126.17 136.76 53.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 0.0 111.042 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.443 HD23 ' HG3' ' A' ' 324' ' ' LYS . 21.8 tp -105.51 105.25 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.594 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 1.4 mtm -107.69 144.18 35.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.716 ' CG ' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -104.38 99.68 9.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.572 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.6 m120 57.68 35.48 25.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.352 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 100.56 11.77 40.18 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.753 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.01 110.73 14.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.377 0.589 . . . . 0.0 110.921 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.401 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.6 OUTLIER -53.82 137.85 37.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.688 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.716 HD11 ' CG ' ' A' ' 318' ' ' GLN . 5.8 mt -126.8 -43.16 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.079 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.443 ' HG3' HD23 ' A' ' 316' ' ' LEU . 0.8 OUTLIER -130.46 151.57 50.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.34 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.0 133.68 41.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.836 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -136.35 160.25 39.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.032 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -147.8 144.22 28.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.825 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.67 HG22 ' CE1' ' A' ' 343' ' ' PHE . 18.0 p -103.78 174.0 6.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.695 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.2 t -55.02 162.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.682 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.557 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.0 mt -108.8 128.55 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.949 0.404 . . . . 0.0 111.245 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.638 ' O ' HG22 ' A' ' 334' ' ' THR . 2.1 mmtt -94.99 93.14 7.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.46 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -57.79 137.38 56.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.693 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ASN . . . . . 0.492 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.2 p-10 44.79 83.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.401 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.779 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.9 t -175.87 173.33 2.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.685 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 334' ' ' THR . 4.1 mt -146.9 -15.97 0.41 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.264 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.411 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.9 m-80 -131.48 60.26 51.14 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.86 0.362 . . . . 0.0 110.08 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.455 ' HB2' ' HG3' ' A' ' 331' ' ' LYS . 73.5 Cg_endo -86.79 167.59 8.4 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.081 2.521 . . . . 0.0 114.106 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 74.0 t80 -119.95 149.46 42.08 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.605 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -132.46 -67.73 0.64 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.909 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ASN . . . . . 0.487 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 11.6 t-20 67.85 36.53 3.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.688 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 293' ' ' ILE . 46.3 mt-10 -91.04 135.0 34.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.519 ' HA ' HG13 ' A' ' 292' ' ' VAL . 1.4 m -104.72 121.69 44.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.836 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.67 ' CE1' HG22 ' A' ' 328' ' ' THR . 60.9 m-85 -109.08 164.72 12.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.891 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 18.3 m -134.7 142.65 46.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.05 0.452 . . . . 0.0 111.73 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.407 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 50.3 m-85 -132.14 162.1 31.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -112.5 77.69 1.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.562 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 351' ' ' GLN . 38.3 t -105.26 122.13 43.98 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.323 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 27.1 Cg_exo -60.85 146.66 97.18 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.571 2.181 . . . . 0.0 111.564 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.44 ' CD1' ' HB3' ' A' ' 284' ' ' PRO . 11.3 t80 -54.08 -23.74 14.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 111.243 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 15.1 pm0 -91.5 -8.59 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.372 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.486 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.1 OUTLIER -104.45 -24.58 13.03 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.961 HD13 ' CD1' ' A' ' 282' ' ' TYR . 1.7 tp -52.4 -32.59 16.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.879 0.371 . . . . 0.0 110.547 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 380' ' ' TYR . 6.4 mt-30 -87.58 3.33 47.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.338 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -124.29 -21.25 5.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.503 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.615 HG12 ' HG2' ' A' ' 318' ' ' GLN . 24.0 m -87.88 166.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.879 0.371 . . . . 0.0 111.285 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' GLN . . . . . 0.409 ' CG ' ' HA3' ' A' ' 379' ' ' GLY . 7.2 mp0 -143.47 126.28 16.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.778 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.508 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 64.5 t -88.26 119.55 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.287 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.5 OUTLIER -102.46 111.65 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.74 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 376' ' ' VAL . 46.6 t -97.52 107.91 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.674 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.979 HG23 ' HB3' ' A' ' 375' ' ' LYS . 3.1 m -110.59 134.41 52.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.011 0.434 . . . . 0.0 111.859 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.888 HG22 HG22 ' A' ' 312' ' ' VAL . 55.5 t -108.37 115.02 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.128 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.823 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.8 mp -118.87 150.31 40.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 111.506 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.547 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.4 OUTLIER -97.22 129.94 44.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.638 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.55 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 27.0 t80 -78.99 146.86 33.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.652 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 367' ' ' ILE . 27.5 m-20 -139.2 66.59 1.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.542 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.665 ' HG2' HD12 ' A' ' 367' ' ' ILE . 0.1 OUTLIER 25.12 -88.26 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.407 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.665 HD12 ' HG2' ' A' ' 366' ' ' LYS . 4.4 mp -82.52 -68.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -47.98 167.53 0.13 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.888 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.9 165.45 13.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.333 . . . . 0.0 110.779 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.62 124.97 35.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.5 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.89 153.64 40.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.522 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.663 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -100.86 111.74 24.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.616 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.777 ' O ' HD22 ' A' ' 273' ' ' LEU . 25.5 mt -79.66 -33.23 14.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.317 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.13 -178.24 41.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.854 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.979 ' HB3' HG23 ' A' ' 360' ' ' THR . 17.1 ptmt -164.66 140.61 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.292 0.568 . . . . 0.0 111.967 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.9 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.77 159.07 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.01 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.437 ' HB3' HG13 ' A' ' 358' ' ' VAL . 9.4 p90 -143.82 131.98 21.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.417 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 378' ' ' VAL . 30.1 m -126.45 109.36 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.793 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 390' ' ' TRP . . . -152.63 -141.08 3.22 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.864 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.418 ' CB ' ' O ' ' A' ' 353' ' ' GLN . 0.1 OUTLIER -105.78 -30.28 9.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.797 0.332 . . . . 0.0 110.898 -179.414 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -79.0 -28.97 43.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.04 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 1.4 m -58.42 176.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.067 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 75.3 p -153.28 148.33 26.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.728 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 95.9 -156.95 21.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.472 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.446 ' HA ' ' HG3' ' A' ' 388' ' ' ARG . . . -47.39 -31.51 4.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.765 0.317 . . . . 0.0 111.447 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.417 ' OE1' ' CE1' ' A' ' 377' ' ' PHE . 13.2 mt-10 -64.67 -54.77 26.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.0 tp -56.99 -34.44 68.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.58 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.446 ' HG3' ' HA ' ' A' ' 385' ' ' ALA . 6.0 mtt180 -61.82 -48.52 80.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.359 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.553 ' NE2' HD12 ' A' ' 280' ' ' LEU . 19.6 t-160 -60.27 -57.53 12.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.508 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 65.2 t-105 -51.41 -44.96 62.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.963 0.411 . . . . 0.0 110.203 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.0 t -68.86 -34.79 76.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.932 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 4.4 t0 -62.04 -31.67 72.1 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.458 ' HA ' HG13 ' A' ' 401' ' ' ILE . 5.7 tpt -66.61 -56.42 10.78 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.74 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.825 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.3 mt -58.42 -21.45 50.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.665 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.421 ' C ' ' HD3' ' A' ' 397' ' ' PRO . . . -70.39 -34.08 72.14 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -127.96 70.52 78.03 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.669 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.52 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 11.2 Cg_exo -71.59 51.65 1.52 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.101 2.534 . . . . 0.0 112.954 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ARG . . . . . 0.52 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 4.7 mmm180 -158.99 -40.89 0.06 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.351 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.417 ' O ' ' HE1' ' A' ' 393' ' ' MET . 0.3 OUTLIER -94.0 160.72 31.73 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.491 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 82.2 Cg_endo -89.87 123.23 1.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.131 2.554 . . . . 0.0 112.664 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.458 HG13 ' HA ' ' A' ' 393' ' ' MET . 1.1 mm -98.38 130.44 47.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.717 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 279' ' ' SER . . . -124.57 146.01 49.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.701 0.286 . . . . 0.0 110.809 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.29 155.78 9.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 111.411 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' TRP . . . . . 0.421 ' CZ3' ' HD3' ' A' ' 297' ' ' LYS . 54.1 m95 -83.63 123.38 29.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.776 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.9 ' HB3' HG11 ' A' ' 376' ' ' VAL . 47.5 m-70 -111.05 119.21 38.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.632 HG23 ' OD1' ' A' ' 275' ' ' ASP . 87.8 m -78.34 116.52 18.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.811 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.836 HD23 HG22 ' A' ' 376' ' ' VAL . 94.9 mt -61.89 127.66 32.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.352 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -114.97 171.59 7.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.561 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 413' ' ' VAL . 60.5 t -54.17 120.25 2.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.663 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 10.6 mt-10 -54.57 -42.37 70.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.879 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -48.87 77.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.36 . . . . 0.0 110.74 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.469 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.5 mt-10 -64.67 -38.84 92.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.349 0.595 . . . . 0.0 109.417 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 375' ' ' LYS . 95.2 t -58.44 -49.27 82.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.544 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -33.71 75.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.936 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -71.21 -31.92 68.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 33.9 mtm -73.46 -34.62 65.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 8.1 mt -81.21 -31.24 34.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -84.83 138.82 32.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.098 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . 0.421 'CA ' ' HB3' ' A' ' 302' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.865 0.364 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.785 HD22 ' O ' ' A' ' 373' ' ' ILE . 48.4 mt -83.76 -31.15 26.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 117.41 -168.47 12.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.225 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.11 132.42 32.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.707 0.289 . . . . 0.0 110.987 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.821 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -118.58 129.29 75.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.058 0.456 . . . . 0.0 110.964 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.821 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.52 124.87 41.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.828 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.608 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 20.5 p90 -142.3 149.67 39.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.691 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.783 ' OG ' ' HB ' ' A' ' 292' ' ' VAL . 13.2 p -109.78 160.65 16.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.233 0.54 . . . . 0.0 112.214 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.74 HD12 ' CD2' ' A' ' 389' ' ' HIS . 6.8 mt -128.69 153.82 46.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.806 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.418 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 9.8 ttp180 -159.27 107.28 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.86 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.959 ' CD1' HD13 ' A' ' 352' ' ' ILE . 31.3 t80 -99.04 139.48 34.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.721 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 287' ' ' GLY . 60.1 t -116.54 92.83 38.55 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 17.1 Cg_exo -65.14 -30.88 55.28 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.891 2.394 . . . . 0.0 112.322 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -31.54 63.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.732 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.84 -11.9 8.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.637 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 73.5 45.41 29.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.059 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -120.08 130.06 54.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 111.447 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.492 HD21 ' CG2' ' A' ' 357' ' ' VAL . 25.0 tp -94.34 148.02 22.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.381 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 3.6 m -136.82 134.3 36.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.254 0.55 . . . . 0.0 111.903 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.47 HG21 HG11 ' A' ' 357' ' ' VAL . 21.5 t -127.81 122.65 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.363 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.783 ' HB ' ' OG ' ' A' ' 279' ' ' SER . 4.3 t -117.68 115.48 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.758 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.704 HG13 HG21 ' A' ' 328' ' ' THR . 40.8 mm -74.6 137.14 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 277' ' ' CYS . 0.6 OUTLIER -113.45 -58.3 2.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.5 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 11.4 pt-20 -175.72 163.77 2.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.665 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.699 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -125.24 149.01 48.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.677 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.421 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 17.7 pttt -146.17 153.29 40.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.104 0.478 . . . . 0.0 111.549 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.0 m120 60.1 27.1 16.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.621 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.699 HD21 ' HB1' ' A' ' 296' ' ' ALA . 91.7 mt -63.36 138.55 58.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.599 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.71 136.73 53.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.689 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.4 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 7.1 mttt -69.51 123.54 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.185 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 363' ' ' ASP . 0.1 OUTLIER -100.49 -11.58 20.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.687 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 53.1 m-20 -103.05 121.94 43.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.807 0.337 . . . . 0.0 110.284 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -47.02 115.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 111.664 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 57.37 17.27 24.55 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.405 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.97 -160.43 10.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.956 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.491 HD13 ' C ' ' A' ' 333' ' ' ASN . 6.3 mt -94.84 -160.86 0.81 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.449 0.3 . . . . 0.0 110.27 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.66 ' HB2' HD23 ' A' ' 335' ' ' LEU . 67.3 m -136.68 171.86 13.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.344 0.592 . . . . 0.0 111.105 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.448 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -132.12 55.12 16.23 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.819 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 309' ' ' ASP . 35.4 Cg_endo -65.97 149.94 85.85 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.168 2.578 . . . . 0.0 114.551 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.539 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 48.1 p90 -154.18 150.09 27.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.401 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.833 HG22 HG22 ' A' ' 361' ' ' VAL . 39.3 t -101.23 148.96 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.836 ' HE3' HD13 ' A' ' 362' ' ' LEU . 11.7 mtmt -130.33 138.54 50.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.154 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.514 HG23 HG13 ' A' ' 357' ' ' VAL . 5.3 mp -115.66 131.06 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.774 0.321 . . . . 0.0 110.771 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -129.13 133.38 47.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.491 HD21 ' CG2' ' A' ' 347' ' ' VAL . 18.9 tp -106.06 104.97 14.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.638 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 3.5 mtm -106.57 142.79 35.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.747 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.2 OUTLIER -102.21 99.77 9.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.48 179.482 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 58.65 38.3 25.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 92.18 22.52 29.65 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.027 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.5 mtpm? -128.86 109.3 11.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.741 0.305 . . . . 0.0 110.805 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.88 131.59 40.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.26 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.747 HD11 ' CB ' ' A' ' 318' ' ' GLN . 4.9 mt -126.01 -42.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.131 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -130.72 151.32 51.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.502 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 132.1 32.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.582 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.441 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 53.2 mmtt -139.34 155.27 47.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.236 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -141.31 149.47 41.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.72 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.765 HG22 ' CE1' ' A' ' 343' ' ' PHE . 21.2 p -106.17 175.51 5.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.826 0.346 . . . . 0.0 111.031 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -57.24 148.7 21.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.69 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.539 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -92.12 122.49 43.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.514 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.661 ' O ' HG22 ' A' ' 334' ' ' THR . 20.3 mmmt -86.67 85.87 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.016 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.68 139.29 50.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.99 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ASN . . . . . 0.491 ' C ' HD13 ' A' ' 307' ' ' LEU . 0.9 OUTLIER 42.81 79.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.496 179.009 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.758 ' O ' HD23 ' A' ' 335' ' ' LEU . 5.1 t -173.44 173.48 3.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.165 0.507 . . . . 0.0 110.911 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 334' ' ' THR . 4.0 mt -146.19 -16.09 0.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.186 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.492 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.57 58.5 36.64 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 110.217 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 84.6 Cg_endo -90.39 167.79 4.24 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.175 2.583 . . . . 0.0 114.076 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.524 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 35.9 t80 -114.1 152.48 31.02 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.067 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.495 ' HB2' HG22 ' A' ' 293' ' ' ILE . 2.2 m-85 -130.03 -70.53 0.63 Allowed 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.921 0.391 . . . . 0.0 111.519 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ASN . . . . . 0.524 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 24.3 t-20 66.67 35.14 5.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.714 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 293' ' ' ILE . 52.1 mt-10 -91.11 133.81 35.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.973 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.53 ' HA ' HG13 ' A' ' 292' ' ' VAL . 1.2 m -104.07 121.25 42.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.695 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.765 ' CE1' HG22 ' A' ' 328' ' ' THR . 69.2 m-85 -110.08 156.5 20.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.022 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 57.9 p -130.65 140.54 50.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.088 0.47 . . . . 0.0 111.588 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.441 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 62.7 m-85 -128.54 165.91 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.58 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -111.6 78.48 1.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.86 HG13 ' HB3' ' A' ' 351' ' ' GLN . 41.4 t -111.72 117.81 47.96 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.059 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.486 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 48.3 Cg_endo -69.52 157.47 60.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.383 2.055 . . . . 0.0 111.434 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -51.3 -23.02 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -86.7 -10.23 54.19 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.86 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -107.8 -33.16 7.34 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.537 0.208 . . . . 0.0 111.544 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.959 HD13 ' CD1' ' A' ' 282' ' ' TYR . 5.1 tp -49.26 -27.21 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.638 0.256 . . . . 0.0 111.136 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' GLN . . . . . 0.424 HE21 ' HB3' ' A' ' 353' ' ' GLN . 0.0 OUTLIER -95.17 -9.42 33.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.842 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -113.29 -18.62 12.02 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.587 HG12 ' HG2' ' A' ' 318' ' ' GLN . 23.7 m -87.92 167.89 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 111.377 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' GLN . . . . . 0.469 ' HA ' ' HA3' ' A' ' 379' ' ' GLY . 3.4 mt-30 -143.81 126.34 15.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.824 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.544 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 53.9 t -89.87 104.83 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.497 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.5 OUTLIER -90.69 110.78 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.615 -179.293 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 376' ' ' VAL . 44.3 t -93.81 107.85 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.981 HG23 ' HB3' ' A' ' 375' ' ' LYS . 5.2 m -111.55 131.77 55.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 0.0 111.968 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.833 HG22 HG22 ' A' ' 312' ' ' VAL . 42.5 t -105.03 119.47 54.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.163 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.836 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.5 mp -124.73 147.61 48.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.134 0.492 . . . . 0.0 111.797 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.455 ' HB3' ' SD ' ' A' ' 302' ' ' MET . 3.4 t70 -91.13 129.87 37.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.012 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.462 ' CB ' HG21 ' A' ' 330' ' ' ILE . 21.7 t80 -79.63 141.95 36.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.232 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 366' ' ' LYS . 80.0 m-20 -138.62 71.77 1.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.496 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.591 ' HB2' HD13 ' A' ' 367' ' ' ILE . 2.5 pttm 24.16 -89.59 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.591 HD13 ' HB2' ' A' ' 366' ' ' LYS . 0.0 OUTLIER -99.19 129.44 49.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.092 0.472 . . . . 0.0 111.156 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.02 179.45 21.98 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.62 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 165.12 13.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.721 0.295 . . . . 0.0 110.686 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 0.2 OUTLIER -100.93 138.72 37.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.834 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -72.68 145.01 47.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.291 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.711 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -101.1 112.44 24.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.135 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.785 ' O ' HD22 ' A' ' 273' ' ' LEU . 12.3 mt -79.98 -33.37 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.336 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 166.35 179.21 39.57 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.945 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.981 ' HB3' HG23 ' A' ' 360' ' ' THR . 13.3 ptmt -161.2 140.37 10.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.24 0.543 . . . . 0.0 112.075 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.913 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -111.84 159.06 12.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.21 179.324 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.468 ' HB3' HG13 ' A' ' 358' ' ' VAL . 14.8 p90 -142.98 135.17 27.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 0.0 111.546 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 378' ' ' VAL . 18.8 m -130.22 100.2 4.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.986 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 166.94 -156.62 28.6 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.165 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.423 ' CD1' ' O ' ' A' ' 353' ' ' GLN . 0.0 OUTLIER -51.17 153.04 2.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 111.188 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.16 31.09 20.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 20.2 m -121.34 161.9 21.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.883 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 48.1 p -153.33 147.96 26.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.729 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 94.86 -156.91 22.04 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.522 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.418 ' HA ' ' HG3' ' A' ' 388' ' ' ARG . . . -50.44 -31.14 14.28 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -63.94 -51.88 62.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.429 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.02 -32.42 69.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.571 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 31.7 mtt180 -63.55 -50.88 67.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.619 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.74 ' CD2' HD12 ' A' ' 280' ' ' LEU . 16.2 t-160 -56.82 -54.14 49.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.544 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 61.1 t-105 -54.06 -50.67 66.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.091 0.472 . . . . 0.0 110.335 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.4 t -63.69 -34.94 78.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.345 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 8.2 t0 -62.74 -36.57 83.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.047 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.762 ' CE ' HD11 ' A' ' 352' ' ' ILE . 31.2 ttp -62.96 -55.32 26.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.724 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.796 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -57.52 -24.68 57.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.662 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -79.94 -37.75 33.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.299 0.571 . . . . 0.0 109.526 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 399' ' ' ARG . 13.6 m-80 -126.82 60.99 43.61 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.646 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.523 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 3.9 Cg_endo -45.11 -79.32 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.791 2.994 . . . . 0.0 113.266 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -48.51 -21.8 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.126 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' A' ' 396' ' ' ASN . 1.1 tpt180 -93.73 126.71 48.59 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.826 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.34 131.39 21.72 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.46 2.106 . . . . 0.0 112.547 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.456 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.1 mm -110.46 112.06 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.093 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 279' ' ' SER . . . -108.95 145.65 35.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.687 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.95 152.7 6.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.927 0.394 . . . . 0.0 111.322 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' TRP . . . . . 0.43 ' CH2' ' HG3' ' A' ' 295' ' ' GLU . 64.2 m95 -80.89 118.74 22.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.823 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.913 ' HB3' HG11 ' A' ' 376' ' ' VAL . 46.3 m-70 -107.17 119.77 40.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 86.6 m -78.29 116.26 18.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.091 0.472 . . . . 0.0 110.961 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.832 HD23 HG22 ' A' ' 376' ' ' VAL . 94.9 mt -61.75 127.55 31.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.28 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -114.42 171.9 7.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.491 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 413' ' ' VAL . 57.1 t -54.58 115.65 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.711 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 3.6 mp0 -52.05 -41.16 62.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.803 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -57.21 -48.91 77.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 110.622 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.467 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 24.4 mt-10 -65.04 -39.91 94.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.845 HG11 ' HG3' ' A' ' 375' ' ' LYS . 70.5 t -59.5 -49.54 83.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.158 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.498 ' HA ' HD12 ' A' ' 417' ' ' LEU . 0.7 OUTLIER -62.33 -37.15 84.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.741 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -66.17 -35.26 80.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 63.3 mtm -70.24 -30.36 67.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 414' ' ' ASP . 8.0 mt -81.27 -34.43 32.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.87 -179.73 5.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.089 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.092 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.779 0.323 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.716 HD22 ' O ' ' A' ' 373' ' ' ILE . 44.6 mt -77.44 -31.94 54.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.12 -159.63 16.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.192 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.52 ' OD1' HG23 ' A' ' 406' ' ' THR . 28.3 m-20 -148.17 131.12 16.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.787 0.327 . . . . 0.0 110.56 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.898 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -120.63 130.14 74.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 110.935 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.898 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.21 126.22 42.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.736 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.619 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.5 p90 -141.94 149.33 39.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.321 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.0 OUTLIER -99.75 159.37 15.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.045 -178.62 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.606 HD13 ' HE3' ' A' ' 393' ' ' MET . 85.2 mt -130.49 144.99 51.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.855 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.406 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 7.2 ttm180 -158.86 103.94 1.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.781 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.905 ' CD1' HD13 ' A' ' 352' ' ' ILE . 27.8 t80 -99.22 138.86 35.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.241 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.8 t -123.55 94.59 46.16 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.394 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.537 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.15 -32.57 16.71 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.927 2.418 . . . . 0.0 112.325 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.53 -29.8 7.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.176 0.512 . . . . 0.0 110.07 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.95 -21.1 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.117 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 81.06 48.03 6.26 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.538 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -123.76 129.32 50.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.058 0.456 . . . . 0.0 111.626 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.711 HD11 ' HE1' ' A' ' 393' ' ' MET . 33.7 tp -96.08 147.74 23.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.9 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 2.6 m -136.05 135.99 39.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.319 0.58 . . . . 0.0 111.998 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.43 118.19 44.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.12 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 341' ' ' GLU . 23.1 t -113.92 115.74 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.058 0.456 . . . . 0.0 111.961 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.718 HG22 ' HB2' ' A' ' 339' ' ' TYR . 34.2 mm -74.75 137.02 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.49 -60.34 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 4.9 pt-20 -175.73 155.89 1.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.357 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.771 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -112.03 153.3 27.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.724 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -150.95 150.71 31.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.148 0.499 . . . . 0.0 111.614 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 61.38 22.74 13.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.005 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.782 HD13 ' CG ' ' A' ' 310' ' ' PRO . 52.0 mt -57.8 138.46 55.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.109 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -64.09 149.88 46.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.502 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.507 ' HE3' HD11 ' A' ' 335' ' ' LEU . 11.1 mttt -88.32 116.22 26.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.54 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.427 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 9.0 mmm -95.93 -19.98 19.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.486 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 48.6 m-20 -91.91 121.57 33.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.543 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -48.35 115.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.648 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 56.17 18.56 20.81 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.304 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.42 -157.74 9.75 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.005 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 307' ' ' LEU . 7.0 mt -98.53 -161.38 0.87 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.781 0.324 . . . . 0.0 110.529 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.54 ' HB2' HD23 ' A' ' 335' ' ' LEU . 15.1 m -134.91 171.89 13.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.246 0.546 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.422 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -135.16 56.61 16.91 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.782 ' CG ' HD13 ' A' ' 299' ' ' LEU . 73.7 Cg_endo -77.57 143.68 21.78 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.963 2.442 . . . . 0.0 114.805 -177.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.575 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 10.6 p90 -138.8 166.94 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.242 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.802 HG22 HG22 ' A' ' 361' ' ' VAL . 24.4 t -112.73 149.96 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.665 ' CE ' HD13 ' A' ' 362' ' ' LEU . 7.0 mttm -133.97 144.05 48.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.871 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.478 HD11 HD11 ' A' ' 293' ' ' ILE . 5.4 mp -118.86 124.09 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 111.201 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -117.98 130.98 56.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.597 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.567 ' HG ' HD12 ' A' ' 323' ' ' LEU . 22.5 tp -102.82 104.64 14.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 0.0 OUTLIER -127.59 129.09 46.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.408 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.764 ' HB3' HG12 ' A' ' 355' ' ' VAL . 1.2 pt20 -105.53 103.15 12.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 110.372 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 318' ' ' GLN . 83.2 m-20 71.15 36.43 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.199 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 82.12 21.22 61.3 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.175 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.6 mtpm? -113.34 109.07 18.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.837 0.318 . . . . 0.0 110.628 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -56.92 127.2 30.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.221 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.757 HD11 ' HG2' ' A' ' 318' ' ' GLN . 11.9 mt -122.7 -56.01 1.79 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.914 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.506 ' HB2' ' HE2' ' A' ' 345' ' ' PHE . 11.7 mttp -137.85 153.98 49.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.944 0.402 . . . . 0.0 111.256 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.57 129.42 20.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.435 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.407 ' HD3' ' CD2' ' A' ' 343' ' ' PHE . 1.2 mttt -127.37 167.88 15.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 111.269 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.55 144.87 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.713 HG22 ' CE1' ' A' ' 343' ' ' PHE . 17.3 p -104.21 178.35 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 7.2 p -57.52 176.5 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.502 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.575 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.4 mt -118.21 118.39 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.97 0.414 . . . . 0.0 111.329 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.645 ' O ' HG22 ' A' ' 334' ' ' THR . 8.8 mmtt -82.95 84.86 7.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.978 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -55.96 136.86 51.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.015 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.45 82.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.294 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.698 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.9 t -176.45 173.86 2.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.725 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 334' ' ' THR . 4.3 mt -145.13 -16.31 0.5 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.219 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.487 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.6 m-80 -132.9 56.05 20.3 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 120.796 0.332 . . . . 0.0 110.117 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 55.8 Cg_endo -88.32 167.67 6.43 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.199 2.599 . . . . 0.0 113.79 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.435 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 1.1 t80 -107.04 160.83 15.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.327 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.718 ' HB2' HG22 ' A' ' 293' ' ' ILE . 70.9 m-85 -134.01 -64.49 0.7 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.865 0.364 . . . . 0.0 111.075 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 56.99 36.95 28.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.976 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.529 ' O ' HG13 ' A' ' 292' ' ' VAL . 47.5 mt-10 -92.97 142.13 27.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.778 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 12.7 m -114.0 120.56 41.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.44 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.713 ' CE1' HG22 ' A' ' 328' ' ' THR . 79.4 m-85 -112.97 153.42 28.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.252 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 9.7 m -123.74 137.73 54.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.152 0.501 . . . . 0.0 111.675 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.506 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 32.2 m-85 -120.88 165.96 14.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.584 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -116.43 72.43 0.82 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.85 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.92 HG13 ' HB3' ' A' ' 351' ' ' GLN . 40.0 t -108.97 117.53 53.53 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.236 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 38.4 Cg_endo -67.61 153.33 76.53 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.113 1.875 . . . . 0.0 111.104 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -48.19 -24.58 1.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.38 -18.02 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.925 0.342 . . . . 0.0 111.925 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.92 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.1 OUTLIER -96.0 -36.56 11.0 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.905 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.3 tp -48.36 -27.12 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 111.243 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' GLN . . . . . 0.422 ' O ' ' CD2' ' A' ' 380' ' ' TYR . 5.6 mt-30 -89.16 -17.77 28.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.987 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.499 ' HA ' ' HD2' ' A' ' 380' ' ' TYR . 0.0 OUTLIER -119.06 10.52 12.16 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.764 HG12 ' HB3' ' A' ' 318' ' ' GLN . 31.0 m -108.36 167.71 3.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' GLN . . . . . 0.706 ' OE1' HD23 ' A' ' 417' ' ' LEU . 21.9 mt-30 -141.22 126.45 18.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.922 0.392 . . . . 0.0 111.224 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.516 ' CG2' HD21 ' A' ' 289' ' ' LEU . 85.4 t -97.25 117.66 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.13 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.632 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.2 OUTLIER -105.22 116.13 48.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.085 -178.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.544 ' HB ' HG23 ' A' ' 376' ' ' VAL . 47.7 t -94.66 107.77 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.976 HG23 ' HB3' ' A' ' 375' ' ' LYS . 5.2 m -109.76 134.74 51.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.062 0.458 . . . . 0.0 111.993 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.802 HG22 HG22 ' A' ' 312' ' ' VAL . 47.5 t -110.88 118.88 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.237 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.665 HD13 ' CE ' ' A' ' 313' ' ' LYS . 3.7 mp -119.8 143.49 47.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.975 0.417 . . . . 0.0 111.43 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.427 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 3.4 t70 -90.37 126.44 35.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.716 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.459 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 22.7 t80 -81.94 141.82 32.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.782 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 367' ' ' ILE . 28.0 m-20 -132.03 73.78 1.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.983 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.517 ' HG2' HD12 ' A' ' 367' ' ' ILE . 0.0 OUTLIER 31.24 -84.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.673 ' H ' HD12 ' A' ' 367' ' ' ILE . 5.1 mp -27.57 -83.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -169.56 -52.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.935 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 109.86 2.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.001 0.429 . . . . 0.0 110.928 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' ASN . . . . . 0.443 ' ND2' ' CD2' ' A' ' 364' ' ' TYR . 0.2 OUTLIER -92.82 145.61 24.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.907 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.01 157.28 20.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.714 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -100.9 111.29 23.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.076 0.465 . . . . 0.0 111.269 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.716 ' O ' HD22 ' A' ' 273' ' ' LEU . 1.4 mm -75.61 -35.64 32.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.817 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' GLY . . . . . 0.521 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 157.29 -174.6 34.81 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.44 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.976 ' HB3' HG23 ' A' ' 360' ' ' THR . 15.9 ptmt -164.31 141.03 6.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.195 0.521 . . . . 0.0 111.851 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.952 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -111.93 158.63 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.167 179.31 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.632 ' HB3' HG13 ' A' ' 358' ' ' VAL . 5.4 p90 -142.1 148.25 38.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.006 0.431 . . . . 0.0 111.593 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 19.8 m -140.85 127.76 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.857 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.44 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 159.26 -137.12 4.99 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.263 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.499 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 0.2 OUTLIER -64.71 -77.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -50.74 -25.02 3.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.809 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 23.0 m -53.24 159.74 1.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.916 0.389 . . . . 0.0 110.679 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 58.8 p -155.95 150.05 25.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.716 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 81.65 -154.75 34.66 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.238 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -45.17 -31.97 1.66 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.753 0.311 . . . . 0.0 111.68 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -63.52 -55.34 24.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.767 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 32.9 tp -57.12 -36.57 70.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.67 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 384' ' ' GLY . 2.6 mtt180 -59.11 -44.77 92.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.129 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.471 ' CD2' HD12 ' A' ' 280' ' ' LEU . 16.6 t-160 -59.95 -57.43 12.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.93 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.516 ' CZ3' ' HE1' ' A' ' 393' ' ' MET . 71.3 t-105 -50.51 -46.43 57.15 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.174 0.512 . . . . 0.0 109.954 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.6 t -67.04 -33.44 75.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.597 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.531 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.8 OUTLIER -64.65 -38.0 89.49 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.565 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.756 ' SD ' HD11 ' A' ' 352' ' ' ILE . 7.6 ttm -62.21 -53.61 52.73 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.88 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.704 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.6 mt -61.64 -35.9 79.24 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.338 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.1 -29.55 69.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.865 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.407 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.3 m-80 -114.28 71.48 2.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.66 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.537 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 52.6 Cg_endo -70.28 32.88 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.249 2.633 . . . . 0.0 113.594 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ARG . . . . . 0.515 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 16.5 mmm180 -159.33 -44.31 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.979 0.419 . . . . 0.0 110.854 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.444 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.0 OUTLIER -93.92 136.95 23.27 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.314 -178.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 58.9 Cg_endo -71.34 156.46 58.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.52 2.147 . . . . 0.0 112.814 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.531 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.89 116.92 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.61 144.1 35.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.702 0.287 . . . . 0.0 110.822 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.56 153.09 10.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.972 0.415 . . . . 0.0 111.388 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' TRP . . . . . 0.414 ' CH2' ' HG3' ' A' ' 295' ' ' GLU . 59.0 m95 -82.24 118.71 23.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.952 ' HB3' HG11 ' A' ' 376' ' ' VAL . 55.9 m-70 -106.74 123.68 48.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.52 HG23 ' OD1' ' A' ' 275' ' ' ASP . 88.6 m -78.29 118.56 20.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.783 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.736 HD23 HG22 ' A' ' 376' ' ' VAL . 58.7 mt -64.5 127.98 33.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.102 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.483 ' C ' HD12 ' A' ' 273' ' ' LEU . 7.2 mt-30 -117.9 170.89 8.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.893 ' O ' HG23 ' A' ' 413' ' ' VAL . 60.8 t -55.64 119.91 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.863 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.469 ' CG ' ' HD2' ' A' ' 375' ' ' LYS . 26.9 mt-10 -53.74 -42.54 68.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.969 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -49.36 76.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.759 0.314 . . . . 0.0 110.64 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.464 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 22.2 mt-10 -65.06 -37.96 89.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 409' ' ' VAL . 63.8 t -59.33 -50.18 80.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.463 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.36 -40.55 91.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.776 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -66.42 -33.85 76.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.03 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' MET . . . . . 0.67 ' HE3' ' HA ' ' A' ' 413' ' ' VAL . 71.6 mtm -71.81 -28.21 63.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.967 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.706 HD23 ' OE1' ' A' ' 356' ' ' GLN . 5.8 mt -79.19 -33.72 43.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.856 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.9 145.77 40.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.055 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.105 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.807 0.337 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.505 HD12 ' C ' ' A' ' 408' ' ' GLN . 18.7 mt -88.42 -30.12 19.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 114.31 -166.38 12.15 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.319 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.26 132.48 23.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.722 0.296 . . . . 0.0 110.771 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.834 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -121.78 131.51 72.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.074 0.464 . . . . 0.0 111.043 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.834 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -98.84 125.42 44.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.938 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.611 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.7 p90 -142.11 150.47 41.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.439 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -103.75 161.17 14.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.395 0.617 . . . . 0.0 112.356 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.602 HD12 ' CD2' ' A' ' 389' ' ' HIS . 10.9 mt -133.39 150.26 51.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.857 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.8 106.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.928 0.395 . . . . 0.0 111.362 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.901 ' CD1' HD13 ' A' ' 352' ' ' ILE . 27.7 t80 -99.93 138.12 37.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.211 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.29 95.03 46.11 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.431 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.506 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.24 -32.13 17.12 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.853 2.369 . . . . 0.0 112.238 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -30.65 7.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.155 0.502 . . . . 0.0 109.887 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.34 -20.55 8.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.918 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.15 48.24 6.57 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.565 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -123.86 129.97 51.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.842 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.438 HD21 ' CG2' ' A' ' 357' ' ' VAL . 40.6 tp -95.67 147.54 23.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.968 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 343' ' ' PHE . 5.4 m -137.85 140.16 40.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.551 . . . . 0.0 111.98 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.462 HG21 HG11 ' A' ' 357' ' ' VAL . 23.6 t -132.49 125.33 53.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.451 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 341' ' ' GLU . 21.7 t -118.68 115.41 47.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.904 0.383 . . . . 0.0 111.997 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 314' ' ' ILE . 38.7 mm -74.51 136.99 24.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.56 -58.62 2.12 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.429 ' HG3' ' CH2' ' A' ' 404' ' ' TRP . 8.7 pt-20 -175.59 162.01 2.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.139 -0.625 . . . . 0.0 112.335 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.787 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -118.43 153.58 33.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.764 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.435 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 11.8 pttt -150.93 148.52 28.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.11 0.481 . . . . 0.0 111.705 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 60.65 23.85 13.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.067 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.787 HD21 ' HB1' ' A' ' 296' ' ' ALA . 52.1 mt -56.88 138.09 54.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.083 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 143.33 51.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.322 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.431 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 35.3 mttt -85.14 108.39 17.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.644 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.515 ' HG2' ' HB3' ' A' ' 363' ' ' ASP . 0.0 OUTLIER -83.02 -20.94 34.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.958 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 56.0 m-20 -96.16 116.25 28.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.838 0.351 . . . . 0.0 110.718 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.3 t -49.95 116.11 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.444 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 63.26 14.28 53.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.419 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.32 -156.75 9.22 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.79 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.7 mt -100.8 -162.26 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.658 ' HB2' HD23 ' A' ' 335' ' ' LEU . 67.3 m -135.61 172.07 13.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.139 0.495 . . . . 0.0 110.927 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.423 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -133.73 56.02 18.33 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.708 ' CG ' HD13 ' A' ' 299' ' ' LEU . 72.8 Cg_endo -77.11 147.08 26.06 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.88 2.387 . . . . 0.0 114.969 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.562 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 11.5 p90 -141.53 167.74 21.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.069 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.926 HG22 HG22 ' A' ' 361' ' ' VAL . 29.4 t -116.89 148.18 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.844 ' HE3' HD13 ' A' ' 362' ' ' LEU . 17.3 mttt -129.84 157.13 43.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.968 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 293' ' ' ILE . 5.3 mp -132.74 128.48 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.647 0.261 . . . . 0.0 110.819 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -126.4 138.46 53.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.887 0.375 . . . . 0.0 111.077 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.448 ' HB2' ' CE2' ' A' ' 345' ' ' PHE . 29.7 tp -99.36 108.38 20.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -107.45 121.11 43.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.162 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.954 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -92.24 100.17 12.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 57.84 38.37 27.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.834 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.01 28.84 24.69 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.668 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.24 109.48 9.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.357 . . . . 0.0 110.918 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -53.31 129.65 32.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.155 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.954 HD11 ' CB ' ' A' ' 318' ' ' GLN . 10.5 mt -123.52 -46.06 2.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.063 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -130.56 151.37 51.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.85 132.79 40.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.763 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -136.97 156.52 48.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.881 0.372 . . . . 0.0 111.117 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 0.5 OUTLIER -146.87 143.85 28.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.9 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.643 HG21 HG13 ' A' ' 293' ' ' ILE . 13.7 p -101.49 177.46 4.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.757 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 11.1 t -59.49 166.14 2.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.582 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.562 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 5.5 mt -108.15 130.21 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.005 0.431 . . . . 0.0 111.246 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.629 ' O ' HG22 ' A' ' 334' ' ' THR . 22.3 mmmt -97.67 89.92 4.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.378 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -57.57 137.58 56.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.756 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 44.9 85.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.366 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.759 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.5 t -176.72 173.47 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.696 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.759 HD23 ' O ' ' A' ' 334' ' ' THR . 4.6 mt -147.14 -16.1 0.4 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.425 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.2 m-80 -134.07 58.94 34.68 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.817 0.341 . . . . 0.0 110.158 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.461 ' HB2' ' HG3' ' A' ' 331' ' ' LYS . 80.9 Cg_endo -86.63 167.59 8.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.076 2.517 . . . . 0.0 113.952 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 68.1 t80 -116.86 152.04 35.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.995 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.425 ' HB2' HG22 ' A' ' 293' ' ' ILE . 92.9 m-85 -133.19 -68.73 0.57 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' ASN . . . . . 0.519 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 14.5 t-20 66.24 38.29 4.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.812 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 292' ' ' VAL . 52.0 mt-10 -91.02 141.9 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.663 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 85.5 p -110.09 121.92 46.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 111.662 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.638 ' CE1' HG22 ' A' ' 328' ' ' THR . 58.0 m-85 -111.71 163.1 14.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.032 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 13.2 m -133.8 145.14 49.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.139 0.495 . . . . 0.0 111.643 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' A' ' 316' ' ' LEU . 35.1 m-85 -131.26 165.79 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.436 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -114.57 79.45 1.27 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.006 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.901 HG13 ' HB3' ' A' ' 351' ' ' GLN . 50.4 t -115.27 123.58 31.43 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.352 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.524 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 73.8 Cg_endo -75.2 158.91 41.17 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.529 2.153 . . . . 0.0 111.376 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -51.37 -21.13 2.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -90.66 -8.68 49.35 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.901 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.6 OUTLIER -111.75 -27.23 8.59 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.901 HD13 ' CD1' ' A' ' 282' ' ' TYR . 5.7 tp -47.47 -28.66 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -95.09 -25.14 16.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -91.45 -4.91 55.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.872 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 351' ' ' GLN . 31.4 m -108.92 167.84 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 111.388 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' GLN . . . . . 0.415 ' OE1' HD23 ' A' ' 417' ' ' LEU . 11.0 mt-30 -144.73 126.44 15.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.655 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.556 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 58.9 t -87.17 109.41 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.379 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.6 OUTLIER -94.63 111.85 26.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.15 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.521 ' HB ' HG23 ' A' ' 376' ' ' VAL . 39.7 t -95.62 107.87 20.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.769 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.973 HG23 ' HB3' ' A' ' 375' ' ' LYS . 6.3 m -109.39 139.32 44.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.064 0.459 . . . . 0.0 111.845 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.926 HG22 HG22 ' A' ' 312' ' ' VAL . 59.9 t -115.56 120.58 65.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.03 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.844 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.6 mp -120.89 142.92 49.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.363 . . . . 0.0 111.755 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 302' ' ' MET . 2.6 t70 -90.15 124.43 34.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.511 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.486 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 19.8 t80 -76.01 146.77 39.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.786 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -143.5 58.92 1.39 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.505 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.659 ' HG3' HD13 ' A' ' 367' ' ' ILE . 1.1 tppt? 35.17 -104.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.45 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.659 HD13 ' HG3' ' A' ' 366' ' ' LYS . 0.9 OUTLIER -84.22 137.43 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.344 0.593 . . . . 0.0 111.048 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.22 -178.43 30.47 Favored Glycine 0 C--N 1.318 -0.452 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.596 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.9 165.65 12.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 0.0 110.579 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.39 139.95 40.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.665 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ASP . . . . . 0.446 ' HB2' ' HG2' ' A' ' 302' ' ' MET . 2.5 m-20 -71.05 152.05 43.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.893 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.731 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -100.88 111.44 23.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.063 0.459 . . . . 0.0 111.003 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.507 HG21 HD22 ' A' ' 299' ' ' LEU . 2.3 mm -72.06 -32.22 42.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.072 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 152.1 -178.81 29.12 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.973 ' HB3' HG23 ' A' ' 360' ' ' THR . 15.4 ptmt -160.55 140.78 11.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.34 0.591 . . . . 0.0 111.864 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.932 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.52 158.9 12.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.158 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.547 ' HB2' HD21 ' A' ' 417' ' ' LEU . 2.6 p90 -141.58 145.2 34.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.918 0.39 . . . . 0.0 111.224 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 378' ' ' VAL . 15.3 m -134.79 101.15 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.146 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.472 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 172.25 -159.23 30.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.631 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.43 ' O ' ' HB2' ' A' ' 381' ' ' ASN . 0.1 OUTLIER -47.77 162.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.632 0.253 . . . . 0.0 110.986 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 380' ' ' TYR . 15.8 m120 70.66 -57.29 0.59 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.48 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 383' ' ' THR . 0.9 OUTLIER -44.48 165.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.908 0.385 . . . . 0.0 111.464 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 382' ' ' SER . 44.4 p -158.09 154.14 27.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.917 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 92.27 -142.83 16.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.573 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -56.96 -33.02 66.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.854 0.359 . . . . 0.0 111.325 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.88 -55.15 21.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.082 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 22.3 tp -64.66 -32.64 74.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.352 . . . . 0.0 110.332 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -65.39 -28.5 69.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.371 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.602 ' CD2' HD12 ' A' ' 280' ' ' LEU . 20.6 t-160 -79.89 -54.05 6.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.815 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.556 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 51.2 t-105 -51.27 -47.22 62.54 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.048 0.451 . . . . 0.0 109.944 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 15.0 t -67.81 -29.28 68.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.722 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.505 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.3 OUTLIER -62.98 -42.9 99.96 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.789 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.81 ' CE ' HD11 ' A' ' 352' ' ' ILE . 30.4 ttp -59.61 -52.49 65.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.671 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.804 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.6 mt -56.66 -31.74 64.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.329 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.46 -30.19 69.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 109.722 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 398' ' ' ARG . 17.1 m-80 -115.26 71.12 2.99 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.614 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.535 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 39.9 Cg_endo -68.07 31.37 0.14 Allowed 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.225 2.616 . . . . 0.0 113.396 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ARG . . . . . 0.535 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 2.5 mmt180 -158.2 -42.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.092 0.472 . . . . 0.0 110.34 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.633 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 38.8 ttt85 -93.86 145.73 30.4 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.858 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.633 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 84.4 Cg_endo -81.03 156.24 20.09 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.457 2.105 . . . . 0.0 112.925 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -125.5 116.44 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.778 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -108.33 144.9 35.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.685 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.39 154.88 10.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.916 0.389 . . . . 0.0 111.298 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' TRP . . . . . 0.435 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 49.8 m95 -81.35 120.79 25.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.932 ' HB3' HG11 ' A' ' 376' ' ' VAL . 46.1 m-70 -108.54 122.7 47.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.516 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -78.24 117.19 19.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.746 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.787 HD23 HG22 ' A' ' 376' ' ' VAL . 79.9 mt -62.61 127.67 32.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.086 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.505 ' C ' HD12 ' A' ' 273' ' ' LEU . 6.3 mt-30 -116.06 168.94 9.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.828 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.853 ' O ' HG23 ' A' ' 413' ' ' VAL . 59.6 t -55.7 119.34 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.798 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.731 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 20.0 mt-10 -52.7 -43.63 65.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.911 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -56.52 -48.8 76.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.34 . . . . 0.0 110.657 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.461 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.0 mt-10 -65.52 -38.51 89.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 375' ' ' LYS . 73.4 t -59.43 -49.91 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.229 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -40.64 90.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.888 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -64.84 -35.86 82.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.108 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 48.9 mtm -72.27 -34.24 68.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.547 HD21 ' HB2' ' A' ' 377' ' ' PHE . 17.4 mt -76.77 -31.24 56.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -71.07 143.06 50.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.173 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.15 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . 0.435 'CA ' ' HB3' ' A' ' 302' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.743 0.306 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.794 HD22 ' O ' ' A' ' 373' ' ' ILE . 33.9 mt -81.4 -33.92 31.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.06 -165.67 13.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.215 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.632 ' OD1' HG23 ' A' ' 406' ' ' THR . 9.7 m-20 -142.33 133.23 25.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 110.875 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.862 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -121.87 131.07 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 0.0 111.026 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.862 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -98.38 126.02 43.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.831 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.618 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.7 p90 -141.89 149.94 40.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.202 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.38 159.53 15.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.085 -178.543 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.878 HD12 ' CD2' ' A' ' 389' ' ' HIS . 75.4 mt -128.9 148.34 50.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.177 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -158.81 104.58 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 111.597 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.992 ' CD1' HD13 ' A' ' 352' ' ' ILE . 29.9 t80 -96.65 139.54 32.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.385 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 287' ' ' GLY . 61.1 t -116.12 92.96 37.29 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 17.1 Cg_exo -65.27 -32.49 51.27 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.941 2.427 . . . . 0.0 112.366 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -31.62 62.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.872 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.6 -10.08 9.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.639 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 71.86 45.56 42.3 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.036 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -120.91 130.18 53.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.926 0.393 . . . . 0.0 111.55 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.492 HD21 ' CG2' ' A' ' 357' ' ' VAL . 32.7 tp -93.75 147.58 22.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.135 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.9 m -136.69 136.99 39.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.32 0.581 . . . . 0.0 112.122 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.09 123.8 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.455 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 341' ' ' GLU . 27.1 t -118.04 115.08 47.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.03 0.443 . . . . 0.0 111.767 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.682 HG13 HG21 ' A' ' 328' ' ' THR . 38.8 mm -74.7 137.04 23.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.429 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.5 OUTLIER -113.74 -59.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -177.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.447 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 2.4 pt-20 -175.7 159.48 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.362 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.815 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -118.73 154.01 33.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.873 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -150.87 151.89 32.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.968 0.414 . . . . 0.0 111.679 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 25.8 m120 60.91 24.76 14.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.796 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.815 HD21 ' HB1' ' A' ' 296' ' ' ALA . 54.8 mt -59.69 139.38 57.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.282 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -62.17 144.49 55.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.483 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.416 ' HE3' HD11 ' A' ' 335' ' ' LEU . 9.5 mttp -84.19 118.73 24.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.548 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.567 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.7 mmt -93.91 -18.78 21.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.334 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 49.5 m-20 -98.39 116.97 31.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.841 0.353 . . . . 0.0 110.619 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -48.95 116.68 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.443 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.8 16.59 39.29 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.287 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.79 -157.58 9.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.804 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 307' ' ' LEU . 7.6 mt -100.33 -161.08 0.84 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.83 0.348 . . . . 0.0 110.702 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.618 ' HB2' HD23 ' A' ' 335' ' ' LEU . 70.9 m -139.39 172.13 13.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.33 0.586 . . . . 0.0 111.077 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.401 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -131.99 57.44 29.93 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.593 ' CG ' HD13 ' A' ' 299' ' ' LEU . 57.7 Cg_endo -72.75 144.65 39.67 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.132 2.555 . . . . 0.0 114.682 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.553 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 38.4 p90 -143.61 163.47 33.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.252 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.753 HG22 HG22 ' A' ' 361' ' ' VAL . 38.0 t -111.6 149.97 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.43 0.633 . . . . 0.0 112.577 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.841 ' HE3' HD13 ' A' ' 362' ' ' LEU . 11.1 mtmt -131.4 138.49 49.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.378 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.462 HG23 HG13 ' A' ' 357' ' ' VAL . 5.2 mp -111.69 132.44 60.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 0.0 110.8 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 358' ' ' VAL . 18.8 m80 -127.76 135.32 49.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 0.0 110.975 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.923 HD23 ' HD3' ' A' ' 324' ' ' LYS . 51.5 tp -103.76 110.84 23.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' MET . . . . . 0.404 ' HA ' ' HG ' ' A' ' 323' ' ' LEU . 2.9 mtm -117.0 134.96 54.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.539 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.822 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.0 OUTLIER -93.65 99.49 11.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.29 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 10.1 m120 59.52 37.7 22.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.36 7.43 60.63 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.224 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 317' ' ' MET . 5.5 mptt -111.02 109.76 20.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.834 0.317 . . . . 0.0 110.975 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.39 131.59 33.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.377 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.723 HD11 ' CB ' ' A' ' 318' ' ' GLN . 5.9 mt -125.35 -47.72 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.261 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.923 ' HD3' HD23 ' A' ' 316' ' ' LEU . 0.1 OUTLIER -129.89 160.59 33.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.085 0.469 . . . . 0.0 111.448 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.31 143.74 37.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.881 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 314' ' ' ILE . 20.9 mmtm -145.78 162.13 38.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.943 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.6 146.75 27.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.701 HG22 ' CE1' ' A' ' 343' ' ' PHE . 14.6 p -106.11 176.73 5.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 13.3 t -58.09 164.61 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.514 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.553 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.4 mt -107.83 123.55 63.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.938 0.399 . . . . 0.0 111.39 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.643 ' O ' HG22 ' A' ' 334' ' ' THR . 4.5 mmpt? -86.28 87.45 7.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.953 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -55.14 136.42 48.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.987 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 44.22 85.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.33 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.752 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.9 t -178.55 174.21 1.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.808 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 334' ' ' THR . 4.4 mt -145.59 -16.71 0.48 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.176 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.3 m-80 -132.65 56.36 22.17 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.318 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 46.8 Cg_endo -89.54 167.76 5.04 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.165 2.577 . . . . 0.0 113.628 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.447 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -108.97 160.67 15.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.299 179.302 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.636 ' HB2' HG22 ' A' ' 293' ' ' ILE . 81.6 m-85 -133.96 -63.97 0.71 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.755 0.312 . . . . 0.0 111.224 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.5 t30 59.12 38.52 23.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.956 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.547 ' O ' HG13 ' A' ' 292' ' ' VAL . 31.7 mt-10 -93.4 144.69 25.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.679 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 99.3 p -114.67 122.5 46.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 111.718 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.701 ' CE1' HG22 ' A' ' 328' ' ' THR . 76.3 m-85 -114.87 152.85 31.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.156 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 64.4 p -129.37 138.93 51.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.116 0.484 . . . . 0.0 111.763 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -125.13 166.01 17.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.569 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -111.02 76.84 1.0 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.829 HG13 ' HB3' ' A' ' 351' ' ' GLN . 50.0 t -110.0 122.2 39.62 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.035 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.53 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 71.0 Cg_endo -75.28 157.83 41.39 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.418 2.079 . . . . 0.0 111.64 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -51.72 -22.68 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.702 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -87.27 -8.55 56.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.829 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -111.97 -28.4 8.04 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.641 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.992 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.4 tp -52.2 -29.94 12.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.767 0.318 . . . . 0.0 110.864 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 353' ' ' GLN . . . . . 0.415 ' O ' ' CG ' ' A' ' 380' ' ' TYR . 77.9 mt-30 -93.67 3.31 55.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.411 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -124.1 -21.78 4.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.471 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.822 HG12 ' HG2' ' A' ' 318' ' ' GLN . 32.4 m -88.04 163.28 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.002 0.429 . . . . 0.0 111.485 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' GLN . . . . . 0.497 ' OE1' HD22 ' A' ' 417' ' ' LEU . 4.2 mt-30 -137.88 126.28 23.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.5 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.511 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 88.9 t -88.3 116.2 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 0.0 110.28 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.4 OUTLIER -100.28 113.8 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.758 -179.157 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.569 ' HB ' HG23 ' A' ' 376' ' ' VAL . 47.8 t -99.09 107.79 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.97 HG23 ' HB3' ' A' ' 375' ' ' LYS . 3.7 m -110.4 135.38 51.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.964 0.411 . . . . 0.0 111.825 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.753 HG22 HG22 ' A' ' 312' ' ' VAL . 45.7 t -109.38 118.74 57.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.228 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.841 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.8 mp -121.28 145.76 47.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.502 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.567 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -94.57 125.16 39.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.664 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.47 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 24.6 t80 -75.75 146.91 39.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.899 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -145.54 60.94 1.28 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.596 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.579 ' HG3' HD13 ' A' ' 367' ' ' ILE . 0.0 OUTLIER 38.33 -106.35 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.154 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.579 HD13 ' HG3' ' A' ' 366' ' ' LYS . 0.9 OUTLIER -83.65 137.28 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.364 0.602 . . . . 0.0 110.963 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 101.94 169.07 27.3 Favored Glycine 0 C--N 1.319 -0.394 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.538 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.92 140.76 58.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.802 0.334 . . . . 0.0 110.641 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.83 149.65 43.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.641 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.92 149.76 30.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.055 0.455 . . . . 0.0 111.57 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.549 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -100.95 111.11 23.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.72 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.794 ' O ' HD22 ' A' ' 273' ' ' LEU . 33.3 mt -82.39 -32.73 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.491 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' GLY . . . . . 0.502 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 167.05 -178.5 41.24 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.034 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.97 ' HB3' HG23 ' A' ' 360' ' ' THR . 17.5 ptmt -164.72 140.98 5.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.221 0.534 . . . . 0.0 112.041 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.925 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.53 159.27 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.048 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.458 ' HB3' HG13 ' A' ' 358' ' ' VAL . 22.1 p90 -144.85 132.0 20.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.055 0.455 . . . . 0.0 111.79 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 378' ' ' VAL . 22.9 m -125.21 108.97 20.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.756 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -148.73 -149.42 4.97 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.646 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.415 ' CG ' ' O ' ' A' ' 353' ' ' GLN . 0.0 OUTLIER -100.42 -26.3 13.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.747 0.308 . . . . 0.0 110.937 -179.67 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -84.07 -28.0 27.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.967 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' SER . . . . . 0.42 ' HG ' ' HD2' ' A' ' 377' ' ' PHE . 3.5 m -54.78 175.66 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.161 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 22.2 p -148.56 148.54 30.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.742 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 92.4 -158.65 24.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.41 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -46.49 -31.32 2.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 111.601 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.03 -54.68 38.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.625 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 23.8 tp -56.4 -34.4 66.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.728 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 384' ' ' GLY . 11.3 mtm180 -62.0 -46.84 87.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.523 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.878 ' CD2' HD12 ' A' ' 280' ' ' LEU . 15.2 t-160 -62.58 -53.84 48.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.148 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.511 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 68.1 t-105 -54.83 -51.44 65.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.952 0.406 . . . . 0.0 110.461 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.5 t -66.25 -32.61 74.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.144 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.575 ' HB3' HD12 ' A' ' 401' ' ' ILE . 6.4 m-20 -64.87 -31.59 72.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.79 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.668 ' CE ' HD11 ' A' ' 352' ' ' ILE . 25.8 ttp -65.88 -54.27 28.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.91 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.807 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.5 mt -55.76 -22.79 25.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.124 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -80.8 -38.45 28.44 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 399' ' ' ARG . 40.0 m-80 -125.01 60.37 27.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.563 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.523 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 2.4 Cg_endo -44.06 -77.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.759 2.973 . . . . 0.0 113.356 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -51.38 -17.85 0.86 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.406 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' A' ' 396' ' ' ASN . 0.9 OUTLIER -93.67 133.47 27.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.906 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 74.1 Cg_endo -75.41 115.41 4.22 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.435 2.09 . . . . 0.0 112.548 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -93.62 108.39 20.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.881 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.57 144.0 32.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.737 0.303 . . . . 0.0 110.623 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.44 154.38 12.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.406 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -82.46 117.12 22.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.925 ' HB3' HG11 ' A' ' 376' ' ' VAL . 48.9 m-70 -106.68 118.38 36.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.576 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.632 HG23 ' OD1' ' A' ' 275' ' ' ASP . 91.6 m -78.33 116.25 18.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.952 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.841 HD23 HG22 ' A' ' 376' ' ' VAL . 93.5 mt -61.29 127.94 33.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.405 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.466 ' C ' HD12 ' A' ' 273' ' ' LEU . 6.6 mt-30 -116.04 172.25 7.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.497 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.832 ' O ' HG23 ' A' ' 413' ' ' VAL . 61.2 t -54.98 121.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.549 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 23.9 mt-10 -55.16 -42.47 73.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.88 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.16 -49.11 76.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.458 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.7 mt-10 -64.89 -38.17 90.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.371 0.605 . . . . 0.0 109.418 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 409' ' ' VAL . 94.9 t -57.28 -47.29 84.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.534 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.16 -30.61 71.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -72.43 -37.92 68.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 36.2 mtm -67.91 -32.3 72.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.497 HD22 ' OE1' ' A' ' 356' ' ' GLN . 11.7 mt -80.13 -33.92 38.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -63.04 146.1 53.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.036 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 25.4 t . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.247 -0.883 . . . . 0.0 111.091 179.95 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 8.3 tptt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.831 0.348 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.653 HD22 ' O ' ' A' ' 373' ' ' ILE . 41.4 mt -77.64 -36.28 51.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 124.11 -164.35 17.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.162 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.04 132.53 22.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.703 0.287 . . . . 0.0 110.72 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.701 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -122.71 122.43 65.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.161 0.505 . . . . 0.0 110.821 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.701 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -92.01 126.17 36.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.786 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.616 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.0 p90 -142.22 148.94 38.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.383 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -101.92 160.61 14.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.064 -178.685 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.831 HD12 ' CD2' ' A' ' 389' ' ' HIS . 73.0 mt -128.81 147.81 50.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.214 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 290' ' ' THR . 1.6 ttm180 -158.92 106.7 1.84 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.579 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.979 ' CD1' HD13 ' A' ' 352' ' ' ILE . 30.0 t80 -98.25 139.52 33.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.599 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 287' ' ' GLY . 83.1 t -116.37 93.11 38.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 16.5 Cg_exo -65.65 -30.94 50.58 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.892 2.394 . . . . 0.0 112.211 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -30.67 65.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.699 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -122.4 -5.3 8.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.643 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 66.49 45.98 80.97 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.629 -0.795 . . . . 0.0 112.033 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -121.36 129.32 53.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 111.493 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.446 HD21 ' CG2' ' A' ' 357' ' ' VAL . 34.2 tp -93.05 147.64 22.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.068 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 343' ' ' PHE . 1.6 m -136.68 136.7 39.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.347 0.594 . . . . 0.0 112.177 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.404 HG21 HG11 ' A' ' 357' ' ' VAL . 15.1 t -128.36 123.53 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.306 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 341' ' ' GLU . 38.1 t -117.25 116.04 50.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.995 0.426 . . . . 0.0 111.942 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.71 HG13 HG21 ' A' ' 328' ' ' THR . 26.6 mm -74.55 137.05 23.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 277' ' ' CYS . 0.7 OUTLIER -113.46 -57.44 2.28 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 4.9 pt-20 -175.96 158.53 2.05 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.131 -0.628 . . . . 0.0 112.444 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.787 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -117.98 145.56 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.497 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.427 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 10.7 pttt -145.68 151.04 37.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 111.542 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 30.8 m120 61.47 23.01 13.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.072 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.787 HD21 ' HB1' ' A' ' 296' ' ' ALA . 58.2 mt -56.79 138.27 53.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.901 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -66.34 150.67 48.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.562 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.44 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 25.1 mttt -86.43 115.59 24.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.614 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.471 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 6.9 mmm -94.12 -18.37 21.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.563 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 55.6 m-20 -94.88 118.56 31.98 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.764 0.316 . . . . 0.0 110.332 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -47.61 115.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.02 0.438 . . . . 0.0 111.598 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.5 16.83 37.98 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.433 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.37 -159.26 10.07 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.961 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' A' ' 307' ' ' LEU . 6.6 mt -96.67 -161.55 0.88 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.72 0.295 . . . . 0.0 110.292 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.479 ' HB2' HD23 ' A' ' 335' ' ' LEU . 5.5 m -134.97 170.66 15.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.228 0.537 . . . . 0.0 111.166 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.453 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 6.8 m-20 -135.72 55.44 12.53 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.586 ' CG ' HD13 ' A' ' 299' ' ' LEU . 34.4 Cg_endo -66.88 154.81 73.32 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.233 2.622 . . . . 0.0 114.697 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.517 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 48.6 p90 -153.06 149.55 28.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.503 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.958 HG22 HG22 ' A' ' 361' ' ' VAL . 41.0 t -99.98 150.14 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.872 ' HE2' HD13 ' A' ' 362' ' ' LEU . 5.6 mtmm -133.08 136.16 45.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.219 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.639 HG23 HG13 ' A' ' 357' ' ' VAL . 5.1 mp -107.72 137.27 39.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.251 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -131.45 128.45 39.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.388 . . . . 0.0 111.21 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 324' ' ' LYS . 28.6 tp -104.64 106.64 17.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.464 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' MET . . . . . 0.738 ' HE2' HD22 ' A' ' 417' ' ' LEU . 1.6 mtm -112.87 140.65 47.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.912 0.387 . . . . 0.0 111.243 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.72 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.0 OUTLIER -101.38 99.48 9.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.324 179.435 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 30.0 m120 55.46 38.14 29.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 93.22 25.8 18.08 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.866 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 317' ' ' MET . 3.8 mptt -130.67 109.26 10.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.888 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.406 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -52.22 130.78 31.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.449 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.685 HD11 ' CG ' ' A' ' 318' ' ' GLN . 8.9 mt -124.34 -53.56 1.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.969 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 18.7 mmtt -130.64 150.2 51.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.06 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 314' ' ' ILE . 0.6 OUTLIER -143.44 120.1 11.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.815 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.467 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 7.8 mmtm -118.39 172.75 7.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.995 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.415 ' HB3' ' HG2' ' A' ' 313' ' ' LYS . 0.0 OUTLIER -155.15 138.5 15.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.261 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.71 HG21 HG13 ' A' ' 293' ' ' ILE . 25.1 p -92.06 -171.65 2.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.855 0.36 . . . . 0.0 110.47 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.407 HG22 ' HE1' ' A' ' 339' ' ' TYR . 9.8 t -70.54 171.71 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.064 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.535 HG21 ' CB ' ' A' ' 364' ' ' TYR . 2.3 mp -110.3 114.35 46.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.078 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 310' ' ' PRO . 0.0 OUTLIER -75.08 90.78 2.51 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.336 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -58.42 135.96 57.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.404 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' ASN . . . . . 0.41 ' C ' HD13 ' A' ' 307' ' ' LEU . 1.3 p-10 41.29 80.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.528 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.6 ' O ' HD23 ' A' ' 335' ' ' LEU . 3.5 t -179.06 173.64 1.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.963 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 334' ' ' THR . 0.9 OUTLIER -145.49 -11.46 0.53 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.224 -178.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.478 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.3 m-80 -137.84 59.33 19.08 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.733 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.536 ' HG3' ' HG3' ' A' ' 331' ' ' LYS . 54.8 Cg_endo -98.48 167.91 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.532 2.822 . . . . 0.0 113.509 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.435 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.6 OUTLIER -104.12 160.79 14.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.729 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.48 ' CB ' HG22 ' A' ' 293' ' ' ILE . 6.7 m-85 -129.73 -75.71 0.55 Allowed 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.981 0.42 . . . . 0.0 111.778 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 69.93 35.4 2.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.491 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.571 ' O ' HG13 ' A' ' 292' ' ' VAL . 29.3 mt-10 -91.12 143.11 27.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.584 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 26.5 p -115.41 121.29 42.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.0 111.765 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.703 ' CE1' HG22 ' A' ' 328' ' ' THR . 71.7 m-85 -110.49 159.98 17.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.977 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 6.2 m -135.72 137.97 42.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.118 0.485 . . . . 0.0 111.828 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.467 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 57.1 m-85 -125.25 166.07 17.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.609 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -112.29 74.49 0.87 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.866 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 351' ' ' GLN . 47.7 t -108.31 122.75 39.53 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.534 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 74.5 Cg_endo -75.76 158.06 39.36 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.418 2.079 . . . . 0.0 111.547 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -51.71 -22.43 3.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.629 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -87.82 -8.56 55.74 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.825 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.2 OUTLIER -112.59 -28.2 7.92 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.696 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.979 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.0 tp -51.44 -34.89 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.79 0.329 . . . . 0.0 110.779 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.99 3.07 54.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.374 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -123.06 -15.99 7.14 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.72 HG12 ' HG2' ' A' ' 318' ' ' GLN . 33.7 m -95.63 165.15 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.858 0.361 . . . . 0.0 111.469 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 380' ' ' TYR . 0.5 OUTLIER -140.85 126.49 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.989 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.639 HG13 HG23 ' A' ' 314' ' ' ILE . 47.7 t -89.11 110.18 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.442 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.5 OUTLIER -95.83 110.01 23.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.503 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.584 ' HB ' HG23 ' A' ' 376' ' ' VAL . 43.1 t -91.9 107.89 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.868 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.976 HG23 ' HB3' ' A' ' 375' ' ' LYS . 4.3 m -112.68 126.93 55.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.021 0.439 . . . . 0.0 111.949 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.958 HG22 HG22 ' A' ' 312' ' ' VAL . 46.7 t -101.98 118.37 48.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.216 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.872 HD13 ' HE2' ' A' ' 313' ' ' LYS . 2.7 mp -119.44 147.33 44.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 0.0 111.529 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 310' ' ' PRO . 5.2 t70 -90.02 130.19 36.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.821 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.535 ' CB ' HG21 ' A' ' 330' ' ' ILE . 8.9 t80 -81.95 141.45 33.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.584 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -143.01 78.83 1.62 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.157 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.45 ' N ' ' CE1' ' A' ' 364' ' ' TYR . 6.3 tptm 50.33 -89.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.575 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.514 ' O ' ' C ' ' A' ' 368' ' ' GLY . 40.0 mm -134.89 -69.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.412 0.149 . . . . 0.0 111.008 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 367' ' ' ILE . . . -7.4 -102.95 0.0 OUTLIER Glycine 0 C--N 1.336 0.556 0 O-C-N 123.68 0.612 . . . . 0.0 114.19 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.74 154.24 47.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.939 0.399 . . . . 0.0 111.216 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.61 119.94 40.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.13 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 363' ' ' ASP . 5.7 m-20 -71.27 152.1 43.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.067 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.769 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -100.84 112.62 25.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.392 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.653 ' O ' HD22 ' A' ' 273' ' ' LEU . 1.3 mm -74.31 -34.28 36.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.751 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 155.98 -178.27 32.61 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.32 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.976 ' HB3' HG23 ' A' ' 360' ' ' THR . 11.9 ptmt -161.9 139.64 8.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.351 0.596 . . . . 0.0 112.303 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.919 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.18 158.93 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.077 179.264 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.496 ' HB3' HG13 ' A' ' 358' ' ' VAL . 25.5 p90 -141.2 135.48 30.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.906 0.384 . . . . 0.0 111.6 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 378' ' ' VAL . 15.5 m -125.75 105.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.898 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.486 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 160.0 -159.84 31.06 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.569 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.416 ' N ' ' HG2' ' A' ' 356' ' ' GLN . 0.2 OUTLIER -49.71 164.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 110.861 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 59.0 24.6 12.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.007 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 383' ' ' THR . 4.7 m -127.12 161.21 29.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.705 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 382' ' ' SER . 46.4 p -157.96 148.24 20.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 101.45 -123.88 8.05 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.693 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -83.07 -29.2 28.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.946 0.403 . . . . 0.0 111.354 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -69.42 -50.45 45.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.786 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 46.4 tp -65.11 -37.15 86.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.623 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 385' ' ' ALA . 5.8 ptt180 -62.58 -37.59 86.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.207 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.831 ' CD2' HD12 ' A' ' 280' ' ' LEU . 16.9 t-160 -65.54 -55.48 17.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 110.448 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.575 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 69.1 t-105 -53.83 -50.03 67.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.039 0.447 . . . . 0.0 110.262 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.42 -29.76 69.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.479 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.593 ' HB3' HD12 ' A' ' 401' ' ' ILE . 5.4 m-20 -67.86 -33.02 73.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.714 ' CE ' HD11 ' A' ' 352' ' ' ILE . 27.6 ttp -63.73 -52.61 59.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.695 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.785 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.6 mt -57.02 -22.9 42.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.91 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -81.16 -36.25 30.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.309 0.576 . . . . 0.0 109.483 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.471 ' HB2' HD11 ' A' ' 401' ' ' ILE . 22.7 m-80 -126.11 60.2 34.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.555 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.508 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 3.2 Cg_endo -44.67 -78.69 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.595 2.863 . . . . 0.0 112.91 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -51.24 -18.88 1.03 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.133 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -93.74 132.63 29.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.596 0.236 . . . . 0.0 110.813 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.7 Cg_endo -75.6 124.35 8.18 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.44 2.094 . . . . 0.0 112.712 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.593 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -102.59 107.63 22.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.761 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.28 144.26 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.858 0.361 . . . . 0.0 110.891 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.1 151.22 10.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.375 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' TRP . . . . . 0.427 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 36.4 m95 -78.17 115.77 18.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.688 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.919 ' HB3' HG11 ' A' ' 376' ' ' VAL . 51.0 m-70 -104.15 119.96 40.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.389 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 90.6 m -78.2 116.47 18.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.437 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.743 HD23 HG22 ' A' ' 376' ' ' VAL . 64.2 mt -61.63 126.9 28.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.038 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.44 ' C ' HD12 ' A' ' 273' ' ' LEU . 5.9 mt-30 -115.72 170.08 8.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.944 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.804 ' O ' HG23 ' A' ' 413' ' ' VAL . 55.5 t -54.83 117.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.725 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.769 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 9.0 mp0 -55.4 -41.22 72.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.642 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -56.83 -48.63 77.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 110.58 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.439 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.0 mt-10 -65.7 -40.07 91.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 409' ' ' VAL . 97.9 t -58.59 -48.79 84.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.17 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.05 -35.9 80.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.499 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.32 87.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.617 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' MET . . . . . 0.41 ' SD ' ' CE1' ' A' ' 377' ' ' PHE . 30.3 mtt -61.44 -37.35 83.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.476 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.738 HD22 ' HE2' ' A' ' 317' ' ' MET . 5.7 mt -79.24 -31.69 43.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.833 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -59.83 138.86 57.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 26.7 t . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.055 -179.984 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.789 HD22 ' O ' ' A' ' 373' ' ' ILE . 47.6 mt -88.21 -29.68 20.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.841 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 116.97 -168.1 12.73 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.234 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.18 132.28 26.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 0.0 110.723 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.882 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -120.99 129.93 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.171 0.51 . . . . 0.0 110.983 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.882 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.14 125.38 41.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.829 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.618 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 21.2 p90 -142.29 149.88 40.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.321 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.1 OUTLIER -102.54 161.31 13.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.362 0.601 . . . . 0.0 112.268 -178.584 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.659 HD12 ' CD2' ' A' ' 389' ' ' HIS . 27.7 mt -132.2 149.93 52.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.958 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.413 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.3 OUTLIER -158.92 102.8 1.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.443 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.936 ' CD1' HD13 ' A' ' 352' ' ' ILE . 29.6 t80 -98.57 136.69 38.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 43.0 t -122.8 95.88 45.92 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.535 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.57 -32.2 15.61 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.881 2.387 . . . . 0.0 112.317 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -31.17 6.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.191 0.52 . . . . 0.0 109.957 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.39 -21.15 8.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.813 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 81.16 47.6 6.43 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.778 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -123.65 129.74 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.97 0.414 . . . . 0.0 111.798 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.635 HD21 ' CG2' ' A' ' 357' ' ' VAL . 31.4 tp -95.48 147.67 23.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.994 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 3.4 m -134.73 137.64 43.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 112.0 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.41 ' CG2' HG11 ' A' ' 357' ' ' VAL . 21.6 t -130.87 120.28 47.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.32 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 341' ' ' GLU . 21.7 t -116.2 115.45 49.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.039 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.682 HG22 ' HB2' ' A' ' 339' ' ' TYR . 42.1 mm -75.05 137.13 23.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.446 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.98 -61.97 1.67 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -177.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.438 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 1.5 pt-20 -175.62 151.77 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.329 -0.549 . . . . 0.0 112.329 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.825 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -110.33 154.56 23.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.859 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -150.99 152.17 33.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 111.719 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 60.28 24.35 13.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.932 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.825 HD21 ' HB1' ' A' ' 296' ' ' ALA . 48.8 mt -58.96 138.82 57.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.162 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.463 ' HD2' ' HE2' ' A' ' 302' ' ' MET . 1.0 OUTLIER -62.59 141.62 58.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.31 -179.531 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.401 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 7.7 mttt -80.73 117.81 21.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.694 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.583 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.1 mmt -90.96 -19.03 23.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.343 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 49.2 m-20 -98.78 114.99 27.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.779 0.323 . . . . 0.0 110.524 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 26.3 t -48.84 116.38 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.45 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 62.11 15.44 50.38 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.369 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.29 -157.25 9.39 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.727 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.3 mt -100.34 -161.24 0.85 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 0.0 110.784 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.64 ' HB2' HD23 ' A' ' 335' ' ' LEU . 66.5 m -139.39 172.01 13.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.309 0.576 . . . . 0.0 111.103 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.409 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 15.3 m-20 -131.24 57.13 29.05 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.825 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.566 ' CB ' HD13 ' A' ' 299' ' ' LEU . 50.2 Cg_endo -70.56 148.56 60.13 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.096 2.531 . . . . 0.0 114.82 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.546 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 33.8 p90 -150.35 161.25 42.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.266 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.791 HG22 HG22 ' A' ' 361' ' ' VAL . 38.9 t -110.41 150.0 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.816 ' HE3' HD13 ' A' ' 362' ' ' LEU . 10.3 mtmt -132.41 134.95 45.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.215 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.536 HG23 HG13 ' A' ' 357' ' ' VAL . 5.3 mp -108.79 131.57 59.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.954 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -127.01 142.5 51.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.877 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.417 HD21 HG22 ' A' ' 347' ' ' VAL . 28.9 tp -113.31 106.01 14.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.527 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.5 mtm -106.79 131.17 54.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.311 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.939 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.4 OUTLIER -99.62 99.54 10.41 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.248 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 59.94 36.92 21.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.731 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 88.3 26.52 27.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.714 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.42 109.4 11.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.785 0.326 . . . . 0.0 110.883 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.79 129.24 25.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.184 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.939 HD11 ' CB ' ' A' ' 318' ' ' GLN . 10.0 mt -123.21 -41.38 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.47 147.74 49.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.897 0.38 . . . . 0.0 111.371 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -135.56 117.51 15.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.433 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 15.9 mmtp -124.26 160.85 27.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.927 0.394 . . . . 0.0 111.384 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.93 148.27 33.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.716 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.672 HG21 HG13 ' A' ' 293' ' ' ILE . 20.5 p -106.37 176.04 5.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.956 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.33 158.66 5.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.703 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.546 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.0 mt -102.13 126.08 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.979 0.418 . . . . 0.0 111.383 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.64 ' O ' HG22 ' A' ' 334' ' ' THR . 3.7 mmpt? -90.64 88.78 7.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.132 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -56.18 136.62 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.877 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 43.9 84.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.285 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.721 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.8 t -177.61 174.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.947 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.721 HD23 ' O ' ' A' ' 334' ' ' THR . 4.4 mt -145.95 -16.57 0.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.149 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.462 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.4 m-80 -132.29 56.99 26.13 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-O 120.765 0.317 . . . . 0.0 110.348 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 59.1 Cg_endo -88.33 167.69 6.41 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.18 2.587 . . . . 0.0 113.707 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.446 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.4 OUTLIER -111.31 159.29 18.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.302 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.682 ' HB2' HG22 ' A' ' 293' ' ' ILE . 83.6 m-85 -134.76 -62.25 0.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.792 0.329 . . . . 0.0 111.241 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.3 t30 57.87 37.58 26.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 292' ' ' VAL . 61.9 mt-10 -92.66 141.47 28.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 91.0 p -110.64 120.27 41.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.888 0.375 . . . . 0.0 111.544 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.639 ' CE1' HG22 ' A' ' 328' ' ' THR . 65.1 m-85 -113.34 147.91 36.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.361 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 83.0 p -123.09 140.5 52.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.972 0.415 . . . . 0.0 111.443 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.433 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 63.1 m-85 -127.24 165.88 18.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.583 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.63 78.1 1.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.817 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 351' ' ' GLN . 46.0 t -111.62 120.67 41.93 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.094 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.7 Cg_endo -72.07 156.97 55.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.468 2.112 . . . . 0.0 111.619 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -51.89 -22.94 4.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.54 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -85.72 -8.55 58.1 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.825 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.9 OUTLIER -109.96 -35.09 6.23 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.521 0.201 . . . . 0.0 111.473 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.936 HD13 ' CD1' ' A' ' 282' ' ' TYR . 5.9 tp -49.24 -26.72 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.651 0.263 . . . . 0.0 111.478 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 353' ' ' GLN . . . . . 0.413 ' O ' ' CD1' ' A' ' 380' ' ' TYR . 17.7 mt-30 -93.27 -7.92 43.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.771 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.418 ' HA ' ' CG ' ' A' ' 380' ' ' TYR . 38.8 mttp -116.41 -23.54 8.27 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 351' ' ' GLN . 35.0 m -88.69 168.03 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.908 0.385 . . . . 0.0 111.428 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 380' ' ' TYR . 5.3 mp0 -143.29 133.48 24.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.1 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.635 ' CG2' HD21 ' A' ' 289' ' ' LEU . 53.1 t -87.0 101.98 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.465 ' CG1' ' HE2' ' A' ' 375' ' ' LYS . 0.8 OUTLIER -86.45 114.18 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.969 -178.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.525 ' HB ' HG23 ' A' ' 376' ' ' VAL . 40.4 t -99.75 107.85 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.92 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.957 HG23 ' HB3' ' A' ' 375' ' ' LYS . 7.4 m -110.93 134.73 52.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 111.628 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.791 HG22 HG22 ' A' ' 312' ' ' VAL . 45.9 t -109.29 121.37 62.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.4 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.816 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.6 mp -123.07 147.55 46.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.918 0.389 . . . . 0.0 111.353 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.583 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.3 OUTLIER -96.54 125.19 40.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.601 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.534 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 20.3 t80 -75.8 139.45 41.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.818 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 367' ' ' ILE . 14.2 m-20 -126.22 70.72 1.24 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.871 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.534 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 0.3 OUTLIER 30.36 -89.35 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.075 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 367' ' ' ILE . 5.1 mp -87.37 -69.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.72 0.295 . . . . 0.0 111.649 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -45.67 175.07 0.01 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.258 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.44 165.64 11.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.721 0.296 . . . . 0.0 110.708 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' ASN . . . . . 0.407 ' OD1' ' CD2' ' A' ' 364' ' ' TYR . 0.4 OUTLIER -93.36 127.56 39.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.701 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.99 150.94 43.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.548 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.454 ' HB1' ' OE1' ' A' ' 410' ' ' GLU . . . -97.32 111.63 23.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.608 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.789 ' O ' HD22 ' A' ' 273' ' ' LEU . 30.0 mt -80.99 -33.12 12.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.386 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 168.13 -179.22 41.43 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.162 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.957 ' HB3' HG23 ' A' ' 360' ' ' THR . 14.8 ptmt -164.67 140.92 5.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.175 0.512 . . . . 0.0 111.791 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.936 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -114.35 158.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.176 179.245 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.568 ' CD1' HG13 ' A' ' 413' ' ' VAL . 43.0 p90 -142.23 132.03 24.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 111.179 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 378' ' ' VAL . 15.8 m -124.97 103.91 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.962 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 161.72 -165.2 35.59 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.042 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.418 ' CG ' ' HA ' ' A' ' 354' ' ' LYS . 0.0 OUTLIER -44.17 150.18 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 111.465 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 14.0 m120 65.45 29.02 11.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.159 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 50.8 m -122.68 164.34 18.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.677 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 43.6 p -154.77 147.94 24.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.815 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 95.3 -157.8 22.08 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.42 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -49.24 -31.49 8.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -63.21 -51.08 67.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.155 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.36 -33.53 71.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.551 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 1.0 OUTLIER -61.8 -49.83 74.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.54 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.659 ' CD2' HD12 ' A' ' 280' ' ' LEU . 17.4 t-160 -57.91 -58.39 8.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.967 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.487 ' CD1' ' HA2' ' A' ' 379' ' ' GLY . 64.0 t-105 -50.83 -46.11 59.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.217 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.5 t -67.75 -35.82 79.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.233 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.438 ' HB3' HD12 ' A' ' 401' ' ' ILE . 4.4 t0 -64.08 -34.92 79.13 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.759 ' CE ' HD11 ' A' ' 352' ' ' ILE . 26.6 ttp -64.5 -58.0 7.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.552 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.761 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.5 mt -55.22 -31.93 61.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.399 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.52 -30.64 69.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.786 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -114.27 70.66 2.06 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.629 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.535 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 42.8 Cg_endo -68.77 37.67 0.21 Allowed 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.203 2.602 . . . . 0.0 113.479 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 398' ' ' ARG . . . . . 0.533 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 10.6 mmm180 -160.0 -45.69 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.918 0.39 . . . . 0.0 110.86 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -93.87 141.82 24.23 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.198 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.7 Cg_endo -75.37 156.31 41.34 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.585 2.19 . . . . 0.0 112.807 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.45 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.2 mm -126.53 119.32 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -111.86 144.53 41.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.721 0.296 . . . . 0.0 110.693 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.31 155.68 11.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.976 0.417 . . . . 0.0 111.378 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -81.69 119.17 23.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.79 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.936 ' HB3' HG11 ' A' ' 376' ' ' VAL . 47.1 m-70 -106.81 122.34 46.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.557 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -78.19 117.09 19.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.672 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.803 HD23 HG22 ' A' ' 376' ' ' VAL . 55.9 mt -62.44 128.37 35.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.194 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.467 ' C ' HD12 ' A' ' 273' ' ' LEU . 5.3 mt-30 -114.46 171.98 7.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.756 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.85 ' O ' HG23 ' A' ' 413' ' ' VAL . 3.6 t -59.46 122.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.509 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 5.4 mt-10 -51.09 -38.37 51.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.325 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -52.64 63.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.651 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.429 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 3.0 mm-40 -60.79 -41.13 95.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 409' ' ' VAL . 61.7 t -56.22 -52.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.251 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.73 -31.32 72.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.597 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -71.64 -34.59 69.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.872 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 40.7 mtm -72.92 -36.88 67.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.769 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.58 -29.23 65.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.79 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -73.67 141.91 46.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.073 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.109 179.955 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.806 0.336 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 373' ' ' ILE . 46.7 mt -95.87 -32.04 12.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.818 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 116.24 -166.82 12.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.946 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -141.08 136.23 31.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.819 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.814 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -125.09 125.4 69.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.207 0.527 . . . . 0.0 110.885 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.814 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.5 OUTLIER -94.52 126.72 39.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.741 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.626 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 19.2 p90 -142.37 150.18 40.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.57 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.1 OUTLIER -103.87 160.36 14.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.05 -178.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.635 HD12 ' CD2' ' A' ' 389' ' ' HIS . 10.6 mt -133.34 150.51 51.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.866 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.97 105.08 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.552 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.946 ' CD1' HD13 ' A' ' 352' ' ' ILE . 28.4 t80 -99.14 138.66 35.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.08 95.28 44.17 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.403 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.532 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 6.9 Cg_exo -70.53 -31.06 17.76 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.844 2.362 . . . . 0.0 112.265 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.26 -32.07 15.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.147 0.499 . . . . 0.0 109.844 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.12 -18.71 9.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.816 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 78.77 47.58 7.73 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.617 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.97 129.46 51.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.04 0.447 . . . . 0.0 111.834 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 33.1 tp -96.55 147.56 23.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.932 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 343' ' ' PHE . 4.3 m -137.63 139.53 40.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.235 0.541 . . . . 0.0 111.995 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.3 t -132.86 123.35 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.529 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 341' ' ' GLU . 21.8 t -116.89 116.21 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.837 HG22 ' HB2' ' A' ' 339' ' ' TYR . 36.5 mm -74.64 135.95 26.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.79 -64.98 1.22 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.443 ' HB3' ' CG ' ' A' ' 338' ' ' TYR . 0.3 OUTLIER -174.67 148.62 1.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.524 -179.315 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.843 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -107.76 154.19 21.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.982 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -150.96 151.86 32.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 111.652 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 62.68 22.81 13.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.843 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.843 HD21 ' HB1' ' A' ' 296' ' ' ALA . 47.8 mt -57.02 138.53 54.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.163 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.35 142.97 58.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.588 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.419 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 14.1 mttt -82.64 113.06 20.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.444 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.44 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 8.2 mmm -91.6 -20.44 21.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.642 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 42.6 m-20 -92.28 118.86 31.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 110.527 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -48.04 115.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.611 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 57.5 17.95 28.16 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.264 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.97 -157.47 9.6 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.001 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.1 mt -99.27 -161.12 0.85 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 0.0 110.54 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.545 ' HB2' HD23 ' A' ' 335' ' ' LEU . 14.8 m -135.68 171.8 13.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.178 0.513 . . . . 0.0 111.017 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.43 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 6.5 m-20 -135.69 56.95 16.71 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.75 ' CG ' HD13 ' A' ' 299' ' ' LEU . 73.3 Cg_endo -77.91 144.21 21.39 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.902 2.402 . . . . 0.0 114.891 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.549 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 10.9 p90 -139.12 167.73 21.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.025 177.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 361' ' ' VAL . 47.6 t -116.85 149.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.325 0.584 . . . . 0.0 112.572 -179.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.853 ' HE3' HD13 ' A' ' 362' ' ' LEU . 13.8 mttt -132.38 155.78 47.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.434 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.519 HG23 HG13 ' A' ' 357' ' ' VAL . 5.4 mp -124.51 134.19 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.417 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -128.93 127.74 42.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.013 0.435 . . . . 0.0 111.049 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' A' ' 324' ' ' LYS . 28.8 tp -99.32 114.27 27.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.288 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.9 mtm -122.05 133.62 54.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 111.441 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.791 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.0 OUTLIER -98.77 99.49 10.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.02 179.205 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 59.95 36.68 21.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.38 25.61 32.89 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.853 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -122.06 117.46 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.7 0.286 . . . . 0.0 110.9 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.584 ' O ' HD23 ' A' ' 323' ' ' LEU . 14.9 mmt180 -51.72 128.21 22.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.219 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.765 HD11 ' HB2' ' A' ' 318' ' ' GLN . 18.1 mt -125.5 -58.86 1.41 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.251 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.907 ' HD3' HD23 ' A' ' 316' ' ' LEU . 0.1 OUTLIER -129.93 159.94 35.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.179 0.514 . . . . 0.0 111.743 -179.167 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 325' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 325' ' ' LYS . 0.3 OUTLIER -139.7 138.07 35.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.721 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.403 ' HB2' ' HB ' ' A' ' 314' ' ' ILE . 1.2 mmtm -143.98 158.62 43.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 111.157 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 0.1 OUTLIER -149.93 145.3 26.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.948 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.714 HG22 ' CE1' ' A' ' 343' ' ' PHE . 12.9 p -102.0 -178.93 3.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.846 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.637 HG23 ' HE3' ' A' ' 331' ' ' LYS . 10.1 t -60.2 172.05 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.463 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.549 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 5.6 mt -113.44 121.54 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 111.454 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.637 ' HE3' HG23 ' A' ' 329' ' ' THR . 7.1 mmpt? -86.43 85.73 7.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.997 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -56.45 136.77 53.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.981 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.19 83.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.255 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.688 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.8 t -176.99 174.0 1.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.76 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 334' ' ' THR . 4.0 mt -145.25 -15.8 0.5 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.378 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.486 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.79 56.09 20.64 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 120.75 0.309 . . . . 0.0 110.516 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 61.3 Cg_endo -89.04 167.69 5.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.15 2.567 . . . . 0.0 113.723 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.443 ' CG ' ' HB3' ' A' ' 295' ' ' GLU . 0.2 OUTLIER -110.03 160.4 16.47 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.456 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.837 ' HB2' HG22 ' A' ' 293' ' ' ILE . 7.9 m-85 -135.17 -50.3 0.75 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.692 0.282 . . . . 0.0 111.192 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 44.41 36.7 1.73 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.029 0.442 . . . . 0.0 110.976 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.526 ' O ' HG13 ' A' ' 292' ' ' VAL . 44.3 mt-10 -90.91 141.25 29.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.816 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 88.0 p -111.24 121.2 44.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.932 0.396 . . . . 0.0 111.558 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.714 ' CE1' HG22 ' A' ' 328' ' ' THR . 67.6 m-85 -111.78 155.21 23.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.058 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 59.6 p -130.91 139.59 50.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.115 0.483 . . . . 0.0 111.692 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -126.41 165.97 18.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.581 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -113.16 76.94 1.01 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.546 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.902 HG13 ' HB3' ' A' ' 351' ' ' GLN . 49.4 t -109.84 122.21 39.76 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.322 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.501 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 63.2 Cg_endo -73.42 158.97 47.43 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.453 2.102 . . . . 0.0 111.492 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -52.06 -20.67 2.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.857 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -90.45 -8.7 49.83 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.902 ' HB3' HG13 ' A' ' 347' ' ' VAL . 1.0 OUTLIER -110.47 -29.73 7.96 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.946 HD13 ' CD1' ' A' ' 282' ' ' TYR . 6.3 tp -47.09 -28.6 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.829 0.347 . . . . 0.0 111.059 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' GLN . . . . . 0.448 ' O ' ' CD2' ' A' ' 380' ' ' TYR . 2.8 mm-40 -95.11 -27.77 15.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.058 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -91.33 -3.94 56.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.875 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.791 HG12 ' HG2' ' A' ' 318' ' ' GLN . 29.9 m -106.96 166.3 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 111.278 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -141.65 126.23 17.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.658 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.519 HG13 HG23 ' A' ' 314' ' ' ILE . 64.9 t -90.77 105.01 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.145 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.3 OUTLIER -93.98 111.34 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.811 -179.008 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.532 ' HB ' HG23 ' A' ' 376' ' ' VAL . 48.2 t -91.52 108.0 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.99 HG23 ' HB3' ' A' ' 375' ' ' LYS . 2.6 m -110.26 131.93 54.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.061 0.457 . . . . 0.0 111.923 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 312' ' ' VAL . 58.2 t -107.05 119.67 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.926 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.853 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.6 mp -119.94 141.88 49.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.992 0.425 . . . . 0.0 111.722 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.44 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 6.3 t70 -90.09 125.94 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.585 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.542 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 24.6 t80 -80.06 145.98 32.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.593 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 367' ' ' ILE . 62.1 m-20 -139.43 64.78 1.45 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.554 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.658 ' CG ' HD12 ' A' ' 367' ' ' ILE . 1.9 tpmt? 27.85 -90.1 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.658 HD12 ' CG ' ' A' ' 366' ' ' LYS . 4.6 mp -82.74 -66.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.726 0.298 . . . . 0.0 111.127 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -47.37 166.43 0.12 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.716 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.84 161.45 21.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.729 0.3 . . . . 0.0 110.658 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.89 120.93 28.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.496 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.16 149.86 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.915 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.762 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -91.0 112.03 23.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.019 0.438 . . . . 0.0 111.119 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.433 ' O ' HD22 ' A' ' 273' ' ' LEU . 1.3 mm -73.26 -33.88 42.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.997 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 155.61 -178.37 32.25 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.258 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.99 ' HB3' HG23 ' A' ' 360' ' ' THR . 12.2 ptmt -162.16 140.59 9.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.294 0.569 . . . . 0.0 112.017 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.936 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.98 158.79 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.155 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.556 ' HB3' HG13 ' A' ' 358' ' ' VAL . 9.4 p90 -139.53 142.95 37.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.933 0.397 . . . . 0.0 111.121 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 378' ' ' VAL . 12.1 m -132.85 87.94 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.066 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.503 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . -178.26 -160.47 24.61 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.267 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.448 ' CD2' ' O ' ' A' ' 353' ' ' GLN . 0.2 OUTLIER -52.0 166.55 0.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.703 0.287 . . . . 0.0 110.981 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.537 ' OD1' HG22 ' A' ' 419' ' ' VAL . 9.2 m-80 57.15 25.68 11.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.958 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 7.3 m -126.31 162.02 26.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 73.2 p -155.77 148.44 24.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.927 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 97.8 -146.08 18.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.649 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -58.99 -30.12 67.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.749 0.309 . . . . 0.0 111.306 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.405 ' OE1' ' CZ ' ' A' ' 377' ' ' PHE . 14.4 mt-10 -65.05 -59.12 4.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.19 -32.06 71.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.501 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 2.6 ptt180 -64.94 -31.7 73.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.324 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.635 ' CD2' HD12 ' A' ' 280' ' ' LEU . 17.5 t-160 -77.29 -57.33 3.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.513 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 50.4 t-105 -49.47 -44.95 46.21 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.093 0.473 . . . . 0.0 109.901 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.0 t -69.06 -30.67 69.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.739 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.528 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.3 OUTLIER -63.14 -42.25 99.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.923 179.119 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.803 ' CE ' HD11 ' A' ' 352' ' ' ILE . 31.9 ttp -59.96 -54.83 41.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.971 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.797 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.4 mt -56.46 -31.57 64.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.417 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.2 -31.61 71.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.529 . . . . 0.0 109.691 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' A' ' 398' ' ' ARG . 36.0 m-80 -115.17 71.17 2.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.55 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.532 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 39.6 Cg_endo -68.34 35.29 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.249 2.632 . . . . 0.0 113.443 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' ARG . . . . . 0.51 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 11.3 mmm180 -159.26 -45.23 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.0 0.428 . . . . 0.0 110.578 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.405 ' NH1' ' HB2' ' A' ' 399' ' ' ARG . 0.2 OUTLIER -94.04 140.75 23.01 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.037 -179.19 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 72.3 Cg_endo -75.02 156.3 42.89 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.52 2.147 . . . . 0.0 112.839 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -124.99 117.95 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.578 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -110.13 144.57 38.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.677 0.275 . . . . 0.0 110.763 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.77 155.57 10.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.965 0.412 . . . . 0.0 111.246 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -82.23 121.63 26.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.753 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.936 ' HB3' HG11 ' A' ' 376' ' ' VAL . 54.3 m-70 -109.46 122.68 47.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.593 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 90.4 m -78.28 117.11 19.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.542 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.768 HD23 HG22 ' A' ' 376' ' ' VAL . 61.8 mt -62.16 128.09 34.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.253 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -114.44 173.29 6.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.672 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.812 ' O ' HG23 ' A' ' 413' ' ' VAL . 4.6 t -58.54 115.77 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.818 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.762 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 4.6 mp0 -52.42 -25.52 10.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.42 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.424 ' H ' HG12 ' A' ' 409' ' ' VAL . 2.3 mt-10 -72.94 -51.18 19.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.481 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.434 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 2.6 mm-40 -64.35 -38.8 92.33 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.897 HG11 ' HG3' ' A' ' 375' ' ' LYS . 59.6 t -56.8 -50.63 74.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.363 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.448 ' HA ' HD12 ' A' ' 417' ' ' LEU . 0.1 OUTLIER -63.86 -30.9 71.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.495 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.49 67.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.943 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 42.2 mtm -70.55 -38.55 74.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.777 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.464 HD21 ' CB ' ' A' ' 377' ' ' PHE . 9.7 mt -68.01 -29.95 69.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -88.25 126.4 35.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.078 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' VAL . . . . . 0.537 HG22 ' OD1' ' A' ' 381' ' ' ASN . 20.7 t . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.176 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.762 0.315 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.818 HD22 ' O ' ' A' ' 373' ' ' ILE . 72.3 mt -86.34 -33.89 20.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.777 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 124.12 -166.07 16.82 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.307 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.457 ' OD1' HG23 ' A' ' 406' ' ' THR . 36.0 m-20 -140.91 132.55 27.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.75 0.31 . . . . 0.0 110.709 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.849 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -123.14 130.17 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.165 0.507 . . . . 0.0 111.013 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.849 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -98.71 126.38 44.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.67 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.611 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.3 p90 -142.2 150.0 40.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.399 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.9 159.65 15.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.21 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.58 HD12 ' CD2' ' A' ' 389' ' ' HIS . 31.8 mt -130.7 149.39 52.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.798 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -158.95 106.47 1.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.611 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.967 ' CD1' HD13 ' A' ' 352' ' ' ILE . 27.7 t80 -101.49 137.91 39.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.14 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 44.2 t -123.5 95.81 44.58 Favored Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.539 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.3 Cg_exo -70.54 -34.38 12.06 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.931 2.421 . . . . 0.0 112.733 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.25 -30.71 5.02 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.16 0.505 . . . . 0.0 109.957 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -116.64 -21.72 8.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.844 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.26 48.87 6.17 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.642 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -124.15 129.74 51.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.073 0.463 . . . . 0.0 111.891 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 352' ' ' ILE . 39.2 tp -95.43 147.63 23.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.867 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 343' ' ' PHE . 8.3 m -139.33 138.7 36.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 112.06 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.5 124.41 57.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.316 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 341' ' ' GLU . 25.3 t -117.16 114.67 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.028 0.442 . . . . 0.0 111.852 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.788 HG22 ' HB2' ' A' ' 339' ' ' TYR . 26.1 mm -74.68 137.01 23.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.453 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.29 -60.49 1.87 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 2.4 pt-20 -175.81 159.28 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.243 0.544 . . . . 0.0 112.24 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.769 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -123.64 149.5 45.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.853 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -145.55 153.68 41.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.987 0.423 . . . . 0.0 111.375 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 60.54 29.02 18.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.495 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.769 HD21 ' HB1' ' A' ' 296' ' ' ALA . 91.8 mt -66.01 138.79 58.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.951 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -58.41 148.59 27.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.59 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.404 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 0.1 OUTLIER -89.45 121.9 32.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.465 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.53 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.8 mmt -96.48 -16.67 21.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.316 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 33.1 m-20 -106.97 101.3 10.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.767 0.318 . . . . 0.0 110.504 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.07 116.61 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.54 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.04 87.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.907 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -124.93 -139.47 5.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.85 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.505 HD12 ' HB2' ' A' ' 333' ' ' ASN . 34.1 mt -119.46 -159.21 0.76 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.01 0.433 . . . . 0.0 110.566 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.666 ' HB2' HD23 ' A' ' 335' ' ' LEU . 66.5 m -135.68 172.06 13.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.222 0.534 . . . . 0.0 110.638 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.407 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -131.44 57.57 31.91 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.037 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 363' ' ' ASP . 38.3 Cg_endo -67.66 153.85 74.97 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.136 2.557 . . . . 0.0 114.51 -177.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.548 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 25.1 p90 -156.82 148.3 22.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.355 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 1.009 HG22 HG22 ' A' ' 361' ' ' VAL . 39.8 t -102.99 143.59 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.701 ' HE3' HD13 ' A' ' 362' ' ' LEU . 17.7 mttt -122.08 157.43 31.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.278 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.405 HG23 HG13 ' A' ' 357' ' ' VAL . 5.4 mp -131.51 124.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.651 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -123.5 133.25 54.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 111.157 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.416 HD21 HG22 ' A' ' 347' ' ' VAL . 22.5 tp -102.15 105.83 16.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.285 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' MET . . . . . 0.448 ' HE2' HD22 ' A' ' 417' ' ' LEU . 0.9 OUTLIER -107.2 143.6 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.245 -179.47 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.794 ' HB2' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -105.58 99.56 9.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.416 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 59.84 37.75 21.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.937 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 90.16 25.56 26.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.902 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 317' ' ' MET . 7.8 mmtm -128.88 109.47 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.451 ' O ' HD23 ' A' ' 323' ' ' LEU . 7.9 ptt180 -52.84 130.81 34.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.227 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.794 HD11 ' HB2' ' A' ' 318' ' ' GLN . 8.3 mt -126.26 -43.21 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.241 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 3.2 mmpt? -130.62 158.08 41.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.921 0.391 . . . . 0.0 111.341 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.59 134.21 23.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.837 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -142.3 159.11 42.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.916 0.388 . . . . 0.0 111.247 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 2.9 mttt -142.75 154.65 44.46 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.601 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.795 HG22 ' CE1' ' A' ' 343' ' ' PHE . 13.4 p -111.12 177.22 4.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.847 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.4 142.99 36.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.693 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.548 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.2 mt -90.55 119.17 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.109 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.614 ' O ' HG22 ' A' ' 334' ' ' THR . 1.1 mmpt? -83.56 89.47 7.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.3 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -57.42 137.4 56.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.799 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' ASN . . . . . 0.505 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.2 p-10 43.91 83.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.365 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.756 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.5 t -176.82 174.78 1.73 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.803 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 334' ' ' THR . 5.1 mt -146.65 -16.96 0.42 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.223 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.464 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.7 m-80 -132.6 59.26 42.11 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.387 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 44.5 Cg_endo -92.47 167.66 2.79 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.301 2.667 . . . . 0.0 113.756 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.453 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.4 OUTLIER -107.82 160.82 15.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.053 179.153 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.788 ' HB2' HG22 ' A' ' 293' ' ' ILE . 78.8 m-85 -133.93 -61.62 0.79 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.857 0.361 . . . . 0.0 111.236 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 54.76 36.9 27.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.536 ' O ' HG13 ' A' ' 292' ' ' VAL . 51.6 mt-10 -92.33 142.44 27.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 14.9 m -112.67 117.22 31.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.442 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.795 ' CE1' HG22 ' A' ' 328' ' ' THR . 81.2 m-85 -109.72 156.93 19.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.276 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 17.4 p -129.67 142.67 50.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 111.683 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -128.59 165.96 19.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.539 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -112.88 78.31 1.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.78 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.903 HG13 ' HB3' ' A' ' 351' ' ' GLN . 44.0 t -112.95 118.47 44.52 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.499 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 43.2 Cg_endo -68.7 151.87 74.52 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.286 1.991 . . . . 0.0 111.113 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -47.5 -24.39 0.83 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 354' ' ' LYS . 47.3 mt-10 -83.02 -20.7 34.53 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.903 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -93.67 -39.36 10.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.967 HD13 ' CD1' ' A' ' 282' ' ' TYR . 3.8 tp -45.62 -28.12 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.911 0.386 . . . . 0.0 110.994 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 353' ' ' GLN . . . . . 0.458 HE21 HD22 ' A' ' 394' ' ' LEU . 14.9 mm-40 -86.41 -31.11 21.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.806 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 350' ' ' GLU . 3.2 pttm -105.34 11.37 32.87 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.701 HG12 ' HG2' ' A' ' 318' ' ' GLN . 32.6 m -112.98 163.61 9.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.733 0.302 . . . . 0.0 110.883 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.2 126.51 18.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.222 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.527 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 86.5 t -89.56 134.06 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.195 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.527 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.5 OUTLIER -117.52 116.93 53.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.96 0.409 . . . . 0.0 111.692 -179.323 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.541 HG11 ' CD2' ' A' ' 278' ' ' PHE . 46.0 t -97.67 108.11 21.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.834 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.982 HG23 ' HB3' ' A' ' 375' ' ' LYS . 2.2 m -111.65 132.09 54.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.945 0.403 . . . . 0.0 111.978 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 1.009 HG22 HG22 ' A' ' 312' ' ' VAL . 52.7 t -106.59 113.8 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.906 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.701 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.1 mp -118.6 146.92 44.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.046 0.451 . . . . 0.0 111.69 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.53 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -92.9 134.33 35.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.443 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.521 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 6.9 t80 -90.29 144.28 25.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.064 0.459 . . . . 0.0 110.911 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.51 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 19.8 m-20 -128.61 105.68 8.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.018 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.521 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 1.4 pttt -29.9 -56.07 0.17 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.024 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.65 HD13 ' N ' ' A' ' 367' ' ' ILE . 1.4 mm -91.01 -77.75 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.429 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -53.13 -175.46 0.06 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.087 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.01 165.97 17.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 111.095 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.13 145.7 47.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.077 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -106.11 151.56 24.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.68 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.619 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.35 110.32 22.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.04 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.818 ' O ' HD22 ' A' ' 273' ' ' LEU . 36.9 mt -81.26 -34.17 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.196 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 170.63 178.01 41.05 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.098 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.982 ' HB3' HG23 ' A' ' 360' ' ' THR . 16.9 ptmt -164.44 140.47 6.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.192 0.52 . . . . 0.0 111.729 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.921 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.24 158.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.116 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.501 ' HB3' HG13 ' A' ' 358' ' ' VAL . 44.1 p90 -140.68 150.63 43.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 111.345 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 378' ' ' VAL . 15.4 m -142.46 111.11 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.997 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 173.34 -154.28 19.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.908 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 382' ' ' SER . 0.2 OUTLIER -53.21 -70.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.744 0.307 . . . . 0.0 111.41 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -66.41 68.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.966 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' SER . . . . . 0.427 ' O ' HG23 ' A' ' 383' ' ' THR . 0.7 OUTLIER -164.65 165.49 20.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.733 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 382' ' ' SER . 34.5 p -158.03 148.26 20.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 95.74 -143.0 16.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.705 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.437 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -57.43 -30.2 64.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.382 . . . . 0.0 111.332 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -68.22 -52.59 32.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.089 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 31.0 tp -68.94 -32.82 72.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 110.336 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 385' ' ' ALA . 0.0 OUTLIER -66.93 -30.07 70.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.253 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.58 ' CD2' HD12 ' A' ' 280' ' ' LEU . 20.1 t-160 -77.9 -52.77 8.32 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.646 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.527 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 65.0 t-105 -51.57 -49.02 62.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.074 0.464 . . . . 0.0 109.764 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.2 t -65.69 -29.99 70.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.721 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.516 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.4 OUTLIER -62.54 -43.76 98.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.753 179.037 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.851 ' CE ' HD11 ' A' ' 352' ' ' ILE . 29.8 ttp -60.39 -52.48 65.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.665 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.739 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.7 mt -57.96 -33.37 68.79 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.36 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -67.89 -30.52 69.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.305 0.574 . . . . 0.0 109.692 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.3 m-80 -114.92 71.41 2.63 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.591 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.541 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 41.4 Cg_endo -68.7 32.95 0.16 Allowed 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.23 2.62 . . . . 0.0 113.534 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' ARG . . . . . 0.541 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 0.5 OUTLIER -158.77 -44.56 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.933 0.397 . . . . 0.0 110.77 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.417 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.0 OUTLIER -93.84 137.6 23.07 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.154 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 58.3 Cg_endo -71.43 156.37 58.51 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.571 2.181 . . . . 0.0 112.902 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -126.14 116.11 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.786 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.85 144.71 34.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.312 . . . . 0.0 110.828 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.34 154.25 10.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.37 . . . . 0.0 111.344 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -81.97 120.9 25.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.921 ' HB3' HG11 ' A' ' 376' ' ' VAL . 55.2 m-70 -109.61 122.36 47.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.457 HG23 ' OD1' ' A' ' 275' ' ' ASP . 85.4 m -78.26 117.27 19.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.674 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.761 HD23 HG22 ' A' ' 376' ' ' VAL . 45.2 mt -61.73 127.81 33.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.013 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -115.32 169.58 9.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.888 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.877 ' O ' HG23 ' A' ' 413' ' ' VAL . 41.1 t -55.59 121.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.973 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.619 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 6.7 mt-10 -55.17 -40.6 70.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.451 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.75 -51.13 71.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.469 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.456 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.1 mt-10 -63.57 -40.13 96.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 375' ' ' LYS . 98.6 t -56.45 -48.03 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.295 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -63.13 -40.19 96.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.745 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.98 81.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.039 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 40.6 mtm -68.99 -32.81 72.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.756 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.448 HD22 ' HE2' ' A' ' 317' ' ' MET . 10.9 mt -70.84 -31.16 67.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.811 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -84.51 156.12 21.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.094 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . 0.413 'CA ' ' HB3' ' A' ' 302' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.817 0.341 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.772 HD22 ' O ' ' A' ' 373' ' ' ILE . 47.9 mt -90.2 -35.97 15.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.798 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 127.57 -162.52 21.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.335 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.32 133.37 22.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.691 0.281 . . . . 0.0 110.731 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.873 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -123.04 128.98 75.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.302 0.573 . . . . 0.0 111.165 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.873 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -96.26 126.71 41.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.556 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.622 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.2 p90 -142.16 149.51 39.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.474 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -100.94 160.47 14.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.04 -178.767 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.89 HD12 ' CD2' ' A' ' 389' ' ' HIS . 67.0 mt -130.21 147.05 51.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.162 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 290' ' ' THR . 0.7 OUTLIER -158.86 106.48 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 0.0 111.141 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 1.0 ' CD1' HD13 ' A' ' 352' ' ' ILE . 38.0 t80 -99.12 139.4 34.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.549 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 287' ' ' GLY . 98.9 t -114.89 93.8 35.54 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.97 0.414 . . . . 0.0 109.956 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.669 ' HD3' ' HB3' ' A' ' 397' ' ' PRO . 16.7 Cg_exo -66.33 -31.38 43.52 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.916 2.411 . . . . 0.0 112.343 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -28.39 67.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.807 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -123.66 -2.92 8.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.677 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 62.97 46.55 93.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.09 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -121.98 128.83 51.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.059 0.457 . . . . 0.0 111.338 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.462 HD21 ' CG2' ' A' ' 357' ' ' VAL . 32.8 tp -93.08 147.64 22.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.332 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 343' ' ' PHE . 1.8 m -136.0 137.34 41.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.344 0.592 . . . . 0.0 111.857 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.1 t -129.95 122.98 55.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.439 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 341' ' ' GLU . 24.0 t -116.21 116.12 51.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.979 0.418 . . . . 0.0 111.788 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.702 HG13 HG21 ' A' ' 328' ' ' THR . 34.8 mm -76.09 136.89 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.447 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.21 -59.62 1.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -177.728 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.486 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 2.2 pt-20 -175.64 156.79 1.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.479 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.793 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -117.59 150.63 38.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.766 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.405 ' HE3' ' CE3' ' A' ' 404' ' ' TRP . 11.3 pttp -147.73 152.36 37.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 111.507 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 62.92 24.24 14.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.833 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.793 HD21 ' HB1' ' A' ' 296' ' ' ALA . 60.7 mt -59.79 138.68 57.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.997 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -67.01 147.99 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.705 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.438 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 20.0 mttp -81.11 120.9 25.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.581 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.465 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 4.5 mmm -101.13 -15.38 17.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.644 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 52.9 m-20 -98.52 123.05 42.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.839 0.352 . . . . 0.0 110.548 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.0 t -48.07 114.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.627 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 56.77 17.89 22.86 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.274 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.13 -159.72 10.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.06 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 6.6 mt -95.56 -161.67 0.88 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 110.466 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.527 ' HB2' HD23 ' A' ' 335' ' ' LEU . 14.4 m -133.99 171.81 13.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.278 0.561 . . . . 0.0 111.181 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.418 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 13.7 m-20 -131.87 56.11 21.99 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.627 ' CG ' HD13 ' A' ' 299' ' ' LEU . 58.5 Cg_endo -73.01 146.28 41.29 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.047 2.498 . . . . 0.0 114.842 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.53 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 42.2 p90 -146.2 165.85 27.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.171 -1.377 . . . . 0.0 107.948 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.897 HG22 HG22 ' A' ' 361' ' ' VAL . 48.1 t -115.11 149.95 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.84 ' HE3' HD13 ' A' ' 362' ' ' LEU . 13.0 mttt -129.44 164.48 23.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.042 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.542 HG23 HG13 ' A' ' 357' ' ' VAL . 4.8 mp -137.86 124.97 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.689 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -119.46 135.56 54.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.89 0.376 . . . . 0.0 111.313 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 345' ' ' PHE . 20.5 tp -103.92 105.55 15.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.457 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.1 mtm -111.04 127.9 55.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.408 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.771 ' HB2' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -91.38 99.6 12.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.283 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 3.7 m120 55.16 38.1 29.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.024 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 91.79 27.48 16.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.867 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 317' ' ' MET . 2.3 mptt -130.71 109.39 10.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.732 0.301 . . . . 0.0 110.843 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.503 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.9 OUTLIER -51.35 130.42 27.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.364 -179.793 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 318' ' ' GLN . 15.9 mt -124.58 -58.93 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.132 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.66 152.06 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.8 128.86 20.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.709 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -125.71 167.31 15.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.98 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.418 ' CB ' ' HG2' ' A' ' 313' ' ' LYS . 36.6 pttt -147.54 148.66 31.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.142 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.784 HG22 ' CE1' ' A' ' 343' ' ' PHE . 9.7 p -104.7 179.83 4.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.749 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.581 HG22 ' OE2' ' A' ' 341' ' ' GLU . 10.1 t -59.15 172.28 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.53 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.4 mt -116.96 125.1 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.955 0.407 . . . . 0.0 111.377 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.62 ' O ' HG22 ' A' ' 334' ' ' THR . 0.2 OUTLIER -91.08 91.45 8.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.281 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -58.83 137.09 57.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.833 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' ASN . . . . . 0.454 ' C ' HD13 ' A' ' 307' ' ' LEU . 0.9 OUTLIER 44.54 80.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.413 179.106 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.706 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.7 t -172.98 173.49 3.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.556 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 334' ' ' THR . 3.2 mt -146.99 -14.75 0.41 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.391 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.486 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.8 m-80 -135.81 57.63 19.78 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 120.704 0.288 . . . . 0.0 110.506 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 45.5 Cg_endo -92.79 167.82 2.58 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.155 2.57 . . . . 0.0 113.721 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.447 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.6 OUTLIER -106.31 160.76 15.12 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.192 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.623 ' HB2' HG22 ' A' ' 293' ' ' ILE . 66.1 m-85 -132.65 -66.83 0.67 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.916 0.388 . . . . 0.0 110.982 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 60.72 37.35 19.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.843 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.581 ' OE2' HG22 ' A' ' 329' ' ' THR . 29.9 mt-10 -93.65 143.91 25.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 93.1 p -113.21 121.92 45.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.007 0.432 . . . . 0.0 111.481 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.784 ' CE1' HG22 ' A' ' 328' ' ' THR . 36.7 m-85 -110.42 164.85 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.321 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 21.6 m -137.49 140.1 40.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.092 0.472 . . . . 0.0 111.679 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 316' ' ' LEU . 38.3 m-85 -126.88 166.0 18.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.503 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.33 72.99 0.79 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.727 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.824 HG13 ' HB3' ' A' ' 351' ' ' GLN . 46.9 t -108.38 121.08 44.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.135 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.562 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 68.5 Cg_endo -74.4 157.84 44.93 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.358 2.038 . . . . 0.0 111.247 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -50.9 -22.23 2.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -89.15 -8.46 53.65 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.824 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -111.98 -27.19 8.52 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 1.0 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.5 tp -48.37 -26.92 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.741 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 353' ' ' GLN . . . . . 0.544 ' NE2' HD13 ' A' ' 394' ' ' LEU . 3.6 mm-40 -95.09 -26.58 15.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.618 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 380' ' ' TYR . 48.0 mtpt -92.32 -0.66 57.37 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.883 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 351' ' ' GLN . 24.8 m -110.24 163.18 7.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.92 0.39 . . . . 0.0 111.317 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.24 126.33 21.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.62 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.542 HG13 HG23 ' A' ' 314' ' ' ILE . 98.9 t -90.88 111.81 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.533 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.529 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.6 OUTLIER -99.95 109.39 24.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.399 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.553 ' HB ' HG23 ' A' ' 376' ' ' VAL . 48.8 t -90.48 108.0 19.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.978 HG23 ' HB3' ' A' ' 375' ' ' LYS . 1.5 m -108.25 133.43 52.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.02 0.438 . . . . 0.0 111.894 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.897 HG22 HG22 ' A' ' 312' ' ' VAL . 51.1 t -108.3 114.8 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.839 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.84 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.5 mp -118.3 150.05 40.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.063 0.458 . . . . 0.0 111.838 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.465 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 1.3 t70 -95.53 132.36 40.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.679 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.529 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 26.8 t80 -83.74 146.2 28.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.538 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -141.2 64.28 1.42 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.7 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.529 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 0.0 OUTLIER 33.2 -92.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.212 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 47.5 mm -81.11 -71.38 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.668 0.271 . . . . 0.0 111.409 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -42.91 163.81 0.03 OUTLIER Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.969 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 165.49 12.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 0.0 110.886 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.93 130.98 34.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.94 139.38 35.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.675 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -87.71 111.57 21.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.882 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.772 ' O ' HD22 ' A' ' 273' ' ' LEU . 37.2 mt -79.78 -34.42 15.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.01 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.92 -179.81 40.97 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.961 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.978 ' HB3' HG23 ' A' ' 360' ' ' THR . 9.6 ptmt -164.6 140.62 5.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.513 . . . . 0.0 111.81 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.957 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -109.47 158.89 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.128 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.471 ' CD1' HG13 ' A' ' 413' ' ' VAL . 17.6 p90 -139.58 151.4 46.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 0.0 111.813 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 378' ' ' VAL . 17.0 m -148.39 121.4 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.03 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.433 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 169.57 -151.35 17.02 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.371 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.406 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 0.2 OUTLIER -43.2 -69.83 0.12 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.863 0.364 . . . . 0.0 111.233 179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -60.97 -155.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.186 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' SER . . . . . 0.407 ' CB ' ' CE2' ' A' ' 377' ' ' PHE . 0.7 OUTLIER 70.21 166.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 110.86 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 50.0 p -158.12 146.86 19.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.802 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 92.93 -154.66 22.07 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.825 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.481 ' HA ' ' HG3' ' A' ' 388' ' ' ARG . . . -43.35 -34.26 1.2 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.8 -56.08 18.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.729 0.299 . . . . 0.0 110.797 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.76 -35.96 79.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.463 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.481 ' HG3' ' HA ' ' A' ' 385' ' ' ALA . 4.0 mtt85 -61.77 -41.37 97.62 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.978 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.89 ' CD2' HD12 ' A' ' 280' ' ' LEU . 13.9 t-160 -60.99 -55.69 29.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.738 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.469 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 62.5 t-105 -55.44 -50.99 68.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.462 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -37.26 86.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.312 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.554 ' HB3' HD12 ' A' ' 401' ' ' ILE . 14.8 m-20 -63.07 -32.83 74.29 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.712 ' CE ' HD11 ' A' ' 352' ' ' ILE . 26.0 ttp -63.42 -56.4 16.54 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.776 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -56.38 -23.26 36.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.715 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.4 ' C ' ' HD3' ' A' ' 397' ' ' PRO . . . -78.99 -33.63 44.87 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.372 0.606 . . . . 0.0 109.374 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.426 ' N ' ' HD3' ' A' ' 397' ' ' PRO . 28.6 m-80 -130.1 59.76 47.45 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.459 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.669 ' HB3' ' HD3' ' A' ' 284' ' ' PRO . 65.5 Cg_exo -46.28 -76.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.921 2.414 . . . . 0.0 112.992 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -49.45 -21.94 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.87 133.49 27.67 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 110.881 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.3 Cg_endo -75.21 133.76 16.66 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.492 2.128 . . . . 0.0 112.614 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.1 mm -111.68 110.75 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.803 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.18 143.96 34.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.783 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.43 152.39 7.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.874 0.369 . . . . 0.0 111.378 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' TRP . . . . . 0.405 ' CE3' ' HE3' ' A' ' 297' ' ' LYS . 63.3 m95 -80.12 124.09 28.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.686 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.957 ' HB3' HG11 ' A' ' 376' ' ' VAL . 61.0 m-70 -112.31 123.0 49.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.628 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 91.5 m -78.36 117.08 19.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.653 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.755 HD23 HG22 ' A' ' 376' ' ' VAL . 80.9 mt -62.45 127.73 32.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.077 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -115.85 170.26 8.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.791 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.857 ' O ' HG23 ' A' ' 413' ' ' VAL . 61.1 t -55.22 117.39 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.812 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.675 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 6.3 mp0 -52.01 -43.09 63.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.832 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -58.06 -50.16 74.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.738 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.455 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 23.0 mt-10 -64.04 -38.8 92.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 409' ' ' VAL . 89.0 t -57.43 -48.32 83.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.286 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -64.42 -30.6 71.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.468 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.37 -39.66 85.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.611 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' MET . . . . . 0.409 ' SD ' ' CZ ' ' A' ' 377' ' ' PHE . 11.0 mtt -60.66 -41.6 95.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.532 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 5.2 mt -73.57 -30.57 63.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.934 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -93.36 113.72 25.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.075 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.163 179.933 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.8 0.333 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.792 HD22 ' O ' ' A' ' 373' ' ' ILE . 55.0 mt -89.73 -48.43 7.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 135.16 -170.16 23.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.19 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.64 ' OD1' HG23 ' A' ' 406' ' ' THR . 3.2 m-20 -136.74 135.15 37.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.719 0.295 . . . . 0.0 111.01 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.795 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -125.37 128.7 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.03 0.443 . . . . 0.0 110.875 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.795 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.5 OUTLIER -97.37 126.6 42.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.826 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.612 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.0 p90 -142.22 152.15 42.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.406 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.49 163.4 12.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.005 -178.786 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.673 HD12 ' CD2' ' A' ' 389' ' ' HIS . 96.1 mt -136.81 143.43 43.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.281 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -159.13 110.76 2.11 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.884 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.858 ' CD1' HD13 ' A' ' 352' ' ' ILE . 26.9 t80 -104.42 139.15 39.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.802 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.54 97.22 42.48 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.537 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.84 -33.47 7.9 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.669 2.246 . . . . 0.0 112.632 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -29.36 6.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.165 0.507 . . . . 0.0 109.983 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.29 -18.16 8.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.945 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.79 48.87 8.29 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.548 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -123.69 129.9 51.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.986 0.422 . . . . 0.0 111.621 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.904 HD11 ' HE1' ' A' ' 393' ' ' MET . 38.5 tp -97.42 147.49 24.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.977 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 2.8 m -137.61 137.21 38.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.429 0.633 . . . . 0.0 111.965 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.7 t -130.92 123.6 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.162 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 341' ' ' GLU . 23.9 t -117.9 115.13 47.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.057 0.456 . . . . 0.0 111.794 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.622 HG13 HG21 ' A' ' 328' ' ' THR . 40.0 mm -74.83 137.11 23.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.02 -59.4 2.02 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 4.7 pt-20 -175.75 162.89 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.415 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.739 ' CB ' HD11 ' A' ' 299' ' ' LEU . . . -122.31 153.06 39.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.897 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -149.61 150.02 31.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.104 0.478 . . . . 0.0 111.534 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 60.38 26.27 15.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.878 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.739 HD11 ' CB ' ' A' ' 296' ' ' ALA . 94.2 mt -62.08 138.75 58.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.832 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.81 150.7 23.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.57 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.409 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 23.6 mttt -91.58 115.84 28.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.423 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.516 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.5 mmt -88.56 -19.26 26.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.541 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 50.1 m-20 -99.26 112.16 24.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.512 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -49.27 116.37 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.476 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 65.69 12.74 57.5 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.536 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.17 -151.01 7.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.75 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 307' ' ' LEU . 10.6 mt -108.29 -161.51 0.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.697 0.284 . . . . 0.0 110.68 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.622 ' HB2' HD23 ' A' ' 335' ' ' LEU . 49.8 m -137.68 172.04 13.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.369 0.604 . . . . 0.0 111.276 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.407 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 8.7 m-20 -131.38 57.86 34.13 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.735 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.44 ' CB ' HD13 ' A' ' 299' ' ' LEU . 45.0 Cg_endo -69.74 151.92 69.32 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.196 2.597 . . . . 0.0 114.729 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.513 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 35.0 p90 -154.35 155.44 35.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.108 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.871 HG22 HG22 ' A' ' 361' ' ' VAL . 47.1 t -106.38 149.79 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.762 ' HE3' HD13 ' A' ' 362' ' ' LEU . 9.9 mtmt -131.93 140.99 49.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.307 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.551 HD11 HD11 ' A' ' 293' ' ' ILE . 5.3 mp -115.79 127.74 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.556 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -122.39 133.4 54.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.369 . . . . 0.0 111.378 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.661 HD23 ' HG3' ' A' ' 324' ' ' LYS . 38.7 tp -106.39 107.53 18.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.095 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.1 mtm -116.12 147.82 40.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.391 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.67 ' HG3' HD11 ' A' ' 323' ' ' LEU . 0.1 OUTLIER -107.0 99.47 9.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.521 179.535 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 56.55 37.83 29.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 96.6 13.82 46.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.166 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 317' ' ' MET . 32.3 mmtt -119.18 109.12 15.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.808 0.304 . . . . 0.0 110.734 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.48 135.37 56.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.4 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.67 HD11 ' HG3' ' A' ' 318' ' ' GLN . 3.3 mt -127.08 -49.36 1.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.849 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.661 ' HG3' HD23 ' A' ' 316' ' ' LEU . 2.5 mttt -130.53 148.97 52.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.962 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.25 119.54 10.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.753 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -122.96 155.88 35.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.423 ' HB3' ' HG2' ' A' ' 313' ' ' LYS . 14.6 ptmt -137.58 148.58 45.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.842 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.73 HG22 ' CE1' ' A' ' 343' ' ' PHE . 4.3 p -101.71 -179.0 3.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.844 0.354 . . . . 0.0 110.712 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.0 t -60.45 162.2 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.468 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.513 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.6 mt -105.07 121.92 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.921 0.391 . . . . 0.0 111.219 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.479 ' HB3' HG21 ' A' ' 334' ' ' THR . 0.7 OUTLIER -85.6 94.65 9.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.109 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -60.8 136.8 58.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.928 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 43.83 83.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.51 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.738 ' O ' HD23 ' A' ' 335' ' ' LEU . 3.5 t -177.06 174.5 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.879 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 334' ' ' THR . 4.3 mt -145.26 -16.86 0.49 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.294 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 296' ' ' ALA . 1.1 m-80 -131.42 61.68 60.41 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.862 0.363 . . . . 0.0 110.05 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.413 ' HB2' ' CD ' ' A' ' 331' ' ' LYS . 64.6 Cg_endo -88.57 167.63 6.11 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.145 2.564 . . . . 0.0 114.045 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 58.8 t80 -114.09 153.18 29.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.846 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.538 ' HB2' HG22 ' A' ' 293' ' ' ILE . 83.9 m-85 -132.98 -69.83 0.55 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.85 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' ASN . . . . . 0.505 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 26.2 t-20 64.45 37.21 8.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.505 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.541 ' O ' HG13 ' A' ' 292' ' ' VAL . 31.3 mt-10 -91.42 142.9 27.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.787 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 13.7 m -110.28 122.18 47.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 0.0 111.581 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.73 ' CE1' HG22 ' A' ' 328' ' ' THR . 65.6 m-85 -113.2 148.36 35.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.091 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 3.0 m -120.8 140.0 52.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.1 0.476 . . . . 0.0 111.554 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.511 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 45.0 m-85 -126.88 165.87 18.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.437 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -116.62 76.1 1.01 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.958 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.907 HG13 ' HB3' ' A' ' 351' ' ' GLN . 55.7 t -109.16 122.92 38.31 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.209 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.529 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.4 Cg_endo -72.3 156.43 54.93 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.293 1.996 . . . . 0.0 111.3 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -50.68 -21.92 1.82 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.67 -8.5 52.27 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.907 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -107.88 -31.36 8.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.858 HD13 ' CD1' ' A' ' 282' ' ' TYR . 6.4 tp -46.81 -27.28 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 111.319 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -90.02 -47.54 7.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.627 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.446 ' CG ' ' HA ' ' A' ' 351' ' ' GLN . 5.9 ptpt -80.72 2.18 27.1 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 351' ' ' GLN . 33.1 m -107.66 165.38 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.729 0.299 . . . . 0.0 110.872 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.67 126.46 15.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.087 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.561 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 61.4 t -88.54 114.14 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.276 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.498 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.4 OUTLIER -100.16 116.29 43.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.756 -179.169 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.553 HG13 ' CG1' ' A' ' 312' ' ' VAL . 58.3 t -98.46 108.11 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.856 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.932 HG23 ' HB3' ' A' ' 375' ' ' LYS . 1.6 m -108.73 132.68 53.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.998 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.871 HG22 HG22 ' A' ' 312' ' ' VAL . 54.6 t -105.93 114.96 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.636 178.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.762 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.3 mp -118.71 147.84 43.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.096 0.474 . . . . 0.0 111.895 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.516 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.8 t70 -93.8 137.36 33.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.744 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.508 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 30.7 t80 -90.09 145.62 24.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.376 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 367' ' ' ILE . 48.3 m-20 -142.53 66.22 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.813 ' CG ' HD12 ' A' ' 367' ' ' ILE . 0.0 OUTLIER 35.77 -92.24 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.312 179.157 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.813 HD12 ' CG ' ' A' ' 366' ' ' LYS . 4.6 mp -86.48 -65.44 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.792 0.329 . . . . 0.0 111.238 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -41.84 159.47 0.04 OUTLIER Glycine 0 C--N 1.332 0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.178 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.86 149.79 49.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.31 . . . . 0.0 110.889 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.03 126.41 29.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.781 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.01 148.9 37.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.15 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.65 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -95.4 110.89 22.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.792 ' O ' HD22 ' A' ' 273' ' ' LEU . 23.9 mt -79.59 -32.88 14.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.316 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' GLY . . . . . 0.44 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 166.48 -178.87 40.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.746 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.932 ' HB3' HG23 ' A' ' 360' ' ' THR . 10.9 ptmt -164.54 141.04 6.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.181 0.515 . . . . 0.0 111.686 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.899 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.86 158.79 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.226 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.498 ' HB3' HG13 ' A' ' 358' ' ' VAL . 8.3 p90 -141.78 143.03 33.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.374 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 378' ' ' VAL . 7.6 m -131.86 90.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.082 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.45 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . -177.64 -158.0 19.71 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.45 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -56.73 173.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 110.803 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 23.5 m120 51.18 26.55 2.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.273 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' SER . . . . . 0.433 ' O ' HG23 ' A' ' 383' ' ' THR . 0.7 OUTLIER -132.19 165.53 23.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 382' ' ' SER . 34.1 p -158.02 150.65 22.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.903 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 97.97 -147.54 18.62 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.434 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -55.37 -30.4 60.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 111.379 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.409 ' OE1' ' CZ ' ' A' ' 377' ' ' PHE . 0.3 OUTLIER -68.53 -54.42 16.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.984 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.9 tp -67.96 -30.91 70.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.781 0.324 . . . . 0.0 110.43 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 5.1 ptt180 -68.23 -28.21 67.03 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.329 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.673 ' CD2' HD12 ' A' ' 280' ' ' LEU . 18.4 t-160 -81.33 -54.48 5.44 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.456 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.561 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 48.2 t-105 -49.96 -43.97 50.44 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.008 0.432 . . . . 0.0 109.863 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 31.3 t -69.72 -34.1 73.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.694 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.467 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.5 OUTLIER -61.08 -39.57 90.4 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.664 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.904 ' HE1' HD11 ' A' ' 289' ' ' LEU . 19.8 ttm -59.42 -53.79 54.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.115 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.798 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.9 mt -63.81 -29.74 70.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.374 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.82 -31.02 71.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.226 0.536 . . . . 0.0 109.694 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -125.3 77.86 67.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.329 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.537 ' HB3' ' CG ' ' A' ' 284' ' ' PRO . 6.0 Cg_exo -77.8 42.76 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.145 2.564 . . . . 0.0 113.162 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' ARG . . . . . 0.505 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 16.2 mmm-85 -158.98 -46.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.069 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.21 142.84 25.45 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.925 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 63.4 Cg_endo -73.01 156.27 52.2 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.654 2.236 . . . . 0.0 112.904 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.81 114.69 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.749 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.91 144.21 35.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.759 0.314 . . . . 0.0 110.832 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.43 154.68 10.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.959 0.409 . . . . 0.0 111.291 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -81.38 120.35 24.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.959 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.899 ' HB3' HG11 ' A' ' 376' ' ' VAL . 48.3 m-70 -109.56 117.72 34.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.459 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.64 HG23 ' OD1' ' A' ' 275' ' ' ASP . 89.8 m -78.43 116.22 18.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.792 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.825 HD23 HG22 ' A' ' 376' ' ' VAL . 93.7 mt -61.09 128.12 34.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.347 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.417 ' C ' HD12 ' A' ' 273' ' ' LEU . 5.2 mt-30 -115.47 171.96 7.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.558 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.888 ' O ' HG23 ' A' ' 413' ' ' VAL . 44.2 t -54.59 120.72 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.65 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 14.8 mt-10 -54.29 -41.56 69.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.815 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.16 -51.33 70.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 0.0 110.539 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.49 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 24.6 mt-10 -62.49 -39.83 94.73 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.889 HG11 ' HG3' ' A' ' 375' ' ' LYS . 75.6 t -57.64 -50.11 78.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.378 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -60.08 -37.79 80.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.64 76.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.058 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 51.0 mtm -69.19 -31.62 70.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.473 HD21 ' HB2' ' A' ' 377' ' ' PHE . 9.0 mt -79.14 -34.18 43.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -70.62 174.7 5.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.099 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.057 179.987 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.819 0.343 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 373' ' ' ILE . 22.0 mt -94.78 -33.95 12.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.811 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 117.75 -163.98 12.73 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.177 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.49 ' OD1' HG23 ' A' ' 406' ' ' THR . 28.3 m-20 -143.6 132.18 22.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.731 0.301 . . . . 0.0 110.589 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.912 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -121.04 131.57 72.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.184 0.516 . . . . 0.0 111.184 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.912 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -99.59 125.08 45.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.709 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.626 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 16.0 p90 -139.91 150.69 44.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.24 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.0 OUTLIER -99.62 158.03 16.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.056 -178.473 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.555 HD13 ' HE3' ' A' ' 393' ' ' MET . 77.3 mt -129.44 144.87 51.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.018 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.416 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 22.7 ttp85 -158.89 109.22 2.02 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.702 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.834 ' CD1' HD13 ' A' ' 352' ' ' ILE . 26.1 t80 -103.39 137.98 40.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.93 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.0 t -122.29 94.6 47.78 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.541 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.5 Cg_exo -70.04 -32.63 17.06 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.939 2.426 . . . . 0.0 112.44 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.44 -30.03 7.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.184 0.516 . . . . 0.0 110.015 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.53 -21.45 7.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.962 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.92 48.44 6.11 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.549 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -124.04 130.18 52.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.983 0.421 . . . . 0.0 111.803 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.754 HD11 ' HE1' ' A' ' 393' ' ' MET . 33.2 tp -95.66 147.5 23.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.74 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 343' ' ' PHE . 7.1 m -138.19 136.58 36.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.31 0.576 . . . . 0.0 112.001 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.36 123.92 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.297 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 341' ' ' GLU . 34.8 t -118.06 115.44 48.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.976 0.417 . . . . 0.0 112.006 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.712 HG22 ' HB2' ' A' ' 339' ' ' TYR . 31.3 mm -73.85 135.34 27.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.62 -62.76 1.53 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.486 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 1.6 pt-20 -175.55 150.15 1.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.247 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.87 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -110.46 157.77 19.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.168 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -150.98 153.41 35.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.014 0.435 . . . . 0.0 111.724 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 59.08 25.2 13.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.93 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.87 HD21 ' HB1' ' A' ' 296' ' ' ALA . 49.6 mt -59.04 138.63 57.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.168 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.83 144.78 47.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.415 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 25.5 mttp -85.69 109.64 18.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.42 ' HG2' ' HB3' ' A' ' 363' ' ' ASP . 0.0 OUTLIER -86.13 -21.62 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.872 -179.404 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 50.5 m-20 -95.39 123.56 38.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 20.5 t -54.19 117.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.546 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.11 16.74 34.61 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.407 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.84 -154.92 8.71 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.679 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 15.1 mt -102.26 -161.36 0.84 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.788 0.327 . . . . 0.0 110.43 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.646 ' HB2' HD23 ' A' ' 335' ' ' LEU . 68.8 m -135.32 172.05 13.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.231 0.539 . . . . 0.0 110.972 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -133.53 55.86 18.09 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.738 ' CG ' HD13 ' A' ' 299' ' ' LEU . 69.5 Cg_endo -76.71 142.58 23.02 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.944 2.429 . . . . 0.0 114.93 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.604 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 14.7 p90 -137.46 167.05 22.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.36 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.906 HG22 HG22 ' A' ' 361' ' ' VAL . 43.1 t -113.05 150.07 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.837 ' HE2' HD13 ' A' ' 362' ' ' LEU . 7.5 mttm -133.41 139.91 47.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.189 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 293' ' ' ILE . 5.4 mp -114.63 131.01 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.685 0.279 . . . . 0.0 111.03 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -127.37 134.08 49.97 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.863 0.363 . . . . 0.0 111.015 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 324' ' ' LYS . 22.5 tp -103.99 106.47 16.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.409 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.6 mtm -110.7 135.33 51.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.138 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.721 ' HB2' HD11 ' A' ' 323' ' ' LEU . 0.5 OUTLIER -95.48 99.46 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.546 179.628 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 59.58 35.66 22.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.301 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 98.21 7.99 55.56 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.676 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.712 ' HG3' HD21 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -115.47 112.74 22.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.387 0.593 . . . . 0.0 110.94 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.513 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.4 OUTLIER -52.25 134.19 33.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.526 -179.581 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.721 HD11 ' HB2' ' A' ' 318' ' ' GLN . 13.4 mt -125.91 -45.95 1.71 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.104 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 9.5 mmtp -130.59 153.63 48.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.364 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 117.31 10.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.903 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.451 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 3.4 mmtm -123.63 164.68 18.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.104 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.52 152.68 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.97 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.727 HG22 ' CE1' ' A' ' 343' ' ' PHE . 16.1 p -109.83 -178.89 3.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 11.3 t -63.0 165.85 6.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.604 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.9 mt -108.49 117.29 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 111.509 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.659 ' O ' HG22 ' A' ' 334' ' ' THR . 8.3 mmpt? -80.07 85.95 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.875 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -55.12 135.84 48.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.021 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.32 83.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.49 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.773 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.5 t -175.63 174.39 2.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.681 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.773 HD23 ' O ' ' A' ' 334' ' ' THR . 5.2 mt -145.59 -17.16 0.48 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.185 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.486 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.72 56.53 22.98 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.908 0.385 . . . . 0.0 110.123 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 42.7 Cg_endo -90.1 167.79 4.51 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.203 2.602 . . . . 0.0 113.746 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -109.63 159.6 16.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.167 179.244 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.712 ' HB2' HG22 ' A' ' 293' ' ' ILE . 51.1 m-85 -132.48 -62.32 0.83 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.68 37.42 25.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.564 ' O ' HG13 ' A' ' 292' ' ' VAL . 30.1 mt-10 -92.47 144.47 25.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.706 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 51.6 p -115.48 120.76 40.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.393 . . . . 0.0 111.749 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.727 ' CE1' HG22 ' A' ' 328' ' ' THR . 80.8 m-85 -112.38 155.06 24.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.11 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 83.4 p -127.16 139.62 52.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.083 0.468 . . . . 0.0 111.591 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.451 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 66.3 m-85 -127.89 165.86 19.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.545 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.56 79.93 1.33 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.998 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' A' ' 351' ' ' GLN . 47.9 t -112.16 118.99 45.04 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.991 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.449 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 37.2 Cg_endo -66.52 154.02 75.88 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.321 2.014 . . . . 0.0 111.353 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -51.9 -24.74 6.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.752 0.31 . . . . 0.0 111.444 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.27 -8.57 57.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.54 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.551 ' HB3' HG13 ' A' ' 347' ' ' VAL . 31.2 mt-30 -105.99 -37.14 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.667 0.27 . . . . 0.0 111.329 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.834 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.7 tp -47.13 -25.52 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 111.195 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 353' ' ' GLN . . . . . 0.409 ' O ' ' CD1' ' A' ' 380' ' ' TYR . 3.0 mt-30 -88.99 -24.86 22.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.831 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.484 ' HA ' ' CD1' ' A' ' 380' ' ' TYR . 0.6 OUTLIER -111.69 2.14 17.08 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.012 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 351' ' ' GLN . 33.8 m -96.77 167.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.766 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' GLN . . . . . 0.423 ' HA ' ' HA3' ' A' ' 379' ' ' GLY . 7.4 mt-30 -141.28 126.33 18.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.928 0.394 . . . . 0.0 111.472 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.571 ' CG2' HD21 ' A' ' 289' ' ' LEU . 99.6 t -96.93 115.33 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.833 178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.4 OUTLIER -101.22 117.17 46.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.529 ' HB ' HG23 ' A' ' 376' ' ' VAL . 45.9 t -98.22 107.85 20.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.435 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.966 HG23 ' HB3' ' A' ' 375' ' ' LYS . 4.7 m -111.28 129.58 55.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.054 0.454 . . . . 0.0 111.9 -178.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.906 HG22 HG22 ' A' ' 312' ' ' VAL . 58.5 t -103.81 121.1 54.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.074 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.837 HD13 ' HE2' ' A' ' 313' ' ' LYS . 2.8 mp -123.18 146.26 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 111.816 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 310' ' ' PRO . 5.0 t70 -90.17 137.62 32.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.642 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.599 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 25.0 t80 -94.14 142.52 27.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.425 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 367' ' ' ILE . 1.2 m-20 -139.08 68.9 1.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.584 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.599 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 0.0 OUTLIER 27.91 -86.54 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 365' ' ' ASP . 42.7 mm -87.52 -67.15 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.75 0.309 . . . . 0.0 111.129 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -43.06 165.01 0.02 OUTLIER Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.091 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.8 165.56 12.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.848 0.356 . . . . 0.0 111.007 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.25 121.32 31.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 371' ' ' ASP . . . . . 0.415 ' HB2' ' HG2' ' A' ' 302' ' ' MET . 1.3 m-20 -71.23 147.25 48.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.51 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -91.7 110.22 21.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.094 0.473 . . . . 0.0 111.373 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.589 ' O ' HD22 ' A' ' 273' ' ' LEU . 2.4 mm -71.95 -35.57 54.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.783 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 374' ' ' GLY . . . . . 0.426 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 157.38 -175.16 34.84 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.117 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.966 ' HB3' HG23 ' A' ' 360' ' ' THR . 9.9 ptmt -164.1 140.5 6.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.287 0.565 . . . . 0.0 111.906 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.944 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.71 158.85 13.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.219 179.375 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.513 ' HB3' HG13 ' A' ' 358' ' ' VAL . 2.6 p90 -140.45 150.85 44.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.563 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 17.1 m -151.31 127.96 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.151 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.506 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 133.81 126.45 2.67 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.953 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.484 ' CD1' ' HA ' ' A' ' 354' ' ' LYS . 0.0 OUTLIER 58.97 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.649 0.261 . . . . 0.0 111.104 179.746 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 379' ' ' GLY . 0.3 OUTLIER -71.72 -161.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.313 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 382' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 383' ' ' THR . 0.7 OUTLIER 69.8 166.8 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 110.93 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 382' ' ' SER . 42.2 p -158.09 147.33 19.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.867 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 90.14 -139.85 15.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.813 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -49.53 -31.9 11.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.701 0.286 . . . . 0.0 111.766 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -68.59 -58.88 3.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.903 0.382 . . . . 0.0 110.206 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.45 -30.91 71.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.368 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 4.7 ptt180 -65.52 -28.63 69.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.312 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.441 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 19.7 t-160 -81.56 -58.13 3.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.715 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.561 ' CZ3' ' HE1' ' A' ' 393' ' ' MET . 73.9 t-105 -49.82 -46.32 50.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.07 0.462 . . . . 0.0 109.979 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 5.4 t -64.49 -32.94 74.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.593 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.54 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.6 OUTLIER -65.47 -40.46 93.19 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.639 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.776 ' SD ' HD11 ' A' ' 352' ' ' ILE . 7.1 ttm -57.86 -53.06 62.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.378 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.724 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.8 mt -61.94 -34.37 75.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.359 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.65 -29.71 69.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.181 0.515 . . . . 0.0 109.943 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -114.1 71.04 2.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.754 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.543 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 48.6 Cg_endo -70.07 33.98 0.21 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.167 2.578 . . . . 0.0 113.486 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 398' ' ' ARG . . . . . 0.543 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 10.2 mmm180 -159.25 -47.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.952 0.406 . . . . 0.0 110.952 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.486 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 36.1 ttt180 -93.94 136.66 23.55 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.385 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.486 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 48.6 Cg_endo -68.48 156.41 65.71 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.601 2.201 . . . . 0.0 112.939 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.54 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.37 118.72 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.797 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -105.64 144.58 32.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.839 0.352 . . . . 0.0 110.729 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.07 154.51 15.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.159 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -85.81 119.28 25.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.774 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.944 ' HB3' HG11 ' A' ' 376' ' ' VAL . 58.4 m-70 -108.56 122.16 46.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.251 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.49 HG23 ' OD1' ' A' ' 275' ' ' ASP . 89.9 m -78.08 117.41 19.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.721 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.737 HD23 HG22 ' A' ' 376' ' ' VAL . 67.5 mt -61.66 127.57 32.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.2 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.477 ' C ' HD12 ' A' ' 273' ' ' LEU . 6.0 mt-30 -115.0 169.07 9.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.755 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.889 ' O ' HG23 ' A' ' 413' ' ' VAL . 45.0 t -56.76 121.25 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.479 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 5.7 mt-10 -52.2 -44.83 64.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.993 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.06 -49.66 75.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 110.74 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.444 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 29.8 mt-10 -64.59 -38.76 92.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 409' ' ' VAL . 96.3 t -58.24 -49.49 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.381 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.57 -34.07 72.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.829 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -72.58 -36.72 68.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.028 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 59.8 mtm -70.84 -32.8 69.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 377' ' ' PHE . 12.0 mt -70.69 -30.77 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.914 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -79.03 116.8 19.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.092 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.143 179.986 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.819 0.342 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.793 HD22 ' O ' ' A' ' 373' ' ' ILE . 60.8 mt -89.14 -31.57 17.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.942 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.24 -165.73 13.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.233 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.18 133.06 27.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.806 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -121.94 129.56 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.088 0.47 . . . . 0.0 110.914 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.806 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -96.86 125.35 41.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.668 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.609 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.6 p90 -142.08 149.29 39.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.406 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.97 161.31 13.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.269 -178.632 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.635 HD12 ' CD2' ' A' ' 389' ' ' HIS . 11.3 mt -133.27 149.67 51.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.942 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.418 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.1 OUTLIER -158.92 105.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.446 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.908 ' CD1' HD13 ' A' ' 352' ' ' ILE . 30.7 t80 -98.19 134.87 40.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.832 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.51 97.88 48.56 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.526 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.9 Cg_exo -72.46 -31.49 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.691 2.261 . . . . 0.0 112.377 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.26 -30.26 6.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.294 0.569 . . . . 0.0 109.715 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.16 -17.38 8.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.767 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.11 47.94 10.46 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.689 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -123.31 129.38 51.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.934 0.397 . . . . 0.0 111.853 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.464 HD21 ' CG2' ' A' ' 357' ' ' VAL . 36.5 tp -92.59 147.66 22.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.796 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 2.9 m -137.16 138.54 40.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.323 0.582 . . . . 0.0 112.091 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.1 t -131.42 123.91 53.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.449 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 341' ' ' GLU . 29.0 t -116.74 115.3 48.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.942 0.401 . . . . 0.0 111.848 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.712 HG13 HG21 ' A' ' 328' ' ' THR . 31.6 mm -75.83 133.7 30.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.57 -59.86 1.89 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.476 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 7.3 pt-20 -175.72 165.17 3.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.241 0.543 . . . . 0.0 112.081 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.911 ' CB ' HD11 ' A' ' 299' ' ' LEU . . . -127.84 155.35 44.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.258 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.402 ' HD2' ' CH2' ' A' ' 404' ' ' TRP . 10.4 ptmt -149.7 150.2 31.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 111.5 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 59.87 26.34 15.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.735 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.911 HD11 ' CB ' ' A' ' 296' ' ' ALA . 87.5 mt -64.83 139.0 58.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.108 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -57.62 145.61 33.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.381 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.622 ' HG3' HD21 ' A' ' 335' ' ' LEU . 0.0 OUTLIER -94.94 127.77 41.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.405 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.509 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 14.7 mmt -97.78 -9.82 25.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.405 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 25.4 m-20 -108.52 119.17 38.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.718 0.294 . . . . 0.0 110.445 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.32 118.77 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.576 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 76.86 2.18 75.83 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.195 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' GLY . . . . . 0.407 ' O ' HD23 ' A' ' 307' ' ' LEU . . . -120.82 -123.26 3.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.932 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 333' ' ' ASN . 44.0 mt -137.32 -159.28 0.94 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.906 0.384 . . . . 0.0 110.071 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.506 ' HB3' ' HD3' ' A' ' 310' ' ' PRO . 0.2 OUTLIER -140.13 167.98 20.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.933 0.397 . . . . 0.0 110.255 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.08 64.43 52.8 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 308' ' ' SER . 60.7 Cg_endo -74.03 142.68 31.49 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.827 2.351 . . . . 0.0 114.697 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 43.1 p90 -144.25 158.52 43.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.212 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.838 HG22 HG22 ' A' ' 361' ' ' VAL . 44.2 t -107.82 149.91 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.409 0.623 . . . . 0.0 112.625 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.854 ' HE3' HD13 ' A' ' 362' ' ' LEU . 9.7 mtmt -132.85 136.94 46.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.517 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.576 HG23 HG13 ' A' ' 357' ' ' VAL . 5.4 mp -107.97 136.97 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.513 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 77.9 m80 -130.89 133.6 46.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.379 . . . . 0.0 111.131 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.474 HD21 HG22 ' A' ' 347' ' ' VAL . 35.0 tp -106.79 110.23 22.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.376 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.7 mtm -118.99 139.73 51.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.939 0.4 . . . . 0.0 111.378 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.551 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -99.63 99.44 10.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.411 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 13.8 m120 53.02 38.1 26.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.4 26.82 12.83 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.87 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.8 mptt -129.23 109.3 11.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.706 0.288 . . . . 0.0 110.779 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.501 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -52.14 130.0 29.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.52 -179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.551 HD11 ' CB ' ' A' ' 318' ' ' GLN . 11.5 mt -125.86 -55.04 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.973 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -130.62 150.71 51.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.319 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' LYS . . . . . 0.422 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -144.45 123.41 12.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.422 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 21.6 mmtt -125.19 170.79 10.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.407 ' HB3' ' HG2' ' A' ' 313' ' ' LYS . 0.5 OUTLIER -150.25 147.01 27.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.897 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.755 HG22 ' CE1' ' A' ' 343' ' ' PHE . 5.5 p -104.27 -178.71 3.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.758 0.313 . . . . 0.0 110.782 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 13.9 t -60.33 164.02 4.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.432 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.569 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.9 mt -108.11 116.87 52.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.973 0.416 . . . . 0.0 111.379 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.612 ' O ' HG22 ' A' ' 334' ' ' THR . 0.7 OUTLIER -78.81 85.93 4.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.034 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -53.51 136.45 38.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.167 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' ASN . . . . . 0.529 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.1 p-10 43.6 86.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.277 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.627 ' O ' HD23 ' A' ' 335' ' ' LEU . 5.0 t 177.31 173.16 0.5 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.52 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.627 HD23 ' O ' ' A' ' 334' ' ' THR . 2.8 mt -144.28 -15.29 0.58 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.357 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.434 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.0 OUTLIER -132.6 61.14 55.11 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-O 120.857 0.361 . . . . 0.0 110.039 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 52.0 Cg_endo -91.21 167.71 3.55 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.196 2.597 . . . . 0.0 114.028 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.476 ' CD1' ' HB3' ' A' ' 295' ' ' GLU . 20.7 t80 -110.76 154.09 24.41 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.748 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.553 ' HB2' HG22 ' A' ' 293' ' ' ILE . 75.8 m-85 -131.39 -68.93 0.64 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.855 0.36 . . . . 0.0 111.727 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' ASN . . . . . 0.421 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 0.1 OUTLIER 63.71 36.65 10.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.703 -179.4 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.551 ' O ' HG13 ' A' ' 292' ' ' VAL . 37.4 mt-10 -91.8 144.68 25.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.6 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 51.5 p -114.87 121.81 44.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.934 0.397 . . . . 0.0 111.656 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.755 ' CE1' HG22 ' A' ' 328' ' ' THR . 63.6 m-85 -113.75 151.84 31.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.163 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 87.9 p -125.97 138.89 53.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.155 0.502 . . . . 0.0 111.789 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.435 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 56.9 m-85 -125.42 166.05 17.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.585 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -113.27 78.21 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.913 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.89 HG13 ' HB3' ' A' ' 351' ' ' GLN . 48.6 t -110.6 122.12 39.25 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.82 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.525 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.4 Cg_endo -72.54 157.55 52.51 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.352 2.035 . . . . 0.0 111.657 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -51.46 -21.89 2.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.841 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.33 -8.54 53.04 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.89 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -109.86 -30.31 7.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.908 HD13 ' CD1' ' A' ' 282' ' ' TYR . 6.4 tp -47.4 -28.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.811 0.338 . . . . 0.0 111.026 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 353' ' ' GLN . . . . . 0.438 ' O ' ' CD2' ' A' ' 380' ' ' TYR . 2.9 mm-40 -95.0 -25.82 16.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.897 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -95.1 0.84 54.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.875 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 351' ' ' GLN . 17.2 m -113.18 161.11 12.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.833 0.349 . . . . 0.0 111.302 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -137.1 126.34 24.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.713 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 314' ' ' ILE . 91.6 t -87.08 107.43 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.402 . . . . 0.0 110.248 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.453 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.7 OUTLIER -93.36 113.68 28.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.592 -179.29 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.542 ' HB ' HG23 ' A' ' 376' ' ' VAL . 41.7 t -96.69 107.74 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.915 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.959 HG23 ' HB3' ' A' ' 375' ' ' LYS . 1.7 m -109.01 131.34 55.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.966 0.412 . . . . 0.0 111.774 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.838 HG22 HG22 ' A' ' 312' ' ' VAL . 50.5 t -106.16 114.95 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.946 178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.854 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.5 mp -118.3 150.54 39.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.025 0.44 . . . . 0.0 111.885 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.509 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.1 t70 -94.76 131.37 40.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.361 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.606 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 25.1 t80 -85.67 146.91 26.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.759 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 367' ' ' ILE . 75.1 m-20 -140.29 62.86 1.49 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.321 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.606 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 0.0 OUTLIER 29.09 -87.62 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 179.477 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 365' ' ' ASP . 46.2 mm -81.79 -71.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.745 0.307 . . . . 0.0 111.186 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -43.85 164.9 0.03 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.037 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.94 165.61 12.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.935 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.83 134.92 33.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.947 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' ASP . . . . . 0.429 ' HB2' ' HG3' ' A' ' 302' ' ' MET . 1.8 m-20 -85.8 151.3 23.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.035 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.604 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.07 111.34 23.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.974 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.793 ' O ' HD22 ' A' ' 273' ' ' LEU . 31.3 mt -80.97 -34.08 13.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.086 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' GLY . . . . . 0.455 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 167.29 -178.96 41.16 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.88 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.959 ' HB3' HG23 ' A' ' 360' ' ' THR . 14.7 ptmt -164.59 141.07 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.196 0.522 . . . . 0.0 111.792 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.95 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.78 158.99 13.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.189 179.516 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.541 ' CB ' HD21 ' A' ' 417' ' ' LEU . 2.8 p90 -141.04 144.77 35.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 0.0 111.266 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 378' ' ' VAL . 13.5 m -134.87 104.43 5.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.115 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 169.18 -161.18 34.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.369 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.438 ' CD2' ' O ' ' A' ' 353' ' ' GLN . 0.2 OUTLIER -48.64 170.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.531 0.205 . . . . 0.0 110.749 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 380' ' ' TYR . 2.4 m-80 67.44 -63.1 0.31 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.086 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' SER . . . . . 0.41 ' O ' HG23 ' A' ' 383' ' ' THR . 0.8 OUTLIER -45.75 165.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.888 0.375 . . . . 0.0 111.355 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 382' ' ' SER . 42.9 p -158.09 151.23 23.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.927 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 98.93 -143.92 16.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.658 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -57.47 -31.17 65.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.838 0.352 . . . . 0.0 111.307 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -68.09 -52.81 30.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.003 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 20.5 tp -66.13 -31.75 72.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.867 0.365 . . . . 0.0 110.387 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -65.12 -29.69 70.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.456 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.635 ' CD2' HD12 ' A' ' 280' ' ' LEU . 20.3 t-160 -77.99 -53.07 7.84 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.535 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 55.7 t-105 -51.36 -49.23 61.89 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.177 0.513 . . . . 0.0 109.993 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -29.32 69.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.696 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.469 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.5 OUTLIER -61.98 -42.54 99.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.672 178.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.747 ' CE ' HD11 ' A' ' 352' ' ' ILE . 27.9 ttp -59.53 -52.61 64.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.58 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.771 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.9 mt -60.87 -30.01 69.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.361 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.98 -33.02 75.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.218 0.532 . . . . 0.0 109.584 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -126.24 77.9 71.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.278 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.539 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 2.7 Cg_exo -75.79 44.37 1.27 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.238 2.625 . . . . 0.0 113.258 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 398' ' ' ARG . . . . . 0.539 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 0.4 OUTLIER -158.12 -46.52 0.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.231 179.675 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.428 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.3 OUTLIER -94.15 139.43 22.53 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.721 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 56.7 Cg_endo -70.48 156.16 62.05 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.548 2.165 . . . . 0.0 113.015 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.02 113.73 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.603 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.24 145.01 32.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.731 0.301 . . . . 0.0 110.801 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.95 154.39 11.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.912 0.386 . . . . 0.0 111.195 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' TRP . . . . . 0.402 ' CH2' ' HD2' ' A' ' 297' ' ' LYS . 64.0 m95 -81.6 120.52 25.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.95 ' HB3' HG11 ' A' ' 376' ' ' VAL . 49.1 m-70 -108.86 121.87 45.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.427 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.0 m -78.3 116.44 18.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.89 HD23 HG22 ' A' ' 376' ' ' VAL . 96.6 mt -62.45 128.1 34.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.004 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.441 ' C ' HD12 ' A' ' 273' ' ' LEU . 7.6 mt-30 -116.9 171.64 7.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.778 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.897 ' O ' HG23 ' A' ' 413' ' ' VAL . 43.5 t -56.57 120.81 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.604 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 19.0 mt-10 -53.73 -43.25 68.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.857 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -57.31 -49.52 75.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 0.0 110.602 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.448 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 30.7 mt-10 -64.55 -39.28 93.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 409' ' ' VAL . 74.8 t -58.57 -49.93 80.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.258 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -59.59 -38.32 80.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.2 84.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 51.6 mtm -67.08 -31.02 71.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.921 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.541 HD21 ' CB ' ' A' ' 377' ' ' PHE . 12.6 mt -78.53 -34.8 46.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -63.62 139.08 58.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.071 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.125 179.967 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.868 0.366 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.81 HD22 ' O ' ' A' ' 373' ' ' ILE . 42.5 mt -98.9 -38.88 8.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 125.17 -160.63 19.77 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.271 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.485 ' OD1' HG23 ' A' ' 406' ' ' THR . 11.9 m-20 -147.13 131.93 17.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.733 0.301 . . . . 0.0 110.75 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.796 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -119.97 132.2 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.144 0.497 . . . . 0.0 111.174 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.796 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -99.48 126.01 45.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.758 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.617 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.7 p90 -141.94 151.53 42.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.303 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.68 160.75 14.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.987 -178.451 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.674 HD12 ' CD2' ' A' ' 389' ' ' HIS . 98.2 mt -134.44 144.18 47.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.318 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -159.02 111.19 2.18 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.909 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' TYR . . . . . 0.923 ' CD1' HD13 ' A' ' 352' ' ' ILE . 25.1 t80 -104.45 138.85 40.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.977 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.04 94.29 47.37 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.544 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.5 Cg_exo -70.24 -33.86 14.01 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.916 2.411 . . . . 0.0 112.385 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -30.23 5.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.157 0.503 . . . . 0.0 110.019 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.72 -20.0 8.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.985 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.75 48.16 6.8 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.639 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.57 130.27 52.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.008 0.433 . . . . 0.0 111.703 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.967 HD11 ' HE1' ' A' ' 393' ' ' MET . 28.7 tp -97.82 147.53 24.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.868 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 343' ' ' PHE . 12.2 m -138.82 136.67 35.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.272 0.558 . . . . 0.0 112.002 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.411 HG21 HG11 ' A' ' 357' ' ' VAL . 11.9 t -129.15 125.36 62.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.372 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 341' ' ' GLU . 24.5 t -119.2 115.34 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.965 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.715 HG13 HG21 ' A' ' 328' ' ' THR . 34.3 mm -74.69 137.02 23.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.463 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.6 OUTLIER -114.22 -62.22 1.63 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.759 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.456 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 1.9 pt-20 -175.02 150.27 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.568 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.756 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -109.5 154.65 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.931 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.92 152.42 33.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.045 0.45 . . . . 0.0 111.552 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 61.29 24.19 14.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.853 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.756 HD21 ' HB1' ' A' ' 296' ' ' ALA . 66.5 mt -59.14 141.23 54.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.109 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.524 ' HD2' ' HE2' ' A' ' 302' ' ' MET . 3.5 ttmt -63.69 146.4 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.424 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.611 ' HE3' HD11 ' A' ' 335' ' ' LEU . 17.8 mttt -84.91 116.99 23.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.522 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' MET . . . . . 0.524 ' HE2' ' HD2' ' A' ' 300' ' ' LYS . 10.5 mmt -93.46 -18.89 21.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.488 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 35.7 m-20 -103.98 102.65 12.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.852 0.358 . . . . 0.0 110.573 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.14 116.46 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.445 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 83.98 -4.34 83.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.811 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.53 -149.1 7.23 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.881 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 60.3 mt -107.49 -159.97 0.71 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.01 0.433 . . . . 0.0 110.79 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.624 ' HB2' HD23 ' A' ' 335' ' ' LEU . 73.4 m -132.9 172.22 12.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.252 0.549 . . . . 0.0 110.725 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.92 57.58 32.71 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.673 ' CG ' HD13 ' A' ' 299' ' ' LEU . 74.2 Cg_endo -76.23 143.42 25.29 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.02 2.48 . . . . 0.0 114.901 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.619 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 8.5 p90 -140.48 168.12 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.124 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.858 HG22 HG22 ' A' ' 361' ' ' VAL . 42.5 t -116.36 149.96 18.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.371 0.605 . . . . 0.0 112.508 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.665 ' HE3' HD13 ' A' ' 362' ' ' LEU . 9.2 mttm -131.0 152.76 49.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.383 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.56 HG23 HG13 ' A' ' 357' ' ' VAL . 5.3 mp -123.18 135.09 64.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.763 0.316 . . . . 0.0 110.579 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 79.9 m80 -130.98 132.54 45.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.35 . . . . 0.0 110.994 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.3 tp -105.79 106.67 17.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.407 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.8 mtm -111.58 126.78 55.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.131 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.961 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.4 OUTLIER -95.77 99.56 11.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.477 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 59.91 37.76 21.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.706 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.09 21.43 49.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.675 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -121.65 109.65 15.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.745 0.307 . . . . 0.0 110.806 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 10.8 ptt85 -51.25 128.07 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.351 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.961 HD11 ' CB ' ' A' ' 318' ' ' GLN . 9.3 mt -123.6 -49.53 1.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -135.03 147.92 49.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' LYS . . . . . 0.42 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.4 OUTLIER -144.09 120.56 11.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.584 179.616 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -125.5 166.43 16.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.231 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -142.87 149.92 39.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.793 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.715 HG21 HG13 ' A' ' 293' ' ' ILE . 20.7 p -104.75 176.52 5.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.029 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.2 p -59.6 162.43 5.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.577 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.619 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.2 mt -105.84 123.88 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 111.434 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.619 ' O ' HG22 ' A' ' 334' ' ' THR . 9.7 mmtm -89.16 88.17 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.049 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -55.1 136.3 48.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.987 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' ASN . . . . . 0.409 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.3 p-10 43.91 87.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.311 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.772 ' O ' HD23 ' A' ' 335' ' ' LEU . 3.9 t -179.11 174.55 1.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.518 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.772 HD23 ' O ' ' A' ' 334' ' ' THR . 4.7 mt -145.96 -16.91 0.46 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.203 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' ASN . . . . . 0.467 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.5 m-80 -133.46 57.77 28.85 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.774 0.321 . . . . 0.0 110.283 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 53.3 Cg_endo -90.16 167.76 4.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.204 2.602 . . . . 0.0 113.738 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 338' ' ' TYR . . . . . 0.463 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.5 OUTLIER -110.15 159.07 17.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.305 179.549 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 339' ' ' TYR . . . . . 0.612 ' HB2' HG22 ' A' ' 293' ' ' ILE . 6.1 m-85 -134.25 -62.29 0.76 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.31 38.65 23.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.669 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.557 ' O ' HG13 ' A' ' 292' ' ' VAL . 32.1 mt-10 -91.91 143.2 26.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.77 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 4.2 m -114.03 119.51 37.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 111.656 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' PHE . . . . . 0.708 ' CE1' HG22 ' A' ' 328' ' ' THR . 78.3 m-85 -111.02 153.77 25.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.248 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 73.5 m -128.38 142.29 51.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.012 0.434 . . . . 0.0 111.408 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -130.85 165.87 22.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -114.02 76.22 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.675 HG13 ' HB3' ' A' ' 351' ' ' GLN . 48.2 t -109.04 125.27 31.93 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.017 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.537 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 73.9 Cg_endo -76.67 155.42 35.35 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.499 2.132 . . . . 0.0 111.678 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -50.95 -23.13 2.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.839 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.23 -8.6 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' GLN . . . . . 0.675 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -112.69 -31.69 6.67 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.696 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.923 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.0 tp -47.98 -27.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 111.134 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -92.14 -20.69 20.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.616 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -99.92 -21.32 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.679 0.276 . . . . 0.0 111.638 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.92 167.88 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.919 0.39 . . . . 0.0 111.222 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' GLN . . . . . 0.639 ' OE1' HD23 ' A' ' 417' ' ' LEU . 8.8 pt20 -148.59 126.95 12.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.028 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.584 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 47.7 t -86.9 114.19 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.637 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.636 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.2 OUTLIER -97.63 109.68 23.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.205 -179.514 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.526 ' HB ' HG23 ' A' ' 376' ' ' VAL . 26.8 t -93.48 107.76 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.979 HG23 ' HB3' ' A' ' 375' ' ' LYS . 11.0 m -109.33 141.08 42.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.91 0.386 . . . . 0.0 111.575 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.858 HG22 HG22 ' A' ' 312' ' ' VAL . 41.8 t -115.46 120.2 64.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.072 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.665 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.5 mp -124.62 147.21 48.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.058 0.456 . . . . 0.0 111.679 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.522 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.9 OUTLIER -91.96 134.47 34.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.328 179.552 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 365' ' ' ASP . 7.0 t80 -90.83 141.73 28.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.0 110.831 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.463 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 14.0 m-20 -126.16 117.13 22.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.89 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.663 ' CG ' HD12 ' A' ' 367' ' ' ILE . 0.0 OUTLIER -34.24 -54.08 0.5 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.955 -179.215 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.663 HD12 ' CG ' ' A' ' 366' ' ' LYS . 5.2 mp -100.82 -73.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.364 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -50.79 165.79 0.65 Allowed Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.887 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -68.29 165.68 18.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 110.963 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.21 138.42 47.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.81 149.39 21.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.52 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.3 110.99 23.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.12 0.486 . . . . 0.0 110.977 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.81 ' O ' HD22 ' A' ' 273' ' ' LEU . 43.6 mt -83.44 -34.54 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.192 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.57 175.02 37.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.037 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.979 ' HB3' HG23 ' A' ' 360' ' ' THR . 11.6 ptmt -160.47 140.96 11.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.217 0.532 . . . . 0.0 111.779 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.943 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -111.61 159.21 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.472 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.636 ' HB3' HG13 ' A' ' 358' ' ' VAL . 20.8 p90 -143.1 131.98 22.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.985 0.422 . . . . 0.0 111.133 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 378' ' ' VAL . 19.6 m -126.55 100.77 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.045 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.518 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 165.13 -155.0 26.12 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.27 -0.967 . . . . 0.0 113.122 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.27 158.06 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.848 0.356 . . . . 0.0 111.233 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.5 t30 56.18 29.99 15.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.236 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 7.2 m -124.96 160.91 27.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.83 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 32.4 p -153.86 148.29 26.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.725 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 96.73 -156.0 20.94 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.477 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.4 ' HA ' ' HG3' ' A' ' 388' ' ' ARG . . . -48.34 -32.13 7.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -63.96 -51.14 65.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.173 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 42.0 tp -59.38 -33.95 71.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 0.0 110.582 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 384' ' ' GLY . 23.6 mtm180 -61.46 -49.34 77.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.343 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.674 ' CD2' HD12 ' A' ' 280' ' ' LEU . 14.8 t-160 -60.76 -57.93 10.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.792 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' TRP . . . . . 0.584 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 58.0 t-105 -49.52 -44.29 46.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.05 0.452 . . . . 0.0 110.004 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 4.7 t -68.57 -36.81 79.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.803 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.437 ' HB3' HD12 ' A' ' 401' ' ' ILE . 1.9 t0 -63.08 -36.22 82.85 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.967 ' HE1' HD11 ' A' ' 289' ' ' LEU . 10.2 ttm -61.84 -55.09 33.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.189 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.752 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.1 mt -60.85 -33.26 72.79 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.331 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.37 -29.81 70.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.276 0.56 . . . . 0.0 109.84 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -114.97 71.68 2.73 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.596 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.544 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 50.4 Cg_endo -70.47 33.88 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.186 2.59 . . . . 0.0 113.616 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' ARG . . . . . 0.518 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 23.7 mmm-85 -159.51 -44.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.922 0.391 . . . . 0.0 110.972 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.4 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 1.7 tpp180 -93.96 140.48 22.96 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.455 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 57.0 Cg_endo -70.43 156.47 61.53 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.742 2.295 . . . . 0.0 112.751 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -128.15 113.45 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.818 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.27 144.46 32.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 110.82 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.67 153.71 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.963 0.411 . . . . 0.0 111.235 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 404' ' ' TRP . . . . . 0.413 ' CZ3' ' HB2' ' A' ' 277' ' ' CYS . 55.8 m95 -83.02 120.01 25.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.943 ' HB3' HG11 ' A' ' 376' ' ' VAL . 45.4 m-70 -108.21 120.82 43.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.576 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.485 HG23 ' OD1' ' A' ' 275' ' ' ASP . 89.2 m -78.36 116.21 18.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.024 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.879 HD23 HG22 ' A' ' 376' ' ' VAL . 84.8 mt -62.47 128.2 34.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.288 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -114.82 170.9 7.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.512 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 413' ' ' VAL . 47.0 t -52.71 115.77 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.52 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 4.1 mp0 -54.77 -43.07 72.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.79 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -55.35 -47.55 75.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.802 0.334 . . . . 0.0 110.537 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.441 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 35.2 mt-10 -64.24 -48.71 74.74 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 409' ' ' VAL . 92.0 t -48.86 -45.41 15.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.771 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -52.99 -38.28 62.11 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.837 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -69.22 -44.28 72.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.749 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' MET . . . . . 0.574 ' HE2' ' HA ' ' A' ' 413' ' ' VAL . 2.5 mpp? -56.96 -31.44 65.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.644 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.639 HD23 ' OE1' ' A' ' 356' ' ' GLN . 2.6 mt -89.84 -33.52 16.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.915 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -56.19 137.67 51.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.262 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.226 -0.893 . . . . 0.0 111.087 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 373' ' ' ILE . 34.8 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.879 0.371 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.92 -162.71 16.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.266 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -144.01 135.41 25.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.77 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.875 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -124.46 128.95 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.097 0.475 . . . . 0.0 110.914 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.875 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -98.03 127.15 43.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.717 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.615 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.5 p90 -141.85 150.26 41.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.012 0.434 . . . . 0.0 110.341 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.62 161.67 13.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.018 -178.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.746 HD12 ' CD2' ' A' ' 389' ' ' HIS . 94.8 mt -133.57 143.9 48.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.15 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.94 106.82 1.84 Allowed 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.972 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.918 ' CD1' HD13 ' A' ' 352' ' ' ILE . 25.7 t80 -100.68 137.44 39.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.986 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.61 94.76 48.38 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.547 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 8.1 Cg_exo -69.89 -33.9 15.21 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.937 2.425 . . . . 0.0 112.425 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.51 -30.19 4.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.196 0.522 . . . . 0.0 110.042 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.44 -20.29 8.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.967 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.31 48.65 6.7 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.542 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -124.58 129.8 51.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 0.0 111.792 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.791 HD11 ' HE1' ' A' ' 393' ' ' MET . 33.2 tp -95.42 147.6 23.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.805 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 7.4 m -138.48 134.52 34.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.385 0.612 . . . . 0.0 111.936 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 8.7 t -127.24 123.13 61.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.206 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 341' ' ' GLU . 22.1 t -117.24 114.95 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.912 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.688 HG13 HG21 ' A' ' 328' ' ' THR . 35.9 mm -74.59 136.95 24.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.424 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.02 -60.9 1.82 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.44 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 0.9 OUTLIER -175.61 157.42 2.05 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.488 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.833 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -117.12 151.73 36.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.773 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -148.08 153.54 39.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.612 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 60.98 23.98 14.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.872 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.833 HD21 ' HB1' ' A' ' 296' ' ' ALA . 50.3 mt -58.92 138.79 57.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.07 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.04 146.9 53.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.504 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.43 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 16.0 mttt -85.41 114.39 22.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.581 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.458 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 9.9 mmm -92.93 -18.81 22.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.729 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 46.7 m-20 -96.17 118.35 32.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.844 0.355 . . . . 0.0 110.635 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.15 116.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.426 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 60.05 16.57 41.14 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.334 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.59 -157.08 9.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.8 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 16.5 mt -100.82 -160.38 0.79 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 110.492 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.542 ' HB2' HD23 ' A' ' 335' ' ' LEU . 15.2 m -135.07 172.03 13.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.239 0.542 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.419 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 8.9 m-20 -133.69 56.36 19.89 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.738 ' CG ' HD13 ' A' ' 299' ' ' LEU . 64.6 Cg_endo -75.39 141.71 25.86 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.044 2.496 . . . . 0.0 114.75 -177.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.568 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 17.1 p90 -139.85 165.31 27.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.424 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.849 HG22 HG22 ' A' ' 361' ' ' VAL . 42.4 t -112.81 149.98 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.822 ' HE2' HD13 ' A' ' 362' ' ' LEU . 6.6 mttm -132.02 151.92 51.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.197 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.469 HG23 HG13 ' A' ' 357' ' ' VAL . 5.2 mp -125.51 133.96 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.763 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.44 125.69 37.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.815 0.34 . . . . 0.0 111.181 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.499 HD23 ' HG3' ' A' ' 324' ' ' LYS . 27.5 tp -96.01 106.68 18.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.312 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.4 mtm -112.68 145.6 40.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 111.467 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.729 ' CG ' HD11 ' A' ' 323' ' ' LEU . 0.9 OUTLIER -99.44 99.73 10.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.066 179.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 10.9 p30 42.83 37.45 1.08 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.386 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 104.46 28.85 5.59 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.982 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 317' ' ' MET . 0.2 OUTLIER -136.99 109.38 7.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.725 0.298 . . . . 0.0 110.885 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.407 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.1 OUTLIER -54.13 130.84 39.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.729 HD11 ' CG ' ' A' ' 318' ' ' GLN . 7.6 mt -125.0 -51.66 1.67 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.202 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.499 ' HG3' HD23 ' A' ' 316' ' ' LEU . 2.2 mttt -130.62 153.42 48.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.037 0.446 . . . . 0.0 111.516 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.11 130.5 33.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.431 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.447 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 44.6 mmtt -135.44 160.38 38.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.96 0.409 . . . . 0.0 111.314 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 0.0 OUTLIER -148.68 143.52 26.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.796 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.739 HG22 ' CE1' ' A' ' 343' ' ' PHE . 14.5 p -101.22 176.63 5.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.95 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 10.1 t -56.96 169.88 0.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.504 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.568 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.3 mt -112.39 120.59 62.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.948 0.404 . . . . 0.0 111.465 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.662 ' O ' HG22 ' A' ' 334' ' ' THR . 3.7 mmpt? -82.74 84.59 7.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.762 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.23 135.45 44.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.082 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.3 83.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.39 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.695 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.8 t -176.86 174.08 1.82 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.748 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 334' ' ' THR . 4.3 mt -145.06 -16.33 0.51 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.322 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.49 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 4.9 m-80 -132.9 55.63 18.19 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.863 0.364 . . . . 0.0 110.213 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 51.4 Cg_endo -88.64 167.64 6.02 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.137 2.558 . . . . 0.0 113.636 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.44 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -110.9 160.02 17.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.3 179.181 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.626 ' HB2' HG22 ' A' ' 293' ' ' ILE . 86.6 m-85 -133.45 -63.63 0.75 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 111.325 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 58.36 37.55 25.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.753 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.545 ' O ' HG13 ' A' ' 292' ' ' VAL . 41.9 mt-10 -91.39 142.99 27.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.808 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.94 120.08 40.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.416 . . . . 0.0 111.566 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.739 ' CE1' HG22 ' A' ' 328' ' ' THR . 52.2 m-85 -112.58 146.74 38.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.208 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 18.1 p -118.97 142.2 47.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 0.0 111.457 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.447 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 40.0 m-85 -129.63 165.83 20.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.517 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -116.57 79.81 1.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.512 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.656 HG11 ' HA ' ' A' ' 352' ' ' ILE . 24.7 t -110.11 122.74 37.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.438 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 24.4 Cg_exo -62.19 147.92 94.15 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.51 2.14 . . . . 0.0 111.464 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -53.95 -24.02 15.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 111.336 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -91.64 -8.66 46.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.564 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.431 ' CB ' ' HD2' ' A' ' 348' ' ' PRO . 1.1 tt0 -106.52 -25.54 11.8 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.918 HD13 ' CD1' ' A' ' 282' ' ' TYR . 2.1 tp -48.68 -27.68 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 110.66 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . 0.458 HE21 HD22 ' A' ' 394' ' ' LEU . 20.2 mt-30 -90.57 -23.08 20.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.107 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -95.58 -4.83 43.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 31.3 m -106.61 167.77 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.881 0.372 . . . . 0.0 111.306 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -144.49 126.49 15.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.039 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.639 ' O ' HG22 ' A' ' 378' ' ' VAL . 66.8 t -90.83 115.64 30.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.268 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.3 OUTLIER -101.29 116.83 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.755 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.549 ' HB ' HG23 ' A' ' 376' ' ' VAL . 48.3 t -97.33 108.06 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.939 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.96 HG23 ' HB3' ' A' ' 375' ' ' LYS . 6.5 m -110.68 133.81 53.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.027 0.442 . . . . 0.0 111.801 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.849 HG22 HG22 ' A' ' 312' ' ' VAL . 42.9 t -107.57 119.8 57.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.13 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.822 HD13 ' HE2' ' A' ' 313' ' ' LYS . 3.5 mp -121.46 148.0 45.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.978 0.418 . . . . 0.0 111.741 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.458 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 4.1 t70 -92.8 131.97 37.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.358 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -87.97 146.95 25.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.66 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.462 -179.507 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.917 0.389 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.17 151.02 44.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.431 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.836 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -95.89 109.8 22.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 0.0 111.352 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.466 ' O ' HD22 ' A' ' 273' ' ' LEU . 0.9 OUTLIER -73.34 -35.25 45.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.78 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 156.13 179.05 30.88 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.059 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.96 ' HB3' HG23 ' A' ' 360' ' ' THR . 0.0 OUTLIER -160.23 142.32 12.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.363 0.601 . . . . 0.0 112.029 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.913 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -109.22 158.67 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.879 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.591 ' HB3' HG13 ' A' ' 358' ' ' VAL . 19.7 p90 -141.41 141.96 33.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.059 0.457 . . . . 0.0 111.721 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 357' ' ' VAL . 17.1 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.791 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.754 0.311 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.47 -34.62 78.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.569 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 4.5 ptm180 -64.18 -35.78 81.89 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.269 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.746 ' CD2' HD12 ' A' ' 280' ' ' LEU . 18.8 t-160 -67.43 -53.56 28.03 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.163 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.537 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 68.2 t-105 -54.99 -40.62 70.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.017 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -42.13 76.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.989 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 7.7 t0 -59.86 -34.31 72.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.638 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.791 ' HE1' HD11 ' A' ' 289' ' ' LEU . 8.4 ttm -60.36 -56.65 18.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.405 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.768 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.0 OUTLIER -58.82 -29.96 67.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.472 178.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.55 -31.49 70.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.188 0.518 . . . . 0.0 109.942 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -114.29 70.79 2.09 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.639 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.55 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 43.4 Cg_endo -69.08 35.37 0.19 Allowed 'Trans proline' 0 N--CA 1.474 0.364 0 C-N-CA 123.291 2.661 . . . . 0.0 113.642 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . 0.55 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 19.8 mmt85 -159.95 -44.35 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.955 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.91 142.17 24.68 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.57 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 58.3 Cg_endo -71.18 156.38 59.48 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.661 2.241 . . . . 0.0 112.953 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -127.74 110.26 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.664 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -103.73 144.36 31.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.844 0.354 . . . . 0.0 110.833 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.25 153.21 11.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.29 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -81.95 120.72 25.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.736 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.913 ' HB3' HG11 ' A' ' 376' ' ' VAL . 60.5 m-70 -111.28 118.37 35.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 85.0 m -78.24 116.7 18.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.946 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.791 HD23 HG22 ' A' ' 376' ' ' VAL . 95.9 mt -61.59 127.35 31.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.313 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -113.42 167.17 10.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.54 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 413' ' ' VAL . 90.5 t -52.58 117.85 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.836 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 8.6 mt-10 -50.48 -45.79 56.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.153 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -55.34 -45.96 76.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 0.0 110.947 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.499 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 16.5 mt-10 -66.71 -38.58 87.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 409' ' ' VAL . 73.4 t -58.39 -48.15 85.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.255 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.537 179.713 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 373' ' ' ILE . 63.8 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.914 0.388 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 118.2 -166.08 12.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.231 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . 0.533 ' OD1' HG23 ' A' ' 406' ' ' THR . 12.3 m-20 -142.86 132.53 23.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.776 0.322 . . . . 0.0 110.63 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.846 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -120.17 130.75 73.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.163 0.506 . . . . 0.0 111.03 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.846 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.84 124.7 42.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.732 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.659 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 19.1 p90 -141.96 148.22 38.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.436 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 292' ' ' VAL . 0.0 OUTLIER -101.04 160.9 13.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.175 -178.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.609 HD12 ' CD2' ' A' ' 389' ' ' HIS . 9.2 mt -133.66 150.25 51.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.03 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -158.81 112.14 2.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.243 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.92 ' CD1' HD13 ' A' ' 352' ' ' ILE . 32.7 t80 -106.14 131.66 53.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.766 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.46 98.04 50.94 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.501 ' CG ' ' CB ' ' A' ' 397' ' ' PRO . 6.4 Cg_exo -71.06 -33.26 12.02 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.673 2.249 . . . . 0.0 112.67 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.2 -29.76 6.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.181 0.515 . . . . 0.0 110.058 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.81 -21.67 8.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.957 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.81 48.78 6.41 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.747 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -124.98 130.05 51.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.994 0.426 . . . . 0.0 111.68 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.469 HD21 ' CG2' ' A' ' 357' ' ' VAL . 30.5 tp -93.79 147.89 22.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.092 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.9 m -135.16 140.66 45.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.305 0.574 . . . . 0.0 112.022 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 18.2 t -134.01 120.91 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.357 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 341' ' ' GLU . 32.3 t -116.19 116.3 51.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.012 0.434 . . . . 0.0 112.057 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.683 HG22 ' HB2' ' A' ' 339' ' ' TYR . 40.1 mm -74.96 135.69 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.649 HD22 ' OE1' ' A' ' 295' ' ' GLU . 0.7 OUTLIER -113.47 -61.89 1.67 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.649 ' OE1' HD22 ' A' ' 294' ' ' LEU . 11.1 pm0 -174.16 148.16 1.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.512 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.808 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -108.38 153.63 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.006 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.84 152.49 33.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.077 0.465 . . . . 0.0 111.488 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 61.02 24.75 14.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.808 HD21 ' HB1' ' A' ' 296' ' ' ALA . 60.3 mt -59.66 139.01 57.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.222 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.68 143.77 53.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.404 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.427 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 15.9 mttp -84.61 115.18 22.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.601 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.52 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.6 mmt -90.74 -20.0 22.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.408 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 41.9 m-20 -99.81 123.79 44.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.876 0.369 . . . . 0.0 110.709 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 48.8 t -60.56 118.83 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.215 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 64.0 13.51 53.04 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.718 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.89 -144.46 6.19 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.694 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' A' ' 333' ' ' ASN . 19.9 mt -115.46 -159.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.848 0.356 . . . . 0.0 110.511 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 334' ' ' THR . 5.6 m -138.26 172.01 13.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.314 0.578 . . . . 0.0 110.92 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.96 71.5 77.9 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.616 ' CG ' HD13 ' A' ' 299' ' ' LEU . 95.3 Cg_endo -87.73 143.27 6.07 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.526 2.151 . . . . 0.0 115.351 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.581 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 9.8 p90 -139.49 167.65 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.039 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.802 HG22 HG22 ' A' ' 361' ' ' VAL . 42.7 t -118.0 149.56 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.386 0.612 . . . . 0.0 112.504 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.827 ' HE3' HD13 ' A' ' 362' ' ' LEU . 13.8 mttt -131.09 146.97 52.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.292 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.475 ' N ' HD12 ' A' ' 314' ' ' ILE . 4.6 mp -122.6 131.87 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.622 0.248 . . . . 0.0 111.089 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -130.17 134.89 47.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.93 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 347' ' ' VAL . 26.7 tp -104.14 107.17 17.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.612 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.74 126.67 52.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.904 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.4 OUTLIER -95.16 99.8 11.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 60.15 37.92 20.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.727 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.03 22.35 45.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.78 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt -123.85 109.56 13.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.452 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -54.19 130.7 39.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.904 HD11 ' CB ' ' A' ' 318' ' ' GLN . 6.9 mt -126.71 -42.21 1.79 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.234 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -130.6 147.69 52.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.212 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 115.61 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.954 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -124.09 166.51 15.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.48 149.51 30.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.07 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.662 HG21 HG13 ' A' ' 293' ' ' ILE . 21.2 p -106.11 174.05 6.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.736 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.76 174.07 0.37 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.43 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.581 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.7 mt -119.87 118.96 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.051 0.453 . . . . 0.0 111.688 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.732 ' HB3' HG21 ' A' ' 334' ' ' THR . 0.0 OUTLIER -82.57 91.19 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.249 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -56.88 137.21 55.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.885 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . 0.51 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.0 OUTLIER 46.85 83.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.592 179.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.749 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.5 t -177.2 174.05 1.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.486 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.749 HD23 ' O ' ' A' ' 334' ' ' THR . 4.0 mt -146.17 -16.22 0.45 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.401 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.478 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.9 m-80 -133.97 57.18 22.97 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.486 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 59.2 Cg_endo -90.41 167.74 4.23 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.095 2.53 . . . . 0.0 113.662 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.411 ' CZ ' ' OE1' ' A' ' 295' ' ' GLU . 1.3 t80 -105.26 160.68 14.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.201 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.683 ' HB2' HG22 ' A' ' 293' ' ' ILE . 9.3 m-85 -131.72 -65.38 0.76 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.963 0.411 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 59.11 36.85 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.946 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.559 ' O ' HG13 ' A' ' 292' ' ' VAL . 41.8 mt-10 -93.92 144.79 25.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.78 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 98.5 p -116.56 123.07 46.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 0.0 111.375 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.61 ' CE1' HG22 ' A' ' 328' ' ' THR . 66.0 m-85 -116.35 150.61 37.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.192 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 41.8 p -121.53 143.16 49.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.119 0.485 . . . . 0.0 111.462 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -129.58 164.95 22.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.572 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.71 80.32 1.36 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.637 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 351' ' ' GLN . 71.0 t -113.09 123.77 32.88 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.117 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 351' ' ' GLN . 56.1 Cg_endo -70.69 153.4 64.66 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.491 2.127 . . . . 0.0 111.523 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -51.21 -24.14 4.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.489 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -85.42 -8.6 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.823 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.753 ' O ' HG22 ' A' ' 355' ' ' VAL . 24.5 mt-30 -107.21 -36.79 6.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.653 0.264 . . . . 0.0 111.62 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.92 HD13 ' CD1' ' A' ' 282' ' ' TYR . 6.1 tp -46.45 -27.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.846 0.355 . . . . 0.0 111.118 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . 0.434 HE21 HD22 ' A' ' 394' ' ' LEU . 1.7 mt-30 -90.77 -27.79 18.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.678 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 351' ' ' GLN . 14.9 ptmt -109.95 15.67 22.44 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 351' ' ' GLN . 31.1 m -116.09 167.91 8.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.766 0.317 . . . . 0.0 110.64 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . 0.408 ' HG3' ' C ' ' A' ' 355' ' ' VAL . 3.0 mt-30 -140.11 138.65 35.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.0 0.429 . . . . 0.0 111.447 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.511 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 91.9 t -104.39 106.96 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.903 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.506 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.3 OUTLIER -91.01 114.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.98 0.419 . . . . 0.0 112.033 -178.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.533 ' HB ' HG23 ' A' ' 376' ' ' VAL . 43.9 t -98.73 108.08 21.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.637 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.969 HG23 ' HB3' ' A' ' 375' ' ' LYS . 3.5 m -109.27 136.11 49.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 0.0 111.995 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.802 HG22 HG22 ' A' ' 312' ' ' VAL . 47.2 t -111.1 120.25 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.913 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.827 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.6 mp -122.45 150.22 42.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.032 0.444 . . . . 0.0 111.718 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.52 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.9 t70 -96.4 131.26 43.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.586 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.478 ' HB2' HG21 ' A' ' 330' ' ' ILE . 27.3 t80 -83.96 146.82 27.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.535 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.323 -179.526 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 CA-C-O 120.945 0.403 . . . . 0.0 110.811 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.78 139.94 30.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.54 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -86.91 110.87 20.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.111 0.481 . . . . 0.0 110.899 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.806 ' O ' HD22 ' A' ' 273' ' ' LEU . 33.4 mt -80.34 -34.64 14.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.073 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.22 178.92 39.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.303 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.969 ' HB3' HG23 ' A' ' 360' ' ' THR . 17.2 ptmt -162.75 141.27 8.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.179 0.514 . . . . 0.0 111.604 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.848 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.24 158.77 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.103 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.505 ' HB3' HG13 ' A' ' 358' ' ' VAL . 13.3 p90 -141.77 145.2 34.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.801 0.334 . . . . 0.0 111.039 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 378' ' ' VAL . 20.4 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.166 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.756 0.313 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 48.6 tp -57.56 -36.62 71.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.625 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 5.1 mtp85 -60.6 -46.75 89.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.384 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.609 ' CD2' HD12 ' A' ' 280' ' ' LEU . 18.6 t-160 -61.76 -56.22 21.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.511 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 63.5 t-105 -50.91 -49.64 59.17 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.153 0.501 . . . . 0.0 109.723 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.9 t -65.03 -30.39 71.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.606 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.455 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.6 OUTLIER -62.36 -42.32 99.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.968 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.42 ' CE ' ' CZ3' ' A' ' 390' ' ' TRP . 22.3 ttp -58.66 -55.58 33.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.68 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.807 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.8 mt -59.21 -24.63 63.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.567 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 392' ' ' ASP . . . -67.65 -34.95 77.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -126.96 74.03 76.48 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.466 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.501 ' CB ' ' CG ' ' A' ' 284' ' ' PRO . 8.4 Cg_exo -72.38 50.4 1.59 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.997 2.465 . . . . 0.0 113.032 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . 0.485 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 4.5 mmm180 -158.37 -45.69 0.06 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.178 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -94.27 158.48 35.79 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.353 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 90.5 Cg_endo -87.56 138.71 4.63 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.012 2.475 . . . . 0.0 112.815 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.461 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.1 mm -112.14 120.16 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.587 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -112.07 145.23 40.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.758 0.313 . . . . 0.0 110.938 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -163.04 155.26 18.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 0.0 111.349 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -83.13 116.38 22.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.697 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.848 ' HB3' HG11 ' A' ' 376' ' ' VAL . 29.3 m-70 -103.81 120.75 41.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.78 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.533 HG23 ' OD1' ' A' ' 275' ' ' ASP . 86.9 m -78.18 116.44 18.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.226 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.73 HD23 HG22 ' A' ' 376' ' ' VAL . 67.3 mt -61.64 127.44 31.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.218 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -114.16 168.82 9.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.878 ' O ' HG23 ' A' ' 413' ' ' VAL . 61.2 t -55.73 119.93 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.54 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 19.4 mt-10 -53.52 -42.34 67.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.756 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.58 -50.06 74.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.332 . . . . 0.0 110.613 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.462 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.1 mt-10 -64.52 -38.27 90.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 409' ' ' VAL . 81.0 t -59.06 -49.96 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.351 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.926 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.789 HD22 ' O ' ' A' ' 373' ' ' ILE . 68.6 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.983 0.421 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.09 -165.63 13.61 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.036 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . 0.549 ' OD1' HG23 ' A' ' 406' ' ' THR . 14.6 m-20 -141.94 136.95 30.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.332 . . . . 0.0 110.827 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.893 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -124.11 130.22 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.139 0.495 . . . . 0.0 110.919 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.893 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.2 126.23 42.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.76 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.622 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.7 p90 -142.08 151.19 42.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.331 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.1 OUTLIER -99.67 162.25 13.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.027 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.603 HD12 ' CD2' ' A' ' 389' ' ' HIS . 94.4 mt -134.74 144.15 47.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.085 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.4 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 9.7 ttm180 -159.13 106.55 1.79 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.966 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.896 ' CD1' HD13 ' A' ' 352' ' ' ILE . 28.9 t80 -101.22 137.21 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.845 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 44.9 t -122.31 97.79 44.79 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.524 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.53 -32.62 9.59 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.687 2.258 . . . . 0.0 112.612 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.04 -30.12 5.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.193 0.521 . . . . 0.0 109.919 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.52 -18.95 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.909 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 77.48 48.59 7.95 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.692 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -123.79 130.14 52.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 111.745 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.799 HD11 ' HE1' ' A' ' 393' ' ' MET . 34.8 tp -96.09 147.63 23.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.924 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 343' ' ' PHE . 4.9 m -136.35 138.42 41.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.356 0.598 . . . . 0.0 112.045 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.486 HG21 HG11 ' A' ' 357' ' ' VAL . 17.1 t -131.95 120.97 45.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.312 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 341' ' ' GLU . 30.5 t -116.97 115.56 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.08 0.467 . . . . 0.0 111.938 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.832 HG22 ' HB2' ' A' ' 339' ' ' TYR . 37.0 mm -74.17 136.98 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 277' ' ' CYS . 0.3 OUTLIER -112.44 -61.48 1.72 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.028 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.443 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 0.3 OUTLIER -175.71 151.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.24 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.74 ' HB3' HD11 ' A' ' 299' ' ' LEU . . . -112.48 152.66 28.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.849 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.426 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 7.8 pttt -149.07 152.64 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.478 . . . . 0.0 111.458 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 60.04 27.09 16.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.565 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' ' 296' ' ' ALA . 87.1 mt -63.97 139.21 58.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.951 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -60.59 149.61 34.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.514 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.403 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 8.4 mttp -90.03 119.32 30.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.573 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.508 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.7 mmt -92.26 -17.24 25.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.402 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 54.4 m-20 -99.66 115.77 30.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.849 0.357 . . . . 0.0 110.601 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.58 116.06 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.445 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.09 47.27 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.45 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.6 -156.89 9.35 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.704 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 307' ' ' LEU . 7.9 mt -101.43 -161.05 0.83 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.837 0.351 . . . . 0.0 110.789 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.614 ' HB2' HD23 ' A' ' 335' ' ' LEU . 66.6 m -139.51 172.19 13.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.302 0.573 . . . . 0.0 111.11 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.411 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -129.73 57.49 31.02 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.455 ' CB ' HD13 ' A' ' 299' ' ' LEU . 37.5 Cg_endo -68.29 150.82 76.65 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.146 2.564 . . . . 0.0 114.688 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.571 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 53.0 p90 -154.36 156.7 37.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.249 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.834 HG22 HG22 ' A' ' 361' ' ' VAL . 36.6 t -106.73 149.8 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.834 ' HE3' HD13 ' A' ' 362' ' ' LEU . 12.1 mtmt -130.39 152.81 49.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.253 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.421 ' CG2' HG13 ' A' ' 357' ' ' VAL . 5.4 mp -126.51 133.35 68.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.521 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' A' ' 325' ' ' LYS . 13.3 m80 -129.85 127.35 40.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.143 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.48 HD21 HG22 ' A' ' 347' ' ' VAL . 22.0 tp -100.04 105.1 16.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.453 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.2 mtm -108.06 138.86 43.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.28 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.821 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -100.56 99.58 10.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.364 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 57.21 37.36 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.82 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 91.18 28.72 14.17 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.804 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.31 109.58 9.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.762 0.315 . . . . 0.0 110.988 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 13.3 mtm-85 -49.77 128.5 18.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.292 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.821 HD11 ' CB ' ' A' ' 318' ' ' GLN . 11.4 mt -123.31 -49.63 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.232 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -130.59 150.93 51.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.345 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . 0.422 ' HA ' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -134.92 132.33 38.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.678 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.461 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 14.5 mmtt -138.25 159.53 41.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.889 0.376 . . . . 0.0 111.133 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -148.15 143.38 27.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.81 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.776 HG22 ' CE1' ' A' ' 343' ' ' PHE . 5.1 p -99.46 178.89 4.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.331 . . . . 0.0 110.689 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.2 t -59.81 162.61 5.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.264 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.571 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -106.27 122.28 59.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.884 0.373 . . . . 0.0 111.273 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.659 ' O ' HG22 ' A' ' 334' ' ' THR . 2.2 mmpt? -85.4 89.86 7.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.075 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -55.39 136.53 49.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.857 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 43.68 84.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.316 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.758 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.9 t -177.21 174.01 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.814 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 334' ' ' THR . 4.4 mt -146.42 -16.27 0.44 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.258 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.0 m-80 -132.24 57.69 31.31 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 120.72 0.295 . . . . 0.0 110.446 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 43.5 Cg_endo -92.4 167.79 2.82 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.26 2.64 . . . . 0.0 113.73 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.438 ' CG ' ' HB3' ' A' ' 295' ' ' GLU . 0.2 OUTLIER -106.99 160.81 15.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.235 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.832 ' HB2' HG22 ' A' ' 293' ' ' ILE . 47.7 m-85 -134.84 -51.62 0.79 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.689 0.281 . . . . 0.0 111.269 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.457 ' ND2' ' C ' ' A' ' 339' ' ' TYR . 1.8 p30 44.45 36.12 1.56 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.105 0.479 . . . . 0.0 110.975 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.544 ' O ' HG13 ' A' ' 292' ' ' VAL . 28.0 mt-10 -91.02 140.68 29.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 80.6 p -110.85 121.36 45.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.936 0.398 . . . . 0.0 111.667 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.776 ' CE1' HG22 ' A' ' 328' ' ' THR . 82.9 m-85 -111.31 156.65 21.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.01 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 56.5 m -130.91 138.65 49.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.449 . . . . 0.0 111.698 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.461 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 63.8 m-85 -127.91 165.92 19.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.604 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -115.5 79.12 1.25 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.247 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.535 HG13 ' HB3' ' A' ' 351' ' ' GLN . 37.3 t -106.44 123.19 39.58 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.268 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 35.5 Cg_exo -60.28 150.89 77.56 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.576 2.184 . . . . 0.0 111.855 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -57.16 -23.83 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -91.53 -8.59 47.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.491 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.535 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -105.2 -24.41 12.74 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.896 HD13 ' CD1' ' A' ' 282' ' ' TYR . 3.2 tp -53.0 -27.61 13.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 0.0 110.759 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -95.01 3.05 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.378 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -122.27 -20.78 6.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.6 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.652 HG12 ' HG2' ' A' ' 318' ' ' GLN . 34.4 m -87.87 167.9 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 111.483 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -139.92 126.55 20.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.291 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.522 ' CG2' HD21 ' A' ' 289' ' ' LEU . 52.4 t -95.17 103.68 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.099 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.609 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.4 OUTLIER -92.04 115.55 31.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.903 -179.007 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.559 ' HB ' HG23 ' A' ' 376' ' ' VAL . 56.7 t -94.92 108.18 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.463 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 1.006 HG23 ' HB3' ' A' ' 375' ' ' LYS . 2.3 m -110.59 134.43 52.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 0.0 112.014 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.834 HG22 HG22 ' A' ' 312' ' ' VAL . 48.6 t -109.58 115.12 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.276 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.834 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.9 mp -118.28 148.61 42.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 111.467 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.508 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.1 OUTLIER -98.43 125.02 43.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -72.45 144.56 48.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.875 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.071 -179.954 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . 0.421 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.761 0.315 . . . . 0.0 110.842 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.59 149.33 25.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.3 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.792 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.29 111.49 23.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.789 ' O ' HD22 ' A' ' 273' ' ' LEU . 32.8 mt -79.62 -33.99 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.186 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 169.01 179.2 40.92 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.08 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 1.006 ' HB3' HG23 ' A' ' 360' ' ' THR . 15.6 ptmt -164.56 141.34 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.109 0.481 . . . . 0.0 111.794 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.909 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.67 158.81 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.29 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.549 ' HB3' HG13 ' A' ' 358' ' ' VAL . 6.7 p90 -138.32 140.97 39.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 111.334 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 378' ' ' VAL . 28.0 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.914 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 . . . . . 0 CA--C 1.52 -0.203 0 CA-C-O 120.823 0.344 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.68 -32.56 71.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.269 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.1 OUTLIER -61.54 -41.9 98.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.203 179.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.603 ' CD2' HD12 ' A' ' 280' ' ' LEU . 16.5 t-160 -65.43 -58.0 6.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.619 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.488 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 62.9 t-105 -49.71 -44.68 48.4 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.136 0.493 . . . . 0.0 109.927 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.21 -34.29 77.17 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.553 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.465 ' HB3' HD12 ' A' ' 401' ' ' ILE . 1.8 t0 -65.17 -36.39 84.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.8 ' SD ' HD11 ' A' ' 352' ' ' ILE . 14.0 ttm -61.36 -57.57 11.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.119 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.771 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -61.05 -29.25 69.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.439 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.03 73.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.209 0.528 . . . . 0.0 109.843 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -125.46 77.74 68.52 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.374 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.53 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 5.8 Cg_exo -76.98 44.93 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.131 2.554 . . . . 0.0 113.002 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . 0.53 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 9.9 mmm180 -159.94 -46.74 0.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.908 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.26 137.4 22.82 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.961 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 56.6 Cg_endo -70.41 156.24 62.07 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.553 2.169 . . . . 0.0 112.747 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.26 117.13 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.971 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -108.82 144.36 36.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.716 0.293 . . . . 0.0 110.731 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -166.49 156.9 12.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.918 0.39 . . . . 0.0 111.376 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . 0.426 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 57.9 m95 -84.38 121.48 27.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.84 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.909 ' HB3' HG11 ' A' ' 376' ' ' VAL . 53.4 m-70 -110.09 122.62 48.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.405 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.549 HG23 ' OD1' ' A' ' 275' ' ' ASP . 88.6 m -78.29 118.21 20.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.751 HD23 HG22 ' A' ' 376' ' ' VAL . 67.3 mt -64.02 128.16 34.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.178 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -116.75 169.97 8.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.73 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.893 ' O ' HG23 ' A' ' 413' ' ' VAL . 58.8 t -53.96 119.44 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.792 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 36.8 mt-10 -54.57 -43.67 72.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.993 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -56.33 -47.65 78.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 110.721 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.6 mt-10 -66.54 -38.07 86.37 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 409' ' ' VAL . 57.4 t -60.15 -50.73 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.335 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.167 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.703 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 408' ' ' GLN . 18.3 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.815 0.341 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 119.41 -169.17 13.62 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.255 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . 0.772 ' OD1' HG23 ' A' ' 406' ' ' THR . 2.8 m-20 -138.76 134.24 33.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.745 0.307 . . . . 0.0 110.818 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.898 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -125.11 130.67 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.2 0.524 . . . . 0.0 111.013 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.898 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -99.11 126.93 44.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.725 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.605 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.4 p90 -142.04 151.83 42.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.324 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.42 161.44 13.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.965 -178.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.559 HD12 ' CD2' ' A' ' 389' ' ' HIS . 83.9 mt -135.65 141.74 45.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.486 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -158.94 114.7 2.59 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.856 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.937 ' CD1' HD13 ' A' ' 352' ' ' ILE . 25.0 t80 -105.98 138.87 41.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.64 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.35 97.51 45.0 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.531 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.4 -32.0 10.68 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.552 2.168 . . . . 0.0 112.472 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.6 -29.84 7.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.229 0.538 . . . . 0.0 109.941 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.28 -17.5 8.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.052 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.72 48.44 8.83 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.587 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -123.62 130.45 52.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.441 . . . . 0.0 111.834 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.887 HD11 ' HE1' ' A' ' 393' ' ' MET . 28.7 tp -95.76 147.56 23.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.793 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 3.1 m -137.39 134.29 35.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.331 0.586 . . . . 0.0 112.062 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 3.3 t -127.29 123.67 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.146 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 341' ' ' GLU . 39.7 t -118.17 115.26 47.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.062 0.458 . . . . 0.0 111.848 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.741 HG22 ' HB2' ' A' ' 339' ' ' TYR . 34.2 mm -74.55 137.04 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.437 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.5 OUTLIER -113.86 -60.64 1.86 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.456 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 2.6 pt-20 -175.63 157.8 2.1 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.296 -0.561 . . . . 0.0 112.448 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.811 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -115.98 154.04 30.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.897 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.0 ptmm? -150.93 151.97 32.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.037 0.446 . . . . 0.0 111.614 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 59.58 23.95 12.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.986 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.811 HD21 ' HB1' ' A' ' 296' ' ' ALA . 55.2 mt -58.14 138.91 55.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.077 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -62.6 144.44 56.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.472 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.426 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 11.2 mttt -83.46 114.63 21.61 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.449 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.451 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 5.8 mmm -93.79 -17.75 22.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.739 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 45.6 m-20 -96.03 117.89 31.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.4 116.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.643 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.39 16.32 35.02 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.423 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.27 -156.26 9.19 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.938 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 307' ' ' LEU . 8.3 mt -100.63 -160.43 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 110.305 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.663 ' HB2' HD23 ' A' ' 335' ' ' LEU . 65.3 m -135.98 171.77 13.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.231 0.539 . . . . 0.0 111.122 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.427 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 5.9 m-20 -134.47 56.5 18.36 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.729 ' CG ' HD13 ' A' ' 299' ' ' LEU . 72.4 Cg_endo -77.27 144.72 23.5 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.886 2.39 . . . . 0.0 115.043 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.548 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 11.3 p90 -139.07 167.9 21.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.185 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 361' ' ' VAL . 47.4 t -114.08 150.08 16.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.432 0.634 . . . . 0.0 112.663 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.656 ' CE ' HD13 ' A' ' 362' ' ' LEU . 7.0 mtmm -134.14 156.79 47.68 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.186 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.625 ' CG2' HG13 ' A' ' 357' ' ' VAL . 5.4 mp -129.96 138.44 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.707 0.289 . . . . 0.0 111.061 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . 0.412 ' O ' HG23 ' A' ' 358' ' ' VAL . 2.2 m170 -130.66 121.59 25.83 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.462 HD21 HG22 ' A' ' 347' ' ' VAL . 36.3 tp -87.96 106.78 18.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.804 0.335 . . . . 0.0 110.117 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 31.7 mtp -109.26 128.59 55.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.299 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.793 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.3 OUTLIER -104.93 103.31 12.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.991 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 61.31 37.67 16.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.782 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 83.79 25.04 47.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.565 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -129.3 110.07 11.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 110.847 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -56.68 135.55 55.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.793 HD11 ' CB ' ' A' ' 318' ' ' GLN . 5.7 mt -125.01 -48.13 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.29 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 345' ' ' PHE . 0.4 OUTLIER -130.54 147.22 52.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.961 0.41 . . . . 0.0 111.353 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.39 140.6 52.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.515 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 1.7 mmpt? -139.79 162.61 34.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 0.0 111.153 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.404 ' CB ' ' HG2' ' A' ' 313' ' ' LYS . 0.0 OUTLIER -152.21 149.85 29.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.889 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.713 HG22 ' CE1' ' A' ' 343' ' ' PHE . 15.6 p -110.29 179.47 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.943 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.457 HG23 ' HE3' ' A' ' 331' ' ' LYS . 12.6 t -59.03 167.21 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.518 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.548 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.2 mt -110.74 122.4 65.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.928 0.394 . . . . 0.0 111.338 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.457 ' HE3' HG23 ' A' ' 329' ' ' THR . 9.0 mmpt? -86.95 93.06 9.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.854 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -60.71 136.69 58.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.238 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 43.94 84.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.537 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.568 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.7 t -179.38 171.02 1.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.434 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.663 HD23 ' HB2' ' A' ' 308' ' ' SER . 1.6 mt -140.73 -14.36 0.94 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.495 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.45 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.1 m-80 -133.53 58.52 33.93 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-O 120.692 0.282 . . . . 0.0 110.378 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 52.0 Cg_endo -90.49 167.69 4.16 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.146 2.564 . . . . 0.0 113.686 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.45 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.4 OUTLIER -109.53 160.72 16.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.329 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.741 ' HB2' HG22 ' A' ' 293' ' ' ILE . 63.9 m-85 -133.99 -63.43 0.73 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.826 0.346 . . . . 0.0 111.243 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 58.15 37.96 26.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.579 ' O ' HG13 ' A' ' 292' ' ' VAL . 31.2 mt-10 -93.3 145.51 24.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.711 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 78.0 p -116.07 121.5 42.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.927 0.394 . . . . 0.0 111.586 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.713 ' CE1' HG22 ' A' ' 328' ' ' THR . 70.2 m-85 -113.05 151.33 30.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.349 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 15.1 m -121.88 138.44 54.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.083 0.468 . . . . 0.0 111.546 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 289' ' ' LEU . 34.2 m-85 -124.36 165.93 16.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.547 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.21 73.55 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.799 HG13 ' HB3' ' A' ' 351' ' ' GLN . 74.1 t -108.01 131.75 21.53 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.159 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 84.4 Cg_endo -82.24 154.94 16.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.778 2.319 . . . . 0.0 111.715 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -51.26 -22.71 2.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.829 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -86.42 -8.6 57.5 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.799 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -112.71 -29.86 7.28 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.937 HD13 ' CD1' ' A' ' 282' ' ' TYR . 3.9 tp -51.14 -33.67 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.665 0.269 . . . . 0.0 111.034 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -88.47 1.48 54.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.699 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -122.73 -20.65 5.85 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.511 HG23 ' CZ2' ' A' ' 390' ' ' TRP . 36.0 m -91.65 167.99 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.968 0.413 . . . . 0.0 111.386 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.49 127.83 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.775 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.625 HG13 ' CG2' ' A' ' 314' ' ' ILE . 98.9 t -86.86 104.77 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.439 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.5 OUTLIER -90.23 109.67 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.618 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.584 ' HB ' HG23 ' A' ' 376' ' ' VAL . 43.9 t -90.53 108.02 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.788 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.891 HG23 ' HB3' ' A' ' 375' ' ' LYS . 11.8 m -110.96 129.74 55.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 111.949 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 312' ' ' VAL . 48.7 t -104.12 131.0 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.114 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.656 HD13 ' CE ' ' A' ' 313' ' ' LYS . 3.9 mp -129.93 145.6 51.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.925 0.393 . . . . 0.0 111.481 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.451 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 9.1 t70 -90.08 126.81 35.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -79.42 146.97 32.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.562 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.33 . . . . 0.0 111.745 -179.442 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.837 0.351 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.09 157.25 38.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.914 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.466 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.68 109.45 22.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.08 0.467 . . . . 0.0 111.216 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.424 HG21 HD22 ' A' ' 299' ' ' LEU . 2.0 mm -71.4 -35.08 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.941 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . 0.407 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 157.47 -174.1 34.93 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.154 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.891 ' HB3' HG23 ' A' ' 360' ' ' THR . 18.2 ptmt -162.47 140.7 8.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.394 0.597 . . . . 0.0 112.058 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.985 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.9 158.9 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.174 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.538 ' HB3' HG13 ' A' ' 358' ' ' VAL . 25.7 p90 -139.54 140.57 37.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.954 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 357' ' ' VAL . 11.5 m . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.474 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.442 0.163 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 26.2 tp -71.32 -35.64 71.3 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.369 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 7.7 ptt180 -62.85 -33.58 75.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.345 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.559 ' CD2' HD12 ' A' ' 280' ' ' LEU . 18.5 t-160 -70.27 -55.44 9.23 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.321 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.585 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 58.4 t-105 -50.12 -45.13 52.68 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.092 0.472 . . . . 0.0 109.907 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.54 -33.21 73.71 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.614 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.47 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.5 OUTLIER -62.11 -39.38 92.29 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.887 ' HE1' HD11 ' A' ' 289' ' ' LEU . 20.1 ttm -59.18 -53.03 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.978 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.79 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -64.26 -30.7 71.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.244 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.68 -31.56 72.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.184 0.516 . . . . 0.0 109.668 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -125.49 77.92 68.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.337 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.546 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 5.9 Cg_exo -76.87 42.88 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.111 2.541 . . . . 0.0 113.061 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . 0.546 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 20.4 mmt180 -158.88 -47.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.093 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.41 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.1 OUTLIER -94.27 140.26 22.74 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.167 -179.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.41 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 57.9 Cg_endo -70.73 156.32 61.05 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.677 2.251 . . . . 0.0 112.885 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -127.76 115.35 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.745 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.56 144.44 33.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.808 0.337 . . . . 0.0 111.039 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.5 153.95 11.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.124 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . 0.406 ' CZ3' ' HB2' ' A' ' 277' ' ' CYS . 33.4 m95 -81.83 121.75 26.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.906 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.985 ' HB3' HG11 ' A' ' 376' ' ' VAL . 56.7 m-70 -111.98 117.61 33.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.551 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.772 HG23 ' OD1' ' A' ' 275' ' ' ASP . 89.6 m -78.44 116.46 18.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.859 HD23 HG22 ' A' ' 376' ' ' VAL . 95.0 mt -60.53 127.61 32.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.134 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.515 ' C ' HD12 ' A' ' 273' ' ' LEU . 5.2 mt-30 -115.06 168.8 9.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.605 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.825 ' O ' HG23 ' A' ' 413' ' ' VAL . 91.8 t -55.3 120.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.466 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 14.8 mt-10 -52.35 -41.13 62.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.774 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.62 -51.08 71.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.638 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.509 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 19.7 mt-10 -63.76 -38.8 92.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 409' ' ' VAL . 97.5 t -57.36 -49.15 81.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.147 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.471 179.583 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.796 HD22 ' O ' ' A' ' 373' ' ' ILE . 55.5 mt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.36 -166.08 15.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.247 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . 0.744 ' OD1' HG23 ' A' ' 406' ' ' THR . 27.6 m-20 -142.12 130.7 22.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.897 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.809 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -120.04 131.01 73.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.809 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.5 OUTLIER -99.99 126.02 46.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.898 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.634 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.4 p90 -142.32 152.59 43.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.345 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.49 161.3 13.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.134 -178.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.552 HD12 ' CD2' ' A' ' 389' ' ' HIS . 95.4 mt -135.08 142.82 46.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.053 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -158.85 110.89 2.19 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.092 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.842 ' CD1' HD13 ' A' ' 352' ' ' ILE . 22.0 t80 -102.87 139.36 38.55 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.896 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.04 94.18 47.49 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.542 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 8.0 Cg_exo -69.86 -32.72 17.6 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.914 2.41 . . . . 0.0 112.337 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -29.79 8.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.089 0.471 . . . . 0.0 109.96 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.73 -20.22 7.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.073 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.14 48.02 6.7 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.585 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -123.08 129.87 52.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.029 0.443 . . . . 0.0 111.802 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.893 HD11 ' HE1' ' A' ' 393' ' ' MET . 36.6 tp -96.88 147.55 23.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.991 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 8.7 m -138.25 137.01 37.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.444 0.64 . . . . 0.0 111.993 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.7 t -129.88 124.06 57.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.238 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 341' ' ' GLU . 24.5 t -119.69 115.43 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.094 0.473 . . . . 0.0 111.902 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.671 HG13 HG21 ' A' ' 328' ' ' THR . 44.2 mm -74.52 137.2 23.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.17 -58.64 2.12 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 16.8 pt-20 -175.74 162.1 2.65 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.537 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.767 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -119.06 152.41 36.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.647 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.438 ' HD2' ' CH2' ' A' ' 404' ' ' TRP . 0.4 OUTLIER -150.65 150.19 30.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.124 0.488 . . . . 0.0 111.572 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 61.61 24.02 14.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.996 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.767 HD21 ' HB1' ' A' ' 296' ' ' ALA . 53.4 mt -57.7 138.31 55.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 110.796 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.54 129.35 39.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.475 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.449 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 14.9 mttt -63.44 112.11 2.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.279 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' A' ' 371' ' ' ASP . 0.2 OUTLIER -85.06 -19.85 31.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.8 -179.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 28.7 m-20 -99.34 117.2 33.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.652 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 23.8 t -50.06 116.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.268 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 63.93 14.12 54.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.428 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -129.03 -159.88 10.09 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.677 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.1 mt -98.13 -162.87 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.792 0.33 . . . . 0.0 110.66 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.521 ' HB2' HD23 ' A' ' 335' ' ' LEU . 13.0 m -135.69 172.02 13.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.38 0.609 . . . . 0.0 111.205 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.422 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -134.16 56.18 17.96 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.829 178.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.712 ' CG ' HD13 ' A' ' 299' ' ' LEU . 66.7 Cg_endo -75.58 142.66 26.43 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.114 2.542 . . . . 0.0 115.034 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.625 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 7.1 p90 -140.57 168.17 20.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.006 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 361' ' ' VAL . 41.3 t -117.02 149.83 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.442 ' CE ' HD13 ' A' ' 362' ' ' LEU . 9.2 mttm -130.7 160.19 35.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.316 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.438 HG23 HG13 ' A' ' 357' ' ' VAL . 5.3 mp -128.82 136.42 59.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.526 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 79.1 m80 -130.83 130.84 44.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.884 0.373 . . . . 0.0 110.987 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 324' ' ' LYS . 41.1 tp -108.94 108.12 18.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.376 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 3.4 mtm -117.79 134.55 54.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.438 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.591 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.0 OUTLIER -95.4 99.62 11.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.414 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 59.44 37.69 22.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.08 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 92.73 17.15 45.86 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.181 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 317' ' ' MET . 10.6 mmmm -120.33 109.06 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.841 0.32 . . . . 0.0 110.805 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.39 132.02 38.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.615 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 318' ' ' GLN . 5.0 mt -125.89 -50.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.85 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 12.1 mmtm -130.7 146.04 52.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.959 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . 0.417 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -143.5 116.4 8.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.613 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -118.87 168.58 10.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.966 0.412 . . . . 0.0 111.291 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 15.2 ptpt -148.71 145.27 27.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.836 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.671 HG21 HG13 ' A' ' 293' ' ' ILE . 14.4 p -102.15 173.76 6.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.829 0.347 . . . . 0.0 110.924 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.492 HG22 ' OE2' ' A' ' 341' ' ' GLU . 6.3 t -54.68 175.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.675 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.625 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -118.5 124.08 72.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 111.432 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.665 ' O ' HG22 ' A' ' 334' ' ' THR . 0.1 OUTLIER -87.73 87.08 7.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.981 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -54.93 136.21 47.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.96 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 44.81 84.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.401 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 331' ' ' LYS . 4.9 t -178.02 173.66 1.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.784 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.658 HD23 ' O ' ' A' ' 334' ' ' THR . 3.8 mt -144.94 -15.94 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.373 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.433 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.32 57.61 30.61 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.843 0.354 . . . . 0.0 110.106 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 66.3 Cg_endo -86.27 167.62 9.13 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.133 2.555 . . . . 0.0 113.891 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 50.7 t80 -112.48 155.48 24.19 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.95 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.512 ' HB2' HG22 ' A' ' 293' ' ' ILE . 76.0 m-85 -133.2 -71.61 0.52 Allowed 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.817 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.537 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 24.2 t-20 66.16 37.54 5.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.542 ' O ' HG13 ' A' ' 292' ' ' VAL . 38.4 mt-10 -91.15 142.27 27.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.52 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 94.5 p -112.63 121.7 45.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.023 0.439 . . . . 0.0 111.757 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.671 ' HE1' HG22 ' A' ' 328' ' ' THR . 64.8 m-85 -113.85 148.53 36.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.014 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 52.1 p -122.99 140.47 52.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.043 0.449 . . . . 0.0 111.532 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -129.51 165.85 20.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.493 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -115.78 80.67 1.48 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.416 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.564 HG11 ' HA ' ' A' ' 352' ' ' ILE . 33.3 t -108.19 122.81 39.43 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.287 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.427 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 27.7 Cg_exo -60.84 149.43 88.29 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.578 2.185 . . . . 0.0 111.8 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -55.2 -23.91 24.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.138 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -91.48 -8.7 46.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.522 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.563 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.2 OUTLIER -105.53 -25.93 12.11 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.842 HD13 ' CD1' ' A' ' 282' ' ' TYR . 3.1 tp -50.15 -25.66 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.727 0.299 . . . . 0.0 110.874 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -93.45 -17.06 23.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.359 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -102.6 -17.28 15.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.635 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.591 HG12 ' HG2' ' A' ' 318' ' ' GLN . 30.9 m -89.47 168.04 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.827 0.346 . . . . 0.0 111.17 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -142.99 126.36 16.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.282 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.523 ' CG2' HD21 ' A' ' 289' ' ' LEU . 74.2 t -92.16 101.37 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.036 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.7 OUTLIER -89.18 112.04 23.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.863 -178.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.535 HG11 ' CD2' ' A' ' 278' ' ' PHE . 16.2 t -95.57 107.86 20.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.813 HG23 ' HB3' ' A' ' 375' ' ' LYS . 8.7 m -108.31 142.95 37.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 111.697 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 312' ' ' VAL . 60.3 t -118.5 115.77 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.203 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.465 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.7 mp -119.42 149.91 41.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 111.191 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.48 ' HB3' ' SD ' ' A' ' 302' ' ' MET . 0.1 OUTLIER -97.88 131.64 44.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.699 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -80.98 140.84 34.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.683 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.314 -179.666 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.728 0.299 . . . . 0.0 110.533 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . 0.507 ' HB2' ' SD ' ' A' ' 302' ' ' MET . 0.0 OUTLIER -98.01 142.45 29.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.967 0.413 . . . . 0.0 110.685 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.604 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -82.65 122.51 28.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.26 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.796 ' O ' HD22 ' A' ' 273' ' ' LEU . 13.0 mt -82.43 -30.08 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.787 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . 0.491 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 169.41 -179.3 42.05 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.74 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.813 ' HB3' HG23 ' A' ' 360' ' ' THR . 17.7 ptmt -164.61 140.93 6.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 111.934 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.821 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.37 158.6 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.098 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.56 ' CD1' HG13 ' A' ' 413' ' ' VAL . 53.0 p90 -143.26 144.37 32.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.849 0.357 . . . . 0.0 111.055 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 378' ' ' VAL . 25.3 m . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.214 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.822 0.344 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 21.3 tp -62.21 -28.19 69.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.549 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -69.06 -32.44 71.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.382 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.552 ' CD2' HD12 ' A' ' 280' ' ' LEU . 20.8 t-160 -78.88 -51.27 9.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.687 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.488 ' CH2' HG23 ' A' ' 357' ' ' VAL . 63.4 t-105 -51.84 -46.9 64.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.042 0.449 . . . . 0.0 110.051 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -33.61 76.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.607 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.478 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.8 OUTLIER -62.48 -38.33 89.42 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.893 ' HE1' HD11 ' A' ' 289' ' ' LEU . 11.5 ttm -61.35 -52.61 63.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.067 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.751 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.4 mt -61.88 -35.88 79.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.407 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.85 -29.64 70.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.205 0.526 . . . . 0.0 109.851 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 398' ' ' ARG . 11.3 m-80 -114.79 71.91 2.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.537 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.542 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 48.2 Cg_endo -70.42 32.9 0.21 Allowed 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.219 2.613 . . . . 0.0 113.552 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . 0.527 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 3.1 mmm180 -159.08 -46.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.013 0.435 . . . . 0.0 110.981 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.466 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 17.2 ttp180 -94.03 134.92 25.24 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.352 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.466 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 39.5 Cg_endo -66.41 156.35 65.68 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.7 2.266 . . . . 0.0 112.84 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -126.14 115.93 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.651 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.63 144.38 32.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.791 0.329 . . . . 0.0 110.853 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -166.6 152.1 8.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.16 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . 0.438 ' CH2' ' HD2' ' A' ' 297' ' ' LYS . 61.2 m95 -80.34 118.1 21.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.885 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.821 ' HB3' HG11 ' A' ' 376' ' ' VAL . 28.9 m-70 -105.01 117.01 32.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.572 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.744 HG23 ' OD1' ' A' ' 275' ' ' ASP . 88.7 m -78.32 115.42 18.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.781 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.819 HD23 HG22 ' A' ' 376' ' ' VAL . 89.7 mt -60.23 127.12 30.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.359 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.459 ' C ' HD12 ' A' ' 273' ' ' LEU . 4.0 mt-30 -112.94 171.63 7.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.582 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.877 ' O ' HG23 ' A' ' 413' ' ' VAL . 59.0 t -55.8 123.36 6.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.991 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.604 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 6.8 mt-10 -55.32 -42.3 73.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.704 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.16 -50.32 73.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.79 0.329 . . . . 0.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.461 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.2 mt-10 -62.89 -39.42 94.42 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 409' ' ' VAL . 89.4 t -56.08 -48.65 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.372 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.781 HD22 ' O ' ' A' ' 373' ' ' ILE . 42.7 mt . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.804 0.335 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 121.68 -164.54 14.8 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.185 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . 0.624 ' OD1' HG23 ' A' ' 406' ' ' THR . 30.0 m-20 -143.3 130.94 21.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.812 0.339 . . . . 0.0 110.844 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.783 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -120.34 128.85 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.061 0.458 . . . . 0.0 110.804 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.783 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -96.91 126.53 42.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.948 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.635 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.6 p90 -142.15 150.64 41.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.267 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.3 OUTLIER -99.43 163.21 12.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.281 0.562 . . . . 0.0 112.084 -178.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.835 HD12 ' CD2' ' A' ' 389' ' ' HIS . 76.6 mt -133.44 144.26 49.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.213 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 7.8 ttp85 -159.19 106.82 1.79 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.82 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.938 ' CD1' HD13 ' A' ' 352' ' ' ILE . 27.6 t80 -98.25 139.57 33.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.481 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 287' ' ' GLY . 44.4 t -116.14 92.98 37.46 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 16.4 Cg_exo -66.03 -31.8 45.49 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.94 2.426 . . . . 0.0 112.501 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -30.96 62.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.921 0.391 . . . . 0.0 110.751 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -121.54 -12.06 8.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.717 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 74.07 45.53 25.63 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.992 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -120.03 130.06 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 111.464 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.96 HD11 ' HE1' ' A' ' 393' ' ' MET . 33.1 tp -94.3 147.58 23.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.225 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 3.9 m -136.26 137.6 40.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.276 0.56 . . . . 0.0 111.924 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 15.1 t -131.78 121.82 48.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.369 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 341' ' ' GLU . 20.5 t -116.9 115.14 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.967 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.664 HG13 HG21 ' A' ' 328' ' ' THR . 41.6 mm -74.17 137.09 23.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.45 HD22 ' OE1' ' A' ' 295' ' ' GLU . 0.5 OUTLIER -113.38 -58.2 2.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.47 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 0.3 OUTLIER -175.73 164.42 2.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.391 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.777 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -123.94 153.35 41.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.798 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.48 150.93 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.693 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 61.24 24.32 14.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.915 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.777 HD21 ' HB1' ' A' ' 296' ' ' ALA . 58.9 mt -58.84 138.38 57.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.079 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -61.01 142.79 56.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.492 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.403 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 4.8 mttp -82.0 118.6 23.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.539 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.517 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.5 mmt -93.75 -18.93 21.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.395 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 44.6 m-20 -99.65 117.04 33.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.911 0.386 . . . . 0.0 110.745 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.01 116.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.438 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 61.33 15.41 45.16 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.354 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.34 -156.46 9.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.8 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 307' ' ' LEU . 7.7 mt -100.78 -161.18 0.84 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.847 0.356 . . . . 0.0 110.741 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.633 ' HB2' HD23 ' A' ' 335' ' ' LEU . 58.5 m -138.15 172.13 13.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.313 0.577 . . . . 0.0 111.066 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -131.77 57.73 32.5 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.557 ' CB ' HD13 ' A' ' 299' ' ' LEU . 60.3 Cg_endo -74.33 143.2 31.18 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.987 2.458 . . . . 0.0 114.707 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.547 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 31.6 p90 -143.71 162.16 36.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.363 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 361' ' ' VAL . 39.7 t -109.37 149.9 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.425 0.631 . . . . 0.0 112.461 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.827 ' HE3' HD13 ' A' ' 362' ' ' LEU . 10.5 mtmt -132.38 134.81 45.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.388 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.484 HG23 HG13 ' A' ' 357' ' ' VAL . 4.7 mp -101.43 145.4 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.802 0.334 . . . . 0.0 110.65 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 358' ' ' VAL . 0.5 OUTLIER -135.43 133.9 39.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.069 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.0 tp -117.95 109.18 16.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.514 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 0.0 OUTLIER -117.31 148.01 42.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.395 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.545 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.2 OUTLIER -105.74 99.63 9.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.294 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 59.51 38.15 22.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.082 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.8 10.75 57.45 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.226 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 317' ' ' MET . 4.5 mmtt -117.61 109.33 16.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.878 0.339 . . . . 0.0 110.849 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.66 136.92 54.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.294 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 318' ' ' GLN . 1.7 mt -128.71 -45.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.117 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 148.8 52.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.287 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . 0.45 ' CG ' ' CD2' ' A' ' 315' ' ' HIS . 0.5 OUTLIER -142.51 125.61 16.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.456 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.03 165.44 17.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.976 0.417 . . . . 0.0 111.248 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -146.16 142.0 28.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.538 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.669 HG22 ' CE2' ' A' ' 343' ' ' PHE . 5.8 p -98.57 -179.63 4.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.868 0.366 . . . . 0.0 111.026 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.4 p -60.02 159.41 9.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.537 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.2 mt -102.71 122.12 54.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.894 0.378 . . . . 0.0 111.38 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.477 ' HB3' HG21 ' A' ' 334' ' ' THR . 2.3 mmtt -87.4 92.14 8.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.956 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -61.47 136.83 58.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.168 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . 0.436 ' C ' HD13 ' A' ' 307' ' ' LEU . 1.0 OUTLIER 44.76 82.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.464 179.055 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.728 ' O ' HD23 ' A' ' 335' ' ' LEU . 3.7 t -175.92 174.37 2.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.791 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.728 HD23 ' O ' ' A' ' 334' ' ' THR . 4.5 mt -144.95 -16.86 0.51 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.264 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.435 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.5 m-80 -132.54 58.87 39.4 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 60.3 Cg_endo -88.26 167.6 6.51 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.174 2.582 . . . . 0.0 113.867 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.483 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 12.6 t80 -107.39 158.03 17.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.907 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.582 ' HB2' HG22 ' A' ' 293' ' ' ILE . 63.7 m-85 -132.37 -71.73 0.53 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.88 0.372 . . . . 0.0 111.28 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.483 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 9.6 t-20 63.87 34.98 11.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.019 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.491 ' O ' HG13 ' A' ' 292' ' ' VAL . 37.9 mt-10 -91.15 140.39 29.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.718 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.2 m -111.21 121.32 44.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.97 0.414 . . . . 0.0 111.66 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.669 ' CE2' HG22 ' A' ' 328' ' ' THR . 67.3 m-85 -113.34 148.34 35.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.101 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 23.9 m -127.02 138.21 53.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.028 0.442 . . . . 0.0 111.533 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -127.06 165.82 18.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.596 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -110.44 77.14 1.02 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.719 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.885 HG13 ' HB3' ' A' ' 351' ' ' GLN . 40.5 t -108.04 114.17 60.09 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.983 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.439 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 32.9 Cg_endo -65.49 157.43 58.26 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.338 2.026 . . . . 0.0 111.395 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -51.42 -25.24 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.482 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -85.23 -11.55 54.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.576 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.885 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.6 OUTLIER -102.08 -36.38 8.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.575 0.226 . . . . 0.0 111.187 -179.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.938 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.9 tp -50.81 -28.61 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.32 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -95.0 0.82 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.677 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -125.64 -13.83 6.4 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.545 HG12 ' HG2' ' A' ' 318' ' ' GLN . 26.5 m -94.09 166.84 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 111.271 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -143.2 126.38 16.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.518 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 85.9 t -89.09 115.61 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.205 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.616 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.2 OUTLIER -101.54 109.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.584 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.562 ' HB ' HG23 ' A' ' 376' ' ' VAL . 42.9 t -93.69 107.84 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.961 HG23 ' HB3' ' A' ' 375' ' ' LYS . 3.6 m -110.74 134.21 52.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.964 0.412 . . . . 0.0 111.587 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 312' ' ' VAL . 40.9 t -108.19 117.22 53.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.223 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.827 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.4 mp -120.63 148.16 44.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.013 0.435 . . . . 0.0 111.604 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.517 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -96.01 131.95 41.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.46 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 365' ' ' ASP . 8.5 t80 -87.04 142.63 27.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.736 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . 0.448 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 22.9 m-20 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.639 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.829 0.347 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -98.94 139.82 34.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.013 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.673 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -87.15 110.84 20.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.176 0.513 . . . . 0.0 110.852 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.781 ' O ' HD22 ' A' ' 273' ' ' LEU . 37.3 mt -79.83 -34.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.285 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . 0.542 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 168.71 -178.51 42.09 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.746 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.961 ' HB3' HG23 ' A' ' 360' ' ' THR . 11.0 ptmt -164.83 140.74 5.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.336 0.589 . . . . 0.0 112.275 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.908 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.81 159.15 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.746 178.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.622 ' CD1' HG13 ' A' ' 413' ' ' VAL . 27.5 p90 -146.44 131.99 18.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 0.0 111.756 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 378' ' ' VAL . 26.5 m . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.787 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.693 0.282 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 39.5 tp -72.24 -36.09 68.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 0.0 110.298 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 9.8 ptt180 -62.45 -32.04 72.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.235 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.835 ' CD2' HD12 ' A' ' 280' ' ' LEU . 17.7 t-160 -74.26 -52.08 13.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.42 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.518 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 70.0 t-105 -54.91 -45.28 74.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.53 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -37.86 84.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 13.0 t0 -61.2 -35.64 77.72 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.96 ' HE1' HD11 ' A' ' 289' ' ' LEU . 10.9 ttm -59.68 -52.82 63.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.174 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.768 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.3 mt -61.75 -25.83 67.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.964 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -76.72 -44.77 32.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.255 0.55 . . . . 0.0 109.594 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.441 ' HB2' HD11 ' A' ' 401' ' ' ILE . 21.9 m-80 -119.33 64.39 7.6 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.489 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.517 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 5.0 Cg_endo -45.67 -80.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.498 2.799 . . . . 0.0 113.23 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.51 -17.56 2.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.421 ' HB3' ' HB3' ' A' ' 396' ' ' ASN . 0.0 OUTLIER -93.79 116.72 66.83 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.818 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 34.6 Cg_exo -57.5 136.83 78.28 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.472 2.115 . . . . 0.0 112.691 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.47 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.2 mm -116.75 107.38 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.327 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.81 143.62 36.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.858 0.361 . . . . 0.0 110.829 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.52 152.33 10.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.321 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -79.13 116.31 19.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.582 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.908 ' HB3' HG11 ' A' ' 376' ' ' VAL . 33.5 m-70 -102.87 119.88 39.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.685 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.624 HG23 ' OD1' ' A' ' 275' ' ' ASP . 74.4 m -78.33 116.01 18.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.4 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.865 HD23 HG22 ' A' ' 376' ' ' VAL . 93.4 mt -62.38 127.78 32.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.252 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.425 ' C ' HD12 ' A' ' 273' ' ' LEU . 7.2 mt-30 -115.88 172.57 7.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.856 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.887 ' O ' HG23 ' A' ' 413' ' ' VAL . 41.3 t -56.18 121.82 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.002 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.673 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 12.2 mt-10 -54.23 -43.65 71.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.101 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.5 -50.4 73.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.886 0.374 . . . . 0.0 110.795 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.447 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.4 mt-10 -63.38 -37.8 88.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 409' ' ' VAL . 99.6 t -57.61 -48.09 83.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.715 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.777 HD22 ' O ' ' A' ' 373' ' ' ILE . 62.5 mt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.919 0.39 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.63 -163.2 16.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.255 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . 0.632 ' OD1' HG23 ' A' ' 406' ' ' THR . 8.4 m-20 -143.44 135.87 27.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.71 0.291 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.796 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -123.63 129.43 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.057 0.456 . . . . 0.0 110.822 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.796 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.4 OUTLIER -97.35 124.96 41.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.017 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.606 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 20.3 p90 -142.26 149.73 39.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.802 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.755 ' OG ' ' HB ' ' A' ' 292' ' ' VAL . 16.1 p -110.83 168.0 9.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.197 0.522 . . . . 0.0 111.892 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.553 HD12 ' NE2' ' A' ' 389' ' ' HIS . 1.2 mt -137.67 160.09 40.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.78 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.488 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.9 OUTLIER -159.14 102.47 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.767 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.961 ' CD1' HD13 ' A' ' 352' ' ' ILE . 39.7 t80 -100.14 130.82 46.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.944 0.402 . . . . 0.0 111.878 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.48 97.82 51.16 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.508 ' CG ' ' CB ' ' A' ' 397' ' ' PRO . 6.0 Cg_exo -71.13 -29.93 16.88 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.643 2.229 . . . . 0.0 112.299 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -30.56 11.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.187 0.518 . . . . 0.0 109.774 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.76 -20.83 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.822 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.44 47.17 7.01 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.908 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -123.98 129.66 51.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 111.482 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.404 HD21 ' CG2' ' A' ' 357' ' ' VAL . 33.5 tp -96.36 147.63 23.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.26 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 343' ' ' PHE . 6.0 m -135.28 137.24 42.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.287 0.565 . . . . 0.0 112.003 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.8 t -130.33 123.07 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.412 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.755 ' HB ' ' OG ' ' A' ' 279' ' ' SER . 5.0 t -118.54 116.32 50.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.664 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.652 HG13 HG21 ' A' ' 328' ' ' THR . 44.1 mm -75.65 137.15 23.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.569 HD22 ' OE1' ' A' ' 295' ' ' GLU . 0.8 OUTLIER -114.16 -57.94 2.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.569 ' OE1' HD22 ' A' ' 294' ' ' LEU . 1.2 pt-20 -175.54 162.43 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.422 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.754 ' CB ' HD11 ' A' ' 299' ' ' LEU . . . -122.33 154.81 37.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.933 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.421 ' HD3' ' CZ3' ' A' ' 404' ' ' TRP . 4.0 ptmt -150.79 150.4 30.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 111.519 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 59.62 25.54 14.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.754 HD11 ' CB ' ' A' ' 296' ' ' ALA . 89.3 mt -61.43 138.95 58.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.813 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -58.25 151.48 19.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.546 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.452 ' HE3' HD11 ' A' ' 335' ' ' LEU . 13.7 mttp -91.46 118.13 30.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.547 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.547 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.6 mmt -91.48 -18.57 23.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.341 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 30.6 m-20 -104.46 98.18 7.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.729 0.3 . . . . 0.0 110.408 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.22 114.73 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 111.44 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.95 -3.52 84.68 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.681 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -129.36 -143.17 5.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.87 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.492 HD12 ' HB2' ' A' ' 333' ' ' ASN . 34.6 mt -113.63 -159.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.909 0.385 . . . . 0.0 110.842 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.638 ' HB2' HD23 ' A' ' 335' ' ' LEU . 74.2 m -134.74 172.24 13.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.307 0.575 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.405 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -129.13 58.07 34.59 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.443 ' CB ' HD13 ' A' ' 299' ' ' LEU . 47.6 Cg_endo -70.15 150.64 66.13 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.13 2.554 . . . . 0.0 114.974 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.557 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 51.4 p90 -153.51 156.54 38.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.169 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.888 HG22 HG22 ' A' ' 361' ' ' VAL . 42.7 t -107.6 149.97 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.823 ' HE3' HD13 ' A' ' 362' ' ' LEU . 12.8 mtmt -131.09 139.21 49.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.313 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.411 HD11 ' CG1' ' A' ' 293' ' ' ILE . 5.2 mp -114.77 130.31 69.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.296 . . . . 0.0 110.963 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -126.17 136.76 53.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 0.0 111.042 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.443 HD23 ' HG3' ' A' ' 324' ' ' LYS . 21.8 tp -105.51 105.25 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.594 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 1.4 mtm -107.69 144.18 35.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.716 ' CG ' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -104.38 99.68 9.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.572 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 57.68 35.48 25.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.352 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 100.56 11.77 40.18 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.753 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.01 110.73 14.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.377 0.589 . . . . 0.0 110.921 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.401 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.6 OUTLIER -53.82 137.85 37.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.688 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.716 HD11 ' CG ' ' A' ' 318' ' ' GLN . 5.8 mt -126.8 -43.16 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.079 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.443 ' HG3' HD23 ' A' ' 316' ' ' LEU . 0.8 OUTLIER -130.46 151.57 50.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.34 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.0 133.68 41.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.836 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -136.35 160.25 39.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.032 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -147.8 144.22 28.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.825 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.67 HG22 ' CE1' ' A' ' 343' ' ' PHE . 18.0 p -103.78 174.0 6.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.695 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.2 t -55.02 162.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.682 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.557 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.0 mt -108.8 128.55 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.949 0.404 . . . . 0.0 111.245 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.638 ' O ' HG22 ' A' ' 334' ' ' THR . 2.1 mmtt -94.99 93.14 7.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.46 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -57.79 137.38 56.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.693 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . 0.492 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.2 p-10 44.79 83.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.401 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.779 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.9 t -175.87 173.33 2.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.685 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 334' ' ' THR . 4.1 mt -146.9 -15.97 0.41 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.264 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.411 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.9 m-80 -131.48 60.26 51.14 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.86 0.362 . . . . 0.0 110.08 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.455 ' HB2' ' HG3' ' A' ' 331' ' ' LYS . 73.5 Cg_endo -86.79 167.59 8.4 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.081 2.521 . . . . 0.0 114.106 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 74.0 t80 -119.95 149.46 42.08 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.605 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -132.46 -67.73 0.64 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.909 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.487 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 11.6 t-20 67.85 36.53 3.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.688 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 293' ' ' ILE . 46.3 mt-10 -91.04 135.0 34.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . 0.519 ' HA ' HG13 ' A' ' 292' ' ' VAL . 1.4 m -104.72 121.69 44.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.836 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.67 ' CE1' HG22 ' A' ' 328' ' ' THR . 60.9 m-85 -109.08 164.72 12.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.891 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 18.3 m -134.7 142.65 46.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.05 0.452 . . . . 0.0 111.73 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.407 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 50.3 m-85 -132.14 162.1 31.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -112.5 77.69 1.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.562 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 351' ' ' GLN . 38.3 t -105.26 122.13 43.98 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.323 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 27.1 Cg_exo -60.85 146.66 97.18 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.571 2.181 . . . . 0.0 111.564 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.44 ' CD1' ' HB3' ' A' ' 284' ' ' PRO . 11.3 t80 -54.08 -23.74 14.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 111.243 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 15.1 pm0 -91.5 -8.59 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.372 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.486 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.1 OUTLIER -104.45 -24.58 13.03 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.961 HD13 ' CD1' ' A' ' 282' ' ' TYR . 1.7 tp -52.4 -32.59 16.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.879 0.371 . . . . 0.0 110.547 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -87.58 3.33 47.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.338 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -124.29 -21.25 5.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.503 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.615 HG12 ' HG2' ' A' ' 318' ' ' GLN . 24.0 m -87.88 166.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.879 0.371 . . . . 0.0 111.285 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -143.47 126.28 16.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.778 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.508 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 64.5 t -88.26 119.55 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.287 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.5 OUTLIER -102.46 111.65 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.74 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 376' ' ' VAL . 46.6 t -97.52 107.91 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.674 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.979 HG23 ' HB3' ' A' ' 375' ' ' LYS . 3.1 m -110.59 134.41 52.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.011 0.434 . . . . 0.0 111.859 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.888 HG22 HG22 ' A' ' 312' ' ' VAL . 55.5 t -108.37 115.02 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.128 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.823 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.8 mp -118.87 150.31 40.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 111.506 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.547 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.4 OUTLIER -97.22 129.94 44.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.638 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -78.99 146.86 33.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.652 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.542 -179.527 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.802 0.334 . . . . 0.0 110.5 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.89 153.64 40.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.522 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.663 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -100.86 111.74 24.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.616 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.777 ' O ' HD22 ' A' ' 273' ' ' LEU . 25.5 mt -79.66 -33.23 14.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.317 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.13 -178.24 41.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.854 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.979 ' HB3' HG23 ' A' ' 360' ' ' THR . 17.1 ptmt -164.66 140.61 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.292 0.568 . . . . 0.0 111.967 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.9 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.77 159.07 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.01 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.437 ' HB3' HG13 ' A' ' 358' ' ' VAL . 9.4 p90 -143.82 131.98 21.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.417 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 378' ' ' VAL . 30.1 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.793 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.417 ' OE1' ' CE1' ' A' ' 377' ' ' PHE . 13.2 mt-10 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.749 0.309 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.0 tp -56.99 -34.44 68.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.58 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 6.0 mtt180 -61.82 -48.52 80.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.359 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.553 ' NE2' HD12 ' A' ' 280' ' ' LEU . 19.6 t-160 -60.27 -57.53 12.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.508 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 65.2 t-105 -51.41 -44.96 62.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.963 0.411 . . . . 0.0 110.203 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.0 t -68.86 -34.79 76.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.932 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 4.4 t0 -62.04 -31.67 72.1 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.458 ' HA ' HG13 ' A' ' 401' ' ' ILE . 5.7 tpt -66.61 -56.42 10.78 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.74 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.825 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.3 mt -58.42 -21.45 50.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.665 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.421 ' C ' ' HD3' ' A' ' 397' ' ' PRO . . . -70.39 -34.08 72.14 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -127.96 70.52 78.03 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.669 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.52 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 11.2 Cg_exo -71.59 51.65 1.52 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.101 2.534 . . . . 0.0 112.954 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . 0.52 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 4.7 mmm180 -158.99 -40.89 0.06 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.351 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.417 ' O ' ' HE1' ' A' ' 393' ' ' MET . 0.3 OUTLIER -94.0 160.72 31.73 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.491 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 82.2 Cg_endo -89.87 123.23 1.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.131 2.554 . . . . 0.0 112.664 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.458 HG13 ' HA ' ' A' ' 393' ' ' MET . 1.1 mm -98.38 130.44 47.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.717 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 279' ' ' SER . . . -124.57 146.01 49.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.701 0.286 . . . . 0.0 110.809 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.29 155.78 9.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 111.411 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . 0.421 ' CZ3' ' HD3' ' A' ' 297' ' ' LYS . 54.1 m95 -83.63 123.38 29.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.776 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.9 ' HB3' HG11 ' A' ' 376' ' ' VAL . 47.5 m-70 -111.05 119.21 38.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.632 HG23 ' OD1' ' A' ' 275' ' ' ASP . 87.8 m -78.34 116.52 18.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.811 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.836 HD23 HG22 ' A' ' 376' ' ' VAL . 94.9 mt -61.89 127.66 32.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.352 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -114.97 171.59 7.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.561 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 413' ' ' VAL . 60.5 t -54.17 120.25 2.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.663 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 10.6 mt-10 -54.57 -42.37 70.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.879 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -48.87 77.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.36 . . . . 0.0 110.74 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.469 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.5 mt-10 -64.67 -38.84 92.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.349 0.595 . . . . 0.0 109.417 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 375' ' ' LYS . 95.2 t -58.44 -49.27 82.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.544 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.936 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.785 HD22 ' O ' ' A' ' 373' ' ' ILE . 48.4 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.791 0.329 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 117.41 -168.47 12.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.225 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.11 132.42 32.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.707 0.289 . . . . 0.0 110.987 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.821 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -118.58 129.29 75.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.058 0.456 . . . . 0.0 110.964 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.821 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.52 124.87 41.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.828 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.608 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 20.5 p90 -142.3 149.67 39.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.691 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.783 ' OG ' ' HB ' ' A' ' 292' ' ' VAL . 13.2 p -109.78 160.65 16.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.233 0.54 . . . . 0.0 112.214 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.74 HD12 ' CD2' ' A' ' 389' ' ' HIS . 6.8 mt -128.69 153.82 46.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.806 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.418 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 9.8 ttp180 -159.27 107.28 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.86 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.959 ' CD1' HD13 ' A' ' 352' ' ' ILE . 31.3 t80 -99.04 139.48 34.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.721 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 287' ' ' GLY . 60.1 t -116.54 92.83 38.55 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 17.1 Cg_exo -65.14 -30.88 55.28 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.891 2.394 . . . . 0.0 112.322 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -31.54 63.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.732 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.84 -11.9 8.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.637 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 73.5 45.41 29.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.059 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -120.08 130.06 54.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 111.447 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.492 HD21 ' CG2' ' A' ' 357' ' ' VAL . 25.0 tp -94.34 148.02 22.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.381 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 3.6 m -136.82 134.3 36.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.254 0.55 . . . . 0.0 111.903 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.47 HG21 HG11 ' A' ' 357' ' ' VAL . 21.5 t -127.81 122.65 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.363 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.783 ' HB ' ' OG ' ' A' ' 279' ' ' SER . 4.3 t -117.68 115.48 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.758 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.704 HG13 HG21 ' A' ' 328' ' ' THR . 40.8 mm -74.6 137.14 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 277' ' ' CYS . 0.6 OUTLIER -113.45 -58.3 2.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.5 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 11.4 pt-20 -175.72 163.77 2.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.665 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.699 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -125.24 149.01 48.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.677 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.421 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 17.7 pttt -146.17 153.29 40.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.104 0.478 . . . . 0.0 111.549 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 60.1 27.1 16.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.621 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.699 HD21 ' HB1' ' A' ' 296' ' ' ALA . 91.7 mt -63.36 138.55 58.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.599 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.71 136.73 53.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.689 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.4 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 7.1 mttt -69.51 123.54 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.185 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 363' ' ' ASP . 0.1 OUTLIER -100.49 -11.58 20.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.687 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 53.1 m-20 -103.05 121.94 43.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.807 0.337 . . . . 0.0 110.284 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -47.02 115.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 111.664 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 57.37 17.27 24.55 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.405 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.97 -160.43 10.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.956 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.491 HD13 ' C ' ' A' ' 333' ' ' ASN . 6.3 mt -94.84 -160.86 0.81 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.449 0.3 . . . . 0.0 110.27 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.66 ' HB2' HD23 ' A' ' 335' ' ' LEU . 67.3 m -136.68 171.86 13.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.344 0.592 . . . . 0.0 111.105 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.448 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -132.12 55.12 16.23 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.819 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 309' ' ' ASP . 35.4 Cg_endo -65.97 149.94 85.85 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.168 2.578 . . . . 0.0 114.551 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.539 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 48.1 p90 -154.18 150.09 27.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.401 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.833 HG22 HG22 ' A' ' 361' ' ' VAL . 39.3 t -101.23 148.96 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.836 ' HE3' HD13 ' A' ' 362' ' ' LEU . 11.7 mtmt -130.33 138.54 50.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.154 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.514 HG23 HG13 ' A' ' 357' ' ' VAL . 5.3 mp -115.66 131.06 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.774 0.321 . . . . 0.0 110.771 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -129.13 133.38 47.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.491 HD21 ' CG2' ' A' ' 347' ' ' VAL . 18.9 tp -106.06 104.97 14.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.638 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 3.5 mtm -106.57 142.79 35.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.747 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.2 OUTLIER -102.21 99.77 9.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.48 179.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 58.65 38.3 25.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 92.18 22.52 29.65 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.027 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.5 mtpm? -128.86 109.3 11.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.741 0.305 . . . . 0.0 110.805 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.88 131.59 40.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.26 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.747 HD11 ' CB ' ' A' ' 318' ' ' GLN . 4.9 mt -126.01 -42.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.131 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -130.72 151.32 51.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.502 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 132.1 32.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.582 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.441 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 53.2 mmtt -139.34 155.27 47.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.236 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -141.31 149.47 41.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.72 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.765 HG22 ' CE1' ' A' ' 343' ' ' PHE . 21.2 p -106.17 175.51 5.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.826 0.346 . . . . 0.0 111.031 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -57.24 148.7 21.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.69 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.539 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -92.12 122.49 43.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.514 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.661 ' O ' HG22 ' A' ' 334' ' ' THR . 20.3 mmmt -86.67 85.87 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.016 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.68 139.29 50.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.99 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . 0.491 ' C ' HD13 ' A' ' 307' ' ' LEU . 0.9 OUTLIER 42.81 79.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.496 179.009 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.758 ' O ' HD23 ' A' ' 335' ' ' LEU . 5.1 t -173.44 173.48 3.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.165 0.507 . . . . 0.0 110.911 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 334' ' ' THR . 4.0 mt -146.19 -16.09 0.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.186 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.492 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.57 58.5 36.64 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 110.217 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 84.6 Cg_endo -90.39 167.79 4.24 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.175 2.583 . . . . 0.0 114.076 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.524 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 35.9 t80 -114.1 152.48 31.02 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.067 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.495 ' HB2' HG22 ' A' ' 293' ' ' ILE . 2.2 m-85 -130.03 -70.53 0.63 Allowed 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.921 0.391 . . . . 0.0 111.519 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.524 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 24.3 t-20 66.67 35.14 5.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.714 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 293' ' ' ILE . 52.1 mt-10 -91.11 133.81 35.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.973 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . 0.53 ' HA ' HG13 ' A' ' 292' ' ' VAL . 1.2 m -104.07 121.25 42.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.695 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.765 ' CE1' HG22 ' A' ' 328' ' ' THR . 69.2 m-85 -110.08 156.5 20.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.022 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 57.9 p -130.65 140.54 50.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.088 0.47 . . . . 0.0 111.588 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.441 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 62.7 m-85 -128.54 165.91 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.58 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -111.6 78.48 1.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.86 HG13 ' HB3' ' A' ' 351' ' ' GLN . 41.4 t -111.72 117.81 47.96 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.059 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.486 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 48.3 Cg_endo -69.52 157.47 60.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.383 2.055 . . . . 0.0 111.434 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -51.3 -23.02 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -86.7 -10.23 54.19 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.86 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -107.8 -33.16 7.34 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.537 0.208 . . . . 0.0 111.544 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.959 HD13 ' CD1' ' A' ' 282' ' ' TYR . 5.1 tp -49.26 -27.21 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.638 0.256 . . . . 0.0 111.136 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . 0.721 HE21 HD22 ' A' ' 394' ' ' LEU . 2.6 mm-40 -95.17 -9.42 33.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.842 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -113.29 -18.62 12.02 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.587 HG12 ' HG2' ' A' ' 318' ' ' GLN . 23.7 m -87.92 167.89 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 111.377 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -143.81 126.34 15.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.824 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.544 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 53.9 t -89.87 104.83 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.497 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.5 OUTLIER -90.69 110.78 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.615 -179.293 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 376' ' ' VAL . 44.3 t -93.81 107.85 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.981 HG23 ' HB3' ' A' ' 375' ' ' LYS . 5.2 m -111.55 131.77 55.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 0.0 111.968 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.833 HG22 HG22 ' A' ' 312' ' ' VAL . 42.5 t -105.03 119.47 54.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.163 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.836 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.5 mp -124.73 147.61 48.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.134 0.492 . . . . 0.0 111.797 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.455 ' HB3' ' SD ' ' A' ' 302' ' ' MET . 3.4 t70 -91.13 129.87 37.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.012 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.462 ' CB ' HG21 ' A' ' 330' ' ' ILE . 21.7 t80 -79.63 141.95 36.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.232 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.496 -179.442 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.91 0.386 . . . . 0.0 110.834 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -72.68 145.01 47.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.291 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.711 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -101.1 112.44 24.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.135 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.785 ' O ' HD22 ' A' ' 273' ' ' LEU . 12.3 mt -79.98 -33.37 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.336 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 166.35 179.21 39.57 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.945 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.981 ' HB3' HG23 ' A' ' 360' ' ' THR . 13.3 ptmt -161.2 140.37 10.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.24 0.543 . . . . 0.0 112.075 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.913 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -111.84 159.06 12.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.21 179.324 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.468 ' HB3' HG13 ' A' ' 358' ' ' VAL . 14.8 p90 -142.98 135.17 27.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 0.0 111.546 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 378' ' ' VAL . 18.8 m . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.986 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.527 0.203 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.02 -32.42 69.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.571 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 31.7 mtt180 -63.55 -50.88 67.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.619 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.74 ' CD2' HD12 ' A' ' 280' ' ' LEU . 16.2 t-160 -56.82 -54.14 49.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.544 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 61.1 t-105 -54.06 -50.67 66.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.091 0.472 . . . . 0.0 110.335 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.4 t -63.69 -34.94 78.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.345 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 8.2 t0 -62.74 -36.57 83.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.047 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.762 ' CE ' HD11 ' A' ' 352' ' ' ILE . 31.2 ttp -62.96 -55.32 26.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.724 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.796 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -57.52 -24.68 57.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.662 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -79.94 -37.75 33.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.299 0.571 . . . . 0.0 109.526 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 399' ' ' ARG . 13.6 m-80 -126.82 60.99 43.61 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.646 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.523 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 3.9 Cg_endo -45.11 -79.32 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.791 2.994 . . . . 0.0 113.266 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -48.51 -21.8 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.126 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' A' ' 396' ' ' ASN . 1.1 tpt180 -93.73 126.71 48.59 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.826 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.34 131.39 21.72 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.46 2.106 . . . . 0.0 112.547 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.456 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.1 mm -110.46 112.06 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.093 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 279' ' ' SER . . . -108.95 145.65 35.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.687 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.95 152.7 6.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.927 0.394 . . . . 0.0 111.322 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . 0.43 ' CH2' ' HG3' ' A' ' 295' ' ' GLU . 64.2 m95 -80.89 118.74 22.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.823 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.913 ' HB3' HG11 ' A' ' 376' ' ' VAL . 46.3 m-70 -107.17 119.77 40.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 86.6 m -78.29 116.26 18.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.091 0.472 . . . . 0.0 110.961 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.832 HD23 HG22 ' A' ' 376' ' ' VAL . 94.9 mt -61.75 127.55 31.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.28 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -114.42 171.9 7.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.491 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 413' ' ' VAL . 57.1 t -54.58 115.65 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.711 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 3.6 mp0 -52.05 -41.16 62.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.803 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -57.21 -48.91 77.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 110.622 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.467 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 24.4 mt-10 -65.04 -39.91 94.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.845 HG11 ' HG3' ' A' ' 375' ' ' LYS . 70.5 t -59.5 -49.54 83.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.158 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.741 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.716 HD22 ' O ' ' A' ' 373' ' ' ILE . 44.6 mt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.896 0.379 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.12 -159.63 16.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.192 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . 0.52 ' OD1' HG23 ' A' ' 406' ' ' THR . 28.3 m-20 -148.17 131.12 16.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.787 0.327 . . . . 0.0 110.56 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.898 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -120.63 130.14 74.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 110.935 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.898 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.21 126.22 42.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.736 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.619 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.5 p90 -141.94 149.33 39.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.321 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.0 OUTLIER -99.75 159.37 15.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.045 -178.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.606 HD13 ' HE3' ' A' ' 393' ' ' MET . 85.2 mt -130.49 144.99 51.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.855 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.406 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 7.2 ttm180 -158.86 103.94 1.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.781 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.905 ' CD1' HD13 ' A' ' 352' ' ' ILE . 27.8 t80 -99.22 138.86 35.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.241 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.8 t -123.55 94.59 46.16 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.394 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.537 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.15 -32.57 16.71 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.927 2.418 . . . . 0.0 112.325 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.53 -29.8 7.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.176 0.512 . . . . 0.0 110.07 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.95 -21.1 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.117 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 81.06 48.03 6.26 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.538 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -123.76 129.32 50.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.058 0.456 . . . . 0.0 111.626 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.711 HD11 ' HE1' ' A' ' 393' ' ' MET . 33.7 tp -96.08 147.74 23.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.9 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 2.6 m -136.05 135.99 39.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.319 0.58 . . . . 0.0 111.998 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.43 118.19 44.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.12 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 341' ' ' GLU . 23.1 t -113.92 115.74 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.058 0.456 . . . . 0.0 111.961 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.718 HG22 ' HB2' ' A' ' 339' ' ' TYR . 34.2 mm -74.75 137.02 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.49 -60.34 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 4.9 pt-20 -175.73 155.89 1.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.357 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.771 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -112.03 153.3 27.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.724 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -150.95 150.71 31.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.148 0.499 . . . . 0.0 111.614 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 61.38 22.74 13.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.005 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.782 HD13 ' CG ' ' A' ' 310' ' ' PRO . 52.0 mt -57.8 138.46 55.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.109 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -64.09 149.88 46.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.502 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.507 ' HE3' HD11 ' A' ' 335' ' ' LEU . 11.1 mttt -88.32 116.22 26.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.54 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.427 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 9.0 mmm -95.93 -19.98 19.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.486 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 48.6 m-20 -91.91 121.57 33.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.543 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -48.35 115.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.648 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 56.17 18.56 20.81 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.304 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.42 -157.74 9.75 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.005 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 307' ' ' LEU . 7.0 mt -98.53 -161.38 0.87 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.781 0.324 . . . . 0.0 110.529 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.54 ' HB2' HD23 ' A' ' 335' ' ' LEU . 15.1 m -134.91 171.89 13.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.246 0.546 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.422 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -135.16 56.61 16.91 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.782 ' CG ' HD13 ' A' ' 299' ' ' LEU . 73.7 Cg_endo -77.57 143.68 21.78 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.963 2.442 . . . . 0.0 114.805 -177.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.575 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 10.6 p90 -138.8 166.94 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.242 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.802 HG22 HG22 ' A' ' 361' ' ' VAL . 24.4 t -112.73 149.96 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.665 ' CE ' HD13 ' A' ' 362' ' ' LEU . 7.0 mttm -133.97 144.05 48.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.871 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.478 HD11 HD11 ' A' ' 293' ' ' ILE . 5.4 mp -118.86 124.09 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 111.201 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 70.2 m80 -117.98 130.98 56.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.597 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.567 ' HG ' HD12 ' A' ' 323' ' ' LEU . 22.5 tp -102.82 104.64 14.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 0.0 OUTLIER -127.59 129.09 46.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.408 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.764 ' HB3' HG12 ' A' ' 355' ' ' VAL . 0.0 OUTLIER -105.53 103.15 12.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 110.372 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 318' ' ' GLN . 83.2 m-20 71.15 36.43 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.199 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 82.12 21.22 61.3 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.175 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.6 mtpm? -113.34 109.07 18.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.837 0.318 . . . . 0.0 110.628 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -56.92 127.2 30.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.221 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.757 HD11 ' HG2' ' A' ' 318' ' ' GLN . 11.9 mt -122.7 -56.01 1.79 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.914 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.506 ' HB2' ' HE2' ' A' ' 345' ' ' PHE . 11.7 mttp -137.85 153.98 49.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.944 0.402 . . . . 0.0 111.256 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . 0.422 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -142.57 129.42 20.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.435 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.407 ' HD3' ' CD2' ' A' ' 343' ' ' PHE . 1.2 mttt -127.37 167.88 15.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 111.269 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.55 144.87 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.713 HG22 ' CE1' ' A' ' 343' ' ' PHE . 17.3 p -104.21 178.35 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 7.2 p -57.52 176.5 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.502 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.575 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.4 mt -118.21 118.39 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.97 0.414 . . . . 0.0 111.329 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.645 ' O ' HG22 ' A' ' 334' ' ' THR . 8.8 mmtt -82.95 84.86 7.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.978 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -55.96 136.86 51.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.015 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.45 82.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.294 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.698 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.9 t -176.45 173.86 2.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.725 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 334' ' ' THR . 4.3 mt -145.13 -16.31 0.5 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.219 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.487 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.6 m-80 -132.9 56.05 20.3 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 120.796 0.332 . . . . 0.0 110.117 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 55.8 Cg_endo -88.32 167.67 6.43 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.199 2.599 . . . . 0.0 113.79 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.435 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 1.1 t80 -107.04 160.83 15.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.327 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.718 ' HB2' HG22 ' A' ' 293' ' ' ILE . 70.9 m-85 -134.01 -64.49 0.7 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.865 0.364 . . . . 0.0 111.075 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 56.99 36.95 28.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.976 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.529 ' O ' HG13 ' A' ' 292' ' ' VAL . 47.5 mt-10 -92.97 142.13 27.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.778 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 12.7 m -114.0 120.56 41.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.44 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.713 ' CE1' HG22 ' A' ' 328' ' ' THR . 79.4 m-85 -112.97 153.42 28.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.252 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 9.7 m -123.74 137.73 54.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.152 0.501 . . . . 0.0 111.675 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.506 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 32.2 m-85 -120.88 165.96 14.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.584 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -116.43 72.43 0.82 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.85 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.92 HG13 ' HB3' ' A' ' 351' ' ' GLN . 40.0 t -108.97 117.53 53.53 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.236 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 38.4 Cg_endo -67.61 153.33 76.53 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.113 1.875 . . . . 0.0 111.104 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -48.19 -24.58 1.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.38 -18.02 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.925 0.342 . . . . 0.0 111.925 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.92 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.1 OUTLIER -96.0 -36.56 11.0 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.905 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.3 tp -48.36 -27.12 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 111.243 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -89.16 -17.77 28.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.987 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 351' ' ' GLN . 0.0 OUTLIER -119.06 10.52 12.16 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.764 HG12 ' HB3' ' A' ' 318' ' ' GLN . 31.0 m -108.36 167.71 3.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -141.22 126.45 18.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.922 0.392 . . . . 0.0 111.224 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.516 ' CG2' HD21 ' A' ' 289' ' ' LEU . 85.4 t -97.25 117.66 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.13 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.632 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.2 OUTLIER -105.22 116.13 48.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.085 -178.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.544 ' HB ' HG23 ' A' ' 376' ' ' VAL . 47.7 t -94.66 107.77 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.976 HG23 ' HB3' ' A' ' 375' ' ' LYS . 5.2 m -109.76 134.74 51.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.062 0.458 . . . . 0.0 111.993 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.802 HG22 HG22 ' A' ' 312' ' ' VAL . 47.5 t -110.88 118.88 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.237 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.665 HD13 ' CE ' ' A' ' 313' ' ' LYS . 3.7 mp -119.8 143.49 47.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.975 0.417 . . . . 0.0 111.43 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.427 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 3.4 t70 -90.37 126.44 35.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.716 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.443 ' CD2' ' ND2' ' A' ' 370' ' ' ASN . 22.7 t80 -81.94 141.82 32.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.782 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.983 -179.963 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . 0.443 ' ND2' ' CD2' ' A' ' 364' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.775 0.322 . . . . 0.0 110.907 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.01 157.28 20.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.714 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -100.9 111.29 23.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.076 0.465 . . . . 0.0 111.269 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.716 ' O ' HD22 ' A' ' 273' ' ' LEU . 1.4 mm -75.61 -35.64 32.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.817 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . 0.521 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 157.29 -174.6 34.81 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.44 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.976 ' HB3' HG23 ' A' ' 360' ' ' THR . 15.9 ptmt -164.31 141.03 6.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.195 0.521 . . . . 0.0 111.851 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.952 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -111.93 158.63 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.167 179.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.632 ' HB3' HG13 ' A' ' 358' ' ' VAL . 5.4 p90 -142.1 148.25 38.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.006 0.431 . . . . 0.0 111.593 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 19.8 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.857 179.933 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.736 0.303 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 32.9 tp -57.12 -36.57 70.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.67 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 2.6 mtt180 -59.11 -44.77 92.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.129 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.471 ' CD2' HD12 ' A' ' 280' ' ' LEU . 16.6 t-160 -59.95 -57.43 12.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.93 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.516 ' CZ3' ' HE1' ' A' ' 393' ' ' MET . 71.3 t-105 -50.51 -46.43 57.15 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.174 0.512 . . . . 0.0 109.954 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.6 t -67.04 -33.44 75.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.597 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.531 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.8 OUTLIER -64.65 -38.0 89.49 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.756 ' SD ' HD11 ' A' ' 352' ' ' ILE . 7.6 ttm -62.21 -53.61 52.73 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.88 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.704 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.6 mt -61.64 -35.9 79.24 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.338 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.1 -29.55 69.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.865 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.407 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.3 m-80 -114.28 71.48 2.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.66 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.537 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 52.6 Cg_endo -70.28 32.88 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.249 2.633 . . . . 0.0 113.594 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . 0.515 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 16.5 mmm180 -159.33 -44.31 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.979 0.419 . . . . 0.0 110.854 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.444 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.0 OUTLIER -93.92 136.95 23.27 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.314 -178.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 58.9 Cg_endo -71.34 156.46 58.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.52 2.147 . . . . 0.0 112.814 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.531 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.89 116.92 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.61 144.1 35.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.702 0.287 . . . . 0.0 110.822 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.56 153.09 10.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.972 0.415 . . . . 0.0 111.388 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . 0.414 ' CH2' ' HG3' ' A' ' 295' ' ' GLU . 59.0 m95 -82.24 118.71 23.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.952 ' HB3' HG11 ' A' ' 376' ' ' VAL . 55.9 m-70 -106.74 123.68 48.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.52 HG23 ' OD1' ' A' ' 275' ' ' ASP . 88.6 m -78.29 118.56 20.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.783 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.736 HD23 HG22 ' A' ' 376' ' ' VAL . 58.7 mt -64.5 127.98 33.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.102 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.483 ' C ' HD12 ' A' ' 273' ' ' LEU . 7.2 mt-30 -117.9 170.89 8.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.893 ' O ' HG23 ' A' ' 413' ' ' VAL . 60.8 t -55.64 119.91 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.863 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.469 ' CG ' ' HD2' ' A' ' 375' ' ' LYS . 26.9 mt-10 -53.74 -42.54 68.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.969 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -49.36 76.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.759 0.314 . . . . 0.0 110.64 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.464 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 22.2 mt-10 -65.06 -37.96 89.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 409' ' ' VAL . 63.8 t -59.33 -50.18 80.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.463 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.776 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.505 HD12 ' C ' ' A' ' 408' ' ' GLN . 18.7 mt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.846 0.355 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 114.31 -166.38 12.15 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.319 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.26 132.48 23.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.722 0.296 . . . . 0.0 110.771 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.834 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -121.78 131.51 72.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.074 0.464 . . . . 0.0 111.043 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.834 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -98.84 125.42 44.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.938 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.611 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.7 p90 -142.11 150.47 41.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.439 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -103.75 161.17 14.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.395 0.617 . . . . 0.0 112.356 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.602 HD12 ' CD2' ' A' ' 389' ' ' HIS . 10.9 mt -133.39 150.26 51.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.857 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.8 106.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.928 0.395 . . . . 0.0 111.362 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.901 ' CD1' HD13 ' A' ' 352' ' ' ILE . 27.7 t80 -99.93 138.12 37.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.211 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.29 95.03 46.11 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.431 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.506 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.24 -32.13 17.12 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.853 2.369 . . . . 0.0 112.238 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -30.65 7.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.155 0.502 . . . . 0.0 109.887 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.34 -20.55 8.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.918 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.15 48.24 6.57 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.565 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -123.86 129.97 51.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.842 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.438 HD21 ' CG2' ' A' ' 357' ' ' VAL . 40.6 tp -95.67 147.54 23.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.968 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 343' ' ' PHE . 5.4 m -137.85 140.16 40.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.551 . . . . 0.0 111.98 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.462 HG21 HG11 ' A' ' 357' ' ' VAL . 23.6 t -132.49 125.33 53.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.451 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 341' ' ' GLU . 21.7 t -118.68 115.41 47.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.904 0.383 . . . . 0.0 111.997 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 314' ' ' ILE . 38.7 mm -74.51 136.99 24.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.56 -58.62 2.12 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.429 ' HG3' ' CH2' ' A' ' 404' ' ' TRP . 8.7 pt-20 -175.59 162.01 2.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.139 -0.625 . . . . 0.0 112.335 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.787 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -118.43 153.58 33.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.764 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.435 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 11.8 pttt -150.93 148.52 28.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.11 0.481 . . . . 0.0 111.705 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 60.65 23.85 13.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.067 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.787 HD21 ' HB1' ' A' ' 296' ' ' ALA . 52.1 mt -56.88 138.09 54.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.083 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 143.33 51.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.322 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.431 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 35.3 mttt -85.14 108.39 17.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.644 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.515 ' HG2' ' HB3' ' A' ' 363' ' ' ASP . 0.0 OUTLIER -83.02 -20.94 34.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.958 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 56.0 m-20 -96.16 116.25 28.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.838 0.351 . . . . 0.0 110.718 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.3 t -49.95 116.11 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.444 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 63.26 14.28 53.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.419 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.32 -156.75 9.22 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.79 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.7 mt -100.8 -162.26 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.658 ' HB2' HD23 ' A' ' 335' ' ' LEU . 67.3 m -135.61 172.07 13.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.139 0.495 . . . . 0.0 110.927 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.423 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -133.73 56.02 18.33 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.708 ' CG ' HD13 ' A' ' 299' ' ' LEU . 72.8 Cg_endo -77.11 147.08 26.06 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.88 2.387 . . . . 0.0 114.969 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.562 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 11.5 p90 -141.53 167.74 21.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.069 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.926 HG22 HG22 ' A' ' 361' ' ' VAL . 29.4 t -116.89 148.18 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.844 ' HE3' HD13 ' A' ' 362' ' ' LEU . 17.3 mttt -129.84 157.13 43.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.968 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 293' ' ' ILE . 5.3 mp -132.74 128.48 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.647 0.261 . . . . 0.0 110.819 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -126.4 138.46 53.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.887 0.375 . . . . 0.0 111.077 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.448 ' HB2' ' CE2' ' A' ' 345' ' ' PHE . 29.7 tp -99.36 108.38 20.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -107.45 121.11 43.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.162 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.954 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -92.24 100.17 12.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 57.84 38.37 27.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.834 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.01 28.84 24.69 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.668 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.24 109.48 9.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.357 . . . . 0.0 110.918 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -53.31 129.65 32.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.155 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.954 HD11 ' CB ' ' A' ' 318' ' ' GLN . 10.5 mt -123.52 -46.06 2.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.063 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -130.56 151.37 51.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.85 132.79 40.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.763 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -136.97 156.52 48.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.881 0.372 . . . . 0.0 111.117 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 0.5 OUTLIER -146.87 143.85 28.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.9 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.643 HG21 HG13 ' A' ' 293' ' ' ILE . 13.7 p -101.49 177.46 4.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.757 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 11.1 t -59.49 166.14 2.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.582 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.562 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 5.5 mt -108.15 130.21 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.005 0.431 . . . . 0.0 111.246 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.629 ' O ' HG22 ' A' ' 334' ' ' THR . 22.3 mmmt -97.67 89.92 4.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.378 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -57.57 137.58 56.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.756 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 44.9 85.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.366 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.759 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.5 t -176.72 173.47 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.696 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.759 HD23 ' O ' ' A' ' 334' ' ' THR . 4.6 mt -147.14 -16.1 0.4 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.425 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.2 m-80 -134.07 58.94 34.68 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.817 0.341 . . . . 0.0 110.158 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.461 ' HB2' ' HG3' ' A' ' 331' ' ' LYS . 80.9 Cg_endo -86.63 167.59 8.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.076 2.517 . . . . 0.0 113.952 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 68.1 t80 -116.86 152.04 35.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.995 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.425 ' HB2' HG22 ' A' ' 293' ' ' ILE . 92.9 m-85 -133.19 -68.73 0.57 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.519 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 14.5 t-20 66.24 38.29 4.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.812 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 292' ' ' VAL . 52.0 mt-10 -91.02 141.9 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.663 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 85.5 p -110.09 121.92 46.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 111.662 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.638 ' CE1' HG22 ' A' ' 328' ' ' THR . 58.0 m-85 -111.71 163.1 14.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.032 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 13.2 m -133.8 145.14 49.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.139 0.495 . . . . 0.0 111.643 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' A' ' 316' ' ' LEU . 35.1 m-85 -131.26 165.79 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.436 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -114.57 79.45 1.27 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.006 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.901 HG13 ' HB3' ' A' ' 351' ' ' GLN . 50.4 t -115.27 123.58 31.43 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.352 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.524 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 73.8 Cg_endo -75.2 158.91 41.17 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.529 2.153 . . . . 0.0 111.376 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -51.37 -21.13 2.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -90.66 -8.68 49.35 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.901 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.6 OUTLIER -111.75 -27.23 8.59 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.901 HD13 ' CD1' ' A' ' 282' ' ' TYR . 5.7 tp -47.47 -28.66 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -95.09 -25.14 16.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -91.45 -4.91 55.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.872 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 351' ' ' GLN . 31.4 m -108.92 167.84 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 111.388 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -144.73 126.44 15.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.655 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.556 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 58.9 t -87.17 109.41 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.379 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.6 OUTLIER -94.63 111.85 26.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.521 ' HB ' HG23 ' A' ' 376' ' ' VAL . 39.7 t -95.62 107.87 20.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.769 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.973 HG23 ' HB3' ' A' ' 375' ' ' LYS . 6.3 m -109.39 139.32 44.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.064 0.459 . . . . 0.0 111.845 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.926 HG22 HG22 ' A' ' 312' ' ' VAL . 59.9 t -115.56 120.58 65.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.03 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.844 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.6 mp -120.89 142.92 49.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.363 . . . . 0.0 111.755 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 302' ' ' MET . 2.6 t70 -90.15 124.43 34.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.511 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -76.01 146.77 39.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.786 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 . . . . . 0 CA--C 1.53 0.208 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.505 -179.535 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.844 0.354 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . 0.446 ' HB2' ' HG2' ' A' ' 302' ' ' MET . 2.5 m-20 -71.05 152.05 43.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.893 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.731 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -100.88 111.44 23.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.063 0.459 . . . . 0.0 111.003 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.507 HG21 HD22 ' A' ' 299' ' ' LEU . 2.3 mm -72.06 -32.22 42.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.072 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 152.1 -178.81 29.12 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.973 ' HB3' HG23 ' A' ' 360' ' ' THR . 15.4 ptmt -160.55 140.78 11.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.34 0.591 . . . . 0.0 111.864 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.932 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.52 158.9 12.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.158 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.505 ' HB3' HG13 ' A' ' 358' ' ' VAL . 2.6 p90 -141.58 145.2 34.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.918 0.39 . . . . 0.0 111.224 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 378' ' ' VAL . 15.3 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.146 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.644 0.259 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 22.3 tp -64.66 -32.64 74.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.352 . . . . 0.0 110.332 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -65.39 -28.5 69.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.371 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.602 ' CD2' HD12 ' A' ' 280' ' ' LEU . 20.6 t-160 -79.89 -54.05 6.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.815 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.556 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 51.2 t-105 -51.27 -47.22 62.54 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.048 0.451 . . . . 0.0 109.944 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 15.0 t -67.81 -29.28 68.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.722 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.505 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.3 OUTLIER -62.98 -42.9 99.96 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.789 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.81 ' CE ' HD11 ' A' ' 352' ' ' ILE . 30.4 ttp -59.61 -52.49 65.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.671 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.804 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.6 mt -56.66 -31.74 64.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.329 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.46 -30.19 69.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 109.722 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 398' ' ' ARG . 17.1 m-80 -115.26 71.12 2.99 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.614 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.535 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 39.9 Cg_endo -68.07 31.37 0.14 Allowed 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.225 2.616 . . . . 0.0 113.396 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . 0.535 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 2.5 mmt180 -158.2 -42.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.092 0.472 . . . . 0.0 110.34 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.633 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 38.8 ttt85 -93.86 145.73 30.4 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.858 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.633 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 84.4 Cg_endo -81.03 156.24 20.09 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.457 2.105 . . . . 0.0 112.925 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -125.5 116.44 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.778 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -108.33 144.9 35.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.685 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.39 154.88 10.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.916 0.389 . . . . 0.0 111.298 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . 0.435 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 49.8 m95 -81.35 120.79 25.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.932 ' HB3' HG11 ' A' ' 376' ' ' VAL . 46.1 m-70 -108.54 122.7 47.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.516 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -78.24 117.19 19.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.746 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.787 HD23 HG22 ' A' ' 376' ' ' VAL . 79.9 mt -62.61 127.67 32.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.086 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.505 ' C ' HD12 ' A' ' 273' ' ' LEU . 6.3 mt-30 -116.06 168.94 9.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.828 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.853 ' O ' HG23 ' A' ' 413' ' ' VAL . 59.6 t -55.7 119.34 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.798 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.731 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 20.0 mt-10 -52.7 -43.63 65.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.911 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -56.52 -48.8 76.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.34 . . . . 0.0 110.657 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.461 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.0 mt-10 -65.52 -38.51 89.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 375' ' ' LYS . 73.4 t -59.43 -49.91 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.229 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.888 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.794 HD22 ' O ' ' A' ' 373' ' ' ILE . 33.9 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.898 0.38 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.06 -165.67 13.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.215 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . 0.632 ' OD1' HG23 ' A' ' 406' ' ' THR . 9.7 m-20 -142.33 133.23 25.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 110.875 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.862 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -121.87 131.07 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 0.0 111.026 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.862 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -98.38 126.02 43.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.831 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.618 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.7 p90 -141.89 149.94 40.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.202 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.38 159.53 15.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.085 -178.543 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.878 HD12 ' CD2' ' A' ' 389' ' ' HIS . 75.4 mt -128.9 148.34 50.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.177 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -158.81 104.58 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 111.597 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.992 ' CD1' HD13 ' A' ' 352' ' ' ILE . 29.9 t80 -96.65 139.54 32.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.385 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 287' ' ' GLY . 61.1 t -116.12 92.96 37.29 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 17.1 Cg_exo -65.27 -32.49 51.27 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.941 2.427 . . . . 0.0 112.366 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -31.62 62.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.872 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.6 -10.08 9.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.639 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 71.86 45.56 42.3 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.036 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -120.91 130.18 53.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.926 0.393 . . . . 0.0 111.55 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.492 HD21 ' CG2' ' A' ' 357' ' ' VAL . 32.7 tp -93.75 147.58 22.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.135 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.9 m -136.69 136.99 39.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.32 0.581 . . . . 0.0 112.122 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.09 123.8 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.455 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 341' ' ' GLU . 27.1 t -118.04 115.08 47.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.03 0.443 . . . . 0.0 111.767 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.682 HG13 HG21 ' A' ' 328' ' ' THR . 38.8 mm -74.7 137.04 23.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.429 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.5 OUTLIER -113.74 -59.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -177.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.447 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 2.4 pt-20 -175.7 159.48 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.362 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.815 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -118.73 154.01 33.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.873 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -150.87 151.89 32.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.968 0.414 . . . . 0.0 111.679 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 60.91 24.76 14.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.796 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.815 HD21 ' HB1' ' A' ' 296' ' ' ALA . 54.8 mt -59.69 139.38 57.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.282 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -62.17 144.49 55.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.483 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.416 ' HE3' HD11 ' A' ' 335' ' ' LEU . 9.5 mttp -84.19 118.73 24.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.548 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.567 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.7 mmt -93.91 -18.78 21.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.334 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 49.5 m-20 -98.39 116.97 31.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.841 0.353 . . . . 0.0 110.619 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -48.95 116.68 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.443 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.8 16.59 39.29 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.287 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.79 -157.58 9.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.804 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 307' ' ' LEU . 7.6 mt -100.33 -161.08 0.84 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.83 0.348 . . . . 0.0 110.702 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.618 ' HB2' HD23 ' A' ' 335' ' ' LEU . 70.9 m -139.39 172.13 13.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.33 0.586 . . . . 0.0 111.077 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.401 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -131.99 57.44 29.93 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.593 ' CG ' HD13 ' A' ' 299' ' ' LEU . 57.7 Cg_endo -72.75 144.65 39.67 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.132 2.555 . . . . 0.0 114.682 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.553 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 38.4 p90 -143.61 163.47 33.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.252 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.753 HG22 HG22 ' A' ' 361' ' ' VAL . 38.0 t -111.6 149.97 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.43 0.633 . . . . 0.0 112.577 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.841 ' HE3' HD13 ' A' ' 362' ' ' LEU . 11.1 mtmt -131.4 138.49 49.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.378 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.462 HG23 HG13 ' A' ' 357' ' ' VAL . 5.2 mp -111.69 132.44 60.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 0.0 110.8 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 358' ' ' VAL . 18.8 m80 -127.76 135.32 49.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 0.0 110.975 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.923 HD23 ' HD3' ' A' ' 324' ' ' LYS . 51.5 tp -103.76 110.84 23.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . 0.404 ' HA ' ' HG ' ' A' ' 323' ' ' LEU . 2.9 mtm -117.0 134.96 54.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.539 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.822 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.0 OUTLIER -93.65 99.49 11.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.29 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 59.52 37.7 22.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.36 7.43 60.63 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.224 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 317' ' ' MET . 5.5 mptt -111.02 109.76 20.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.834 0.317 . . . . 0.0 110.975 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.39 131.59 33.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.377 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.723 HD11 ' CB ' ' A' ' 318' ' ' GLN . 5.9 mt -125.35 -47.72 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.261 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.923 ' HD3' HD23 ' A' ' 316' ' ' LEU . 0.1 OUTLIER -129.89 160.59 33.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.085 0.469 . . . . 0.0 111.448 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.31 143.74 37.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.881 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 314' ' ' ILE . 20.9 mmtm -145.78 162.13 38.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.943 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.6 146.75 27.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.701 HG22 ' CE1' ' A' ' 343' ' ' PHE . 14.6 p -106.11 176.73 5.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 13.3 t -58.09 164.61 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.514 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.553 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.4 mt -107.83 123.55 63.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.938 0.399 . . . . 0.0 111.39 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.643 ' O ' HG22 ' A' ' 334' ' ' THR . 4.5 mmpt? -86.28 87.45 7.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.953 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -55.14 136.42 48.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.987 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 44.22 85.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.33 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.752 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.9 t -178.55 174.21 1.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.808 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 334' ' ' THR . 4.4 mt -145.59 -16.71 0.48 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.176 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.3 m-80 -132.65 56.36 22.17 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.318 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 46.8 Cg_endo -89.54 167.76 5.04 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.165 2.577 . . . . 0.0 113.628 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.447 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -108.97 160.67 15.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.299 179.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.636 ' HB2' HG22 ' A' ' 293' ' ' ILE . 81.6 m-85 -133.96 -63.97 0.71 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.755 0.312 . . . . 0.0 111.224 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.5 t30 59.12 38.52 23.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.956 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.547 ' O ' HG13 ' A' ' 292' ' ' VAL . 31.7 mt-10 -93.4 144.69 25.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.679 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 99.3 p -114.67 122.5 46.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 111.718 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.701 ' CE1' HG22 ' A' ' 328' ' ' THR . 76.3 m-85 -114.87 152.85 31.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.156 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 64.4 p -129.37 138.93 51.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.116 0.484 . . . . 0.0 111.763 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -125.13 166.01 17.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.569 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -111.02 76.84 1.0 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.829 HG13 ' HB3' ' A' ' 351' ' ' GLN . 50.0 t -110.0 122.2 39.62 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.035 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.53 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 71.0 Cg_endo -75.28 157.83 41.39 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.418 2.079 . . . . 0.0 111.64 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -51.72 -22.68 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.702 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -87.27 -8.55 56.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.829 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -111.97 -28.4 8.04 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.992 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.4 tp -52.2 -29.94 12.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.767 0.318 . . . . 0.0 110.864 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.67 3.31 55.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.411 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -124.1 -21.78 4.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.471 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.822 HG12 ' HG2' ' A' ' 318' ' ' GLN . 32.4 m -88.04 163.28 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.002 0.429 . . . . 0.0 111.485 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -137.88 126.28 23.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.5 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.511 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 88.9 t -88.3 116.2 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 0.0 110.28 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.4 OUTLIER -100.28 113.8 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.758 -179.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.569 ' HB ' HG23 ' A' ' 376' ' ' VAL . 47.8 t -99.09 107.79 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.97 HG23 ' HB3' ' A' ' 375' ' ' LYS . 3.7 m -110.4 135.38 51.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.964 0.411 . . . . 0.0 111.825 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.753 HG22 HG22 ' A' ' 312' ' ' VAL . 45.7 t -109.38 118.74 57.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.228 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.841 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.8 mp -121.28 145.76 47.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.502 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.567 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -94.57 125.16 39.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.664 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -75.75 146.91 39.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.899 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.596 -179.576 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.791 0.329 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.92 149.76 30.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.055 0.455 . . . . 0.0 111.57 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.549 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -100.95 111.11 23.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.72 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.794 ' O ' HD22 ' A' ' 273' ' ' LEU . 33.3 mt -82.39 -32.73 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.491 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . 0.502 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 167.05 -178.5 41.24 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.034 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.97 ' HB3' HG23 ' A' ' 360' ' ' THR . 17.5 ptmt -164.72 140.98 5.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.221 0.534 . . . . 0.0 112.041 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.925 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.53 159.27 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.048 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.458 ' HB3' HG13 ' A' ' 358' ' ' VAL . 22.1 p90 -144.85 132.0 20.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.055 0.455 . . . . 0.0 111.79 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 378' ' ' VAL . 22.9 m . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.756 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.897 0.38 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 23.8 tp -56.4 -34.4 66.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.728 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -62.0 -46.84 87.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.523 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.878 ' CD2' HD12 ' A' ' 280' ' ' LEU . 15.2 t-160 -62.58 -53.84 48.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.148 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.511 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 68.1 t-105 -54.83 -51.44 65.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.952 0.406 . . . . 0.0 110.461 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.5 t -66.25 -32.61 74.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.144 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.575 ' HB3' HD12 ' A' ' 401' ' ' ILE . 6.4 m-20 -64.87 -31.59 72.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.79 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.668 ' CE ' HD11 ' A' ' 352' ' ' ILE . 25.8 ttp -65.88 -54.27 28.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.91 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.807 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.5 mt -55.76 -22.79 25.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.124 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -80.8 -38.45 28.44 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 399' ' ' ARG . 40.0 m-80 -125.01 60.37 27.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.563 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.523 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 2.4 Cg_endo -44.06 -77.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.759 2.973 . . . . 0.0 113.356 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -51.38 -17.85 0.86 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.406 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' A' ' 396' ' ' ASN . 0.9 OUTLIER -93.67 133.47 27.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.906 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 74.1 Cg_endo -75.41 115.41 4.22 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.435 2.09 . . . . 0.0 112.548 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -93.62 108.39 20.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.881 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.57 144.0 32.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.737 0.303 . . . . 0.0 110.623 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.44 154.38 12.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.406 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -82.46 117.12 22.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.925 ' HB3' HG11 ' A' ' 376' ' ' VAL . 48.9 m-70 -106.68 118.38 36.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.576 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.632 HG23 ' OD1' ' A' ' 275' ' ' ASP . 91.6 m -78.33 116.25 18.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.952 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.841 HD23 HG22 ' A' ' 376' ' ' VAL . 93.5 mt -61.29 127.94 33.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.405 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.466 ' C ' HD12 ' A' ' 273' ' ' LEU . 6.6 mt-30 -116.04 172.25 7.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.497 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.832 ' O ' HG23 ' A' ' 413' ' ' VAL . 61.2 t -54.98 121.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.549 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 23.9 mt-10 -55.16 -42.47 73.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.88 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.16 -49.11 76.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.458 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.7 mt-10 -64.89 -38.17 90.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.371 0.605 . . . . 0.0 109.418 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 409' ' ' VAL . 94.9 t -57.28 -47.29 84.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.534 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.979 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.653 HD22 ' O ' ' A' ' 373' ' ' ILE . 41.4 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.943 0.402 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 124.11 -164.35 17.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.162 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.04 132.53 22.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.703 0.287 . . . . 0.0 110.72 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.701 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -122.71 122.43 65.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.161 0.505 . . . . 0.0 110.821 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.701 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -92.01 126.17 36.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.786 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.616 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.0 p90 -142.22 148.94 38.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.383 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -101.92 160.61 14.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.064 -178.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.831 HD12 ' CD2' ' A' ' 389' ' ' HIS . 73.0 mt -128.81 147.81 50.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.214 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 290' ' ' THR . 1.6 ttm180 -158.92 106.7 1.84 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.579 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.979 ' CD1' HD13 ' A' ' 352' ' ' ILE . 30.0 t80 -98.25 139.52 33.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.599 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 287' ' ' GLY . 83.1 t -116.37 93.11 38.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 16.5 Cg_exo -65.65 -30.94 50.58 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.892 2.394 . . . . 0.0 112.211 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -30.67 65.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.699 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -122.4 -5.3 8.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.643 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 66.49 45.98 80.97 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.629 -0.795 . . . . 0.0 112.033 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -121.36 129.32 53.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 111.493 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.446 HD21 ' CG2' ' A' ' 357' ' ' VAL . 34.2 tp -93.05 147.64 22.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.068 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 343' ' ' PHE . 1.6 m -136.68 136.7 39.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.347 0.594 . . . . 0.0 112.177 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.404 HG21 HG11 ' A' ' 357' ' ' VAL . 15.1 t -128.36 123.53 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.306 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 341' ' ' GLU . 38.1 t -117.25 116.04 50.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.995 0.426 . . . . 0.0 111.942 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.71 HG13 HG21 ' A' ' 328' ' ' THR . 26.6 mm -74.55 137.05 23.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 277' ' ' CYS . 0.7 OUTLIER -113.46 -57.44 2.28 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 4.9 pt-20 -175.96 158.53 2.05 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.131 -0.628 . . . . 0.0 112.444 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.787 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -117.98 145.56 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.497 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.427 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 10.7 pttt -145.68 151.04 37.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 111.542 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 61.47 23.01 13.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.072 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.787 HD21 ' HB1' ' A' ' 296' ' ' ALA . 58.2 mt -56.79 138.27 53.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.901 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -66.34 150.67 48.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.562 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.44 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 25.1 mttt -86.43 115.59 24.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.614 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.471 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 6.9 mmm -94.12 -18.37 21.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.563 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 55.6 m-20 -94.88 118.56 31.98 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.764 0.316 . . . . 0.0 110.332 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -47.61 115.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.02 0.438 . . . . 0.0 111.598 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.5 16.83 37.98 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.433 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.37 -159.26 10.07 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.961 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' A' ' 307' ' ' LEU . 6.6 mt -96.67 -161.55 0.88 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.72 0.295 . . . . 0.0 110.292 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.479 ' HB2' HD23 ' A' ' 335' ' ' LEU . 5.5 m -134.97 170.66 15.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.228 0.537 . . . . 0.0 111.166 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.453 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 6.8 m-20 -135.72 55.44 12.53 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.586 ' CG ' HD13 ' A' ' 299' ' ' LEU . 34.4 Cg_endo -66.88 154.81 73.32 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.233 2.622 . . . . 0.0 114.697 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.517 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 48.6 p90 -153.06 149.55 28.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.503 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.958 HG22 HG22 ' A' ' 361' ' ' VAL . 41.0 t -99.98 150.14 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.872 ' HE2' HD13 ' A' ' 362' ' ' LEU . 5.6 mtmm -133.08 136.16 45.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.219 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.639 HG23 HG13 ' A' ' 357' ' ' VAL . 5.1 mp -107.72 137.27 39.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.251 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -131.45 128.45 39.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.388 . . . . 0.0 111.21 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 324' ' ' LYS . 28.6 tp -104.64 106.64 17.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.464 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.6 mtm -112.87 140.65 47.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.912 0.387 . . . . 0.0 111.243 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.72 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.1 OUTLIER -101.38 99.48 9.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.324 179.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 55.46 38.14 29.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 93.22 25.8 18.08 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.866 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 317' ' ' MET . 3.8 mptt -130.67 109.26 10.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.888 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.406 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -52.22 130.78 31.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.449 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.685 HD11 ' CG ' ' A' ' 318' ' ' GLN . 8.9 mt -124.34 -53.56 1.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.969 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 18.7 mmtt -130.64 150.2 51.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.06 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 314' ' ' ILE . 0.6 OUTLIER -143.44 120.1 11.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.815 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.467 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 7.8 mmtm -118.39 172.75 7.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.995 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.415 ' HB3' ' HG2' ' A' ' 313' ' ' LYS . 0.0 OUTLIER -155.15 138.5 15.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.261 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.71 HG21 HG13 ' A' ' 293' ' ' ILE . 25.1 p -92.06 -171.65 2.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.855 0.36 . . . . 0.0 110.47 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.407 HG22 ' HE1' ' A' ' 339' ' ' TYR . 9.8 t -70.54 171.71 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.064 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.535 HG21 ' CB ' ' A' ' 364' ' ' TYR . 2.3 mp -110.3 114.35 46.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.078 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 310' ' ' PRO . 0.0 OUTLIER -75.08 90.78 2.51 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -58.42 135.96 57.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.404 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . 0.41 ' C ' HD13 ' A' ' 307' ' ' LEU . 1.3 p-10 41.29 80.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.528 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.6 ' O ' HD23 ' A' ' 335' ' ' LEU . 3.5 t -179.06 173.64 1.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.963 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 334' ' ' THR . 0.9 OUTLIER -145.49 -11.46 0.53 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.224 -178.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.478 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.3 m-80 -137.84 59.33 19.08 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.733 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.536 ' HG3' ' HG3' ' A' ' 331' ' ' LYS . 54.8 Cg_endo -98.48 167.91 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.532 2.822 . . . . 0.0 113.509 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.435 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.6 OUTLIER -104.12 160.79 14.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.729 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.48 ' CB ' HG22 ' A' ' 293' ' ' ILE . 6.7 m-85 -129.73 -75.71 0.55 Allowed 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.981 0.42 . . . . 0.0 111.778 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 69.93 35.4 2.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.491 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.571 ' O ' HG13 ' A' ' 292' ' ' VAL . 29.3 mt-10 -91.12 143.11 27.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.584 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 26.5 p -115.41 121.29 42.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.0 111.765 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.703 ' CE1' HG22 ' A' ' 328' ' ' THR . 71.7 m-85 -110.49 159.98 17.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.977 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 6.2 m -135.72 137.97 42.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.118 0.485 . . . . 0.0 111.828 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.467 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 57.1 m-85 -125.25 166.07 17.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.609 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -112.29 74.49 0.87 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.866 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 351' ' ' GLN . 47.7 t -108.31 122.75 39.53 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.534 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 74.5 Cg_endo -75.76 158.06 39.36 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.418 2.079 . . . . 0.0 111.547 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -51.71 -22.43 3.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.629 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -87.82 -8.56 55.74 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.825 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.2 OUTLIER -112.59 -28.2 7.92 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.696 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.979 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.0 tp -51.44 -34.89 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.79 0.329 . . . . 0.0 110.779 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . 0.654 HE21 HD22 ' A' ' 394' ' ' LEU . 4.5 mt-30 -89.99 3.07 54.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.374 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -123.06 -15.99 7.14 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.72 HG12 ' HG2' ' A' ' 318' ' ' GLN . 33.7 m -95.63 165.15 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.858 0.361 . . . . 0.0 111.469 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.85 126.49 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.989 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.639 HG13 HG23 ' A' ' 314' ' ' ILE . 47.7 t -89.11 110.18 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.442 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.5 OUTLIER -95.83 110.01 23.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.503 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.584 ' HB ' HG23 ' A' ' 376' ' ' VAL . 43.1 t -91.9 107.89 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.868 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.976 HG23 ' HB3' ' A' ' 375' ' ' LYS . 4.3 m -112.68 126.93 55.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.021 0.439 . . . . 0.0 111.949 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.958 HG22 HG22 ' A' ' 312' ' ' VAL . 46.7 t -101.98 118.37 48.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.216 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.872 HD13 ' HE2' ' A' ' 313' ' ' LYS . 2.7 mp -119.44 147.33 44.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 0.0 111.529 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 310' ' ' PRO . 5.2 t70 -90.02 130.19 36.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.821 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.535 ' CB ' HG21 ' A' ' 330' ' ' ILE . 8.9 t80 -81.95 141.45 33.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.584 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.157 -179.72 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.128 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 363' ' ' ASP . 5.7 m-20 -71.27 152.1 43.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.067 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.769 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -100.84 112.62 25.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.392 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.653 ' O ' HD22 ' A' ' 273' ' ' LEU . 1.3 mm -74.31 -34.28 36.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.751 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 155.98 -178.27 32.61 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.32 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.976 ' HB3' HG23 ' A' ' 360' ' ' THR . 11.9 ptmt -161.9 139.64 8.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.351 0.596 . . . . 0.0 112.303 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.919 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.18 158.93 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.077 179.264 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.496 ' HB3' HG13 ' A' ' 358' ' ' VAL . 25.5 p90 -141.2 135.48 30.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.906 0.384 . . . . 0.0 111.6 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 378' ' ' VAL . 15.5 m . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.898 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 120.658 0.266 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 46.4 tp -65.11 -37.15 86.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.623 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -62.58 -37.59 86.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.207 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.831 ' CD2' HD12 ' A' ' 280' ' ' LEU . 16.9 t-160 -65.54 -55.48 17.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 110.448 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.575 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 69.1 t-105 -53.83 -50.03 67.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.039 0.447 . . . . 0.0 110.262 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.42 -29.76 69.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.479 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.593 ' HB3' HD12 ' A' ' 401' ' ' ILE . 5.4 m-20 -67.86 -33.02 73.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.714 ' CE ' HD11 ' A' ' 352' ' ' ILE . 27.6 ttp -63.73 -52.61 59.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.695 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.785 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.6 mt -57.02 -22.9 42.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.91 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -81.16 -36.25 30.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.309 0.576 . . . . 0.0 109.483 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.471 ' HB2' HD11 ' A' ' 401' ' ' ILE . 22.7 m-80 -126.11 60.2 34.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.555 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.508 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 3.2 Cg_endo -44.67 -78.69 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.595 2.863 . . . . 0.0 112.91 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -51.24 -18.88 1.03 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.133 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -93.74 132.63 29.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.596 0.236 . . . . 0.0 110.813 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.7 Cg_endo -75.6 124.35 8.18 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.44 2.094 . . . . 0.0 112.712 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.593 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -102.59 107.63 22.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.761 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.28 144.26 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.858 0.361 . . . . 0.0 110.891 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.1 151.22 10.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.375 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . 0.427 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 36.4 m95 -78.17 115.77 18.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.688 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.919 ' HB3' HG11 ' A' ' 376' ' ' VAL . 51.0 m-70 -104.15 119.96 40.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.389 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 90.6 m -78.2 116.47 18.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.437 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.743 HD23 HG22 ' A' ' 376' ' ' VAL . 64.2 mt -61.63 126.9 28.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.038 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.44 ' C ' HD12 ' A' ' 273' ' ' LEU . 5.9 mt-30 -115.72 170.08 8.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.944 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.804 ' O ' HG23 ' A' ' 413' ' ' VAL . 55.5 t -54.83 117.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.725 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.769 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 9.0 mp0 -55.4 -41.22 72.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.642 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -56.83 -48.63 77.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 110.58 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.439 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.0 mt-10 -65.7 -40.07 91.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 409' ' ' VAL . 97.9 t -58.59 -48.79 84.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.17 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.499 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.789 HD22 ' O ' ' A' ' 373' ' ' ILE . 47.6 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.914 0.388 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 116.97 -168.1 12.73 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.234 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.18 132.28 26.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 0.0 110.723 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.882 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -120.99 129.93 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.171 0.51 . . . . 0.0 110.983 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.882 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.14 125.38 41.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.829 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.618 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 21.2 p90 -142.29 149.88 40.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.321 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.1 OUTLIER -102.54 161.31 13.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.362 0.601 . . . . 0.0 112.268 -178.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.659 HD12 ' CD2' ' A' ' 389' ' ' HIS . 27.7 mt -132.2 149.93 52.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.958 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.413 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.3 OUTLIER -158.92 102.8 1.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.443 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.936 ' CD1' HD13 ' A' ' 352' ' ' ILE . 29.6 t80 -98.57 136.69 38.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 43.0 t -122.8 95.88 45.92 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.535 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.57 -32.2 15.61 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.881 2.387 . . . . 0.0 112.317 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -31.17 6.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.191 0.52 . . . . 0.0 109.957 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.39 -21.15 8.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.813 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 81.16 47.6 6.43 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.778 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -123.65 129.74 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.97 0.414 . . . . 0.0 111.798 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.635 HD21 ' CG2' ' A' ' 357' ' ' VAL . 31.4 tp -95.48 147.67 23.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.994 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 3.4 m -134.73 137.64 43.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 112.0 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.41 ' CG2' HG11 ' A' ' 357' ' ' VAL . 21.6 t -130.87 120.28 47.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.32 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 341' ' ' GLU . 21.7 t -116.2 115.45 49.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.039 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.682 HG22 ' HB2' ' A' ' 339' ' ' TYR . 42.1 mm -75.05 137.13 23.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.446 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.98 -61.97 1.67 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -177.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.438 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 1.5 pt-20 -175.62 151.77 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.329 -0.549 . . . . 0.0 112.329 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.825 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -110.33 154.56 23.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.859 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -150.99 152.17 33.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 111.719 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 60.28 24.35 13.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.932 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.825 HD21 ' HB1' ' A' ' 296' ' ' ALA . 48.8 mt -58.96 138.82 57.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.162 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.463 ' HD2' ' HE2' ' A' ' 302' ' ' MET . 1.0 OUTLIER -62.59 141.62 58.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.31 -179.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.401 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 7.7 mttt -80.73 117.81 21.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.694 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.583 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.1 mmt -90.96 -19.03 23.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.343 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 49.2 m-20 -98.78 114.99 27.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.779 0.323 . . . . 0.0 110.524 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 26.3 t -48.84 116.38 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.45 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 62.11 15.44 50.38 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.369 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.29 -157.25 9.39 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.727 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.3 mt -100.34 -161.24 0.85 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 0.0 110.784 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.64 ' HB2' HD23 ' A' ' 335' ' ' LEU . 66.5 m -139.39 172.01 13.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.309 0.576 . . . . 0.0 111.103 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.409 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 15.3 m-20 -131.24 57.13 29.05 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.825 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.566 ' CB ' HD13 ' A' ' 299' ' ' LEU . 50.2 Cg_endo -70.56 148.56 60.13 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.096 2.531 . . . . 0.0 114.82 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.546 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 33.8 p90 -150.35 161.25 42.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.266 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.791 HG22 HG22 ' A' ' 361' ' ' VAL . 38.9 t -110.41 150.0 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.816 ' HE3' HD13 ' A' ' 362' ' ' LEU . 10.3 mtmt -132.41 134.95 45.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.215 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.536 HG23 HG13 ' A' ' 357' ' ' VAL . 5.3 mp -108.79 131.57 59.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.954 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -127.01 142.5 51.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.877 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.417 HD21 HG22 ' A' ' 347' ' ' VAL . 28.9 tp -113.31 106.01 14.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.527 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.5 mtm -106.79 131.17 54.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.311 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.939 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.4 OUTLIER -99.62 99.54 10.41 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.248 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 59.94 36.92 21.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.731 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 88.3 26.52 27.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.714 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.42 109.4 11.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.785 0.326 . . . . 0.0 110.883 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.79 129.24 25.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.184 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.939 HD11 ' CB ' ' A' ' 318' ' ' GLN . 10.0 mt -123.21 -41.38 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.47 147.74 49.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.897 0.38 . . . . 0.0 111.371 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -135.56 117.51 15.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.433 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 15.9 mmtp -124.26 160.85 27.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.927 0.394 . . . . 0.0 111.384 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.93 148.27 33.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.716 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.672 HG21 HG13 ' A' ' 293' ' ' ILE . 20.5 p -106.37 176.04 5.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.956 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.33 158.66 5.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.703 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.546 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.0 mt -102.13 126.08 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.979 0.418 . . . . 0.0 111.383 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.64 ' O ' HG22 ' A' ' 334' ' ' THR . 3.7 mmpt? -90.64 88.78 7.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.132 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -56.18 136.62 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.877 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 43.9 84.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.285 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.721 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.8 t -177.61 174.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.947 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.721 HD23 ' O ' ' A' ' 334' ' ' THR . 4.4 mt -145.95 -16.57 0.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.149 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.462 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.4 m-80 -132.29 56.99 26.13 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-O 120.765 0.317 . . . . 0.0 110.348 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 59.1 Cg_endo -88.33 167.69 6.41 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.18 2.587 . . . . 0.0 113.707 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.446 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.4 OUTLIER -111.31 159.29 18.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.302 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.682 ' HB2' HG22 ' A' ' 293' ' ' ILE . 83.6 m-85 -134.76 -62.25 0.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.792 0.329 . . . . 0.0 111.241 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.3 t30 57.87 37.58 26.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 292' ' ' VAL . 61.9 mt-10 -92.66 141.47 28.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 91.0 p -110.64 120.27 41.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.888 0.375 . . . . 0.0 111.544 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.639 ' CE1' HG22 ' A' ' 328' ' ' THR . 65.1 m-85 -113.34 147.91 36.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.361 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 83.0 p -123.09 140.5 52.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.972 0.415 . . . . 0.0 111.443 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.433 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 63.1 m-85 -127.24 165.88 18.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.583 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.63 78.1 1.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.817 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 351' ' ' GLN . 46.0 t -111.62 120.67 41.93 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.094 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.7 Cg_endo -72.07 156.97 55.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.468 2.112 . . . . 0.0 111.619 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -51.89 -22.94 4.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.54 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -85.72 -8.55 58.1 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.825 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.9 OUTLIER -109.96 -35.09 6.23 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.521 0.201 . . . . 0.0 111.473 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.936 HD13 ' CD1' ' A' ' 282' ' ' TYR . 5.9 tp -49.24 -26.72 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.651 0.263 . . . . 0.0 111.478 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -93.27 -7.92 43.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.771 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -116.41 -23.54 8.27 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 351' ' ' GLN . 35.0 m -88.69 168.03 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.908 0.385 . . . . 0.0 111.428 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -143.29 133.48 24.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.1 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.635 ' CG2' HD21 ' A' ' 289' ' ' LEU . 53.1 t -87.0 101.98 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.465 ' CG1' ' HE2' ' A' ' 375' ' ' LYS . 0.8 OUTLIER -86.45 114.18 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.969 -178.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.525 ' HB ' HG23 ' A' ' 376' ' ' VAL . 40.4 t -99.75 107.85 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.92 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.957 HG23 ' HB3' ' A' ' 375' ' ' LYS . 7.4 m -110.93 134.73 52.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 111.628 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.791 HG22 HG22 ' A' ' 312' ' ' VAL . 45.9 t -109.29 121.37 62.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.4 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.816 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.6 mp -123.07 147.55 46.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.918 0.389 . . . . 0.0 111.353 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.583 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.3 OUTLIER -96.54 125.19 40.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.601 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.407 ' CD2' ' OD1' ' A' ' 370' ' ' ASN . 20.3 t80 -75.8 139.45 41.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.818 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.871 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . 0.407 ' OD1' ' CD2' ' A' ' 364' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.8 0.333 . . . . 0.0 110.701 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.99 150.94 43.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.548 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.454 ' HB1' ' OE1' ' A' ' 410' ' ' GLU . . . -97.32 111.63 23.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.608 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.789 ' O ' HD22 ' A' ' 273' ' ' LEU . 30.0 mt -80.99 -33.12 12.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.386 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 168.13 -179.22 41.43 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.162 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.957 ' HB3' HG23 ' A' ' 360' ' ' THR . 14.8 ptmt -164.67 140.92 5.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.175 0.512 . . . . 0.0 111.791 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.936 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -114.35 158.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.176 179.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.568 ' CD1' HG13 ' A' ' 413' ' ' VAL . 43.0 p90 -142.23 132.03 24.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 111.179 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 378' ' ' VAL . 15.8 m . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.962 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.627 0.251 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.36 -33.53 71.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.551 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 1.0 OUTLIER -61.8 -49.83 74.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.54 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.659 ' CD2' HD12 ' A' ' 280' ' ' LEU . 17.4 t-160 -57.91 -58.39 8.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.967 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.481 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 64.0 t-105 -50.83 -46.11 59.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.217 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.5 t -67.75 -35.82 79.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.233 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.438 ' HB3' HD12 ' A' ' 401' ' ' ILE . 4.4 t0 -64.08 -34.92 79.13 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.759 ' CE ' HD11 ' A' ' 352' ' ' ILE . 26.6 ttp -64.5 -58.0 7.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.552 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.761 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.5 mt -55.22 -31.93 61.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.399 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.52 -30.64 69.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.786 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -114.27 70.66 2.06 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.629 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.535 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 42.8 Cg_endo -68.77 37.67 0.21 Allowed 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.203 2.602 . . . . 0.0 113.479 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . 0.533 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 10.6 mmm180 -160.0 -45.69 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.918 0.39 . . . . 0.0 110.86 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -93.87 141.82 24.23 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.198 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.7 Cg_endo -75.37 156.31 41.34 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.585 2.19 . . . . 0.0 112.807 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.45 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.2 mm -126.53 119.32 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -111.86 144.53 41.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.721 0.296 . . . . 0.0 110.693 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.31 155.68 11.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.976 0.417 . . . . 0.0 111.378 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -81.69 119.17 23.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.79 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.936 ' HB3' HG11 ' A' ' 376' ' ' VAL . 47.1 m-70 -106.81 122.34 46.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.557 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -78.19 117.09 19.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.672 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.803 HD23 HG22 ' A' ' 376' ' ' VAL . 55.9 mt -62.44 128.37 35.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.194 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.467 ' C ' HD12 ' A' ' 273' ' ' LEU . 5.3 mt-30 -114.46 171.98 7.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.756 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.85 ' O ' HG23 ' A' ' 413' ' ' VAL . 3.6 t -59.46 122.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.509 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 5.4 mt-10 -51.09 -38.37 51.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.325 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -52.64 63.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.651 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.429 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 3.0 mm-40 -60.79 -41.13 95.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 409' ' ' VAL . 61.7 t -56.22 -52.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.251 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.597 179.812 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 373' ' ' ILE . 46.7 mt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.788 0.328 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 116.24 -166.82 12.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.946 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -141.08 136.23 31.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.819 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.814 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -125.09 125.4 69.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.207 0.527 . . . . 0.0 110.885 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.814 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.5 OUTLIER -94.52 126.72 39.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.741 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.626 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 19.2 p90 -142.37 150.18 40.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.57 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.1 OUTLIER -103.87 160.36 14.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.05 -178.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.635 HD12 ' CD2' ' A' ' 389' ' ' HIS . 10.6 mt -133.34 150.51 51.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.866 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.97 105.08 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.552 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.946 ' CD1' HD13 ' A' ' 352' ' ' ILE . 28.4 t80 -99.14 138.66 35.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.08 95.28 44.17 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.403 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.532 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 6.9 Cg_exo -70.53 -31.06 17.76 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.844 2.362 . . . . 0.0 112.265 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.26 -32.07 15.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.147 0.499 . . . . 0.0 109.844 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.12 -18.71 9.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.816 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 78.77 47.58 7.73 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.617 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.97 129.46 51.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.04 0.447 . . . . 0.0 111.834 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 33.1 tp -96.55 147.56 23.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.932 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 343' ' ' PHE . 4.3 m -137.63 139.53 40.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.235 0.541 . . . . 0.0 111.995 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.3 t -132.86 123.35 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.529 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 341' ' ' GLU . 21.8 t -116.89 116.21 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.837 HG22 ' HB2' ' A' ' 339' ' ' TYR . 36.5 mm -74.64 135.95 26.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.79 -64.98 1.22 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.443 ' HB3' ' CG ' ' A' ' 338' ' ' TYR . 0.3 OUTLIER -174.67 148.62 1.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.524 -179.315 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.843 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -107.76 154.19 21.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.982 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -150.96 151.86 32.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 111.652 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 62.68 22.81 13.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.843 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.843 HD21 ' HB1' ' A' ' 296' ' ' ALA . 47.8 mt -57.02 138.53 54.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.163 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.35 142.97 58.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.588 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.419 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 14.1 mttt -82.64 113.06 20.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.444 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.44 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 8.2 mmm -91.6 -20.44 21.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.642 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 42.6 m-20 -92.28 118.86 31.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 110.527 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -48.04 115.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.611 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 57.5 17.95 28.16 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.264 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.97 -157.47 9.6 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.001 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.1 mt -99.27 -161.12 0.85 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 0.0 110.54 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.545 ' HB2' HD23 ' A' ' 335' ' ' LEU . 14.8 m -135.68 171.8 13.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.178 0.513 . . . . 0.0 111.017 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.43 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 6.5 m-20 -135.69 56.95 16.71 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.75 ' CG ' HD13 ' A' ' 299' ' ' LEU . 73.3 Cg_endo -77.91 144.21 21.39 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.902 2.402 . . . . 0.0 114.891 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.549 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 10.9 p90 -139.12 167.73 21.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.025 177.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 361' ' ' VAL . 47.6 t -116.85 149.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.325 0.584 . . . . 0.0 112.572 -179.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.853 ' HE3' HD13 ' A' ' 362' ' ' LEU . 13.8 mttt -132.38 155.78 47.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.434 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.519 HG23 HG13 ' A' ' 357' ' ' VAL . 5.4 mp -124.51 134.19 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.417 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -128.93 127.74 42.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.013 0.435 . . . . 0.0 111.049 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' A' ' 324' ' ' LYS . 28.8 tp -99.32 114.27 27.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.288 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.9 mtm -122.05 133.62 54.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 111.441 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.791 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.0 OUTLIER -98.77 99.49 10.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.02 179.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 59.95 36.68 21.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.38 25.61 32.89 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.853 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -122.06 117.46 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.7 0.286 . . . . 0.0 110.9 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.584 ' O ' HD23 ' A' ' 323' ' ' LEU . 14.9 mmt180 -51.72 128.21 22.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.219 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.765 HD11 ' HB2' ' A' ' 318' ' ' GLN . 18.1 mt -125.5 -58.86 1.41 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.251 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.907 ' HD3' HD23 ' A' ' 316' ' ' LEU . 0.1 OUTLIER -129.93 159.94 35.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.179 0.514 . . . . 0.0 111.743 -179.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 325' ' ' LYS . 0.3 OUTLIER -139.7 138.07 35.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.721 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.403 ' HB2' ' HB ' ' A' ' 314' ' ' ILE . 1.2 mmtm -143.98 158.62 43.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 111.157 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 0.1 OUTLIER -149.93 145.3 26.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.948 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.714 HG22 ' CE1' ' A' ' 343' ' ' PHE . 12.9 p -102.0 -178.93 3.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.846 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.637 HG23 ' HE3' ' A' ' 331' ' ' LYS . 10.1 t -60.2 172.05 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.463 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.549 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 5.6 mt -113.44 121.54 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 111.454 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.637 ' HE3' HG23 ' A' ' 329' ' ' THR . 7.1 mmpt? -86.43 85.73 7.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.997 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -56.45 136.77 53.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.981 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.19 83.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.255 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.688 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.8 t -176.99 174.0 1.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.76 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 334' ' ' THR . 4.0 mt -145.25 -15.8 0.5 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.378 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.486 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.79 56.09 20.64 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 120.75 0.309 . . . . 0.0 110.516 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 61.3 Cg_endo -89.04 167.69 5.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.15 2.567 . . . . 0.0 113.723 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.443 ' CG ' ' HB3' ' A' ' 295' ' ' GLU . 0.2 OUTLIER -110.03 160.4 16.47 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.456 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.837 ' HB2' HG22 ' A' ' 293' ' ' ILE . 7.9 m-85 -135.17 -50.3 0.75 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.692 0.282 . . . . 0.0 111.192 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.449 ' ND2' ' C ' ' A' ' 339' ' ' TYR . 1.7 p30 44.41 36.7 1.73 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.029 0.442 . . . . 0.0 110.976 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.526 ' O ' HG13 ' A' ' 292' ' ' VAL . 44.3 mt-10 -90.91 141.25 29.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.816 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 88.0 p -111.24 121.2 44.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.932 0.396 . . . . 0.0 111.558 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.714 ' CE1' HG22 ' A' ' 328' ' ' THR . 67.6 m-85 -111.78 155.21 23.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.058 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 59.6 p -130.91 139.59 50.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.115 0.483 . . . . 0.0 111.692 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -126.41 165.97 18.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.581 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -113.16 76.94 1.01 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.546 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.902 HG13 ' HB3' ' A' ' 351' ' ' GLN . 49.4 t -109.84 122.21 39.76 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.322 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.501 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 63.2 Cg_endo -73.42 158.97 47.43 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.453 2.102 . . . . 0.0 111.492 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -52.06 -20.67 2.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.857 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -90.45 -8.7 49.83 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.902 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -110.47 -29.73 7.96 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.946 HD13 ' CD1' ' A' ' 282' ' ' TYR . 6.3 tp -47.09 -28.6 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.829 0.347 . . . . 0.0 111.059 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -95.11 -27.77 15.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.058 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -91.33 -3.94 56.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.875 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.791 HG12 ' HG2' ' A' ' 318' ' ' GLN . 29.9 m -106.96 166.3 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 111.278 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -141.65 126.23 17.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.658 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.519 HG13 HG23 ' A' ' 314' ' ' ILE . 64.9 t -90.77 105.01 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.145 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.3 OUTLIER -93.98 111.34 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.811 -179.008 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.532 ' HB ' HG23 ' A' ' 376' ' ' VAL . 48.2 t -91.52 108.0 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.99 HG23 ' HB3' ' A' ' 375' ' ' LYS . 2.6 m -110.26 131.93 54.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.061 0.457 . . . . 0.0 111.923 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 312' ' ' VAL . 58.2 t -107.05 119.67 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.926 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.853 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.6 mp -119.94 141.88 49.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.992 0.425 . . . . 0.0 111.722 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.44 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 6.3 t70 -90.09 125.94 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.585 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -80.06 145.98 32.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.593 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.554 -179.481 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.889 0.376 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.16 149.86 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.915 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.762 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -91.0 112.03 23.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.019 0.438 . . . . 0.0 111.119 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.433 ' O ' HD22 ' A' ' 273' ' ' LEU . 1.3 mm -73.26 -33.88 42.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.997 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 155.61 -178.37 32.25 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.258 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.99 ' HB3' HG23 ' A' ' 360' ' ' THR . 12.2 ptmt -162.16 140.59 9.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.294 0.569 . . . . 0.0 112.017 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.936 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.98 158.79 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.155 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.556 ' HB3' HG13 ' A' ' 358' ' ' VAL . 9.4 p90 -139.53 142.95 37.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.933 0.397 . . . . 0.0 111.121 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 378' ' ' VAL . 12.1 m . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.066 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.405 ' OE1' ' CZ ' ' A' ' 377' ' ' PHE . 14.4 mt-10 . . . . . 0 CA--C 1.522 -0.101 0 CA-C-O 120.808 0.337 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.19 -32.06 71.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.501 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 2.6 ptt180 -64.94 -31.7 73.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.324 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.635 ' CD2' HD12 ' A' ' 280' ' ' LEU . 17.5 t-160 -77.29 -57.33 3.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.513 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 50.4 t-105 -49.47 -44.95 46.21 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.093 0.473 . . . . 0.0 109.901 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.0 t -69.06 -30.67 69.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.739 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.528 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.3 OUTLIER -63.14 -42.25 99.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.923 179.119 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.803 ' CE ' HD11 ' A' ' 352' ' ' ILE . 31.9 ttp -59.96 -54.83 41.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.971 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.797 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.4 mt -56.46 -31.57 64.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.417 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.2 -31.61 71.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.529 . . . . 0.0 109.691 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' A' ' 398' ' ' ARG . 36.0 m-80 -115.17 71.17 2.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.55 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.532 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 39.6 Cg_endo -68.34 35.29 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.249 2.632 . . . . 0.0 113.443 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . 0.51 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 11.3 mmm180 -159.26 -45.23 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.0 0.428 . . . . 0.0 110.578 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.405 ' NH1' ' HB2' ' A' ' 399' ' ' ARG . 0.2 OUTLIER -94.04 140.75 23.01 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.037 -179.19 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 72.3 Cg_endo -75.02 156.3 42.89 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.52 2.147 . . . . 0.0 112.839 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -124.99 117.95 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.578 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -110.13 144.57 38.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.677 0.275 . . . . 0.0 110.763 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.77 155.57 10.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.965 0.412 . . . . 0.0 111.246 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -82.23 121.63 26.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.753 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.936 ' HB3' HG11 ' A' ' 376' ' ' VAL . 54.3 m-70 -109.46 122.68 47.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.593 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 90.4 m -78.28 117.11 19.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.542 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.768 HD23 HG22 ' A' ' 376' ' ' VAL . 61.8 mt -62.16 128.09 34.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.253 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -114.44 173.29 6.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.672 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.812 ' O ' HG23 ' A' ' 413' ' ' VAL . 4.6 t -58.54 115.77 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.818 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.762 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 4.6 mp0 -52.42 -25.52 10.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.42 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.424 ' H ' HG12 ' A' ' 409' ' ' VAL . 2.3 mt-10 -72.94 -51.18 19.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.481 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.434 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 2.6 mm-40 -64.35 -38.8 92.33 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.897 HG11 ' HG3' ' A' ' 375' ' ' LYS . 59.6 t -56.8 -50.63 74.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.363 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.495 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.818 HD22 ' O ' ' A' ' 373' ' ' ILE . 72.3 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.918 0.39 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 124.12 -166.07 16.82 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.307 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . 0.457 ' OD1' HG23 ' A' ' 406' ' ' THR . 36.0 m-20 -140.91 132.55 27.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.75 0.31 . . . . 0.0 110.709 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.849 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -123.14 130.17 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.165 0.507 . . . . 0.0 111.013 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.849 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -98.71 126.38 44.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.67 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.611 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.3 p90 -142.2 150.0 40.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.399 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.9 159.65 15.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.21 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.58 HD12 ' CD2' ' A' ' 389' ' ' HIS . 31.8 mt -130.7 149.39 52.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.798 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -158.95 106.47 1.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.611 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.967 ' CD1' HD13 ' A' ' 352' ' ' ILE . 27.7 t80 -101.49 137.91 39.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.14 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 44.2 t -123.5 95.81 44.58 Favored Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.539 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.3 Cg_exo -70.54 -34.38 12.06 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.931 2.421 . . . . 0.0 112.733 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.25 -30.71 5.02 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.16 0.505 . . . . 0.0 109.957 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -116.64 -21.72 8.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.844 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.26 48.87 6.17 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.642 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -124.15 129.74 51.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.073 0.463 . . . . 0.0 111.891 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 352' ' ' ILE . 39.2 tp -95.43 147.63 23.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.867 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 343' ' ' PHE . 8.3 m -139.33 138.7 36.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 112.06 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.5 124.41 57.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.316 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 341' ' ' GLU . 25.3 t -117.16 114.67 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.028 0.442 . . . . 0.0 111.852 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.788 HG22 ' HB2' ' A' ' 339' ' ' TYR . 26.1 mm -74.68 137.01 23.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.453 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.29 -60.49 1.87 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 2.4 pt-20 -175.81 159.28 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.243 0.544 . . . . 0.0 112.24 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.769 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -123.64 149.5 45.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.853 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -145.55 153.68 41.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.987 0.423 . . . . 0.0 111.375 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 60.54 29.02 18.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.495 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.769 HD21 ' HB1' ' A' ' 296' ' ' ALA . 91.8 mt -66.01 138.79 58.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.951 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -58.41 148.59 27.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.59 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.404 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 0.1 OUTLIER -89.45 121.9 32.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.465 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.53 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.8 mmt -96.48 -16.67 21.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.316 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 33.1 m-20 -106.97 101.3 10.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.767 0.318 . . . . 0.0 110.504 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.07 116.61 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.54 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.04 87.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.907 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -124.93 -139.47 5.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.85 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.505 HD12 ' HB2' ' A' ' 333' ' ' ASN . 34.1 mt -119.46 -159.21 0.76 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.01 0.433 . . . . 0.0 110.566 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.666 ' HB2' HD23 ' A' ' 335' ' ' LEU . 66.5 m -135.68 172.06 13.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.222 0.534 . . . . 0.0 110.638 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.407 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -131.44 57.57 31.91 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 363' ' ' ASP . 38.3 Cg_endo -67.66 153.85 74.97 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.136 2.557 . . . . 0.0 114.51 -177.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.548 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 25.1 p90 -156.82 148.3 22.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.355 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 1.009 HG22 HG22 ' A' ' 361' ' ' VAL . 39.8 t -102.99 143.59 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.701 ' HE3' HD13 ' A' ' 362' ' ' LEU . 17.7 mttt -122.08 157.43 31.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.278 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.405 HG23 HG13 ' A' ' 357' ' ' VAL . 5.4 mp -131.51 124.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.651 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -123.5 133.25 54.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 111.157 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.416 HD21 HG22 ' A' ' 347' ' ' VAL . 22.5 tp -102.15 105.83 16.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.285 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 0.9 OUTLIER -107.2 143.6 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.245 -179.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.794 ' HB2' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -105.58 99.56 9.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.416 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 59.84 37.75 21.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.937 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 90.16 25.56 26.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.902 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 317' ' ' MET . 7.8 mmtm -128.88 109.47 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.451 ' O ' HD23 ' A' ' 323' ' ' LEU . 7.9 ptt180 -52.84 130.81 34.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.227 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.794 HD11 ' HB2' ' A' ' 318' ' ' GLN . 8.3 mt -126.26 -43.21 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.241 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 3.2 mmpt? -130.62 158.08 41.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.921 0.391 . . . . 0.0 111.341 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.59 134.21 23.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.837 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -142.3 159.11 42.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.916 0.388 . . . . 0.0 111.247 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 2.9 mttt -142.75 154.65 44.46 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.601 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.795 HG22 ' CE1' ' A' ' 343' ' ' PHE . 13.4 p -111.12 177.22 4.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.847 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.4 142.99 36.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.693 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.548 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.2 mt -90.55 119.17 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.109 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.614 ' O ' HG22 ' A' ' 334' ' ' THR . 1.1 mmpt? -83.56 89.47 7.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.3 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -57.42 137.4 56.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.799 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . 0.505 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.2 p-10 43.91 83.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.365 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.756 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.5 t -176.82 174.78 1.73 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.803 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 334' ' ' THR . 5.1 mt -146.65 -16.96 0.42 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.223 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.464 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.7 m-80 -132.6 59.26 42.11 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.387 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 44.5 Cg_endo -92.47 167.66 2.79 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.301 2.667 . . . . 0.0 113.756 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.453 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.4 OUTLIER -107.82 160.82 15.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.053 179.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.788 ' HB2' HG22 ' A' ' 293' ' ' ILE . 78.8 m-85 -133.93 -61.62 0.79 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.857 0.361 . . . . 0.0 111.236 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 54.76 36.9 27.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.536 ' O ' HG13 ' A' ' 292' ' ' VAL . 51.6 mt-10 -92.33 142.44 27.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 14.9 m -112.67 117.22 31.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.442 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.795 ' CE1' HG22 ' A' ' 328' ' ' THR . 81.2 m-85 -109.72 156.93 19.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.276 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 17.4 p -129.67 142.67 50.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 111.683 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -128.59 165.96 19.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.539 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -112.88 78.31 1.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.78 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.903 HG13 ' HB3' ' A' ' 351' ' ' GLN . 44.0 t -112.95 118.47 44.52 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.499 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 43.2 Cg_endo -68.7 151.87 74.52 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.286 1.991 . . . . 0.0 111.113 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -47.5 -24.39 0.83 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 354' ' ' LYS . 47.3 mt-10 -83.02 -20.7 34.53 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.903 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -93.67 -39.36 10.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.967 HD13 ' CD1' ' A' ' 282' ' ' TYR . 3.8 tp -45.62 -28.12 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.911 0.386 . . . . 0.0 110.994 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . 0.458 HE21 HD22 ' A' ' 394' ' ' LEU . 14.9 mm-40 -86.41 -31.11 21.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.806 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 350' ' ' GLU . 3.2 pttm -105.34 11.37 32.87 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.701 HG12 ' HG2' ' A' ' 318' ' ' GLN . 32.6 m -112.98 163.61 9.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.733 0.302 . . . . 0.0 110.883 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.2 126.51 18.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.222 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.527 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 86.5 t -89.56 134.06 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.195 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.527 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.5 OUTLIER -117.52 116.93 53.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.96 0.409 . . . . 0.0 111.692 -179.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.541 HG11 ' CD2' ' A' ' 278' ' ' PHE . 46.0 t -97.67 108.11 21.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.834 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.982 HG23 ' HB3' ' A' ' 375' ' ' LYS . 2.2 m -111.65 132.09 54.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.945 0.403 . . . . 0.0 111.978 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 1.009 HG22 HG22 ' A' ' 312' ' ' VAL . 52.7 t -106.59 113.8 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.906 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.701 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.1 mp -118.6 146.92 44.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.046 0.451 . . . . 0.0 111.69 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.53 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -92.9 134.33 35.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.443 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 365' ' ' ASP . 6.9 t80 -90.29 144.28 25.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.064 0.459 . . . . 0.0 110.911 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . 0.51 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 19.8 m-20 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.018 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.89 0.376 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -106.11 151.56 24.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.68 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.619 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.35 110.32 22.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.04 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.818 ' O ' HD22 ' A' ' 273' ' ' LEU . 36.9 mt -81.26 -34.17 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.196 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 170.63 178.01 41.05 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.098 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.982 ' HB3' HG23 ' A' ' 360' ' ' THR . 16.9 ptmt -164.44 140.47 6.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.192 0.52 . . . . 0.0 111.729 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.921 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.24 158.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.116 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.501 ' HB3' HG13 ' A' ' 358' ' ' VAL . 44.1 p90 -140.68 150.63 43.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 111.345 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 378' ' ' VAL . 15.4 m . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.997 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.485 0.183 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 31.0 tp -68.94 -32.82 72.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 110.336 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -66.93 -30.07 70.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.253 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.58 ' CD2' HD12 ' A' ' 280' ' ' LEU . 20.1 t-160 -77.9 -52.77 8.32 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.646 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.527 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 65.0 t-105 -51.57 -49.02 62.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.074 0.464 . . . . 0.0 109.764 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.2 t -65.69 -29.99 70.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.721 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.516 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.4 OUTLIER -62.54 -43.76 98.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.753 179.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.851 ' CE ' HD11 ' A' ' 352' ' ' ILE . 29.8 ttp -60.39 -52.48 65.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.665 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.739 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.7 mt -57.96 -33.37 68.79 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.36 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -67.89 -30.52 69.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.305 0.574 . . . . 0.0 109.692 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.3 m-80 -114.92 71.41 2.63 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.591 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.541 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 41.4 Cg_endo -68.7 32.95 0.16 Allowed 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.23 2.62 . . . . 0.0 113.534 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . 0.541 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 0.5 OUTLIER -158.77 -44.56 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.933 0.397 . . . . 0.0 110.77 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.417 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.0 OUTLIER -93.84 137.6 23.07 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.154 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 58.3 Cg_endo -71.43 156.37 58.51 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.571 2.181 . . . . 0.0 112.902 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -126.14 116.11 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.786 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.85 144.71 34.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.312 . . . . 0.0 110.828 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.34 154.25 10.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.37 . . . . 0.0 111.344 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -81.97 120.9 25.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.921 ' HB3' HG11 ' A' ' 376' ' ' VAL . 55.2 m-70 -109.61 122.36 47.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.457 HG23 ' OD1' ' A' ' 275' ' ' ASP . 85.4 m -78.26 117.27 19.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.674 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.761 HD23 HG22 ' A' ' 376' ' ' VAL . 45.2 mt -61.73 127.81 33.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.013 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -115.32 169.58 9.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.888 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.877 ' O ' HG23 ' A' ' 413' ' ' VAL . 41.1 t -55.59 121.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.973 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.619 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 6.7 mt-10 -55.17 -40.6 70.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.451 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.75 -51.13 71.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.469 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.456 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.1 mt-10 -63.57 -40.13 96.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 375' ' ' LYS . 98.6 t -56.45 -48.03 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.295 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 24.0 t0 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.745 179.89 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.772 HD22 ' O ' ' A' ' 373' ' ' ILE . 47.9 mt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.911 0.386 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 127.57 -162.52 21.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.335 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.32 133.37 22.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.691 0.281 . . . . 0.0 110.731 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.873 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -123.04 128.98 75.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.302 0.573 . . . . 0.0 111.165 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.873 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -96.26 126.71 41.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.556 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.622 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.2 p90 -142.16 149.51 39.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.474 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -100.94 160.47 14.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.04 -178.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.89 HD12 ' CD2' ' A' ' 389' ' ' HIS . 67.0 mt -130.21 147.05 51.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.162 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 290' ' ' THR . 0.7 OUTLIER -158.86 106.48 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 0.0 111.141 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 1.0 ' CD1' HD13 ' A' ' 352' ' ' ILE . 38.0 t80 -99.12 139.4 34.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.549 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 287' ' ' GLY . 98.9 t -114.89 93.8 35.54 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.97 0.414 . . . . 0.0 109.956 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.669 ' HD3' ' HB3' ' A' ' 397' ' ' PRO . 16.7 Cg_exo -66.33 -31.38 43.52 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.916 2.411 . . . . 0.0 112.343 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -28.39 67.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.807 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -123.66 -2.92 8.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.677 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 62.97 46.55 93.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.09 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -121.98 128.83 51.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.059 0.457 . . . . 0.0 111.338 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.462 HD21 ' CG2' ' A' ' 357' ' ' VAL . 32.8 tp -93.08 147.64 22.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.332 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 343' ' ' PHE . 1.8 m -136.0 137.34 41.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.344 0.592 . . . . 0.0 111.857 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.1 t -129.95 122.98 55.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.439 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 341' ' ' GLU . 24.0 t -116.21 116.12 51.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.979 0.418 . . . . 0.0 111.788 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.702 HG13 HG21 ' A' ' 328' ' ' THR . 34.8 mm -76.09 136.89 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.447 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.21 -59.62 1.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -177.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.486 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 2.2 pt-20 -175.64 156.79 1.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.479 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.793 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -117.59 150.63 38.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.766 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.405 ' HE3' ' CE3' ' A' ' 404' ' ' TRP . 11.3 pttp -147.73 152.36 37.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 111.507 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 62.92 24.24 14.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.833 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.793 HD21 ' HB1' ' A' ' 296' ' ' ALA . 60.7 mt -59.79 138.68 57.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.997 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -67.01 147.99 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.705 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.438 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 20.0 mttp -81.11 120.9 25.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.581 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.465 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 4.5 mmm -101.13 -15.38 17.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.644 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 52.9 m-20 -98.52 123.05 42.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.839 0.352 . . . . 0.0 110.548 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.0 t -48.07 114.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.627 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 56.77 17.89 22.86 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.274 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.13 -159.72 10.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.06 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 6.6 mt -95.56 -161.67 0.88 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 110.466 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.527 ' HB2' HD23 ' A' ' 335' ' ' LEU . 14.4 m -133.99 171.81 13.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.278 0.561 . . . . 0.0 111.181 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.418 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 13.7 m-20 -131.87 56.11 21.99 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.627 ' CG ' HD13 ' A' ' 299' ' ' LEU . 58.5 Cg_endo -73.01 146.28 41.29 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.047 2.498 . . . . 0.0 114.842 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.53 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 42.2 p90 -146.2 165.85 27.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.171 -1.377 . . . . 0.0 107.948 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.897 HG22 HG22 ' A' ' 361' ' ' VAL . 48.1 t -115.11 149.95 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.84 ' HE3' HD13 ' A' ' 362' ' ' LEU . 13.0 mttt -129.44 164.48 23.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.042 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.542 HG23 HG13 ' A' ' 357' ' ' VAL . 4.8 mp -137.86 124.97 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.689 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -119.46 135.56 54.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.89 0.376 . . . . 0.0 111.313 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 345' ' ' PHE . 20.5 tp -103.92 105.55 15.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.457 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.1 mtm -111.04 127.9 55.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.408 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.771 ' HB2' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -91.38 99.6 12.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.283 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 55.16 38.1 29.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.024 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 91.79 27.48 16.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.867 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 317' ' ' MET . 2.3 mptt -130.71 109.39 10.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.732 0.301 . . . . 0.0 110.843 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.503 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.9 OUTLIER -51.35 130.42 27.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.364 -179.793 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 318' ' ' GLN . 15.9 mt -124.58 -58.93 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.132 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.66 152.06 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.8 128.86 20.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.709 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -125.71 167.31 15.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.98 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.418 ' CB ' ' HG2' ' A' ' 313' ' ' LYS . 36.6 pttt -147.54 148.66 31.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.142 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.784 HG22 ' CE1' ' A' ' 343' ' ' PHE . 9.7 p -104.7 179.83 4.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.749 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.581 HG22 ' OE2' ' A' ' 341' ' ' GLU . 10.1 t -59.15 172.28 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.53 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.4 mt -116.96 125.1 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.955 0.407 . . . . 0.0 111.377 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.62 ' O ' HG22 ' A' ' 334' ' ' THR . 0.2 OUTLIER -91.08 91.45 8.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.281 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -58.83 137.09 57.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.833 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . 0.454 ' C ' HD13 ' A' ' 307' ' ' LEU . 0.9 OUTLIER 44.54 80.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.413 179.106 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.706 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.7 t -172.98 173.49 3.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.556 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 334' ' ' THR . 3.2 mt -146.99 -14.75 0.41 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.391 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.486 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.8 m-80 -135.81 57.63 19.78 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 120.704 0.288 . . . . 0.0 110.506 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 45.5 Cg_endo -92.79 167.82 2.58 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.155 2.57 . . . . 0.0 113.721 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.447 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.6 OUTLIER -106.31 160.76 15.12 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.192 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.623 ' HB2' HG22 ' A' ' 293' ' ' ILE . 66.1 m-85 -132.65 -66.83 0.67 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.916 0.388 . . . . 0.0 110.982 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 60.72 37.35 19.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.843 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.581 ' OE2' HG22 ' A' ' 329' ' ' THR . 29.9 mt-10 -93.65 143.91 25.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 93.1 p -113.21 121.92 45.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.007 0.432 . . . . 0.0 111.481 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.784 ' CE1' HG22 ' A' ' 328' ' ' THR . 36.7 m-85 -110.42 164.85 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.321 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 21.6 m -137.49 140.1 40.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.092 0.472 . . . . 0.0 111.679 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 316' ' ' LEU . 38.3 m-85 -126.88 166.0 18.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.503 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.33 72.99 0.79 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.727 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.824 HG13 ' HB3' ' A' ' 351' ' ' GLN . 46.9 t -108.38 121.08 44.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.135 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.562 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 68.5 Cg_endo -74.4 157.84 44.93 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.358 2.038 . . . . 0.0 111.247 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -50.9 -22.23 2.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -89.15 -8.46 53.65 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.824 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -111.98 -27.19 8.52 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 1.0 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.5 tp -48.37 -26.92 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.741 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . 0.544 ' NE2' HD13 ' A' ' 394' ' ' LEU . 3.6 mm-40 -95.09 -26.58 15.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.618 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -92.32 -0.66 57.37 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.883 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 351' ' ' GLN . 24.8 m -110.24 163.18 7.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.92 0.39 . . . . 0.0 111.317 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -139.24 126.33 21.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.62 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.542 HG13 HG23 ' A' ' 314' ' ' ILE . 98.9 t -90.88 111.81 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.533 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.529 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.6 OUTLIER -99.95 109.39 24.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.399 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.553 ' HB ' HG23 ' A' ' 376' ' ' VAL . 48.8 t -90.48 108.0 19.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.978 HG23 ' HB3' ' A' ' 375' ' ' LYS . 1.5 m -108.25 133.43 52.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.02 0.438 . . . . 0.0 111.894 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.897 HG22 HG22 ' A' ' 312' ' ' VAL . 51.1 t -108.3 114.8 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.839 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.84 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.5 mp -118.3 150.05 40.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.063 0.458 . . . . 0.0 111.838 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.465 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 1.3 t70 -95.53 132.36 40.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.679 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -83.74 146.2 28.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.538 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 . . . . . 0 CA--C 1.531 0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.7 -179.372 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.523 -0.068 0 CA-C-O 120.94 0.4 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.94 139.38 35.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.675 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -87.71 111.57 21.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.882 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.772 ' O ' HD22 ' A' ' 273' ' ' LEU . 37.2 mt -79.78 -34.42 15.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.01 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.92 -179.81 40.97 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.961 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.978 ' HB3' HG23 ' A' ' 360' ' ' THR . 9.6 ptmt -164.6 140.62 5.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.513 . . . . 0.0 111.81 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.957 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -109.47 158.89 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.128 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.471 ' CD1' HG13 ' A' ' 413' ' ' VAL . 17.6 p90 -139.58 151.4 46.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 0.0 111.813 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 378' ' ' VAL . 17.0 m . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.03 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.729 0.299 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.76 -35.96 79.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.463 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 392' ' ' ASP . 4.0 mtt85 -61.77 -41.37 97.62 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.978 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.89 ' CD2' HD12 ' A' ' 280' ' ' LEU . 13.9 t-160 -60.99 -55.69 29.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.738 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.469 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 62.5 t-105 -55.44 -50.99 68.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.462 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -37.26 86.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.312 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.554 ' HB3' HD12 ' A' ' 401' ' ' ILE . 14.8 m-20 -63.07 -32.83 74.29 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.712 ' CE ' HD11 ' A' ' 352' ' ' ILE . 26.0 ttp -63.42 -56.4 16.54 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.776 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -56.38 -23.26 36.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.715 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.4 ' C ' ' HD3' ' A' ' 397' ' ' PRO . . . -78.99 -33.63 44.87 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.372 0.606 . . . . 0.0 109.374 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.426 ' N ' ' HD3' ' A' ' 397' ' ' PRO . 28.6 m-80 -130.1 59.76 47.45 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.459 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.669 ' HB3' ' HD3' ' A' ' 284' ' ' PRO . 65.5 Cg_exo -46.28 -76.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.921 2.414 . . . . 0.0 112.992 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -49.45 -21.94 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.87 133.49 27.67 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 110.881 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.3 Cg_endo -75.21 133.76 16.66 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.492 2.128 . . . . 0.0 112.614 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.1 mm -111.68 110.75 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.803 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.18 143.96 34.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.783 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.43 152.39 7.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.874 0.369 . . . . 0.0 111.378 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . 0.405 ' CE3' ' HE3' ' A' ' 297' ' ' LYS . 63.3 m95 -80.12 124.09 28.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.686 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.957 ' HB3' HG11 ' A' ' 376' ' ' VAL . 61.0 m-70 -112.31 123.0 49.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.628 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 91.5 m -78.36 117.08 19.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.653 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.755 HD23 HG22 ' A' ' 376' ' ' VAL . 80.9 mt -62.45 127.73 32.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.077 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -115.85 170.26 8.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.791 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.857 ' O ' HG23 ' A' ' 413' ' ' VAL . 61.1 t -55.22 117.39 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.812 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.675 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 6.3 mp0 -52.01 -43.09 63.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.832 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -58.06 -50.16 74.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.738 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.455 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 23.0 mt-10 -64.04 -38.8 92.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 409' ' ' VAL . 89.0 t -57.43 -48.32 83.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.286 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 33.1 t0 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.468 179.504 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.792 HD22 ' O ' ' A' ' 373' ' ' ILE . 55.0 mt . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.922 0.391 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 135.16 -170.16 23.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.19 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . 0.64 ' OD1' HG23 ' A' ' 406' ' ' THR . 3.2 m-20 -136.74 135.15 37.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.719 0.295 . . . . 0.0 111.01 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.795 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -125.37 128.7 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.03 0.443 . . . . 0.0 110.875 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.795 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.5 OUTLIER -97.37 126.6 42.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.826 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.612 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.0 p90 -142.22 152.15 42.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.406 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.49 163.4 12.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.005 -178.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.673 HD12 ' CD2' ' A' ' 389' ' ' HIS . 96.1 mt -136.81 143.43 43.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.281 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -159.13 110.76 2.11 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.884 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.858 ' CD1' HD13 ' A' ' 352' ' ' ILE . 26.9 t80 -104.42 139.15 39.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.802 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.54 97.22 42.48 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.537 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.84 -33.47 7.9 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.669 2.246 . . . . 0.0 112.632 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -29.36 6.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.165 0.507 . . . . 0.0 109.983 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.29 -18.16 8.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.945 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.79 48.87 8.29 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.548 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -123.69 129.9 51.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.986 0.422 . . . . 0.0 111.621 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.904 HD11 ' HE1' ' A' ' 393' ' ' MET . 38.5 tp -97.42 147.49 24.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.977 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 2.8 m -137.61 137.21 38.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.429 0.633 . . . . 0.0 111.965 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.7 t -130.92 123.6 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.162 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 341' ' ' GLU . 23.9 t -117.9 115.13 47.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.057 0.456 . . . . 0.0 111.794 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.622 HG13 HG21 ' A' ' 328' ' ' THR . 40.0 mm -74.83 137.11 23.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.02 -59.4 2.02 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 4.7 pt-20 -175.75 162.89 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.415 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.739 ' CB ' HD11 ' A' ' 299' ' ' LEU . . . -122.31 153.06 39.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.897 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -149.61 150.02 31.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.104 0.478 . . . . 0.0 111.534 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 60.38 26.27 15.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.878 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.739 HD11 ' CB ' ' A' ' 296' ' ' ALA . 94.2 mt -62.08 138.75 58.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.832 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.81 150.7 23.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.57 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.409 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 23.6 mttt -91.58 115.84 28.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.423 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.516 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.5 mmt -88.56 -19.26 26.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.541 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 50.1 m-20 -99.26 112.16 24.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.512 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -49.27 116.37 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.476 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 65.69 12.74 57.5 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.536 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.17 -151.01 7.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.75 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 307' ' ' LEU . 10.6 mt -108.29 -161.51 0.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.697 0.284 . . . . 0.0 110.68 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.622 ' HB2' HD23 ' A' ' 335' ' ' LEU . 49.8 m -137.68 172.04 13.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.369 0.604 . . . . 0.0 111.276 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.407 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 8.7 m-20 -131.38 57.86 34.13 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.735 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.44 ' CB ' HD13 ' A' ' 299' ' ' LEU . 45.0 Cg_endo -69.74 151.92 69.32 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.196 2.597 . . . . 0.0 114.729 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.513 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 35.0 p90 -154.35 155.44 35.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.108 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.871 HG22 HG22 ' A' ' 361' ' ' VAL . 47.1 t -106.38 149.79 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.762 ' HE3' HD13 ' A' ' 362' ' ' LEU . 9.9 mtmt -131.93 140.99 49.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.307 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.551 HD11 HD11 ' A' ' 293' ' ' ILE . 5.3 mp -115.79 127.74 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.556 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . 0.415 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 57.7 m80 -122.39 133.4 54.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.369 . . . . 0.0 111.378 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.661 HD23 ' HG3' ' A' ' 324' ' ' LYS . 38.7 tp -106.39 107.53 18.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.095 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.1 mtm -116.12 147.82 40.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.391 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.67 ' HG3' HD11 ' A' ' 323' ' ' LEU . 1.4 mt-30 -107.0 99.47 9.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.521 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 56.55 37.83 29.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 96.6 13.82 46.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.166 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 317' ' ' MET . 32.3 mmtt -119.18 109.12 15.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.808 0.304 . . . . 0.0 110.734 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.48 135.37 56.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.4 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.67 HD11 ' HG3' ' A' ' 318' ' ' GLN . 3.3 mt -127.08 -49.36 1.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.849 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.661 ' HG3' HD23 ' A' ' 316' ' ' LEU . 2.5 mttt -130.53 148.97 52.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.962 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . 0.415 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -144.25 119.54 10.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.753 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -122.96 155.88 35.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.423 ' HB3' ' HG2' ' A' ' 313' ' ' LYS . 14.6 ptmt -137.58 148.58 45.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.842 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.73 HG22 ' CE1' ' A' ' 343' ' ' PHE . 4.3 p -101.71 -179.0 3.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.844 0.354 . . . . 0.0 110.712 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.0 t -60.45 162.2 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.468 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.513 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.6 mt -105.07 121.92 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.921 0.391 . . . . 0.0 111.219 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.479 ' HB3' HG21 ' A' ' 334' ' ' THR . 0.7 OUTLIER -85.6 94.65 9.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.109 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -60.8 136.8 58.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.928 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 43.83 83.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.51 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.738 ' O ' HD23 ' A' ' 335' ' ' LEU . 3.5 t -177.06 174.5 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.879 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 334' ' ' THR . 4.3 mt -145.26 -16.86 0.49 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.294 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 296' ' ' ALA . 1.1 m-80 -131.42 61.68 60.41 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.862 0.363 . . . . 0.0 110.05 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.413 ' HB2' ' CD ' ' A' ' 331' ' ' LYS . 64.6 Cg_endo -88.57 167.63 6.11 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.145 2.564 . . . . 0.0 114.045 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 58.8 t80 -114.09 153.18 29.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.846 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.538 ' HB2' HG22 ' A' ' 293' ' ' ILE . 83.9 m-85 -132.98 -69.83 0.55 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.85 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.505 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 26.2 t-20 64.45 37.21 8.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.505 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.541 ' O ' HG13 ' A' ' 292' ' ' VAL . 31.3 mt-10 -91.42 142.9 27.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.787 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 13.7 m -110.28 122.18 47.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 0.0 111.581 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.73 ' CE1' HG22 ' A' ' 328' ' ' THR . 65.6 m-85 -113.2 148.36 35.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.091 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 3.0 m -120.8 140.0 52.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.1 0.476 . . . . 0.0 111.554 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.511 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 45.0 m-85 -126.88 165.87 18.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.437 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -116.62 76.1 1.01 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.958 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.907 HG13 ' HB3' ' A' ' 351' ' ' GLN . 55.7 t -109.16 122.92 38.31 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.209 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.529 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.4 Cg_endo -72.3 156.43 54.93 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.293 1.996 . . . . 0.0 111.3 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -50.68 -21.92 1.82 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.67 -8.5 52.27 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.907 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -107.88 -31.36 8.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.858 HD13 ' CD1' ' A' ' 282' ' ' TYR . 6.4 tp -46.81 -27.28 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 111.319 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -90.02 -47.54 7.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.627 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.446 ' CG ' ' HA ' ' A' ' 351' ' ' GLN . 5.9 ptpt -80.72 2.18 27.1 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 351' ' ' GLN . 33.1 m -107.66 165.38 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.729 0.299 . . . . 0.0 110.872 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.67 126.46 15.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.087 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.561 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 61.4 t -88.54 114.14 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.276 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.498 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.4 OUTLIER -100.16 116.29 43.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.756 -179.169 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.553 HG13 ' CG1' ' A' ' 312' ' ' VAL . 58.3 t -98.46 108.11 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.856 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.932 HG23 ' HB3' ' A' ' 375' ' ' LYS . 1.6 m -108.73 132.68 53.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.998 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.871 HG22 HG22 ' A' ' 312' ' ' VAL . 54.6 t -105.93 114.96 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.636 178.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.762 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.3 mp -118.71 147.84 43.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.096 0.474 . . . . 0.0 111.895 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.516 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.8 t70 -93.8 137.36 33.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.744 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -90.09 145.62 24.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.376 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 . . . . . 0 C--N 1.33 -0.268 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.288 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.916 0.388 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.01 148.9 37.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.15 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.65 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -95.4 110.89 22.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.792 ' O ' HD22 ' A' ' 273' ' ' LEU . 23.9 mt -79.59 -32.88 14.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.316 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . 0.44 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 166.48 -178.87 40.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.746 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.932 ' HB3' HG23 ' A' ' 360' ' ' THR . 10.9 ptmt -164.54 141.04 6.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.181 0.515 . . . . 0.0 111.686 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.899 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.86 158.79 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.226 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.498 ' HB3' HG13 ' A' ' 358' ' ' VAL . 8.3 p90 -141.78 143.03 33.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.374 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 378' ' ' VAL . 7.6 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.082 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.409 ' OE1' ' CZ ' ' A' ' 377' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.57 0.224 . . . . 0.0 110.984 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.9 tp -67.96 -30.91 70.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.781 0.324 . . . . 0.0 110.43 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 5.1 ptt180 -68.23 -28.21 67.03 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.329 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.673 ' CD2' HD12 ' A' ' 280' ' ' LEU . 18.4 t-160 -81.33 -54.48 5.44 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.456 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.561 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 48.2 t-105 -49.96 -43.97 50.44 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.008 0.432 . . . . 0.0 109.863 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 31.3 t -69.72 -34.1 73.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.694 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.467 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.5 OUTLIER -61.08 -39.57 90.4 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.904 ' HE1' HD11 ' A' ' 289' ' ' LEU . 19.8 ttm -59.42 -53.79 54.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.115 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.798 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.9 mt -63.81 -29.74 70.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.374 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.82 -31.02 71.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.226 0.536 . . . . 0.0 109.694 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -125.3 77.86 67.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.329 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.537 ' HB3' ' CG ' ' A' ' 284' ' ' PRO . 6.0 Cg_exo -77.8 42.76 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.145 2.564 . . . . 0.0 113.162 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . 0.505 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 16.2 mmm-85 -158.98 -46.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.069 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.21 142.84 25.45 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.925 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 63.4 Cg_endo -73.01 156.27 52.2 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.654 2.236 . . . . 0.0 112.904 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.81 114.69 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.749 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.91 144.21 35.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.759 0.314 . . . . 0.0 110.832 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.43 154.68 10.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.959 0.409 . . . . 0.0 111.291 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -81.38 120.35 24.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.959 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.899 ' HB3' HG11 ' A' ' 376' ' ' VAL . 48.3 m-70 -109.56 117.72 34.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.459 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.64 HG23 ' OD1' ' A' ' 275' ' ' ASP . 89.8 m -78.43 116.22 18.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.792 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.825 HD23 HG22 ' A' ' 376' ' ' VAL . 93.7 mt -61.09 128.12 34.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.347 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.417 ' C ' HD12 ' A' ' 273' ' ' LEU . 5.2 mt-30 -115.47 171.96 7.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.558 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.888 ' O ' HG23 ' A' ' 413' ' ' VAL . 44.2 t -54.59 120.72 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.65 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 14.8 mt-10 -54.29 -41.56 69.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.815 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.16 -51.33 70.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 0.0 110.539 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.49 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 24.6 mt-10 -62.49 -39.83 94.73 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.889 HG11 ' HG3' ' A' ' 375' ' ' LYS . 75.6 t -57.64 -50.11 78.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.378 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 58.2 t0 . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.887 179.982 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 373' ' ' ILE . 22.0 mt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.827 0.346 . . . . 0.0 110.811 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 117.75 -163.98 12.73 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.177 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . 0.49 ' OD1' HG23 ' A' ' 406' ' ' THR . 28.3 m-20 -143.6 132.18 22.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.731 0.301 . . . . 0.0 110.589 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.912 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -121.04 131.57 72.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.184 0.516 . . . . 0.0 111.184 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.912 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -99.59 125.08 45.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.709 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.626 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 16.0 p90 -139.91 150.69 44.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.24 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.0 OUTLIER -99.62 158.03 16.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.056 -178.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.555 HD13 ' HE3' ' A' ' 393' ' ' MET . 77.3 mt -129.44 144.87 51.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.018 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.416 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 22.7 ttp85 -158.89 109.22 2.02 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.702 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.834 ' CD1' HD13 ' A' ' 352' ' ' ILE . 26.1 t80 -103.39 137.98 40.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.93 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.0 t -122.29 94.6 47.78 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.541 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.5 Cg_exo -70.04 -32.63 17.06 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.939 2.426 . . . . 0.0 112.44 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.44 -30.03 7.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.184 0.516 . . . . 0.0 110.015 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.53 -21.45 7.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.962 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.92 48.44 6.11 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.549 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -124.04 130.18 52.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.983 0.421 . . . . 0.0 111.803 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.754 HD11 ' HE1' ' A' ' 393' ' ' MET . 33.2 tp -95.66 147.5 23.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.74 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 343' ' ' PHE . 7.1 m -138.19 136.58 36.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.31 0.576 . . . . 0.0 112.001 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.36 123.92 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.297 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 341' ' ' GLU . 34.8 t -118.06 115.44 48.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.976 0.417 . . . . 0.0 112.006 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.712 HG22 ' HB2' ' A' ' 339' ' ' TYR . 31.3 mm -73.85 135.34 27.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.62 -62.76 1.53 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.486 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 1.6 pt-20 -175.55 150.15 1.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.247 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.87 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -110.46 157.77 19.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.168 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -150.98 153.41 35.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.014 0.435 . . . . 0.0 111.724 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 59.08 25.2 13.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.93 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.87 HD21 ' HB1' ' A' ' 296' ' ' ALA . 49.6 mt -59.04 138.63 57.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.168 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.83 144.78 47.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.415 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 25.5 mttp -85.69 109.64 18.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.42 ' HG2' ' HB3' ' A' ' 363' ' ' ASP . 0.0 OUTLIER -86.13 -21.62 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.872 -179.404 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 50.5 m-20 -95.39 123.56 38.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 20.5 t -54.19 117.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.546 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.11 16.74 34.61 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.407 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.84 -154.92 8.71 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.679 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 15.1 mt -102.26 -161.36 0.84 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.788 0.327 . . . . 0.0 110.43 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.646 ' HB2' HD23 ' A' ' 335' ' ' LEU . 68.8 m -135.32 172.05 13.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.231 0.539 . . . . 0.0 110.972 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -133.53 55.86 18.09 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.738 ' CG ' HD13 ' A' ' 299' ' ' LEU . 69.5 Cg_endo -76.71 142.58 23.02 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.944 2.429 . . . . 0.0 114.93 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.604 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 14.7 p90 -137.46 167.05 22.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.36 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.906 HG22 HG22 ' A' ' 361' ' ' VAL . 43.1 t -113.05 150.07 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.837 ' HE2' HD13 ' A' ' 362' ' ' LEU . 7.5 mttm -133.41 139.91 47.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.189 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 293' ' ' ILE . 5.4 mp -114.63 131.01 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.685 0.279 . . . . 0.0 111.03 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -127.37 134.08 49.97 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.863 0.363 . . . . 0.0 111.015 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 324' ' ' LYS . 22.5 tp -103.99 106.47 16.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.409 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.6 mtm -110.7 135.33 51.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.138 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.721 ' HB2' HD11 ' A' ' 323' ' ' LEU . 0.5 OUTLIER -95.48 99.46 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.546 179.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 59.58 35.66 22.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.301 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 98.21 7.99 55.56 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.676 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.712 ' HG3' HD21 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -115.47 112.74 22.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.387 0.593 . . . . 0.0 110.94 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.513 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.4 OUTLIER -52.25 134.19 33.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.526 -179.581 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.721 HD11 ' HB2' ' A' ' 318' ' ' GLN . 13.4 mt -125.91 -45.95 1.71 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.104 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 9.5 mmtp -130.59 153.63 48.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.364 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 117.31 10.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.903 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.451 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 3.4 mmtm -123.63 164.68 18.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.104 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.52 152.68 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.97 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.727 HG22 ' CE1' ' A' ' 343' ' ' PHE . 16.1 p -109.83 -178.89 3.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 11.3 t -63.0 165.85 6.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.604 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.9 mt -108.49 117.29 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 111.509 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.659 ' O ' HG22 ' A' ' 334' ' ' THR . 8.3 mmpt? -80.07 85.95 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.875 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -55.12 135.84 48.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.021 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.32 83.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.49 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.773 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.5 t -175.63 174.39 2.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.681 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.773 HD23 ' O ' ' A' ' 334' ' ' THR . 5.2 mt -145.59 -17.16 0.48 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.185 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.486 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.72 56.53 22.98 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.908 0.385 . . . . 0.0 110.123 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 42.7 Cg_endo -90.1 167.79 4.51 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.203 2.602 . . . . 0.0 113.746 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -109.63 159.6 16.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.167 179.244 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.712 ' HB2' HG22 ' A' ' 293' ' ' ILE . 51.1 m-85 -132.48 -62.32 0.83 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.68 37.42 25.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.564 ' O ' HG13 ' A' ' 292' ' ' VAL . 30.1 mt-10 -92.47 144.47 25.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.706 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 51.6 p -115.48 120.76 40.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.393 . . . . 0.0 111.749 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.727 ' CE1' HG22 ' A' ' 328' ' ' THR . 80.8 m-85 -112.38 155.06 24.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.11 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 83.4 p -127.16 139.62 52.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.083 0.468 . . . . 0.0 111.591 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.451 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 66.3 m-85 -127.89 165.86 19.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.545 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.56 79.93 1.33 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.998 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' A' ' 351' ' ' GLN . 47.9 t -112.16 118.99 45.04 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.991 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.449 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 37.2 Cg_endo -66.52 154.02 75.88 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.321 2.014 . . . . 0.0 111.353 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -51.9 -24.74 6.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.752 0.31 . . . . 0.0 111.444 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.27 -8.57 57.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.54 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.551 ' HB3' HG13 ' A' ' 347' ' ' VAL . 31.2 mt-30 -105.99 -37.14 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.667 0.27 . . . . 0.0 111.329 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.834 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.7 tp -47.13 -25.52 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 111.195 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -88.99 -24.86 22.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.831 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.41 ' HG3' ' HA ' ' A' ' 351' ' ' GLN . 0.6 OUTLIER -111.69 2.14 17.08 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.012 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 351' ' ' GLN . 33.8 m -96.77 167.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.766 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -141.28 126.33 18.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.928 0.394 . . . . 0.0 111.472 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.571 ' CG2' HD21 ' A' ' 289' ' ' LEU . 99.6 t -96.93 115.33 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.833 178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.4 OUTLIER -101.22 117.17 46.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.529 ' HB ' HG23 ' A' ' 376' ' ' VAL . 45.9 t -98.22 107.85 20.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.435 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.966 HG23 ' HB3' ' A' ' 375' ' ' LYS . 4.7 m -111.28 129.58 55.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.054 0.454 . . . . 0.0 111.9 -178.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.906 HG22 HG22 ' A' ' 312' ' ' VAL . 58.5 t -103.81 121.1 54.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.074 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.837 HD13 ' HE2' ' A' ' 313' ' ' LYS . 2.8 mp -123.18 146.26 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 111.816 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 310' ' ' PRO . 5.0 t70 -90.17 137.62 32.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.642 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.405 ' CB ' HG21 ' A' ' 330' ' ' ILE . 25.0 t80 -94.14 142.52 27.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.425 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.584 -179.488 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.902 0.382 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . 0.415 ' HB2' ' HG2' ' A' ' 302' ' ' MET . 1.3 m-20 -71.23 147.25 48.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.51 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -91.7 110.22 21.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.094 0.473 . . . . 0.0 111.373 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.589 ' O ' HD22 ' A' ' 273' ' ' LEU . 2.4 mm -71.95 -35.57 54.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.783 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . 0.426 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 157.38 -175.16 34.84 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.117 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.966 ' HB3' HG23 ' A' ' 360' ' ' THR . 9.9 ptmt -164.1 140.5 6.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.287 0.565 . . . . 0.0 111.906 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.944 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.71 158.85 13.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.219 179.375 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.513 ' HB3' HG13 ' A' ' 358' ' ' VAL . 2.6 p90 -140.45 150.85 44.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.563 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.151 179.837 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 . . . . . 0 CA--C 1.52 -0.197 0 CA-C-O 120.903 0.382 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.45 -30.91 71.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.368 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 4.7 ptt180 -65.52 -28.63 69.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.312 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.441 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 19.7 t-160 -81.56 -58.13 3.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.715 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.561 ' CZ3' ' HE1' ' A' ' 393' ' ' MET . 73.9 t-105 -49.82 -46.32 50.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.07 0.462 . . . . 0.0 109.979 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 5.4 t -64.49 -32.94 74.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.593 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.54 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.6 OUTLIER -65.47 -40.46 93.19 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.776 ' SD ' HD11 ' A' ' 352' ' ' ILE . 7.1 ttm -57.86 -53.06 62.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.378 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.724 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.8 mt -61.94 -34.37 75.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.359 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.65 -29.71 69.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.181 0.515 . . . . 0.0 109.943 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -114.1 71.04 2.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.754 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.543 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 48.6 Cg_endo -70.07 33.98 0.21 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.167 2.578 . . . . 0.0 113.486 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . 0.543 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 10.2 mmm180 -159.25 -47.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.952 0.406 . . . . 0.0 110.952 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.486 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 36.1 ttt180 -93.94 136.66 23.55 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.385 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.486 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 48.6 Cg_endo -68.48 156.41 65.71 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.601 2.201 . . . . 0.0 112.939 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.54 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.37 118.72 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.797 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -105.64 144.58 32.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.839 0.352 . . . . 0.0 110.729 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.07 154.51 15.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.159 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -85.81 119.28 25.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.774 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.944 ' HB3' HG11 ' A' ' 376' ' ' VAL . 58.4 m-70 -108.56 122.16 46.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.251 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.49 HG23 ' OD1' ' A' ' 275' ' ' ASP . 89.9 m -78.08 117.41 19.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.721 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.737 HD23 HG22 ' A' ' 376' ' ' VAL . 67.5 mt -61.66 127.57 32.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.2 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.477 ' C ' HD12 ' A' ' 273' ' ' LEU . 6.0 mt-30 -115.0 169.07 9.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.755 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.889 ' O ' HG23 ' A' ' 413' ' ' VAL . 45.0 t -56.76 121.25 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.479 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 5.7 mt-10 -52.2 -44.83 64.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.993 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.06 -49.66 75.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 110.74 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.444 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 29.8 mt-10 -64.59 -38.76 92.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 409' ' ' VAL . 96.3 t -58.24 -49.49 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.381 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 t70 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.829 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.793 HD22 ' O ' ' A' ' 373' ' ' ILE . 60.8 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.868 0.366 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.24 -165.73 13.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.233 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.18 133.06 27.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.806 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -121.94 129.56 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.088 0.47 . . . . 0.0 110.914 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.806 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -96.86 125.35 41.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.668 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.609 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.6 p90 -142.08 149.29 39.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.406 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.97 161.31 13.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.269 -178.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.635 HD12 ' CD2' ' A' ' 389' ' ' HIS . 11.3 mt -133.27 149.67 51.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.942 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.418 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.1 OUTLIER -158.92 105.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.446 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.908 ' CD1' HD13 ' A' ' 352' ' ' ILE . 30.7 t80 -98.19 134.87 40.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.832 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.51 97.88 48.56 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.526 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.9 Cg_exo -72.46 -31.49 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.691 2.261 . . . . 0.0 112.377 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.26 -30.26 6.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.294 0.569 . . . . 0.0 109.715 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.16 -17.38 8.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.767 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.11 47.94 10.46 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.689 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -123.31 129.38 51.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.934 0.397 . . . . 0.0 111.853 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.464 HD21 ' CG2' ' A' ' 357' ' ' VAL . 36.5 tp -92.59 147.66 22.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.796 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 2.9 m -137.16 138.54 40.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.323 0.582 . . . . 0.0 112.091 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.1 t -131.42 123.91 53.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.449 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 341' ' ' GLU . 29.0 t -116.74 115.3 48.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.942 0.401 . . . . 0.0 111.848 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.712 HG13 HG21 ' A' ' 328' ' ' THR . 31.6 mm -75.83 133.7 30.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.57 -59.86 1.89 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.476 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 7.3 pt-20 -175.72 165.17 3.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.241 0.543 . . . . 0.0 112.081 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.911 ' CB ' HD11 ' A' ' 299' ' ' LEU . . . -127.84 155.35 44.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.258 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.402 ' HD2' ' CH2' ' A' ' 404' ' ' TRP . 10.4 ptmt -149.7 150.2 31.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 111.5 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 59.87 26.34 15.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.735 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.911 HD11 ' CB ' ' A' ' 296' ' ' ALA . 87.5 mt -64.83 139.0 58.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.108 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -57.62 145.61 33.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.381 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.622 ' HG3' HD21 ' A' ' 335' ' ' LEU . 0.0 OUTLIER -94.94 127.77 41.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.405 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.509 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 14.7 mmt -97.78 -9.82 25.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.405 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 25.4 m-20 -108.52 119.17 38.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.718 0.294 . . . . 0.0 110.445 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.32 118.77 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.576 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 76.86 2.18 75.83 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.195 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . 0.407 ' O ' HD23 ' A' ' 307' ' ' LEU . . . -120.82 -123.26 3.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.932 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 333' ' ' ASN . 44.0 mt -137.32 -159.28 0.94 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.906 0.384 . . . . 0.0 110.071 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.506 ' HB3' ' HD3' ' A' ' 310' ' ' PRO . 0.2 OUTLIER -140.13 167.98 20.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.933 0.397 . . . . 0.0 110.255 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.08 64.43 52.8 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 308' ' ' SER . 60.7 Cg_endo -74.03 142.68 31.49 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.827 2.351 . . . . 0.0 114.697 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 43.1 p90 -144.25 158.52 43.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.212 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.838 HG22 HG22 ' A' ' 361' ' ' VAL . 44.2 t -107.82 149.91 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.409 0.623 . . . . 0.0 112.625 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.854 ' HE3' HD13 ' A' ' 362' ' ' LEU . 9.7 mtmt -132.85 136.94 46.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.517 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.576 HG23 HG13 ' A' ' 357' ' ' VAL . 5.4 mp -107.97 136.97 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.513 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 77.9 m80 -130.89 133.6 46.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.379 . . . . 0.0 111.131 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.474 HD21 HG22 ' A' ' 347' ' ' VAL . 35.0 tp -106.79 110.23 22.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.376 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.7 mtm -118.99 139.73 51.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.939 0.4 . . . . 0.0 111.378 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.551 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.1 OUTLIER -99.63 99.44 10.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.411 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 53.02 38.1 26.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.4 26.82 12.83 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.87 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.8 mptt -129.23 109.3 11.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.706 0.288 . . . . 0.0 110.779 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.501 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -52.14 130.0 29.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.52 -179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.551 HD11 ' CB ' ' A' ' 318' ' ' GLN . 11.5 mt -125.86 -55.04 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.973 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -130.62 150.71 51.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.319 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . 0.422 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -144.45 123.41 12.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.422 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 21.6 mmtt -125.19 170.79 10.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.407 ' HB3' ' HG2' ' A' ' 313' ' ' LYS . 0.5 OUTLIER -150.25 147.01 27.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.897 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.755 HG22 ' CE1' ' A' ' 343' ' ' PHE . 5.5 p -104.27 -178.71 3.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.758 0.313 . . . . 0.0 110.782 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 13.9 t -60.33 164.02 4.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.432 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.569 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.9 mt -108.11 116.87 52.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.973 0.416 . . . . 0.0 111.379 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.612 ' O ' HG22 ' A' ' 334' ' ' THR . 0.7 OUTLIER -78.81 85.93 4.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.034 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -53.51 136.45 38.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.167 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . 0.529 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.1 p-10 43.6 86.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.277 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.627 ' O ' HD23 ' A' ' 335' ' ' LEU . 5.0 t 177.31 173.16 0.5 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.52 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.627 HD23 ' O ' ' A' ' 334' ' ' THR . 2.8 mt -144.28 -15.29 0.58 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.357 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.434 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.0 OUTLIER -132.6 61.14 55.11 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-O 120.857 0.361 . . . . 0.0 110.039 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 52.0 Cg_endo -91.21 167.71 3.55 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.196 2.597 . . . . 0.0 114.028 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.476 ' CD1' ' HB3' ' A' ' 295' ' ' GLU . 20.7 t80 -110.76 154.09 24.41 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.748 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.553 ' HB2' HG22 ' A' ' 293' ' ' ILE . 75.8 m-85 -131.39 -68.93 0.64 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.855 0.36 . . . . 0.0 111.727 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.421 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 0.1 OUTLIER 63.71 36.65 10.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.703 -179.4 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.551 ' O ' HG13 ' A' ' 292' ' ' VAL . 37.4 mt-10 -91.8 144.68 25.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.6 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 51.5 p -114.87 121.81 44.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.934 0.397 . . . . 0.0 111.656 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.755 ' CE1' HG22 ' A' ' 328' ' ' THR . 63.6 m-85 -113.75 151.84 31.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.163 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 87.9 p -125.97 138.89 53.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.155 0.502 . . . . 0.0 111.789 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.435 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 56.9 m-85 -125.42 166.05 17.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.585 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -113.27 78.21 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.913 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.89 HG13 ' HB3' ' A' ' 351' ' ' GLN . 48.6 t -110.6 122.12 39.25 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.82 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.525 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.4 Cg_endo -72.54 157.55 52.51 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.352 2.035 . . . . 0.0 111.657 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -51.46 -21.89 2.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.841 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.33 -8.54 53.04 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.89 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -109.86 -30.31 7.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.908 HD13 ' CD1' ' A' ' 282' ' ' TYR . 6.4 tp -47.4 -28.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.811 0.338 . . . . 0.0 111.026 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -95.0 -25.82 16.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.897 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -95.1 0.84 54.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.875 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 351' ' ' GLN . 17.2 m -113.18 161.11 12.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.833 0.349 . . . . 0.0 111.302 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -137.1 126.34 24.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.713 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 314' ' ' ILE . 91.6 t -87.08 107.43 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.402 . . . . 0.0 110.248 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.453 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.7 OUTLIER -93.36 113.68 28.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.592 -179.29 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.542 ' HB ' HG23 ' A' ' 376' ' ' VAL . 41.7 t -96.69 107.74 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.915 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.959 HG23 ' HB3' ' A' ' 375' ' ' LYS . 1.7 m -109.01 131.34 55.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.966 0.412 . . . . 0.0 111.774 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.838 HG22 HG22 ' A' ' 312' ' ' VAL . 50.5 t -106.16 114.95 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.946 178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.854 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.5 mp -118.3 150.54 39.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.025 0.44 . . . . 0.0 111.885 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.509 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.1 t70 -94.76 131.37 40.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.361 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.467 ' CB ' HG21 ' A' ' 330' ' ' ILE . 25.1 t80 -85.67 146.91 26.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.759 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.321 -179.553 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.874 0.369 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . 0.429 ' HB2' ' HG3' ' A' ' 302' ' ' MET . 1.8 m-20 -85.8 151.3 23.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.035 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.604 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.07 111.34 23.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.974 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.793 ' O ' HD22 ' A' ' 273' ' ' LEU . 31.3 mt -80.97 -34.08 13.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.086 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . 0.455 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 167.29 -178.96 41.16 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.88 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.959 ' HB3' HG23 ' A' ' 360' ' ' THR . 14.7 ptmt -164.59 141.07 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.196 0.522 . . . . 0.0 111.792 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.95 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.78 158.99 13.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.189 179.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.453 ' HB3' HG13 ' A' ' 358' ' ' VAL . 2.8 p90 -141.04 144.77 35.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 0.0 111.266 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 378' ' ' VAL . 13.5 m . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.115 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.567 0.223 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 20.5 tp -66.13 -31.75 72.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.867 0.365 . . . . 0.0 110.387 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -65.12 -29.69 70.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.456 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.635 ' CD2' HD12 ' A' ' 280' ' ' LEU . 20.3 t-160 -77.99 -53.07 7.84 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.535 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 55.7 t-105 -51.36 -49.23 61.89 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.177 0.513 . . . . 0.0 109.993 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -29.32 69.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.696 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.469 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.5 OUTLIER -61.98 -42.54 99.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.672 178.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.747 ' CE ' HD11 ' A' ' 352' ' ' ILE . 27.9 ttp -59.53 -52.61 64.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.58 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.771 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.9 mt -60.87 -30.01 69.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.361 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.98 -33.02 75.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.218 0.532 . . . . 0.0 109.584 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -126.24 77.9 71.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.278 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.539 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 2.7 Cg_exo -75.79 44.37 1.27 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.238 2.625 . . . . 0.0 113.258 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . 0.539 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 0.4 OUTLIER -158.12 -46.52 0.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.231 179.675 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.428 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.3 OUTLIER -94.15 139.43 22.53 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.721 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 56.7 Cg_endo -70.48 156.16 62.05 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.548 2.165 . . . . 0.0 113.015 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.02 113.73 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.603 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.24 145.01 32.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.731 0.301 . . . . 0.0 110.801 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.95 154.39 11.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.912 0.386 . . . . 0.0 111.195 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . 0.402 ' CH2' ' HD2' ' A' ' 297' ' ' LYS . 64.0 m95 -81.6 120.52 25.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.95 ' HB3' HG11 ' A' ' 376' ' ' VAL . 49.1 m-70 -108.86 121.87 45.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.427 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.0 m -78.3 116.44 18.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.89 HD23 HG22 ' A' ' 376' ' ' VAL . 96.6 mt -62.45 128.1 34.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.004 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.441 ' C ' HD12 ' A' ' 273' ' ' LEU . 7.6 mt-30 -116.9 171.64 7.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.778 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.897 ' O ' HG23 ' A' ' 413' ' ' VAL . 43.5 t -56.57 120.81 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.604 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 19.0 mt-10 -53.73 -43.25 68.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.857 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -57.31 -49.52 75.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 0.0 110.602 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.448 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 30.7 mt-10 -64.55 -39.28 93.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 409' ' ' VAL . 74.8 t -58.57 -49.93 80.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.258 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 18.3 t0 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.921 179.918 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.81 HD22 ' O ' ' A' ' 373' ' ' ILE . 42.5 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.83 0.347 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 125.17 -160.63 19.77 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.271 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . 0.485 ' OD1' HG23 ' A' ' 406' ' ' THR . 11.9 m-20 -147.13 131.93 17.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.733 0.301 . . . . 0.0 110.75 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.796 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -119.97 132.2 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.144 0.497 . . . . 0.0 111.174 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.796 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -99.48 126.01 45.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.758 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.617 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.7 p90 -141.94 151.53 42.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.303 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.68 160.75 14.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.987 -178.451 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.674 HD12 ' CD2' ' A' ' 389' ' ' HIS . 98.2 mt -134.44 144.18 47.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.318 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -159.02 111.19 2.18 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.909 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . 0.923 ' CD1' HD13 ' A' ' 352' ' ' ILE . 25.1 t80 -104.45 138.85 40.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.977 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.04 94.29 47.37 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.544 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.5 Cg_exo -70.24 -33.86 14.01 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.916 2.411 . . . . 0.0 112.385 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -30.23 5.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.157 0.503 . . . . 0.0 110.019 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.72 -20.0 8.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.985 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.75 48.16 6.8 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.639 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.57 130.27 52.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.008 0.433 . . . . 0.0 111.703 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.967 HD11 ' HE1' ' A' ' 393' ' ' MET . 28.7 tp -97.82 147.53 24.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.868 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 343' ' ' PHE . 12.2 m -138.82 136.67 35.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.272 0.558 . . . . 0.0 112.002 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.411 HG21 HG11 ' A' ' 357' ' ' VAL . 11.9 t -129.15 125.36 62.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.372 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 341' ' ' GLU . 24.5 t -119.2 115.34 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.965 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.715 HG13 HG21 ' A' ' 328' ' ' THR . 34.3 mm -74.69 137.02 23.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.463 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.6 OUTLIER -114.22 -62.22 1.63 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.456 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 1.9 pt-20 -175.02 150.27 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.568 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.756 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -109.5 154.65 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.931 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.92 152.42 33.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.045 0.45 . . . . 0.0 111.552 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 61.29 24.19 14.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.853 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.756 HD21 ' HB1' ' A' ' 296' ' ' ALA . 66.5 mt -59.14 141.23 54.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.109 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.524 ' HD2' ' HE2' ' A' ' 302' ' ' MET . 3.5 ttmt -63.69 146.4 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.424 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.611 ' HE3' HD11 ' A' ' 335' ' ' LEU . 17.8 mttt -84.91 116.99 23.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.522 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' MET . . . . . 0.524 ' HE2' ' HD2' ' A' ' 300' ' ' LYS . 10.5 mmt -93.46 -18.89 21.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.488 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 35.7 m-20 -103.98 102.65 12.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.852 0.358 . . . . 0.0 110.573 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.14 116.46 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.445 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 83.98 -4.34 83.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.811 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.53 -149.1 7.23 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.881 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 60.3 mt -107.49 -159.97 0.71 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.01 0.433 . . . . 0.0 110.79 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.624 ' HB2' HD23 ' A' ' 335' ' ' LEU . 73.4 m -132.9 172.22 12.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.252 0.549 . . . . 0.0 110.725 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.92 57.58 32.71 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.673 ' CG ' HD13 ' A' ' 299' ' ' LEU . 74.2 Cg_endo -76.23 143.42 25.29 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.02 2.48 . . . . 0.0 114.901 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.619 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 8.5 p90 -140.48 168.12 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.124 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.858 HG22 HG22 ' A' ' 361' ' ' VAL . 42.5 t -116.36 149.96 18.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.371 0.605 . . . . 0.0 112.508 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.665 ' HE3' HD13 ' A' ' 362' ' ' LEU . 9.2 mttm -131.0 152.76 49.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.383 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.56 HG23 HG13 ' A' ' 357' ' ' VAL . 5.3 mp -123.18 135.09 64.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.763 0.316 . . . . 0.0 110.579 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 79.9 m80 -130.98 132.54 45.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.35 . . . . 0.0 110.994 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.3 tp -105.79 106.67 17.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.407 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.8 mtm -111.58 126.78 55.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.131 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.961 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.4 OUTLIER -95.77 99.56 11.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.477 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 59.91 37.76 21.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.706 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.09 21.43 49.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.675 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -121.65 109.65 15.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.745 0.307 . . . . 0.0 110.806 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 10.8 ptt85 -51.25 128.07 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.351 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.961 HD11 ' CB ' ' A' ' 318' ' ' GLN . 9.3 mt -123.6 -49.53 1.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -135.03 147.92 49.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . 0.42 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.4 OUTLIER -144.09 120.56 11.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.584 179.616 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -125.5 166.43 16.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.231 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -142.87 149.92 39.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.793 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.715 HG21 HG13 ' A' ' 293' ' ' ILE . 20.7 p -104.75 176.52 5.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.029 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.2 p -59.6 162.43 5.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.577 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.619 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.2 mt -105.84 123.88 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 111.434 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.619 ' O ' HG22 ' A' ' 334' ' ' THR . 9.7 mmtm -89.16 88.17 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.049 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -55.1 136.3 48.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.987 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' ASN . . . . . 0.409 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.3 p-10 43.91 87.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.311 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.772 ' O ' HD23 ' A' ' 335' ' ' LEU . 3.9 t -179.11 174.55 1.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.518 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.772 HD23 ' O ' ' A' ' 334' ' ' THR . 4.7 mt -145.96 -16.91 0.46 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.203 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' ASN . . . . . 0.467 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.5 m-80 -133.46 57.77 28.85 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.774 0.321 . . . . 0.0 110.283 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 53.3 Cg_endo -90.16 167.76 4.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.204 2.602 . . . . 0.0 113.738 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' TYR . . . . . 0.463 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.5 OUTLIER -110.15 159.07 17.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.305 179.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' TYR . . . . . 0.612 ' HB2' HG22 ' A' ' 293' ' ' ILE . 6.1 m-85 -134.25 -62.29 0.76 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.31 38.65 23.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.669 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.557 ' O ' HG13 ' A' ' 292' ' ' VAL . 32.1 mt-10 -91.91 143.2 26.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.77 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 4.2 m -114.03 119.51 37.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 111.656 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' PHE . . . . . 0.708 ' CE1' HG22 ' A' ' 328' ' ' THR . 78.3 m-85 -111.02 153.77 25.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.248 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 73.5 m -128.38 142.29 51.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.012 0.434 . . . . 0.0 111.408 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -130.85 165.87 22.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -114.02 76.22 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.675 HG13 ' HB3' ' A' ' 351' ' ' GLN . 48.2 t -109.04 125.27 31.93 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.017 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.537 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 73.9 Cg_endo -76.67 155.42 35.35 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.499 2.132 . . . . 0.0 111.678 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -50.95 -23.13 2.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.839 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.23 -8.6 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' GLN . . . . . 0.675 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -112.69 -31.69 6.67 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.696 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.923 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.0 tp -47.98 -27.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 111.134 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' GLN . . . . . 0.424 HE21 HD22 ' A' ' 394' ' ' LEU . 21.8 mt-30 -92.14 -20.69 20.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.616 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -99.92 -21.32 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.679 0.276 . . . . 0.0 111.638 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.92 167.88 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.919 0.39 . . . . 0.0 111.222 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -148.59 126.95 12.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.028 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.584 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 47.7 t -86.9 114.19 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.637 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.636 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.2 OUTLIER -97.63 109.68 23.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.205 -179.514 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.526 ' HB ' HG23 ' A' ' 376' ' ' VAL . 26.8 t -93.48 107.76 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.979 HG23 ' HB3' ' A' ' 375' ' ' LYS . 11.0 m -109.33 141.08 42.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.91 0.386 . . . . 0.0 111.575 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.858 HG22 HG22 ' A' ' 312' ' ' VAL . 41.8 t -115.46 120.2 64.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.072 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.665 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.5 mp -124.62 147.21 48.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.058 0.456 . . . . 0.0 111.679 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.522 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.9 OUTLIER -91.96 134.47 34.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.328 179.552 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 365' ' ' ASP . 7.0 t80 -90.83 141.73 28.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.0 110.831 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . 0.463 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 14.0 m-20 . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.89 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.13 0 CA-C-O 120.85 0.357 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.81 149.39 21.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.52 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.3 110.99 23.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.12 0.486 . . . . 0.0 110.977 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.81 ' O ' HD22 ' A' ' 273' ' ' LEU . 43.6 mt -83.44 -34.54 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.192 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.57 175.02 37.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.037 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.979 ' HB3' HG23 ' A' ' 360' ' ' THR . 11.6 ptmt -160.47 140.96 11.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.217 0.532 . . . . 0.0 111.779 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.943 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -111.61 159.21 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.472 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.636 ' HB3' HG13 ' A' ' 358' ' ' VAL . 20.8 p90 -143.1 131.98 22.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.985 0.422 . . . . 0.0 111.133 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 378' ' ' VAL . 19.6 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.045 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.667 0.27 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 42.0 tp -59.38 -33.95 71.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 0.0 110.582 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 23.6 mtm180 -61.46 -49.34 77.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.343 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.674 ' CD2' HD12 ' A' ' 280' ' ' LEU . 14.8 t-160 -60.76 -57.93 10.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.792 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' TRP . . . . . 0.584 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 58.0 t-105 -49.52 -44.29 46.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.05 0.452 . . . . 0.0 110.004 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 4.7 t -68.57 -36.81 79.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.803 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' ASP . . . . . 0.437 ' HB3' HD12 ' A' ' 401' ' ' ILE . 1.9 t0 -63.08 -36.22 82.85 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' MET . . . . . 0.967 ' HE1' HD11 ' A' ' 289' ' ' LEU . 10.2 ttm -61.84 -55.09 33.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.189 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.752 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.1 mt -60.85 -33.26 72.79 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.331 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.37 -29.81 70.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.276 0.56 . . . . 0.0 109.84 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -114.97 71.68 2.73 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.596 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.544 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 50.4 Cg_endo -70.47 33.88 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.186 2.59 . . . . 0.0 113.616 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . 0.518 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 23.7 mmm-85 -159.51 -44.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.922 0.391 . . . . 0.0 110.972 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.4 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 1.7 tpp180 -93.96 140.48 22.96 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.455 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 57.0 Cg_endo -70.43 156.47 61.53 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.742 2.295 . . . . 0.0 112.751 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -128.15 113.45 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.818 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.27 144.46 32.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 110.82 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.67 153.71 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.963 0.411 . . . . 0.0 111.235 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . 0.413 ' CZ3' ' HB2' ' A' ' 277' ' ' CYS . 55.8 m95 -83.02 120.01 25.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.943 ' HB3' HG11 ' A' ' 376' ' ' VAL . 45.4 m-70 -108.21 120.82 43.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.576 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.485 HG23 ' OD1' ' A' ' 275' ' ' ASP . 89.2 m -78.36 116.21 18.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.024 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.879 HD23 HG22 ' A' ' 376' ' ' VAL . 84.8 mt -62.47 128.2 34.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.288 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -114.82 170.9 7.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.512 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 413' ' ' VAL . 47.0 t -52.71 115.77 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.52 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 4.1 mp0 -54.77 -43.07 72.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.79 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -55.35 -47.55 75.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.802 0.334 . . . . 0.0 110.537 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.441 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 35.2 mt-10 -64.24 -48.71 74.74 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 409' ' ' VAL . 92.0 t -48.86 -45.41 15.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.771 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.8 t70 . . . . . 0 C--N 1.333 -0.147 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.837 179.067 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.82 0.343 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 373' ' ' ILE . 34.8 mt -108.84 -40.16 5.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.92 -162.71 16.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.266 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -144.01 135.41 25.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.77 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.875 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -124.46 128.95 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.097 0.475 . . . . 0.0 110.914 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.875 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -98.03 127.15 43.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.717 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.615 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.5 p90 -141.85 150.26 41.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.012 0.434 . . . . 0.0 110.341 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.62 161.67 13.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.018 -178.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.746 HD12 ' CD2' ' A' ' 389' ' ' HIS . 94.8 mt -133.57 143.9 48.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.15 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.94 106.82 1.84 Allowed 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.972 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.918 ' CD1' HD13 ' A' ' 352' ' ' ILE . 25.7 t80 -100.68 137.44 39.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.986 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.61 94.76 48.38 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.547 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 8.1 Cg_exo -69.89 -33.9 15.21 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.937 2.425 . . . . 0.0 112.425 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.51 -30.19 4.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.196 0.522 . . . . 0.0 110.042 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.44 -20.29 8.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.967 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.31 48.65 6.7 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.542 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -124.58 129.8 51.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 0.0 111.792 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.791 HD11 ' HE1' ' A' ' 393' ' ' MET . 33.2 tp -95.42 147.6 23.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.805 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 7.4 m -138.48 134.52 34.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.385 0.612 . . . . 0.0 111.936 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 8.7 t -127.24 123.13 61.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.206 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 341' ' ' GLU . 22.1 t -117.24 114.95 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.912 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.688 HG13 HG21 ' A' ' 328' ' ' THR . 35.9 mm -74.59 136.95 24.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.424 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.02 -60.9 1.82 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.44 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 0.9 OUTLIER -175.61 157.42 2.05 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.488 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.833 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -117.12 151.73 36.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.773 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -148.08 153.54 39.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.612 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 60.98 23.98 14.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.872 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.833 HD21 ' HB1' ' A' ' 296' ' ' ALA . 50.3 mt -58.92 138.79 57.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.07 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.04 146.9 53.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.504 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.43 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 16.0 mttt -85.41 114.39 22.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.581 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.458 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 9.9 mmm -92.93 -18.81 22.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.729 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 46.7 m-20 -96.17 118.35 32.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.844 0.355 . . . . 0.0 110.635 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.15 116.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.426 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 60.05 16.57 41.14 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.334 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.59 -157.08 9.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.8 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 16.5 mt -100.82 -160.38 0.79 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 110.492 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.542 ' HB2' HD23 ' A' ' 335' ' ' LEU . 15.2 m -135.07 172.03 13.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.239 0.542 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.419 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 8.9 m-20 -133.69 56.36 19.89 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.738 ' CG ' HD13 ' A' ' 299' ' ' LEU . 64.6 Cg_endo -75.39 141.71 25.86 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.044 2.496 . . . . 0.0 114.75 -177.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.568 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 17.1 p90 -139.85 165.31 27.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.424 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.849 HG22 HG22 ' A' ' 361' ' ' VAL . 42.4 t -112.81 149.98 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.822 ' HE2' HD13 ' A' ' 362' ' ' LEU . 6.6 mttm -132.02 151.92 51.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.197 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.469 HG23 HG13 ' A' ' 357' ' ' VAL . 5.2 mp -125.51 133.96 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.763 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.44 125.69 37.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.815 0.34 . . . . 0.0 111.181 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.499 HD23 ' HG3' ' A' ' 324' ' ' LYS . 27.5 tp -96.01 106.68 18.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.312 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.4 mtm -112.68 145.6 40.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 111.467 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.729 ' CG ' HD11 ' A' ' 323' ' ' LEU . 0.9 OUTLIER -99.44 99.73 10.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.066 179.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 10.9 p30 42.83 37.45 1.08 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.386 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 104.46 28.85 5.59 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.982 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 317' ' ' MET . 0.2 OUTLIER -136.99 109.38 7.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.725 0.298 . . . . 0.0 110.885 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.407 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.1 OUTLIER -54.13 130.84 39.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.729 HD11 ' CG ' ' A' ' 318' ' ' GLN . 7.6 mt -125.0 -51.66 1.67 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.202 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.499 ' HG3' HD23 ' A' ' 316' ' ' LEU . 2.2 mttt -130.62 153.42 48.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.037 0.446 . . . . 0.0 111.516 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.11 130.5 33.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.431 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.447 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 44.6 mmtt -135.44 160.38 38.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.96 0.409 . . . . 0.0 111.314 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 0.0 OUTLIER -148.68 143.52 26.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.796 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.739 HG22 ' CE1' ' A' ' 343' ' ' PHE . 14.5 p -101.22 176.63 5.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.95 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 10.1 t -56.96 169.88 0.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.504 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.568 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.3 mt -112.39 120.59 62.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.948 0.404 . . . . 0.0 111.465 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.662 ' O ' HG22 ' A' ' 334' ' ' THR . 3.7 mmpt? -82.74 84.59 7.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.762 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.23 135.45 44.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.082 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.3 83.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.39 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.695 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.8 t -176.86 174.08 1.82 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.748 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 334' ' ' THR . 4.3 mt -145.06 -16.33 0.51 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.322 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.49 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 4.9 m-80 -132.9 55.63 18.19 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.863 0.364 . . . . 0.0 110.213 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 51.4 Cg_endo -88.64 167.64 6.02 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.137 2.558 . . . . 0.0 113.636 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.44 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -110.9 160.02 17.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.3 179.181 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.626 ' HB2' HG22 ' A' ' 293' ' ' ILE . 86.6 m-85 -133.45 -63.63 0.75 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 111.325 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 58.36 37.55 25.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.753 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.545 ' O ' HG13 ' A' ' 292' ' ' VAL . 41.9 mt-10 -91.39 142.99 27.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.808 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.94 120.08 40.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.416 . . . . 0.0 111.566 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.739 ' CE1' HG22 ' A' ' 328' ' ' THR . 52.2 m-85 -112.58 146.74 38.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.208 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 18.1 p -118.97 142.2 47.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 0.0 111.457 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.447 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 40.0 m-85 -129.63 165.83 20.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.517 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -116.57 79.81 1.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.512 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.656 HG11 ' HA ' ' A' ' 352' ' ' ILE . 24.7 t -110.11 122.74 37.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.438 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 24.4 Cg_exo -62.19 147.92 94.15 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.51 2.14 . . . . 0.0 111.464 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -53.95 -24.02 15.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 111.336 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -91.64 -8.66 46.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.564 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.431 ' CB ' ' HD2' ' A' ' 348' ' ' PRO . 1.1 tt0 -106.52 -25.54 11.8 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.918 HD13 ' CD1' ' A' ' 282' ' ' TYR . 2.1 tp -48.68 -27.68 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 110.66 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . 0.458 HE21 HD22 ' A' ' 394' ' ' LEU . 20.2 mt-30 -90.57 -23.08 20.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.107 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -95.58 -4.83 43.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 31.3 m -106.61 167.77 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.881 0.372 . . . . 0.0 111.306 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -144.49 126.49 15.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.039 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.639 ' O ' HG22 ' A' ' 378' ' ' VAL . 66.8 t -90.83 115.64 30.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.268 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.3 OUTLIER -101.29 116.83 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.755 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.549 ' HB ' HG23 ' A' ' 376' ' ' VAL . 48.3 t -97.33 108.06 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.939 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.96 HG23 ' HB3' ' A' ' 375' ' ' LYS . 6.5 m -110.68 133.81 53.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.027 0.442 . . . . 0.0 111.801 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.849 HG22 HG22 ' A' ' 312' ' ' VAL . 42.9 t -107.57 119.8 57.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.13 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.822 HD13 ' HE2' ' A' ' 313' ' ' LYS . 3.5 mp -121.46 148.0 45.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.978 0.418 . . . . 0.0 111.741 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.458 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 4.1 t70 -92.8 131.97 37.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.358 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.573 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 26.0 t80 -87.97 146.95 25.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.66 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 367' ' ' ILE . 23.2 m-20 -142.73 61.62 1.42 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.462 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.625 ' HG2' HD12 ' A' ' 367' ' ' ILE . 12.9 tttp 34.78 -89.66 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.625 HD12 ' HG2' ' A' ' 366' ' ' LYS . 4.5 mp -84.82 -66.42 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.694 0.283 . . . . 0.0 111.209 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -43.53 163.5 0.04 OUTLIER Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.925 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 31.2 tttp -65.79 159.34 25.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.22 122.15 28.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.17 151.02 44.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.431 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.836 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -95.89 109.8 22.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 0.0 111.352 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.466 ' O ' HD22 ' A' ' 273' ' ' LEU . 0.9 OUTLIER -73.34 -35.25 45.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.78 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 156.13 179.05 30.88 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.059 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.96 ' HB3' HG23 ' A' ' 360' ' ' THR . 0.0 OUTLIER -160.23 142.32 12.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.363 0.601 . . . . 0.0 112.029 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.913 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -109.22 158.67 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.879 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.591 ' HB3' HG13 ' A' ' 358' ' ' VAL . 19.7 p90 -141.41 141.96 33.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.059 0.457 . . . . 0.0 111.721 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 357' ' ' VAL . 17.1 m -132.29 135.72 57.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.791 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.453 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 144.14 -156.15 26.59 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.145 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -46.42 -73.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.48 -23.66 6.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.032 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . 0.413 ' O ' HG23 ' A' ' 383' ' ' THR . 12.1 m -65.19 159.81 22.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 110.857 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 382' ' ' SER . 39.3 p -158.04 155.08 28.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.002 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 78.6 -128.85 8.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.65 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -67.29 -29.91 69.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 111.264 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.404 ' HB2' ' HB3' ' A' ' 382' ' ' SER . 1.3 mt-10 -71.94 -49.02 41.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.614 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.47 -34.62 78.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.569 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 385' ' ' ALA . 4.5 ptm180 -64.18 -35.78 81.89 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.269 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.746 ' CD2' HD12 ' A' ' 280' ' ' LEU . 18.8 t-160 -67.43 -53.56 28.03 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.163 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.537 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 68.2 t-105 -54.99 -40.62 70.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.017 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -42.13 76.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.989 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 7.7 t0 -59.86 -34.31 72.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.638 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.791 ' HE1' HD11 ' A' ' 289' ' ' LEU . 8.4 ttm -60.36 -56.65 18.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.405 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.768 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.0 OUTLIER -58.82 -29.96 67.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.472 178.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.55 -31.49 70.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.188 0.518 . . . . 0.0 109.942 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -114.29 70.79 2.09 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.639 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.55 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 43.4 Cg_endo -69.08 35.37 0.19 Allowed 'Trans proline' 0 N--CA 1.474 0.364 0 C-N-CA 123.291 2.661 . . . . 0.0 113.642 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . 0.55 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 19.8 mmt85 -159.95 -44.35 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.955 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.91 142.17 24.68 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.57 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 58.3 Cg_endo -71.18 156.38 59.48 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.661 2.241 . . . . 0.0 112.953 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -127.74 110.26 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.664 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -103.73 144.36 31.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.844 0.354 . . . . 0.0 110.833 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.25 153.21 11.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.29 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -81.95 120.72 25.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.736 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.913 ' HB3' HG11 ' A' ' 376' ' ' VAL . 60.5 m-70 -111.28 118.37 35.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 85.0 m -78.24 116.7 18.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.946 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.791 HD23 HG22 ' A' ' 376' ' ' VAL . 95.9 mt -61.59 127.35 31.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.313 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -113.42 167.17 10.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.54 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 413' ' ' VAL . 90.5 t -52.58 117.85 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.836 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 8.6 mt-10 -50.48 -45.79 56.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.153 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -55.34 -45.96 76.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 0.0 110.947 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.499 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 16.5 mt-10 -66.71 -38.58 87.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 409' ' ' VAL . 73.4 t -58.39 -48.15 85.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.255 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -65.73 -31.78 72.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.537 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.21 80.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.586 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . 0.403 ' SD ' ' CE1' ' A' ' 377' ' ' PHE . 15.0 mtt -65.33 -50.05 67.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.461 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.2 mt -58.17 -30.68 66.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.941 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.49 118.98 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.04 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.081 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.848 0.356 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 373' ' ' ILE . 63.8 mt -90.74 -32.79 16.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 118.2 -166.08 12.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.231 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.533 ' OD1' HG23 ' A' ' 406' ' ' THR . 12.3 m-20 -142.86 132.53 23.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.776 0.322 . . . . 0.0 110.63 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.846 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -120.17 130.75 73.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.163 0.506 . . . . 0.0 111.03 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.846 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.84 124.7 42.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.732 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.659 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 19.1 p90 -141.96 148.22 38.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.436 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 292' ' ' VAL . 0.0 OUTLIER -101.04 160.9 13.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.175 -178.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.609 HD12 ' CD2' ' A' ' 389' ' ' HIS . 9.2 mt -133.66 150.25 51.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.03 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -158.81 112.14 2.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.243 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.92 ' CD1' HD13 ' A' ' 352' ' ' ILE . 32.7 t80 -106.14 131.66 53.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.766 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.46 98.04 50.94 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.501 ' CG ' ' CB ' ' A' ' 397' ' ' PRO . 6.4 Cg_exo -71.06 -33.26 12.02 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.673 2.249 . . . . 0.0 112.67 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.2 -29.76 6.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.181 0.515 . . . . 0.0 110.058 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.81 -21.67 8.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.957 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.81 48.78 6.41 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.747 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -124.98 130.05 51.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.994 0.426 . . . . 0.0 111.68 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.469 HD21 ' CG2' ' A' ' 357' ' ' VAL . 30.5 tp -93.79 147.89 22.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.092 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.9 m -135.16 140.66 45.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.305 0.574 . . . . 0.0 112.022 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 18.2 t -134.01 120.91 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.357 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 341' ' ' GLU . 32.3 t -116.19 116.3 51.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.012 0.434 . . . . 0.0 112.057 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.683 HG22 ' HB2' ' A' ' 339' ' ' TYR . 40.1 mm -74.96 135.69 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.649 HD22 ' OE1' ' A' ' 295' ' ' GLU . 0.7 OUTLIER -113.47 -61.89 1.67 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.649 ' OE1' HD22 ' A' ' 294' ' ' LEU . 11.1 pm0 -174.16 148.16 1.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.512 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.808 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -108.38 153.63 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.006 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.84 152.49 33.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.077 0.465 . . . . 0.0 111.488 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 61.02 24.75 14.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.808 HD21 ' HB1' ' A' ' 296' ' ' ALA . 60.3 mt -59.66 139.01 57.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.222 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.68 143.77 53.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.404 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.427 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 15.9 mttp -84.61 115.18 22.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.601 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.52 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.6 mmt -90.74 -20.0 22.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.408 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 41.9 m-20 -99.81 123.79 44.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.876 0.369 . . . . 0.0 110.709 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 48.8 t -60.56 118.83 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.215 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 64.0 13.51 53.04 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.718 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.89 -144.46 6.19 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.694 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' A' ' 333' ' ' ASN . 19.9 mt -115.46 -159.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.848 0.356 . . . . 0.0 110.511 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 334' ' ' THR . 5.6 m -138.26 172.01 13.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.314 0.578 . . . . 0.0 110.92 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.96 71.5 77.9 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.616 ' CG ' HD13 ' A' ' 299' ' ' LEU . 95.3 Cg_endo -87.73 143.27 6.07 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.526 2.151 . . . . 0.0 115.351 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.581 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 9.8 p90 -139.49 167.65 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.039 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.802 HG22 HG22 ' A' ' 361' ' ' VAL . 42.7 t -118.0 149.56 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.386 0.612 . . . . 0.0 112.504 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.827 ' HE3' HD13 ' A' ' 362' ' ' LEU . 13.8 mttt -131.09 146.97 52.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.292 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.475 ' N ' HD12 ' A' ' 314' ' ' ILE . 4.6 mp -122.6 131.87 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.622 0.248 . . . . 0.0 111.089 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -130.17 134.89 47.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.93 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 347' ' ' VAL . 26.7 tp -104.14 107.17 17.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.612 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.74 126.67 52.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.904 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.4 OUTLIER -95.16 99.8 11.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 60.15 37.92 20.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.727 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.03 22.35 45.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.78 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt -123.85 109.56 13.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.452 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -54.19 130.7 39.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.904 HD11 ' CB ' ' A' ' 318' ' ' GLN . 6.9 mt -126.71 -42.21 1.79 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.234 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -130.6 147.69 52.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.212 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 115.61 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.954 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -124.09 166.51 15.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.48 149.51 30.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.07 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.662 HG21 HG13 ' A' ' 293' ' ' ILE . 21.2 p -106.11 174.05 6.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.736 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.76 174.07 0.37 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.43 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.581 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.7 mt -119.87 118.96 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.051 0.453 . . . . 0.0 111.688 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.732 ' HB3' HG21 ' A' ' 334' ' ' THR . 0.0 OUTLIER -82.57 91.19 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.249 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -56.88 137.21 55.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.885 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . 0.51 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.0 OUTLIER 46.85 83.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.592 179.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.749 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.5 t -177.2 174.05 1.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.486 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.749 HD23 ' O ' ' A' ' 334' ' ' THR . 4.0 mt -146.17 -16.22 0.45 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.401 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.478 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.9 m-80 -133.97 57.18 22.97 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.486 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 59.2 Cg_endo -90.41 167.74 4.23 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.095 2.53 . . . . 0.0 113.662 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.411 ' CZ ' ' OE1' ' A' ' 295' ' ' GLU . 1.3 t80 -105.26 160.68 14.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.201 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.683 ' HB2' HG22 ' A' ' 293' ' ' ILE . 9.3 m-85 -131.72 -65.38 0.76 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.963 0.411 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 59.11 36.85 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.946 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.559 ' O ' HG13 ' A' ' 292' ' ' VAL . 41.8 mt-10 -93.92 144.79 25.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.78 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 98.5 p -116.56 123.07 46.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 0.0 111.375 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.61 ' CE1' HG22 ' A' ' 328' ' ' THR . 66.0 m-85 -116.35 150.61 37.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.192 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 41.8 p -121.53 143.16 49.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.119 0.485 . . . . 0.0 111.462 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -129.58 164.95 22.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.572 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.71 80.32 1.36 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.637 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 351' ' ' GLN . 71.0 t -113.09 123.77 32.88 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.117 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 351' ' ' GLN . 56.1 Cg_endo -70.69 153.4 64.66 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.491 2.127 . . . . 0.0 111.523 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -51.21 -24.14 4.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.489 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -85.42 -8.6 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.823 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.753 ' O ' HG22 ' A' ' 355' ' ' VAL . 24.5 mt-30 -107.21 -36.79 6.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.653 0.264 . . . . 0.0 111.62 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.92 HD13 ' CD1' ' A' ' 282' ' ' TYR . 6.1 tp -46.45 -27.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.846 0.355 . . . . 0.0 111.118 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . 0.441 ' O ' ' CD1' ' A' ' 380' ' ' TYR . 1.7 mt-30 -90.77 -27.79 18.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.678 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.503 ' HA ' ' CD1' ' A' ' 380' ' ' TYR . 14.9 ptmt -109.95 15.67 22.44 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 351' ' ' GLN . 31.1 m -116.09 167.91 8.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.766 0.317 . . . . 0.0 110.64 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . 0.446 HE21 HD23 ' A' ' 417' ' ' LEU . 3.0 mt-30 -140.11 138.65 35.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.0 0.429 . . . . 0.0 111.447 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.511 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 91.9 t -104.39 106.96 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.903 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.506 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.3 OUTLIER -91.01 114.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.98 0.419 . . . . 0.0 112.033 -178.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.533 ' HB ' HG23 ' A' ' 376' ' ' VAL . 43.9 t -98.73 108.08 21.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.637 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.969 HG23 ' HB3' ' A' ' 375' ' ' LYS . 3.5 m -109.27 136.11 49.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 0.0 111.995 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.802 HG22 HG22 ' A' ' 312' ' ' VAL . 47.2 t -111.1 120.25 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.913 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.827 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.6 mp -122.45 150.22 42.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.032 0.444 . . . . 0.0 111.718 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.52 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.9 t70 -96.4 131.26 43.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.586 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.572 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 27.3 t80 -83.96 146.82 27.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.535 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 367' ' ' ILE . 35.9 m-20 -140.36 65.55 1.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.323 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.666 ' HB2' HD12 ' A' ' 367' ' ' ILE . 18.4 mttt 28.12 -84.91 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.666 HD12 ' HB2' ' A' ' 366' ' ' LYS . 5.0 mp -86.38 -70.68 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.807 0.337 . . . . 0.0 111.26 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -44.12 164.28 0.04 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.149 -0.548 . . . . 0.0 113.024 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 40.6 tttt -66.01 161.34 21.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.9 134.03 35.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.811 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.78 139.94 30.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.54 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -86.91 110.87 20.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.111 0.481 . . . . 0.0 110.899 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.806 ' O ' HD22 ' A' ' 273' ' ' LEU . 33.4 mt -80.34 -34.64 14.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.073 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.22 178.92 39.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.303 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.969 ' HB3' HG23 ' A' ' 360' ' ' THR . 17.2 ptmt -162.75 141.27 8.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.179 0.514 . . . . 0.0 111.604 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.848 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.24 158.77 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.103 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.505 ' HB3' HG13 ' A' ' 358' ' ' VAL . 13.3 p90 -141.77 145.2 34.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.801 0.334 . . . . 0.0 111.039 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 378' ' ' VAL . 20.4 m -141.46 114.21 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.166 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.455 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 167.01 -148.89 13.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.049 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.503 ' CD1' ' HA ' ' A' ' 354' ' ' LYS . 0.0 OUTLIER -50.08 -75.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.76 0.314 . . . . 0.0 111.349 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -69.82 80.72 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.816 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 383' ' ' THR . 15.6 m -165.14 163.39 20.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.797 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 382' ' ' SER . 43.9 p -158.09 147.87 19.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.735 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 94.02 -157.75 22.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.618 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -45.46 -31.24 1.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -63.88 -55.06 25.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.858 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 48.6 tp -57.56 -36.62 71.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.625 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 5.1 mtp85 -60.6 -46.75 89.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.384 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.609 ' CD2' HD12 ' A' ' 280' ' ' LEU . 18.6 t-160 -61.76 -56.22 21.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.511 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 63.5 t-105 -50.91 -49.64 59.17 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.153 0.501 . . . . 0.0 109.723 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.9 t -65.03 -30.39 71.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.606 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.455 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.6 OUTLIER -62.36 -42.32 99.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.968 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.42 ' CE ' ' CZ3' ' A' ' 390' ' ' TRP . 22.3 ttp -58.66 -55.58 33.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.68 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.807 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.8 mt -59.21 -24.63 63.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.567 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 392' ' ' ASP . . . -67.65 -34.95 77.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -126.96 74.03 76.48 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.466 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.501 ' CB ' ' CG ' ' A' ' 284' ' ' PRO . 8.4 Cg_exo -72.38 50.4 1.59 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.997 2.465 . . . . 0.0 113.032 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . 0.485 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 4.5 mmm180 -158.37 -45.69 0.06 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.178 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -94.27 158.48 35.79 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.353 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 90.5 Cg_endo -87.56 138.71 4.63 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.012 2.475 . . . . 0.0 112.815 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.461 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.1 mm -112.14 120.16 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.587 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -112.07 145.23 40.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.758 0.313 . . . . 0.0 110.938 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -163.04 155.26 18.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 0.0 111.349 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -83.13 116.38 22.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.697 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.848 ' HB3' HG11 ' A' ' 376' ' ' VAL . 29.3 m-70 -103.81 120.75 41.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.78 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.533 HG23 ' OD1' ' A' ' 275' ' ' ASP . 86.9 m -78.18 116.44 18.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.226 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.73 HD23 HG22 ' A' ' 376' ' ' VAL . 67.3 mt -61.64 127.44 31.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.218 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -114.16 168.82 9.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.878 ' O ' HG23 ' A' ' 413' ' ' VAL . 61.2 t -55.73 119.93 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.54 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 19.4 mt-10 -53.52 -42.34 67.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.756 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.58 -50.06 74.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.332 . . . . 0.0 110.613 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.462 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.1 mt-10 -64.52 -38.27 90.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 409' ' ' VAL . 81.0 t -59.06 -49.96 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.351 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.43 ' HA ' HD12 ' A' ' 417' ' ' LEU . 1.6 m-20 -61.16 -36.51 80.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.926 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -69.52 -36.07 76.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.067 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 44.6 mtm -70.2 -36.37 74.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.446 HD23 HE21 ' A' ' 356' ' ' GLN . 15.2 mt -69.27 -31.16 69.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.973 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -71.52 145.56 49.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 29.0 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.074 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.839 0.352 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.789 HD22 ' O ' ' A' ' 373' ' ' ILE . 68.6 mt -85.93 -31.89 21.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.09 -165.63 13.61 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.036 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.549 ' OD1' HG23 ' A' ' 406' ' ' THR . 14.6 m-20 -141.94 136.95 30.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.332 . . . . 0.0 110.827 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.893 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -124.11 130.22 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.139 0.495 . . . . 0.0 110.919 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.893 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.2 126.23 42.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.76 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.622 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.7 p90 -142.08 151.19 42.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.331 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.1 OUTLIER -99.67 162.25 13.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.027 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.603 HD12 ' CD2' ' A' ' 389' ' ' HIS . 94.4 mt -134.74 144.15 47.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.085 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.4 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 9.7 ttm180 -159.13 106.55 1.79 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.966 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.896 ' CD1' HD13 ' A' ' 352' ' ' ILE . 28.9 t80 -101.22 137.21 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.845 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 44.9 t -122.31 97.79 44.79 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.524 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.53 -32.62 9.59 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.687 2.258 . . . . 0.0 112.612 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.04 -30.12 5.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.193 0.521 . . . . 0.0 109.919 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.52 -18.95 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.909 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 77.48 48.59 7.95 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.692 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -123.79 130.14 52.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 111.745 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.799 HD11 ' HE1' ' A' ' 393' ' ' MET . 34.8 tp -96.09 147.63 23.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.924 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 343' ' ' PHE . 4.9 m -136.35 138.42 41.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.356 0.598 . . . . 0.0 112.045 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.486 HG21 HG11 ' A' ' 357' ' ' VAL . 17.1 t -131.95 120.97 45.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.312 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 341' ' ' GLU . 30.5 t -116.97 115.56 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.08 0.467 . . . . 0.0 111.938 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.832 HG22 ' HB2' ' A' ' 339' ' ' TYR . 37.0 mm -74.17 136.98 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 277' ' ' CYS . 0.3 OUTLIER -112.44 -61.48 1.72 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.028 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.443 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 0.3 OUTLIER -175.71 151.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.24 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.74 ' HB3' HD11 ' A' ' 299' ' ' LEU . . . -112.48 152.66 28.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.849 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.426 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 7.8 pttt -149.07 152.64 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.478 . . . . 0.0 111.458 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 60.04 27.09 16.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.565 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' ' 296' ' ' ALA . 87.1 mt -63.97 139.21 58.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.951 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -60.59 149.61 34.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.514 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.403 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 8.4 mttp -90.03 119.32 30.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.573 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.508 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.7 mmt -92.26 -17.24 25.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.402 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 54.4 m-20 -99.66 115.77 30.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.849 0.357 . . . . 0.0 110.601 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.58 116.06 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.445 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.09 47.27 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.45 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.6 -156.89 9.35 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.704 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 307' ' ' LEU . 7.9 mt -101.43 -161.05 0.83 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.837 0.351 . . . . 0.0 110.789 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.614 ' HB2' HD23 ' A' ' 335' ' ' LEU . 66.6 m -139.51 172.19 13.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.302 0.573 . . . . 0.0 111.11 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.411 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -129.73 57.49 31.02 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.455 ' CB ' HD13 ' A' ' 299' ' ' LEU . 37.5 Cg_endo -68.29 150.82 76.65 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.146 2.564 . . . . 0.0 114.688 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.571 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 53.0 p90 -154.36 156.7 37.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.249 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.834 HG22 HG22 ' A' ' 361' ' ' VAL . 36.6 t -106.73 149.8 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.834 ' HE3' HD13 ' A' ' 362' ' ' LEU . 12.1 mtmt -130.39 152.81 49.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.253 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.421 ' CG2' HG13 ' A' ' 357' ' ' VAL . 5.4 mp -126.51 133.35 68.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.521 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' A' ' 325' ' ' LYS . 13.3 m80 -129.85 127.35 40.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.143 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.48 HD21 HG22 ' A' ' 347' ' ' VAL . 22.0 tp -100.04 105.1 16.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.453 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.2 mtm -108.06 138.86 43.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.28 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.821 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -100.56 99.58 10.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.364 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 57.21 37.36 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.82 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 91.18 28.72 14.17 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.804 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.31 109.58 9.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.762 0.315 . . . . 0.0 110.988 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 13.3 mtm-85 -49.77 128.5 18.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.292 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.821 HD11 ' CB ' ' A' ' 318' ' ' GLN . 11.4 mt -123.31 -49.63 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.232 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -130.59 150.93 51.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.345 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . 0.422 ' HA ' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -134.92 132.33 38.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.678 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.461 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 14.5 mmtt -138.25 159.53 41.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.889 0.376 . . . . 0.0 111.133 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -148.15 143.38 27.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.81 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.776 HG22 ' CE1' ' A' ' 343' ' ' PHE . 5.1 p -99.46 178.89 4.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.331 . . . . 0.0 110.689 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.2 t -59.81 162.61 5.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.264 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.571 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -106.27 122.28 59.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.884 0.373 . . . . 0.0 111.273 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.659 ' O ' HG22 ' A' ' 334' ' ' THR . 2.2 mmpt? -85.4 89.86 7.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.075 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -55.39 136.53 49.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.857 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 43.68 84.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.316 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.758 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.9 t -177.21 174.01 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.814 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 334' ' ' THR . 4.4 mt -146.42 -16.27 0.44 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.258 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.0 m-80 -132.24 57.69 31.31 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 120.72 0.295 . . . . 0.0 110.446 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 43.5 Cg_endo -92.4 167.79 2.82 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.26 2.64 . . . . 0.0 113.73 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.438 ' CG ' ' HB3' ' A' ' 295' ' ' GLU . 0.2 OUTLIER -106.99 160.81 15.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.235 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.832 ' HB2' HG22 ' A' ' 293' ' ' ILE . 47.7 m-85 -134.84 -51.62 0.79 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.689 0.281 . . . . 0.0 111.269 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.457 ' ND2' ' C ' ' A' ' 339' ' ' TYR . 1.8 p30 44.45 36.12 1.56 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.105 0.479 . . . . 0.0 110.975 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.544 ' O ' HG13 ' A' ' 292' ' ' VAL . 28.0 mt-10 -91.02 140.68 29.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 80.6 p -110.85 121.36 45.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.936 0.398 . . . . 0.0 111.667 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.776 ' CE1' HG22 ' A' ' 328' ' ' THR . 82.9 m-85 -111.31 156.65 21.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.01 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 56.5 m -130.91 138.65 49.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.449 . . . . 0.0 111.698 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.461 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 63.8 m-85 -127.91 165.92 19.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.604 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -115.5 79.12 1.25 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.247 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.535 HG13 ' HB3' ' A' ' 351' ' ' GLN . 37.3 t -106.44 123.19 39.58 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.268 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 35.5 Cg_exo -60.28 150.89 77.56 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.576 2.184 . . . . 0.0 111.855 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -57.16 -23.83 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -91.53 -8.59 47.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.491 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.535 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -105.2 -24.41 12.74 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.896 HD13 ' CD1' ' A' ' 282' ' ' TYR . 3.2 tp -53.0 -27.61 13.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 0.0 110.759 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . 0.412 ' O ' ' CD1' ' A' ' 380' ' ' TYR . 14.1 mt-30 -95.01 3.05 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.378 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.469 ' HA ' ' CD1' ' A' ' 380' ' ' TYR . 24.2 mtpp -122.27 -20.78 6.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.6 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.652 HG12 ' HG2' ' A' ' 318' ' ' GLN . 34.4 m -87.87 167.9 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 111.483 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . 0.535 ' OE1' HD23 ' A' ' 417' ' ' LEU . 35.3 mt-30 -139.92 126.55 20.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.522 ' CG2' HD21 ' A' ' 289' ' ' LEU . 52.4 t -95.17 103.68 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.099 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.609 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.4 OUTLIER -92.04 115.55 31.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.903 -179.007 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.559 ' HB ' HG23 ' A' ' 376' ' ' VAL . 56.7 t -94.92 108.18 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.463 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 1.006 HG23 ' HB3' ' A' ' 375' ' ' LYS . 2.3 m -110.59 134.43 52.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 0.0 112.014 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.834 HG22 HG22 ' A' ' 312' ' ' VAL . 48.6 t -109.58 115.12 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.276 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.834 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.9 mp -118.28 148.61 42.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 111.467 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.508 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.1 OUTLIER -98.43 125.02 43.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.444 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 26.9 t80 -72.45 144.56 48.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 367' ' ' ILE . 19.8 m-20 -132.72 72.4 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.071 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.649 ' HG2' HD12 ' A' ' 367' ' ' ILE . 0.0 OUTLIER 32.96 -88.79 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.685 ' H ' HD12 ' A' ' 367' ' ' ILE . 5.2 mp -22.96 -86.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -161.47 -55.67 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.632 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -65.42 141.71 58.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.928 0.394 . . . . 0.0 110.616 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . 0.421 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 0.7 OUTLIER -120.98 148.85 43.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.842 -179.529 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.59 149.33 25.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.3 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.792 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.29 111.49 23.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.789 ' O ' HD22 ' A' ' 273' ' ' LEU . 32.8 mt -79.62 -33.99 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.186 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 169.01 179.2 40.92 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.08 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 1.006 ' HB3' HG23 ' A' ' 360' ' ' THR . 15.6 ptmt -164.56 141.34 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.109 0.481 . . . . 0.0 111.794 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.909 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.67 158.81 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.29 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.549 ' HB3' HG13 ' A' ' 358' ' ' VAL . 6.7 p90 -138.32 140.97 39.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 111.334 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 378' ' ' VAL . 28.0 m -139.85 104.85 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.914 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.514 ' HA2' ' CG ' ' A' ' 390' ' ' TRP . . . 166.56 -146.89 11.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.342 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 354' ' ' LYS . 0.0 OUTLIER -45.49 137.58 4.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.691 0.281 . . . . 0.0 110.43 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 72.84 -153.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . 0.426 ' O ' HG23 ' A' ' 383' ' ' THR . 0.7 OUTLIER 64.22 165.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.726 0.298 . . . . 0.0 110.601 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 382' ' ' SER . 39.9 p -158.28 147.5 19.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.066 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 102.04 -145.43 16.64 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.951 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -57.4 -31.2 65.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.732 0.301 . . . . 0.0 111.648 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -64.91 -59.1 4.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.823 0.344 . . . . 0.0 110.706 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.68 -32.56 71.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.269 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.1 OUTLIER -61.54 -41.9 98.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.203 179.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.603 ' CD2' HD12 ' A' ' 280' ' ' LEU . 16.5 t-160 -65.43 -58.0 6.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.619 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.514 ' CG ' ' HA2' ' A' ' 379' ' ' GLY . 62.9 t-105 -49.71 -44.68 48.4 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.136 0.493 . . . . 0.0 109.927 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.21 -34.29 77.17 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.553 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.465 ' HB3' HD12 ' A' ' 401' ' ' ILE . 1.8 t0 -65.17 -36.39 84.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.8 ' SD ' HD11 ' A' ' 352' ' ' ILE . 14.0 ttm -61.36 -57.57 11.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.119 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.771 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -61.05 -29.25 69.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.439 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.03 73.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.209 0.528 . . . . 0.0 109.843 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -125.46 77.74 68.52 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.374 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.53 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 5.8 Cg_exo -76.98 44.93 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.131 2.554 . . . . 0.0 113.002 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . 0.53 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 9.9 mmm180 -159.94 -46.74 0.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.908 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.26 137.4 22.82 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.961 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 56.6 Cg_endo -70.41 156.24 62.07 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.553 2.169 . . . . 0.0 112.747 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.26 117.13 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.971 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -108.82 144.36 36.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.716 0.293 . . . . 0.0 110.731 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -166.49 156.9 12.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.918 0.39 . . . . 0.0 111.376 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . 0.426 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 57.9 m95 -84.38 121.48 27.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.84 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.909 ' HB3' HG11 ' A' ' 376' ' ' VAL . 53.4 m-70 -110.09 122.62 48.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.405 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.549 HG23 ' OD1' ' A' ' 275' ' ' ASP . 88.6 m -78.29 118.21 20.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.751 HD23 HG22 ' A' ' 376' ' ' VAL . 67.3 mt -64.02 128.16 34.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.178 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -116.75 169.97 8.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.73 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.893 ' O ' HG23 ' A' ' 413' ' ' VAL . 58.8 t -53.96 119.44 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.792 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 36.8 mt-10 -54.57 -43.67 72.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.993 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -56.33 -47.65 78.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 110.721 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.6 mt-10 -66.54 -38.07 86.37 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 409' ' ' VAL . 57.4 t -60.15 -50.73 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.335 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.654 ' HA ' HD12 ' A' ' 417' ' ' LEU . 0.2 OUTLIER -62.77 -38.16 89.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.703 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.13 -31.87 72.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.017 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 45.4 mtm -72.16 -30.38 64.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.83 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' A' ' 414' ' ' ASP . 4.2 mt -77.49 -34.19 54.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -65.68 143.73 57.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.044 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 1.5 pttt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.823 0.345 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 408' ' ' GLN . 18.3 mt -78.65 -34.89 46.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 119.41 -169.17 13.62 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.255 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.772 ' OD1' HG23 ' A' ' 406' ' ' THR . 2.8 m-20 -138.76 134.24 33.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.745 0.307 . . . . 0.0 110.818 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.898 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -125.11 130.67 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.2 0.524 . . . . 0.0 111.013 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.898 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -99.11 126.93 44.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.725 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.605 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.4 p90 -142.04 151.83 42.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.324 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.42 161.44 13.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.965 -178.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.559 HD12 ' CD2' ' A' ' 389' ' ' HIS . 83.9 mt -135.65 141.74 45.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.486 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -158.94 114.7 2.59 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.856 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.937 ' CD1' HD13 ' A' ' 352' ' ' ILE . 25.0 t80 -105.98 138.87 41.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.64 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.35 97.51 45.0 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.531 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.4 -32.0 10.68 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.552 2.168 . . . . 0.0 112.472 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.6 -29.84 7.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.229 0.538 . . . . 0.0 109.941 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.28 -17.5 8.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.052 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.72 48.44 8.83 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.587 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -123.62 130.45 52.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.441 . . . . 0.0 111.834 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.887 HD11 ' HE1' ' A' ' 393' ' ' MET . 28.7 tp -95.76 147.56 23.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.793 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 3.1 m -137.39 134.29 35.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.331 0.586 . . . . 0.0 112.062 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 3.3 t -127.29 123.67 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.146 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 341' ' ' GLU . 39.7 t -118.17 115.26 47.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.062 0.458 . . . . 0.0 111.848 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.741 HG22 ' HB2' ' A' ' 339' ' ' TYR . 34.2 mm -74.55 137.04 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.437 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.5 OUTLIER -113.86 -60.64 1.86 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.456 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 2.6 pt-20 -175.63 157.8 2.1 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.296 -0.561 . . . . 0.0 112.448 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.811 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -115.98 154.04 30.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.897 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.0 ptmm? -150.93 151.97 32.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.037 0.446 . . . . 0.0 111.614 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 59.58 23.95 12.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.986 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.811 HD21 ' HB1' ' A' ' 296' ' ' ALA . 55.2 mt -58.14 138.91 55.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.077 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -62.6 144.44 56.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.472 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.426 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 11.2 mttt -83.46 114.63 21.61 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.449 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.451 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 5.8 mmm -93.79 -17.75 22.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.739 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 45.6 m-20 -96.03 117.89 31.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.4 116.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.643 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.39 16.32 35.02 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.423 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.27 -156.26 9.19 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.938 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 307' ' ' LEU . 8.3 mt -100.63 -160.43 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 110.305 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.663 ' HB2' HD23 ' A' ' 335' ' ' LEU . 65.3 m -135.98 171.77 13.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.231 0.539 . . . . 0.0 111.122 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.427 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 5.9 m-20 -134.47 56.5 18.36 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.729 ' CG ' HD13 ' A' ' 299' ' ' LEU . 72.4 Cg_endo -77.27 144.72 23.5 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.886 2.39 . . . . 0.0 115.043 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.548 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 11.3 p90 -139.07 167.9 21.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.185 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 361' ' ' VAL . 47.4 t -114.08 150.08 16.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.432 0.634 . . . . 0.0 112.663 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.656 ' CE ' HD13 ' A' ' 362' ' ' LEU . 7.0 mtmm -134.14 156.79 47.68 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.186 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.625 ' CG2' HG13 ' A' ' 357' ' ' VAL . 5.4 mp -129.96 138.44 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.707 0.289 . . . . 0.0 111.061 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . 0.412 ' O ' HG23 ' A' ' 358' ' ' VAL . 2.2 m170 -130.66 121.59 25.83 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.462 HD21 HG22 ' A' ' 347' ' ' VAL . 36.3 tp -87.96 106.78 18.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.804 0.335 . . . . 0.0 110.117 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . 0.594 ' CE ' HD13 ' A' ' 417' ' ' LEU . 31.7 mtp -109.26 128.59 55.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.299 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.793 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.3 OUTLIER -104.93 103.31 12.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.991 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 61.31 37.67 16.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.782 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 83.79 25.04 47.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.565 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -129.3 110.07 11.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 110.847 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -56.68 135.55 55.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.793 HD11 ' CB ' ' A' ' 318' ' ' GLN . 5.7 mt -125.01 -48.13 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.29 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 345' ' ' PHE . 0.4 OUTLIER -130.54 147.22 52.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.961 0.41 . . . . 0.0 111.353 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.39 140.6 52.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.515 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 1.7 mmpt? -139.79 162.61 34.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 0.0 111.153 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.404 ' CB ' ' HG2' ' A' ' 313' ' ' LYS . 0.0 OUTLIER -152.21 149.85 29.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.889 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.713 HG22 ' CE1' ' A' ' 343' ' ' PHE . 15.6 p -110.29 179.47 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.943 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.457 HG23 ' HE3' ' A' ' 331' ' ' LYS . 12.6 t -59.03 167.21 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.518 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.548 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.2 mt -110.74 122.4 65.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.928 0.394 . . . . 0.0 111.338 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.457 ' HE3' HG23 ' A' ' 329' ' ' THR . 9.0 mmpt? -86.95 93.06 9.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.854 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -60.71 136.69 58.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.238 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 43.94 84.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.537 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.568 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.7 t -179.38 171.02 1.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.434 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.663 HD23 ' HB2' ' A' ' 308' ' ' SER . 1.6 mt -140.73 -14.36 0.94 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.495 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.45 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.1 m-80 -133.53 58.52 33.93 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-O 120.692 0.282 . . . . 0.0 110.378 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 52.0 Cg_endo -90.49 167.69 4.16 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.146 2.564 . . . . 0.0 113.686 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.45 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.4 OUTLIER -109.53 160.72 16.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.329 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.741 ' HB2' HG22 ' A' ' 293' ' ' ILE . 63.9 m-85 -133.99 -63.43 0.73 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.826 0.346 . . . . 0.0 111.243 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 58.15 37.96 26.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.579 ' O ' HG13 ' A' ' 292' ' ' VAL . 31.2 mt-10 -93.3 145.51 24.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.711 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 78.0 p -116.07 121.5 42.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.927 0.394 . . . . 0.0 111.586 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.713 ' CE1' HG22 ' A' ' 328' ' ' THR . 70.2 m-85 -113.05 151.33 30.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.349 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 15.1 m -121.88 138.44 54.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.083 0.468 . . . . 0.0 111.546 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 289' ' ' LEU . 34.2 m-85 -124.36 165.93 16.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.547 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.21 73.55 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.799 HG13 ' HB3' ' A' ' 351' ' ' GLN . 74.1 t -108.01 131.75 21.53 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.159 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 84.4 Cg_endo -82.24 154.94 16.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.778 2.319 . . . . 0.0 111.715 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -51.26 -22.71 2.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.829 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -86.42 -8.6 57.5 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.799 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -112.71 -29.86 7.28 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.937 HD13 ' CD1' ' A' ' 282' ' ' TYR . 3.9 tp -51.14 -33.67 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.665 0.269 . . . . 0.0 111.034 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -88.47 1.48 54.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.699 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.463 ' HA ' ' CD1' ' A' ' 380' ' ' TYR . 23.9 mttm -122.73 -20.65 5.85 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.511 HG23 ' CZ2' ' A' ' 390' ' ' TRP . 36.0 m -91.65 167.99 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.968 0.413 . . . . 0.0 111.386 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.49 127.83 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.775 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.625 HG13 ' CG2' ' A' ' 314' ' ' ILE . 98.9 t -86.86 104.77 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.439 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.5 OUTLIER -90.23 109.67 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.618 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.584 ' HB ' HG23 ' A' ' 376' ' ' VAL . 43.9 t -90.53 108.02 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.788 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.891 HG23 ' HB3' ' A' ' 375' ' ' LYS . 11.8 m -110.96 129.74 55.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 111.949 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 312' ' ' VAL . 48.7 t -104.12 131.0 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.114 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.656 HD13 ' CE ' ' A' ' 313' ' ' LYS . 3.9 mp -129.93 145.6 51.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.925 0.393 . . . . 0.0 111.481 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.451 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 9.1 t70 -90.08 126.81 35.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.554 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 29.1 t80 -79.42 146.97 32.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.562 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -141.3 64.98 1.4 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.33 . . . . 0.0 111.745 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.69 ' HG2' HD12 ' A' ' 367' ' ' ILE . 1.7 tptt 31.39 -91.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.69 HD12 ' HG2' ' A' ' 366' ' ' LYS . 4.5 mp -84.77 -66.93 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-O 120.748 0.309 . . . . 0.0 111.361 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -45.87 168.25 0.04 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.761 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -65.7 164.29 14.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.728 0.299 . . . . 0.0 110.626 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.47 126.41 35.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.65 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.09 157.25 38.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.914 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.466 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.68 109.45 22.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.08 0.467 . . . . 0.0 111.216 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.424 HG21 HD22 ' A' ' 299' ' ' LEU . 2.0 mm -71.4 -35.08 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.941 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . 0.407 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 157.47 -174.1 34.93 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.154 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.891 ' HB3' HG23 ' A' ' 360' ' ' THR . 18.2 ptmt -162.47 140.7 8.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.394 0.597 . . . . 0.0 112.058 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.985 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.9 158.9 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.174 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.538 ' HB3' HG13 ' A' ' 358' ' ' VAL . 25.7 p90 -139.54 140.57 37.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.954 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 357' ' ' VAL . 11.5 m -130.19 110.53 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.474 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.583 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 141.2 -150.62 21.97 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.5 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.463 ' CD1' ' HA ' ' A' ' 354' ' ' LYS . 0.2 OUTLIER -44.09 156.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.871 0.367 . . . . 0.0 111.508 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.2 m120 55.13 36.23 26.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.004 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 3.1 m -138.75 161.51 37.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.977 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 52.0 p -157.94 148.03 20.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.911 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 101.16 -124.08 8.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.743 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -83.6 -28.54 28.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 111.495 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -70.91 -45.32 64.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.23 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 26.2 tp -71.32 -35.64 71.3 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.369 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 385' ' ' ALA . 7.7 ptt180 -62.85 -33.58 75.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.345 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.559 ' CD2' HD12 ' A' ' 280' ' ' LEU . 18.5 t-160 -70.27 -55.44 9.23 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.321 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.585 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 58.4 t-105 -50.12 -45.13 52.68 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.092 0.472 . . . . 0.0 109.907 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.54 -33.21 73.71 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.614 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.47 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.5 OUTLIER -62.11 -39.38 92.29 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.887 ' HE1' HD11 ' A' ' 289' ' ' LEU . 20.1 ttm -59.18 -53.03 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.978 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.79 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -64.26 -30.7 71.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.244 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.68 -31.56 72.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.184 0.516 . . . . 0.0 109.668 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -125.49 77.92 68.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.337 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.546 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 5.9 Cg_exo -76.87 42.88 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.111 2.541 . . . . 0.0 113.061 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . 0.546 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 20.4 mmt180 -158.88 -47.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.093 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.41 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.1 OUTLIER -94.27 140.26 22.74 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.167 -179.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.41 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 57.9 Cg_endo -70.73 156.32 61.05 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.677 2.251 . . . . 0.0 112.885 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -127.76 115.35 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.745 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.56 144.44 33.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.808 0.337 . . . . 0.0 111.039 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.5 153.95 11.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.124 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . 0.406 ' CZ3' ' HB2' ' A' ' 277' ' ' CYS . 33.4 m95 -81.83 121.75 26.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.906 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.985 ' HB3' HG11 ' A' ' 376' ' ' VAL . 56.7 m-70 -111.98 117.61 33.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.551 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.772 HG23 ' OD1' ' A' ' 275' ' ' ASP . 89.6 m -78.44 116.46 18.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.859 HD23 HG22 ' A' ' 376' ' ' VAL . 95.0 mt -60.53 127.61 32.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.134 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.515 ' C ' HD12 ' A' ' 273' ' ' LEU . 5.2 mt-30 -115.06 168.8 9.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.605 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.825 ' O ' HG23 ' A' ' 413' ' ' VAL . 91.8 t -55.3 120.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.466 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 14.8 mt-10 -52.35 -41.13 62.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.774 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.62 -51.08 71.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.638 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.509 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 19.7 mt-10 -63.76 -38.8 92.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 409' ' ' VAL . 97.5 t -57.36 -49.15 81.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.147 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.41 -32.57 73.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.471 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.22 90.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.651 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . 0.451 ' SD ' ' CE1' ' A' ' 377' ' ' PHE . 9.1 mtt -64.87 -50.84 64.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.497 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.594 HD13 ' CE ' ' A' ' 317' ' ' MET . 10.2 mt -59.87 -28.21 67.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.932 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -71.75 -175.26 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.998 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.102 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.788 0.328 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.796 HD22 ' O ' ' A' ' 373' ' ' ILE . 55.5 mt -75.63 -31.11 59.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.36 -166.08 15.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.247 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.744 ' OD1' HG23 ' A' ' 406' ' ' THR . 27.6 m-20 -142.12 130.7 22.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.897 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.809 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -120.04 131.01 73.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.809 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.5 OUTLIER -99.99 126.02 46.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.898 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.634 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.4 p90 -142.32 152.59 43.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.345 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.49 161.3 13.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.134 -178.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.552 HD12 ' CD2' ' A' ' 389' ' ' HIS . 95.4 mt -135.08 142.82 46.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.053 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -158.85 110.89 2.19 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.092 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.842 ' CD1' HD13 ' A' ' 352' ' ' ILE . 22.0 t80 -102.87 139.36 38.55 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.896 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.04 94.18 47.49 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.542 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 8.0 Cg_exo -69.86 -32.72 17.6 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.914 2.41 . . . . 0.0 112.337 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -29.79 8.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.089 0.471 . . . . 0.0 109.96 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.73 -20.22 7.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.073 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.14 48.02 6.7 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.585 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -123.08 129.87 52.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.029 0.443 . . . . 0.0 111.802 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.893 HD11 ' HE1' ' A' ' 393' ' ' MET . 36.6 tp -96.88 147.55 23.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.991 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 8.7 m -138.25 137.01 37.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.444 0.64 . . . . 0.0 111.993 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.7 t -129.88 124.06 57.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.238 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 341' ' ' GLU . 24.5 t -119.69 115.43 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.094 0.473 . . . . 0.0 111.902 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.671 HG13 HG21 ' A' ' 328' ' ' THR . 44.2 mm -74.52 137.2 23.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.17 -58.64 2.12 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 16.8 pt-20 -175.74 162.1 2.65 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.537 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.767 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -119.06 152.41 36.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.647 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.438 ' HD2' ' CH2' ' A' ' 404' ' ' TRP . 0.4 OUTLIER -150.65 150.19 30.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.124 0.488 . . . . 0.0 111.572 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 61.61 24.02 14.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.996 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.767 HD21 ' HB1' ' A' ' 296' ' ' ALA . 53.4 mt -57.7 138.31 55.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 110.796 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.54 129.35 39.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.475 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.449 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 14.9 mttt -63.44 112.11 2.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.279 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' A' ' 371' ' ' ASP . 0.2 OUTLIER -85.06 -19.85 31.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.8 -179.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 28.7 m-20 -99.34 117.2 33.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.652 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 23.8 t -50.06 116.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.268 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 63.93 14.12 54.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.428 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -129.03 -159.88 10.09 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.677 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.1 mt -98.13 -162.87 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.792 0.33 . . . . 0.0 110.66 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.521 ' HB2' HD23 ' A' ' 335' ' ' LEU . 13.0 m -135.69 172.02 13.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.38 0.609 . . . . 0.0 111.205 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.422 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -134.16 56.18 17.96 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.829 178.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.712 ' CG ' HD13 ' A' ' 299' ' ' LEU . 66.7 Cg_endo -75.58 142.66 26.43 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.114 2.542 . . . . 0.0 115.034 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.625 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 7.1 p90 -140.57 168.17 20.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.006 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 361' ' ' VAL . 41.3 t -117.02 149.83 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.442 ' CE ' HD13 ' A' ' 362' ' ' LEU . 9.2 mttm -130.7 160.19 35.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.316 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.438 HG23 HG13 ' A' ' 357' ' ' VAL . 5.3 mp -128.82 136.42 59.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.526 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 79.1 m80 -130.83 130.84 44.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.884 0.373 . . . . 0.0 110.987 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 324' ' ' LYS . 41.1 tp -108.94 108.12 18.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.376 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 3.4 mtm -117.79 134.55 54.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.438 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.591 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.0 OUTLIER -95.4 99.62 11.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.414 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 59.44 37.69 22.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.08 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 92.73 17.15 45.86 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.181 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 317' ' ' MET . 10.6 mmmm -120.33 109.06 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.841 0.32 . . . . 0.0 110.805 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.39 132.02 38.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.615 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 318' ' ' GLN . 5.0 mt -125.89 -50.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.85 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 12.1 mmtm -130.7 146.04 52.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.959 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . 0.417 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -143.5 116.4 8.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.613 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -118.87 168.58 10.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.966 0.412 . . . . 0.0 111.291 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 15.2 ptpt -148.71 145.27 27.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.836 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.671 HG21 HG13 ' A' ' 293' ' ' ILE . 14.4 p -102.15 173.76 6.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.829 0.347 . . . . 0.0 110.924 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.492 HG22 ' OE2' ' A' ' 341' ' ' GLU . 6.3 t -54.68 175.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.675 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.625 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -118.5 124.08 72.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 111.432 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.665 ' O ' HG22 ' A' ' 334' ' ' THR . 0.1 OUTLIER -87.73 87.08 7.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.981 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -54.93 136.21 47.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.96 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 44.81 84.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.401 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 331' ' ' LYS . 4.9 t -178.02 173.66 1.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.784 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.658 HD23 ' O ' ' A' ' 334' ' ' THR . 3.8 mt -144.94 -15.94 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.373 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.433 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.32 57.61 30.61 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.843 0.354 . . . . 0.0 110.106 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 66.3 Cg_endo -86.27 167.62 9.13 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.133 2.555 . . . . 0.0 113.891 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 50.7 t80 -112.48 155.48 24.19 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.95 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.512 ' HB2' HG22 ' A' ' 293' ' ' ILE . 76.0 m-85 -133.2 -71.61 0.52 Allowed 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.817 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.537 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 24.2 t-20 66.16 37.54 5.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.542 ' O ' HG13 ' A' ' 292' ' ' VAL . 38.4 mt-10 -91.15 142.27 27.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.52 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 94.5 p -112.63 121.7 45.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.023 0.439 . . . . 0.0 111.757 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.671 ' HE1' HG22 ' A' ' 328' ' ' THR . 64.8 m-85 -113.85 148.53 36.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.014 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 52.1 p -122.99 140.47 52.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.043 0.449 . . . . 0.0 111.532 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -129.51 165.85 20.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.493 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -115.78 80.67 1.48 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.416 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.564 HG11 ' HA ' ' A' ' 352' ' ' ILE . 33.3 t -108.19 122.81 39.43 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.287 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.427 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 27.7 Cg_exo -60.84 149.43 88.29 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.578 2.185 . . . . 0.0 111.8 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -55.2 -23.91 24.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.138 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -91.48 -8.7 46.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.522 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.563 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.2 OUTLIER -105.53 -25.93 12.11 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.842 HD13 ' CD1' ' A' ' 282' ' ' TYR . 3.1 tp -50.15 -25.66 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.727 0.299 . . . . 0.0 110.874 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -93.45 -17.06 23.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.359 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -102.6 -17.28 15.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.635 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.591 HG12 ' HG2' ' A' ' 318' ' ' GLN . 30.9 m -89.47 168.04 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.827 0.346 . . . . 0.0 111.17 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . 0.579 ' NE2' HD23 ' A' ' 417' ' ' LEU . 5.1 mt-30 -142.99 126.36 16.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.282 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.523 ' CG2' HD21 ' A' ' 289' ' ' LEU . 74.2 t -92.16 101.37 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.036 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.7 OUTLIER -89.18 112.04 23.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.863 -178.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.535 HG11 ' CD2' ' A' ' 278' ' ' PHE . 16.2 t -95.57 107.86 20.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.813 HG23 ' HB3' ' A' ' 375' ' ' LYS . 8.7 m -108.31 142.95 37.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 111.697 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 312' ' ' VAL . 60.3 t -118.5 115.77 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.203 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.465 ' O ' ' CD1' ' A' ' 311' ' ' TYR . 3.7 mp -119.42 149.91 41.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 111.191 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.48 ' HB3' ' SD ' ' A' ' 302' ' ' MET . 0.1 OUTLIER -97.88 131.64 44.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.699 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.577 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 20.6 t80 -80.98 140.84 34.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.683 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 366' ' ' LYS . 69.9 m-20 -132.45 72.58 1.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.314 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.577 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 9.8 tttp 16.1 -86.79 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 33.0 mm -77.57 -77.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.495 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -46.09 165.26 0.08 OUTLIER Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.991 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -65.85 165.68 12.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.849 0.357 . . . . 0.0 111.04 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 0.1 OUTLIER -87.9 132.57 34.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.533 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . 0.507 ' HB2' ' SD ' ' A' ' 302' ' ' MET . 0.0 OUTLIER -98.01 142.45 29.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.967 0.413 . . . . 0.0 110.685 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.604 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -82.65 122.51 28.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.26 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.796 ' O ' HD22 ' A' ' 273' ' ' LEU . 13.0 mt -82.43 -30.08 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.787 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . 0.491 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 169.41 -179.3 42.05 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.74 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.813 ' HB3' HG23 ' A' ' 360' ' ' THR . 17.7 ptmt -164.61 140.93 6.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 111.934 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.821 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.37 158.6 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.098 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.56 ' CD1' HG13 ' A' ' 413' ' ' VAL . 53.0 p90 -143.26 144.37 32.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.849 0.357 . . . . 0.0 111.055 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 378' ' ' VAL . 25.3 m -144.68 108.09 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.214 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 152.96 141.56 3.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.248 -0.977 . . . . 0.0 113.377 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 39.68 -85.97 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 379' ' ' GLY . 9.6 m120 -79.79 86.16 5.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.886 0.374 . . . . 0.0 111.02 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . 0.489 ' HG ' ' HE2' ' A' ' 377' ' ' PHE . 38.3 m -164.54 159.22 19.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.942 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 58.0 p -152.73 147.96 26.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.765 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 90.01 -146.57 18.81 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.451 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -53.98 -30.76 48.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.319 . . . . 0.0 111.492 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.68 -60.07 3.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 21.3 tp -62.21 -28.19 69.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.549 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -69.06 -32.44 71.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.382 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.552 ' CD2' HD12 ' A' ' 280' ' ' LEU . 20.8 t-160 -78.88 -51.27 9.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.687 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.493 ' CD1' ' HA2' ' A' ' 379' ' ' GLY . 63.4 t-105 -51.84 -46.9 64.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.042 0.449 . . . . 0.0 110.051 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -33.61 76.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.607 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.478 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.8 OUTLIER -62.48 -38.33 89.42 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.893 ' HE1' HD11 ' A' ' 289' ' ' LEU . 11.5 ttm -61.35 -52.61 63.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.067 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.751 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.4 mt -61.88 -35.88 79.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.407 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.85 -29.64 70.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.205 0.526 . . . . 0.0 109.851 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 398' ' ' ARG . 11.3 m-80 -114.79 71.91 2.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.537 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.542 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 48.2 Cg_endo -70.42 32.9 0.21 Allowed 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.219 2.613 . . . . 0.0 113.552 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . 0.527 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 3.1 mmm180 -159.08 -46.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.013 0.435 . . . . 0.0 110.981 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.466 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 17.2 ttp180 -94.03 134.92 25.24 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.352 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.466 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 39.5 Cg_endo -66.41 156.35 65.68 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.7 2.266 . . . . 0.0 112.84 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -126.14 115.93 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.651 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.63 144.38 32.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.791 0.329 . . . . 0.0 110.853 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -166.6 152.1 8.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.16 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . 0.438 ' CH2' ' HD2' ' A' ' 297' ' ' LYS . 61.2 m95 -80.34 118.1 21.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.885 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.821 ' HB3' HG11 ' A' ' 376' ' ' VAL . 28.9 m-70 -105.01 117.01 32.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.572 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.744 HG23 ' OD1' ' A' ' 275' ' ' ASP . 88.7 m -78.32 115.42 18.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.781 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.819 HD23 HG22 ' A' ' 376' ' ' VAL . 89.7 mt -60.23 127.12 30.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.359 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.459 ' C ' HD12 ' A' ' 273' ' ' LEU . 4.0 mt-30 -112.94 171.63 7.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.582 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.877 ' O ' HG23 ' A' ' 413' ' ' VAL . 59.0 t -55.8 123.36 6.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.991 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.604 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 6.8 mt-10 -55.32 -42.3 73.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.704 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.16 -50.32 73.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.79 0.329 . . . . 0.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.461 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.2 mt-10 -62.89 -39.42 94.42 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 409' ' ' VAL . 89.4 t -56.08 -48.65 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.372 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.42 ' HA ' HD12 ' A' ' 417' ' ' LEU . 1.0 OUTLIER -56.84 -33.89 67.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 179.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 412' ' ' GLU . . . -59.98 -48.46 81.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.568 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . 0.489 ' HG2' ' CZ ' ' A' ' 377' ' ' PHE . 0.0 OUTLIER -55.05 -36.14 65.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.75 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.579 HD23 ' NE2' ' A' ' 356' ' ' GLN . 5.7 mt -82.57 -32.51 28.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.887 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -84.29 122.9 29.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.083 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 419' ' ' VAL . 21.6 t . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.126 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 11.1 tptt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.817 0.341 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.781 HD22 ' O ' ' A' ' 373' ' ' ILE . 42.7 mt -89.43 -30.81 18.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.045 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 121.68 -164.54 14.8 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.185 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.624 ' OD1' HG23 ' A' ' 406' ' ' THR . 30.0 m-20 -143.3 130.94 21.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.812 0.339 . . . . 0.0 110.844 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.783 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -120.34 128.85 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.061 0.458 . . . . 0.0 110.804 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.783 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -96.91 126.53 42.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.948 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.635 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.6 p90 -142.15 150.64 41.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.267 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.3 OUTLIER -99.43 163.21 12.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.281 0.562 . . . . 0.0 112.084 -178.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.835 HD12 ' CD2' ' A' ' 389' ' ' HIS . 76.6 mt -133.44 144.26 49.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.213 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 7.8 ttp85 -159.19 106.82 1.79 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.82 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.938 ' CD1' HD13 ' A' ' 352' ' ' ILE . 27.6 t80 -98.25 139.57 33.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.481 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 287' ' ' GLY . 44.4 t -116.14 92.98 37.46 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 16.4 Cg_exo -66.03 -31.8 45.49 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.94 2.426 . . . . 0.0 112.501 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -30.96 62.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.921 0.391 . . . . 0.0 110.751 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -121.54 -12.06 8.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.717 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 74.07 45.53 25.63 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.992 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -120.03 130.06 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 111.464 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.96 HD11 ' HE1' ' A' ' 393' ' ' MET . 33.1 tp -94.3 147.58 23.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.225 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 3.9 m -136.26 137.6 40.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.276 0.56 . . . . 0.0 111.924 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 15.1 t -131.78 121.82 48.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.369 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 341' ' ' GLU . 20.5 t -116.9 115.14 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.967 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.664 HG13 HG21 ' A' ' 328' ' ' THR . 41.6 mm -74.17 137.09 23.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.45 HD22 ' OE1' ' A' ' 295' ' ' GLU . 0.5 OUTLIER -113.38 -58.2 2.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.47 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 0.3 OUTLIER -175.73 164.42 2.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.391 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.777 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -123.94 153.35 41.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.798 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.48 150.93 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.693 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 61.24 24.32 14.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.915 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.777 HD21 ' HB1' ' A' ' 296' ' ' ALA . 58.9 mt -58.84 138.38 57.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.079 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -61.01 142.79 56.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.492 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.403 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 4.8 mttp -82.0 118.6 23.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.539 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.517 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.5 mmt -93.75 -18.93 21.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.395 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 44.6 m-20 -99.65 117.04 33.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.911 0.386 . . . . 0.0 110.745 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.01 116.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.438 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 61.33 15.41 45.16 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.354 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.34 -156.46 9.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.8 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 307' ' ' LEU . 7.7 mt -100.78 -161.18 0.84 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.847 0.356 . . . . 0.0 110.741 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.633 ' HB2' HD23 ' A' ' 335' ' ' LEU . 58.5 m -138.15 172.13 13.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.313 0.577 . . . . 0.0 111.066 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -131.77 57.73 32.5 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.557 ' CB ' HD13 ' A' ' 299' ' ' LEU . 60.3 Cg_endo -74.33 143.2 31.18 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.987 2.458 . . . . 0.0 114.707 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.547 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 31.6 p90 -143.71 162.16 36.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.363 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 361' ' ' VAL . 39.7 t -109.37 149.9 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.425 0.631 . . . . 0.0 112.461 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.827 ' HE3' HD13 ' A' ' 362' ' ' LEU . 10.5 mtmt -132.38 134.81 45.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.388 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.484 HG23 HG13 ' A' ' 357' ' ' VAL . 4.7 mp -101.43 145.4 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.802 0.334 . . . . 0.0 110.65 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 358' ' ' VAL . 0.5 OUTLIER -135.43 133.9 39.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.069 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.0 tp -117.95 109.18 16.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.514 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 0.0 OUTLIER -117.31 148.01 42.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.395 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.545 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.2 OUTLIER -105.74 99.63 9.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.294 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 59.51 38.15 22.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.082 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.8 10.75 57.45 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.226 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 317' ' ' MET . 4.5 mmtt -117.61 109.33 16.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.878 0.339 . . . . 0.0 110.849 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.66 136.92 54.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.294 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 318' ' ' GLN . 1.7 mt -128.71 -45.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.117 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 148.8 52.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.287 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . 0.45 ' CG ' ' CD2' ' A' ' 315' ' ' HIS . 0.5 OUTLIER -142.51 125.61 16.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.456 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.03 165.44 17.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.976 0.417 . . . . 0.0 111.248 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -146.16 142.0 28.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.538 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.669 HG22 ' CE2' ' A' ' 343' ' ' PHE . 5.8 p -98.57 -179.63 4.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.868 0.366 . . . . 0.0 111.026 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.4 p -60.02 159.41 9.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.537 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.2 mt -102.71 122.12 54.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.894 0.378 . . . . 0.0 111.38 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.477 ' HB3' HG21 ' A' ' 334' ' ' THR . 2.3 mmtt -87.4 92.14 8.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.956 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -61.47 136.83 58.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.168 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . 0.436 ' C ' HD13 ' A' ' 307' ' ' LEU . 1.0 OUTLIER 44.76 82.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.464 179.055 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.728 ' O ' HD23 ' A' ' 335' ' ' LEU . 3.7 t -175.92 174.37 2.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.791 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.728 HD23 ' O ' ' A' ' 334' ' ' THR . 4.5 mt -144.95 -16.86 0.51 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.264 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.435 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.5 m-80 -132.54 58.87 39.4 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 60.3 Cg_endo -88.26 167.6 6.51 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.174 2.582 . . . . 0.0 113.867 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.483 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 12.6 t80 -107.39 158.03 17.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.907 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.582 ' HB2' HG22 ' A' ' 293' ' ' ILE . 63.7 m-85 -132.37 -71.73 0.53 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.88 0.372 . . . . 0.0 111.28 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.483 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 9.6 t-20 63.87 34.98 11.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.019 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.491 ' O ' HG13 ' A' ' 292' ' ' VAL . 37.9 mt-10 -91.15 140.39 29.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.718 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.2 m -111.21 121.32 44.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.97 0.414 . . . . 0.0 111.66 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.669 ' CE2' HG22 ' A' ' 328' ' ' THR . 67.3 m-85 -113.34 148.34 35.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.101 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 23.9 m -127.02 138.21 53.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.028 0.442 . . . . 0.0 111.533 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -127.06 165.82 18.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.596 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -110.44 77.14 1.02 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.719 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.885 HG13 ' HB3' ' A' ' 351' ' ' GLN . 40.5 t -108.04 114.17 60.09 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.983 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.439 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 32.9 Cg_endo -65.49 157.43 58.26 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.338 2.026 . . . . 0.0 111.395 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -51.42 -25.24 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.482 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -85.23 -11.55 54.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.576 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.885 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.6 OUTLIER -102.08 -36.38 8.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.575 0.226 . . . . 0.0 111.187 -179.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.938 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.9 tp -50.81 -28.61 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.32 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -95.0 0.82 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.677 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -125.64 -13.83 6.4 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.545 HG12 ' HG2' ' A' ' 318' ' ' GLN . 26.5 m -94.09 166.84 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 111.271 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . 0.412 ' CG ' ' HA3' ' A' ' 379' ' ' GLY . 7.5 mp0 -143.2 126.38 16.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.518 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 85.9 t -89.09 115.61 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.205 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.616 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.2 OUTLIER -101.54 109.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.584 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.562 ' HB ' HG23 ' A' ' 376' ' ' VAL . 42.9 t -93.69 107.84 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.961 HG23 ' HB3' ' A' ' 375' ' ' LYS . 3.6 m -110.74 134.21 52.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.964 0.412 . . . . 0.0 111.587 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 312' ' ' VAL . 40.9 t -108.19 117.22 53.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.223 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.827 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.4 mp -120.63 148.16 44.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.013 0.435 . . . . 0.0 111.604 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.517 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -96.01 131.95 41.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.46 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 365' ' ' ASP . 8.5 t80 -87.04 142.63 27.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.736 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.448 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 22.9 m-20 -126.41 104.54 8.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.639 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.438 ' HD3' HG12 ' A' ' 367' ' ' ILE . 0.0 OUTLIER -29.18 -46.22 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.915 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.438 HG12 ' HD3' ' A' ' 366' ' ' LYS . 39.5 mm -107.15 -69.33 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.745 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -57.41 166.67 5.4 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.482 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.73 165.61 20.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.5 135.5 45.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.776 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -98.94 139.82 34.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.013 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.673 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -87.15 110.84 20.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.176 0.513 . . . . 0.0 110.852 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.781 ' O ' HD22 ' A' ' 273' ' ' LEU . 37.3 mt -79.83 -34.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.285 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . 0.542 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 168.71 -178.51 42.09 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.746 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.961 ' HB3' HG23 ' A' ' 360' ' ' THR . 11.0 ptmt -164.83 140.74 5.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.336 0.589 . . . . 0.0 112.275 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.908 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.81 159.15 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.746 178.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.622 ' CD1' HG13 ' A' ' 413' ' ' VAL . 27.5 p90 -146.44 131.99 18.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 0.0 111.756 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 378' ' ' VAL . 26.5 m -127.01 105.6 14.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.787 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.412 ' HA3' ' CG ' ' A' ' 356' ' ' GLN . . . -145.7 -149.42 5.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.775 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.84 -31.11 13.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.805 0.336 . . . . 0.0 110.727 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.6 -27.52 41.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.79 173.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 68.6 p -153.52 148.21 26.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 93.18 -147.09 18.43 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.702 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.514 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -57.44 -29.49 64.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.931 0.396 . . . . 0.0 111.245 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -72.29 -41.24 66.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.903 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 39.5 tp -72.24 -36.09 68.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 0.0 110.298 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 385' ' ' ALA . 9.8 ptt180 -62.45 -32.04 72.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.235 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.835 ' CD2' HD12 ' A' ' 280' ' ' LEU . 17.7 t-160 -74.26 -52.08 13.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.42 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.518 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 70.0 t-105 -54.91 -45.28 74.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.53 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -37.86 84.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 13.0 t0 -61.2 -35.64 77.72 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.96 ' HE1' HD11 ' A' ' 289' ' ' LEU . 10.9 ttm -59.68 -52.82 63.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.174 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.768 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.3 mt -61.75 -25.83 67.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.964 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -76.72 -44.77 32.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.255 0.55 . . . . 0.0 109.594 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.441 ' HB2' HD11 ' A' ' 401' ' ' ILE . 21.9 m-80 -119.33 64.39 7.6 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.489 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.517 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 5.0 Cg_endo -45.67 -80.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.498 2.799 . . . . 0.0 113.23 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.51 -17.56 2.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.421 ' HB3' ' HB3' ' A' ' 396' ' ' ASN . 0.0 OUTLIER -93.79 116.72 66.83 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.818 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 34.6 Cg_exo -57.5 136.83 78.28 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.472 2.115 . . . . 0.0 112.691 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.47 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.2 mm -116.75 107.38 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.327 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.81 143.62 36.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.858 0.361 . . . . 0.0 110.829 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.52 152.33 10.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.321 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -79.13 116.31 19.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.582 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.908 ' HB3' HG11 ' A' ' 376' ' ' VAL . 33.5 m-70 -102.87 119.88 39.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.685 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.624 HG23 ' OD1' ' A' ' 275' ' ' ASP . 74.4 m -78.33 116.01 18.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.4 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.865 HD23 HG22 ' A' ' 376' ' ' VAL . 93.4 mt -62.38 127.78 32.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.252 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.425 ' C ' HD12 ' A' ' 273' ' ' LEU . 7.2 mt-30 -115.88 172.57 7.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.856 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.887 ' O ' HG23 ' A' ' 413' ' ' VAL . 41.3 t -56.18 121.82 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.002 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.673 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 12.2 mt-10 -54.23 -43.65 71.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.101 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.5 -50.4 73.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.886 0.374 . . . . 0.0 110.795 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.447 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.4 mt-10 -63.38 -37.8 88.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 409' ' ' VAL . 99.6 t -57.61 -48.09 83.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.715 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -31.1 72.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -75.05 -30.95 61.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.075 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 28.7 mtm -72.15 -32.96 67.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.998 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 9.4 mt -78.16 -32.79 50.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -87.88 -177.07 5.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 28.6 t . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.037 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.777 HD22 ' O ' ' A' ' 373' ' ' ILE . 62.5 mt -75.13 -33.05 61.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.63 -163.2 16.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.255 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.632 ' OD1' HG23 ' A' ' 406' ' ' THR . 8.4 m-20 -143.44 135.87 27.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.71 0.291 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.796 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -123.63 129.43 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.057 0.456 . . . . 0.0 110.822 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.796 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.4 OUTLIER -97.35 124.96 41.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.017 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.606 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 20.3 p90 -142.26 149.73 39.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.802 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.755 ' OG ' ' HB ' ' A' ' 292' ' ' VAL . 16.1 p -110.83 168.0 9.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.197 0.522 . . . . 0.0 111.892 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.553 HD12 ' NE2' ' A' ' 389' ' ' HIS . 1.2 mt -137.67 160.09 40.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.78 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.488 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.9 OUTLIER -159.14 102.47 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.767 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.961 ' CD1' HD13 ' A' ' 352' ' ' ILE . 39.7 t80 -100.14 130.82 46.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.944 0.402 . . . . 0.0 111.878 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.48 97.82 51.16 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.508 ' CG ' ' CB ' ' A' ' 397' ' ' PRO . 6.0 Cg_exo -71.13 -29.93 16.88 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.643 2.229 . . . . 0.0 112.299 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -30.56 11.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.187 0.518 . . . . 0.0 109.774 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.76 -20.83 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.822 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.44 47.17 7.01 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.908 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -123.98 129.66 51.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 111.482 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.404 HD21 ' CG2' ' A' ' 357' ' ' VAL . 33.5 tp -96.36 147.63 23.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.26 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 343' ' ' PHE . 6.0 m -135.28 137.24 42.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.287 0.565 . . . . 0.0 112.003 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.8 t -130.33 123.07 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.412 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.755 ' HB ' ' OG ' ' A' ' 279' ' ' SER . 5.0 t -118.54 116.32 50.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.664 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.652 HG13 HG21 ' A' ' 328' ' ' THR . 44.1 mm -75.65 137.15 23.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.569 HD22 ' OE1' ' A' ' 295' ' ' GLU . 0.8 OUTLIER -114.16 -57.94 2.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.569 ' OE1' HD22 ' A' ' 294' ' ' LEU . 1.2 pt-20 -175.54 162.43 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.422 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.754 ' CB ' HD11 ' A' ' 299' ' ' LEU . . . -122.33 154.81 37.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.933 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.421 ' HD3' ' CZ3' ' A' ' 404' ' ' TRP . 4.0 ptmt -150.79 150.4 30.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 111.519 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 59.62 25.54 14.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.754 HD11 ' CB ' ' A' ' 296' ' ' ALA . 89.3 mt -61.43 138.95 58.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.813 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -58.25 151.48 19.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.546 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.452 ' HE3' HD11 ' A' ' 335' ' ' LEU . 13.7 mttp -91.46 118.13 30.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.547 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.547 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.6 mmt -91.48 -18.57 23.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.341 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 30.6 m-20 -104.46 98.18 7.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.729 0.3 . . . . 0.0 110.408 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.22 114.73 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 111.44 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.95 -3.52 84.68 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.681 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -129.36 -143.17 5.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.87 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.492 HD12 ' HB2' ' A' ' 333' ' ' ASN . 34.6 mt -113.63 -159.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.909 0.385 . . . . 0.0 110.842 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.638 ' HB2' HD23 ' A' ' 335' ' ' LEU . 74.2 m -134.74 172.24 13.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.307 0.575 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.405 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -129.13 58.07 34.59 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.443 ' CB ' HD13 ' A' ' 299' ' ' LEU . 47.6 Cg_endo -70.15 150.64 66.13 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.13 2.554 . . . . 0.0 114.974 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.557 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 51.4 p90 -153.51 156.54 38.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.169 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.888 HG22 HG22 ' A' ' 361' ' ' VAL . 42.7 t -107.6 149.97 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.823 ' HE3' HD13 ' A' ' 362' ' ' LEU . 12.8 mtmt -131.09 139.21 49.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.313 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.411 HD11 ' CG1' ' A' ' 293' ' ' ILE . 5.2 mp -114.77 130.31 69.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.296 . . . . 0.0 110.963 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -126.17 136.76 53.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 0.0 111.042 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.443 HD23 ' HG3' ' A' ' 324' ' ' LYS . 21.8 tp -105.51 105.25 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.594 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 1.4 mtm -107.69 144.18 35.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.716 ' CG ' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -104.38 99.68 9.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.572 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 57.68 35.48 25.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.352 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 100.56 11.77 40.18 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.753 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.01 110.73 14.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.377 0.589 . . . . 0.0 110.921 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.401 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.6 OUTLIER -53.82 137.85 37.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.688 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.716 HD11 ' CG ' ' A' ' 318' ' ' GLN . 5.8 mt -126.8 -43.16 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.079 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.443 ' HG3' HD23 ' A' ' 316' ' ' LEU . 0.8 OUTLIER -130.46 151.57 50.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.34 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.0 133.68 41.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.836 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -136.35 160.25 39.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.032 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -147.8 144.22 28.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.825 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.67 HG22 ' CE1' ' A' ' 343' ' ' PHE . 18.0 p -103.78 174.0 6.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.695 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.2 t -55.02 162.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.682 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.557 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.0 mt -108.8 128.55 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.949 0.404 . . . . 0.0 111.245 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.638 ' O ' HG22 ' A' ' 334' ' ' THR . 2.1 mmtt -94.99 93.14 7.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.46 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -57.79 137.38 56.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.693 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . 0.492 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.2 p-10 44.79 83.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.401 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.779 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.9 t -175.87 173.33 2.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.685 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 334' ' ' THR . 4.1 mt -146.9 -15.97 0.41 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.264 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.411 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.9 m-80 -131.48 60.26 51.14 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.86 0.362 . . . . 0.0 110.08 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.455 ' HB2' ' HG3' ' A' ' 331' ' ' LYS . 73.5 Cg_endo -86.79 167.59 8.4 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.081 2.521 . . . . 0.0 114.106 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 74.0 t80 -119.95 149.46 42.08 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.605 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -132.46 -67.73 0.64 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.909 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.487 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 11.6 t-20 67.85 36.53 3.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.688 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 293' ' ' ILE . 46.3 mt-10 -91.04 135.0 34.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.519 ' HA ' HG13 ' A' ' 292' ' ' VAL . 1.4 m -104.72 121.69 44.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.836 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.67 ' CE1' HG22 ' A' ' 328' ' ' THR . 60.9 m-85 -109.08 164.72 12.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.891 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 18.3 m -134.7 142.65 46.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.05 0.452 . . . . 0.0 111.73 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.407 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 50.3 m-85 -132.14 162.1 31.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -112.5 77.69 1.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.562 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 351' ' ' GLN . 38.3 t -105.26 122.13 43.98 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.323 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 351' ' ' GLN . 27.1 Cg_exo -60.85 146.66 97.18 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.571 2.181 . . . . 0.0 111.564 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.44 ' CD1' ' HB3' ' A' ' 284' ' ' PRO . 11.3 t80 -54.08 -23.74 14.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 111.243 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 15.1 pm0 -91.5 -8.59 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.372 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.486 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.1 OUTLIER -104.45 -24.58 13.03 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.961 HD13 ' CD1' ' A' ' 282' ' ' TYR . 1.7 tp -52.4 -32.59 16.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.879 0.371 . . . . 0.0 110.547 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 380' ' ' TYR . 6.4 mt-30 -87.58 3.33 47.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.338 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -124.29 -21.25 5.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.503 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.615 HG12 ' HG2' ' A' ' 318' ' ' GLN . 24.0 m -87.88 166.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.879 0.371 . . . . 0.0 111.285 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . 0.409 ' CG ' ' HA3' ' A' ' 379' ' ' GLY . 7.2 mp0 -143.47 126.28 16.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.778 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.508 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 64.5 t -88.26 119.55 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.287 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.5 OUTLIER -102.46 111.65 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.74 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 376' ' ' VAL . 46.6 t -97.52 107.91 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.674 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.979 HG23 ' HB3' ' A' ' 375' ' ' LYS . 3.1 m -110.59 134.41 52.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.011 0.434 . . . . 0.0 111.859 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.888 HG22 HG22 ' A' ' 312' ' ' VAL . 55.5 t -108.37 115.02 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.128 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.823 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.8 mp -118.87 150.31 40.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 111.506 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.547 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.4 OUTLIER -97.22 129.94 44.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.638 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.55 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 27.0 t80 -78.99 146.86 33.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.652 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 367' ' ' ILE . 27.5 m-20 -139.2 66.59 1.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.542 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.665 ' HG2' HD12 ' A' ' 367' ' ' ILE . 0.1 OUTLIER 25.12 -88.26 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.665 HD12 ' HG2' ' A' ' 366' ' ' LYS . 4.4 mp -82.52 -68.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -47.98 167.53 0.13 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.888 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.9 165.45 13.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.333 . . . . 0.0 110.779 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.62 124.97 35.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.5 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.89 153.64 40.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.522 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.663 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -100.86 111.74 24.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.616 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.777 ' O ' HD22 ' A' ' 273' ' ' LEU . 25.5 mt -79.66 -33.23 14.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.317 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.13 -178.24 41.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.854 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.979 ' HB3' HG23 ' A' ' 360' ' ' THR . 17.1 ptmt -164.66 140.61 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.292 0.568 . . . . 0.0 111.967 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.9 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.77 159.07 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.01 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.437 ' HB3' HG13 ' A' ' 358' ' ' VAL . 9.4 p90 -143.82 131.98 21.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.417 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 378' ' ' VAL . 30.1 m -126.45 109.36 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.793 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 390' ' ' TRP . . . -152.63 -141.08 3.22 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.864 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.418 ' CB ' ' O ' ' A' ' 353' ' ' GLN . 0.1 OUTLIER -105.78 -30.28 9.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.797 0.332 . . . . 0.0 110.898 -179.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -79.0 -28.97 43.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.04 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 1.4 m -58.42 176.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.067 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 75.3 p -153.28 148.33 26.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.728 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 95.9 -156.95 21.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.472 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.446 ' HA ' ' HG3' ' A' ' 388' ' ' ARG . . . -47.39 -31.51 4.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.765 0.317 . . . . 0.0 111.447 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.417 ' OE1' ' CE1' ' A' ' 377' ' ' PHE . 13.2 mt-10 -64.67 -54.77 26.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.0 tp -56.99 -34.44 68.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.58 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.446 ' HG3' ' HA ' ' A' ' 385' ' ' ALA . 6.0 mtt180 -61.82 -48.52 80.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.359 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.553 ' NE2' HD12 ' A' ' 280' ' ' LEU . 19.6 t-160 -60.27 -57.53 12.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.508 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 65.2 t-105 -51.41 -44.96 62.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.963 0.411 . . . . 0.0 110.203 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.0 t -68.86 -34.79 76.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.932 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 4.4 t0 -62.04 -31.67 72.1 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.458 ' HA ' HG13 ' A' ' 401' ' ' ILE . 5.7 tpt -66.61 -56.42 10.78 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.74 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.825 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.3 mt -58.42 -21.45 50.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.665 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.421 ' C ' ' HD3' ' A' ' 397' ' ' PRO . . . -70.39 -34.08 72.14 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -127.96 70.52 78.03 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.669 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.52 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 11.2 Cg_exo -71.59 51.65 1.52 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.101 2.534 . . . . 0.0 112.954 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . 0.52 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 4.7 mmm180 -158.99 -40.89 0.06 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.351 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.417 ' O ' ' HE1' ' A' ' 393' ' ' MET . 0.3 OUTLIER -94.0 160.72 31.73 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.491 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 82.2 Cg_endo -89.87 123.23 1.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.131 2.554 . . . . 0.0 112.664 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.458 HG13 ' HA ' ' A' ' 393' ' ' MET . 1.1 mm -98.38 130.44 47.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.717 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 279' ' ' SER . . . -124.57 146.01 49.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.701 0.286 . . . . 0.0 110.809 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.29 155.78 9.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 111.411 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . 0.421 ' CZ3' ' HD3' ' A' ' 297' ' ' LYS . 54.1 m95 -83.63 123.38 29.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.776 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.9 ' HB3' HG11 ' A' ' 376' ' ' VAL . 47.5 m-70 -111.05 119.21 38.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.632 HG23 ' OD1' ' A' ' 275' ' ' ASP . 87.8 m -78.34 116.52 18.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.811 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.836 HD23 HG22 ' A' ' 376' ' ' VAL . 94.9 mt -61.89 127.66 32.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.352 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -114.97 171.59 7.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.561 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 413' ' ' VAL . 60.5 t -54.17 120.25 2.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.663 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 10.6 mt-10 -54.57 -42.37 70.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.879 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -48.87 77.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.36 . . . . 0.0 110.74 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.469 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 25.5 mt-10 -64.67 -38.84 92.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.349 0.595 . . . . 0.0 109.417 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 375' ' ' LYS . 95.2 t -58.44 -49.27 82.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.544 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -33.71 75.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.936 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -71.21 -31.92 68.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 33.9 mtm -73.46 -34.62 65.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 8.1 mt -81.21 -31.24 34.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -84.83 138.82 32.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.098 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . 0.421 'CA ' ' HB3' ' A' ' 302' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.865 0.364 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.785 HD22 ' O ' ' A' ' 373' ' ' ILE . 48.4 mt -83.76 -31.15 26.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 117.41 -168.47 12.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.225 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.11 132.42 32.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.707 0.289 . . . . 0.0 110.987 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.821 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -118.58 129.29 75.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.058 0.456 . . . . 0.0 110.964 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.821 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.52 124.87 41.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.828 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.608 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 20.5 p90 -142.3 149.67 39.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.691 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.783 ' OG ' ' HB ' ' A' ' 292' ' ' VAL . 13.2 p -109.78 160.65 16.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.233 0.54 . . . . 0.0 112.214 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.74 HD12 ' CD2' ' A' ' 389' ' ' HIS . 6.8 mt -128.69 153.82 46.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.806 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.418 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 9.8 ttp180 -159.27 107.28 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.86 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.959 ' CD1' HD13 ' A' ' 352' ' ' ILE . 31.3 t80 -99.04 139.48 34.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.721 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 287' ' ' GLY . 60.1 t -116.54 92.83 38.55 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 17.1 Cg_exo -65.14 -30.88 55.28 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.891 2.394 . . . . 0.0 112.322 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -31.54 63.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.732 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.84 -11.9 8.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.637 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 73.5 45.41 29.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.059 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -120.08 130.06 54.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 111.447 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.492 HD21 ' CG2' ' A' ' 357' ' ' VAL . 25.0 tp -94.34 148.02 22.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.381 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 3.6 m -136.82 134.3 36.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.254 0.55 . . . . 0.0 111.903 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.47 HG21 HG11 ' A' ' 357' ' ' VAL . 21.5 t -127.81 122.65 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.363 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.783 ' HB ' ' OG ' ' A' ' 279' ' ' SER . 4.3 t -117.68 115.48 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.758 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.704 HG13 HG21 ' A' ' 328' ' ' THR . 40.8 mm -74.6 137.14 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 277' ' ' CYS . 0.6 OUTLIER -113.45 -58.3 2.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.5 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 11.4 pt-20 -175.72 163.77 2.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.665 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.699 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -125.24 149.01 48.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.677 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.421 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 17.7 pttt -146.17 153.29 40.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.104 0.478 . . . . 0.0 111.549 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 60.1 27.1 16.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.621 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.699 HD21 ' HB1' ' A' ' 296' ' ' ALA . 91.7 mt -63.36 138.55 58.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.599 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.71 136.73 53.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.689 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.4 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 7.1 mttt -69.51 123.54 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.185 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 363' ' ' ASP . 0.1 OUTLIER -100.49 -11.58 20.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.687 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 53.1 m-20 -103.05 121.94 43.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.807 0.337 . . . . 0.0 110.284 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -47.02 115.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 111.664 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 57.37 17.27 24.55 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.405 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.97 -160.43 10.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.956 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.491 HD13 ' C ' ' A' ' 333' ' ' ASN . 6.3 mt -94.84 -160.86 0.81 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.449 0.3 . . . . 0.0 110.27 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.66 ' HB2' HD23 ' A' ' 335' ' ' LEU . 67.3 m -136.68 171.86 13.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.344 0.592 . . . . 0.0 111.105 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.448 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 1.1 m-20 -132.12 55.12 16.23 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.819 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 309' ' ' ASP . 35.4 Cg_endo -65.97 149.94 85.85 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.168 2.578 . . . . 0.0 114.551 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.539 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 48.1 p90 -154.18 150.09 27.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.401 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.833 HG22 HG22 ' A' ' 361' ' ' VAL . 39.3 t -101.23 148.96 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.836 ' HE3' HD13 ' A' ' 362' ' ' LEU . 11.7 mtmt -130.33 138.54 50.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.154 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.514 HG23 HG13 ' A' ' 357' ' ' VAL . 5.3 mp -115.66 131.06 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.774 0.321 . . . . 0.0 110.771 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -129.13 133.38 47.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.491 HD21 ' CG2' ' A' ' 347' ' ' VAL . 18.9 tp -106.06 104.97 14.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.638 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 3.5 mtm -106.57 142.79 35.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.747 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.2 OUTLIER -102.21 99.77 9.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.48 179.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 58.65 38.3 25.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 92.18 22.52 29.65 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.027 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.5 mtpm? -128.86 109.3 11.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.741 0.305 . . . . 0.0 110.805 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.88 131.59 40.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.26 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.747 HD11 ' CB ' ' A' ' 318' ' ' GLN . 4.9 mt -126.01 -42.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.131 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -130.72 151.32 51.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.502 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 132.1 32.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.582 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.441 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 53.2 mmtt -139.34 155.27 47.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.236 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -141.31 149.47 41.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.72 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.765 HG22 ' CE1' ' A' ' 343' ' ' PHE . 21.2 p -106.17 175.51 5.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.826 0.346 . . . . 0.0 111.031 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -57.24 148.7 21.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.69 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.539 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.1 mt -92.12 122.49 43.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.514 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.661 ' O ' HG22 ' A' ' 334' ' ' THR . 20.3 mmmt -86.67 85.87 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.016 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.68 139.29 50.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.99 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . 0.491 ' C ' HD13 ' A' ' 307' ' ' LEU . 0.9 OUTLIER 42.81 79.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.496 179.009 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.758 ' O ' HD23 ' A' ' 335' ' ' LEU . 5.1 t -173.44 173.48 3.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.165 0.507 . . . . 0.0 110.911 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 334' ' ' THR . 4.0 mt -146.19 -16.09 0.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.186 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.492 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.57 58.5 36.64 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 110.217 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 84.6 Cg_endo -90.39 167.79 4.24 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.175 2.583 . . . . 0.0 114.076 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.524 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 35.9 t80 -114.1 152.48 31.02 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.067 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.495 ' HB2' HG22 ' A' ' 293' ' ' ILE . 2.2 m-85 -130.03 -70.53 0.63 Allowed 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.921 0.391 . . . . 0.0 111.519 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.524 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 24.3 t-20 66.67 35.14 5.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.714 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 293' ' ' ILE . 52.1 mt-10 -91.11 133.81 35.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.973 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.53 ' HA ' HG13 ' A' ' 292' ' ' VAL . 1.2 m -104.07 121.25 42.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.695 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.765 ' CE1' HG22 ' A' ' 328' ' ' THR . 69.2 m-85 -110.08 156.5 20.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.022 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 57.9 p -130.65 140.54 50.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.088 0.47 . . . . 0.0 111.588 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.441 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 62.7 m-85 -128.54 165.91 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.58 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -111.6 78.48 1.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.86 HG13 ' HB3' ' A' ' 351' ' ' GLN . 41.4 t -111.72 117.81 47.96 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.059 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.486 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 48.3 Cg_endo -69.52 157.47 60.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.383 2.055 . . . . 0.0 111.434 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -51.3 -23.02 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -86.7 -10.23 54.19 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.86 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -107.8 -33.16 7.34 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.537 0.208 . . . . 0.0 111.544 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.959 HD13 ' CD1' ' A' ' 282' ' ' TYR . 5.1 tp -49.26 -27.21 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.638 0.256 . . . . 0.0 111.136 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . 0.721 HE21 HD22 ' A' ' 394' ' ' LEU . 2.6 mm-40 -95.17 -9.42 33.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.842 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -113.29 -18.62 12.02 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.587 HG12 ' HG2' ' A' ' 318' ' ' GLN . 23.7 m -87.92 167.89 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 111.377 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . 0.469 ' HA ' ' HA3' ' A' ' 379' ' ' GLY . 3.4 mt-30 -143.81 126.34 15.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.824 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.544 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 53.9 t -89.87 104.83 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.497 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.5 OUTLIER -90.69 110.78 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.615 -179.293 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 376' ' ' VAL . 44.3 t -93.81 107.85 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.981 HG23 ' HB3' ' A' ' 375' ' ' LYS . 5.2 m -111.55 131.77 55.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 0.0 111.968 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.833 HG22 HG22 ' A' ' 312' ' ' VAL . 42.5 t -105.03 119.47 54.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.163 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.836 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.5 mp -124.73 147.61 48.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.134 0.492 . . . . 0.0 111.797 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.455 ' HB3' ' SD ' ' A' ' 302' ' ' MET . 3.4 t70 -91.13 129.87 37.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.012 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.462 ' CB ' HG21 ' A' ' 330' ' ' ILE . 21.7 t80 -79.63 141.95 36.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.232 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 366' ' ' LYS . 80.0 m-20 -138.62 71.77 1.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.496 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.591 ' HB2' HD13 ' A' ' 367' ' ' ILE . 2.5 pttm 24.16 -89.59 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.591 HD13 ' HB2' ' A' ' 366' ' ' LYS . 0.0 OUTLIER -99.19 129.44 49.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.092 0.472 . . . . 0.0 111.156 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.02 179.45 21.98 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.62 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 165.12 13.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.721 0.295 . . . . 0.0 110.686 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 0.2 OUTLIER -100.93 138.72 37.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.834 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -72.68 145.01 47.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.291 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.711 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -101.1 112.44 24.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.135 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.785 ' O ' HD22 ' A' ' 273' ' ' LEU . 12.3 mt -79.98 -33.37 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.336 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 166.35 179.21 39.57 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.945 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.981 ' HB3' HG23 ' A' ' 360' ' ' THR . 13.3 ptmt -161.2 140.37 10.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.24 0.543 . . . . 0.0 112.075 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.913 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -111.84 159.06 12.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.21 179.324 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.468 ' HB3' HG13 ' A' ' 358' ' ' VAL . 14.8 p90 -142.98 135.17 27.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 0.0 111.546 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 378' ' ' VAL . 18.8 m -130.22 100.2 4.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.986 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 166.94 -156.62 28.6 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.165 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.423 ' CD1' ' O ' ' A' ' 353' ' ' GLN . 0.0 OUTLIER -51.17 153.04 2.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 111.188 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.16 31.09 20.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 20.2 m -121.34 161.9 21.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.883 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 48.1 p -153.33 147.96 26.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.729 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 94.86 -156.91 22.04 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.522 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.418 ' HA ' ' HG3' ' A' ' 388' ' ' ARG . . . -50.44 -31.14 14.28 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -63.94 -51.88 62.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.429 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.02 -32.42 69.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.571 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 31.7 mtt180 -63.55 -50.88 67.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.619 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.74 ' CD2' HD12 ' A' ' 280' ' ' LEU . 16.2 t-160 -56.82 -54.14 49.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.544 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 61.1 t-105 -54.06 -50.67 66.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.091 0.472 . . . . 0.0 110.335 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.4 t -63.69 -34.94 78.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.345 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 388' ' ' ARG . 8.2 t0 -62.74 -36.57 83.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.047 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.762 ' CE ' HD11 ' A' ' 352' ' ' ILE . 31.2 ttp -62.96 -55.32 26.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.724 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.796 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -57.52 -24.68 57.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.662 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -79.94 -37.75 33.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.299 0.571 . . . . 0.0 109.526 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 399' ' ' ARG . 13.6 m-80 -126.82 60.99 43.61 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.646 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.523 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 3.9 Cg_endo -45.11 -79.32 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.791 2.994 . . . . 0.0 113.266 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -48.51 -21.8 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.126 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' A' ' 396' ' ' ASN . 1.1 tpt180 -93.73 126.71 48.59 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.826 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.34 131.39 21.72 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.46 2.106 . . . . 0.0 112.547 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.456 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.1 mm -110.46 112.06 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.093 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 279' ' ' SER . . . -108.95 145.65 35.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.687 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.95 152.7 6.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.927 0.394 . . . . 0.0 111.322 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . 0.43 ' CH2' ' HG3' ' A' ' 295' ' ' GLU . 64.2 m95 -80.89 118.74 22.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.823 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.913 ' HB3' HG11 ' A' ' 376' ' ' VAL . 46.3 m-70 -107.17 119.77 40.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 86.6 m -78.29 116.26 18.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.091 0.472 . . . . 0.0 110.961 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.832 HD23 HG22 ' A' ' 376' ' ' VAL . 94.9 mt -61.75 127.55 31.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.28 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -114.42 171.9 7.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.491 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 413' ' ' VAL . 57.1 t -54.58 115.65 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.711 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 3.6 mp0 -52.05 -41.16 62.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.803 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -57.21 -48.91 77.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 110.622 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.467 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 24.4 mt-10 -65.04 -39.91 94.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.845 HG11 ' HG3' ' A' ' 375' ' ' LYS . 70.5 t -59.5 -49.54 83.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.158 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.498 ' HA ' HD12 ' A' ' 417' ' ' LEU . 0.7 OUTLIER -62.33 -37.15 84.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.741 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -66.17 -35.26 80.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 63.3 mtm -70.24 -30.36 67.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 414' ' ' ASP . 8.0 mt -81.27 -34.43 32.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.87 -179.73 5.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.089 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.092 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.779 0.323 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.716 HD22 ' O ' ' A' ' 373' ' ' ILE . 44.6 mt -77.44 -31.94 54.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 122.12 -159.63 16.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.192 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.52 ' OD1' HG23 ' A' ' 406' ' ' THR . 28.3 m-20 -148.17 131.12 16.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.787 0.327 . . . . 0.0 110.56 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.898 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -120.63 130.14 74.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 110.935 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.898 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.21 126.22 42.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.736 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.619 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.5 p90 -141.94 149.33 39.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.321 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.0 OUTLIER -99.75 159.37 15.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.045 -178.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.606 HD13 ' HE3' ' A' ' 393' ' ' MET . 85.2 mt -130.49 144.99 51.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.855 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.406 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 7.2 ttm180 -158.86 103.94 1.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.781 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.905 ' CD1' HD13 ' A' ' 352' ' ' ILE . 27.8 t80 -99.22 138.86 35.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.241 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.8 t -123.55 94.59 46.16 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.394 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.537 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.15 -32.57 16.71 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.927 2.418 . . . . 0.0 112.325 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.53 -29.8 7.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.176 0.512 . . . . 0.0 110.07 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.95 -21.1 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.117 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 81.06 48.03 6.26 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.538 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -123.76 129.32 50.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.058 0.456 . . . . 0.0 111.626 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.711 HD11 ' HE1' ' A' ' 393' ' ' MET . 33.7 tp -96.08 147.74 23.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.9 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 2.6 m -136.05 135.99 39.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.319 0.58 . . . . 0.0 111.998 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.43 118.19 44.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.12 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 341' ' ' GLU . 23.1 t -113.92 115.74 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.058 0.456 . . . . 0.0 111.961 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.718 HG22 ' HB2' ' A' ' 339' ' ' TYR . 34.2 mm -74.75 137.02 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.49 -60.34 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 4.9 pt-20 -175.73 155.89 1.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.357 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.771 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -112.03 153.3 27.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.724 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -150.95 150.71 31.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.148 0.499 . . . . 0.0 111.614 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 61.38 22.74 13.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.005 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.782 HD13 ' CG ' ' A' ' 310' ' ' PRO . 52.0 mt -57.8 138.46 55.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.109 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -64.09 149.88 46.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.502 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.507 ' HE3' HD11 ' A' ' 335' ' ' LEU . 11.1 mttt -88.32 116.22 26.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.54 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.427 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 9.0 mmm -95.93 -19.98 19.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.486 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 48.6 m-20 -91.91 121.57 33.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.543 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -48.35 115.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.648 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 56.17 18.56 20.81 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.304 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.42 -157.74 9.75 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.005 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 307' ' ' LEU . 7.0 mt -98.53 -161.38 0.87 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.781 0.324 . . . . 0.0 110.529 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.54 ' HB2' HD23 ' A' ' 335' ' ' LEU . 15.1 m -134.91 171.89 13.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.246 0.546 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.422 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -135.16 56.61 16.91 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.782 ' CG ' HD13 ' A' ' 299' ' ' LEU . 73.7 Cg_endo -77.57 143.68 21.78 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.963 2.442 . . . . 0.0 114.805 -177.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.575 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 10.6 p90 -138.8 166.94 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.242 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.802 HG22 HG22 ' A' ' 361' ' ' VAL . 24.4 t -112.73 149.96 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.665 ' CE ' HD13 ' A' ' 362' ' ' LEU . 7.0 mttm -133.97 144.05 48.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.871 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.478 HD11 HD11 ' A' ' 293' ' ' ILE . 5.4 mp -118.86 124.09 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 111.201 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 70.2 m80 -117.98 130.98 56.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.597 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.567 ' HG ' HD12 ' A' ' 323' ' ' LEU . 22.5 tp -102.82 104.64 14.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 0.0 OUTLIER -127.59 129.09 46.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.408 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.764 ' HB3' HG12 ' A' ' 355' ' ' VAL . 0.0 OUTLIER -105.53 103.15 12.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 110.372 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 318' ' ' GLN . 83.2 m-20 71.15 36.43 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.199 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 82.12 21.22 61.3 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.175 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.6 mtpm? -113.34 109.07 18.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.837 0.318 . . . . 0.0 110.628 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -56.92 127.2 30.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.221 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.757 HD11 ' HG2' ' A' ' 318' ' ' GLN . 11.9 mt -122.7 -56.01 1.79 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.914 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.506 ' HB2' ' HE2' ' A' ' 345' ' ' PHE . 11.7 mttp -137.85 153.98 49.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.944 0.402 . . . . 0.0 111.256 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . 0.422 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -142.57 129.42 20.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.435 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.407 ' HD3' ' CD2' ' A' ' 343' ' ' PHE . 1.2 mttt -127.37 167.88 15.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 111.269 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.55 144.87 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.713 HG22 ' CE1' ' A' ' 343' ' ' PHE . 17.3 p -104.21 178.35 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 7.2 p -57.52 176.5 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.502 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.575 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.4 mt -118.21 118.39 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.97 0.414 . . . . 0.0 111.329 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.645 ' O ' HG22 ' A' ' 334' ' ' THR . 8.8 mmtt -82.95 84.86 7.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.978 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -55.96 136.86 51.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.015 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.45 82.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.294 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.698 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.9 t -176.45 173.86 2.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.725 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 334' ' ' THR . 4.3 mt -145.13 -16.31 0.5 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.219 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.487 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.6 m-80 -132.9 56.05 20.3 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 120.796 0.332 . . . . 0.0 110.117 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 55.8 Cg_endo -88.32 167.67 6.43 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.199 2.599 . . . . 0.0 113.79 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.435 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 1.1 t80 -107.04 160.83 15.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.327 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.718 ' HB2' HG22 ' A' ' 293' ' ' ILE . 70.9 m-85 -134.01 -64.49 0.7 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.865 0.364 . . . . 0.0 111.075 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 56.99 36.95 28.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.976 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.529 ' O ' HG13 ' A' ' 292' ' ' VAL . 47.5 mt-10 -92.97 142.13 27.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.778 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 12.7 m -114.0 120.56 41.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.44 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.713 ' CE1' HG22 ' A' ' 328' ' ' THR . 79.4 m-85 -112.97 153.42 28.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.252 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 9.7 m -123.74 137.73 54.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.152 0.501 . . . . 0.0 111.675 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.506 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 32.2 m-85 -120.88 165.96 14.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.584 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -116.43 72.43 0.82 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.85 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.92 HG13 ' HB3' ' A' ' 351' ' ' GLN . 40.0 t -108.97 117.53 53.53 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.236 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 38.4 Cg_endo -67.61 153.33 76.53 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.113 1.875 . . . . 0.0 111.104 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -48.19 -24.58 1.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.38 -18.02 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.925 0.342 . . . . 0.0 111.925 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.92 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.1 OUTLIER -96.0 -36.56 11.0 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.905 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.3 tp -48.36 -27.12 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 111.243 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . 0.422 ' O ' ' CD2' ' A' ' 380' ' ' TYR . 5.6 mt-30 -89.16 -17.77 28.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.987 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.499 ' HA ' ' HD2' ' A' ' 380' ' ' TYR . 0.0 OUTLIER -119.06 10.52 12.16 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.764 HG12 ' HB3' ' A' ' 318' ' ' GLN . 31.0 m -108.36 167.71 3.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . 0.706 ' OE1' HD23 ' A' ' 417' ' ' LEU . 21.9 mt-30 -141.22 126.45 18.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.922 0.392 . . . . 0.0 111.224 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.516 ' CG2' HD21 ' A' ' 289' ' ' LEU . 85.4 t -97.25 117.66 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.13 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.632 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.2 OUTLIER -105.22 116.13 48.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.085 -178.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.544 ' HB ' HG23 ' A' ' 376' ' ' VAL . 47.7 t -94.66 107.77 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.976 HG23 ' HB3' ' A' ' 375' ' ' LYS . 5.2 m -109.76 134.74 51.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.062 0.458 . . . . 0.0 111.993 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.802 HG22 HG22 ' A' ' 312' ' ' VAL . 47.5 t -110.88 118.88 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.237 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.665 HD13 ' CE ' ' A' ' 313' ' ' LYS . 3.7 mp -119.8 143.49 47.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.975 0.417 . . . . 0.0 111.43 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.427 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 3.4 t70 -90.37 126.44 35.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.716 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.459 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 22.7 t80 -81.94 141.82 32.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.782 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 367' ' ' ILE . 28.0 m-20 -132.03 73.78 1.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.983 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.517 ' HG2' HD12 ' A' ' 367' ' ' ILE . 0.0 OUTLIER 31.24 -84.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.673 ' H ' HD12 ' A' ' 367' ' ' ILE . 5.1 mp -27.57 -83.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -169.56 -52.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.935 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 109.86 2.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.001 0.429 . . . . 0.0 110.928 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . 0.443 ' ND2' ' CD2' ' A' ' 364' ' ' TYR . 0.2 OUTLIER -92.82 145.61 24.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.907 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.01 157.28 20.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.714 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -100.9 111.29 23.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.076 0.465 . . . . 0.0 111.269 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.716 ' O ' HD22 ' A' ' 273' ' ' LEU . 1.4 mm -75.61 -35.64 32.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.817 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . 0.521 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 157.29 -174.6 34.81 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.44 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.976 ' HB3' HG23 ' A' ' 360' ' ' THR . 15.9 ptmt -164.31 141.03 6.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.195 0.521 . . . . 0.0 111.851 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.952 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -111.93 158.63 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.167 179.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.632 ' HB3' HG13 ' A' ' 358' ' ' VAL . 5.4 p90 -142.1 148.25 38.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.006 0.431 . . . . 0.0 111.593 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 19.8 m -140.85 127.76 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.857 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.44 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 159.26 -137.12 4.99 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.263 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.499 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 0.2 OUTLIER -64.71 -77.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -50.74 -25.02 3.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.809 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 23.0 m -53.24 159.74 1.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.916 0.389 . . . . 0.0 110.679 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 58.8 p -155.95 150.05 25.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.716 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 81.65 -154.75 34.66 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.238 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -45.17 -31.97 1.66 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.753 0.311 . . . . 0.0 111.68 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -63.52 -55.34 24.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.767 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 32.9 tp -57.12 -36.57 70.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.67 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 384' ' ' GLY . 2.6 mtt180 -59.11 -44.77 92.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.129 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.471 ' CD2' HD12 ' A' ' 280' ' ' LEU . 16.6 t-160 -59.95 -57.43 12.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.93 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.516 ' CZ3' ' HE1' ' A' ' 393' ' ' MET . 71.3 t-105 -50.51 -46.43 57.15 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.174 0.512 . . . . 0.0 109.954 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.6 t -67.04 -33.44 75.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.597 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.531 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.8 OUTLIER -64.65 -38.0 89.49 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.756 ' SD ' HD11 ' A' ' 352' ' ' ILE . 7.6 ttm -62.21 -53.61 52.73 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.88 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.704 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.6 mt -61.64 -35.9 79.24 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.338 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.1 -29.55 69.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.865 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.407 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.3 m-80 -114.28 71.48 2.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.66 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.537 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 52.6 Cg_endo -70.28 32.88 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.249 2.633 . . . . 0.0 113.594 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . 0.515 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 16.5 mmm180 -159.33 -44.31 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.979 0.419 . . . . 0.0 110.854 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.444 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.0 OUTLIER -93.92 136.95 23.27 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.314 -178.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 58.9 Cg_endo -71.34 156.46 58.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.52 2.147 . . . . 0.0 112.814 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.531 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.89 116.92 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.61 144.1 35.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.702 0.287 . . . . 0.0 110.822 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.56 153.09 10.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.972 0.415 . . . . 0.0 111.388 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . 0.414 ' CH2' ' HG3' ' A' ' 295' ' ' GLU . 59.0 m95 -82.24 118.71 23.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.952 ' HB3' HG11 ' A' ' 376' ' ' VAL . 55.9 m-70 -106.74 123.68 48.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.52 HG23 ' OD1' ' A' ' 275' ' ' ASP . 88.6 m -78.29 118.56 20.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.783 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.736 HD23 HG22 ' A' ' 376' ' ' VAL . 58.7 mt -64.5 127.98 33.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.102 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.483 ' C ' HD12 ' A' ' 273' ' ' LEU . 7.2 mt-30 -117.9 170.89 8.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.893 ' O ' HG23 ' A' ' 413' ' ' VAL . 60.8 t -55.64 119.91 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.863 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.469 ' CG ' ' HD2' ' A' ' 375' ' ' LYS . 26.9 mt-10 -53.74 -42.54 68.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.969 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -49.36 76.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.759 0.314 . . . . 0.0 110.64 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.464 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 22.2 mt-10 -65.06 -37.96 89.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 409' ' ' VAL . 63.8 t -59.33 -50.18 80.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.463 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.36 -40.55 91.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.776 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -66.42 -33.85 76.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.03 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . 0.67 ' HE3' ' HA ' ' A' ' 413' ' ' VAL . 71.6 mtm -71.81 -28.21 63.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.967 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.706 HD23 ' OE1' ' A' ' 356' ' ' GLN . 5.8 mt -79.19 -33.72 43.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.856 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.9 145.77 40.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.055 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.105 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.807 0.337 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.505 HD12 ' C ' ' A' ' 408' ' ' GLN . 18.7 mt -88.42 -30.12 19.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 114.31 -166.38 12.15 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.319 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.26 132.48 23.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.722 0.296 . . . . 0.0 110.771 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.834 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -121.78 131.51 72.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.074 0.464 . . . . 0.0 111.043 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.834 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -98.84 125.42 44.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.938 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.611 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.7 p90 -142.11 150.47 41.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.439 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -103.75 161.17 14.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.395 0.617 . . . . 0.0 112.356 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.602 HD12 ' CD2' ' A' ' 389' ' ' HIS . 10.9 mt -133.39 150.26 51.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.857 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.8 106.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.928 0.395 . . . . 0.0 111.362 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.901 ' CD1' HD13 ' A' ' 352' ' ' ILE . 27.7 t80 -99.93 138.12 37.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.211 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.29 95.03 46.11 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.431 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.506 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.24 -32.13 17.12 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.853 2.369 . . . . 0.0 112.238 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -30.65 7.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.155 0.502 . . . . 0.0 109.887 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.34 -20.55 8.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.918 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.15 48.24 6.57 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.565 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -123.86 129.97 51.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.842 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.438 HD21 ' CG2' ' A' ' 357' ' ' VAL . 40.6 tp -95.67 147.54 23.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.968 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 343' ' ' PHE . 5.4 m -137.85 140.16 40.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.551 . . . . 0.0 111.98 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.462 HG21 HG11 ' A' ' 357' ' ' VAL . 23.6 t -132.49 125.33 53.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.451 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 341' ' ' GLU . 21.7 t -118.68 115.41 47.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.904 0.383 . . . . 0.0 111.997 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 314' ' ' ILE . 38.7 mm -74.51 136.99 24.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.56 -58.62 2.12 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.429 ' HG3' ' CH2' ' A' ' 404' ' ' TRP . 8.7 pt-20 -175.59 162.01 2.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.139 -0.625 . . . . 0.0 112.335 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.787 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -118.43 153.58 33.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.764 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.435 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 11.8 pttt -150.93 148.52 28.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.11 0.481 . . . . 0.0 111.705 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 60.65 23.85 13.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.067 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.787 HD21 ' HB1' ' A' ' 296' ' ' ALA . 52.1 mt -56.88 138.09 54.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.083 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 143.33 51.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.322 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.431 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 35.3 mttt -85.14 108.39 17.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.644 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.515 ' HG2' ' HB3' ' A' ' 363' ' ' ASP . 0.0 OUTLIER -83.02 -20.94 34.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.958 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 56.0 m-20 -96.16 116.25 28.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.838 0.351 . . . . 0.0 110.718 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.3 t -49.95 116.11 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.444 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 63.26 14.28 53.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.419 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.32 -156.75 9.22 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.79 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.7 mt -100.8 -162.26 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.658 ' HB2' HD23 ' A' ' 335' ' ' LEU . 67.3 m -135.61 172.07 13.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.139 0.495 . . . . 0.0 110.927 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.423 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -133.73 56.02 18.33 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.708 ' CG ' HD13 ' A' ' 299' ' ' LEU . 72.8 Cg_endo -77.11 147.08 26.06 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.88 2.387 . . . . 0.0 114.969 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.562 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 11.5 p90 -141.53 167.74 21.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.069 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.926 HG22 HG22 ' A' ' 361' ' ' VAL . 29.4 t -116.89 148.18 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.844 ' HE3' HD13 ' A' ' 362' ' ' LEU . 17.3 mttt -129.84 157.13 43.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.968 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 293' ' ' ILE . 5.3 mp -132.74 128.48 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.647 0.261 . . . . 0.0 110.819 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -126.4 138.46 53.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.887 0.375 . . . . 0.0 111.077 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.448 ' HB2' ' CE2' ' A' ' 345' ' ' PHE . 29.7 tp -99.36 108.38 20.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -107.45 121.11 43.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.162 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.954 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -92.24 100.17 12.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 57.84 38.37 27.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.834 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.01 28.84 24.69 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.668 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.24 109.48 9.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.357 . . . . 0.0 110.918 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -53.31 129.65 32.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.155 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.954 HD11 ' CB ' ' A' ' 318' ' ' GLN . 10.5 mt -123.52 -46.06 2.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.063 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -130.56 151.37 51.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.85 132.79 40.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.763 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -136.97 156.52 48.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.881 0.372 . . . . 0.0 111.117 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 0.5 OUTLIER -146.87 143.85 28.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.9 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.643 HG21 HG13 ' A' ' 293' ' ' ILE . 13.7 p -101.49 177.46 4.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.757 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 11.1 t -59.49 166.14 2.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.582 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.562 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 5.5 mt -108.15 130.21 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.005 0.431 . . . . 0.0 111.246 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.629 ' O ' HG22 ' A' ' 334' ' ' THR . 22.3 mmmt -97.67 89.92 4.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.378 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -57.57 137.58 56.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.756 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 44.9 85.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.366 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.759 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.5 t -176.72 173.47 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.696 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.759 HD23 ' O ' ' A' ' 334' ' ' THR . 4.6 mt -147.14 -16.1 0.4 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.425 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.2 m-80 -134.07 58.94 34.68 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.817 0.341 . . . . 0.0 110.158 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.461 ' HB2' ' HG3' ' A' ' 331' ' ' LYS . 80.9 Cg_endo -86.63 167.59 8.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.076 2.517 . . . . 0.0 113.952 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 68.1 t80 -116.86 152.04 35.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.995 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.425 ' HB2' HG22 ' A' ' 293' ' ' ILE . 92.9 m-85 -133.19 -68.73 0.57 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.519 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 14.5 t-20 66.24 38.29 4.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.812 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 292' ' ' VAL . 52.0 mt-10 -91.02 141.9 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.663 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 85.5 p -110.09 121.92 46.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 111.662 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.638 ' CE1' HG22 ' A' ' 328' ' ' THR . 58.0 m-85 -111.71 163.1 14.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.032 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 13.2 m -133.8 145.14 49.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.139 0.495 . . . . 0.0 111.643 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' A' ' 316' ' ' LEU . 35.1 m-85 -131.26 165.79 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.436 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -114.57 79.45 1.27 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.006 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.901 HG13 ' HB3' ' A' ' 351' ' ' GLN . 50.4 t -115.27 123.58 31.43 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.352 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.524 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 73.8 Cg_endo -75.2 158.91 41.17 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.529 2.153 . . . . 0.0 111.376 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -51.37 -21.13 2.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -90.66 -8.68 49.35 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.901 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.6 OUTLIER -111.75 -27.23 8.59 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.901 HD13 ' CD1' ' A' ' 282' ' ' TYR . 5.7 tp -47.47 -28.66 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -95.09 -25.14 16.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -91.45 -4.91 55.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.872 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 351' ' ' GLN . 31.4 m -108.92 167.84 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 111.388 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . 0.415 ' OE1' HD23 ' A' ' 417' ' ' LEU . 11.0 mt-30 -144.73 126.44 15.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.655 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.556 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 58.9 t -87.17 109.41 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.379 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.6 OUTLIER -94.63 111.85 26.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.521 ' HB ' HG23 ' A' ' 376' ' ' VAL . 39.7 t -95.62 107.87 20.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.769 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.973 HG23 ' HB3' ' A' ' 375' ' ' LYS . 6.3 m -109.39 139.32 44.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.064 0.459 . . . . 0.0 111.845 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.926 HG22 HG22 ' A' ' 312' ' ' VAL . 59.9 t -115.56 120.58 65.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.03 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.844 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.6 mp -120.89 142.92 49.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.363 . . . . 0.0 111.755 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 302' ' ' MET . 2.6 t70 -90.15 124.43 34.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.511 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.486 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 19.8 t80 -76.01 146.77 39.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.786 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -143.5 58.92 1.39 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.505 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.659 ' HG3' HD13 ' A' ' 367' ' ' ILE . 1.1 tppt? 35.17 -104.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.45 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.659 HD13 ' HG3' ' A' ' 366' ' ' LYS . 0.9 OUTLIER -84.22 137.43 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.344 0.593 . . . . 0.0 111.048 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.22 -178.43 30.47 Favored Glycine 0 C--N 1.318 -0.452 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.596 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.9 165.65 12.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 0.0 110.579 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.39 139.95 40.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.665 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . 0.446 ' HB2' ' HG2' ' A' ' 302' ' ' MET . 2.5 m-20 -71.05 152.05 43.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.893 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.731 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -100.88 111.44 23.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.063 0.459 . . . . 0.0 111.003 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.507 HG21 HD22 ' A' ' 299' ' ' LEU . 2.3 mm -72.06 -32.22 42.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.072 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 152.1 -178.81 29.12 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.973 ' HB3' HG23 ' A' ' 360' ' ' THR . 15.4 ptmt -160.55 140.78 11.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.34 0.591 . . . . 0.0 111.864 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.932 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.52 158.9 12.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.158 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.547 ' HB2' HD21 ' A' ' 417' ' ' LEU . 2.6 p90 -141.58 145.2 34.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.918 0.39 . . . . 0.0 111.224 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 378' ' ' VAL . 15.3 m -134.79 101.15 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.146 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.472 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 172.25 -159.23 30.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.631 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.43 ' O ' ' HB2' ' A' ' 381' ' ' ASN . 0.1 OUTLIER -47.77 162.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.632 0.253 . . . . 0.0 110.986 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 380' ' ' TYR . 29.4 m-80 70.66 -57.29 0.59 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.48 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 383' ' ' THR . 0.9 OUTLIER -44.48 165.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.908 0.385 . . . . 0.0 111.464 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 382' ' ' SER . 44.4 p -158.09 154.14 27.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.917 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 92.27 -142.83 16.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.573 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -56.96 -33.02 66.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.854 0.359 . . . . 0.0 111.325 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.88 -55.15 21.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.082 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 22.3 tp -64.66 -32.64 74.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.352 . . . . 0.0 110.332 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -65.39 -28.5 69.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.371 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.602 ' CD2' HD12 ' A' ' 280' ' ' LEU . 20.6 t-160 -79.89 -54.05 6.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.815 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.556 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 51.2 t-105 -51.27 -47.22 62.54 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.048 0.451 . . . . 0.0 109.944 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 15.0 t -67.81 -29.28 68.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.722 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.505 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.3 OUTLIER -62.98 -42.9 99.96 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.789 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.81 ' CE ' HD11 ' A' ' 352' ' ' ILE . 30.4 ttp -59.61 -52.49 65.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.671 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.804 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.6 mt -56.66 -31.74 64.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.329 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.46 -30.19 69.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 109.722 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 398' ' ' ARG . 17.1 m-80 -115.26 71.12 2.99 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.614 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.535 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 39.9 Cg_endo -68.07 31.37 0.14 Allowed 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.225 2.616 . . . . 0.0 113.396 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . 0.535 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 2.5 mmt180 -158.2 -42.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.092 0.472 . . . . 0.0 110.34 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.633 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 38.8 ttt85 -93.86 145.73 30.4 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.858 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.633 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 84.4 Cg_endo -81.03 156.24 20.09 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.457 2.105 . . . . 0.0 112.925 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -125.5 116.44 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.778 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -108.33 144.9 35.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.685 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.39 154.88 10.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.916 0.389 . . . . 0.0 111.298 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . 0.435 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 49.8 m95 -81.35 120.79 25.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.932 ' HB3' HG11 ' A' ' 376' ' ' VAL . 46.1 m-70 -108.54 122.7 47.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.516 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -78.24 117.19 19.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.746 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.787 HD23 HG22 ' A' ' 376' ' ' VAL . 79.9 mt -62.61 127.67 32.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.086 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.505 ' C ' HD12 ' A' ' 273' ' ' LEU . 6.3 mt-30 -116.06 168.94 9.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.828 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.853 ' O ' HG23 ' A' ' 413' ' ' VAL . 59.6 t -55.7 119.34 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.798 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.731 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 20.0 mt-10 -52.7 -43.63 65.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.911 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -56.52 -48.8 76.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.34 . . . . 0.0 110.657 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.461 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.0 mt-10 -65.52 -38.51 89.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 375' ' ' LYS . 73.4 t -59.43 -49.91 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.229 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -40.64 90.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.888 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -64.84 -35.86 82.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.108 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 48.9 mtm -72.27 -34.24 68.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.547 HD21 ' HB2' ' A' ' 377' ' ' PHE . 17.4 mt -76.77 -31.24 56.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -71.07 143.06 50.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.173 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.15 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . 0.435 'CA ' ' HB3' ' A' ' 302' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.743 0.306 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.794 HD22 ' O ' ' A' ' 373' ' ' ILE . 33.9 mt -81.4 -33.92 31.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.06 -165.67 13.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.215 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.632 ' OD1' HG23 ' A' ' 406' ' ' THR . 9.7 m-20 -142.33 133.23 25.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 110.875 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.862 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -121.87 131.07 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 0.0 111.026 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.862 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -98.38 126.02 43.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.831 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.618 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.7 p90 -141.89 149.94 40.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.202 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.38 159.53 15.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.085 -178.543 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.878 HD12 ' CD2' ' A' ' 389' ' ' HIS . 75.4 mt -128.9 148.34 50.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.177 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -158.81 104.58 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 111.597 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.992 ' CD1' HD13 ' A' ' 352' ' ' ILE . 29.9 t80 -96.65 139.54 32.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.385 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 287' ' ' GLY . 61.1 t -116.12 92.96 37.29 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 17.1 Cg_exo -65.27 -32.49 51.27 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.941 2.427 . . . . 0.0 112.366 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -31.62 62.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.872 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -120.6 -10.08 9.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.639 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 71.86 45.56 42.3 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.036 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -120.91 130.18 53.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.926 0.393 . . . . 0.0 111.55 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.492 HD21 ' CG2' ' A' ' 357' ' ' VAL . 32.7 tp -93.75 147.58 22.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.135 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.9 m -136.69 136.99 39.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.32 0.581 . . . . 0.0 112.122 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.09 123.8 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.455 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 341' ' ' GLU . 27.1 t -118.04 115.08 47.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.03 0.443 . . . . 0.0 111.767 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.682 HG13 HG21 ' A' ' 328' ' ' THR . 38.8 mm -74.7 137.04 23.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.429 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.5 OUTLIER -113.74 -59.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -177.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.447 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 2.4 pt-20 -175.7 159.48 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.362 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.815 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -118.73 154.01 33.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.873 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -150.87 151.89 32.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.968 0.414 . . . . 0.0 111.679 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 60.91 24.76 14.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.796 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.815 HD21 ' HB1' ' A' ' 296' ' ' ALA . 54.8 mt -59.69 139.38 57.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.282 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -62.17 144.49 55.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.483 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.416 ' HE3' HD11 ' A' ' 335' ' ' LEU . 9.5 mttp -84.19 118.73 24.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.548 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.567 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.7 mmt -93.91 -18.78 21.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.334 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 49.5 m-20 -98.39 116.97 31.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.841 0.353 . . . . 0.0 110.619 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -48.95 116.68 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.443 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.8 16.59 39.29 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.287 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.79 -157.58 9.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.804 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 307' ' ' LEU . 7.6 mt -100.33 -161.08 0.84 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.83 0.348 . . . . 0.0 110.702 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.618 ' HB2' HD23 ' A' ' 335' ' ' LEU . 70.9 m -139.39 172.13 13.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.33 0.586 . . . . 0.0 111.077 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.401 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -131.99 57.44 29.93 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.593 ' CG ' HD13 ' A' ' 299' ' ' LEU . 57.7 Cg_endo -72.75 144.65 39.67 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.132 2.555 . . . . 0.0 114.682 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.553 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 38.4 p90 -143.61 163.47 33.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.252 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.753 HG22 HG22 ' A' ' 361' ' ' VAL . 38.0 t -111.6 149.97 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.43 0.633 . . . . 0.0 112.577 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.841 ' HE3' HD13 ' A' ' 362' ' ' LEU . 11.1 mtmt -131.4 138.49 49.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.378 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.462 HG23 HG13 ' A' ' 357' ' ' VAL . 5.2 mp -111.69 132.44 60.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 0.0 110.8 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 358' ' ' VAL . 18.8 m80 -127.76 135.32 49.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 0.0 110.975 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.923 HD23 ' HD3' ' A' ' 324' ' ' LYS . 51.5 tp -103.76 110.84 23.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . 0.404 ' HA ' ' HG ' ' A' ' 323' ' ' LEU . 2.9 mtm -117.0 134.96 54.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.539 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.822 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.0 OUTLIER -93.65 99.49 11.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.29 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 59.52 37.7 22.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.36 7.43 60.63 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.224 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 317' ' ' MET . 5.5 mptt -111.02 109.76 20.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.834 0.317 . . . . 0.0 110.975 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.39 131.59 33.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.377 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.723 HD11 ' CB ' ' A' ' 318' ' ' GLN . 5.9 mt -125.35 -47.72 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.261 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.923 ' HD3' HD23 ' A' ' 316' ' ' LEU . 0.1 OUTLIER -129.89 160.59 33.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.085 0.469 . . . . 0.0 111.448 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.31 143.74 37.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.881 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 314' ' ' ILE . 20.9 mmtm -145.78 162.13 38.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.943 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.6 146.75 27.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.701 HG22 ' CE1' ' A' ' 343' ' ' PHE . 14.6 p -106.11 176.73 5.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 13.3 t -58.09 164.61 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.514 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.553 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.4 mt -107.83 123.55 63.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.938 0.399 . . . . 0.0 111.39 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.643 ' O ' HG22 ' A' ' 334' ' ' THR . 4.5 mmpt? -86.28 87.45 7.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.953 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -55.14 136.42 48.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.987 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 44.22 85.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.33 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.752 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.9 t -178.55 174.21 1.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.808 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 334' ' ' THR . 4.4 mt -145.59 -16.71 0.48 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.176 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.3 m-80 -132.65 56.36 22.17 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.318 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 46.8 Cg_endo -89.54 167.76 5.04 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.165 2.577 . . . . 0.0 113.628 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.447 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -108.97 160.67 15.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.299 179.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.636 ' HB2' HG22 ' A' ' 293' ' ' ILE . 81.6 m-85 -133.96 -63.97 0.71 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.755 0.312 . . . . 0.0 111.224 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.5 t30 59.12 38.52 23.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.956 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.547 ' O ' HG13 ' A' ' 292' ' ' VAL . 31.7 mt-10 -93.4 144.69 25.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.679 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 99.3 p -114.67 122.5 46.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 111.718 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.701 ' CE1' HG22 ' A' ' 328' ' ' THR . 76.3 m-85 -114.87 152.85 31.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.156 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 64.4 p -129.37 138.93 51.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.116 0.484 . . . . 0.0 111.763 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -125.13 166.01 17.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.569 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -111.02 76.84 1.0 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.829 HG13 ' HB3' ' A' ' 351' ' ' GLN . 50.0 t -110.0 122.2 39.62 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.035 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.53 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 71.0 Cg_endo -75.28 157.83 41.39 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.418 2.079 . . . . 0.0 111.64 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -51.72 -22.68 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.702 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -87.27 -8.55 56.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.829 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -111.97 -28.4 8.04 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.992 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.4 tp -52.2 -29.94 12.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.767 0.318 . . . . 0.0 110.864 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . 0.415 ' O ' ' CG ' ' A' ' 380' ' ' TYR . 77.9 mt-30 -93.67 3.31 55.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.411 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -124.1 -21.78 4.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.471 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.822 HG12 ' HG2' ' A' ' 318' ' ' GLN . 32.4 m -88.04 163.28 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.002 0.429 . . . . 0.0 111.485 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . 0.497 ' OE1' HD22 ' A' ' 417' ' ' LEU . 4.2 mt-30 -137.88 126.28 23.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.5 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.511 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 88.9 t -88.3 116.2 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 0.0 110.28 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.4 OUTLIER -100.28 113.8 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.758 -179.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.569 ' HB ' HG23 ' A' ' 376' ' ' VAL . 47.8 t -99.09 107.79 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.97 HG23 ' HB3' ' A' ' 375' ' ' LYS . 3.7 m -110.4 135.38 51.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.964 0.411 . . . . 0.0 111.825 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.753 HG22 HG22 ' A' ' 312' ' ' VAL . 45.7 t -109.38 118.74 57.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.228 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.841 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.8 mp -121.28 145.76 47.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.502 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.567 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -94.57 125.16 39.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.664 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.47 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 24.6 t80 -75.75 146.91 39.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.899 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -145.54 60.94 1.28 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.596 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.579 ' HG3' HD13 ' A' ' 367' ' ' ILE . 0.0 OUTLIER 38.33 -106.35 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.154 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.579 HD13 ' HG3' ' A' ' 366' ' ' LYS . 0.9 OUTLIER -83.65 137.28 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.364 0.602 . . . . 0.0 110.963 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 101.94 169.07 27.3 Favored Glycine 0 C--N 1.319 -0.394 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.538 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.92 140.76 58.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.802 0.334 . . . . 0.0 110.641 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.83 149.65 43.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.641 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.92 149.76 30.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.055 0.455 . . . . 0.0 111.57 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.549 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -100.95 111.11 23.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.72 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.794 ' O ' HD22 ' A' ' 273' ' ' LEU . 33.3 mt -82.39 -32.73 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.491 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . 0.502 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 167.05 -178.5 41.24 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.034 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.97 ' HB3' HG23 ' A' ' 360' ' ' THR . 17.5 ptmt -164.72 140.98 5.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.221 0.534 . . . . 0.0 112.041 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.925 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.53 159.27 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.048 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.458 ' HB3' HG13 ' A' ' 358' ' ' VAL . 22.1 p90 -144.85 132.0 20.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.055 0.455 . . . . 0.0 111.79 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 378' ' ' VAL . 22.9 m -125.21 108.97 20.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.756 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -148.73 -149.42 4.97 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.646 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.415 ' CG ' ' O ' ' A' ' 353' ' ' GLN . 0.0 OUTLIER -100.42 -26.3 13.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.747 0.308 . . . . 0.0 110.937 -179.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -84.07 -28.0 27.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.967 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . 0.42 ' HG ' ' HD2' ' A' ' 377' ' ' PHE . 3.5 m -54.78 175.66 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.161 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 22.2 p -148.56 148.54 30.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.742 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 92.4 -158.65 24.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.41 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -46.49 -31.32 2.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 111.601 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.03 -54.68 38.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.625 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 23.8 tp -56.4 -34.4 66.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.728 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 384' ' ' GLY . 11.3 mtm180 -62.0 -46.84 87.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.523 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.878 ' CD2' HD12 ' A' ' 280' ' ' LEU . 15.2 t-160 -62.58 -53.84 48.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.148 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.511 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 68.1 t-105 -54.83 -51.44 65.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.952 0.406 . . . . 0.0 110.461 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.5 t -66.25 -32.61 74.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.144 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.575 ' HB3' HD12 ' A' ' 401' ' ' ILE . 6.4 m-20 -64.87 -31.59 72.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.79 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.668 ' CE ' HD11 ' A' ' 352' ' ' ILE . 25.8 ttp -65.88 -54.27 28.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.91 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.807 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.5 mt -55.76 -22.79 25.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.124 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -80.8 -38.45 28.44 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 399' ' ' ARG . 40.0 m-80 -125.01 60.37 27.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.563 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.523 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 2.4 Cg_endo -44.06 -77.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.759 2.973 . . . . 0.0 113.356 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -51.38 -17.85 0.86 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.406 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' A' ' 396' ' ' ASN . 0.9 OUTLIER -93.67 133.47 27.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.906 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 74.1 Cg_endo -75.41 115.41 4.22 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.435 2.09 . . . . 0.0 112.548 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -93.62 108.39 20.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.881 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.57 144.0 32.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.737 0.303 . . . . 0.0 110.623 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.44 154.38 12.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.406 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -82.46 117.12 22.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.925 ' HB3' HG11 ' A' ' 376' ' ' VAL . 48.9 m-70 -106.68 118.38 36.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.576 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.632 HG23 ' OD1' ' A' ' 275' ' ' ASP . 91.6 m -78.33 116.25 18.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.952 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.841 HD23 HG22 ' A' ' 376' ' ' VAL . 93.5 mt -61.29 127.94 33.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.405 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.466 ' C ' HD12 ' A' ' 273' ' ' LEU . 6.6 mt-30 -116.04 172.25 7.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.497 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.832 ' O ' HG23 ' A' ' 413' ' ' VAL . 61.2 t -54.98 121.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.549 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 23.9 mt-10 -55.16 -42.47 73.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.88 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.16 -49.11 76.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.458 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.7 mt-10 -64.89 -38.17 90.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.371 0.605 . . . . 0.0 109.418 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 409' ' ' VAL . 94.9 t -57.28 -47.29 84.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.534 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.16 -30.61 71.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -72.43 -37.92 68.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 36.2 mtm -67.91 -32.3 72.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.497 HD22 ' OE1' ' A' ' 356' ' ' GLN . 11.7 mt -80.13 -33.92 38.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -63.04 146.1 53.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.036 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 25.4 t . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.247 -0.883 . . . . 0.0 111.091 179.95 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 8.3 tptt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.831 0.348 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.653 HD22 ' O ' ' A' ' 373' ' ' ILE . 41.4 mt -77.64 -36.28 51.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 124.11 -164.35 17.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.162 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.04 132.53 22.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.703 0.287 . . . . 0.0 110.72 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.701 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -122.71 122.43 65.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.161 0.505 . . . . 0.0 110.821 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.701 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -92.01 126.17 36.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.786 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.616 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.0 p90 -142.22 148.94 38.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.383 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -101.92 160.61 14.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.064 -178.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.831 HD12 ' CD2' ' A' ' 389' ' ' HIS . 73.0 mt -128.81 147.81 50.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.214 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 290' ' ' THR . 1.6 ttm180 -158.92 106.7 1.84 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.579 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.979 ' CD1' HD13 ' A' ' 352' ' ' ILE . 30.0 t80 -98.25 139.52 33.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.599 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 287' ' ' GLY . 83.1 t -116.37 93.11 38.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 397' ' ' PRO . 16.5 Cg_exo -65.65 -30.94 50.58 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.892 2.394 . . . . 0.0 112.211 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -30.67 65.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.699 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -122.4 -5.3 8.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.643 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 66.49 45.98 80.97 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.629 -0.795 . . . . 0.0 112.033 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -121.36 129.32 53.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 111.493 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.446 HD21 ' CG2' ' A' ' 357' ' ' VAL . 34.2 tp -93.05 147.64 22.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.068 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 343' ' ' PHE . 1.6 m -136.68 136.7 39.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.347 0.594 . . . . 0.0 112.177 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.404 HG21 HG11 ' A' ' 357' ' ' VAL . 15.1 t -128.36 123.53 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.306 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 341' ' ' GLU . 38.1 t -117.25 116.04 50.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.995 0.426 . . . . 0.0 111.942 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.71 HG13 HG21 ' A' ' 328' ' ' THR . 26.6 mm -74.55 137.05 23.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 277' ' ' CYS . 0.7 OUTLIER -113.46 -57.44 2.28 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 4.9 pt-20 -175.96 158.53 2.05 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.131 -0.628 . . . . 0.0 112.444 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.787 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -117.98 145.56 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.497 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.427 ' HD3' ' CH2' ' A' ' 404' ' ' TRP . 10.7 pttt -145.68 151.04 37.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 111.542 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 61.47 23.01 13.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.072 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.787 HD21 ' HB1' ' A' ' 296' ' ' ALA . 58.2 mt -56.79 138.27 53.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.901 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -66.34 150.67 48.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.562 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.44 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 25.1 mttt -86.43 115.59 24.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.614 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.471 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 6.9 mmm -94.12 -18.37 21.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.563 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 55.6 m-20 -94.88 118.56 31.98 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.764 0.316 . . . . 0.0 110.332 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -47.61 115.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.02 0.438 . . . . 0.0 111.598 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.5 16.83 37.98 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.433 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.37 -159.26 10.07 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.961 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' A' ' 307' ' ' LEU . 6.6 mt -96.67 -161.55 0.88 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.72 0.295 . . . . 0.0 110.292 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.479 ' HB2' HD23 ' A' ' 335' ' ' LEU . 5.5 m -134.97 170.66 15.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.228 0.537 . . . . 0.0 111.166 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.453 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 6.8 m-20 -135.72 55.44 12.53 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.586 ' CG ' HD13 ' A' ' 299' ' ' LEU . 34.4 Cg_endo -66.88 154.81 73.32 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.233 2.622 . . . . 0.0 114.697 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.517 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 48.6 p90 -153.06 149.55 28.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.503 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.958 HG22 HG22 ' A' ' 361' ' ' VAL . 41.0 t -99.98 150.14 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.872 ' HE2' HD13 ' A' ' 362' ' ' LEU . 5.6 mtmm -133.08 136.16 45.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.219 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.639 HG23 HG13 ' A' ' 357' ' ' VAL . 5.1 mp -107.72 137.27 39.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.251 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -131.45 128.45 39.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.388 . . . . 0.0 111.21 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 324' ' ' LYS . 28.6 tp -104.64 106.64 17.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.464 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . 0.738 ' HE2' HD22 ' A' ' 417' ' ' LEU . 1.6 mtm -112.87 140.65 47.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.912 0.387 . . . . 0.0 111.243 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.72 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.1 OUTLIER -101.38 99.48 9.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.324 179.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 55.46 38.14 29.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 93.22 25.8 18.08 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.866 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 317' ' ' MET . 3.8 mptt -130.67 109.26 10.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.888 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.406 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -52.22 130.78 31.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.449 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.685 HD11 ' CG ' ' A' ' 318' ' ' GLN . 8.9 mt -124.34 -53.56 1.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.969 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 18.7 mmtt -130.64 150.2 51.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.06 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 314' ' ' ILE . 0.6 OUTLIER -143.44 120.1 11.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.815 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.467 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 7.8 mmtm -118.39 172.75 7.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.995 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.415 ' HB3' ' HG2' ' A' ' 313' ' ' LYS . 0.0 OUTLIER -155.15 138.5 15.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.261 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.71 HG21 HG13 ' A' ' 293' ' ' ILE . 25.1 p -92.06 -171.65 2.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.855 0.36 . . . . 0.0 110.47 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.407 HG22 ' HE1' ' A' ' 339' ' ' TYR . 9.8 t -70.54 171.71 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.064 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.535 HG21 ' CB ' ' A' ' 364' ' ' TYR . 2.3 mp -110.3 114.35 46.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.078 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 310' ' ' PRO . 0.0 OUTLIER -75.08 90.78 2.51 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -58.42 135.96 57.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.404 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . 0.41 ' C ' HD13 ' A' ' 307' ' ' LEU . 1.3 p-10 41.29 80.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.528 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.6 ' O ' HD23 ' A' ' 335' ' ' LEU . 3.5 t -179.06 173.64 1.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.963 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 334' ' ' THR . 0.9 OUTLIER -145.49 -11.46 0.53 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.224 -178.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.478 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.3 m-80 -137.84 59.33 19.08 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.733 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.536 ' HG3' ' HG3' ' A' ' 331' ' ' LYS . 54.8 Cg_endo -98.48 167.91 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.532 2.822 . . . . 0.0 113.509 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.435 ' HA ' ' CB ' ' A' ' 295' ' ' GLU . 0.6 OUTLIER -104.12 160.79 14.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.729 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.48 ' CB ' HG22 ' A' ' 293' ' ' ILE . 6.7 m-85 -129.73 -75.71 0.55 Allowed 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.981 0.42 . . . . 0.0 111.778 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 69.93 35.4 2.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.491 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.571 ' O ' HG13 ' A' ' 292' ' ' VAL . 29.3 mt-10 -91.12 143.11 27.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.584 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 26.5 p -115.41 121.29 42.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.0 111.765 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.703 ' CE1' HG22 ' A' ' 328' ' ' THR . 71.7 m-85 -110.49 159.98 17.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.977 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 6.2 m -135.72 137.97 42.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.118 0.485 . . . . 0.0 111.828 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.467 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 57.1 m-85 -125.25 166.07 17.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.609 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -112.29 74.49 0.87 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.866 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 351' ' ' GLN . 47.7 t -108.31 122.75 39.53 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.534 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 74.5 Cg_endo -75.76 158.06 39.36 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.418 2.079 . . . . 0.0 111.547 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -51.71 -22.43 3.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.629 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -87.82 -8.56 55.74 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.825 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.2 OUTLIER -112.59 -28.2 7.92 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.696 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.979 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.0 tp -51.44 -34.89 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.79 0.329 . . . . 0.0 110.779 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . 0.654 HE21 HD22 ' A' ' 394' ' ' LEU . 4.5 mt-30 -89.99 3.07 54.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.374 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -123.06 -15.99 7.14 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.72 HG12 ' HG2' ' A' ' 318' ' ' GLN . 33.7 m -95.63 165.15 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.858 0.361 . . . . 0.0 111.469 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 380' ' ' TYR . 0.1 OUTLIER -140.85 126.49 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.989 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.639 HG13 HG23 ' A' ' 314' ' ' ILE . 47.7 t -89.11 110.18 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.442 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.5 OUTLIER -95.83 110.01 23.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.503 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.584 ' HB ' HG23 ' A' ' 376' ' ' VAL . 43.1 t -91.9 107.89 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.868 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.976 HG23 ' HB3' ' A' ' 375' ' ' LYS . 4.3 m -112.68 126.93 55.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.021 0.439 . . . . 0.0 111.949 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.958 HG22 HG22 ' A' ' 312' ' ' VAL . 46.7 t -101.98 118.37 48.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.216 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.872 HD13 ' HE2' ' A' ' 313' ' ' LYS . 2.7 mp -119.44 147.33 44.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 0.0 111.529 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 310' ' ' PRO . 5.2 t70 -90.02 130.19 36.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.821 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.535 ' CB ' HG21 ' A' ' 330' ' ' ILE . 8.9 t80 -81.95 141.45 33.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.584 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -143.01 78.83 1.62 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.157 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.45 ' N ' ' CE1' ' A' ' 364' ' ' TYR . 6.3 tptm 50.33 -89.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.575 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.514 ' O ' ' C ' ' A' ' 368' ' ' GLY . 40.0 mm -134.89 -69.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.412 0.149 . . . . 0.0 111.008 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 367' ' ' ILE . . . -7.4 -102.95 0.0 OUTLIER Glycine 0 C--N 1.336 0.556 0 O-C-N 123.68 0.612 . . . . 0.0 114.19 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.74 154.24 47.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.939 0.399 . . . . 0.0 111.216 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.61 119.94 40.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.13 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 363' ' ' ASP . 5.7 m-20 -71.27 152.1 43.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.067 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.769 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -100.84 112.62 25.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.392 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.653 ' O ' HD22 ' A' ' 273' ' ' LEU . 1.3 mm -74.31 -34.28 36.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.751 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 155.98 -178.27 32.61 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.32 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.976 ' HB3' HG23 ' A' ' 360' ' ' THR . 11.9 ptmt -161.9 139.64 8.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.351 0.596 . . . . 0.0 112.303 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.919 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.18 158.93 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.077 179.264 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.496 ' HB3' HG13 ' A' ' 358' ' ' VAL . 25.5 p90 -141.2 135.48 30.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.906 0.384 . . . . 0.0 111.6 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 378' ' ' VAL . 15.5 m -125.75 105.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.898 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.486 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 160.0 -159.84 31.06 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.569 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.416 ' N ' ' HG2' ' A' ' 356' ' ' GLN . 0.2 OUTLIER -49.71 164.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 110.861 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 59.0 24.6 12.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.007 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 383' ' ' THR . 4.7 m -127.12 161.21 29.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.705 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 382' ' ' SER . 46.4 p -157.96 148.24 20.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 101.45 -123.88 8.05 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.693 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -83.07 -29.2 28.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.946 0.403 . . . . 0.0 111.354 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -69.42 -50.45 45.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.786 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 46.4 tp -65.11 -37.15 86.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.623 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 385' ' ' ALA . 5.8 ptt180 -62.58 -37.59 86.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.207 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.831 ' CD2' HD12 ' A' ' 280' ' ' LEU . 16.9 t-160 -65.54 -55.48 17.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 110.448 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.575 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 69.1 t-105 -53.83 -50.03 67.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.039 0.447 . . . . 0.0 110.262 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.42 -29.76 69.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.479 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.593 ' HB3' HD12 ' A' ' 401' ' ' ILE . 5.4 m-20 -67.86 -33.02 73.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.714 ' CE ' HD11 ' A' ' 352' ' ' ILE . 27.6 ttp -63.73 -52.61 59.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.695 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.785 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.6 mt -57.02 -22.9 42.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.91 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -81.16 -36.25 30.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.309 0.576 . . . . 0.0 109.483 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.471 ' HB2' HD11 ' A' ' 401' ' ' ILE . 22.7 m-80 -126.11 60.2 34.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.555 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.508 ' CB ' ' HD3' ' A' ' 284' ' ' PRO . 3.2 Cg_endo -44.67 -78.69 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.595 2.863 . . . . 0.0 112.91 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -51.24 -18.88 1.03 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.133 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -93.74 132.63 29.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.596 0.236 . . . . 0.0 110.813 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.7 Cg_endo -75.6 124.35 8.18 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.44 2.094 . . . . 0.0 112.712 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.593 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -102.59 107.63 22.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.761 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.28 144.26 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.858 0.361 . . . . 0.0 110.891 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.1 151.22 10.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.375 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . 0.427 ' CH2' ' HD3' ' A' ' 297' ' ' LYS . 36.4 m95 -78.17 115.77 18.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.688 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.919 ' HB3' HG11 ' A' ' 376' ' ' VAL . 51.0 m-70 -104.15 119.96 40.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.389 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 90.6 m -78.2 116.47 18.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.437 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.743 HD23 HG22 ' A' ' 376' ' ' VAL . 64.2 mt -61.63 126.9 28.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.038 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.44 ' C ' HD12 ' A' ' 273' ' ' LEU . 5.9 mt-30 -115.72 170.08 8.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.944 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.804 ' O ' HG23 ' A' ' 413' ' ' VAL . 55.5 t -54.83 117.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.725 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.769 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 9.0 mp0 -55.4 -41.22 72.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.642 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -56.83 -48.63 77.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 110.58 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.439 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 26.0 mt-10 -65.7 -40.07 91.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 409' ' ' VAL . 97.9 t -58.59 -48.79 84.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.17 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.05 -35.9 80.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.499 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.32 87.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.617 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . 0.41 ' SD ' ' CE1' ' A' ' 377' ' ' PHE . 30.3 mtt -61.44 -37.35 83.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.476 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.738 HD22 ' HE2' ' A' ' 317' ' ' MET . 5.7 mt -79.24 -31.69 43.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.833 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -59.83 138.86 57.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 26.7 t . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.055 -179.984 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.789 HD22 ' O ' ' A' ' 373' ' ' ILE . 47.6 mt -88.21 -29.68 20.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.841 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 116.97 -168.1 12.73 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.234 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.18 132.28 26.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 0.0 110.723 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.882 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -120.99 129.93 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.171 0.51 . . . . 0.0 110.983 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.882 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -97.14 125.38 41.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.829 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.618 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 21.2 p90 -142.29 149.88 40.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.321 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.1 OUTLIER -102.54 161.31 13.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.362 0.601 . . . . 0.0 112.268 -178.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.659 HD12 ' CD2' ' A' ' 389' ' ' HIS . 27.7 mt -132.2 149.93 52.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.958 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.413 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.3 OUTLIER -158.92 102.8 1.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.443 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.936 ' CD1' HD13 ' A' ' 352' ' ' ILE . 29.6 t80 -98.57 136.69 38.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 43.0 t -122.8 95.88 45.92 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.535 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.1 Cg_exo -70.57 -32.2 15.61 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.881 2.387 . . . . 0.0 112.317 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -31.17 6.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.191 0.52 . . . . 0.0 109.957 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.39 -21.15 8.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.813 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 81.16 47.6 6.43 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.778 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -123.65 129.74 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.97 0.414 . . . . 0.0 111.798 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.635 HD21 ' CG2' ' A' ' 357' ' ' VAL . 31.4 tp -95.48 147.67 23.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.994 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 3.4 m -134.73 137.64 43.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 112.0 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.41 ' CG2' HG11 ' A' ' 357' ' ' VAL . 21.6 t -130.87 120.28 47.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.32 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 341' ' ' GLU . 21.7 t -116.2 115.45 49.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.039 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.682 HG22 ' HB2' ' A' ' 339' ' ' TYR . 42.1 mm -75.05 137.13 23.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.446 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.98 -61.97 1.67 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -177.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.438 ' CB ' ' HA ' ' A' ' 338' ' ' TYR . 1.5 pt-20 -175.62 151.77 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.329 -0.549 . . . . 0.0 112.329 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.825 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -110.33 154.56 23.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.859 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -150.99 152.17 33.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 111.719 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 60.28 24.35 13.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.932 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.825 HD21 ' HB1' ' A' ' 296' ' ' ALA . 48.8 mt -58.96 138.82 57.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.162 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.463 ' HD2' ' HE2' ' A' ' 302' ' ' MET . 1.0 OUTLIER -62.59 141.62 58.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.31 -179.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.401 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 7.7 mttt -80.73 117.81 21.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.694 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.583 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 10.1 mmt -90.96 -19.03 23.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.343 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 49.2 m-20 -98.78 114.99 27.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.779 0.323 . . . . 0.0 110.524 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 26.3 t -48.84 116.38 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.45 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 62.11 15.44 50.38 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.369 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -127.29 -157.25 9.39 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.727 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.3 mt -100.34 -161.24 0.85 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 0.0 110.784 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.64 ' HB2' HD23 ' A' ' 335' ' ' LEU . 66.5 m -139.39 172.01 13.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.309 0.576 . . . . 0.0 111.103 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.409 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 15.3 m-20 -131.24 57.13 29.05 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.825 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.566 ' CB ' HD13 ' A' ' 299' ' ' LEU . 50.2 Cg_endo -70.56 148.56 60.13 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.096 2.531 . . . . 0.0 114.82 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.546 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 33.8 p90 -150.35 161.25 42.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.266 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.791 HG22 HG22 ' A' ' 361' ' ' VAL . 38.9 t -110.41 150.0 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.816 ' HE3' HD13 ' A' ' 362' ' ' LEU . 10.3 mtmt -132.41 134.95 45.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.215 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.536 HG23 HG13 ' A' ' 357' ' ' VAL . 5.3 mp -108.79 131.57 59.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.954 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -127.01 142.5 51.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.877 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.417 HD21 HG22 ' A' ' 347' ' ' VAL . 28.9 tp -113.31 106.01 14.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.527 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.5 mtm -106.79 131.17 54.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.311 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.939 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.4 OUTLIER -99.62 99.54 10.41 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.248 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 59.94 36.92 21.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.731 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 88.3 26.52 27.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.714 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.42 109.4 11.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.785 0.326 . . . . 0.0 110.883 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.79 129.24 25.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.184 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.939 HD11 ' CB ' ' A' ' 318' ' ' GLN . 10.0 mt -123.21 -41.38 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.47 147.74 49.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.897 0.38 . . . . 0.0 111.371 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -135.56 117.51 15.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.433 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 15.9 mmtp -124.26 160.85 27.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.927 0.394 . . . . 0.0 111.384 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.93 148.27 33.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.716 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.672 HG21 HG13 ' A' ' 293' ' ' ILE . 20.5 p -106.37 176.04 5.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.956 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.33 158.66 5.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.703 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.546 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 4.0 mt -102.13 126.08 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.979 0.418 . . . . 0.0 111.383 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.64 ' O ' HG22 ' A' ' 334' ' ' THR . 3.7 mmpt? -90.64 88.78 7.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.132 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -56.18 136.62 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.877 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 43.9 84.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.285 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.721 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.8 t -177.61 174.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.947 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.721 HD23 ' O ' ' A' ' 334' ' ' THR . 4.4 mt -145.95 -16.57 0.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.149 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.462 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.4 m-80 -132.29 56.99 26.13 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-O 120.765 0.317 . . . . 0.0 110.348 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 59.1 Cg_endo -88.33 167.69 6.41 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.18 2.587 . . . . 0.0 113.707 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.446 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.4 OUTLIER -111.31 159.29 18.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.302 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.682 ' HB2' HG22 ' A' ' 293' ' ' ILE . 83.6 m-85 -134.76 -62.25 0.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.792 0.329 . . . . 0.0 111.241 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.3 t30 57.87 37.58 26.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 292' ' ' VAL . 61.9 mt-10 -92.66 141.47 28.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 91.0 p -110.64 120.27 41.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.888 0.375 . . . . 0.0 111.544 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.639 ' CE1' HG22 ' A' ' 328' ' ' THR . 65.1 m-85 -113.34 147.91 36.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.361 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 83.0 p -123.09 140.5 52.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.972 0.415 . . . . 0.0 111.443 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.433 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 63.1 m-85 -127.24 165.88 18.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.583 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.63 78.1 1.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.817 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 351' ' ' GLN . 46.0 t -111.62 120.67 41.93 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.094 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.7 Cg_endo -72.07 156.97 55.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.468 2.112 . . . . 0.0 111.619 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -51.89 -22.94 4.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.54 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -85.72 -8.55 58.1 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.825 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.9 OUTLIER -109.96 -35.09 6.23 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.521 0.201 . . . . 0.0 111.473 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.936 HD13 ' CD1' ' A' ' 282' ' ' TYR . 5.9 tp -49.24 -26.72 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.651 0.263 . . . . 0.0 111.478 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . 0.413 ' O ' ' CD1' ' A' ' 380' ' ' TYR . 17.7 mt-30 -93.27 -7.92 43.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.771 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.418 ' HA ' ' CG ' ' A' ' 380' ' ' TYR . 38.8 mttp -116.41 -23.54 8.27 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 351' ' ' GLN . 35.0 m -88.69 168.03 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.908 0.385 . . . . 0.0 111.428 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 380' ' ' TYR . 5.3 mp0 -143.29 133.48 24.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.1 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.635 ' CG2' HD21 ' A' ' 289' ' ' LEU . 53.1 t -87.0 101.98 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.465 ' CG1' ' HE2' ' A' ' 375' ' ' LYS . 0.8 OUTLIER -86.45 114.18 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.969 -178.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.525 ' HB ' HG23 ' A' ' 376' ' ' VAL . 40.4 t -99.75 107.85 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.92 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.957 HG23 ' HB3' ' A' ' 375' ' ' LYS . 7.4 m -110.93 134.73 52.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 111.628 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.791 HG22 HG22 ' A' ' 312' ' ' VAL . 45.9 t -109.29 121.37 62.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.4 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.816 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.6 mp -123.07 147.55 46.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.918 0.389 . . . . 0.0 111.353 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.583 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.3 OUTLIER -96.54 125.19 40.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.601 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.534 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 20.3 t80 -75.8 139.45 41.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.818 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 367' ' ' ILE . 14.2 m-20 -126.22 70.72 1.24 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.871 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.534 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 0.3 OUTLIER 30.36 -89.35 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.075 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 367' ' ' ILE . 5.1 mp -87.37 -69.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.72 0.295 . . . . 0.0 111.649 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -45.67 175.07 0.01 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.258 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.44 165.64 11.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.721 0.296 . . . . 0.0 110.708 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . 0.407 ' OD1' ' CD2' ' A' ' 364' ' ' TYR . 0.4 OUTLIER -93.36 127.56 39.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.701 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.99 150.94 43.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.548 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.454 ' HB1' ' OE1' ' A' ' 410' ' ' GLU . . . -97.32 111.63 23.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.608 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.789 ' O ' HD22 ' A' ' 273' ' ' LEU . 30.0 mt -80.99 -33.12 12.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.386 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 168.13 -179.22 41.43 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.162 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.957 ' HB3' HG23 ' A' ' 360' ' ' THR . 14.8 ptmt -164.67 140.92 5.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.175 0.512 . . . . 0.0 111.791 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.936 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -114.35 158.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.176 179.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.568 ' CD1' HG13 ' A' ' 413' ' ' VAL . 43.0 p90 -142.23 132.03 24.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 111.179 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 378' ' ' VAL . 15.8 m -124.97 103.91 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.962 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 161.72 -165.2 35.59 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.042 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.418 ' CG ' ' HA ' ' A' ' 354' ' ' LYS . 0.0 OUTLIER -44.17 150.18 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 111.465 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 14.0 m120 65.45 29.02 11.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.159 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 50.8 m -122.68 164.34 18.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.677 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 43.6 p -154.77 147.94 24.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.815 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 95.3 -157.8 22.08 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.42 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -49.24 -31.49 8.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -63.21 -51.08 67.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.155 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.36 -33.53 71.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.551 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 1.0 OUTLIER -61.8 -49.83 74.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.54 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.659 ' CD2' HD12 ' A' ' 280' ' ' LEU . 17.4 t-160 -57.91 -58.39 8.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.967 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.487 ' CD1' ' HA2' ' A' ' 379' ' ' GLY . 64.0 t-105 -50.83 -46.11 59.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.217 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 1.5 t -67.75 -35.82 79.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.233 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.438 ' HB3' HD12 ' A' ' 401' ' ' ILE . 4.4 t0 -64.08 -34.92 79.13 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.759 ' CE ' HD11 ' A' ' 352' ' ' ILE . 26.6 ttp -64.5 -58.0 7.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.552 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.761 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.5 mt -55.22 -31.93 61.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.399 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.52 -30.64 69.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.786 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -114.27 70.66 2.06 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.629 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.535 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 42.8 Cg_endo -68.77 37.67 0.21 Allowed 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.203 2.602 . . . . 0.0 113.479 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . 0.533 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 10.6 mmm180 -160.0 -45.69 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.918 0.39 . . . . 0.0 110.86 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -93.87 141.82 24.23 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.198 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.7 Cg_endo -75.37 156.31 41.34 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.585 2.19 . . . . 0.0 112.807 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.45 ' CG2' ' CD2' ' A' ' 389' ' ' HIS . 1.2 mm -126.53 119.32 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -111.86 144.53 41.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.721 0.296 . . . . 0.0 110.693 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.31 155.68 11.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.976 0.417 . . . . 0.0 111.378 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -81.69 119.17 23.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.79 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.936 ' HB3' HG11 ' A' ' 376' ' ' VAL . 47.1 m-70 -106.81 122.34 46.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.557 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -78.19 117.09 19.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.672 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.803 HD23 HG22 ' A' ' 376' ' ' VAL . 55.9 mt -62.44 128.37 35.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.194 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.467 ' C ' HD12 ' A' ' 273' ' ' LEU . 5.3 mt-30 -114.46 171.98 7.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.756 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.85 ' O ' HG23 ' A' ' 413' ' ' VAL . 3.6 t -59.46 122.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.509 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 5.4 mt-10 -51.09 -38.37 51.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.325 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -52.64 63.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.651 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.429 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 3.0 mm-40 -60.79 -41.13 95.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 409' ' ' VAL . 61.7 t -56.22 -52.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.251 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.73 -31.32 72.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.597 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -71.64 -34.59 69.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.872 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 40.7 mtm -72.92 -36.88 67.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.769 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.58 -29.23 65.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.79 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -73.67 141.91 46.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.073 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.109 179.955 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.806 0.336 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 373' ' ' ILE . 46.7 mt -95.87 -32.04 12.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.818 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 116.24 -166.82 12.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.946 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -141.08 136.23 31.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.819 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.814 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -125.09 125.4 69.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.207 0.527 . . . . 0.0 110.885 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.814 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.5 OUTLIER -94.52 126.72 39.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.741 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.626 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 19.2 p90 -142.37 150.18 40.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.57 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.1 OUTLIER -103.87 160.36 14.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.05 -178.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.635 HD12 ' CD2' ' A' ' 389' ' ' HIS . 10.6 mt -133.34 150.51 51.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.866 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.97 105.08 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.552 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.946 ' CD1' HD13 ' A' ' 352' ' ' ILE . 28.4 t80 -99.14 138.66 35.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.08 95.28 44.17 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.403 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.532 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 6.9 Cg_exo -70.53 -31.06 17.76 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.844 2.362 . . . . 0.0 112.265 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.26 -32.07 15.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.147 0.499 . . . . 0.0 109.844 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -117.12 -18.71 9.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.816 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 78.77 47.58 7.73 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.617 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.97 129.46 51.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.04 0.447 . . . . 0.0 111.834 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 33.1 tp -96.55 147.56 23.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.932 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 343' ' ' PHE . 4.3 m -137.63 139.53 40.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.235 0.541 . . . . 0.0 111.995 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.3 t -132.86 123.35 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.529 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 341' ' ' GLU . 21.8 t -116.89 116.21 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.837 HG22 ' HB2' ' A' ' 339' ' ' TYR . 36.5 mm -74.64 135.95 26.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.79 -64.98 1.22 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.443 ' HB3' ' CG ' ' A' ' 338' ' ' TYR . 0.3 OUTLIER -174.67 148.62 1.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.524 -179.315 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.843 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -107.76 154.19 21.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.982 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -150.96 151.86 32.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 111.652 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 62.68 22.81 13.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.843 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.843 HD21 ' HB1' ' A' ' 296' ' ' ALA . 47.8 mt -57.02 138.53 54.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.163 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.35 142.97 58.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.588 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.419 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 14.1 mttt -82.64 113.06 20.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.444 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.44 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 8.2 mmm -91.6 -20.44 21.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.642 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 42.6 m-20 -92.28 118.86 31.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 110.527 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -48.04 115.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.611 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 57.5 17.95 28.16 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.264 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -125.97 -157.47 9.6 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.001 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 7.1 mt -99.27 -161.12 0.85 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 0.0 110.54 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.545 ' HB2' HD23 ' A' ' 335' ' ' LEU . 14.8 m -135.68 171.8 13.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.178 0.513 . . . . 0.0 111.017 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.43 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 6.5 m-20 -135.69 56.95 16.71 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.75 ' CG ' HD13 ' A' ' 299' ' ' LEU . 73.3 Cg_endo -77.91 144.21 21.39 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.902 2.402 . . . . 0.0 114.891 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.549 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 10.9 p90 -139.12 167.73 21.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.025 177.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 361' ' ' VAL . 47.6 t -116.85 149.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.325 0.584 . . . . 0.0 112.572 -179.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.853 ' HE3' HD13 ' A' ' 362' ' ' LEU . 13.8 mttt -132.38 155.78 47.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.434 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.519 HG23 HG13 ' A' ' 357' ' ' VAL . 5.4 mp -124.51 134.19 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.417 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -128.93 127.74 42.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.013 0.435 . . . . 0.0 111.049 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' A' ' 324' ' ' LYS . 28.8 tp -99.32 114.27 27.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.288 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.9 mtm -122.05 133.62 54.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 111.441 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.791 ' HG2' HG12 ' A' ' 355' ' ' VAL . 0.0 OUTLIER -98.77 99.49 10.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.02 179.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 59.95 36.68 21.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.38 25.61 32.89 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.853 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -122.06 117.46 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.7 0.286 . . . . 0.0 110.9 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.584 ' O ' HD23 ' A' ' 323' ' ' LEU . 14.9 mmt180 -51.72 128.21 22.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.219 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.765 HD11 ' HB2' ' A' ' 318' ' ' GLN . 18.1 mt -125.5 -58.86 1.41 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.251 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.907 ' HD3' HD23 ' A' ' 316' ' ' LEU . 0.1 OUTLIER -129.93 159.94 35.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.179 0.514 . . . . 0.0 111.743 -179.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 325' ' ' LYS . 0.3 OUTLIER -139.7 138.07 35.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.721 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.403 ' HB2' ' HB ' ' A' ' 314' ' ' ILE . 1.2 mmtm -143.98 158.62 43.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 111.157 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 0.1 OUTLIER -149.93 145.3 26.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.948 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.714 HG22 ' CE1' ' A' ' 343' ' ' PHE . 12.9 p -102.0 -178.93 3.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.846 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.637 HG23 ' HE3' ' A' ' 331' ' ' LYS . 10.1 t -60.2 172.05 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.463 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.549 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 5.6 mt -113.44 121.54 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 111.454 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.637 ' HE3' HG23 ' A' ' 329' ' ' THR . 7.1 mmpt? -86.43 85.73 7.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.997 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -56.45 136.77 53.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.981 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.19 83.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.255 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.688 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.8 t -176.99 174.0 1.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.76 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 334' ' ' THR . 4.0 mt -145.25 -15.8 0.5 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.378 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.486 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.79 56.09 20.64 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 120.75 0.309 . . . . 0.0 110.516 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 61.3 Cg_endo -89.04 167.69 5.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.15 2.567 . . . . 0.0 113.723 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.443 ' CG ' ' HB3' ' A' ' 295' ' ' GLU . 0.2 OUTLIER -110.03 160.4 16.47 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.456 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.837 ' HB2' HG22 ' A' ' 293' ' ' ILE . 7.9 m-85 -135.17 -50.3 0.75 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.692 0.282 . . . . 0.0 111.192 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.449 ' ND2' ' C ' ' A' ' 339' ' ' TYR . 1.7 p30 44.41 36.7 1.73 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.029 0.442 . . . . 0.0 110.976 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.526 ' O ' HG13 ' A' ' 292' ' ' VAL . 44.3 mt-10 -90.91 141.25 29.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.816 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 88.0 p -111.24 121.2 44.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.932 0.396 . . . . 0.0 111.558 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.714 ' CE1' HG22 ' A' ' 328' ' ' THR . 67.6 m-85 -111.78 155.21 23.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.058 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 59.6 p -130.91 139.59 50.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.115 0.483 . . . . 0.0 111.692 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -126.41 165.97 18.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.581 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -113.16 76.94 1.01 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.546 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.902 HG13 ' HB3' ' A' ' 351' ' ' GLN . 49.4 t -109.84 122.21 39.76 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.322 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.501 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 63.2 Cg_endo -73.42 158.97 47.43 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.453 2.102 . . . . 0.0 111.492 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -52.06 -20.67 2.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.857 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -90.45 -8.7 49.83 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.902 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -110.47 -29.73 7.96 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.946 HD13 ' CD1' ' A' ' 282' ' ' TYR . 6.3 tp -47.09 -28.6 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.829 0.347 . . . . 0.0 111.059 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . 0.448 ' O ' ' CD2' ' A' ' 380' ' ' TYR . 2.8 mm-40 -95.11 -27.77 15.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.058 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -91.33 -3.94 56.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.875 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.791 HG12 ' HG2' ' A' ' 318' ' ' GLN . 29.9 m -106.96 166.3 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 111.278 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -141.65 126.23 17.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.658 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.519 HG13 HG23 ' A' ' 314' ' ' ILE . 64.9 t -90.77 105.01 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.145 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.3 OUTLIER -93.98 111.34 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.811 -179.008 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.532 ' HB ' HG23 ' A' ' 376' ' ' VAL . 48.2 t -91.52 108.0 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.99 HG23 ' HB3' ' A' ' 375' ' ' LYS . 2.6 m -110.26 131.93 54.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.061 0.457 . . . . 0.0 111.923 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 312' ' ' VAL . 58.2 t -107.05 119.67 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.926 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.853 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.6 mp -119.94 141.88 49.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.992 0.425 . . . . 0.0 111.722 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.44 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 6.3 t70 -90.09 125.94 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.585 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.542 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 24.6 t80 -80.06 145.98 32.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.593 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 367' ' ' ILE . 62.1 m-20 -139.43 64.78 1.45 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.554 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.658 ' CG ' HD12 ' A' ' 367' ' ' ILE . 1.9 tpmt? 27.85 -90.1 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.658 HD12 ' CG ' ' A' ' 366' ' ' LYS . 4.6 mp -82.74 -66.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.726 0.298 . . . . 0.0 111.127 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -47.37 166.43 0.12 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.716 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.84 161.45 21.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.729 0.3 . . . . 0.0 110.658 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.89 120.93 28.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.496 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.16 149.86 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.915 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.762 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -91.0 112.03 23.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.019 0.438 . . . . 0.0 111.119 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.433 ' O ' HD22 ' A' ' 273' ' ' LEU . 1.3 mm -73.26 -33.88 42.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.997 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 155.61 -178.37 32.25 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.258 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.99 ' HB3' HG23 ' A' ' 360' ' ' THR . 12.2 ptmt -162.16 140.59 9.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.294 0.569 . . . . 0.0 112.017 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.936 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.98 158.79 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.155 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.556 ' HB3' HG13 ' A' ' 358' ' ' VAL . 9.4 p90 -139.53 142.95 37.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.933 0.397 . . . . 0.0 111.121 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 378' ' ' VAL . 12.1 m -132.85 87.94 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.066 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.503 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . -178.26 -160.47 24.61 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.267 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.448 ' CD2' ' O ' ' A' ' 353' ' ' GLN . 0.2 OUTLIER -52.0 166.55 0.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.703 0.287 . . . . 0.0 110.981 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.537 ' OD1' HG22 ' A' ' 419' ' ' VAL . 9.2 m-80 57.15 25.68 11.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.958 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 7.3 m -126.31 162.02 26.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 73.2 p -155.77 148.44 24.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.927 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 97.8 -146.08 18.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.649 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -58.99 -30.12 67.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.749 0.309 . . . . 0.0 111.306 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.405 ' OE1' ' CZ ' ' A' ' 377' ' ' PHE . 14.4 mt-10 -65.05 -59.12 4.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.19 -32.06 71.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.501 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 2.6 ptt180 -64.94 -31.7 73.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.324 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.635 ' CD2' HD12 ' A' ' 280' ' ' LEU . 17.5 t-160 -77.29 -57.33 3.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.513 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 50.4 t-105 -49.47 -44.95 46.21 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.093 0.473 . . . . 0.0 109.901 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.0 t -69.06 -30.67 69.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.739 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.528 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.3 OUTLIER -63.14 -42.25 99.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.923 179.119 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.803 ' CE ' HD11 ' A' ' 352' ' ' ILE . 31.9 ttp -59.96 -54.83 41.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.971 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.797 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.4 mt -56.46 -31.57 64.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.417 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -68.2 -31.61 71.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.529 . . . . 0.0 109.691 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' A' ' 398' ' ' ARG . 36.0 m-80 -115.17 71.17 2.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.55 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.532 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 39.6 Cg_endo -68.34 35.29 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.249 2.632 . . . . 0.0 113.443 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . 0.51 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 11.3 mmm180 -159.26 -45.23 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.0 0.428 . . . . 0.0 110.578 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.405 ' NH1' ' HB2' ' A' ' 399' ' ' ARG . 0.2 OUTLIER -94.04 140.75 23.01 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.037 -179.19 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 72.3 Cg_endo -75.02 156.3 42.89 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.52 2.147 . . . . 0.0 112.839 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -124.99 117.95 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.578 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -110.13 144.57 38.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.677 0.275 . . . . 0.0 110.763 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.77 155.57 10.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.965 0.412 . . . . 0.0 111.246 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -82.23 121.63 26.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.753 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.936 ' HB3' HG11 ' A' ' 376' ' ' VAL . 54.3 m-70 -109.46 122.68 47.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.593 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 90.4 m -78.28 117.11 19.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.542 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.768 HD23 HG22 ' A' ' 376' ' ' VAL . 61.8 mt -62.16 128.09 34.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.253 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -114.44 173.29 6.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.672 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.812 ' O ' HG23 ' A' ' 413' ' ' VAL . 4.6 t -58.54 115.77 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.818 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.762 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 4.6 mp0 -52.42 -25.52 10.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.42 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.424 ' H ' HG12 ' A' ' 409' ' ' VAL . 2.3 mt-10 -72.94 -51.18 19.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.481 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.434 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 2.6 mm-40 -64.35 -38.8 92.33 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.897 HG11 ' HG3' ' A' ' 375' ' ' LYS . 59.6 t -56.8 -50.63 74.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.363 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.448 ' HA ' HD12 ' A' ' 417' ' ' LEU . 0.1 OUTLIER -63.86 -30.9 71.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.495 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.49 67.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.943 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 42.2 mtm -70.55 -38.55 74.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.777 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.464 HD21 ' CB ' ' A' ' 377' ' ' PHE . 9.7 mt -68.01 -29.95 69.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -88.25 126.4 35.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.078 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . 0.537 HG22 ' OD1' ' A' ' 381' ' ' ASN . 20.7 t . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.176 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.762 0.315 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.818 HD22 ' O ' ' A' ' 373' ' ' ILE . 72.3 mt -86.34 -33.89 20.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.777 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 124.12 -166.07 16.82 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.307 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.457 ' OD1' HG23 ' A' ' 406' ' ' THR . 36.0 m-20 -140.91 132.55 27.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.75 0.31 . . . . 0.0 110.709 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.849 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -123.14 130.17 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.165 0.507 . . . . 0.0 111.013 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.849 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -98.71 126.38 44.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.67 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.611 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.3 p90 -142.2 150.0 40.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.399 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.9 159.65 15.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.21 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.58 HD12 ' CD2' ' A' ' 389' ' ' HIS . 31.8 mt -130.7 149.39 52.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.798 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -158.95 106.47 1.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.611 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.967 ' CD1' HD13 ' A' ' 352' ' ' ILE . 27.7 t80 -101.49 137.91 39.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.14 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 44.2 t -123.5 95.81 44.58 Favored Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.539 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.3 Cg_exo -70.54 -34.38 12.06 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.931 2.421 . . . . 0.0 112.733 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.25 -30.71 5.02 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.16 0.505 . . . . 0.0 109.957 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -116.64 -21.72 8.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.844 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.26 48.87 6.17 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.642 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -124.15 129.74 51.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.073 0.463 . . . . 0.0 111.891 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 352' ' ' ILE . 39.2 tp -95.43 147.63 23.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.867 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 343' ' ' PHE . 8.3 m -139.33 138.7 36.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 112.06 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.5 124.41 57.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.316 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 341' ' ' GLU . 25.3 t -117.16 114.67 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.028 0.442 . . . . 0.0 111.852 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.788 HG22 ' HB2' ' A' ' 339' ' ' TYR . 26.1 mm -74.68 137.01 23.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.453 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.29 -60.49 1.87 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 2.4 pt-20 -175.81 159.28 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.243 0.544 . . . . 0.0 112.24 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.769 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -123.64 149.5 45.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.853 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -145.55 153.68 41.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.987 0.423 . . . . 0.0 111.375 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 60.54 29.02 18.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.495 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.769 HD21 ' HB1' ' A' ' 296' ' ' ALA . 91.8 mt -66.01 138.79 58.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.951 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -58.41 148.59 27.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.59 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.404 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 0.1 OUTLIER -89.45 121.9 32.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.465 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.53 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.8 mmt -96.48 -16.67 21.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.316 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 33.1 m-20 -106.97 101.3 10.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.767 0.318 . . . . 0.0 110.504 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.07 116.61 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.54 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.04 87.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.907 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -124.93 -139.47 5.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.85 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.505 HD12 ' HB2' ' A' ' 333' ' ' ASN . 34.1 mt -119.46 -159.21 0.76 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.01 0.433 . . . . 0.0 110.566 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.666 ' HB2' HD23 ' A' ' 335' ' ' LEU . 66.5 m -135.68 172.06 13.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.222 0.534 . . . . 0.0 110.638 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.407 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 0.6 OUTLIER -131.44 57.57 31.91 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 363' ' ' ASP . 38.3 Cg_endo -67.66 153.85 74.97 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.136 2.557 . . . . 0.0 114.51 -177.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.548 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 25.1 p90 -156.82 148.3 22.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.355 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 1.009 HG22 HG22 ' A' ' 361' ' ' VAL . 39.8 t -102.99 143.59 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.701 ' HE3' HD13 ' A' ' 362' ' ' LEU . 17.7 mttt -122.08 157.43 31.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.278 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.405 HG23 HG13 ' A' ' 357' ' ' VAL . 5.4 mp -131.51 124.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.651 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -123.5 133.25 54.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 111.157 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.416 HD21 HG22 ' A' ' 347' ' ' VAL . 22.5 tp -102.15 105.83 16.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.285 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . 0.448 ' HE2' HD22 ' A' ' 417' ' ' LEU . 0.9 OUTLIER -107.2 143.6 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.245 -179.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.794 ' HB2' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -105.58 99.56 9.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.416 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 59.84 37.75 21.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.937 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 90.16 25.56 26.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.902 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 317' ' ' MET . 7.8 mmtm -128.88 109.47 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.451 ' O ' HD23 ' A' ' 323' ' ' LEU . 7.9 ptt180 -52.84 130.81 34.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.227 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.794 HD11 ' HB2' ' A' ' 318' ' ' GLN . 8.3 mt -126.26 -43.21 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.241 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 3.2 mmpt? -130.62 158.08 41.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.921 0.391 . . . . 0.0 111.341 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.59 134.21 23.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.837 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -142.3 159.11 42.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.916 0.388 . . . . 0.0 111.247 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 313' ' ' LYS . 2.9 mttt -142.75 154.65 44.46 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.601 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.795 HG22 ' CE1' ' A' ' 343' ' ' PHE . 13.4 p -111.12 177.22 4.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.847 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.4 142.99 36.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.693 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.548 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.2 mt -90.55 119.17 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.109 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.614 ' O ' HG22 ' A' ' 334' ' ' THR . 1.1 mmpt? -83.56 89.47 7.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.3 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -57.42 137.4 56.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.799 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . 0.505 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.2 p-10 43.91 83.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.365 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.756 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.5 t -176.82 174.78 1.73 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.803 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 334' ' ' THR . 5.1 mt -146.65 -16.96 0.42 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.223 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.464 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.7 m-80 -132.6 59.26 42.11 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.387 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 44.5 Cg_endo -92.47 167.66 2.79 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.301 2.667 . . . . 0.0 113.756 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.453 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.4 OUTLIER -107.82 160.82 15.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.053 179.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.788 ' HB2' HG22 ' A' ' 293' ' ' ILE . 78.8 m-85 -133.93 -61.62 0.79 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.857 0.361 . . . . 0.0 111.236 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 54.76 36.9 27.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.536 ' O ' HG13 ' A' ' 292' ' ' VAL . 51.6 mt-10 -92.33 142.44 27.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 14.9 m -112.67 117.22 31.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.442 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.795 ' CE1' HG22 ' A' ' 328' ' ' THR . 81.2 m-85 -109.72 156.93 19.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.276 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 17.4 p -129.67 142.67 50.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 111.683 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -128.59 165.96 19.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.539 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -112.88 78.31 1.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.78 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.903 HG13 ' HB3' ' A' ' 351' ' ' GLN . 44.0 t -112.95 118.47 44.52 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.499 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 43.2 Cg_endo -68.7 151.87 74.52 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.286 1.991 . . . . 0.0 111.113 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -47.5 -24.39 0.83 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 354' ' ' LYS . 47.3 mt-10 -83.02 -20.7 34.53 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.903 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -93.67 -39.36 10.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.967 HD13 ' CD1' ' A' ' 282' ' ' TYR . 3.8 tp -45.62 -28.12 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.911 0.386 . . . . 0.0 110.994 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . 0.458 HE21 HD22 ' A' ' 394' ' ' LEU . 14.9 mm-40 -86.41 -31.11 21.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.806 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 350' ' ' GLU . 3.2 pttm -105.34 11.37 32.87 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.701 HG12 ' HG2' ' A' ' 318' ' ' GLN . 32.6 m -112.98 163.61 9.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.733 0.302 . . . . 0.0 110.883 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.2 126.51 18.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.222 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.527 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 86.5 t -89.56 134.06 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.195 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.527 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.5 OUTLIER -117.52 116.93 53.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.96 0.409 . . . . 0.0 111.692 -179.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.541 HG11 ' CD2' ' A' ' 278' ' ' PHE . 46.0 t -97.67 108.11 21.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.834 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.982 HG23 ' HB3' ' A' ' 375' ' ' LYS . 2.2 m -111.65 132.09 54.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.945 0.403 . . . . 0.0 111.978 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 1.009 HG22 HG22 ' A' ' 312' ' ' VAL . 52.7 t -106.59 113.8 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.906 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.701 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.1 mp -118.6 146.92 44.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.046 0.451 . . . . 0.0 111.69 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.53 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.6 OUTLIER -92.9 134.33 35.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.443 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.521 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 6.9 t80 -90.29 144.28 25.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.064 0.459 . . . . 0.0 110.911 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.51 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 19.8 m-20 -128.61 105.68 8.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.018 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.521 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 1.4 pttt -29.9 -56.07 0.17 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.024 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.65 HD13 ' N ' ' A' ' 367' ' ' ILE . 1.4 mm -91.01 -77.75 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.429 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -53.13 -175.46 0.06 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.087 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.01 165.97 17.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 111.095 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.13 145.7 47.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.077 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -106.11 151.56 24.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.68 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.619 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.35 110.32 22.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.04 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.818 ' O ' HD22 ' A' ' 273' ' ' LEU . 36.9 mt -81.26 -34.17 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.196 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 170.63 178.01 41.05 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.098 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.982 ' HB3' HG23 ' A' ' 360' ' ' THR . 16.9 ptmt -164.44 140.47 6.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.192 0.52 . . . . 0.0 111.729 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.921 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.24 158.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.116 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.501 ' HB3' HG13 ' A' ' 358' ' ' VAL . 44.1 p90 -140.68 150.63 43.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 111.345 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 378' ' ' VAL . 15.4 m -142.46 111.11 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.997 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 173.34 -154.28 19.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.908 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 382' ' ' SER . 0.2 OUTLIER -53.21 -70.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.744 0.307 . . . . 0.0 111.41 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -66.41 68.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.966 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . 0.427 ' O ' HG23 ' A' ' 383' ' ' THR . 0.7 OUTLIER -164.65 165.49 20.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.733 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 382' ' ' SER . 34.5 p -158.03 148.26 20.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 95.74 -143.0 16.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.705 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.437 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -57.43 -30.2 64.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.382 . . . . 0.0 111.332 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -68.22 -52.59 32.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.089 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 31.0 tp -68.94 -32.82 72.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 110.336 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 385' ' ' ALA . 0.0 OUTLIER -66.93 -30.07 70.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.253 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.58 ' CD2' HD12 ' A' ' 280' ' ' LEU . 20.1 t-160 -77.9 -52.77 8.32 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.646 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.527 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 65.0 t-105 -51.57 -49.02 62.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.074 0.464 . . . . 0.0 109.764 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.2 t -65.69 -29.99 70.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.721 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.516 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.4 OUTLIER -62.54 -43.76 98.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.753 179.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.851 ' CE ' HD11 ' A' ' 352' ' ' ILE . 29.8 ttp -60.39 -52.48 65.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.665 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.739 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.7 mt -57.96 -33.37 68.79 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.36 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -67.89 -30.52 69.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.305 0.574 . . . . 0.0 109.692 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 398' ' ' ARG . 3.3 m-80 -114.92 71.41 2.63 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.591 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.541 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 41.4 Cg_endo -68.7 32.95 0.16 Allowed 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.23 2.62 . . . . 0.0 113.534 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . 0.541 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 0.5 OUTLIER -158.77 -44.56 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.933 0.397 . . . . 0.0 110.77 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.417 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.0 OUTLIER -93.84 137.6 23.07 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.154 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 58.3 Cg_endo -71.43 156.37 58.51 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.571 2.181 . . . . 0.0 112.902 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -126.14 116.11 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.786 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.85 144.71 34.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.312 . . . . 0.0 110.828 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.34 154.25 10.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.37 . . . . 0.0 111.344 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -81.97 120.9 25.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.921 ' HB3' HG11 ' A' ' 376' ' ' VAL . 55.2 m-70 -109.61 122.36 47.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.457 HG23 ' OD1' ' A' ' 275' ' ' ASP . 85.4 m -78.26 117.27 19.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.674 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.761 HD23 HG22 ' A' ' 376' ' ' VAL . 45.2 mt -61.73 127.81 33.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.013 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -115.32 169.58 9.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.888 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.877 ' O ' HG23 ' A' ' 413' ' ' VAL . 41.1 t -55.59 121.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.973 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.619 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 6.7 mt-10 -55.17 -40.6 70.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.451 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.75 -51.13 71.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.469 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.456 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 27.1 mt-10 -63.57 -40.13 96.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 375' ' ' LYS . 98.6 t -56.45 -48.03 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.295 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -63.13 -40.19 96.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.745 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.98 81.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.039 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 40.6 mtm -68.99 -32.81 72.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.756 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.448 HD22 ' HE2' ' A' ' 317' ' ' MET . 10.9 mt -70.84 -31.16 67.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.811 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -84.51 156.12 21.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.094 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . 0.413 'CA ' ' HB3' ' A' ' 302' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.817 0.341 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.772 HD22 ' O ' ' A' ' 373' ' ' ILE . 47.9 mt -90.2 -35.97 15.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.798 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 127.57 -162.52 21.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.335 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.32 133.37 22.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.691 0.281 . . . . 0.0 110.731 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.873 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.1 OUTLIER -123.04 128.98 75.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.302 0.573 . . . . 0.0 111.165 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.873 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -96.26 126.71 41.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.556 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.622 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.2 p90 -142.16 149.51 39.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.474 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -100.94 160.47 14.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.04 -178.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.89 HD12 ' CD2' ' A' ' 389' ' ' HIS . 67.0 mt -130.21 147.05 51.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.162 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 290' ' ' THR . 0.7 OUTLIER -158.86 106.48 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 0.0 111.141 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 1.0 ' CD1' HD13 ' A' ' 352' ' ' ILE . 38.0 t80 -99.12 139.4 34.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.549 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 287' ' ' GLY . 98.9 t -114.89 93.8 35.54 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.97 0.414 . . . . 0.0 109.956 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.669 ' HD3' ' HB3' ' A' ' 397' ' ' PRO . 16.7 Cg_exo -66.33 -31.38 43.52 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.916 2.411 . . . . 0.0 112.343 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -28.39 67.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.807 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -123.66 -2.92 8.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.677 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 283' ' ' VAL . . . 62.97 46.55 93.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.09 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -121.98 128.83 51.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.059 0.457 . . . . 0.0 111.338 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.462 HD21 ' CG2' ' A' ' 357' ' ' VAL . 32.8 tp -93.08 147.64 22.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.332 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 343' ' ' PHE . 1.8 m -136.0 137.34 41.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.344 0.592 . . . . 0.0 111.857 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.1 t -129.95 122.98 55.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.439 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 341' ' ' GLU . 24.0 t -116.21 116.12 51.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.979 0.418 . . . . 0.0 111.788 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.702 HG13 HG21 ' A' ' 328' ' ' THR . 34.8 mm -76.09 136.89 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.447 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.4 OUTLIER -113.21 -59.62 1.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -177.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.486 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 2.2 pt-20 -175.64 156.79 1.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.479 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.793 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -117.59 150.63 38.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.766 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.405 ' HE3' ' CE3' ' A' ' 404' ' ' TRP . 11.3 pttp -147.73 152.36 37.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 111.507 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 62.92 24.24 14.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.833 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.793 HD21 ' HB1' ' A' ' 296' ' ' ALA . 60.7 mt -59.79 138.68 57.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.997 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -67.01 147.99 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.705 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.438 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 20.0 mttp -81.11 120.9 25.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.581 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.465 ' HG3' ' CB ' ' A' ' 363' ' ' ASP . 4.5 mmm -101.13 -15.38 17.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.644 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 52.9 m-20 -98.52 123.05 42.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.839 0.352 . . . . 0.0 110.548 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.0 t -48.07 114.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.627 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 56.77 17.89 22.86 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.274 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.13 -159.72 10.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.06 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 6.6 mt -95.56 -161.67 0.88 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 110.466 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.527 ' HB2' HD23 ' A' ' 335' ' ' LEU . 14.4 m -133.99 171.81 13.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.278 0.561 . . . . 0.0 111.181 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.418 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 13.7 m-20 -131.87 56.11 21.99 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.627 ' CG ' HD13 ' A' ' 299' ' ' LEU . 58.5 Cg_endo -73.01 146.28 41.29 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.047 2.498 . . . . 0.0 114.842 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.53 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 42.2 p90 -146.2 165.85 27.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.171 -1.377 . . . . 0.0 107.948 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.897 HG22 HG22 ' A' ' 361' ' ' VAL . 48.1 t -115.11 149.95 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.84 ' HE3' HD13 ' A' ' 362' ' ' LEU . 13.0 mttt -129.44 164.48 23.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.042 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.542 HG23 HG13 ' A' ' 357' ' ' VAL . 4.8 mp -137.86 124.97 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.689 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -119.46 135.56 54.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.89 0.376 . . . . 0.0 111.313 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 345' ' ' PHE . 20.5 tp -103.92 105.55 15.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.457 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.1 mtm -111.04 127.9 55.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.408 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.771 ' HB2' HD11 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -91.38 99.6 12.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.283 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 55.16 38.1 29.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.024 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 91.79 27.48 16.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.867 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 317' ' ' MET . 2.3 mptt -130.71 109.39 10.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.732 0.301 . . . . 0.0 110.843 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.503 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.9 OUTLIER -51.35 130.42 27.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.364 -179.793 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 318' ' ' GLN . 15.9 mt -124.58 -58.93 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.132 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.66 152.06 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.8 128.86 20.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.709 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -125.71 167.31 15.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.98 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.418 ' CB ' ' HG2' ' A' ' 313' ' ' LYS . 36.6 pttt -147.54 148.66 31.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.142 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.784 HG22 ' CE1' ' A' ' 343' ' ' PHE . 9.7 p -104.7 179.83 4.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.749 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.581 HG22 ' OE2' ' A' ' 341' ' ' GLU . 10.1 t -59.15 172.28 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.53 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.4 mt -116.96 125.1 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.955 0.407 . . . . 0.0 111.377 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.62 ' O ' HG22 ' A' ' 334' ' ' THR . 0.2 OUTLIER -91.08 91.45 8.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.281 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -58.83 137.09 57.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.833 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . 0.454 ' C ' HD13 ' A' ' 307' ' ' LEU . 0.9 OUTLIER 44.54 80.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.413 179.106 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.706 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.7 t -172.98 173.49 3.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.556 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 334' ' ' THR . 3.2 mt -146.99 -14.75 0.41 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.391 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.486 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.8 m-80 -135.81 57.63 19.78 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 120.704 0.288 . . . . 0.0 110.506 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 45.5 Cg_endo -92.79 167.82 2.58 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.155 2.57 . . . . 0.0 113.721 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.447 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.6 OUTLIER -106.31 160.76 15.12 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.192 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.623 ' HB2' HG22 ' A' ' 293' ' ' ILE . 66.1 m-85 -132.65 -66.83 0.67 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.916 0.388 . . . . 0.0 110.982 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 60.72 37.35 19.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.843 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.581 ' OE2' HG22 ' A' ' 329' ' ' THR . 29.9 mt-10 -93.65 143.91 25.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 93.1 p -113.21 121.92 45.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.007 0.432 . . . . 0.0 111.481 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.784 ' CE1' HG22 ' A' ' 328' ' ' THR . 36.7 m-85 -110.42 164.85 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.321 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 21.6 m -137.49 140.1 40.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.092 0.472 . . . . 0.0 111.679 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 316' ' ' LEU . 38.3 m-85 -126.88 166.0 18.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.503 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.33 72.99 0.79 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.727 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.824 HG13 ' HB3' ' A' ' 351' ' ' GLN . 46.9 t -108.38 121.08 44.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.135 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.562 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 68.5 Cg_endo -74.4 157.84 44.93 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.358 2.038 . . . . 0.0 111.247 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -50.9 -22.23 2.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -89.15 -8.46 53.65 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.824 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -111.98 -27.19 8.52 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 1.0 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.5 tp -48.37 -26.92 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.741 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . 0.544 ' NE2' HD13 ' A' ' 394' ' ' LEU . 3.6 mm-40 -95.09 -26.58 15.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.618 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 380' ' ' TYR . 48.0 mtpt -92.32 -0.66 57.37 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.883 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 351' ' ' GLN . 24.8 m -110.24 163.18 7.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.92 0.39 . . . . 0.0 111.317 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -139.24 126.33 21.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.62 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.542 HG13 HG23 ' A' ' 314' ' ' ILE . 98.9 t -90.88 111.81 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.533 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.529 HG11 ' HE2' ' A' ' 375' ' ' LYS . 0.6 OUTLIER -99.95 109.39 24.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.399 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.553 ' HB ' HG23 ' A' ' 376' ' ' VAL . 48.8 t -90.48 108.0 19.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.978 HG23 ' HB3' ' A' ' 375' ' ' LYS . 1.5 m -108.25 133.43 52.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.02 0.438 . . . . 0.0 111.894 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.897 HG22 HG22 ' A' ' 312' ' ' VAL . 51.1 t -108.3 114.8 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.839 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.84 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.5 mp -118.3 150.05 40.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.063 0.458 . . . . 0.0 111.838 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.465 ' CB ' ' HG3' ' A' ' 302' ' ' MET . 1.3 t70 -95.53 132.36 40.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.679 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.529 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 26.8 t80 -83.74 146.2 28.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.538 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -141.2 64.28 1.42 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.7 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.529 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 0.0 OUTLIER 33.2 -92.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.212 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 47.5 mm -81.11 -71.38 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.668 0.271 . . . . 0.0 111.409 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -42.91 163.81 0.03 OUTLIER Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.969 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 165.49 12.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 0.0 110.886 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.93 130.98 34.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.94 139.38 35.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.675 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -87.71 111.57 21.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.882 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.772 ' O ' HD22 ' A' ' 273' ' ' LEU . 37.2 mt -79.78 -34.42 15.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.01 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.92 -179.81 40.97 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.961 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.978 ' HB3' HG23 ' A' ' 360' ' ' THR . 9.6 ptmt -164.6 140.62 5.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.513 . . . . 0.0 111.81 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.957 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -109.47 158.89 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.128 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.471 ' CD1' HG13 ' A' ' 413' ' ' VAL . 17.6 p90 -139.58 151.4 46.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 0.0 111.813 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 378' ' ' VAL . 17.0 m -148.39 121.4 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.03 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.433 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 169.57 -151.35 17.02 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.371 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.406 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 0.2 OUTLIER -43.2 -69.83 0.12 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.863 0.364 . . . . 0.0 111.233 179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -60.97 -155.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.186 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . 0.407 ' CB ' ' CE2' ' A' ' 377' ' ' PHE . 0.7 OUTLIER 70.21 166.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 110.86 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 50.0 p -158.12 146.86 19.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.802 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 92.93 -154.66 22.07 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.825 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.481 ' HA ' ' HG3' ' A' ' 388' ' ' ARG . . . -43.35 -34.26 1.2 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.8 -56.08 18.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.729 0.299 . . . . 0.0 110.797 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.76 -35.96 79.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.463 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.481 ' HG3' ' HA ' ' A' ' 385' ' ' ALA . 4.0 mtt85 -61.77 -41.37 97.62 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.978 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.89 ' CD2' HD12 ' A' ' 280' ' ' LEU . 13.9 t-160 -60.99 -55.69 29.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.738 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.469 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 62.5 t-105 -55.44 -50.99 68.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.462 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -37.26 86.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.312 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.554 ' HB3' HD12 ' A' ' 401' ' ' ILE . 14.8 m-20 -63.07 -32.83 74.29 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.712 ' CE ' HD11 ' A' ' 352' ' ' ILE . 26.0 ttp -63.42 -56.4 16.54 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.776 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.2 mt -56.38 -23.26 36.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.715 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.4 ' C ' ' HD3' ' A' ' 397' ' ' PRO . . . -78.99 -33.63 44.87 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.372 0.606 . . . . 0.0 109.374 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.426 ' N ' ' HD3' ' A' ' 397' ' ' PRO . 28.6 m-80 -130.1 59.76 47.45 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.459 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.669 ' HB3' ' HD3' ' A' ' 284' ' ' PRO . 65.5 Cg_exo -46.28 -76.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.921 2.414 . . . . 0.0 112.992 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -49.45 -21.94 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.87 133.49 27.67 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 110.881 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 73.3 Cg_endo -75.21 133.76 16.66 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.492 2.128 . . . . 0.0 112.614 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.1 mm -111.68 110.75 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.803 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.18 143.96 34.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.783 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.43 152.39 7.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.874 0.369 . . . . 0.0 111.378 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . 0.405 ' CE3' ' HE3' ' A' ' 297' ' ' LYS . 63.3 m95 -80.12 124.09 28.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.686 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.957 ' HB3' HG11 ' A' ' 376' ' ' VAL . 61.0 m-70 -112.31 123.0 49.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.628 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 91.5 m -78.36 117.08 19.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.653 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.755 HD23 HG22 ' A' ' 376' ' ' VAL . 80.9 mt -62.45 127.73 32.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.077 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -115.85 170.26 8.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.791 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.857 ' O ' HG23 ' A' ' 413' ' ' VAL . 61.1 t -55.22 117.39 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.812 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.675 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 6.3 mp0 -52.01 -43.09 63.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.832 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -58.06 -50.16 74.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.738 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.455 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 23.0 mt-10 -64.04 -38.8 92.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 409' ' ' VAL . 89.0 t -57.43 -48.32 83.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.286 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -64.42 -30.6 71.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.468 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.37 -39.66 85.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.611 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . 0.409 ' SD ' ' CZ ' ' A' ' 377' ' ' PHE . 11.0 mtt -60.66 -41.6 95.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.532 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 5.2 mt -73.57 -30.57 63.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.934 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -93.36 113.72 25.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.075 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.163 179.933 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.8 0.333 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.792 HD22 ' O ' ' A' ' 373' ' ' ILE . 55.0 mt -89.73 -48.43 7.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 135.16 -170.16 23.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.19 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.64 ' OD1' HG23 ' A' ' 406' ' ' THR . 3.2 m-20 -136.74 135.15 37.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.719 0.295 . . . . 0.0 111.01 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.795 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -125.37 128.7 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.03 0.443 . . . . 0.0 110.875 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.795 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.5 OUTLIER -97.37 126.6 42.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.826 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.612 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.0 p90 -142.22 152.15 42.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.406 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.49 163.4 12.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.005 -178.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.673 HD12 ' CD2' ' A' ' 389' ' ' HIS . 96.1 mt -136.81 143.43 43.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.281 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -159.13 110.76 2.11 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.884 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.858 ' CD1' HD13 ' A' ' 352' ' ' ILE . 26.9 t80 -104.42 139.15 39.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.802 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.54 97.22 42.48 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.537 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.8 Cg_exo -72.84 -33.47 7.9 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.669 2.246 . . . . 0.0 112.632 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -29.36 6.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.165 0.507 . . . . 0.0 109.983 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.29 -18.16 8.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.945 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.79 48.87 8.29 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.548 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -123.69 129.9 51.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.986 0.422 . . . . 0.0 111.621 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.904 HD11 ' HE1' ' A' ' 393' ' ' MET . 38.5 tp -97.42 147.49 24.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.977 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 2.8 m -137.61 137.21 38.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.429 0.633 . . . . 0.0 111.965 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.7 t -130.92 123.6 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.162 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 341' ' ' GLU . 23.9 t -117.9 115.13 47.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.057 0.456 . . . . 0.0 111.794 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.622 HG13 HG21 ' A' ' 328' ' ' THR . 40.0 mm -74.83 137.11 23.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.02 -59.4 2.02 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 4.7 pt-20 -175.75 162.89 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.415 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.739 ' CB ' HD11 ' A' ' 299' ' ' LEU . . . -122.31 153.06 39.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.897 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -149.61 150.02 31.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.104 0.478 . . . . 0.0 111.534 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 60.38 26.27 15.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.878 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.739 HD11 ' CB ' ' A' ' 296' ' ' ALA . 94.2 mt -62.08 138.75 58.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.832 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.81 150.7 23.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.57 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.409 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 23.6 mttt -91.58 115.84 28.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.423 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.516 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 11.5 mmt -88.56 -19.26 26.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.541 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 50.1 m-20 -99.26 112.16 24.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.512 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.3 t -49.27 116.37 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.476 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 65.69 12.74 57.5 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.536 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.17 -151.01 7.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.75 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 307' ' ' LEU . 10.6 mt -108.29 -161.51 0.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.697 0.284 . . . . 0.0 110.68 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.622 ' HB2' HD23 ' A' ' 335' ' ' LEU . 49.8 m -137.68 172.04 13.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.369 0.604 . . . . 0.0 111.276 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.407 ' N ' ' CD ' ' A' ' 310' ' ' PRO . 8.7 m-20 -131.38 57.86 34.13 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.735 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.44 ' CB ' HD13 ' A' ' 299' ' ' LEU . 45.0 Cg_endo -69.74 151.92 69.32 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.196 2.597 . . . . 0.0 114.729 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.513 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 35.0 p90 -154.35 155.44 35.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.108 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.871 HG22 HG22 ' A' ' 361' ' ' VAL . 47.1 t -106.38 149.79 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.762 ' HE3' HD13 ' A' ' 362' ' ' LEU . 9.9 mtmt -131.93 140.99 49.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.307 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.551 HD11 HD11 ' A' ' 293' ' ' ILE . 5.3 mp -115.79 127.74 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.556 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . 0.415 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 57.7 m80 -122.39 133.4 54.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.369 . . . . 0.0 111.378 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.661 HD23 ' HG3' ' A' ' 324' ' ' LYS . 38.7 tp -106.39 107.53 18.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.095 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.1 mtm -116.12 147.82 40.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.391 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.67 ' HG3' HD11 ' A' ' 323' ' ' LEU . 1.4 mt-30 -107.0 99.47 9.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.521 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 56.55 37.83 29.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 96.6 13.82 46.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.166 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 317' ' ' MET . 32.3 mmtt -119.18 109.12 15.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.808 0.304 . . . . 0.0 110.734 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.48 135.37 56.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.4 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.67 HD11 ' HG3' ' A' ' 318' ' ' GLN . 3.3 mt -127.08 -49.36 1.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.849 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.661 ' HG3' HD23 ' A' ' 316' ' ' LEU . 2.5 mttt -130.53 148.97 52.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.962 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . 0.415 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -144.25 119.54 10.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.753 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -122.96 155.88 35.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.423 ' HB3' ' HG2' ' A' ' 313' ' ' LYS . 14.6 ptmt -137.58 148.58 45.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.842 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.73 HG22 ' CE1' ' A' ' 343' ' ' PHE . 4.3 p -101.71 -179.0 3.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.844 0.354 . . . . 0.0 110.712 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 15.0 t -60.45 162.2 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.468 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.513 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.6 mt -105.07 121.92 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.921 0.391 . . . . 0.0 111.219 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.479 ' HB3' HG21 ' A' ' 334' ' ' THR . 0.7 OUTLIER -85.6 94.65 9.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.109 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -60.8 136.8 58.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.928 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 43.83 83.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.51 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.738 ' O ' HD23 ' A' ' 335' ' ' LEU . 3.5 t -177.06 174.5 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.879 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 334' ' ' THR . 4.3 mt -145.26 -16.86 0.49 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.294 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 296' ' ' ALA . 1.1 m-80 -131.42 61.68 60.41 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.862 0.363 . . . . 0.0 110.05 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.413 ' HB2' ' CD ' ' A' ' 331' ' ' LYS . 64.6 Cg_endo -88.57 167.63 6.11 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.145 2.564 . . . . 0.0 114.045 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 340' ' ' ASN . 58.8 t80 -114.09 153.18 29.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.846 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.538 ' HB2' HG22 ' A' ' 293' ' ' ILE . 83.9 m-85 -132.98 -69.83 0.55 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.85 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.505 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 26.2 t-20 64.45 37.21 8.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.505 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.541 ' O ' HG13 ' A' ' 292' ' ' VAL . 31.3 mt-10 -91.42 142.9 27.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.787 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 13.7 m -110.28 122.18 47.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 0.0 111.581 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.73 ' CE1' HG22 ' A' ' 328' ' ' THR . 65.6 m-85 -113.2 148.36 35.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.091 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 3.0 m -120.8 140.0 52.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.1 0.476 . . . . 0.0 111.554 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.511 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 45.0 m-85 -126.88 165.87 18.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.437 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -116.62 76.1 1.01 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.958 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.907 HG13 ' HB3' ' A' ' 351' ' ' GLN . 55.7 t -109.16 122.92 38.31 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.209 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.529 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.4 Cg_endo -72.3 156.43 54.93 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.293 1.996 . . . . 0.0 111.3 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -50.68 -21.92 1.82 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.67 -8.5 52.27 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.907 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -107.88 -31.36 8.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.858 HD13 ' CD1' ' A' ' 282' ' ' TYR . 6.4 tp -46.81 -27.28 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 111.319 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -90.02 -47.54 7.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.627 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.446 ' CG ' ' HA ' ' A' ' 351' ' ' GLN . 5.9 ptpt -80.72 2.18 27.1 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 351' ' ' GLN . 33.1 m -107.66 165.38 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.729 0.299 . . . . 0.0 110.872 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.67 126.46 15.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.087 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.561 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 61.4 t -88.54 114.14 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.276 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.498 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.4 OUTLIER -100.16 116.29 43.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.756 -179.169 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.553 HG13 ' CG1' ' A' ' 312' ' ' VAL . 58.3 t -98.46 108.11 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.856 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.932 HG23 ' HB3' ' A' ' 375' ' ' LYS . 1.6 m -108.73 132.68 53.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.998 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.871 HG22 HG22 ' A' ' 312' ' ' VAL . 54.6 t -105.93 114.96 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.636 178.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.762 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.3 mp -118.71 147.84 43.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.096 0.474 . . . . 0.0 111.895 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.516 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.8 t70 -93.8 137.36 33.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.744 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.508 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 30.7 t80 -90.09 145.62 24.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.376 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 367' ' ' ILE . 48.3 m-20 -142.53 66.22 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.813 ' CG ' HD12 ' A' ' 367' ' ' ILE . 0.0 OUTLIER 35.77 -92.24 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.312 179.157 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.813 HD12 ' CG ' ' A' ' 366' ' ' LYS . 4.6 mp -86.48 -65.44 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.792 0.329 . . . . 0.0 111.238 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -41.84 159.47 0.04 OUTLIER Glycine 0 C--N 1.332 0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.178 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.86 149.79 49.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.31 . . . . 0.0 110.889 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.03 126.41 29.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.781 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.01 148.9 37.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.15 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.65 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -95.4 110.89 22.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.792 ' O ' HD22 ' A' ' 273' ' ' LEU . 23.9 mt -79.59 -32.88 14.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.316 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . 0.44 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 166.48 -178.87 40.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.746 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.932 ' HB3' HG23 ' A' ' 360' ' ' THR . 10.9 ptmt -164.54 141.04 6.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.181 0.515 . . . . 0.0 111.686 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.899 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -112.86 158.79 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.226 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.498 ' HB3' HG13 ' A' ' 358' ' ' VAL . 8.3 p90 -141.78 143.03 33.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.374 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 378' ' ' VAL . 7.6 m -131.86 90.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.082 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.45 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . -177.64 -158.0 19.71 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.45 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -56.73 173.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 110.803 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 23.5 m120 51.18 26.55 2.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.273 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . 0.433 ' O ' HG23 ' A' ' 383' ' ' THR . 0.7 OUTLIER -132.19 165.53 23.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 382' ' ' SER . 34.1 p -158.02 150.65 22.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.903 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 97.97 -147.54 18.62 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.434 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 388' ' ' ARG . . . -55.37 -30.4 60.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 111.379 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.409 ' OE1' ' CZ ' ' A' ' 377' ' ' PHE . 0.3 OUTLIER -68.53 -54.42 16.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.984 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 24.9 tp -67.96 -30.91 70.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.781 0.324 . . . . 0.0 110.43 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 5.1 ptt180 -68.23 -28.21 67.03 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.329 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.673 ' CD2' HD12 ' A' ' 280' ' ' LEU . 18.4 t-160 -81.33 -54.48 5.44 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.456 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.561 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 48.2 t-105 -49.96 -43.97 50.44 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.008 0.432 . . . . 0.0 109.863 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 31.3 t -69.72 -34.1 73.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.694 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.467 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.5 OUTLIER -61.08 -39.57 90.4 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.904 ' HE1' HD11 ' A' ' 289' ' ' LEU . 19.8 ttm -59.42 -53.79 54.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.115 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.798 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.9 mt -63.81 -29.74 70.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.374 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.82 -31.02 71.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.226 0.536 . . . . 0.0 109.694 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -125.3 77.86 67.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.329 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.537 ' HB3' ' CG ' ' A' ' 284' ' ' PRO . 6.0 Cg_exo -77.8 42.76 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.145 2.564 . . . . 0.0 113.162 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . 0.505 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 16.2 mmm-85 -158.98 -46.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.069 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.21 142.84 25.45 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.925 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 63.4 Cg_endo -73.01 156.27 52.2 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.654 2.236 . . . . 0.0 112.904 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.81 114.69 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.749 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -107.91 144.21 35.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.759 0.314 . . . . 0.0 110.832 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.43 154.68 10.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.959 0.409 . . . . 0.0 111.291 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -81.38 120.35 24.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.959 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.899 ' HB3' HG11 ' A' ' 376' ' ' VAL . 48.3 m-70 -109.56 117.72 34.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.459 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.64 HG23 ' OD1' ' A' ' 275' ' ' ASP . 89.8 m -78.43 116.22 18.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.792 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.825 HD23 HG22 ' A' ' 376' ' ' VAL . 93.7 mt -61.09 128.12 34.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.347 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.417 ' C ' HD12 ' A' ' 273' ' ' LEU . 5.2 mt-30 -115.47 171.96 7.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.558 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.888 ' O ' HG23 ' A' ' 413' ' ' VAL . 44.2 t -54.59 120.72 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.65 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 14.8 mt-10 -54.29 -41.56 69.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.815 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.16 -51.33 70.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 0.0 110.539 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.49 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 24.6 mt-10 -62.49 -39.83 94.73 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.889 HG11 ' HG3' ' A' ' 375' ' ' LYS . 75.6 t -57.64 -50.11 78.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.378 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -60.08 -37.79 80.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.64 76.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.058 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 51.0 mtm -69.19 -31.62 70.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.473 HD21 ' HB2' ' A' ' 377' ' ' PHE . 9.0 mt -79.14 -34.18 43.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -70.62 174.7 5.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.099 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.057 179.987 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.819 0.343 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 373' ' ' ILE . 22.0 mt -94.78 -33.95 12.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.811 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 117.75 -163.98 12.73 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.177 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.49 ' OD1' HG23 ' A' ' 406' ' ' THR . 28.3 m-20 -143.6 132.18 22.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.731 0.301 . . . . 0.0 110.589 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.912 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -121.04 131.57 72.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.184 0.516 . . . . 0.0 111.184 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.912 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -99.59 125.08 45.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.709 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.626 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 16.0 p90 -139.91 150.69 44.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.24 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 401' ' ' ILE . 0.0 OUTLIER -99.62 158.03 16.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.056 -178.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.555 HD13 ' HE3' ' A' ' 393' ' ' MET . 77.3 mt -129.44 144.87 51.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.018 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.416 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 22.7 ttp85 -158.89 109.22 2.02 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.702 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.834 ' CD1' HD13 ' A' ' 352' ' ' ILE . 26.1 t80 -103.39 137.98 40.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.93 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.0 t -122.29 94.6 47.78 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.541 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.5 Cg_exo -70.04 -32.63 17.06 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.939 2.426 . . . . 0.0 112.44 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.44 -30.03 7.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.184 0.516 . . . . 0.0 110.015 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.53 -21.45 7.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.962 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 80.92 48.44 6.11 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.549 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -124.04 130.18 52.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.983 0.421 . . . . 0.0 111.803 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.754 HD11 ' HE1' ' A' ' 393' ' ' MET . 33.2 tp -95.66 147.5 23.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.74 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 343' ' ' PHE . 7.1 m -138.19 136.58 36.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.31 0.576 . . . . 0.0 112.001 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.36 123.92 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.297 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 341' ' ' GLU . 34.8 t -118.06 115.44 48.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.976 0.417 . . . . 0.0 112.006 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.712 HG22 ' HB2' ' A' ' 339' ' ' TYR . 31.3 mm -73.85 135.34 27.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.62 -62.76 1.53 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.486 ' HA ' ' CD2' ' A' ' 339' ' ' TYR . 1.6 pt-20 -175.55 150.15 1.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.247 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.87 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -110.46 157.77 19.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.168 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -150.98 153.41 35.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.014 0.435 . . . . 0.0 111.724 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 59.08 25.2 13.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.93 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.87 HD21 ' HB1' ' A' ' 296' ' ' ALA . 49.6 mt -59.04 138.63 57.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.168 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.83 144.78 47.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.415 ' HA ' ' OG ' ' A' ' 308' ' ' SER . 25.5 mttp -85.69 109.64 18.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.42 ' HG2' ' HB3' ' A' ' 363' ' ' ASP . 0.0 OUTLIER -86.13 -21.62 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.872 -179.404 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 50.5 m-20 -95.39 123.56 38.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 20.5 t -54.19 117.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.546 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 59.11 16.74 34.61 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.407 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.84 -154.92 8.71 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.679 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 15.1 mt -102.26 -161.36 0.84 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.788 0.327 . . . . 0.0 110.43 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.646 ' HB2' HD23 ' A' ' 335' ' ' LEU . 68.8 m -135.32 172.05 13.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.231 0.539 . . . . 0.0 110.972 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 310' ' ' PRO . 0.7 OUTLIER -133.53 55.86 18.09 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.738 ' CG ' HD13 ' A' ' 299' ' ' LEU . 69.5 Cg_endo -76.71 142.58 23.02 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.944 2.429 . . . . 0.0 114.93 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.604 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 14.7 p90 -137.46 167.05 22.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.36 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.906 HG22 HG22 ' A' ' 361' ' ' VAL . 43.1 t -113.05 150.07 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.837 ' HE2' HD13 ' A' ' 362' ' ' LEU . 7.5 mttm -133.41 139.91 47.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.189 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 293' ' ' ILE . 5.4 mp -114.63 131.01 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.685 0.279 . . . . 0.0 111.03 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -127.37 134.08 49.97 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.863 0.363 . . . . 0.0 111.015 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 324' ' ' LYS . 22.5 tp -103.99 106.47 16.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.409 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.6 mtm -110.7 135.33 51.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.138 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.721 ' HB2' HD11 ' A' ' 323' ' ' LEU . 0.5 OUTLIER -95.48 99.46 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.546 179.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 59.58 35.66 22.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.301 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 98.21 7.99 55.56 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.676 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.712 ' HG3' HD21 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -115.47 112.74 22.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.387 0.593 . . . . 0.0 110.94 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.513 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.4 OUTLIER -52.25 134.19 33.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.526 -179.581 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.721 HD11 ' HB2' ' A' ' 318' ' ' GLN . 13.4 mt -125.91 -45.95 1.71 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.104 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 316' ' ' LEU . 9.5 mmtp -130.59 153.63 48.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.364 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 117.31 10.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.903 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.451 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 3.4 mmtm -123.63 164.68 18.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.104 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.52 152.68 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.97 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.727 HG22 ' CE1' ' A' ' 343' ' ' PHE . 16.1 p -109.83 -178.89 3.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 11.3 t -63.0 165.85 6.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.604 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.9 mt -108.49 117.29 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 111.509 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.659 ' O ' HG22 ' A' ' 334' ' ' THR . 8.3 mmpt? -80.07 85.95 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.875 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -55.12 135.84 48.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.021 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.32 83.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.49 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.773 ' O ' HD23 ' A' ' 335' ' ' LEU . 4.5 t -175.63 174.39 2.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.681 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.773 HD23 ' O ' ' A' ' 334' ' ' THR . 5.2 mt -145.59 -17.16 0.48 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.185 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.486 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 2.7 m-80 -132.72 56.53 22.98 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.908 0.385 . . . . 0.0 110.123 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 42.7 Cg_endo -90.1 167.79 4.51 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.203 2.602 . . . . 0.0 113.746 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' ' 295' ' ' GLU . 0.3 OUTLIER -109.63 159.6 16.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.167 179.244 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.712 ' HB2' HG22 ' A' ' 293' ' ' ILE . 51.1 m-85 -132.48 -62.32 0.83 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.68 37.42 25.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.564 ' O ' HG13 ' A' ' 292' ' ' VAL . 30.1 mt-10 -92.47 144.47 25.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.706 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 51.6 p -115.48 120.76 40.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.393 . . . . 0.0 111.749 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.727 ' CE1' HG22 ' A' ' 328' ' ' THR . 80.8 m-85 -112.38 155.06 24.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.11 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 83.4 p -127.16 139.62 52.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.083 0.468 . . . . 0.0 111.591 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.451 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 66.3 m-85 -127.89 165.86 19.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.545 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.56 79.93 1.33 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.998 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' A' ' 351' ' ' GLN . 47.9 t -112.16 118.99 45.04 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.991 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.449 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 37.2 Cg_endo -66.52 154.02 75.88 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.321 2.014 . . . . 0.0 111.353 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -51.9 -24.74 6.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.752 0.31 . . . . 0.0 111.444 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.27 -8.57 57.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.54 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.551 ' HB3' HG13 ' A' ' 347' ' ' VAL . 31.2 mt-30 -105.99 -37.14 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.667 0.27 . . . . 0.0 111.329 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.834 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.7 tp -47.13 -25.52 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 111.195 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . 0.409 ' O ' ' CD1' ' A' ' 380' ' ' TYR . 3.0 mt-30 -88.99 -24.86 22.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.831 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.484 ' HA ' ' CD1' ' A' ' 380' ' ' TYR . 0.6 OUTLIER -111.69 2.14 17.08 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.012 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 351' ' ' GLN . 33.8 m -96.77 167.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.766 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . 0.423 ' HA ' ' HA3' ' A' ' 379' ' ' GLY . 7.4 mt-30 -141.28 126.33 18.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.928 0.394 . . . . 0.0 111.472 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.571 ' CG2' HD21 ' A' ' 289' ' ' LEU . 99.6 t -96.93 115.33 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.833 178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.4 OUTLIER -101.22 117.17 46.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.529 ' HB ' HG23 ' A' ' 376' ' ' VAL . 45.9 t -98.22 107.85 20.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.435 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.966 HG23 ' HB3' ' A' ' 375' ' ' LYS . 4.7 m -111.28 129.58 55.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.054 0.454 . . . . 0.0 111.9 -178.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.906 HG22 HG22 ' A' ' 312' ' ' VAL . 58.5 t -103.81 121.1 54.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.074 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.837 HD13 ' HE2' ' A' ' 313' ' ' LYS . 2.8 mp -123.18 146.26 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 111.816 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 310' ' ' PRO . 5.0 t70 -90.17 137.62 32.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.642 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.599 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 25.0 t80 -94.14 142.52 27.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.425 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 367' ' ' ILE . 1.2 m-20 -139.08 68.9 1.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.584 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.599 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 0.0 OUTLIER 27.91 -86.54 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 365' ' ' ASP . 42.7 mm -87.52 -67.15 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.75 0.309 . . . . 0.0 111.129 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -43.06 165.01 0.02 OUTLIER Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.091 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.8 165.56 12.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.848 0.356 . . . . 0.0 111.007 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.25 121.32 31.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . 0.415 ' HB2' ' HG2' ' A' ' 302' ' ' MET . 1.3 m-20 -71.23 147.25 48.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.51 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -91.7 110.22 21.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.094 0.473 . . . . 0.0 111.373 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.589 ' O ' HD22 ' A' ' 273' ' ' LEU . 2.4 mm -71.95 -35.57 54.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.783 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . 0.426 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 157.38 -175.16 34.84 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.117 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.966 ' HB3' HG23 ' A' ' 360' ' ' THR . 9.9 ptmt -164.1 140.5 6.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.287 0.565 . . . . 0.0 111.906 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.944 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.71 158.85 13.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.219 179.375 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.513 ' HB3' HG13 ' A' ' 358' ' ' VAL . 2.6 p90 -140.45 150.85 44.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.563 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 17.1 m -151.31 127.96 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.151 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.506 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 133.81 126.45 2.67 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.953 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.484 ' CD1' ' HA ' ' A' ' 354' ' ' LYS . 0.0 OUTLIER 58.97 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.649 0.261 . . . . 0.0 111.104 179.746 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 379' ' ' GLY . 0.3 OUTLIER -71.72 -161.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.313 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 383' ' ' THR . 0.7 OUTLIER 69.8 166.8 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 110.93 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 382' ' ' SER . 42.2 p -158.09 147.33 19.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.867 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 90.14 -139.85 15.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.813 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -49.53 -31.9 11.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.701 0.286 . . . . 0.0 111.766 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -68.59 -58.88 3.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.903 0.382 . . . . 0.0 110.206 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.45 -30.91 71.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.368 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 4.7 ptt180 -65.52 -28.63 69.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.312 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.441 ' CD2' ' CG2' ' A' ' 401' ' ' ILE . 19.7 t-160 -81.56 -58.13 3.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.715 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.561 ' CZ3' ' HE1' ' A' ' 393' ' ' MET . 73.9 t-105 -49.82 -46.32 50.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.07 0.462 . . . . 0.0 109.979 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 5.4 t -64.49 -32.94 74.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.593 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.54 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.6 OUTLIER -65.47 -40.46 93.19 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.776 ' SD ' HD11 ' A' ' 352' ' ' ILE . 7.1 ttm -57.86 -53.06 62.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.378 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.724 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.8 mt -61.94 -34.37 75.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.359 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.65 -29.71 69.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.181 0.515 . . . . 0.0 109.943 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -114.1 71.04 2.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.754 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.543 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 48.6 Cg_endo -70.07 33.98 0.21 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.167 2.578 . . . . 0.0 113.486 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . 0.543 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 10.2 mmm180 -159.25 -47.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.952 0.406 . . . . 0.0 110.952 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.486 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 36.1 ttt180 -93.94 136.66 23.55 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.385 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.486 ' HD2' ' HG3' ' A' ' 399' ' ' ARG . 48.6 Cg_endo -68.48 156.41 65.71 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.601 2.201 . . . . 0.0 112.939 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.54 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.37 118.72 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.797 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -105.64 144.58 32.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.839 0.352 . . . . 0.0 110.729 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.07 154.51 15.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.159 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -85.81 119.28 25.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.774 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.944 ' HB3' HG11 ' A' ' 376' ' ' VAL . 58.4 m-70 -108.56 122.16 46.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.251 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.49 HG23 ' OD1' ' A' ' 275' ' ' ASP . 89.9 m -78.08 117.41 19.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.721 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.737 HD23 HG22 ' A' ' 376' ' ' VAL . 67.5 mt -61.66 127.57 32.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.2 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.477 ' C ' HD12 ' A' ' 273' ' ' LEU . 6.0 mt-30 -115.0 169.07 9.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.755 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.889 ' O ' HG23 ' A' ' 413' ' ' VAL . 45.0 t -56.76 121.25 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.479 ' HG2' ' HD2' ' A' ' 375' ' ' LYS . 5.7 mt-10 -52.2 -44.83 64.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.993 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.06 -49.66 75.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 110.74 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.444 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 29.8 mt-10 -64.59 -38.76 92.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 409' ' ' VAL . 96.3 t -58.24 -49.49 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.381 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.57 -34.07 72.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.829 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -72.58 -36.72 68.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.028 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 59.8 mtm -70.84 -32.8 69.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 377' ' ' PHE . 12.0 mt -70.69 -30.77 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.914 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -79.03 116.8 19.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.092 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.143 179.986 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.819 0.342 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.793 HD22 ' O ' ' A' ' 373' ' ' ILE . 60.8 mt -89.14 -31.57 17.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.942 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 120.24 -165.73 13.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.233 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.18 133.06 27.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.806 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -121.94 129.56 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.088 0.47 . . . . 0.0 110.914 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.806 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -96.86 125.35 41.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.668 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.609 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 18.6 p90 -142.08 149.29 39.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.406 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -102.97 161.31 13.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.269 -178.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.635 HD12 ' CD2' ' A' ' 389' ' ' HIS . 11.3 mt -133.27 149.67 51.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.942 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.418 ' HB3' ' HB ' ' A' ' 290' ' ' THR . 0.1 OUTLIER -158.92 105.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.446 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.908 ' CD1' HD13 ' A' ' 352' ' ' ILE . 30.7 t80 -98.19 134.87 40.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.832 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.51 97.88 48.56 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.526 ' CG ' ' HB3' ' A' ' 397' ' ' PRO . 2.9 Cg_exo -72.46 -31.49 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.691 2.261 . . . . 0.0 112.377 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.26 -30.26 6.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.294 0.569 . . . . 0.0 109.715 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -119.16 -17.38 8.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.767 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 76.11 47.94 10.46 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.689 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -123.31 129.38 51.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.934 0.397 . . . . 0.0 111.853 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.464 HD21 ' CG2' ' A' ' 357' ' ' VAL . 36.5 tp -92.59 147.66 22.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.796 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 281' ' ' ARG . 2.9 m -137.16 138.54 40.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.323 0.582 . . . . 0.0 112.091 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.1 t -131.42 123.91 53.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.449 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 341' ' ' GLU . 29.0 t -116.74 115.3 48.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.942 0.401 . . . . 0.0 111.848 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.712 HG13 HG21 ' A' ' 328' ' ' THR . 31.6 mm -75.83 133.7 30.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.57 -59.86 1.89 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.476 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 7.3 pt-20 -175.72 165.17 3.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.241 0.543 . . . . 0.0 112.081 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.911 ' CB ' HD11 ' A' ' 299' ' ' LEU . . . -127.84 155.35 44.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.258 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.402 ' HD2' ' CH2' ' A' ' 404' ' ' TRP . 10.4 ptmt -149.7 150.2 31.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 111.5 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 59.87 26.34 15.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.735 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.911 HD11 ' CB ' ' A' ' 296' ' ' ALA . 87.5 mt -64.83 139.0 58.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.108 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -57.62 145.61 33.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.381 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.622 ' HG3' HD21 ' A' ' 335' ' ' LEU . 0.0 OUTLIER -94.94 127.77 41.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.405 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.509 ' HG3' ' HB3' ' A' ' 363' ' ' ASP . 14.7 mmt -97.78 -9.82 25.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.405 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 25.4 m-20 -108.52 119.17 38.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.718 0.294 . . . . 0.0 110.445 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.32 118.77 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.576 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 76.86 2.18 75.83 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.195 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . 0.407 ' O ' HD23 ' A' ' 307' ' ' LEU . . . -120.82 -123.26 3.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.932 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 333' ' ' ASN . 44.0 mt -137.32 -159.28 0.94 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.906 0.384 . . . . 0.0 110.071 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.506 ' HB3' ' HD3' ' A' ' 310' ' ' PRO . 0.2 OUTLIER -140.13 167.98 20.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.933 0.397 . . . . 0.0 110.255 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.08 64.43 52.8 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 308' ' ' SER . 60.7 Cg_endo -74.03 142.68 31.49 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.827 2.351 . . . . 0.0 114.697 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 43.1 p90 -144.25 158.52 43.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.212 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.838 HG22 HG22 ' A' ' 361' ' ' VAL . 44.2 t -107.82 149.91 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.409 0.623 . . . . 0.0 112.625 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.854 ' HE3' HD13 ' A' ' 362' ' ' LEU . 9.7 mtmt -132.85 136.94 46.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.517 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.576 HG23 HG13 ' A' ' 357' ' ' VAL . 5.4 mp -107.97 136.97 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.513 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 77.9 m80 -130.89 133.6 46.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.379 . . . . 0.0 111.131 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.474 HD21 HG22 ' A' ' 347' ' ' VAL . 35.0 tp -106.79 110.23 22.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.376 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 321' ' ' LYS . 1.7 mtm -118.99 139.73 51.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.939 0.4 . . . . 0.0 111.378 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.551 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.1 OUTLIER -99.63 99.44 10.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.411 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 53.02 38.1 26.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 94.4 26.82 12.83 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.87 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 317' ' ' MET . 1.8 mptt -129.23 109.3 11.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.706 0.288 . . . . 0.0 110.779 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.501 ' O ' HD23 ' A' ' 323' ' ' LEU . 0.0 OUTLIER -52.14 130.0 29.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.52 -179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.551 HD11 ' CB ' ' A' ' 318' ' ' GLN . 11.5 mt -125.86 -55.04 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.973 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -130.62 150.71 51.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.319 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . 0.422 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.0 OUTLIER -144.45 123.41 12.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.422 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 345' ' ' PHE . 21.6 mmtt -125.19 170.79 10.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.407 ' HB3' ' HG2' ' A' ' 313' ' ' LYS . 0.5 OUTLIER -150.25 147.01 27.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.897 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.755 HG22 ' CE1' ' A' ' 343' ' ' PHE . 5.5 p -104.27 -178.71 3.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.758 0.313 . . . . 0.0 110.782 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 13.9 t -60.33 164.02 4.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.432 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.569 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 2.9 mt -108.11 116.87 52.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.973 0.416 . . . . 0.0 111.379 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.612 ' O ' HG22 ' A' ' 334' ' ' THR . 0.7 OUTLIER -78.81 85.93 4.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.034 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -53.51 136.45 38.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.167 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . 0.529 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.1 p-10 43.6 86.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.277 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.627 ' O ' HD23 ' A' ' 335' ' ' LEU . 5.0 t 177.31 173.16 0.5 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.52 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.627 HD23 ' O ' ' A' ' 334' ' ' THR . 2.8 mt -144.28 -15.29 0.58 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.357 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.434 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.0 OUTLIER -132.6 61.14 55.11 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-O 120.857 0.361 . . . . 0.0 110.039 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 52.0 Cg_endo -91.21 167.71 3.55 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.196 2.597 . . . . 0.0 114.028 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.476 ' CD1' ' HB3' ' A' ' 295' ' ' GLU . 20.7 t80 -110.76 154.09 24.41 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.748 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.553 ' HB2' HG22 ' A' ' 293' ' ' ILE . 75.8 m-85 -131.39 -68.93 0.64 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.855 0.36 . . . . 0.0 111.727 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.421 ' HB2' ' CE2' ' A' ' 338' ' ' TYR . 0.1 OUTLIER 63.71 36.65 10.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.703 -179.4 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.551 ' O ' HG13 ' A' ' 292' ' ' VAL . 37.4 mt-10 -91.8 144.68 25.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.6 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 51.5 p -114.87 121.81 44.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.934 0.397 . . . . 0.0 111.656 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.755 ' CE1' HG22 ' A' ' 328' ' ' THR . 63.6 m-85 -113.75 151.84 31.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.163 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 87.9 p -125.97 138.89 53.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.155 0.502 . . . . 0.0 111.789 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.435 ' CZ ' ' HG3' ' A' ' 326' ' ' LYS . 56.9 m-85 -125.42 166.05 17.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.585 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -113.27 78.21 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.913 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.89 HG13 ' HB3' ' A' ' 351' ' ' GLN . 48.6 t -110.6 122.12 39.25 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.82 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.525 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 58.4 Cg_endo -72.54 157.55 52.51 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.352 2.035 . . . . 0.0 111.657 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -51.46 -21.89 2.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.841 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.33 -8.54 53.04 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.89 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -109.86 -30.31 7.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.908 HD13 ' CD1' ' A' ' 282' ' ' TYR . 6.4 tp -47.4 -28.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.811 0.338 . . . . 0.0 111.026 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . 0.438 ' O ' ' CD2' ' A' ' 380' ' ' TYR . 2.9 mm-40 -95.0 -25.82 16.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.897 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -95.1 0.84 54.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.875 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 351' ' ' GLN . 17.2 m -113.18 161.11 12.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.833 0.349 . . . . 0.0 111.302 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -137.1 126.34 24.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.713 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 314' ' ' ILE . 91.6 t -87.08 107.43 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.402 . . . . 0.0 110.248 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.453 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.7 OUTLIER -93.36 113.68 28.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.592 -179.29 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.542 ' HB ' HG23 ' A' ' 376' ' ' VAL . 41.7 t -96.69 107.74 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.915 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.959 HG23 ' HB3' ' A' ' 375' ' ' LYS . 1.7 m -109.01 131.34 55.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.966 0.412 . . . . 0.0 111.774 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.838 HG22 HG22 ' A' ' 312' ' ' VAL . 50.5 t -106.16 114.95 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.946 178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.854 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.5 mp -118.3 150.54 39.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.025 0.44 . . . . 0.0 111.885 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.509 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 1.1 t70 -94.76 131.37 40.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.361 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.606 ' HE1' ' HA ' ' A' ' 366' ' ' LYS . 25.1 t80 -85.67 146.91 26.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.759 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 367' ' ' ILE . 75.1 m-20 -140.29 62.86 1.49 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.321 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.606 ' HA ' ' HE1' ' A' ' 364' ' ' TYR . 0.0 OUTLIER 29.09 -87.62 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 179.477 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 365' ' ' ASP . 46.2 mm -81.79 -71.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.745 0.307 . . . . 0.0 111.186 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -43.85 164.9 0.03 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.037 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.94 165.61 12.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.935 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.83 134.92 33.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.947 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . 0.429 ' HB2' ' HG3' ' A' ' 302' ' ' MET . 1.8 m-20 -85.8 151.3 23.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.035 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.604 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.07 111.34 23.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.974 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.793 ' O ' HD22 ' A' ' 273' ' ' LEU . 31.3 mt -80.97 -34.08 13.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.086 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . 0.455 ' CA ' HD13 ' A' ' 273' ' ' LEU . . . 167.29 -178.96 41.16 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.88 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.959 ' HB3' HG23 ' A' ' 360' ' ' THR . 14.7 ptmt -164.59 141.07 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.196 0.522 . . . . 0.0 111.792 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.95 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -113.78 158.99 13.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.189 179.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.541 ' CB ' HD21 ' A' ' 417' ' ' LEU . 2.8 p90 -141.04 144.77 35.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 0.0 111.266 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 378' ' ' VAL . 13.5 m -134.87 104.43 5.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.115 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 169.18 -161.18 34.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.369 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.438 ' CD2' ' O ' ' A' ' 353' ' ' GLN . 0.2 OUTLIER -48.64 170.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.531 0.205 . . . . 0.0 110.749 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 380' ' ' TYR . 2.4 m-80 67.44 -63.1 0.31 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.086 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . 0.41 ' O ' HG23 ' A' ' 383' ' ' THR . 0.8 OUTLIER -45.75 165.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.888 0.375 . . . . 0.0 111.355 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 382' ' ' SER . 42.9 p -158.09 151.23 23.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.927 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 98.93 -143.92 16.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.658 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -57.47 -31.17 65.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.838 0.352 . . . . 0.0 111.307 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -68.09 -52.81 30.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.003 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 20.5 tp -66.13 -31.75 72.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.867 0.365 . . . . 0.0 110.387 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 392' ' ' ASP . 0.0 OUTLIER -65.12 -29.69 70.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.456 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.635 ' CD2' HD12 ' A' ' 280' ' ' LEU . 20.3 t-160 -77.99 -53.07 7.84 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.535 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 55.7 t-105 -51.36 -49.23 61.89 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.177 0.513 . . . . 0.0 109.993 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -29.32 69.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.696 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.469 ' HB3' HD12 ' A' ' 401' ' ' ILE . 0.5 OUTLIER -61.98 -42.54 99.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.672 178.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.747 ' CE ' HD11 ' A' ' 352' ' ' ILE . 27.9 ttp -59.53 -52.61 64.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.58 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.771 HD21 ' CG2' ' A' ' 352' ' ' ILE . 2.9 mt -60.87 -30.01 69.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.361 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.98 -33.02 75.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.218 0.532 . . . . 0.0 109.584 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -126.24 77.9 71.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.278 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.539 ' C ' ' HG2' ' A' ' 398' ' ' ARG . 2.7 Cg_exo -75.79 44.37 1.27 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.238 2.625 . . . . 0.0 113.258 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . 0.539 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 0.4 OUTLIER -158.12 -46.52 0.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.231 179.675 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.428 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 0.3 OUTLIER -94.15 139.43 22.53 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.721 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 56.7 Cg_endo -70.48 156.16 62.05 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.548 2.165 . . . . 0.0 113.015 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 392' ' ' ASP . 1.2 mm -127.02 113.73 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.603 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -106.24 145.01 32.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.731 0.301 . . . . 0.0 110.801 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.95 154.39 11.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.912 0.386 . . . . 0.0 111.195 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . 0.402 ' CH2' ' HD2' ' A' ' 297' ' ' LYS . 64.0 m95 -81.6 120.52 25.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.95 ' HB3' HG11 ' A' ' 376' ' ' VAL . 49.1 m-70 -108.86 121.87 45.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.427 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.0 m -78.3 116.44 18.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.89 HD23 HG22 ' A' ' 376' ' ' VAL . 96.6 mt -62.45 128.1 34.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.004 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.441 ' C ' HD12 ' A' ' 273' ' ' LEU . 7.6 mt-30 -116.9 171.64 7.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.778 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.897 ' O ' HG23 ' A' ' 413' ' ' VAL . 43.5 t -56.57 120.81 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.604 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 19.0 mt-10 -53.73 -43.25 68.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.857 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -57.31 -49.52 75.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 0.0 110.602 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.448 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 30.7 mt-10 -64.55 -39.28 93.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 409' ' ' VAL . 74.8 t -58.57 -49.93 80.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.258 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -59.59 -38.32 80.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.2 84.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . . . . . . . . . 51.6 mtm -67.08 -31.02 71.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.921 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.541 HD21 ' CB ' ' A' ' 377' ' ' PHE . 12.6 mt -78.53 -34.8 46.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -63.62 139.08 58.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.071 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.125 179.967 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.868 0.366 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.81 HD22 ' O ' ' A' ' 373' ' ' ILE . 42.5 mt -98.9 -38.88 8.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 125.17 -160.63 19.77 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.271 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.485 ' OD1' HG23 ' A' ' 406' ' ' THR . 11.9 m-20 -147.13 131.93 17.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.733 0.301 . . . . 0.0 110.75 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.796 HD13 ' N ' ' A' ' 277' ' ' CYS . 0.0 OUTLIER -119.97 132.2 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.144 0.497 . . . . 0.0 111.174 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.796 ' N ' HD13 ' A' ' 276' ' ' ILE . 0.1 OUTLIER -99.48 126.01 45.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.758 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.617 ' CZ ' ' CD2' ' A' ' 405' ' ' HIS . 17.7 p90 -141.94 151.53 42.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.303 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.68 160.75 14.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.987 -178.451 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.674 HD12 ' CD2' ' A' ' 389' ' ' HIS . 98.2 mt -134.44 144.18 47.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.318 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -159.02 111.19 2.18 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.909 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . 0.923 ' CD1' HD13 ' A' ' 352' ' ' ILE . 25.1 t80 -104.45 138.85 40.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.977 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.04 94.29 47.37 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.544 ' CD ' ' HB2' ' A' ' 397' ' ' PRO . 7.5 Cg_exo -70.24 -33.86 14.01 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.916 2.411 . . . . 0.0 112.385 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -30.23 5.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.157 0.503 . . . . 0.0 110.019 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -118.72 -20.0 8.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.985 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.75 48.16 6.8 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.639 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.57 130.27 52.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.008 0.433 . . . . 0.0 111.703 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.967 HD11 ' HE1' ' A' ' 393' ' ' MET . 28.7 tp -97.82 147.53 24.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.868 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 343' ' ' PHE . 12.2 m -138.82 136.67 35.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.272 0.558 . . . . 0.0 112.002 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.411 HG21 HG11 ' A' ' 357' ' ' VAL . 11.9 t -129.15 125.36 62.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.372 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 341' ' ' GLU . 24.5 t -119.2 115.34 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.965 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.715 HG13 HG21 ' A' ' 328' ' ' THR . 34.3 mm -74.69 137.02 23.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.463 HD23 ' CE2' ' A' ' 338' ' ' TYR . 0.6 OUTLIER -114.22 -62.22 1.63 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.456 ' HB3' ' CD1' ' A' ' 338' ' ' TYR . 1.9 pt-20 -175.02 150.27 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.568 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.756 ' HB1' HD21 ' A' ' 299' ' ' LEU . . . -109.5 154.65 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.931 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.92 152.42 33.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.045 0.45 . . . . 0.0 111.552 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 61.29 24.19 14.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.853 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.756 HD21 ' HB1' ' A' ' 296' ' ' ALA . 66.5 mt -59.14 141.23 54.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.109 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.524 ' HD2' ' HE2' ' A' ' 302' ' ' MET . 3.5 ttmt -63.69 146.4 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.424 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.611 ' HE3' HD11 ' A' ' 335' ' ' LEU . 17.8 mttt -84.91 116.99 23.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.522 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' MET . . . . . 0.524 ' HE2' ' HD2' ' A' ' 300' ' ' LYS . 10.5 mmt -93.46 -18.89 21.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.488 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 307' ' ' LEU . 35.7 m-20 -103.98 102.65 12.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.852 0.358 . . . . 0.0 110.573 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.14 116.46 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.445 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 83.98 -4.34 83.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.811 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -126.53 -149.1 7.23 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.881 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 303' ' ' ASP . 60.3 mt -107.49 -159.97 0.71 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.01 0.433 . . . . 0.0 110.79 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.624 ' HB2' HD23 ' A' ' 335' ' ' LEU . 73.4 m -132.9 172.22 12.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.252 0.549 . . . . 0.0 110.725 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.92 57.58 32.71 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.673 ' CG ' HD13 ' A' ' 299' ' ' LEU . 74.2 Cg_endo -76.23 143.42 25.29 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.02 2.48 . . . . 0.0 114.901 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.619 ' HB3' ' HA ' ' A' ' 330' ' ' ILE . 8.5 p90 -140.48 168.12 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.124 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.858 HG22 HG22 ' A' ' 361' ' ' VAL . 42.5 t -116.36 149.96 18.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.371 0.605 . . . . 0.0 112.508 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.665 ' HE3' HD13 ' A' ' 362' ' ' LEU . 9.2 mttm -131.0 152.76 49.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.383 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.56 HG23 HG13 ' A' ' 357' ' ' VAL . 5.3 mp -123.18 135.09 64.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.763 0.316 . . . . 0.0 110.579 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 325' ' ' LYS . 79.9 m80 -130.98 132.54 45.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.35 . . . . 0.0 110.994 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.3 tp -105.79 106.67 17.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.407 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . . . . . . . . . 2.8 mtm -111.58 126.78 55.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.131 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.961 ' CB ' HD11 ' A' ' 323' ' ' LEU . 0.4 OUTLIER -95.77 99.56 11.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.477 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 59.91 37.76 21.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.706 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . 87.09 21.43 49.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.675 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -121.65 109.65 15.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.745 0.307 . . . . 0.0 110.806 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 10.8 ptt85 -51.25 128.07 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.351 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.961 HD11 ' CB ' ' A' ' 318' ' ' GLN . 9.3 mt -123.6 -49.53 1.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -135.03 147.92 49.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . 0.42 ' HB3' ' CD2' ' A' ' 315' ' ' HIS . 0.4 OUTLIER -144.09 120.56 11.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.584 179.616 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -125.5 166.43 16.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.231 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -142.87 149.92 39.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.793 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.715 HG21 HG13 ' A' ' 293' ' ' ILE . 20.7 p -104.75 176.52 5.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.029 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 1.2 p -59.6 162.43 5.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.577 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.619 ' HA ' ' HB3' ' A' ' 311' ' ' TYR . 3.2 mt -105.84 123.88 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 111.434 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.619 ' O ' HG22 ' A' ' 334' ' ' THR . 9.7 mmtm -89.16 88.17 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.049 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -55.1 136.3 48.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.987 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' ASN . . . . . 0.409 ' HB2' HD12 ' A' ' 307' ' ' LEU . 1.3 p-10 43.91 87.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.311 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.772 ' O ' HD23 ' A' ' 335' ' ' LEU . 3.9 t -179.11 174.55 1.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.518 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.772 HD23 ' O ' ' A' ' 334' ' ' THR . 4.7 mt -145.96 -16.91 0.46 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.203 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' ASN . . . . . 0.467 ' N ' ' HD3' ' A' ' 337' ' ' PRO . 1.5 m-80 -133.46 57.77 28.85 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.774 0.321 . . . . 0.0 110.283 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 336' ' ' ASN . 53.3 Cg_endo -90.16 167.76 4.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.204 2.602 . . . . 0.0 113.738 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' TYR . . . . . 0.463 ' CE2' HD23 ' A' ' 294' ' ' LEU . 0.5 OUTLIER -110.15 159.07 17.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.305 179.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' TYR . . . . . 0.612 ' HB2' HG22 ' A' ' 293' ' ' ILE . 6.1 m-85 -134.25 -62.29 0.76 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.31 38.65 23.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.669 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.557 ' O ' HG13 ' A' ' 292' ' ' VAL . 32.1 mt-10 -91.91 143.2 26.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.77 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 4.2 m -114.03 119.51 37.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 111.656 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' PHE . . . . . 0.708 ' CE1' HG22 ' A' ' 328' ' ' THR . 78.3 m-85 -111.02 153.77 25.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.248 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 73.5 m -128.38 142.29 51.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.012 0.434 . . . . 0.0 111.408 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -130.85 165.87 22.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -114.02 76.22 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.675 HG13 ' HB3' ' A' ' 351' ' ' GLN . 48.2 t -109.04 125.27 31.93 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.017 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.537 ' HG2' ' HB2' ' A' ' 351' ' ' GLN . 73.9 Cg_endo -76.67 155.42 35.35 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.499 2.132 . . . . 0.0 111.678 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -50.95 -23.13 2.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.839 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.23 -8.6 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' GLN . . . . . 0.675 ' HB3' HG13 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -112.69 -31.69 6.67 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.696 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.923 HD13 ' CD1' ' A' ' 282' ' ' TYR . 4.0 tp -47.98 -27.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 111.134 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' GLN . . . . . 0.424 HE21 HD22 ' A' ' 394' ' ' LEU . 21.8 mt-30 -92.14 -20.69 20.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.616 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -99.92 -21.32 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.679 0.276 . . . . 0.0 111.638 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.92 167.88 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.919 0.39 . . . . 0.0 111.222 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . 0.778 ' NE2' HD23 ' A' ' 417' ' ' LEU . 4.2 pt20 -148.59 126.95 12.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.028 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.584 HG23 ' CZ3' ' A' ' 390' ' ' TRP . 47.7 t -86.9 114.19 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.637 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.636 HG13 ' HB3' ' A' ' 377' ' ' PHE . 0.2 OUTLIER -97.63 109.68 23.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.205 -179.514 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.526 ' HB ' HG23 ' A' ' 376' ' ' VAL . 26.8 t -93.48 107.76 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.979 HG23 ' HB3' ' A' ' 375' ' ' LYS . 11.0 m -109.33 141.08 42.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.91 0.386 . . . . 0.0 111.575 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.858 HG22 HG22 ' A' ' 312' ' ' VAL . 41.8 t -115.46 120.2 64.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.072 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.665 HD13 ' HE3' ' A' ' 313' ' ' LYS . 3.5 mp -124.62 147.21 48.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.058 0.456 . . . . 0.0 111.679 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.522 ' HB3' ' HG3' ' A' ' 302' ' ' MET . 0.9 OUTLIER -91.96 134.47 34.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.328 179.552 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 365' ' ' ASP . 7.0 t80 -90.83 141.73 28.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.0 110.831 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.463 ' N ' ' CD1' ' A' ' 364' ' ' TYR . 14.0 m-20 -126.16 117.13 22.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.89 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.663 ' CG ' HD12 ' A' ' 367' ' ' ILE . 0.0 OUTLIER -34.24 -54.08 0.5 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.955 -179.215 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.663 HD12 ' CG ' ' A' ' 366' ' ' LYS . 5.2 mp -100.82 -73.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.364 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -50.79 165.79 0.65 Allowed Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.887 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -68.29 165.68 18.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 110.963 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.21 138.42 47.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.81 149.39 21.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.52 ' HB1' ' OE2' ' A' ' 410' ' ' GLU . . . -98.3 110.99 23.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.12 0.486 . . . . 0.0 110.977 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.81 ' O ' HD22 ' A' ' 273' ' ' LEU . 43.6 mt -83.44 -34.54 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.192 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 167.57 175.02 37.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.037 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.979 ' HB3' HG23 ' A' ' 360' ' ' THR . 11.6 ptmt -160.47 140.96 11.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.217 0.532 . . . . 0.0 111.779 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.943 HG11 ' HB3' ' A' ' 405' ' ' HIS . 0.1 OUTLIER -111.61 159.21 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.472 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.636 ' HB3' HG13 ' A' ' 358' ' ' VAL . 20.8 p90 -143.1 131.98 22.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.985 0.422 . . . . 0.0 111.133 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 378' ' ' VAL . 19.6 m -126.55 100.77 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.045 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.518 ' HA2' ' CD1' ' A' ' 390' ' ' TRP . . . 165.13 -155.0 26.12 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.27 -0.967 . . . . 0.0 113.122 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.27 158.06 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.848 0.356 . . . . 0.0 111.233 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.18 29.99 15.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.236 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 7.2 m -124.96 160.91 27.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.83 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 32.4 p -153.86 148.29 26.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.725 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 388' ' ' ARG . . . 96.73 -156.0 20.94 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.477 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.4 ' HA ' ' HG3' ' A' ' 388' ' ' ARG . . . -48.34 -32.13 7.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -63.96 -51.14 65.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.173 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 42.0 tp -59.38 -33.95 71.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 0.0 110.582 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 384' ' ' GLY . 23.6 mtm180 -61.46 -49.34 77.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.343 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.674 ' CD2' HD12 ' A' ' 280' ' ' LEU . 14.8 t-160 -60.76 -57.93 10.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.792 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' TRP . . . . . 0.584 ' CZ3' HG23 ' A' ' 357' ' ' VAL . 58.0 t-105 -49.52 -44.29 46.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.05 0.452 . . . . 0.0 110.004 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 4.7 t -68.57 -36.81 79.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.803 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.437 ' HB3' HD12 ' A' ' 401' ' ' ILE . 1.9 t0 -63.08 -36.22 82.85 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.967 ' HE1' HD11 ' A' ' 289' ' ' LEU . 10.2 ttm -61.84 -55.09 33.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.189 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.752 HD21 ' CG2' ' A' ' 352' ' ' ILE . 1.1 mt -60.85 -33.26 72.79 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.331 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.37 -29.81 70.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.276 0.56 . . . . 0.0 109.84 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -114.97 71.68 2.73 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.596 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.544 ' HB2' ' CD ' ' A' ' 284' ' ' PRO . 50.4 Cg_endo -70.47 33.88 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.186 2.59 . . . . 0.0 113.616 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . 0.518 ' HG2' ' C ' ' A' ' 397' ' ' PRO . 23.7 mmm-85 -159.51 -44.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.922 0.391 . . . . 0.0 110.972 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.4 ' HG3' ' HD2' ' A' ' 400' ' ' PRO . 1.7 tpp180 -93.96 140.48 22.96 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.455 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 57.0 Cg_endo -70.43 156.47 61.53 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.742 2.295 . . . . 0.0 112.751 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 280' ' ' LEU . 1.2 mm -128.15 113.45 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.818 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 279' ' ' SER . . . -105.27 144.46 32.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 110.82 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.67 153.71 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.963 0.411 . . . . 0.0 111.235 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . 0.413 ' CZ3' ' HB2' ' A' ' 277' ' ' CYS . 55.8 m95 -83.02 120.01 25.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.943 ' HB3' HG11 ' A' ' 376' ' ' VAL . 45.4 m-70 -108.21 120.82 43.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.576 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.485 HG23 ' OD1' ' A' ' 275' ' ' ASP . 89.2 m -78.36 116.21 18.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.024 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.879 HD23 HG22 ' A' ' 376' ' ' VAL . 84.8 mt -62.47 128.2 34.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.288 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -114.82 170.9 7.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.512 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 413' ' ' VAL . 47.0 t -52.71 115.77 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.52 ' OE2' ' HB1' ' A' ' 372' ' ' ALA . 4.1 mp0 -54.77 -43.07 72.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.79 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -55.35 -47.55 75.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.802 0.334 . . . . 0.0 110.537 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.441 ' HG3' ' HB ' ' A' ' 409' ' ' VAL . 35.2 mt-10 -64.24 -48.71 74.74 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 409' ' ' VAL . 92.0 t -48.86 -45.41 15.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.771 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -52.99 -38.28 62.11 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.837 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -69.22 -44.28 72.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.749 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' MET . . . . . 0.574 ' HE2' ' HA ' ' A' ' 413' ' ' VAL . 2.5 mpp? -56.96 -31.44 65.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.644 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.778 HD23 ' NE2' ' A' ' 356' ' ' GLN . 2.6 mt -89.84 -33.52 16.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.915 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -56.19 137.67 51.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.262 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.226 -0.893 . . . . 0.0 111.087 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_